sampleID,AJCC_Stage_nature2012,Age_at_Initial_Pathologic_Diagnosis_nature2012,CN_Clusters_nature2012,Converted_Stage_nature2012,Days_to_Date_of_Last_Contact_nature2012,Days_to_date_of_Death_nature2012,ER_Status_nature2012,Gender_nature2012,HER2_Final_Status_nature2012,Integrated_Clusters_no_exp__nature2012,Integrated_Clusters_unsup_exp__nature2012,Integrated_Clusters_with_PAM50__nature2012,Metastasis_Coded_nature2012,Metastasis_nature2012,Node_Coded_nature2012,Node_nature2012,OS_Time_nature2012,OS_event_nature2012,PAM50Call_RNAseq,PAM50_mRNA_nature2012,PR_Status_nature2012,RPPA_Clusters_nature2012,SigClust_Intrinsic_mRNA_nature2012,SigClust_Unsupervised_mRNA_nature2012,Survival_Data_Form_nature2012,Tumor_T1_Coded_nature2012,Tumor_nature2012,Vital_Status_nature2012,_EVENT,_INTEGRATION,_OS,_OS_IND,_OS_UNIT,_PANCAN_CNA_PANCAN_K8,_PANCAN_Cluster_Cluster_PANCAN,_PANCAN_DNAMethyl_BRCA,_PANCAN_DNAMethyl_PANCAN,_PANCAN_RPPA_PANCAN_K8,_PANCAN_UNC_RNAseq_PANCAN_K16,_PANCAN_miRNA_PANCAN,_PANCAN_mirna_BRCA,_PANCAN_mutation_PANCAN,_PATIENT,_RFS,_RFS_IND,_RFS_UNIT,_TIME_TO_EVENT,_TIME_TO_EVENT_UNIT,_cohort,_primary_disease,_primary_site,additional_pharmaceutical_therapy,additional_radiation_therapy,additional_surgery_locoregional_procedure,additional_surgery_metastatic_procedure,age_at_initial_pathologic_diagnosis,anatomic_neoplasm_subdivision,axillary_lymph_node_stage_method_type,axillary_lymph_node_stage_other_method_descriptive_text,bcr_followup_barcode,bcr_patient_barcode,bcr_sample_barcode,breast_cancer_surgery_margin_status,breast_carcinoma_estrogen_receptor_status,breast_carcinoma_immunohistochemistry_er_pos_finding_scale,breast_carcinoma_immunohistochemistry_pos_cell_score,breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl,breast_carcinoma_primary_surgical_procedure_name,breast_carcinoma_progesterone_receptor_status,breast_carcinoma_surgical_procedure_name,breast_neoplasm_other_surgical_procedure_descriptive_text,cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr,days_to_additional_surgery_locoregional_procedure,days_to_additional_surgery_metastatic_procedure,days_to_birth,days_to_collection,days_to_death,days_to_initial_pathologic_diagnosis,days_to_last_followup,days_to_last_known_alive,days_to_new_tumor_event_additional_surgery_procedure,days_to_new_tumor_event_after_initial_treatment,disease_code,distant_metastasis_present_ind2,er_detection_method_text,er_level_cell_percentage_category,fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng,followup_case_report_form_submission_reason,form_completion_date,gender,her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt,her2_erbb_method_calculation_method_text,her2_erbb_pos_finding_cell_percent_category,her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt,her2_immunohistochemistry_level_result,her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt,her2_neu_breast_carcinoma_copy_analysis_input_total_number,her2_neu_chromosone_17_signal_ratio_value,her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr,histological_type,histological_type_other,history_of_neoadjuvant_treatment,hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr,icd_10,icd_o_3_histology,icd_o_3_site,immunohistochemistry_positive_cell_score,informed_consent_verified,init_pathology_dx_method_other,initial_pathologic_diagnosis_method,initial_weight,is_ffpe,lab_proc_her2_neu_immunohistochemistry_receptor_status,lab_procedure_her2_neu_in_situ_hybrid_outcome_type,lost_follow_up,lymph_node_examined_count,margin_status,menopause_status,metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt,metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts,metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt,metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt,metastatic_breast_carcinoma_estrogen_receptor_status,metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry,metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt,metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry,metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl,metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ,metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr,metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr,metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ,metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt,metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry,metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt,metastatic_breast_carcinoma_progesterone_receptor_status,metastatic_site_at_diagnosis,metastatic_site_at_diagnosis_other,methylation_Clusters_nature2012,miRNA_Clusters_nature2012,mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn,mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn,mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ,new_neoplasm_event_occurrence_anatomic_site,new_neoplasm_event_type,new_neoplasm_occurrence_anatomic_site_text,new_tumor_event_additional_surgery_procedure,new_tumor_event_after_initial_treatment,number_of_lymphnodes_positive_by_he,number_of_lymphnodes_positive_by_ihc,oct_embedded,other_dx,pathologic_M,pathologic_N,pathologic_T,pathologic_stage,pathology_report_file_name,patient_id,person_neoplasm_cancer_status,pgr_detection_method_text,pos_finding_her2_erbb2_other_measurement_scale_text,pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt,pos_finding_progesterone_receptor_other_measurement_scale_text,positive_finding_estrogen_receptor_other_measurement_scale_text,postoperative_rx_tx,primary_lymph_node_presentation_assessment,progesterone_receptor_level_cell_percent_category,project_code,radiation_therapy,sample_type,sample_type_id,surgical_procedure_purpose_other_text,system_version,targeted_molecular_therapy,tissue_prospective_collection_indicator,tissue_retrospective_collection_indicator,tissue_source_site,tumor_tissue_site,vial_number,vital_status,year_of_initial_pathologic_diagnosis,_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon,_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN,_GENOMIC_ID_TCGA_BRCA_RPPA_RBN,_GENOMIC_ID_TCGA_BRCA_mutation,_GENOMIC_ID_TCGA_BRCA_PDMRNAseq,_GENOMIC_ID_TCGA_BRCA_hMethyl450,_GENOMIC_ID_TCGA_BRCA_RPPA,_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV,_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene,_GENOMIC_ID_TCGA_BRCA_hMethyl27,_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV,_GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq,_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene,_GENOMIC_ID_TCGA_BRCA_miRNA_GA,_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile,_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_GA_gene,_GENOMIC_ID_TCGA_BRCA_gistic2thd,_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_HiSeq_gene,_GENOMIC_ID_TCGA_BRCA_G4502A_07_3,_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2,_GENOMIC_ID_TCGA_BRCA_gistic2,_GENOMIC_ID_TCGA_BRCA_PDMarray
tcga.3c.aaau,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-3C-AAAU-01,4047.0,0.0,days,,,,,,,,,,TCGA-3C-AAAU,4047.0,0.0,days,4047.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-3C-AAAU-F68069,TCGA-3C-AAAU,TCGA-3C-AAAU-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-20211.0,3599.0,,0.0,4047.0,,,1808,,,,50-59%,,,2015-3-24,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,60.0,NO,Negative,,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,Lung,Distant Metastasis,,,NO,4.0,,True,No,MX,NX,TX,Stage X,TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf,AAAU,WITH TUMOR,,,,,,NO,YES,50-59%,,NO,Primary Tumor,1,,6th,,NO,YES,3C,Breast,A,LIVING,2004.0,6ef883fc-81f3-4089-95e0-86904ffc0d38,6ef883fc-81f3-4089-95e0-86904ffc0d38,,,TCGA-3C-AAAU-01,TCGA-3C-AAAU-01A-11D-A41Q-05,,TCGA-3C-AAAU-01,,,,TCGA-3C-AAAU-01,,,6ef883fc-81f3-4089-95e0-86904ffc0d38,,TCGA-3C-AAAU-01A-11D-A41E-01,TCGA-3C-AAAU-01,,6ef883fc-81f3-4089-95e0-86904ffc0d38,TCGA-3C-AAAU-01A-11D-A41E-01,
tcga.3c.aali,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-3C-AALI-01,4005.0,0.0,days,,,,,,,,,,TCGA-3C-AALI,4005.0,0.0,days,4005.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-3C-AALI-F68057,TCGA-3C-AALI,TCGA-3C-AALI-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-18538.0,3772.0,,0.0,4005.0,,,,,,,<10%,,,2014-11-13,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Positive,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf,AALI,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,3C,Breast,A,LIVING,2003.0,dd8d3665-ec9d-45be-b7b9-a85dac3585e2,dd8d3665-ec9d-45be-b7b9-a85dac3585e2,,,TCGA-3C-AALI-01,TCGA-3C-AALI-01A-11D-A41Q-05,1B37DE89-DEB6-4049-A2D4-450A4A1DE5D3,TCGA-3C-AALI-01,,,,TCGA-3C-AALI-01,,,dd8d3665-ec9d-45be-b7b9-a85dac3585e2,,TCGA-3C-AALI-01A-11D-A41E-01,TCGA-3C-AALI-01,,dd8d3665-ec9d-45be-b7b9-a85dac3585e2,TCGA-3C-AALI-01A-11D-A41E-01,
tcga.3c.aalj,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-3C-AALJ-01,1474.0,0.0,days,,,,,,,,,,TCGA-3C-AALJ,1474.0,0.0,days,1474.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right,,,TCGA-3C-AALJ-F71675,TCGA-3C-AALJ,,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-22848.0,,,0.0,1474.0,,,,,,,90-99%,,,2015-3-27,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Indeterminate,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,,No,M0,N1a,T2,Stage IIB,,AALJ,TUMOR FREE,,,,,,NO,YES,30-39%,,NO,Primary Tumor,1,,7th,,NO,YES,3C,Breast,,LIVING,2011.0,c924c2a8-ab41-4499-bb30-79705cc17d45,c924c2a8-ab41-4499-bb30-79705cc17d45,,,TCGA-3C-AALJ-01,TCGA-3C-AALJ-01A-31D-A41Q-05,,TCGA-3C-AALJ-01,,,,TCGA-3C-AALJ-01,,,c924c2a8-ab41-4499-bb30-79705cc17d45,,TCGA-3C-AALJ-01A-31D-A41E-01,TCGA-3C-AALJ-01,,c924c2a8-ab41-4499-bb30-79705cc17d45,TCGA-3C-AALJ-01A-31D-A41E-01,
tcga.3c.aalk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-3C-AALK-01,1448.0,0.0,days,,,,,,,,,,TCGA-3C-AALK,1448.0,0.0,days,1448.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right,Sentinel node biopsy alone,,TCGA-3C-AALK-F71676,TCGA-3C-AALK,TCGA-3C-AALK-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-19074.0,1022.0,,0.0,1448.0,,,,,,,70-79%,,,2015-3-27,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Positive,,NO,2.0,Close,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,True,No,M0,N0 (i+),T1c,Stage IA,TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf,AALK,TUMOR FREE,,,,,,NO,YES,80-89%,,NO,Primary Tumor,1,,7th,,NO,YES,3C,Breast,A,LIVING,2011.0,1a19e068-d213-41ef-aebb-104017a883cc,1a19e068-d213-41ef-aebb-104017a883cc,,,TCGA-3C-AALK-01,TCGA-3C-AALK-01A-11D-A41Q-05,4B79D851-B233-49F8-95B1-B4AA057D7FD2,TCGA-3C-AALK-01,,,,TCGA-3C-AALK-01,,,1a19e068-d213-41ef-aebb-104017a883cc,,TCGA-3C-AALK-01A-11D-A41E-01,TCGA-3C-AALK-01,,1a19e068-d213-41ef-aebb-104017a883cc,TCGA-3C-AALK-01A-11D-A41E-01,
tcga.4h.aaak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-4H-AAAK-01,348.0,0.0,days,,,,,,,,,,TCGA-4H-AAAK,348.0,0.0,days,348.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-4H-AAAK-F67414,TCGA-4H-AAAK,TCGA-4H-AAAK-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-18371.0,35.0,,0.0,348.0,,,,,,,60-69%,,,2014-11-13,FEMALE,,,10-19%,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,770.0,NO,Equivocal,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf,AAAK,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,,7th,,YES,NO,4H,Breast,A,LIVING,2013.0,2ea9e472-a408-4ae0-975d-50a566f22b2a,2ea9e472-a408-4ae0-975d-50a566f22b2a,,,TCGA-4H-AAAK-01,TCGA-4H-AAAK-01A-12D-A41Q-05,C1C10723-C328-4CAB-9959-E98025E4CD71,TCGA-4H-AAAK-01,,,,TCGA-4H-AAAK-01,,,2ea9e472-a408-4ae0-975d-50a566f22b2a,,TCGA-4H-AAAK-01A-12D-A41E-01,TCGA-4H-AAAK-01,,2ea9e472-a408-4ae0-975d-50a566f22b2a,TCGA-4H-AAAK-01A-12D-A41E-01,
tcga.5l.aat0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-5L-AAT0-01,1477.0,0.0,days,,,,,,,,,,TCGA-5L-AAT0,1477.0,0.0,days,1477.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,42.0,Right|Right Lower Outer Quadrant,Axillary lymph node dissection alone,,,TCGA-5L-AAT0,TCGA-5L-AAT0-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-15393.0,1320.0,,0.0,1477.0,,,,,,,70-79%,,,2014-8-15,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Incisional Biopsy,80.0,NO,Negative,,,8.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,M0,N0,T2,Stage IIA,TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf,AAT0,TUMOR FREE,,,,,,YES,YES,50-59%,,YES,Primary Tumor,1,,7th,,NO,YES,5L,Breast,A,LIVING,2010.0,32e61645-eb89-49f7-9876-85b1497c7e42,32e61645-eb89-49f7-9876-85b1497c7e42,,,TCGA-5L-AAT0-01,TCGA-5L-AAT0-01A-12D-A41Q-05,,TCGA-5L-AAT0-01,,,,TCGA-5L-AAT0-01,,,32e61645-eb89-49f7-9876-85b1497c7e42,,TCGA-5L-AAT0-01A-12D-A41E-01,TCGA-5L-AAT0-01,,32e61645-eb89-49f7-9876-85b1497c7e42,TCGA-5L-AAT0-01A-12D-A41E-01,
tcga.5l.aat1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-5L-AAT1-01,1471.0,0.0,days,,,,,,,,,,TCGA-5L-AAT1,1471.0,0.0,days,1471.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left,Other (specify),Level 1 clearance,,TCGA-5L-AAT1,TCGA-5L-AAT1-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-23225.0,1259.0,,0.0,1471.0,,,,,,,80-89%,,,2014-8-15,FEMALE,,CISH,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,130.0,NO,Equivocal,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,Bone,,,,,,,,,,,NO,0.0,,False,Yes,M1,N0,T2,Stage IV,TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf,AAT1,WITH TUMOR,,CISH,,,,YES,YES,10-19%,,NO,Primary Tumor,1,,7th,,NO,YES,5L,Breast,A,LIVING,2010.0,34dfa8c6-6445-4ef8-bc3b-b2ba600b5808,34dfa8c6-6445-4ef8-bc3b-b2ba600b5808,,,TCGA-5L-AAT1-01,TCGA-5L-AAT1-01A-12D-A41Q-05,047431B7-6180-49AB-9DD0-D23D794F2953,TCGA-5L-AAT1-01,,,,,,,34dfa8c6-6445-4ef8-bc3b-b2ba600b5808,,TCGA-5L-AAT1-01A-12D-A41E-01,,,34dfa8c6-6445-4ef8-bc3b-b2ba600b5808,TCGA-5L-AAT1-01A-12D-A41E-01,
tcga.5t.a9qa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-5T-A9QA-01,303.0,0.0,days,,,,,,,,,,TCGA-5T-A9QA,303.0,0.0,days,303.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Left,No axillary staging,,TCGA-5T-A9QA-F66889,TCGA-5T-A9QA,TCGA-5T-A9QA-01A,,Positive,3 Point Scale,,,,Negative,,,NO,,,-19031.0,31.0,,0.0,303.0,,,,,,,70-79%,,,2014-10-25,FEMALE,,,10-19%,,2+,,,,,"Other, specify",,No,,C50.9,8523/3,C50.9,2+,YES,,Excisional Biopsy,650.0,NO,Equivocal,Negative,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,NX,T2,Stage IIA,TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf,A9QA,,,,,,,YES,NO,,,YES,Primary Tumor,1,,7th,,YES,NO,5T,Breast,A,LIVING,2013.0,41ab76d7-fae0-490c-9545-be576b64b827,41ab76d7-fae0-490c-9545-be576b64b827,,,TCGA-5T-A9QA-01,TCGA-5T-A9QA-01A-11D-A41Q-05,9E71A150-8FD7-466C-96AF-AAB29520BCDC,TCGA-5T-A9QA-01,,,,TCGA-5T-A9QA-01,,,41ab76d7-fae0-490c-9545-be576b64b827,,TCGA-5T-A9QA-01A-11D-A41E-01,TCGA-5T-A9QA-01,,41ab76d7-fae0-490c-9545-be576b64b827,TCGA-5T-A9QA-01A-11D-A41E-01,
tcga.a1.a0sb,Stage I,70.0,1.0,Stage I,259.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,259.0,0.0,Normal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-A1-A0SB-01,259.0,0.0,days,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-A1-A0SB,,,days,259.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left,Sentinel node biopsy alone,,,TCGA-A1-A0SB,,,Positive,,,,,Negative,Lumpectomy,,,,,-25833.0,,,0.0,259.0,,,,,NO,,70-79%,,,2011-6-30,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8200/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,,0.0,,,No,M0,N0,T1c,Stage I,,A0SB,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,,LIVING,2008.0,a2405d64-34eb-4915-abf7-8530151d5cb0,a2405d64-34eb-4915-abf7-8530151d5cb0,,TCGA-A1-A0SB-01A-11D-A142-09,TCGA-A1-A0SB-01,TCGA-A1-A0SB-01A-11D-A145-05,,TCGA-A1-A0SB-01,TCGA-A1-A0SB-01A-11D-A142-09,,,TCGA-A1-A0SB-01,TCGA-A1-A0SB-01A-11D-A142-09,,a2405d64-34eb-4915-abf7-8530151d5cb0,,TCGA-A1-A0SB-01A-11D-A141-01,TCGA-A1-A0SB-01,,a2405d64-34eb-4915-abf7-8530151d5cb0,TCGA-A1-A0SB-01A-11D-A141-01,
tcga.a1.a0sf,Stage IIA,54.0,3.0,Stage IIA,1463.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1463.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A1-A0SF-01,1463.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 6,mutation c1uster 9,TCGA-A1-A0SF,,,days,1463.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-A1-A0SF,TCGA-A1-A0SF-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-19731.0,1648.0,,0.0,1463.0,,,,,NO,,90-99%,,,2011-5-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,190.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf,A0SF,TUMOR FREE,,,,,,,YES,90-99%,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,A,LIVING,2006.0,28089e15-5e2c-4e83-ba6c-62b3cb40e431,28089e15-5e2c-4e83-ba6c-62b3cb40e431,TCGA-A1-A0SF-01A-21-A17I-20,TCGA-A1-A0SF-01A-11D-A142-09,TCGA-A1-A0SF-01,TCGA-A1-A0SF-01A-11D-A145-05,f0b3d871-c0aa-4ef8-ab74-c3e812393ed5,TCGA-A1-A0SF-01,TCGA-A1-A0SF-01A-11D-A142-09,,,TCGA-A1-A0SF-01,TCGA-A1-A0SF-01A-11D-A142-09,,28089e15-5e2c-4e83-ba6c-62b3cb40e431,,TCGA-A1-A0SF-01A-11D-A141-01,TCGA-A1-A0SF-01,,28089e15-5e2c-4e83-ba6c-62b3cb40e431,TCGA-A1-A0SF-01A-11D-A141-01,
tcga.a1.a0sg,Stage IIB,61.0,4.0,Stage IIB,433.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,433.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A1-A0SG-01,434.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 5,mutation c1uster 9,TCGA-A1-A0SG,,,days,434.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-A1-A0SG,TCGA-A1-A0SG-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-22380.0,1581.0,,0.0,434.0,,,,,,,90-99%,,,2011-5-31,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8507/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,5.0,,,,,,,,,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf,A0SG,,,,,,,,YES,90-99%,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,A,LIVING,2006.0,0df6b948-367d-4951-9d98-d3bebabff63e,0df6b948-367d-4951-9d98-d3bebabff63e,,TCGA-A1-A0SG-01A-11D-A142-09,TCGA-A1-A0SG-01,TCGA-A1-A0SG-01A-11D-A145-05,,TCGA-A1-A0SG-01,TCGA-A1-A0SG-01A-11D-A142-09,,,TCGA-A1-A0SG-01,TCGA-A1-A0SG-01A-11D-A142-09,,0df6b948-367d-4951-9d98-d3bebabff63e,,TCGA-A1-A0SG-01A-11D-A141-01,TCGA-A1-A0SG-01,,0df6b948-367d-4951-9d98-d3bebabff63e,TCGA-A1-A0SG-01A-11D-A141-01,
tcga.a1.a0si,Stage IIB,52.0,3.0,Stage IIB,634.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,634.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A1-A0SI-01,635.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 7,mutation cluster 3,TCGA-A1-A0SI,,,days,635.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-A1-A0SI,TCGA-A1-A0SI-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-19250.0,1267.0,,0.0,635.0,,,,,NO,,50-59%,,,2011-6-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,40.0,NO,Negative,,,23.0,Negative,,,,,,,,,,,,,,,,,,,,,5.0,7.0,,,,,,,,,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf,A0SI,TUMOR FREE,,,,,,,YES,10-19%,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,A,LIVING,2007.0,44d93b9f-95d6-4382-9590-f6e7bdda65c5,44d93b9f-95d6-4382-9590-f6e7bdda65c5,,TCGA-A1-A0SI-01A-11D-A142-09,TCGA-A1-A0SI-01,TCGA-A1-A0SI-01A-11D-A145-05,,TCGA-A1-A0SI-01,TCGA-A1-A0SI-01A-11D-A142-09,,,TCGA-A1-A0SI-01,TCGA-A1-A0SI-01A-11D-A142-09,,44d93b9f-95d6-4382-9590-f6e7bdda65c5,,TCGA-A1-A0SI-01A-11D-A141-01,TCGA-A1-A0SI-01,,44d93b9f-95d6-4382-9590-f6e7bdda65c5,TCGA-A1-A0SI-01A-11D-A141-01,
tcga.a1.a0sn,Stage IIIA,50.0,5.0,Stage IIA,1196.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,1196.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-A1-A0SN-01,1196.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-A1-A0SN,,,days,1196.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-A1-A0SN,TCGA-A1-A0SN-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-18401.0,1091.0,,0.0,1196.0,,,,,,,90-99%,,,2011-5-23,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Positive,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,,4.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf,A0SN,TUMOR FREE,,,,,,,YES,60-69%,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,A,LIVING,2007.0,7fdf1ebf-149a-43d5-bae7-6e01beb647dd,7fdf1ebf-149a-43d5-bae7-6e01beb647dd,,TCGA-A1-A0SN-01A-11D-A142-09,TCGA-A1-A0SN-01,TCGA-A1-A0SN-01A-11D-A145-05,,TCGA-A1-A0SN-01,TCGA-A1-A0SN-01A-11D-A142-09,,,TCGA-A1-A0SN-01,TCGA-A1-A0SN-01A-11D-A142-09,,7fdf1ebf-149a-43d5-bae7-6e01beb647dd,,TCGA-A1-A0SN-01A-11D-A141-01,TCGA-A1-A0SN-01,,7fdf1ebf-149a-43d5-bae7-6e01beb647dd,TCGA-A1-A0SN-01A-11D-A141-01,
tcga.a1.a0sq,Stage IIB,45.0,3.0,Stage IIB,553.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,553.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A1-A0SQ-01,554.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,cluster 2,mutation c1uster 9,TCGA-A1-A0SQ,,,days,554.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-A1-A0SQ,TCGA-A1-A0SQ-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16458.0,967.0,,0.0,554.0,,,,,NO,,90-99%,,,2011-6-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Negative,,,15.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,,1.0,,True,No,MX,N1,T2,Stage IIB,TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf,A0SQ,TUMOR FREE,,,,,,,YES,90-99%,,,Primary Tumor,1,,6th,,NO,YES,A1,Breast,A,LIVING,2007.0,9efdba02-2752-4c89-bb53-e8018f5aa7bf,9efdba02-2752-4c89-bb53-e8018f5aa7bf,TCGA-A1-A0SQ-01A-11-A17I-20,TCGA-A1-A0SQ-01A-21D-A142-09,TCGA-A1-A0SQ-01,TCGA-A1-A0SQ-01A-21D-A145-05,5f624f7e-a0d0-454e-ba7a-6ca212ec4fda,TCGA-A1-A0SQ-01,TCGA-A1-A0SQ-01A-21D-A142-09,,,TCGA-A1-A0SQ-01,TCGA-A1-A0SQ-01A-21D-A142-09,,9efdba02-2752-4c89-bb53-e8018f5aa7bf,,TCGA-A1-A0SQ-01A-21D-A141-01,TCGA-A1-A0SQ-01,,9efdba02-2752-4c89-bb53-e8018f5aa7bf,TCGA-A1-A0SQ-01A-21D-A141-01,
tcga.a2.a0ck,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A0CK-01,4159.0,0.0,days,Iq,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 14,,,TCGA-A2-A0CK,1364.0,1.0,days,4159.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,60.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A0CK-F42396,TCGA-A2-A0CK,TCGA-A2-A0CK-01A,Negative,Positive,3 Point Scale,3+,3 Point Scale,Modified radical mastectomy,Positive,Lumpectomy,,NO,,,-22094.0,3080.0,,0.0,4159.0,,1409.0,1364,,NO,,40-49%,,,2013-4-18,FEMALE,,,,,,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Excisional Biopsy,230.0,NO,Negative,Negative,NO,20.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,,,Positive,50-59%,,,1.2,3 Point Scale,2+,1+,Negative,,10-19%,,Positive,,,,,,,3 Point Scale,"Other, specify",New Primary Tumor,LEFT BREAST,YES,YES,4.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf,A0CK,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,5th,,NO,YES,A2,Breast,A,LIVING,2001.0,fe5e8cb8-45e2-4321-ad32-a776f79bfcac,fe5e8cb8-45e2-4321-ad32-a776f79bfcac,TCGA-A2-A0CK-01A-21-A24A-20,,TCGA-A2-A0CK-01,TCGA-A2-A0CK-01A-11D-A22B-05,9c5f525e-a62e-4bfd-aed9-96603a95f72b,TCGA-A2-A0CK-01,TCGA-A2-A0CK-01A-11D-A228-09,,,TCGA-A2-A0CK-01,,,fe5e8cb8-45e2-4321-ad32-a776f79bfcac,,TCGA-A2-A0CK-01A-11D-A227-01,TCGA-A2-A0CK-01,,fe5e8cb8-45e2-4321-ad32-a776f79bfcac,TCGA-A2-A0CK-01A-11D-A227-01,
tcga.a2.a0co,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-A2-A0CO-01,3492.0,1.0,days,Iq,,,BRCA non-CIMP c9,,,miRNA cluster 3,,,TCGA-A2-A0CO,3492.0,0.0,days,3492.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,85.0,Right,Axillary lymph node dissection alone,,TCGA-A2-A0CO-F42395,TCGA-A2-A0CO,,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-31404.0,,3492.0,0.0,3409.0,,,,,NO,,40-49%,,,2013-4-18,FEMALE,,,,,,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,,,Negative,Negative,NO,11.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0,T3,Stage IIB,,A0CO,TUMOR FREE,,,,,,YES,YES,20-29%,,YES,Primary Tumor,1,,7th,,NO,YES,A2,Breast,,DECEASED,2002.0,cb2d5668-d44b-49dc-8941-79615d2fb6c2,cb2d5668-d44b-49dc-8941-79615d2fb6c2,,,TCGA-A2-A0CO-01,TCGA-A2-A0CO-01A-13D-A22B-05,,TCGA-A2-A0CO-01,TCGA-A2-A0CO-01A-13D-A228-09,,,TCGA-A2-A0CO-01,,,cb2d5668-d44b-49dc-8941-79615d2fb6c2,,TCGA-A2-A0CO-01A-13D-A227-01,TCGA-A2-A0CO-01,,cb2d5668-d44b-49dc-8941-79615d2fb6c2,TCGA-A2-A0CO-01A-13D-A227-01,
tcga.a2.a0cr,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A0CR-01,3283.0,0.0,days,Quiet,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 13,,,TCGA-A2-A0CR,3283.0,0.0,days,3283.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A0CR-F42400,TCGA-A2-A0CR,TCGA-A2-A0CR-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-20075.0,2191.0,,0.0,3283.0,,,,,NO,,60-69%,,,2013-4-18,FEMALE,,,,,,,,1.2,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,1+,YES,,Core needle biopsy,280.0,NO,Negative,Negative,NO,16.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T3,Stage IIB,TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf,A0CR,TUMOR FREE,,,,,,YES,YES,80-89%,,NO,Primary Tumor,1,,7th,,NO,YES,A2,Breast,A,LIVING,2004.0,00e597fa-72b4-4e92-9428-7ec686e4cc0b,00e597fa-72b4-4e92-9428-7ec686e4cc0b,TCGA-A2-A0CR-01A-22-A24A-20,,TCGA-A2-A0CR-01,TCGA-A2-A0CR-01A-11D-A22B-05,3ed7fa0f-b208-4493-aac0-71cb01860ac9,TCGA-A2-A0CR-01,TCGA-A2-A0CR-01A-11D-A228-09,,,TCGA-A2-A0CR-01,,,00e597fa-72b4-4e92-9428-7ec686e4cc0b,,TCGA-A2-A0CR-01A-11D-A227-01,TCGA-A2-A0CR-01,,00e597fa-72b4-4e92-9428-7ec686e4cc0b,TCGA-A2-A0CR-01A-11D-A227-01,
tcga.a2.a0ep,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A0EP-01,3603.0,0.0,days,,,,,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-A2-A0EP,3603.0,0.0,days,3603.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-A2-A0EP-F58499,TCGA-A2-A0EP,,,Positive,3 Point Scale,,,,Negative,Simple Mastectomy,,YES,,,-20585.0,,,0.0,3603.0,,,,,,,80-89%,,,2014-4-11,FEMALE,,,,,,,,1.3,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,,No,M0,N0 (i+),T1,Stage I,,A0EP,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,A2,Breast,,LIVING,2004.0,b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c,b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c,TCGA-A2-A0EP-01A-61-A24A-20,,TCGA-A2-A0EP-01,TCGA-A2-A0EP-01A-52D-A230-05,be62a150-20f9-449e-8992-796d4640879a,TCGA-A2-A0EP-01,TCGA-A2-A0EP-01A-52D-A22X-09,,,TCGA-A2-A0EP-01,,,b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c,,TCGA-A2-A0EP-01A-52D-A22W-01,TCGA-A2-A0EP-01,,b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c,TCGA-A2-A0EP-01A-52D-A22W-01,
tcga.a2.a1fv,Stage IIB,74.0,4.0,Stage IIB,460.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,460.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-A2-A1FV-01,714.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 6,mutation c1uster 9,TCGA-A2-A1FV,714.0,0.0,days,714.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left,Sentinel node biopsy alone,,TCGA-A2-A1FV-F20238,TCGA-A2-A1FV,TCGA-A2-A1FV-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-27287.0,372.0,,0.0,714.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,1+,,,0.92,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,150.0,NO,Negative,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,6.0,,,,,,,,NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf,A1FV,TUMOR FREE,,,,Strong,Strong,,YES,<10%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,ee12f85b-64f8-4052-9477-392c4bd99257,ee12f85b-64f8-4052-9477-392c4bd99257,TCGA-A2-A1FV-01A-21-A17I-20,TCGA-A2-A1FV-01A-11D-A13L-09,TCGA-A2-A1FV-01,TCGA-A2-A1FV-01A-11D-A13K-05,5d85b493-8ea7-46e2-a2f1-f21b8ccc46c8,TCGA-A2-A1FV-01,TCGA-A2-A1FV-01A-11D-A13L-09,,,TCGA-A2-A1FV-01,TCGA-A2-A1FV-01A-11D-A13L-09,,ee12f85b-64f8-4052-9477-392c4bd99257,,TCGA-A2-A1FV-01A-11D-A13J-01,TCGA-A2-A1FV-01,,ee12f85b-64f8-4052-9477-392c4bd99257,TCGA-A2-A1FV-01A-11D-A13J-01,
tcga.a2.a1fw,Stage IIIA,62.0,3.0,Stage IIIA,221.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,221.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-A2-A1FW-01,528.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-A2-A1FW,528.0,0.0,days,528.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A1FW-F20810,TCGA-A2-A1FW,TCGA-A2-A1FW-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,NO,,,-22779.0,198.0,,0.0,528.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,640.0,NO,Negative,,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,5.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf,A1FW,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,2f1af8cf-ded3-45b6-88cd-2c154c66ab8c,2f1af8cf-ded3-45b6-88cd-2c154c66ab8c,TCGA-A2-A1FW-01A-21-A17I-20,TCGA-A2-A1FW-01A-11D-A13L-09,TCGA-A2-A1FW-01,TCGA-A2-A1FW-01A-11D-A13K-05,fdc673b1-add6-4078-8f96-0ed4f6985240,TCGA-A2-A1FW-01,TCGA-A2-A1FW-01A-11D-A13L-09,,,TCGA-A2-A1FW-01,TCGA-A2-A1FW-01A-11D-A13L-09,,2f1af8cf-ded3-45b6-88cd-2c154c66ab8c,,TCGA-A2-A1FW-01A-11D-A13J-01,TCGA-A2-A1FW-01,,2f1af8cf-ded3-45b6-88cd-2c154c66ab8c,TCGA-A2-A1FW-01A-11D-A13J-01,
tcga.a2.a1fx,Stage IIIA,61.0,4.0,Stage IIIA,935.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,935.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-A2-A1FX-01,1847.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-A2-A1FX,1847.0,0.0,days,1847.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A1FX-F59654,TCGA-A2-A1FX,TCGA-A2-A1FX-01A,Negative,Positive,,,,Mastectomy NOS,Positive,Lumpectomy,,NO,,,-22344.0,937.0,,0.0,1847.0,,,,,NO,,70-79%,160,Scheduled Follow-up Submission,2014-5-19,FEMALE,,,,,,60.0,185,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,360.0,NO,,Negative,NO,24.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,6.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf,A1FX,TUMOR FREE,,,,,,YES,YES,60-69%,,YES,Primary Tumor,1,,6th,YES,NO,YES,A2,Breast,A,LIVING,2008.0,60f078d7-d594-48a2-9011-f0f926243a42,60f078d7-d594-48a2-9011-f0f926243a42,TCGA-A2-A1FX-01A-21-A17I-20,TCGA-A2-A1FX-01A-11D-A13L-09,TCGA-A2-A1FX-01,TCGA-A2-A1FX-01A-11D-A13K-05,0b991416-2ca1-4582-b119-e95e4e8ca5e8,TCGA-A2-A1FX-01,TCGA-A2-A1FX-01A-11D-A13L-09,,,TCGA-A2-A1FX-01,TCGA-A2-A1FX-01A-11D-A13L-09,,60f078d7-d594-48a2-9011-f0f926243a42,,TCGA-A2-A1FX-01A-11D-A13J-01,TCGA-A2-A1FX-01,,60f078d7-d594-48a2-9011-f0f926243a42,TCGA-A2-A1FX-01A-11D-A13J-01,
tcga.a2.a1fz,Stage IIA,63.0,3.0,Stage IIA,409.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,409.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A1FZ-01,683.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 6,mutation cluster 4,TCGA-A2-A1FZ,683.0,0.0,days,683.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,Sentinel node biopsy alone,,TCGA-A2-A1FZ-F20803,TCGA-A2-A1FZ,TCGA-A2-A1FZ-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-23055.0,335.0,,0.0,683.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,740.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf,A1FZ,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,27e70f84-80c5-4f6c-9d22-83c5a6e66eb5,27e70f84-80c5-4f6c-9d22-83c5a6e66eb5,TCGA-A2-A1FZ-01A-11-A17I-20,TCGA-A2-A1FZ-01A-51D-A17G-09,TCGA-A2-A1FZ-01,TCGA-A2-A1FZ-01A-51D-A14H-05,5157205e-da8c-4890-9df3-02f40831c268,TCGA-A2-A1FZ-01,TCGA-A2-A1FZ-01A-51D-A17G-09,,,TCGA-A2-A1FZ-01,TCGA-A2-A1FZ-01A-51D-A17G-09,,27e70f84-80c5-4f6c-9d22-83c5a6e66eb5,,TCGA-A2-A1FZ-01A-51D-A14F-01,TCGA-A2-A1FZ-01,,27e70f84-80c5-4f6c-9d22-83c5a6e66eb5,TCGA-A2-A1FZ-01A-51D-A14F-01,
tcga.a2.a1g0,Stage IIB,49.0,3.0,Stage IIB,380.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,380.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A1G0-01,616.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation cluster 4,TCGA-A2-A1G0,616.0,0.0,days,616.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A1G0-F20802,TCGA-A2-A1G0,TCGA-A2-A1G0-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-18002.0,315.0,,0.0,616.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,2+,,,1.2,,"Other, specify",,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,730.0,NO,Equivocal,Negative,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf,A1G0,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,753e77c2-6175-49d8-afd4-3a87d1dc2404,753e77c2-6175-49d8-afd4-3a87d1dc2404,TCGA-A2-A1G0-01A-21-A17I-20,TCGA-A2-A1G0-01A-11D-A13L-09,TCGA-A2-A1G0-01,TCGA-A2-A1G0-01A-11D-A13K-05,5875ba8b-aa27-4573-b1c7-30878613288e,TCGA-A2-A1G0-01,TCGA-A2-A1G0-01A-11D-A13L-09,,,TCGA-A2-A1G0-01,TCGA-A2-A1G0-01A-11D-A13L-09,,753e77c2-6175-49d8-afd4-3a87d1dc2404,,TCGA-A2-A1G0-01A-11D-A13J-01,TCGA-A2-A1G0-01,,753e77c2-6175-49d8-afd4-3a87d1dc2404,TCGA-A2-A1G0-01A-11D-A13J-01,
tcga.a2.a1g1,Stage IIB,85.0,4.0,Stage IIB,371.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,371.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A1G1-01,584.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 14,cluster 6,mutation cluster 5,TCGA-A2-A1G1,584.0,0.0,days,584.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,85.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A1G1-F20808,TCGA-A2-A1G1,TCGA-A2-A1G1-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-31223.0,338.0,,0.0,584.0,,,,,NO,,,51,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,,,2+,30.0,816,16.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Equivocal,Positive,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf,A1G1,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,NO,YES,NO,A2,Breast,A,LIVING,2010.0,122a1ed2-9757-4cac-9656-149da6d872f4,122a1ed2-9757-4cac-9656-149da6d872f4,TCGA-A2-A1G1-01A-11-A17I-20,TCGA-A2-A1G1-01A-21D-A13L-09,TCGA-A2-A1G1-01,TCGA-A2-A1G1-01A-21D-A13K-05,cd315ed6-e7af-4f4e-9990-348e464d5738,TCGA-A2-A1G1-01,TCGA-A2-A1G1-01A-21D-A13L-09,,,TCGA-A2-A1G1-01,TCGA-A2-A1G1-01A-21D-A13L-09,,122a1ed2-9757-4cac-9656-149da6d872f4,,TCGA-A2-A1G1-01A-21D-A13J-01,TCGA-A2-A1G1-01,,122a1ed2-9757-4cac-9656-149da6d872f4,TCGA-A2-A1G1-01A-21D-A13J-01,
tcga.a2.a1g4,Stage IIIA,71.0,4.0,Stage IIIA,372.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,372.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-A2-A1G4-01,595.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-A2-A1G4,595.0,0.0,days,595.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A1G4-F20805,TCGA-A2-A1G4,TCGA-A2-A1G4-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-25966.0,310.0,,0.0,595.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,710.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,2.0,,True,Yes,M0,N1a,T3,Stage IIIA,TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf,A1G4,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2,2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2,TCGA-A2-A1G4-01A-21-A17I-20,TCGA-A2-A1G4-01A-11D-A13L-09,TCGA-A2-A1G4-01,TCGA-A2-A1G4-01A-11D-A13K-05,d573b843-5656-47aa-958a-c295311876f0,TCGA-A2-A1G4-01,TCGA-A2-A1G4-01A-11D-A13L-09,,,TCGA-A2-A1G4-01,TCGA-A2-A1G4-01A-11D-A13L-09,,2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2,,TCGA-A2-A1G4-01A-11D-A13J-01,TCGA-A2-A1G4-01,,2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2,TCGA-A2-A1G4-01A-11D-A13J-01,
tcga.a2.a1g6,Stage IIIA,50.0,1.0,Stage IIIA,132.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N2,132.0,0.0,Normal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A1G6-01,501.0,0.0,days,Quiet,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-A2-A1G6,501.0,0.0,days,501.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Axillary lymph node dissection alone,,TCGA-A2-A1G6-F20947,TCGA-A2-A1G6,TCGA-A2-A1G6-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18514.0,229.0,,0.0,501.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,770.0,NO,Negative,,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf,A1G6,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,8b216b0f-1881-45de-a4ae-78dfd87764fe,8b216b0f-1881-45de-a4ae-78dfd87764fe,TCGA-A2-A1G6-01A-21-A17I-20,TCGA-A2-A1G6-01A-11D-A13L-09,TCGA-A2-A1G6-01,TCGA-A2-A1G6-01A-11D-A13K-05,02e55cff-87a6-4719-b988-4b8f46f079a5,TCGA-A2-A1G6-01,TCGA-A2-A1G6-01A-11D-A13L-09,,,TCGA-A2-A1G6-01,TCGA-A2-A1G6-01A-11D-A13L-09,,8b216b0f-1881-45de-a4ae-78dfd87764fe,,TCGA-A2-A1G6-01A-11D-A13J-01,TCGA-A2-A1G6-01,,8b216b0f-1881-45de-a4ae-78dfd87764fe,TCGA-A2-A1G6-01A-11D-A13J-01,
tcga.a2.a259,Stage IA,70.0,4.0,Stage I,1285.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1285.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-A2-A259-01,1596.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 14,,mutation c1uster 9,TCGA-A2-A259,1596.0,0.0,days,1596.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left,Sentinel node biopsy alone,,TCGA-A2-A259-F31034,TCGA-A2-A259,TCGA-A2-A259-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,YES,,,-25666.0,1238.0,,0.0,1596.0,,,,,NO,,90-99%,125,Scheduled Follow-up Submission,2012-4-23,FEMALE,,,,,,60.0,132,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Negative,Negative,,2.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf,A259,TUMOR FREE,,,,"Strong using Weak, Moderate and Strong","Strong using Weak, Moderate and Strong",,YES,80-89%,,NO,Primary Tumor,1,,6th,YES,NO,YES,A2,Breast,A,LIVING,2007.0,7157ccb4-b4f6-41ba-9f9c-da862b749a57,7157ccb4-b4f6-41ba-9f9c-da862b749a57,TCGA-A2-A259-01A-21-A17I-20,TCGA-A2-A259-01A-11D-A16D-09,TCGA-A2-A259-01,TCGA-A2-A259-01A-11D-A16G-05,f49215ab-aaf7-4a3a-bf77-196395a8cae7,TCGA-A2-A259-01,TCGA-A2-A259-01A-11D-A16D-09,,,TCGA-A2-A259-01,TCGA-A2-A259-01A-11D-A16D-09,,7157ccb4-b4f6-41ba-9f9c-da862b749a57,,TCGA-A2-A259-01A-11D-A16C-01,TCGA-A2-A259-01,,7157ccb4-b4f6-41ba-9f9c-da862b749a57,TCGA-A2-A259-01A-11D-A16C-01,
tcga.a2.a25a,Stage IIA,44.0,2.0,Stage IIA,2968.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2968.0,0.0,Normal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25A-01,3276.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,mutation cluster 4,TCGA-A2-A25A,3276.0,0.0,days,3276.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A25A-F30927,TCGA-A2-A25A,TCGA-A2-A25A-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-16084.0,2927.0,,0.0,3276.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2012-4-19,FEMALE,,,,,2+,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Equivocal,Negative,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,0.0,True,Yes,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf,A25A,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,A2,Breast,A,LIVING,2003.0,50c720f4-dbcb-4b8b-9808-d130f5197d27,50c720f4-dbcb-4b8b-9808-d130f5197d27,TCGA-A2-A25A-01A-21-A17I-20,TCGA-A2-A25A-01A-12D-A16D-09,TCGA-A2-A25A-01,TCGA-A2-A25A-01A-12D-A16G-05,bf3c63c7-643e-43b2-b5ea-3c2185ba9238,TCGA-A2-A25A-01,TCGA-A2-A25A-01A-12D-A16D-09,,,TCGA-A2-A25A-01,TCGA-A2-A25A-01A-12D-A16D-09,,50c720f4-dbcb-4b8b-9808-d130f5197d27,,TCGA-A2-A25A-01A-12D-A16C-01,TCGA-A2-A25A-01,,50c720f4-dbcb-4b8b-9808-d130f5197d27,TCGA-A2-A25A-01A-12D-A16C-01,
tcga.a2.a25b,Stage IIB,39.0,5.0,Stage IIB,258.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,258.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25B-01,1291.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,mutation c1uster 9,TCGA-A2-A25B,1290.0,1.0,days,1291.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,39.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A25B-F70679,TCGA-A2-A25B,TCGA-A2-A25B-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-14454.0,183.0,,0.0,1291.0,,,1290,,NO,,90-99%,,Scheduled Follow-up Submission,2015-3-2,FEMALE,,,,,2+,,,0.93,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,840.0,NO,Equivocal,Negative,NO,8.0,Close,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,Positive,,,,,,,,,,,,,,,4.0,5.0,,,,Bone,Distant Metastasis,,NO,YES,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf,A25B,WITH TUMOR,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b,3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b,TCGA-A2-A25B-01A-21-A17I-20,TCGA-A2-A25B-01A-11D-A167-09,TCGA-A2-A25B-01,TCGA-A2-A25B-01A-11D-A16A-05,b5b0794f-7149-4056-8687-98a9a1401d2c,TCGA-A2-A25B-01,TCGA-A2-A25B-01A-11D-A167-09,,,TCGA-A2-A25B-01,TCGA-A2-A25B-01A-11D-A167-09,,3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b,,TCGA-A2-A25B-01A-11D-A166-01,TCGA-A2-A25B-01,,3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b,TCGA-A2-A25B-01A-11D-A166-01,
tcga.a2.a25c,Stage IIB,50.0,3.0,Stage IIB,285.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,285.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25C-01,523.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,mutation cluster 4,TCGA-A2-A25C,523.0,0.0,days,523.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A25C-F31282,TCGA-A2-A25C,,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-18508.0,,,0.0,523.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-4-17,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A25C,TUMOR FREE,,,,,,,YES,20-29%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,,LIVING,2010.0,f5b16ba5-0fd1-4ca4-865f-fdff0af65901,f5b16ba5-0fd1-4ca4-865f-fdff0af65901,TCGA-A2-A25C-01A-21-A17I-20,TCGA-A2-A25C-01A-11D-A167-09,TCGA-A2-A25C-01,TCGA-A2-A25C-01A-11D-A16A-05,dbc23df1-b14d-4f24-81ef-fc12e2cdda21,TCGA-A2-A25C-01,TCGA-A2-A25C-01A-11D-A167-09,,,TCGA-A2-A25C-01,TCGA-A2-A25C-01A-11D-A167-09,,f5b16ba5-0fd1-4ca4-865f-fdff0af65901,,TCGA-A2-A25C-01A-11D-A166-01,TCGA-A2-A25C-01,,f5b16ba5-0fd1-4ca4-865f-fdff0af65901,TCGA-A2-A25C-01A-11D-A166-01,
tcga.a2.a25d,Stage IIIC,90.0,4.0,Stage IIIC,243.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,243.0,0.0,LumA,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25D-01,552.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 4,TCGA-A2-A25D,552.0,0.0,days,552.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A25D-F30931,TCGA-A2-A25D,TCGA-A2-A25D-01A,,Positive,,,,,Negative,Lumpectomy,,NO,,,-32872.0,224.0,,0.0,552.0,,,,,NO,,70-79%,118,Scheduled Follow-up Submission,2012-4-19,FEMALE,,,,,1+,60.0,145,1.22,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,430.0,NO,Negative,Negative,,24.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,22.0,,True,No,M0,N3a,T2,Stage IIIC,TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf,A25D,TUMOR FREE,,,,,"Moderate using the scale of Weak, Moderate, Strong",,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2010.0,d6b5cec3-edeb-46c5-839b-e62a1e850e0e,d6b5cec3-edeb-46c5-839b-e62a1e850e0e,TCGA-A2-A25D-01A-21-A17I-20,TCGA-A2-A25D-01A-12D-A16D-09,TCGA-A2-A25D-01,TCGA-A2-A25D-01A-12D-A16G-05,6ff66f90-93c3-4c1e-84c6-9db89ca701c2,TCGA-A2-A25D-01,TCGA-A2-A25D-01A-12D-A16D-09,,,TCGA-A2-A25D-01,TCGA-A2-A25D-01A-12D-A16D-09,,d6b5cec3-edeb-46c5-839b-e62a1e850e0e,,TCGA-A2-A25D-01A-12D-A16C-01,TCGA-A2-A25D-01,,d6b5cec3-edeb-46c5-839b-e62a1e850e0e,TCGA-A2-A25D-01A-12D-A16C-01,
tcga.a2.a25e,Stage IIIA,34.0,5.0,Stage IIIA,2511.0,,Positive,FEMALE,Equivocal,,,,Negative,M0,Positive,N2,2511.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25E-01,3204.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,mutation c1uster 9,TCGA-A2-A25E,2989.0,1.0,days,3204.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,34.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A25E-F44982,TCGA-A2-A25E,TCGA-A2-A25E-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-12601.0,2441.0,,0.0,3204.0,,3024.0,2989,,NO,,80-89%,,Scheduled Follow-up Submission,2013-7-2,FEMALE,,,,,2+,,,2.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,200.0,NO,Equivocal,Equivocal,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Negative,1+,,Positive,90-99%,,,,3 Point Scale,3+,2+,,,<10%,,Positive,,,4.0,5.0,,,3 Point Scale,"Other, specify",Locoregional Recurrence,Left Chest Wall,YES,YES,6.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf,A25E,TUMOR FREE,,,,"Strong, using scale of Weak, Moderate and Strong","Moderate using scale of Weak, Moderate, Strong",YES,YES,60-69%,,YES,Primary Tumor,1,,6th,YES,NO,YES,A2,Breast,A,LIVING,2004.0,7265c93b-7138-4bc8-bc9c-22ce1abf0ef2,7265c93b-7138-4bc8-bc9c-22ce1abf0ef2,TCGA-A2-A25E-01A-21-A17I-20,TCGA-A2-A25E-01A-11D-A167-09,TCGA-A2-A25E-01,TCGA-A2-A25E-01A-11D-A16A-05,6a6f4c33-d59e-462a-9fa7-aed32a35ff44,TCGA-A2-A25E-01,TCGA-A2-A25E-01A-11D-A167-09,,,TCGA-A2-A25E-01,TCGA-A2-A25E-01A-11D-A167-09,,7265c93b-7138-4bc8-bc9c-22ce1abf0ef2,,TCGA-A2-A25E-01A-11D-A166-01,TCGA-A2-A25E-01,,7265c93b-7138-4bc8-bc9c-22ce1abf0ef2,TCGA-A2-A25E-01A-11D-A166-01,
tcga.a2.a25f,Stage IIA,66.0,1.0,Stage IIA,113.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,113.0,0.0,Basal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A2-A25F-01,322.0,0.0,days,Kirc+,C4-BRCA/Basal,cluster 1,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,,,mutation c1uster 9,TCGA-A2-A25F,322.0,0.0,days,322.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A25F-F31197,TCGA-A2-A25F,TCGA-A2-A25F-01A,,Negative,,,,,Positive,Lumpectomy,,YES,,,-24319.0,86.0,,0.0,322.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-4-23,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,390.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf,A25F,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A2,Breast,A,LIVING,2011.0,acd59617-770c-4653-891f-71ea87d67c41,acd59617-770c-4653-891f-71ea87d67c41,TCGA-A2-A25F-01A-21-A17I-20,TCGA-A2-A25F-01A-11D-A167-09,TCGA-A2-A25F-01,TCGA-A2-A25F-01A-11D-A16A-05,04f35825-e128-4a77-b58e-7b98019dad24,TCGA-A2-A25F-01,TCGA-A2-A25F-01A-11D-A167-09,,,TCGA-A2-A25F-01,TCGA-A2-A25F-01A-11D-A167-09,,acd59617-770c-4653-891f-71ea87d67c41,,TCGA-A2-A25F-01A-11D-A166-01,TCGA-A2-A25F-01,,acd59617-770c-4653-891f-71ea87d67c41,TCGA-A2-A25F-01A-11D-A166-01,
tcga.a2.a3kc,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A2-A3KC-01,1102.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-A2-A3KC,1102.0,0.0,days,1102.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A3KC-F59210,TCGA-A2-A3KC,TCGA-A2-A3KC-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-20401.0,299.0,,0.0,1102.0,,,,,NO,,90-99%,1.9,,2014-5-5,FEMALE,,,,,2+,20.0,1.8,1.0,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,780.0,NO,Equivocal,Negative,NO,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf,A3KC,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2011.0,7bbe4637-394e-42c0-af7d-6184c3f48916,7bbe4637-394e-42c0-af7d-6184c3f48916,TCGA-A2-A3KC-01A-21-A24A-20,,TCGA-A2-A3KC-01,TCGA-A2-A3KC-01A-11D-A212-05,aa78b6ce-fccf-478e-b4b0-9cebaeeb99fb,TCGA-A2-A3KC-01,TCGA-A2-A3KC-01A-11D-A20S-09,,,TCGA-A2-A3KC-01,,,7bbe4637-394e-42c0-af7d-6184c3f48916,,TCGA-A2-A3KC-01A-11D-A20R-01,TCGA-A2-A3KC-01,,7bbe4637-394e-42c0-af7d-6184c3f48916,TCGA-A2-A3KC-01A-11D-A20R-01,
tcga.a2.a3kd,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A2-A3KD-01,1206.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-A2-A3KD,1206.0,0.0,days,1206.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A3KD-F37343,TCGA-A2-A3KD,TCGA-A2-A3KD-01A,Close,Positive,3 Point Scale,,3 Point Scale,Mastectomy NOS,Positive,Lumpectomy,,YES,,,-17372.0,700.0,,0.0,1206.0,,,,,NO,,90-99%,,,2012-12-3,FEMALE,,,,,1+,,,1.2,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,770.0,NO,Negative,Negative,NO,19.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,1.0,True,No,M0,N1mi,T3,Stage IIIA,TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf,A3KD,TUMOR FREE,,,,Strong,Strong,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2010.0,8a224dc6-632b-418b-bd5e-bcefc8ad049e,8a224dc6-632b-418b-bd5e-bcefc8ad049e,TCGA-A2-A3KD-01A-21-A24A-20,,TCGA-A2-A3KD-01,TCGA-A2-A3KD-01A-12D-A212-05,981593f7-f9eb-44af-a697-624af03e6bbf,TCGA-A2-A3KD-01,TCGA-A2-A3KD-01A-12D-A20S-09,,,TCGA-A2-A3KD-01,,,8a224dc6-632b-418b-bd5e-bcefc8ad049e,,TCGA-A2-A3KD-01A-12D-A20R-01,TCGA-A2-A3KD-01,,8a224dc6-632b-418b-bd5e-bcefc8ad049e,TCGA-A2-A3KD-01A-12D-A20R-01,
tcga.a2.a3xs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-A2-A3XS-01,1032.0,1.0,days,,,,,,,miRNA cluster 4,,,TCGA-A2-A3XS,682.0,1.0,days,1032.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,NO,,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A3XS-F34446,TCGA-A2-A3XS,TCGA-A2-A3XS-01A,Negative,Negative,,,,Mastectomy NOS,Negative,Lumpectomy,,YES,,,-23000.0,3355.0,1032.0,0.0,,,,682,,YES,,,,Additional New Tumor Event,2012-8-15,FEMALE,,,,,,,,1.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,40.0,NO,,Negative,,19.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Lung,Distant Metastasis,,,YES,9.0,0.0,True,No,M0,N2a,T1,Stage IIIA,TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf,A3XS,WITH TUMOR,,,,,,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,A2,Breast,A,DECEASED,2003.0,799df122-75f1-46bf-8b5e-ca557cd38d53,799df122-75f1-46bf-8b5e-ca557cd38d53,,,TCGA-A2-A3XS-01,TCGA-A2-A3XS-01A-11D-A230-05,,TCGA-A2-A3XS-01,TCGA-A2-A3XS-01A-11D-A22X-09,,,TCGA-A2-A3XS-01,,,799df122-75f1-46bf-8b5e-ca557cd38d53,,TCGA-A2-A3XS-01A-11D-A22W-01,TCGA-A2-A3XS-01,,799df122-75f1-46bf-8b5e-ca557cd38d53,TCGA-A2-A3XS-01A-11D-A22W-01,
tcga.a2.a3xt,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A3XT-01,2770.0,0.0,days,,,,,BRCA basal-like c6,,miRNA cluster 4,,,TCGA-A2-A3XT,2770.0,0.0,days,2770.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left,Other (specify),F plus axillary lymph node dissection,TCGA-A2-A3XT-F55841,TCGA-A2-A3XT,TCGA-A2-A3XT-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-16649.0,2164.0,,0.0,2770.0,,,,,,,,,,2014-1-16,FEMALE,,,,,,,,1.13,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,340.0,NO,Negative,Negative,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf,A3XT,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,A2,Breast,A,LIVING,2006.0,e0a10445-6266-4f41-a747-fb19d7182652,e0a10445-6266-4f41-a747-fb19d7182652,TCGA-A2-A3XT-01A-21-A24A-20,,TCGA-A2-A3XT-01,TCGA-A2-A3XT-01A-11D-A230-05,904a9035-e5e9-4a07-99dd-3a74f66c9145,TCGA-A2-A3XT-01,TCGA-A2-A3XT-01A-11D-A22X-09,,,TCGA-A2-A3XT-01,,,e0a10445-6266-4f41-a747-fb19d7182652,,TCGA-A2-A3XT-01A-11D-A22W-01,TCGA-A2-A3XT-01,,e0a10445-6266-4f41-a747-fb19d7182652,TCGA-A2-A3XT-01A-11D-A22W-01,
tcga.a2.a3xu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-A2-A3XU-01,912.0,1.0,days,,,,,BRCA basal-like c6,,miRNA cluster 4,,,TCGA-A2-A3XU,596.0,1.0,days,912.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,35.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A3XU-F34704,TCGA-A2-A3XU,TCGA-A2-A3XU-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-13046.0,2089.0,912.0,0.0,,,,596,,,,,1.5,,2012-8-30,FEMALE,,,,,,60.0,1.66,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,350.0,NO,,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Positive,,,,,,,,,,,,Positive,,,,,,,,"Other, specify",Locoregional Recurrence,Breast,NO,YES,3.0,0.0,True,No,M0,N1mi,T2,Stage IIB,TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf,A3XU,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,A2,Breast,A,DECEASED,2006.0,2ec1df5c-7272-44f4-922c-cdd6ba37f6b6,2ec1df5c-7272-44f4-922c-cdd6ba37f6b6,TCGA-A2-A3XU-01A-21-A24A-20,,TCGA-A2-A3XU-01,TCGA-A2-A3XU-01A-12D-A230-05,2233e116-6f58-4bf5-bcb7-528fc4ff8d30,TCGA-A2-A3XU-01,TCGA-A2-A3XU-01A-12D-A22X-09,,,TCGA-A2-A3XU-01,,,2ec1df5c-7272-44f4-922c-cdd6ba37f6b6,,TCGA-A2-A3XU-01A-12D-A22W-01,TCGA-A2-A3XU-01,,2ec1df5c-7272-44f4-922c-cdd6ba37f6b6,TCGA-A2-A3XU-01A-12D-A22W-01,
tcga.a2.a3xv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A3XV-01,996.0,0.0,days,,,,,BRCA basal-like c6,,,,,TCGA-A2-A3XV,996.0,0.0,days,996.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right,Sentinel node biopsy alone,,TCGA-A2-A3XV-F59117,TCGA-A2-A3XV,,,Positive,3 Point Scale,,,,Negative,Lumpectomy,,YES,,,-16971.0,,,0.0,996.0,,,,,,,<10%,1.7,,2014-5-1,FEMALE,,,,,2+,60.0,4.5,2.6,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Core needle biopsy,,,Equivocal,Positive,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A3XV,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,,LIVING,2011.0,fc2aa9aa-3df5-4723-9892-95edcc92bb6f,fc2aa9aa-3df5-4723-9892-95edcc92bb6f,TCGA-A2-A3XV-01A-41-A24A-20,,TCGA-A2-A3XV-01,TCGA-A2-A3XV-01A-21D-A23D-05,bcfc3c93-8457-45c3-bace-45fb134af40e,TCGA-A2-A3XV-01,TCGA-A2-A3XV-01A-21D-A23C-09,,,TCGA-A2-A3XV-01,,,fc2aa9aa-3df5-4723-9892-95edcc92bb6f,,TCGA-A2-A3XV-01A-21D-A238-01,TCGA-A2-A3XV-01,,fc2aa9aa-3df5-4723-9892-95edcc92bb6f,TCGA-A2-A3XV-01A-21D-A238-01,
tcga.a2.a3xw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A3XW-01,1712.0,0.0,days,,,,,BRCA nonbasal-like c8,,,,,TCGA-A2-A3XW,1712.0,0.0,days,1712.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,42.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A2-A3XW-F55843,TCGA-A2-A3XW,,,Positive,3 Point Scale,,,,Negative,Simple Mastectomy,,YES,,,-15670.0,,,0.0,1712.0,,,,,NO,,90-99%,,,2014-1-16,FEMALE,,,<10%,,,,,1.31,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,2+,YES,,Core needle biopsy,,,Negative,Negative,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,0.0,,No,M0,N1a,T2,Stage IIB,,A3XW,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,,LIVING,2009.0,f6cbfa5a-7d10-4efb-ae74-195e1a1e9774,f6cbfa5a-7d10-4efb-ae74-195e1a1e9774,TCGA-A2-A3XW-01A-21-A24A-20,,TCGA-A2-A3XW-01,TCGA-A2-A3XW-01A-11D-A23D-05,d9ca1e39-2191-444f-b17f-f5f57f73aa0c,TCGA-A2-A3XW-01,TCGA-A2-A3XW-01A-11D-A23C-09,,,TCGA-A2-A3XW-01,,,f6cbfa5a-7d10-4efb-ae74-195e1a1e9774,,TCGA-A2-A3XW-01A-11D-A238-01,TCGA-A2-A3XW-01,,f6cbfa5a-7d10-4efb-ae74-195e1a1e9774,TCGA-A2-A3XW-01A-11D-A238-01,
tcga.a2.a3xx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-A2-A3XX-01,1439.0,1.0,days,,,,,KIRC-like c1,,,,,TCGA-A2-A3XX,1439.0,0.0,days,1439.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A3XX-F43310,TCGA-A2-A3XX,TCGA-A2-A3XX-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-17981.0,1143.0,1439.0,0.0,1168.0,,,,,NO,,,,,2013-5-16,FEMALE,,,,,1+,,,1.25,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,780.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf,A3XX,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,DECEASED,2009.0,043d5dcd-1524-402b-939c-984a1dc916a0,043d5dcd-1524-402b-939c-984a1dc916a0,TCGA-A2-A3XX-01A-41-A24A-20,,TCGA-A2-A3XX-01,TCGA-A2-A3XX-01A-21D-A23D-05,c4757b28-bb38-49bb-bb06-70fa40ad8298,TCGA-A2-A3XX-01,TCGA-A2-A3XX-01A-21D-A23C-09,,,TCGA-A2-A3XX-01,,,043d5dcd-1524-402b-939c-984a1dc916a0,,TCGA-A2-A3XX-01A-21D-A238-01,TCGA-A2-A3XX-01,,043d5dcd-1524-402b-939c-984a1dc916a0,TCGA-A2-A3XX-01A-21D-A238-01,
tcga.a2.a3xy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-A2-A3XY-01,1093.0,1.0,days,,,,,,,,,,TCGA-A2-A3XY,1072.0,1.0,days,1093.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,YES,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A3XY-F55836,TCGA-A2-A3XY,TCGA-A2-A3XY-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18059.0,703.0,1093.0,0.0,786.0,,,1072,,NO,,,,,2014-1-16,FEMALE,,,,,,,,1.13,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,950.0,NO,Negative,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Brain,Distant Metastasis,,NO,YES,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf,A3XY,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,DECEASED,2010.0,42c88ed3-de96-487d-8b03-e1d4269d0505,42c88ed3-de96-487d-8b03-e1d4269d0505,,,TCGA-A2-A3XY-01,TCGA-A2-A3XY-01A-11D-A23D-05,,TCGA-A2-A3XY-01,TCGA-A2-A3XY-01A-11D-A23C-09,,,TCGA-A2-A3XY-01,,,42c88ed3-de96-487d-8b03-e1d4269d0505,,TCGA-A2-A3XY-01A-11D-A238-01,TCGA-A2-A3XY-01,,42c88ed3-de96-487d-8b03-e1d4269d0505,TCGA-A2-A3XY-01A-11D-A238-01,
tcga.a2.a3xz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A3XZ-01,1532.0,0.0,days,,,,,BRCA basal-like c6,,,,,TCGA-A2-A3XZ,1532.0,0.0,days,1532.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A3XZ-F58924,TCGA-A2-A3XZ,TCGA-A2-A3XZ-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-16978.0,909.0,,0.0,1532.0,,,,,,,,,,2014-4-28,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,1100.0,NO,Positive,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T1c,Stage I,TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf,A3XZ,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,A2,Breast,A,LIVING,2009.0,176b2422-3599-41c5-be62-ae6e28d60b90,176b2422-3599-41c5-be62-ae6e28d60b90,TCGA-A2-A3XZ-01A-51-A24A-20,,TCGA-A2-A3XZ-01,TCGA-A2-A3XZ-01A-42D-A23D-05,78747541-53ed-4037-af62-694fc6f00433,TCGA-A2-A3XZ-01,TCGA-A2-A3XZ-01A-42D-A23C-09,,,TCGA-A2-A3XZ-01,,,176b2422-3599-41c5-be62-ae6e28d60b90,,TCGA-A2-A3XZ-01A-42D-A238-01,TCGA-A2-A3XZ-01,,176b2422-3599-41c5-be62-ae6e28d60b90,TCGA-A2-A3XZ-01A-42D-A238-01,
tcga.a2.a3y0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A3Y0-01,1546.0,0.0,days,,,,,,,,,,TCGA-A2-A3Y0,1546.0,0.0,days,1546.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A3Y0-F59118,TCGA-A2-A3Y0,TCGA-A2-A3Y0-01A,,Positive,3 Point Scale,,,,Negative,Modified Radical Mastectomy,,NO,,,-21024.0,845.0,,0.0,1546.0,,,,,,,90-99%,,,2014-5-1,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,850.0,NO,Negative,,NO,39.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf,A3Y0,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,A2,Breast,A,LIVING,2010.0,9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5,9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5,,,TCGA-A2-A3Y0-01,TCGA-A2-A3Y0-01A-11D-A23D-05,,TCGA-A2-A3Y0-01,TCGA-A2-A3Y0-01A-11D-A23C-09,,,TCGA-A2-A3Y0-01,,,9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5,,TCGA-A2-A3Y0-01A-11D-A238-01,TCGA-A2-A3Y0-01,,9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5,TCGA-A2-A3Y0-01A-11D-A238-01,
tcga.a2.a4rw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4RW-01,222.0,0.0,days,,,,,,,,,,TCGA-A2-A4RW,222.0,0.0,days,222.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right|Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A4RW-F59123,TCGA-A2-A4RW,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-18060.0,,,0.0,222.0,,,,,,,80-89%,,,2014-5-1,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,YES,27.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,27.0,0.0,,No,M0,N3a,T2,Stage IIIC,,A4RW,TUMOR FREE,,,,,,,YES,90-99%,,,Primary Tumor,1,,7th,,YES,NO,A2,Breast,,LIVING,2011.0,f8bfd67a-1d78-44b0-9715-712dee01b008,f8bfd67a-1d78-44b0-9715-712dee01b008,,,TCGA-A2-A4RW-01,TCGA-A2-A4RW-01A-21D-A268-05,cee2c148-efa3-45e2-8b28-f65e56a5d2b9,TCGA-A2-A4RW-01,TCGA-A2-A4RW-01A-21D-A25Q-09,,,TCGA-A2-A4RW-01,,,f8bfd67a-1d78-44b0-9715-712dee01b008,,TCGA-A2-A4RW-01A-21D-A25N-01,TCGA-A2-A4RW-01,,f8bfd67a-1d78-44b0-9715-712dee01b008,TCGA-A2-A4RW-01A-21D-A25N-01,
tcga.a2.a4rx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4RX-01,742.0,0.0,days,,,,,,,,,,TCGA-A2-A4RX,742.0,0.0,days,742.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A4RX-F58491,TCGA-A2-A4RX,,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-24779.0,,,0.0,742.0,,,,,,,<10%,,,2014-4-11,FEMALE,,,,,1+,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,1+,YES,,Core needle biopsy,,,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A4RX,TUMOR FREE,,,,,,,YES,<10%,,,Primary Tumor,1,,7th,,YES,NO,A2,Breast,,LIVING,2012.0,cbef9672-38ba-4873-b232-9a656b7428ce,cbef9672-38ba-4873-b232-9a656b7428ce,,,TCGA-A2-A4RX-01,TCGA-A2-A4RX-01A-11D-A268-05,d980ca91-4ae1-4fc2-a4d1-052051aa7d41,TCGA-A2-A4RX-01,TCGA-A2-A4RX-01A-11D-A25Q-09,,,TCGA-A2-A4RX-01,,,cbef9672-38ba-4873-b232-9a656b7428ce,,TCGA-A2-A4RX-01A-11D-A25N-01,TCGA-A2-A4RX-01,,cbef9672-38ba-4873-b232-9a656b7428ce,TCGA-A2-A4RX-01A-11D-A25N-01,
tcga.a2.a4ry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4RY-01,648.0,0.0,days,,,,,,,,,,TCGA-A2-A4RY,648.0,0.0,days,648.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right,Axillary lymph node dissection alone,,TCGA-A2-A4RY-F59208,TCGA-A2-A4RY,TCGA-A2-A4RY-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-17157.0,149.0,,0.0,648.0,,,,,,,90-99%,,,2014-5-5,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,1180.0,NO,Negative,,NO,30.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,18.0,0.0,True,No,M0,N3a,T3,Stage IIIC,TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf,A4RY,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2012.0,51d9b960-276a-4c7b-b135-f2f8c05f3bd6,51d9b960-276a-4c7b-b135-f2f8c05f3bd6,,,TCGA-A2-A4RY-01,TCGA-A2-A4RY-01A-31D-A268-05,e40037c5-5570-43d6-ad24-cd4ceea41828,TCGA-A2-A4RY-01,TCGA-A2-A4RY-01A-31D-A25Q-09,,,TCGA-A2-A4RY-01,,,51d9b960-276a-4c7b-b135-f2f8c05f3bd6,,TCGA-A2-A4RY-01A-31D-A25N-01,TCGA-A2-A4RY-01,,51d9b960-276a-4c7b-b135-f2f8c05f3bd6,TCGA-A2-A4RY-01A-31D-A25N-01,
tcga.a2.a4s0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4S0-01,706.0,0.0,days,,,,,,,,,,TCGA-A2-A4S0,706.0,0.0,days,706.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A4S0-F59120,TCGA-A2-A4S0,TCGA-A2-A4S0-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-28416.0,159.0,,0.0,706.0,,,,,,,90-99%,,,2014-5-1,FEMALE,,,,,1+,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,3+,YES,,Core needle biopsy,960.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf,A4S0,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2012.0,81e350d9-7e2f-4650-9871-54ed2d5a5ab3,81e350d9-7e2f-4650-9871-54ed2d5a5ab3,,,TCGA-A2-A4S0-01,TCGA-A2-A4S0-01A-21D-A268-05,b37a030f-c2f7-4690-8503-78a2af066cdf,TCGA-A2-A4S0-01,TCGA-A2-A4S0-01A-21D-A25Q-09,,,TCGA-A2-A4S0-01,,,81e350d9-7e2f-4650-9871-54ed2d5a5ab3,,TCGA-A2-A4S0-01A-21D-A25N-01,TCGA-A2-A4S0-01,,81e350d9-7e2f-4650-9871-54ed2d5a5ab3,TCGA-A2-A4S0-01A-21D-A25N-01,
tcga.a2.a4s1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4S1-01,820.0,0.0,days,,,,,,,,,,TCGA-A2-A4S1,820.0,0.0,days,820.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A2-A4S1-F58925,TCGA-A2-A4S1,TCGA-A2-A4S1-01A,,Positive,3 Point Scale,,,,Negative,Lumpectomy,,YES,,,-24353.0,282.0,,0.0,820.0,,,,,,,<10%,,,2014-4-28,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,1+,YES,,Core needle biopsy,350.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf,A4S1,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2012.0,3d9d61f1-ad25-45a5-b0be-8698dc4b8c68,3d9d61f1-ad25-45a5-b0be-8698dc4b8c68,,,TCGA-A2-A4S1-01,TCGA-A2-A4S1-01A-21D-A268-05,ae7e510a-5cda-4520-b879-ec7685609a2e,TCGA-A2-A4S1-01,TCGA-A2-A4S1-01A-21D-A25Q-09,,,TCGA-A2-A4S1-01,,,3d9d61f1-ad25-45a5-b0be-8698dc4b8c68,,TCGA-A2-A4S1-01A-21D-A25N-01,TCGA-A2-A4S1-01,,3d9d61f1-ad25-45a5-b0be-8698dc4b8c68,TCGA-A2-A4S1-01A-21D-A25N-01,
tcga.a2.a4s2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4S2-01,643.0,0.0,days,,,,,,,,,,TCGA-A2-A4S2,643.0,0.0,days,643.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right,Axillary lymph node dissection alone,,TCGA-A2-A4S2-F59085,TCGA-A2-A4S2,TCGA-A2-A4S2-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-22936.0,112.0,,0.0,643.0,,,,,,,90-99%,,,2014-4-30,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8524/3,C50.9,2+,YES,,Core needle biopsy,1390.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,0.0,True,No,M0,N2,T3,Stage IIIA,TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf,A4S2,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2012.0,2c6af71f-b876-4475-a94a-61e99075123f,2c6af71f-b876-4475-a94a-61e99075123f,,,TCGA-A2-A4S2-01,TCGA-A2-A4S2-01A-12D-A268-05,e2a6282d-a3b4-42be-b034-d1203d078044,TCGA-A2-A4S2-01,TCGA-A2-A4S2-01A-12D-A25Q-09,,,TCGA-A2-A4S2-01,,,2c6af71f-b876-4475-a94a-61e99075123f,,TCGA-A2-A4S2-01A-12D-A25N-01,TCGA-A2-A4S2-01,,2c6af71f-b876-4475-a94a-61e99075123f,TCGA-A2-A4S2-01A-12D-A25N-01,
tcga.a2.a4s3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A2-A4S3-01,666.0,0.0,days,,,,,,,,,,TCGA-A2-A4S3,666.0,0.0,days,666.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-A2-A4S3-F59128,TCGA-A2-A4S3,TCGA-A2-A4S3-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-21762.0,147.0,,0.0,666.0,,,,,,,90-99%,,,2014-5-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,1500.0,NO,Negative,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf,A4S3,TUMOR FREE,,,,,,,YES,90-99%,,,Primary Tumor,1,,7th,,YES,NO,A2,Breast,A,LIVING,2012.0,a26b4751-91a2-420c-9ff3-7df7361939fd,a26b4751-91a2-420c-9ff3-7df7361939fd,,,TCGA-A2-A4S3-01,TCGA-A2-A4S3-01A-21D-A268-05,18c0493c-af12-4d29-9e41-e4debdf3e0b1,TCGA-A2-A4S3-01,TCGA-A2-A4S3-01A-21D-A25Q-09,,,TCGA-A2-A4S3-01,,,a26b4751-91a2-420c-9ff3-7df7361939fd,,TCGA-A2-A4S3-01A-21D-A25N-01,TCGA-A2-A4S3-01,,a26b4751-91a2-420c-9ff3-7df7361939fd,TCGA-A2-A4S3-01A-21D-A25N-01,
tcga.a7.a13d,Stage IIA,46.0,3.0,Stage IIA,267.0,,Negative,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Negative,N0,267.0,0.0,Basal,Basal-like,Positive,ReacII,-13.0,0.0,followup,T_Other,T2,LIVING,0.0,TCGA-A7-A13D-01,965.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 2,TCGA-A7-A13D,965.0,0.0,days,965.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A13D-F39794,TCGA-A7-A13D,TCGA-A7-A13D-01A,Negative,Negative,,,,Lumpectomy,Positive,Lumpectomy,,NO,,,-17070.0,240.0,,0.0,965.0,,,,FPPP,,,<10%,1.8,,2013-2-1,FEMALE,,,,PathVysion HER-2 D Probe Kit,2+,197.0,1.9,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,240.0,NO,Equivocal,Negative,NO,4.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf,A13D,TUMOR FREE,,,,,,YES,,<10%,TCGA,YES,Primary Tumor,1,,,YES,YES,NO,A7,Breast,A,LIVING,2010.0,3af60b03-66c3-48a1-a42b-1e05fdb529c4,3af60b03-66c3-48a1-a42b-1e05fdb529c4,TCGA-A7-A13D-01A-21-A13E-20,TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01,TCGA-A7-A13D-01A-13D-A12R-05,bf4b9dc3-df06-4735-b9b6-4cc8240c93b7,TCGA-A7-A13D-01,"TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09",,TCGA-A7-A13D-01,TCGA-A7-A13D-01,TCGA-A7-A13D-01A-13D-A12Q-09,,3af60b03-66c3-48a1-a42b-1e05fdb529c4,,TCGA-A7-A13D-01A-13D-A12N-01,TCGA-A7-A13D-01,TCGA-A7-A13D-01A-13R-A12P-07,3af60b03-66c3-48a1-a42b-1e05fdb529c4,TCGA-A7-A13D-01A-13D-A12N-01,TCGA-A7-A13D-01
tcga.a7.a13e,Stage IIB,62.0,1.0,No_Conversion,326.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,326.0,0.0,Basal,Basal-like,Negative,Basal,-13.0,-12.0,followup,T_Other,T2,LIVING,1.0,TCGA-A7-A13E-01,614.0,1.0,days,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,cluster 5,,TCGA-A7-A13E,556.0,1.0,days,614.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,NO,,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A13E-F30405,TCGA-A7-A13E,TCGA-A7-A13E-01A,,Positive,,,,,Negative,Lumpectomy,,NO,,,-22690.0,220.0,614.0,0.0,326.0,,,556,FPPP,,,20-29%,3.0,Additional New Tumor Event,2012-4-9,FEMALE,,,,PathVysion HER-2 D Probe Kit,2+,561.0,3.2,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,730.0,NO,Equivocal,Negative,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,1+,,Negative,,,,,,,,,,,,Negative,,,4.0,5.0,,,,"Other, specify",Distant Metastasis,"Lung, Bone, Liver, Brain and Skin Nodules",,YES,2.0,,False,No,MX,N1,T2,Stage IIB,TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf,A13E,WITH TUMOR,,,,,,,,<10%,TCGA,NO,Primary Tumor,1,,,YES,YES,NO,A7,Breast,A,DECEASED,2010.0,b7f491a9-eddf-43b1-9baf-862db2d50383,b7f491a9-eddf-43b1-9baf-862db2d50383,TCGA-A7-A13E-01A-21-A13E-20,,TCGA-A7-A13E-01,TCGA-A7-A13E-01A-11D-A12R-05,724b7cef-9bb6-4c6b-8c78-b632f910fe85,TCGA-A7-A13E-01,"TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09",,TCGA-A7-A13E-01,TCGA-A7-A13E-01,,,b7f491a9-eddf-43b1-9baf-862db2d50383,,TCGA-A7-A13E-01A-11D-A12N-01,TCGA-A7-A13E-01,TCGA-A7-A13E-01A-11R-A12P-07,b7f491a9-eddf-43b1-9baf-862db2d50383,TCGA-A7-A13E-01A-11D-A12N-01,TCGA-A7-A13E-01
tcga.a7.a13f,Stage IIIA,44.0,3.0,No_Conversion,387.0,,Positive,FEMALE,Negative,1.0,3.0,4.0,Negative,M0,Positive,N1,387.0,0.0,LumB,Luminal B,Positive,LumA/B,0.0,-3.0,followup,T_Other,T3,LIVING,0.0,TCGA-A7-A13F-01,765.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-A7-A13F,765.0,0.0,days,765.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A13F-F39779,TCGA-A7-A13F,,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-16363.0,,,0.0,765.0,,,,,,,,2.8,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,PathVysion HER-2 D Probe Kit,2+,403.0,3.0,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,3.0,,,No,M0,N1a,T3,Stage IIIA,,A13F,TUMOR FREE,,,,,,YES,,,,YES,Primary Tumor,1,,,YES,YES,NO,A7,Breast,,LIVING,2010.0,fc4f35dd-9924-4e5d-ba71-0d7a79752b6a,fc4f35dd-9924-4e5d-ba71-0d7a79752b6a,TCGA-A7-A13F-01A-21-A13E-20,TCGA-A7-A13F-01A-11D-A12Q-09,TCGA-A7-A13F-01,TCGA-A7-A13F-01A-11D-A12R-05,ad57bf3d-f283-4c26-95ad-86a116794296,TCGA-A7-A13F-01,TCGA-A7-A13F-01A-11D-A12Q-09,,TCGA-A7-A13F-01,TCGA-A7-A13F-01,TCGA-A7-A13F-01A-11D-A12Q-09,,fc4f35dd-9924-4e5d-ba71-0d7a79752b6a,,TCGA-A7-A13F-01A-11D-A12N-01,TCGA-A7-A13F-01,TCGA-A7-A13F-01A-11R-A12P-07,fc4f35dd-9924-4e5d-ba71-0d7a79752b6a,TCGA-A7-A13F-01A-11D-A12N-01,TCGA-A7-A13F-01
tcga.a7.a13g,Stage IIA,79.0,2.0,Stage IIA,348.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,348.0,0.0,LumA,,Positive,,,,followup,T_Other,T2,LIVING,0.0,TCGA-A7-A13G-01,718.0,0.0,days,Iq,,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 3,mutation cluster 4,TCGA-A7-A13G,586.0,1.0,days,718.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,79.0,Left,Sentinel node biopsy alone,,TCGA-A7-A13G-F35039,TCGA-A7-A13G,,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-28969.0,,,0.0,718.0,,586.0,586,,NO,,90-99%,,Scheduled Follow-up Submission,2012-9-14,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,3.0,,,,"Other, specify",New Primary Tumor,"Skin, right leg",YES,YES,0.0,,,Yes,MX,N0,T2,Stage IIA,,A13G,TUMOR FREE,,,,,,YES,YES,50-59%,,NO,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,,LIVING,2010.0,ac567288-88cc-4a65-937e-086655c038df,ac567288-88cc-4a65-937e-086655c038df,,TCGA-A7-A13G-01A-11D-A13L-09,TCGA-A7-A13G-01,"TCGA-A7-A13G-01B-04D-A22R-05,TCGA-A7-A13G-01A-11D-A13K-05",,TCGA-A7-A13G-01,TCGA-A7-A13G-01A-11D-A13L-09,,,TCGA-A7-A13G-01,TCGA-A7-A13G-01A-11D-A13L-09,,ac567288-88cc-4a65-937e-086655c038df,,TCGA-A7-A13G-01A-11D-A13J-01,TCGA-A7-A13G-01,,ac567288-88cc-4a65-937e-086655c038df,TCGA-A7-A13G-01A-11D-A13J-01,
tcga.a7.a13h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A13H-01,899.0,0.0,days,Iq,,,BRCA non-CIMP c9,,,miRNA cluster 4,,,TCGA-A7-A13H,795.0,1.0,days,899.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A13H-F41651,TCGA-A7-A13H,TCGA-A7-A13H-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-22643.0,62.0,,0.0,899.0,,840.0,795,,NO,,80-89%,2.7,,2013-3-25,FEMALE,,,,Pathvysion HER2 D Probe Kit,2+,371.0,3.2,2.2,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",New Primary Tumor,Skin lesion-Basal Cell Left Lower Lateral Back,YES,YES,2.0,2.0,False,No,MX,N1a,T2,Stage IIB,TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf,A13H,TUMOR FREE,,,,,,NO,YES,30-39%,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2010.0,4f0fdfc6-6578-4d9a-92ae-6d82291a3785,4f0fdfc6-6578-4d9a-92ae-6d82291a3785,,,TCGA-A7-A13H-01,TCGA-A7-A13H-01A-11D-A22B-05,,TCGA-A7-A13H-01,TCGA-A7-A13H-01A-11D-A228-09,,,TCGA-A7-A13H-01,,,4f0fdfc6-6578-4d9a-92ae-6d82291a3785,,TCGA-A7-A13H-01A-11D-A227-01,TCGA-A7-A13H-01,,4f0fdfc6-6578-4d9a-92ae-6d82291a3785,TCGA-A7-A13H-01A-11D-A227-01,
tcga.a7.a26e,Stage IIIA,71.0,2.0,Stage IIIA,421.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,421.0,0.0,LumA,,Positive,,,,followup,T_Other,T3,LIVING,0.0,TCGA-A7-A26E-01,954.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 1,TCGA-A7-A26E,954.0,0.0,days,954.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A26E-F39792,TCGA-A7-A26E,TCGA-A7-A26E-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-26274.0,372.0,,0.0,954.0,,,,FPPP,NO,,90-99%,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,230.0,NO,Negative,,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,0.0,,False,Yes,MX,N1a,T3,Stage IIIA,TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf,A26E,TUMOR FREE,,,,,,YES,YES,20-29%,TCGA,YES,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,A,LIVING,2010.0,6130b450-8b88-4a9a-b462-a34ec94183c9,6130b450-8b88-4a9a-b462-a34ec94183c9,TCGA-A7-A26E-01A-21-A17I-20,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01,"TCGA-A7-A26E-01A-11D-A27B-05,TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05",1c700207-2bd3-421f-8c10-5365a680df72,TCGA-A7-A26E-01,"TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09",,,TCGA-A7-A26E-01,TCGA-A7-A26E-01A-11D-A167-09,,6130b450-8b88-4a9a-b462-a34ec94183c9,,TCGA-A7-A26E-01A-11D-A275-01,TCGA-A7-A26E-01,,6130b450-8b88-4a9a-b462-a34ec94183c9,TCGA-A7-A26E-01A-11D-A275-01,
tcga.a7.a26f,Stage IA,55.0,3.0,Stage I,257.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,257.0,0.0,Basal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-A7-A26F-01,738.0,0.0,days,BRCA-LUAD+,C4-BRCA/Basal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 4,cluster 5,mutation cluster 3,TCGA-A7-A26F,738.0,0.0,days,738.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left,Sentinel node biopsy alone,,TCGA-A7-A26F-F38499,TCGA-A7-A26F,TCGA-A7-A26F-01A,Negative,Negative,,,,,Negative,Lumpectomy,,NO,,,-20210.0,173.0,,0.0,738.0,,,,,NO,,,1.8,Scheduled Follow-up Submission,2012-12-14,FEMALE,,,,PathVysion HER-2 D probe kit.,2+,330.0,1.9,1.1,,"Other, specify",,No,,C50.9,8575/3,C50.9,,YES,,Fine needle aspiration biopsy,190.0,NO,Equivocal,Negative,NO,1.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,0.0,,False,Yes,M0,N0,T1,Stage IA,TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf,A26F,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,A,LIVING,2010.0,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b,TCGA-A7-A26F-01A-11-A17I-20,TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01,"TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05",6bda0261-6c33-4c86-8cf9-c9dce2bcadec,TCGA-A7-A26F-01,"TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09",,,TCGA-A7-A26F-01,TCGA-A7-A26F-01A-21D-A167-09,,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b,,TCGA-A7-A26F-01A-21D-A166-01,TCGA-A7-A26F-01,,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b,TCGA-A7-A26F-01A-21D-A166-01,
tcga.a7.a26g,Stage IIA,50.0,3.0,Stage IIA,209.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,209.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A7-A26G-01,722.0,0.0,days,COAD-READ,C4-BRCA/Basal,cluster 5,Low purity c2,KIRC-like c1,BRCA basal-like c8,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-A7-A26G,722.0,0.0,days,722.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A26G-F39047,TCGA-A7-A26G,TCGA-A7-A26G-01A,,Negative,,,,,Negative,Other,,NO,,,-18362.0,161.0,,0.0,722.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-1-9,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,410.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0 (i+),T2,Stage IIA,TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf,A26G,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,Total Mastectomy,7th,YES,YES,NO,A7,Breast,A,LIVING,2010.0,8cf1853a-55b2-4fb9-9a65-a46243304d54,8cf1853a-55b2-4fb9-9a65-a46243304d54,TCGA-A7-A26G-01A-11-A17I-20,TCGA-A7-A26G-01A-21D-A167-09,TCGA-A7-A26G-01,TCGA-A7-A26G-01A-21D-A16A-05,1c0d3d0a-579d-4cfc-bea5-cd7ecb74dd88,TCGA-A7-A26G-01,TCGA-A7-A26G-01A-21D-A167-09,,,TCGA-A7-A26G-01,TCGA-A7-A26G-01A-21D-A167-09,,8cf1853a-55b2-4fb9-9a65-a46243304d54,,TCGA-A7-A26G-01A-21D-A166-01,TCGA-A7-A26G-01,,8cf1853a-55b2-4fb9-9a65-a46243304d54,TCGA-A7-A26G-01A-21D-A166-01,
tcga.a7.a26h,Stage IIA,72.0,3.0,Stage IIA,64.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,64.0,0.0,LumA,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-A7-A26H-01,724.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 4,TCGA-A7-A26H,311.0,1.0,days,724.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,NO,,72.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A26H-F39890,TCGA-A7-A26H,TCGA-A7-A26H-01A,,Positive,,,,,Negative,Other,,NO,,,-26423.0,79.0,,0.0,724.0,,,311,,NO,,90-99%,2.2,Scheduled Follow-up Submission,2013-2-5,FEMALE,,,,PathVysion Her-2 D,2+,20.0,5.8,2.6,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Equivocal,Positive,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,,,Positive,10-19%,,,,,,,,,,,Negative,,,4.0,,,,,Liver,Distant Metastasis,,,YES,0.0,1.0,False,Yes,M0,N1a,T1,Stage IIA,TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf,A26H,WITH TUMOR,,,,,,YES,YES,,,NO,Primary Tumor,1,Bilateral Mastectomy,7th,YES,YES,NO,A7,Breast,A,LIVING,2011.0,d1810175-47a5-4409-b1b8-f5ba78ed1c30,d1810175-47a5-4409-b1b8-f5ba78ed1c30,TCGA-A7-A26H-01A-21-A17I-20,TCGA-A7-A26H-01A-11D-A167-09,TCGA-A7-A26H-01,TCGA-A7-A26H-01A-11D-A16A-05,24bf1453-2154-4eb2-a417-274489d22753,TCGA-A7-A26H-01,TCGA-A7-A26H-01A-11D-A167-09,,,TCGA-A7-A26H-01,TCGA-A7-A26H-01A-11D-A167-09,,d1810175-47a5-4409-b1b8-f5ba78ed1c30,,TCGA-A7-A26H-01A-11D-A166-01,TCGA-A7-A26H-01,,d1810175-47a5-4409-b1b8-f5ba78ed1c30,TCGA-A7-A26H-01A-11D-A166-01,
tcga.a7.a26i,Stage IIA,65.0,1.0,Stage IIA,122.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,122.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A7-A26I-01,661.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 4,,mutation cluster 5,TCGA-A7-A26I,661.0,0.0,days,661.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left,Axillary lymph node dissection alone,,TCGA-A7-A26I-F39791,TCGA-A7-A26I,TCGA-A7-A26I-01A,Negative,Negative,,,,Other,Negative,Lumpectomy,Re-Excision of Superior Margin,NO,,,-23948.0,40.0,,0.0,661.0,,,,,NO,,,2.0,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,Path Vysion HER-2 D probe kit,2+,229.0,2.2,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,120.0,NO,Equivocal,Negative,NO,2.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,,False,Yes,M0,N0,T2,Stage IIA,TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf,A26I,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,A,LIVING,2011.0,5610fa97-eac4-4306-aead-983ee6570baf,5610fa97-eac4-4306-aead-983ee6570baf,TCGA-A7-A26I-01A-21-A17I-20,TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01,TCGA-A7-A26I-01A-11D-A16A-05,c74b933c-9dd5-42a6-a906-4951a21e8bc2,TCGA-A7-A26I-01,"TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09",,,TCGA-A7-A26I-01,TCGA-A7-A26I-01A-11D-A167-09,,5610fa97-eac4-4306-aead-983ee6570baf,,TCGA-A7-A26I-01A-11D-A166-01,TCGA-A7-A26I-01,,5610fa97-eac4-4306-aead-983ee6570baf,TCGA-A7-A26I-01A-11D-A166-01,
tcga.a7.a26j,Stage IIA,49.0,3.0,Stage IIA,67.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,67.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-A7-A26J-01,627.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-A7-A26J,627.0,0.0,days,627.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A26J-F39793,TCGA-A7-A26J,,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-17930.0,,,0.0,627.0,,,,FPPP,NO,,90-99%,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A26J,TUMOR FREE,,,,,,YES,YES,70-79%,TCGA,NO,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,,LIVING,2011.0,ed40061b-ad15-4f91-94ae-ae276394f42d,ed40061b-ad15-4f91-94ae-ae276394f42d,,TCGA-A7-A26J-01A-11D-A167-09,TCGA-A7-A26J-01,"TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05",,TCGA-A7-A26J-01,"TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09",,,TCGA-A7-A26J-01,TCGA-A7-A26J-01A-11D-A167-09,,ed40061b-ad15-4f91-94ae-ae276394f42d,,TCGA-A7-A26J-01A-11D-A275-01,TCGA-A7-A26J-01,,ed40061b-ad15-4f91-94ae-ae276394f42d,TCGA-A7-A26J-01A-11D-A275-01,
tcga.a7.a2kd,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,0.0,TCGA-A7-A2KD-01,679.0,0.0,days,Squamous,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-A7-A2KD,679.0,0.0,days,679.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right,No axillary staging,,TCGA-A7-A2KD-F39783,TCGA-A7-A2KD,TCGA-A7-A2KD-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-19563.0,141.0,,0.0,679.0,,,,,,,90-99%,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,260.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,8.0,0.0,False,Yes,MX,N2a,T2,Stage IIIA,TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf,A2KD,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,A,LIVING,2011.0,5e04619f-0fa5-45fa-a30b-31b062600047,5e04619f-0fa5-45fa-a30b-31b062600047,TCGA-A7-A2KD-01A-41-A24A-20,,TCGA-A7-A2KD-01,TCGA-A7-A2KD-01A-31D-A21R-05,58fcf58b-b94c-4605-a0fc-7ddc5e269879,TCGA-A7-A2KD-01,TCGA-A7-A2KD-01A-31D-A21Q-09,,,TCGA-A7-A2KD-01,,,5e04619f-0fa5-45fa-a30b-31b062600047,,TCGA-A7-A2KD-01A-31D-A21P-01,TCGA-A7-A2KD-01,,5e04619f-0fa5-45fa-a30b-31b062600047,TCGA-A7-A2KD-01A-31D-A21P-01,
tcga.a7.a3iy,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A7-A3IY-01,345.0,0.0,days,Kirc+,,,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-A7-A3IY,345.0,0.0,days,345.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A3IY-F33856,TCGA-A7-A3IY,,Negative,Positive,,,,Lumpectomy,Positive,Lumpectomy,,NO,,,-26042.0,,,0.0,345.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-7-20,FEMALE,,,,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,,,Negative,,,1.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage I,,A3IY,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,YES,NO,A7,Breast,,LIVING,2011.0,c4149cf6-980f-4da1-b749-c24aae86f351,c4149cf6-980f-4da1-b749-c24aae86f351,,,TCGA-A7-A3IY-01,TCGA-A7-A3IY-01A-21D-A21R-05,,TCGA-A7-A3IY-01,TCGA-A7-A3IY-01A-21D-A21Q-09,,,TCGA-A7-A3IY-01,,,c4149cf6-980f-4da1-b749-c24aae86f351,,TCGA-A7-A3IY-01A-21D-A21P-01,TCGA-A7-A3IY-01,,c4149cf6-980f-4da1-b749-c24aae86f351,TCGA-A7-A3IY-01A-21D-A21P-01,
tcga.a7.a3iz,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A7-A3IZ-01,322.0,0.0,days,Kirc+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,,TCGA-A7-A3IZ,322.0,0.0,days,322.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A3IZ-F34491,TCGA-A7-A3IZ,TCGA-A7-A3IZ-01A,Negative,Positive,,,,Other,Negative,Lumpectomy,Reexcision,YES,,,-22997.0,86.0,,0.0,322.0,,,,,NO,,90-99%,3.0,,2012-8-16,FEMALE,,,,PathVysion HER-2 D probe kit.,2+,569.0,3.0,1.0,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,290.0,NO,Equivocal,Negative,NO,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,1.0,False,No,M0,N0 (i+),T2,Stage IIA,TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf,A3IZ,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2011.0,e4400dbf-b871-48ab-b571-4f883bb3c24e,e4400dbf-b871-48ab-b571-4f883bb3c24e,TCGA-A7-A3IZ-01A-21-A24A-20,,TCGA-A7-A3IZ-01,TCGA-A7-A3IZ-01A-11D-A212-05,0d5491ae-73ff-44ad-9aba-cde4b61fbf78,TCGA-A7-A3IZ-01,TCGA-A7-A3IZ-01A-11D-A20S-09,,,TCGA-A7-A3IZ-01,,,e4400dbf-b871-48ab-b571-4f883bb3c24e,,TCGA-A7-A3IZ-01A-11D-A20R-01,TCGA-A7-A3IZ-01,,e4400dbf-b871-48ab-b571-4f883bb3c24e,TCGA-A7-A3IZ-01A-11D-A20R-01,
tcga.a7.a3j0,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A7-A3J0-01,313.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,,TCGA-A7-A3J0,313.0,0.0,days,313.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right,Sentinel node biopsy alone,,TCGA-A7-A3J0-F35965,TCGA-A7-A3J0,TCGA-A7-A3J0-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-22672.0,78.0,,0.0,313.0,,,,,NO,,90-99%,,,2012-10-12,FEMALE,,,,,1+,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf,A3J0,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2011.0,1fbf8004-0091-4eb0-9042-d2f1a5174abe,1fbf8004-0091-4eb0-9042-d2f1a5174abe,TCGA-A7-A3J0-01A-21-A24A-20,,TCGA-A7-A3J0-01,TCGA-A7-A3J0-01A-11D-A212-05,d601836e-e95a-41eb-ad27-e72deada49b6,TCGA-A7-A3J0-01,TCGA-A7-A3J0-01A-11D-A20S-09,,,TCGA-A7-A3J0-01,,,1fbf8004-0091-4eb0-9042-d2f1a5174abe,,TCGA-A7-A3J0-01A-11D-A20R-01,TCGA-A7-A3J0-01,,1fbf8004-0091-4eb0-9042-d2f1a5174abe,TCGA-A7-A3J0-01A-11D-A20R-01,
tcga.a7.a3j1,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-A7-A3J1-01,343.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-A7-A3J1,343.0,0.0,days,343.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A3J1-F36693,TCGA-A7-A3J1,TCGA-A7-A3J1-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-23209.0,49.0,,0.0,343.0,,,,,NO,,90-99%,,,2012-11-12,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,Yes,MX,N0,T1c,Stage IA,TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf,A3J1,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2011.0,3b042185-867f-492b-a448-7c51e05f9b42,3b042185-867f-492b-a448-7c51e05f9b42,TCGA-A7-A3J1-01A-21-A24A-20,,TCGA-A7-A3J1-01,TCGA-A7-A3J1-01A-11D-A212-05,88ae23a8-e617-43a4-85be-d4b1f25847ec,TCGA-A7-A3J1-01,TCGA-A7-A3J1-01A-11D-A20S-09,,,TCGA-A7-A3J1-01,,,3b042185-867f-492b-a448-7c51e05f9b42,,TCGA-A7-A3J1-01A-11D-A20R-01,TCGA-A7-A3J1-01,,3b042185-867f-492b-a448-7c51e05f9b42,TCGA-A7-A3J1-01A-11D-A20R-01,
tcga.a7.a3rf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A3RF-01,408.0,0.0,days,Quiet,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA c1uster 10,,,TCGA-A7-A3RF,174.0,1.0,days,408.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,79.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A3RF-F40413,TCGA-A7-A3RF,TCGA-A7-A3RF-01A,Negative,Positive,,,,Other,Positive,Lumpectomy,Left breast reexcision,NO,,,-29184.0,61.0,,0.0,408.0,,,174,,,,90-99%,,,2013-2-19,FEMALE,,,,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Negative,,NO,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Distant Metastasis,,NO,YES,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf,A3RF,WITH TUMOR,,,,,,YES,YES,30-39%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,de0a584e-117e-4cf6-8c4a-6fb040270eda,de0a584e-117e-4cf6-8c4a-6fb040270eda,TCGA-A7-A3RF-01A-21-A24A-20,,TCGA-A7-A3RF-01,TCGA-A7-A3RF-01A-11D-A22B-05,1ecde81b-56db-4c3f-981d-6f1c4baa4a32,TCGA-A7-A3RF-01,TCGA-A7-A3RF-01A-11D-A228-09,,,TCGA-A7-A3RF-01,,,de0a584e-117e-4cf6-8c4a-6fb040270eda,,TCGA-A7-A3RF-01A-11D-A227-01,TCGA-A7-A3RF-01,,de0a584e-117e-4cf6-8c4a-6fb040270eda,TCGA-A7-A3RF-01A-11D-A227-01,
tcga.a7.a425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A425-01,447.0,0.0,days,,,,,,,,,,TCGA-A7-A425,419.0,1.0,days,447.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A425-F41648,TCGA-A7-A425,TCGA-A7-A425-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-25678.0,198.0,,0.0,447.0,,419.0,419,,,,90-99%,2.5,,2013-3-25,FEMALE,,,30-39%,Pathvysion HER-2 D Probe Kit,3+,228.0,2.8,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,400.0,NO,Indeterminate,Negative,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,1+,,Positive,90-99%,,,,3 Point Scale,,,,,<10%,,Negative,,,,,,,3 Point Scale,"Other, specify",Locoregional Recurrence,Left Breast,YES,YES,12.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf,A425,WITH TUMOR,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,0a423f86-ffa5-4c16-97ab-2d262c34fd41,0a423f86-ffa5-4c16-97ab-2d262c34fd41,,,TCGA-A7-A425-01,TCGA-A7-A425-01A-11D-A244-05,45d1596a-0b23-41ad-87c5-b1acc92619d2,TCGA-A7-A425-01,TCGA-A7-A425-01A-11D-A243-09,,,TCGA-A7-A425-01,,,0a423f86-ffa5-4c16-97ab-2d262c34fd41,,TCGA-A7-A425-01A-11D-A242-01,TCGA-A7-A425-01,,0a423f86-ffa5-4c16-97ab-2d262c34fd41,TCGA-A7-A425-01A-11D-A242-01,
tcga.a7.a426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A426-01,364.0,0.0,days,,,,,,,,,,TCGA-A7-A426,364.0,0.0,days,364.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A426-F41743,TCGA-A7-A426,TCGA-A7-A426-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-18296.0,132.0,,0.0,364.0,,,,,,,70-79%,,,2013-3-26,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,180.0,NO,Negative,,NO,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,13.0,,False,Yes,MX,N3a,T3,Stage IIIC,TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf,A426,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,185d3410-2daa-4d28-ab60-a7c13ae9d4fb,185d3410-2daa-4d28-ab60-a7c13ae9d4fb,,,TCGA-A7-A426-01,TCGA-A7-A426-01A-22D-A244-05,,TCGA-A7-A426-01,TCGA-A7-A426-01A-22D-A243-09,,,TCGA-A7-A426-01,,,185d3410-2daa-4d28-ab60-a7c13ae9d4fb,,TCGA-A7-A426-01A-22D-A242-01,TCGA-A7-A426-01,,185d3410-2daa-4d28-ab60-a7c13ae9d4fb,TCGA-A7-A426-01A-22D-A242-01,
tcga.a7.a4sa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SA-01,454.0,0.0,days,,,,,,,,,,TCGA-A7-A4SA,454.0,0.0,days,454.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A4SA-F49560,TCGA-A7-A4SA,TCGA-A7-A4SA-01A,,Positive,3 Point Scale,,,,Negative,Simple Mastectomy,,YES,,,-14906.0,127.0,,0.0,454.0,,,,,,,80-89%,,,2013-10-3,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,220.0,NO,Negative,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf,A4SA,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,781945fb-6d9e-4b45-8082-57675f21dc4a,781945fb-6d9e-4b45-8082-57675f21dc4a,,,TCGA-A7-A4SA-01,TCGA-A7-A4SA-01A-11D-A268-05,95bdb84b-c36a-4c64-8059-445ebf7adbb4,TCGA-A7-A4SA-01,TCGA-A7-A4SA-01A-11D-A25Q-09,,,TCGA-A7-A4SA-01,,,781945fb-6d9e-4b45-8082-57675f21dc4a,,TCGA-A7-A4SA-01A-11D-A25N-01,TCGA-A7-A4SA-01,,781945fb-6d9e-4b45-8082-57675f21dc4a,TCGA-A7-A4SA-01A-11D-A25N-01,
tcga.a7.a4sb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SB-01,418.0,0.0,days,,,,,,,,,,TCGA-A7-A4SB,418.0,0.0,days,418.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A4SB-F49625,TCGA-A7-A4SB,TCGA-A7-A4SB-01A,Negative,Positive,3 Point Scale,,3 Point Scale,Other,Positive,Lumpectomy,Right Breast reexcision,YES,,,-20539.0,75.0,,0.0,418.0,,,,,,,70-79%,,,2013-10-4,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,False,No,M0,N1mi,T3,Stage IIIA,TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf,A4SB,TUMOR FREE,,,,,,YES,YES,50-59%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,352dc94a-fc74-4292-890c-4ed9c22dcfbc,352dc94a-fc74-4292-890c-4ed9c22dcfbc,,,TCGA-A7-A4SB-01,TCGA-A7-A4SB-01A-21D-A268-05,,TCGA-A7-A4SB-01,TCGA-A7-A4SB-01A-21D-A25Q-09,,,TCGA-A7-A4SB-01,,,352dc94a-fc74-4292-890c-4ed9c22dcfbc,,TCGA-A7-A4SB-01A-21D-A25N-01,TCGA-A7-A4SB-01,,352dc94a-fc74-4292-890c-4ed9c22dcfbc,TCGA-A7-A4SB-01A-21D-A25N-01,
tcga.a7.a4sc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SC-01,446.0,0.0,days,,,,,,,,,,TCGA-A7-A4SC,446.0,0.0,days,446.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,,,TCGA-A7-A4SC-F49714,TCGA-A7-A4SC,TCGA-A7-A4SC-01A,,Positive,,,,,Negative,Simple Mastectomy,,YES,,,-23008.0,110.0,,0.0,446.0,,,,,,,90-99%,2.2,,2013-10-8,FEMALE,,,,PathVysion HER-2 D Probe kit,3+,303.0,2.4,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,360.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0,T3,Stage IIB,TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf,A4SC,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,84633979-56dd-4244-90bc-fa4652718880,84633979-56dd-4244-90bc-fa4652718880,,,TCGA-A7-A4SC-01,TCGA-A7-A4SC-01A-12D-A268-05,3d087331-9673-4816-97ac-741f364cccae,,TCGA-A7-A4SC-01A-12D-A25Q-09,,,TCGA-A7-A4SC-01,,,84633979-56dd-4244-90bc-fa4652718880,,,TCGA-A7-A4SC-01,,84633979-56dd-4244-90bc-fa4652718880,,
tcga.a7.a4sd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SD-01,441.0,0.0,days,,,,,,,,,,TCGA-A7-A4SD,441.0,0.0,days,441.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right,Sentinel node biopsy alone,,TCGA-A7-A4SD-F52732,TCGA-A7-A4SD,TCGA-A7-A4SD-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-19131.0,63.0,,0.0,441.0,,,,,,,,5,,2013-12-5,FEMALE,,,,PathVysion HER-2 D Probe Kit,2+,20.0,6.4,1.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,230.0,NO,Equivocal,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf,A4SD,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,cb0d669b-658a-4a41-9904-f838ddb12db2,cb0d669b-658a-4a41-9904-f838ddb12db2,,,TCGA-A7-A4SD-01,TCGA-A7-A4SD-01A-11D-A268-05,148f42bd-6aee-4dc7-bf8b-d5e8580c1b4d,TCGA-A7-A4SD-01,TCGA-A7-A4SD-01A-11D-A25Q-09,,,TCGA-A7-A4SD-01,,,cb0d669b-658a-4a41-9904-f838ddb12db2,,TCGA-A7-A4SD-01A-11D-A25N-01,TCGA-A7-A4SD-01,,cb0d669b-658a-4a41-9904-f838ddb12db2,TCGA-A7-A4SD-01A-11D-A25N-01,
tcga.a7.a4se,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SE-01,644.0,0.0,days,,,,,,,,,,TCGA-A7-A4SE,644.0,0.0,days,644.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left,Sentinel node biopsy alone,,TCGA-A7-A4SE-F50162,TCGA-A7-A4SE,TCGA-A7-A4SE-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-20080.0,306.0,,0.0,644.0,,,,,,,,,,2013-10-16,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Negative,,YES,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf,A4SE,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2011.0,6bb217e7-3fd4-477f-87bf-b55e50a33e45,6bb217e7-3fd4-477f-87bf-b55e50a33e45,,,TCGA-A7-A4SE-01,TCGA-A7-A4SE-01A-11D-A268-05,7309fdea-a4df-4081-adac-88e2966c8642,TCGA-A7-A4SE-01,TCGA-A7-A4SE-01A-11D-A25Q-09,,,TCGA-A7-A4SE-01,,,6bb217e7-3fd4-477f-87bf-b55e50a33e45,,TCGA-A7-A4SE-01A-11D-A25N-01,TCGA-A7-A4SE-01,,6bb217e7-3fd4-477f-87bf-b55e50a33e45,TCGA-A7-A4SE-01A-11D-A25N-01,
tcga.a7.a4sf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A4SF-01,545.0,0.0,days,,,,,,,,,,TCGA-A7-A4SF,545.0,0.0,days,545.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right,Sentinel node biopsy alone,,TCGA-A7-A4SF-F49721,TCGA-A7-A4SF,,Positive,Positive,3 Point Scale,,,Other,Negative,Lumpectomy,Right Breast Reexcision,YES,,,-19985.0,,,0.0,545.0,,,,,,,90-99%,,,2013-10-9,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Positive,,NO,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A4SF,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,,LIVING,2012.0,f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8,f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8,,,TCGA-A7-A4SF-01,TCGA-A7-A4SF-01A-11D-A268-05,e04e9fb6-be99-430f-8f5b-fd4aaba872dc,TCGA-A7-A4SF-01,TCGA-A7-A4SF-01A-11D-A25Q-09,,,TCGA-A7-A4SF-01,,,f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8,,TCGA-A7-A4SF-01A-11D-A25N-01,TCGA-A7-A4SF-01,,f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8,TCGA-A7-A4SF-01A-11D-A25N-01,
tcga.a7.a56d,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A56D-01,448.0,0.0,days,,,,,,,,,,TCGA-A7-A56D,448.0,0.0,days,448.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,84.0,Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A56D-F50426,TCGA-A7-A56D,TCGA-A7-A56D-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-30783.0,140.0,,0.0,448.0,,,,,,,90-99%,,,2013-10-23,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,80.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf,A56D,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4,3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4,,,TCGA-A7-A56D-01,TCGA-A7-A56D-01A-11D-A27Y-05,,TCGA-A7-A56D-01,TCGA-A7-A56D-01A-11D-A27P-09,,,TCGA-A7-A56D-01,,,3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4,,TCGA-A7-A56D-01A-11D-A27O-01,TCGA-A7-A56D-01,,3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4,TCGA-A7-A56D-01A-11D-A27O-01,
tcga.a7.a5zv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A5ZV-01,368.0,0.0,days,,,,,,,,,,TCGA-A7-A5ZV,368.0,0.0,days,368.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left,Sentinel node biopsy alone,,TCGA-A7-A5ZV-F51143,TCGA-A7-A5ZV,,,Negative,,,,,Negative,Lumpectomy,,NO,,,-22966.0,,,0.0,368.0,,,,,,,,2.5,,2013-11-8,FEMALE,,,,PathVysion HER-2 D Probe Kit,2+,40.0,3.8,1.5,,Infiltrating Carcinoma NOS,,No,,C50.9,8010/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A5ZV,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,,LIVING,2012.0,e121ae32-63c2-4b13-b135-d1837fc10999,e121ae32-63c2-4b13-b135-d1837fc10999,,,TCGA-A7-A5ZV-01,TCGA-A7-A5ZV-01A-11D-A28C-05,cc46932d-0799-42ae-8a92-5bf65e381969,TCGA-A7-A5ZV-01,TCGA-A7-A5ZV-01A-11D-A28B-09,,,TCGA-A7-A5ZV-01,,,e121ae32-63c2-4b13-b135-d1837fc10999,,TCGA-A7-A5ZV-01A-11D-A28A-01,TCGA-A7-A5ZV-01,,e121ae32-63c2-4b13-b135-d1837fc10999,TCGA-A7-A5ZV-01A-11D-A28A-01,
tcga.a7.a5zw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A5ZW-01,326.0,0.0,days,,,,,,,,,,TCGA-A7-A5ZW,326.0,0.0,days,326.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A5ZW-F51509,TCGA-A7-A5ZW,TCGA-A7-A5ZW-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,NO,,,-17529.0,77.0,,0.0,326.0,,,,,,,90-99%,,,2013-11-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,60.0,NO,Negative,,NO,1.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf,A5ZW,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2012.0,8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f,8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f,,,TCGA-A7-A5ZW-01,TCGA-A7-A5ZW-01A-12D-A29O-05,,TCGA-A7-A5ZW-01,TCGA-A7-A5ZW-01A-12D-A29N-09,,,TCGA-A7-A5ZW-01,,,8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f,,TCGA-A7-A5ZW-01A-12D-A29M-01,TCGA-A7-A5ZW-01,,8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f,TCGA-A7-A5ZW-01A-12D-A29M-01,
tcga.a7.a5zx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A5ZX-01,336.0,0.0,days,,,,,,,,,,TCGA-A7-A5ZX,336.0,0.0,days,336.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A5ZX-F52721,TCGA-A7-A5ZX,,,Positive,3 Point Scale,,3 Point Scale,,Positive,Other,,YES,,,-17683.0,,,0.0,336.0,,,,,,,,,,2013-12-6,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,24.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,21.0,,,Yes,M0,N3a,T2,Stage IIIC,,A5ZX,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.,7th,,YES,NO,A7,Breast,,LIVING,2012.0,e3c70f4d-4a23-486b-b221-3058b13a1c69,e3c70f4d-4a23-486b-b221-3058b13a1c69,,,TCGA-A7-A5ZX-01,TCGA-A7-A5ZX-01A-12D-A29O-05,,TCGA-A7-A5ZX-01,TCGA-A7-A5ZX-01A-12D-A29N-09,,,TCGA-A7-A5ZX-01,,,e3c70f4d-4a23-486b-b221-3058b13a1c69,,TCGA-A7-A5ZX-01A-12D-A29M-01,TCGA-A7-A5ZX-01,,e3c70f4d-4a23-486b-b221-3058b13a1c69,TCGA-A7-A5ZX-01A-12D-A29M-01,
tcga.a7.a6vv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A6VV-01,313.0,0.0,days,,,,,,,,,,TCGA-A7-A6VV,313.0,0.0,days,313.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A6VV-F57249,TCGA-A7-A6VV,TCGA-A7-A6VV-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18695.0,85.0,,0.0,313.0,,,,,,,,,,2014-3-6,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,1100.0,NO,Negative,,NO,5.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf,A6VV,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2013.0,c02ec36d-9e79-4e2f-a46c-f898838766df,c02ec36d-9e79-4e2f-a46c-f898838766df,,,TCGA-A7-A6VV-01,TCGA-A7-A6VV-01A-22D-A33F-05,66E3766B-46AB-4A9B-8B6E-1EECA04D9B62,TCGA-A7-A6VV-01,,,,TCGA-A7-A6VV-01,,,c02ec36d-9e79-4e2f-a46c-f898838766df,,TCGA-A7-A6VV-01A-22D-A33D-01,TCGA-A7-A6VV-01,,c02ec36d-9e79-4e2f-a46c-f898838766df,TCGA-A7-A6VV-01A-22D-A33D-01,
tcga.a7.a6vw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A6VW-01,285.0,0.0,days,,,,,,,,,,TCGA-A7-A6VW,285.0,0.0,days,285.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left,Sentinel node biopsy alone,,TCGA-A7-A6VW-F57227,TCGA-A7-A6VW,,,Negative,,,,,Negative,Lumpectomy,,NO,,,-17539.0,,,0.0,285.0,,,,,,,,,,2014-3-6,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,2.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A6VW,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,,LIVING,2013.0,f572c953-e1aa-4dd2-a8f8-e292ab7bd139,f572c953-e1aa-4dd2-a8f8-e292ab7bd139,,,TCGA-A7-A6VW-01,TCGA-A7-A6VW-01A-21D-A33F-05,,TCGA-A7-A6VW-01,,,,TCGA-A7-A6VW-01,,,f572c953-e1aa-4dd2-a8f8-e292ab7bd139,,TCGA-A7-A6VW-01A-21D-A33D-01,TCGA-A7-A6VW-01,,f572c953-e1aa-4dd2-a8f8-e292ab7bd139,TCGA-A7-A6VW-01A-21D-A33D-01,
tcga.a7.a6vx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A6VX-01,317.0,0.0,days,,,,,,,,,,TCGA-A7-A6VX,317.0,0.0,days,317.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-A7-A6VX-F57518,TCGA-A7-A6VX,TCGA-A7-A6VX-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-25066.0,73.0,,0.0,317.0,,,,,,Immune Stain by GenPath,90-99%,,,2014-3-13,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf,A6VX,TUMOR FREE,Immune stain by GenPath,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2013.0,aed86155-1d12-4447-bdf6-3aaba9938a71,aed86155-1d12-4447-bdf6-3aaba9938a71,,,TCGA-A7-A6VX-01,TCGA-A7-A6VX-01A-12D-A33F-05,8C0E2DD9-D3B3-4AF6-A450-4B7F1DBA5CE7,TCGA-A7-A6VX-01,,,,TCGA-A7-A6VX-01,,,aed86155-1d12-4447-bdf6-3aaba9938a71,,TCGA-A7-A6VX-01A-12D-A33D-01,TCGA-A7-A6VX-01,,aed86155-1d12-4447-bdf6-3aaba9938a71,TCGA-A7-A6VX-01A-12D-A33D-01,
tcga.a7.a6vy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-A7-A6VY-01,266.0,0.0,days,,,,,,,,,,TCGA-A7-A6VY,266.0,0.0,days,266.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-A7-A6VY-F57257,TCGA-A7-A6VY,TCGA-A7-A6VY-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-17640.0,29.0,,0.0,266.0,,,,,,,,,,2014-3-6,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Negative,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf,A6VY,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,A7,Breast,A,LIVING,2013.0,2fb506f2-4b76-4c20-ae45-8939f2e14753,2fb506f2-4b76-4c20-ae45-8939f2e14753,,,TCGA-A7-A6VY-01,TCGA-A7-A6VY-01A-12D-A33F-05,,TCGA-A7-A6VY-01,,,,TCGA-A7-A6VY-01,,,2fb506f2-4b76-4c20-ae45-8939f2e14753,,TCGA-A7-A6VY-01A-12D-A33D-01,TCGA-A7-A6VY-01,,2fb506f2-4b76-4c20-ae45-8939f2e14753,TCGA-A7-A6VY-01A-12D-A33D-01,
tcga.ac.a23c,,62.0,3.0,Stage IIB,29.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,29.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AC-A23C-01,585.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 7,mutation cluster 4,TCGA-AC-A23C,585.0,0.0,days,585.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left,,,TCGA-AC-A23C-F43235,TCGA-AC-A23C,TCGA-AC-A23C-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-22751.0,198.0,,0.0,585.0,,,,,NO,,90-99%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Positive,Positive,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,1.0,,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf,A23C,TUMOR FREE,,,,,,YES,YES,50-59%,,NO,Primary Tumor,1,,7th,,NO,YES,AC,Breast,A,LIVING,2010.0,052b565f-1955-4c4e-8b1f-dd48743ba944,052b565f-1955-4c4e-8b1f-dd48743ba944,TCGA-AC-A23C-01A-21-A17I-20,TCGA-AC-A23C-01A-12D-A167-09,TCGA-AC-A23C-01,TCGA-AC-A23C-01A-12D-A16A-05,53968cee-b8a9-43d6-b9cd-d4b9cd39baf0,TCGA-AC-A23C-01,TCGA-AC-A23C-01A-12D-A167-09,,,TCGA-AC-A23C-01,TCGA-AC-A23C-01A-12D-A167-09,,052b565f-1955-4c4e-8b1f-dd48743ba944,,TCGA-AC-A23C-01A-12D-A166-01,TCGA-AC-A23C-01,,052b565f-1955-4c4e-8b1f-dd48743ba944,TCGA-AC-A23C-01A-12D-A166-01,
tcga.ac.a23e,,50.0,2.0,Stage IIB,72.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,72.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AC-A23E-01,698.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 4,TCGA-AC-A23E,698.0,0.0,days,698.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Sentinel node biopsy alone,,TCGA-AC-A23E-F43240,TCGA-AC-A23E,TCGA-AC-A23E-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-18500.0,158.0,,0.0,698.0,,,,,NO,,30-39%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,130.0,NO,,,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,2.0,,,,,,,,,NO,1.0,,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf,A23E,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,,,AC,Breast,A,LIVING,2010.0,25be50e7-7705-492d-a44a-0e40180d10c8,25be50e7-7705-492d-a44a-0e40180d10c8,TCGA-AC-A23E-01A-21-A17I-20,TCGA-AC-A23E-01A-11D-A159-09,TCGA-AC-A23E-01,TCGA-AC-A23E-01A-11D-A161-05,f5ca4ea4-d35a-456e-aabb-0aec9f48a7be,TCGA-AC-A23E-01,TCGA-AC-A23E-01A-11D-A159-09,,,TCGA-AC-A23E-01,TCGA-AC-A23E-01A-11D-A159-09,,25be50e7-7705-492d-a44a-0e40180d10c8,,TCGA-AC-A23E-01A-11D-A160-01,TCGA-AC-A23E-01,,25be50e7-7705-492d-a44a-0e40180d10c8,TCGA-AC-A23E-01A-11D-A160-01,
tcga.ac.a23g,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A23G-01,2248.0,0.0,days,Iq,,,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A23G,2248.0,0.0,days,2248.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,76.0,Right Upper Inner Quadrant,,,TCGA-AC-A23G-F43241,TCGA-AC-A23G,TCGA-AC-A23G-01A,,Positive,,,,,Positive,Other,,,,,-27934.0,1590.0,,0.0,2248.0,,,,,NO,,90-99%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,40.0,NO,Positive,Positive,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,False,No,MX,N1,T1c,Stage IIA,TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf,A23G,TUMOR FREE,,,,,,YES,YES,80-89%,,NO,Primary Tumor,1,Right Total Mastectomy and Sentinel Node Biopsy,6th,,NO,YES,AC,Breast,A,LIVING,2006.0,3cd0b704-99b5-401b-8f52-daead9359692,3cd0b704-99b5-401b-8f52-daead9359692,,,TCGA-AC-A23G-01,TCGA-AC-A23G-01A-11D-A212-05,,TCGA-AC-A23G-01,TCGA-AC-A23G-01A-11D-A20S-09,,,TCGA-AC-A23G-01,,,3cd0b704-99b5-401b-8f52-daead9359692,,TCGA-AC-A23G-01A-11D-A20R-01,TCGA-AC-A23G-01,,3cd0b704-99b5-401b-8f52-daead9359692,TCGA-AC-A23G-01A-11D-A20R-01,
tcga.ac.a23h,,90.0,3.0,Stage IIA,81.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,81.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-AC-A23H-01,174.0,1.0,days,High,,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A23H,174.0,0.0,days,174.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant,,,TCGA-AC-A23H-F45572,TCGA-AC-A23H,TCGA-AC-A23H-01A,,Positive,,,,,Negative,Simple Mastectomy,,,,,-32873.0,478.0,174.0,0.0,81.0,,,,,NO,,10-19%,,,2013-7-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,,,False,No,M0,NX,T2,Stage IIA,TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf,A23H,WITH TUMOR,,,,,,NO,NO,,,NO,Primary Tumor,1,,7th,,NO,YES,AC,Breast,A,DECEASED,2009.0,28199d71-9111-4763-a07f-66734769bb98,28199d71-9111-4763-a07f-66734769bb98,,,TCGA-AC-A23H-01,TCGA-AC-A23H-01A-11D-A161-05,,TCGA-AC-A23H-01,TCGA-AC-A23H-01A-11D-A159-09,,,TCGA-AC-A23H-01,,,28199d71-9111-4763-a07f-66734769bb98,,TCGA-AC-A23H-01A-11D-A160-01,TCGA-AC-A23H-01,,28199d71-9111-4763-a07f-66734769bb98,TCGA-AC-A23H-01A-11D-A160-01,
tcga.ac.a2b8,,,2.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A2B8-01,677.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A2B8,654.0,1.0,days,677.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,YES,,,84.0,Right,Axillary lymph node dissection alone,,TCGA-AC-A2B8-F43210,TCGA-AC-A2B8,TCGA-AC-A2B8-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-31003.0,101.0,,0.0,677.0,,672.0,654,,NO,,90-99%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,150.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,"Other, specify",New Primary Tumor,Rectum,YES,YES,0.0,0.0,False,No,M0,N0 (i-),T3,Stage IIB,TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf,A2B8,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,ed74a7e1-90de-4943-9ca2-e7f94a5540e4,ed74a7e1-90de-4943-9ca2-e7f94a5540e4,TCGA-AC-A2B8-01A-21-A24A-20,,TCGA-AC-A2B8-01,TCGA-AC-A2B8-01A-11D-A17F-05,7365ebda-a4f6-4d52-bed9-220059dc5e5e,TCGA-AC-A2B8-01,TCGA-AC-A2B8-01A-11D-A17D-09,,,TCGA-AC-A2B8-01,,,ed74a7e1-90de-4943-9ca2-e7f94a5540e4,,TCGA-AC-A2B8-01A-11D-A17C-01,TCGA-AC-A2B8-01,,ed74a7e1-90de-4943-9ca2-e7f94a5540e4,TCGA-AC-A2B8-01A-11D-A17C-01,
tcga.ac.a2bk,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,0.0,TCGA-AC-A2BK-01,2222.0,0.0,days,High,C4-BRCA/Basal,,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 4,,,TCGA-AC-A2BK,2222.0,0.0,days,2222.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A2BK-F43987,TCGA-AC-A2BK,TCGA-AC-A2BK-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-28625.0,1717.0,,0.0,2222.0,,,,,NO,,,,,2013-6-10,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Negative,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,6.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf,A2BK,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2006.0,08893743-829b-4594-ab67-d5eb5e80a4f3,08893743-829b-4594-ab67-d5eb5e80a4f3,TCGA-AC-A2BK-01A-21-A24A-20,,TCGA-AC-A2BK-01,TCGA-AC-A2BK-01A-11D-A21R-05,1392fc51-37de-493d-a7e9-01269e73c9c5,TCGA-AC-A2BK-01,TCGA-AC-A2BK-01A-11D-A21Q-09,,,TCGA-AC-A2BK-01,,,08893743-829b-4594-ab67-d5eb5e80a4f3,,TCGA-AC-A2BK-01A-11D-A21P-01,TCGA-AC-A2BK-01,,08893743-829b-4594-ab67-d5eb5e80a4f3,TCGA-AC-A2BK-01A-11D-A21P-01,
tcga.ac.a2bm,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,0.0,TCGA-AC-A2BM-01,3022.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A2BM,3022.0,0.0,days,3022.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A2BM-F66202,TCGA-AC-A2BM,TCGA-AC-A2BM-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-15212.0,2164.0,,0.0,3022.0,,,,,NO,,60-69%,,,2014-10-3,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,120.0,NO,,Negative,NO,13.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,1.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf,A2BM,TUMOR FREE,,,,,,NO,YES,10-19%,,NO,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2005.0,54f1981b-9d8f-48cc-9586-d2e9a8d468f5,54f1981b-9d8f-48cc-9586-d2e9a8d468f5,TCGA-AC-A2BM-01A-21-A24A-20,,TCGA-AC-A2BM-01,TCGA-AC-A2BM-01A-11D-A21R-05,2222f10b-39fd-4aa4-8021-7f320c835f88,TCGA-AC-A2BM-01,TCGA-AC-A2BM-01A-11D-A21Q-09,,,TCGA-AC-A2BM-01,,,54f1981b-9d8f-48cc-9586-d2e9a8d468f5,,TCGA-AC-A2BM-01A-11D-A21P-01,TCGA-AC-A2BM-01,,54f1981b-9d8f-48cc-9586-d2e9a8d468f5,TCGA-AC-A2BM-01A-11D-A21P-01,
tcga.ac.a2fb,,,3.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A2FB-01,1234.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A2FB,1234.0,0.0,days,1234.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-AC-A2FB-F45574,TCGA-AC-A2FB,TCGA-AC-A2FB-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-23851.0,576.0,,0.0,1234.0,,,,,NO,,90-99%,,,2013-7-17,FEMALE,,,10-19%,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,140.0,NO,Positive,,NO,1.0,Negative,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf,A2FB,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2009.0,fce0d59e-78a5-4d7b-8136-b8421f5116b0,fce0d59e-78a5-4d7b-8136-b8421f5116b0,TCGA-AC-A2FB-01A-21-A24A-20,,TCGA-AC-A2FB-01,TCGA-AC-A2FB-01A-11D-A17F-05,6bde7ec5-1170-4bdf-afa6-bff4642ef9e3,TCGA-AC-A2FB-01,TCGA-AC-A2FB-01A-11D-A17D-09,,,TCGA-AC-A2FB-01,,,fce0d59e-78a5-4d7b-8136-b8421f5116b0,,TCGA-AC-A2FB-01A-11D-A17C-01,TCGA-AC-A2FB-01,,fce0d59e-78a5-4d7b-8136-b8421f5116b0,TCGA-AC-A2FB-01A-11D-A17C-01,
tcga.ac.a2fe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AC-A2FE-01,2636.0,1.0,days,BRCA-LUAD+,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 5,,,TCGA-AC-A2FE,2496.0,1.0,days,2636.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A2FE-F47725,TCGA-AC-A2FE,TCGA-AC-A2FE-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-22746.0,2228.0,2636.0,0.0,791.0,,,2496,,,,60-69%,,,2013-8-28,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,120.0,NO,,,NO,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Liver,Distant Metastasis,,NO,YES,18.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf,A2FE,WITH TUMOR,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,DECEASED,2005.0,22e03b77-aa0f-4348-98c1-9b0914e8af8b,22e03b77-aa0f-4348-98c1-9b0914e8af8b,TCGA-AC-A2FE-01A-21-A24A-20,,TCGA-AC-A2FE-01,TCGA-AC-A2FE-01A-11D-A19Z-05,419206c6-a1d6-4541-b154-10aae75b04a2,TCGA-AC-A2FE-01,TCGA-AC-A2FE-01A-11D-A19Y-09,,,TCGA-AC-A2FE-01,,,22e03b77-aa0f-4348-98c1-9b0914e8af8b,,TCGA-AC-A2FE-01A-11D-A19X-01,TCGA-AC-A2FE-01,,22e03b77-aa0f-4348-98c1-9b0914e8af8b,TCGA-AC-A2FE-01A-11D-A19X-01,
tcga.ac.a2ff,,,1.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A2FF-01,2759.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A2FF,2759.0,0.0,days,2759.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A2FF-F58655,TCGA-AC-A2FF,TCGA-AC-A2FF-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,,1904.0,,0.0,2759.0,,,,,NO,,30-39%,,,2014-4-17,FEMALE,,,,,,,,1.7,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,130.0,NO,,Negative,NO,7.0,Negative,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,3.0,0.0,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf,A2FF,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2006.0,f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8,f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8,TCGA-AC-A2FF-01A-21-A24A-20,,TCGA-AC-A2FF-01,TCGA-AC-A2FF-01A-11D-A17F-05,588f1cc2-09a3-4ffa-b934-a8b7c4c8524c,TCGA-AC-A2FF-01,TCGA-AC-A2FF-01A-11D-A17D-09,,,TCGA-AC-A2FF-01,,,f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8,,TCGA-AC-A2FF-01A-11D-A17C-01,TCGA-AC-A2FF-01,,f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8,TCGA-AC-A2FF-01A-11D-A17C-01,
tcga.ac.a2fg,,,2.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A2FG-01,1853.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,,,TCGA-AC-A2FG,1853.0,0.0,days,1853.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A2FG-F43221,TCGA-AC-A2FG,TCGA-AC-A2FG-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,YES,,,-29211.0,1517.0,,0.0,1853.0,,,,,NO,,90-99%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,120.0,NO,,Negative,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,1.0,1.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf,A2FG,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2007.0,c4cc228f-ab41-4779-b405-175618e5f77c,c4cc228f-ab41-4779-b405-175618e5f77c,TCGA-AC-A2FG-01A-21-A24A-20,,TCGA-AC-A2FG-01,TCGA-AC-A2FG-01A-11D-A17F-05,4be4e39c-7061-4ef0-8347-75622194af98,TCGA-AC-A2FG-01,TCGA-AC-A2FG-01A-11D-A17D-09,,,TCGA-AC-A2FG-01,,,c4cc228f-ab41-4779-b405-175618e5f77c,,TCGA-AC-A2FG-01A-11D-A17C-01,TCGA-AC-A2FG-01,,c4cc228f-ab41-4779-b405-175618e5f77c,TCGA-AC-A2FG-01A-11D-A17C-01,
tcga.ac.a2fk,,,,,,,,,,,,,,,,,,,Normal,,,,,,,,,,0.0,TCGA-AC-A2FK-01,2650.0,0.0,days,Quiet,,,Low purity c2,,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-AC-A2FK,2650.0,0.0,days,2650.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Outer Quadrant,,,TCGA-AC-A2FK-F66196,TCGA-AC-A2FK,TCGA-AC-A2FK-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16627.0,1833.0,,0.0,2650.0,,,,,NO,,90-99%,,,2014-10-3,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,80.0,NO,,Negative,NO,3.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf,A2FK,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,LIVING,2006.0,1fff796f-626b-4408-9fd1-4fea54e153a6,1fff796f-626b-4408-9fd1-4fea54e153a6,,,TCGA-AC-A2FK-01,TCGA-AC-A2FK-01A-12D-A17Z-05,,TCGA-AC-A2FK-01,TCGA-AC-A2FK-01A-12D-A17W-09,,,TCGA-AC-A2FK-01,,,1fff796f-626b-4408-9fd1-4fea54e153a6,,TCGA-AC-A2FK-01A-12D-A17U-01,TCGA-AC-A2FK-01,,1fff796f-626b-4408-9fd1-4fea54e153a6,TCGA-AC-A2FK-01A-12D-A17U-01,
tcga.ac.a2fm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AC-A2FM-01,792.0,1.0,days,High,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 5,,,TCGA-AC-A2FM,780.0,1.0,days,792.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,87.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-AC-A2FM-F43237,TCGA-AC-A2FM,TCGA-AC-A2FM-01A,,,,,,,,Modified Radical Mastectomy,,YES,,,-31805.0,2606.0,792.0,0.0,,,,780,,YES,,,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,170.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",Distant Metastasis,Bone Marrow,NO,YES,0.0,0.0,False,No,M0,N1mi,T2,Stage IIB,TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf,A2FM,WITH TUMOR,,,,,,NO,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,AC,Breast,A,DECEASED,2004.0,c1280be2-b926-4632-975a-fe52bb04c65d,c1280be2-b926-4632-975a-fe52bb04c65d,TCGA-AC-A2FM-01A-21-A24A-20,,TCGA-AC-A2FM-01,TCGA-AC-A2FM-01A-11D-A19Z-05,26f52e65-dac7-4cd4-9d02-7d01c2c6f0b7,TCGA-AC-A2FM-01,TCGA-AC-A2FM-01A-11D-A19Y-09,,,TCGA-AC-A2FM-01,,,c1280be2-b926-4632-975a-fe52bb04c65d,,TCGA-AC-A2FM-01A-11D-A19X-01,TCGA-AC-A2FM-01,,c1280be2-b926-4632-975a-fe52bb04c65d,TCGA-AC-A2FM-01A-11D-A19X-01,
tcga.ac.a2fo,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A2FO-01,2255.0,0.0,days,Iq,,,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,,,TCGA-AC-A2FO,2255.0,0.0,days,2255.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left Upper Outer Quadrant,Other (specify),Sentinel lymph node plus Level I and Level II lymph nodes,TCGA-AC-A2FO-F43223,TCGA-AC-A2FO,,,Positive,,,,,Negative,Simple Mastectomy,,NO,,,-23928.0,,,0.0,2255.0,,,,,NO,,90-99%,,,2013-5-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,Indeterminate,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,,No,MX,N1,T2,Stage IIB,,A2FO,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,AC,Breast,,LIVING,2005.0,bd07aa68-708b-4bd3-88b9-78a8b9e298f5,bd07aa68-708b-4bd3-88b9-78a8b9e298f5,,,TCGA-AC-A2FO-01,TCGA-AC-A2FO-01A-11D-A17Z-05,,TCGA-AC-A2FO-01,TCGA-AC-A2FO-01A-11D-A17W-09,,,TCGA-AC-A2FO-01,,,bd07aa68-708b-4bd3-88b9-78a8b9e298f5,,TCGA-AC-A2FO-01A-11D-A17U-01,TCGA-AC-A2FO-01,,bd07aa68-708b-4bd3-88b9-78a8b9e298f5,TCGA-AC-A2FO-01A-11D-A17U-01,
tcga.ac.a2qh,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,0.0,TCGA-AC-A2QH-01,1005.0,0.0,days,Squamous,,,Cluster 5,,GBM-like c6,miRNA cluster 13,,,TCGA-AC-A2QH,1005.0,0.0,days,1005.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A2QH-F64100,TCGA-AC-A2QH,,,Negative,,,,,Negative,Modified Radical Mastectomy,,YES,,,-21488.0,,,0.0,1005.0,,,,,NO,,,,,2014-8-26,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,MX,N0,T3,Stage IIB,,A2QH,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2011.0,d848ad65-9261-4854-a6bd-e76484c6a337,d848ad65-9261-4854-a6bd-e76484c6a337,,,TCGA-AC-A2QH-01,"TCGA-AC-A2QH-01A-11D-A18O-05,TCGA-AC-A2QH-01B-04D-A22R-05",,TCGA-AC-A2QH-01,"TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09",,,TCGA-AC-A2QH-01,,,d848ad65-9261-4854-a6bd-e76484c6a337,,TCGA-AC-A2QH-01A-11D-A18N-01,TCGA-AC-A2QH-01,,d848ad65-9261-4854-a6bd-e76484c6a337,TCGA-AC-A2QH-01A-11D-A18N-01,
tcga.ac.a2qi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A2QI-01,588.0,0.0,days,BRCA-LUAD+,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 3,,,TCGA-AC-A2QI,588.0,0.0,days,588.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,76.0,Right,Sentinel node biopsy alone,,TCGA-AC-A2QI-F57047,TCGA-AC-A2QI,TCGA-AC-A2QI-01A,,Positive,,,,,Negative,Other,,,,,-27865.0,91.0,,0.0,588.0,,,,,NO,,90-99%,,,2014-2-28,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf,A2QI,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Total Mastectomy,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,d620baa1-c329-46c6-a56a-dc08dfa23470,d620baa1-c329-46c6-a56a-dc08dfa23470,TCGA-AC-A2QI-01A-21-A24A-20,,TCGA-AC-A2QI-01,TCGA-AC-A2QI-01A-12D-A19Z-05,3d65de31-a929-4c60-af58-5c24b7e3d6a5,TCGA-AC-A2QI-01,TCGA-AC-A2QI-01A-12D-A19Y-09,,,TCGA-AC-A2QI-01,,,d620baa1-c329-46c6-a56a-dc08dfa23470,,TCGA-AC-A2QI-01A-12D-A19X-01,TCGA-AC-A2QI-01,,d620baa1-c329-46c6-a56a-dc08dfa23470,TCGA-AC-A2QI-01A-12D-A19X-01,
tcga.ac.a2qj,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AC-A2QJ-01,446.0,1.0,days,BRCA-LUAD+,,,BRCA non-CIMP c9,KIRC-like c1,,miRNA cluster 5,,,TCGA-AC-A2QJ,237.0,1.0,days,446.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,48.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Other (specify),Sentinel lymph node and axillary lymph node biopsy,TCGA-AC-A2QJ-F44021,TCGA-AC-A2QJ,TCGA-AC-A2QJ-01A,,Negative,,,,,Negative,Other,,NO,,,-17569.0,160.0,446.0,0.0,69.0,,,237,,NO,,,,,2013-6-28,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,150.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Distant Metastasis,,NO,YES,0.0,,False,No,M0,N0,T4b,Stage IIIB,TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf,A2QJ,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,Mastectomy,7th,,YES,NO,AC,Breast,A,DECEASED,2011.0,49a0f1eb-6ece-48fc-970f-3922263fd20b,49a0f1eb-6ece-48fc-970f-3922263fd20b,TCGA-AC-A2QJ-01A-21-A24A-20,,TCGA-AC-A2QJ-01,TCGA-AC-A2QJ-01A-12D-A19Z-05,5755434d-e797-4963-b728-caefc7bd49d5,TCGA-AC-A2QJ-01,TCGA-AC-A2QJ-01A-12D-A19Y-09,,,TCGA-AC-A2QJ-01,,,49a0f1eb-6ece-48fc-970f-3922263fd20b,,TCGA-AC-A2QJ-01A-12D-A19X-01,TCGA-AC-A2QJ-01,,49a0f1eb-6ece-48fc-970f-3922263fd20b,TCGA-AC-A2QJ-01A-12D-A19X-01,
tcga.ac.a3bb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3BB-01,987.0,0.0,days,BRCA-LUAD+,,,BRCA non-CIMP c9,,,miRNA cluster 5,,,TCGA-AC-A3BB,987.0,0.0,days,987.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A3BB-F58953,TCGA-AC-A3BB,TCGA-AC-A3BB-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16983.0,106.0,,0.0,987.0,,,,,NO,,90-99%,,,2014-4-29,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Negative,,NO,14.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf,A3BB,TUMOR FREE,,,,,,YES,,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa,5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa,,,TCGA-AC-A3BB-01,TCGA-AC-A3BB-01A-21D-A19Z-05,,TCGA-AC-A3BB-01,TCGA-AC-A3BB-01A-21D-A19Y-09,,,TCGA-AC-A3BB-01,,,5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa,,TCGA-AC-A3BB-01A-21D-A19X-01,TCGA-AC-A3BB-01,,5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa,TCGA-AC-A3BB-01A-21D-A19X-01,
tcga.ac.a3eh,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AC-A3EH-01,197.0,1.0,days,BRCA-LUAD+,,,BRCA CIMP c7,,,miRNA c1uster 9,,,TCGA-AC-A3EH,197.0,0.0,days,197.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Right,Axillary lymph node dissection alone,,TCGA-AC-A3EH-F65834,TCGA-AC-A3EH,TCGA-AC-A3EH-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,NO,,,-29014.0,67.0,197.0,0.0,17.0,,,,,,,,,,2014-9-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8022/3,C50.9,,YES,,Excisional Biopsy,150.0,NO,Negative,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,12.0,,False,No,M0,N3,T3,Stage IIIC,TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf,A3EH,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,DECEASED,2011.0,616255fe-88b3-4567-ae8d-bd68dd8380a3,616255fe-88b3-4567-ae8d-bd68dd8380a3,,,TCGA-AC-A3EH-01,TCGA-AC-A3EH-01A-22D-A22B-05,,TCGA-AC-A3EH-01,TCGA-AC-A3EH-01A-22D-A228-09,,,TCGA-AC-A3EH-01,,,616255fe-88b3-4567-ae8d-bd68dd8380a3,,TCGA-AC-A3EH-01A-22D-A227-01,TCGA-AC-A3EH-01,,616255fe-88b3-4567-ae8d-bd68dd8380a3,TCGA-AC-A3EH-01A-22D-A227-01,
tcga.ac.a3hn,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A3HN-01,496.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AC-A3HN,496.0,0.0,days,496.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,87.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-AC-A3HN-F65835,TCGA-AC-A3HN,TCGA-AC-A3HN-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-32061.0,97.0,,0.0,496.0,,,,,NO,,90-99%,,,2014-9-30,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,160.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf,A3HN,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,79a14838-69d2-4c73-83a7-b57ff6ecdd79,79a14838-69d2-4c73-83a7-b57ff6ecdd79,TCGA-AC-A3HN-01A-21-A24A-20,,TCGA-AC-A3HN-01,TCGA-AC-A3HN-01A-11D-A212-05,b7044729-14de-486e-932a-ed425ff476f0,TCGA-AC-A3HN-01,TCGA-AC-A3HN-01A-11D-A20S-09,,,TCGA-AC-A3HN-01,,,79a14838-69d2-4c73-83a7-b57ff6ecdd79,,TCGA-AC-A3HN-01A-11D-A20R-01,TCGA-AC-A3HN-01,,79a14838-69d2-4c73-83a7-b57ff6ecdd79,TCGA-AC-A3HN-01A-11D-A20R-01,
tcga.ac.a3od,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AC-A3OD-01,451.0,0.0,days,High,,,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 14,,,TCGA-AC-A3OD,451.0,0.0,days,451.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A3OD-F45582,TCGA-AC-A3OD,TCGA-AC-A3OD-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-25186.0,63.0,,0.0,451.0,,,,,NO,,90-99%,,,2013-7-17,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,30.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,MX,N1mi,T2,Stage IIB,TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf,A3OD,TUMOR FREE,,,,,,NO,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,7c521ef7-4adf-46ef-ade0-088cbe02223d,7c521ef7-4adf-46ef-ade0-088cbe02223d,,,TCGA-AC-A3OD-01,"TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05",,TCGA-AC-A3OD-01,"TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09",,,TCGA-AC-A3OD-01,,,7c521ef7-4adf-46ef-ade0-088cbe02223d,,TCGA-AC-A3OD-01A-11D-A21P-01,TCGA-AC-A3OD-01,,7c521ef7-4adf-46ef-ade0-088cbe02223d,TCGA-AC-A3OD-01A-11D-A21P-01,
tcga.ac.a3qp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3QP-01,675.0,0.0,days,,,,,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3QP,675.0,0.0,days,675.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3QP-F56161,TCGA-AC-A3QP,TCGA-AC-A3QP-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-29113.0,184.0,,0.0,675.0,,,,,NO,,70-79%,2.2,,2014-1-29,FEMALE,,,,,2+,30.0,2.6,1.2,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,150.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,1.0,True,No,MX,N1mi,T2,Stage IIB,TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf,A3QP,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,4545ed8f-a83b-4049-9504-ba673ecd6d1d,4545ed8f-a83b-4049-9504-ba673ecd6d1d,TCGA-AC-A3QP-01A-21-A24A-20,,TCGA-AC-A3QP-01,TCGA-AC-A3QP-01A-11D-A230-05,334363b1-b6e4-4135-a42d-4d49e62ce2c5,TCGA-AC-A3QP-01,TCGA-AC-A3QP-01A-11D-A22X-09,,,TCGA-AC-A3QP-01,,,4545ed8f-a83b-4049-9504-ba673ecd6d1d,,TCGA-AC-A3QP-01A-11D-A22W-01,TCGA-AC-A3QP-01,,4545ed8f-a83b-4049-9504-ba673ecd6d1d,TCGA-AC-A3QP-01A-11D-A22W-01,
tcga.ac.a3qq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3QQ-01,734.0,0.0,days,Iq,,,BRCA non-CIMP c9,,,miRNA c1uster 10,,,TCGA-AC-A3QQ,734.0,0.0,days,734.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3QQ-F66024,TCGA-AC-A3QQ,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-19723.0,,,0.0,734.0,,,,,,,90-99%,,,2014-10-1,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Positive,,NO,5.0,Close,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,MX,N0 (i-),T1c,Stage IA,,A3QQ,TUMOR FREE,,,,,,NO,YES,70-79%,,NO,Primary Tumor,1,Nipple Sparing Total Mastectomy,7th,,YES,NO,AC,Breast,,LIVING,2011.0,bf9ca847-f30f-4dcf-bb91-a483be8db666,bf9ca847-f30f-4dcf-bb91-a483be8db666,,,TCGA-AC-A3QQ-01,TCGA-AC-A3QQ-01A-11D-A22B-05,,TCGA-AC-A3QQ-01,,,,TCGA-AC-A3QQ-01,,,bf9ca847-f30f-4dcf-bb91-a483be8db666,,TCGA-AC-A3QQ-01A-11D-A227-01,TCGA-AC-A3QQ-01,,bf9ca847-f30f-4dcf-bb91-a483be8db666,TCGA-AC-A3QQ-01A-11D-A227-01,
tcga.ac.a3tm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3TM-01,762.0,0.0,days,Iq,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3TM,762.0,0.0,days,762.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3TM-F60193,TCGA-AC-A3TM,TCGA-AC-A3TM-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-18535.0,136.0,,0.0,762.0,,,,,NO,,90-99%,1.9,,2014-5-31,FEMALE,,,,,2+,60.0,3.3,1.9,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Equivocal,Equivocal,NO,4.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,2.0,False,No,M0,N1mi,T3,Stage IIIA,TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf,A3TM,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,902592e6-c7c5-46b8-b70b-5520df79a8a3,902592e6-c7c5-46b8-b70b-5520df79a8a3,TCGA-AC-A3TM-01A-21-A24A-20,,TCGA-AC-A3TM-01,TCGA-AC-A3TM-01A-11D-A22B-05,c53769a6-b6af-4346-9a88-ffa6ffc19bfe,TCGA-AC-A3TM-01,TCGA-AC-A3TM-01A-11D-A228-09,,,TCGA-AC-A3TM-01,,,902592e6-c7c5-46b8-b70b-5520df79a8a3,,TCGA-AC-A3TM-01A-11D-A227-01,TCGA-AC-A3TM-01,,902592e6-c7c5-46b8-b70b-5520df79a8a3,TCGA-AC-A3TM-01A-11D-A227-01,
tcga.ac.a3tn,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3TN-01,456.0,0.0,days,Iq,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3TN,456.0,0.0,days,456.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A3TN-F60190,TCGA-AC-A3TN,TCGA-AC-A3TN-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-27421.0,78.0,,0.0,456.0,,,,,NO,,90-99%,,,2014-5-31,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,"Other method, specify:",140.0,NO,Positive,Indeterminate,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,MX,N0,T3,Stage IIB,TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf,A3TN,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,032db552-7828-4ed4-a1d7-b01b7fa89e29,032db552-7828-4ed4-a1d7-b01b7fa89e29,TCGA-AC-A3TN-01A-21-A24A-20,,TCGA-AC-A3TN-01,TCGA-AC-A3TN-01A-11D-A22B-05,c619a2c9-fbfd-4c44-b40c-3a12259b24c2,TCGA-AC-A3TN-01,TCGA-AC-A3TN-01A-11D-A228-09,,,TCGA-AC-A3TN-01,,,032db552-7828-4ed4-a1d7-b01b7fa89e29,,TCGA-AC-A3TN-01A-11D-A227-01,TCGA-AC-A3TN-01,,032db552-7828-4ed4-a1d7-b01b7fa89e29,TCGA-AC-A3TN-01A-11D-A227-01,
tcga.ac.a3w5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3W5-01,504.0,0.0,days,High,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3W5,504.0,0.0,days,504.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3W5-F56177,TCGA-AC-A3W5,TCGA-AC-A3W5-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-24029.0,120.0,,0.0,504.0,,,,,,,50-59%,,,2014-1-29,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,130.0,NO,,Positive,NO,3.0,Close,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,MX,N0,T2,Stage IIA,TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf,A3W5,TUMOR FREE,,,,,,YES,YES,30-39%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,3e775d6c-3845-49a7-80e0-82c5c68a473c,3e775d6c-3845-49a7-80e0-82c5c68a473c,TCGA-AC-A3W5-01A-21-A24A-20,,TCGA-AC-A3W5-01,TCGA-AC-A3W5-01A-11D-A22B-05,795bf55f-c58c-45f4-9443-7f9fd1ef4c3e,TCGA-AC-A3W5-01,TCGA-AC-A3W5-01A-11D-A228-09,,,TCGA-AC-A3W5-01,,,3e775d6c-3845-49a7-80e0-82c5c68a473c,,TCGA-AC-A3W5-01A-11D-A227-01,TCGA-AC-A3W5-01,,3e775d6c-3845-49a7-80e0-82c5c68a473c,TCGA-AC-A3W5-01A-11D-A227-01,
tcga.ac.a3w6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3W6-01,602.0,0.0,days,Iq,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3W6,602.0,0.0,days,602.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3W6-F57046,TCGA-AC-A3W6,TCGA-AC-A3W6-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-32872.0,101.0,,0.0,602.0,,,,,,,90-99%,,,2014-2-28,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,1+,YES,,Core needle biopsy,140.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,3.0,False,Yes,MX,N1,T3,Stage IIIA,TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf,A3W6,TUMOR FREE,,,,,,NO,YES,20-29%,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,bfedc051-75dd-44f8-add4-40ec7eabf0b0,bfedc051-75dd-44f8-add4-40ec7eabf0b0,TCGA-AC-A3W6-01A-21-A24A-20,,TCGA-AC-A3W6-01,TCGA-AC-A3W6-01A-12D-A22B-05,37b78d3f-d378-49c8-970c-8b83f7372aeb,TCGA-AC-A3W6-01,TCGA-AC-A3W6-01A-12D-A228-09,,,TCGA-AC-A3W6-01,,,bfedc051-75dd-44f8-add4-40ec7eabf0b0,,TCGA-AC-A3W6-01A-12D-A227-01,TCGA-AC-A3W6-01,,bfedc051-75dd-44f8-add4-40ec7eabf0b0,TCGA-AC-A3W6-01A-12D-A227-01,
tcga.ac.a3w7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3W7-01,471.0,0.0,days,Iq,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AC-A3W7,471.0,0.0,days,471.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-AC-A3W7-F57847,TCGA-AC-A3W7,TCGA-AC-A3W7-01A,,Positive,,,,,Negative,Simple Mastectomy,,NO,,,-24327.0,65.0,,0.0,471.0,,,,,,,90-99%,,,2014-3-27,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf,A3W7,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,e5636c48-9d0d-42d5-9ac2-31ad566bd168,e5636c48-9d0d-42d5-9ac2-31ad566bd168,TCGA-AC-A3W7-01A-21-A24A-20,,TCGA-AC-A3W7-01,TCGA-AC-A3W7-01A-11D-A22B-05,1a6ceae8-c0e6-48fe-8ebc-1897613040c1,TCGA-AC-A3W7-01,TCGA-AC-A3W7-01A-11D-A228-09,,,TCGA-AC-A3W7-01,,,e5636c48-9d0d-42d5-9ac2-31ad566bd168,,TCGA-AC-A3W7-01A-11D-A227-01,TCGA-AC-A3W7-01,,e5636c48-9d0d-42d5-9ac2-31ad566bd168,TCGA-AC-A3W7-01A-11D-A227-01,
tcga.ac.a3yi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3YI-01,707.0,0.0,days,,,,,,,,,,TCGA-AC-A3YI,707.0,0.0,days,707.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A3YI-F61513,TCGA-AC-A3YI,TCGA-AC-A3YI-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-27143.0,87.0,,0.0,707.0,,,,,,,90-99%,,,2014-6-30,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Positive,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,12.0,,False,No,MX,N3a,T1c,Stage IIIC,TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf,A3YI,TUMOR FREE,,,,,,YES,YES,20-29%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26,20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26,,,TCGA-AC-A3YI-01,TCGA-AC-A3YI-01A-21D-A23D-05,,TCGA-AC-A3YI-01,TCGA-AC-A3YI-01A-21D-A23C-09,,,TCGA-AC-A3YI-01,,,20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26,,TCGA-AC-A3YI-01A-21D-A238-01,TCGA-AC-A3YI-01,,20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26,TCGA-AC-A3YI-01A-21D-A238-01,
tcga.ac.a3yj,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A3YJ-01,754.0,0.0,days,,,,,BRCA nonbasal-like c8,,,,,TCGA-AC-A3YJ,754.0,0.0,days,754.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right,Sentinel node biopsy alone,,TCGA-AC-A3YJ-F60187,TCGA-AC-A3YJ,TCGA-AC-A3YJ-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-24439.0,114.0,,0.0,754.0,,,,,,,,,,2014-5-31,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8050/3,C50.9,,YES,,Core needle biopsy,220.0,NO,,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf,A3YJ,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,5d5982c0-530f-4b2b-b1fb-d70c8168c793,5d5982c0-530f-4b2b-b1fb-d70c8168c793,TCGA-AC-A3YJ-01A-21-A24A-20,,TCGA-AC-A3YJ-01,TCGA-AC-A3YJ-01A-11D-A230-05,7de47993-6f31-4dd7-8219-b5734464922f,TCGA-AC-A3YJ-01,TCGA-AC-A3YJ-01A-11D-A22X-09,,,TCGA-AC-A3YJ-01,,,5d5982c0-530f-4b2b-b1fb-d70c8168c793,,TCGA-AC-A3YJ-01A-11D-A22W-01,TCGA-AC-A3YJ-01,,5d5982c0-530f-4b2b-b1fb-d70c8168c793,TCGA-AC-A3YJ-01A-11D-A22W-01,
tcga.ac.a4ze,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A4ZE-01,890.0,0.0,days,,,,,,,,,,TCGA-AC-A4ZE,890.0,0.0,days,890.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-AC-A4ZE-F72379,TCGA-AC-A4ZE,TCGA-AC-A4ZE-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-23284.0,169.0,,0.0,890.0,,,,,,,,,,2015-6-9,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,180.0,NO,Positive,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,M0,N0,T3,Stage IIB,TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf,A4ZE,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,089da1d2-bdac-4ef2-9d59-2d144f77d5da,089da1d2-bdac-4ef2-9d59-2d144f77d5da,,,TCGA-AC-A4ZE-01,TCGA-AC-A4ZE-01A-11D-A41Q-05,77F57ED3-C635-4292-9D39-987F74C22793,TCGA-AC-A4ZE-01,,,,TCGA-AC-A4ZE-01,,,089da1d2-bdac-4ef2-9d59-2d144f77d5da,,TCGA-AC-A4ZE-01A-11D-A41E-01,TCGA-AC-A4ZE-01,,089da1d2-bdac-4ef2-9d59-2d144f77d5da,TCGA-AC-A4ZE-01A-11D-A41E-01,
tcga.ac.a5eh,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A5EH-01,511.0,0.0,days,,,,,,,,,,TCGA-AC-A5EH,511.0,0.0,days,511.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,76.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A5EH-F60185,TCGA-AC-A5EH,,,Positive,,,,,Negative,Modified Radical Mastectomy,,NO,,,-27964.0,,,0.0,511.0,,,,,,,20-29%,,,2014-5-31,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,14.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,,No,MX,N1mi,T2,Stage IIB,,A5EH,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2012.0,eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7,eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7,,,TCGA-AC-A5EH-01,TCGA-AC-A5EH-01A-11D-A28C-05,,TCGA-AC-A5EH-01,TCGA-AC-A5EH-01A-11D-A28B-09,,,TCGA-AC-A5EH-01,,,eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7,,TCGA-AC-A5EH-01A-11D-A28A-01,TCGA-AC-A5EH-01,,eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7,TCGA-AC-A5EH-01A-11D-A28A-01,
tcga.ac.a5xs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A5XS-01,588.0,0.0,days,,,,,,,,,,TCGA-AC-A5XS,588.0,0.0,days,588.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-AC-A5XS-F64108,TCGA-AC-A5XS,TCGA-AC-A5XS-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-27160.0,127.0,,0.0,588.0,,,,,,,,,,2014-8-26,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,,NO,8.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,Yes,MX,N0,T2,Stage IIA,TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf,A5XS,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,b713b36d-44c7-41ed-82a5-762322472a56,b713b36d-44c7-41ed-82a5-762322472a56,,,TCGA-AC-A5XS-01,TCGA-AC-A5XS-01A-11D-A29O-05,5bb0d7f3-6b33-4d61-95e4-1a9006c4b4c3,TCGA-AC-A5XS-01,TCGA-AC-A5XS-01A-11D-A29N-09,,,TCGA-AC-A5XS-01,,,b713b36d-44c7-41ed-82a5-762322472a56,,TCGA-AC-A5XS-01A-11D-A29M-01,TCGA-AC-A5XS-01,,b713b36d-44c7-41ed-82a5-762322472a56,TCGA-AC-A5XS-01A-11D-A29M-01,
tcga.ac.a5xu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A5XU-01,455.0,0.0,days,,,,,,,,,,TCGA-AC-A5XU,455.0,0.0,days,455.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-AC-A5XU-F60181,TCGA-AC-A5XU,,,Positive,,,,,Positive,Lumpectomy,,,,,-27191.0,,,0.0,455.0,,,,,,,90-99%,,,2014-5-31,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,MX,N0 (i-),T3,Stage IIB,,A5XU,TUMOR FREE,,,,,,YES,YES,60-69%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2013.0,f48e8432-bcb7-4aa9-9c8f-6de4a96179b2,f48e8432-bcb7-4aa9-9c8f-6de4a96179b2,,,TCGA-AC-A5XU-01,TCGA-AC-A5XU-01A-11D-A28C-05,e6e4ace7-7888-4b68-9662-0b7caa3c68c5,TCGA-AC-A5XU-01,TCGA-AC-A5XU-01A-11D-A28B-09,,,TCGA-AC-A5XU-01,,,f48e8432-bcb7-4aa9-9c8f-6de4a96179b2,,TCGA-AC-A5XU-01A-11D-A28A-01,TCGA-AC-A5XU-01,,f48e8432-bcb7-4aa9-9c8f-6de4a96179b2,TCGA-AC-A5XU-01A-11D-A28A-01,
tcga.ac.a62v,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AC-A62V-01,348.0,1.0,days,,,,,,,,,,TCGA-AC-A62V,348.0,0.0,days,348.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A62V-F60177,TCGA-AC-A62V,TCGA-AC-A62V-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-21389.0,38.0,348.0,0.0,2.0,,,,,,,90-99%,,,2014-5-31,MALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,,,NO,17.0,Negative,,,,,,,,,,,,,,,,,,,Bone,,,,,,,,,,,NO,3.0,,False,No,M1,N1a,T2,Stage IV,TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf,A62V,WITH TUMOR,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,DECEASED,2013.0,7a356940-c460-4714-a949-42afe6ea5d86,7a356940-c460-4714-a949-42afe6ea5d86,,,TCGA-AC-A62V-01,TCGA-AC-A62V-01A-11D-A31V-05,,TCGA-AC-A62V-01,,,,TCGA-AC-A62V-01,,,7a356940-c460-4714-a949-42afe6ea5d86,,TCGA-AC-A62V-01A-11D-A31T-01,TCGA-AC-A62V-01,,7a356940-c460-4714-a949-42afe6ea5d86,TCGA-AC-A62V-01A-11D-A31T-01,
tcga.ac.a62x,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A62X-01,417.0,0.0,days,,,,,,,,,,TCGA-AC-A62X,417.0,0.0,days,417.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A62X-F64105,TCGA-AC-A62X,TCGA-AC-A62X-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,NO,,,-26627.0,70.0,,0.0,417.0,,,,,,,<10%,,,2014-8-26,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,130.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,Yes,MX,N0,T2,Stage IIA,TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf,A62X,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2013.0,cdc523d2-da82-4a3d-a97e-9745c8a802d1,cdc523d2-da82-4a3d-a97e-9745c8a802d1,,,TCGA-AC-A62X-01,TCGA-AC-A62X-01A-11D-A29O-05,4956c5cb-1ab4-46c2-8df0-1d71a2a73f15,TCGA-AC-A62X-01,TCGA-AC-A62X-01A-11D-A29N-09,,,TCGA-AC-A62X-01,,,cdc523d2-da82-4a3d-a97e-9745c8a802d1,,TCGA-AC-A62X-01A-11D-A29M-01,TCGA-AC-A62X-01,,cdc523d2-da82-4a3d-a97e-9745c8a802d1,TCGA-AC-A62X-01A-11D-A29M-01,
tcga.ac.a62y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A62Y-01,530.0,0.0,days,,,,,,,,,,TCGA-AC-A62Y,530.0,0.0,days,530.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Right,Sentinel node biopsy alone,,TCGA-AC-A62Y-F65833,TCGA-AC-A62Y,TCGA-AC-A62Y-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-28876.0,112.0,,0.0,530.0,,,,,,,90-99%,,,2014-9-30,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,50.0,NO,Negative,,NO,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf,A62Y,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,02d9d59b-de6f-41c7-b529-142116debfd9,02d9d59b-de6f-41c7-b529-142116debfd9,,,TCGA-AC-A62Y-01,TCGA-AC-A62Y-01A-11D-A29O-05,,TCGA-AC-A62Y-01,TCGA-AC-A62Y-01A-11D-A29N-09,,,TCGA-AC-A62Y-01,,,02d9d59b-de6f-41c7-b529-142116debfd9,,TCGA-AC-A62Y-01A-11D-A29M-01,TCGA-AC-A62Y-01,,02d9d59b-de6f-41c7-b529-142116debfd9,TCGA-AC-A62Y-01A-11D-A29M-01,
tcga.ac.a6iv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A6IV-01,568.0,0.0,days,,,,,,,,,,TCGA-AC-A6IV,568.0,0.0,days,568.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right,Sentinel node biopsy alone,,TCGA-AC-A6IV-F66023,TCGA-AC-A6IV,TCGA-AC-A6IV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-17521.0,289.0,,0.0,568.0,,,,,,,90-99%,,,2014-10-1,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8524/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Equivocal,,NO,1.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,1.0,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf,A6IV,TUMOR FREE,,,,,,YES,YES,60-69%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2012.0,253e692f-71db-4a5a-b2f4-9e640ef831a2,253e692f-71db-4a5a-b2f4-9e640ef831a2,,,TCGA-AC-A6IV-01,TCGA-AC-A6IV-01A-12D-A33F-05,,TCGA-AC-A6IV-01,,,,TCGA-AC-A6IV-01,,,253e692f-71db-4a5a-b2f4-9e640ef831a2,,TCGA-AC-A6IV-01A-12D-A33D-01,TCGA-AC-A6IV-01,,253e692f-71db-4a5a-b2f4-9e640ef831a2,TCGA-AC-A6IV-01A-12D-A33D-01,
tcga.ac.a6iw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A6IW-01,413.0,0.0,days,,,,,,,,,,TCGA-AC-A6IW,413.0,0.0,days,413.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,73.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-AC-A6IW-F64106,TCGA-AC-A6IW,TCGA-AC-A6IW-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-26896.0,74.0,,0.0,413.0,,,,,,,<10%,,,2014-8-26,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf,A6IW,TUMOR FREE,,,,,,NO,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2013.0,fceb1551-4b16-45de-8ba0-7906aa3fe841,fceb1551-4b16-45de-8ba0-7906aa3fe841,,,TCGA-AC-A6IW-01,TCGA-AC-A6IW-01A-12D-A33F-05,7FE7ED52-C8B0-4C86-BE4E-BF31EFBEA9BB,TCGA-AC-A6IW-01,,,,TCGA-AC-A6IW-01,,,fceb1551-4b16-45de-8ba0-7906aa3fe841,,TCGA-AC-A6IW-01A-12D-A33D-01,TCGA-AC-A6IW-01,,fceb1551-4b16-45de-8ba0-7906aa3fe841,TCGA-AC-A6IW-01A-12D-A33D-01,
tcga.ac.a6ix,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A6IX-01,373.0,0.0,days,,,,,,,,,,TCGA-AC-A6IX,373.0,0.0,days,373.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AC-A6IX-F66025,TCGA-AC-A6IX,TCGA-AC-A6IX-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-17969.0,107.0,,0.0,373.0,,,,,,,90-99%,,,2014-10-1,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,110.0,NO,,,NO,21.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,19.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf,A6IX,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2013.0,ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182,ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182,,,TCGA-AC-A6IX-01,TCGA-AC-A6IX-01A-12D-A32T-05,A01C3771-F0E8-4514-AE2A-927E852F47D8,TCGA-AC-A6IX-01,,,,TCGA-AC-A6IX-01,,,ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182,,TCGA-AC-A6IX-01A-12D-A32H-01,TCGA-AC-A6IX-01,,ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182,TCGA-AC-A6IX-01A-12D-A32H-01,
tcga.ac.a6no,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A6NO-01,51.0,0.0,days,,,,,,,,,,TCGA-AC-A6NO,51.0,0.0,days,51.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Right,Axillary lymph node dissection alone,,,TCGA-AC-A6NO,TCGA-AC-A6NO-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-15996.0,605.0,,0.0,51.0,,,,,,,,,,2014-4-10,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,150.0,NO,Negative,,,16.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf,A6NO,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,5055b564-b80d-4003-b1c1-3fe080c99fc1,5055b564-b80d-4003-b1c1-3fe080c99fc1,,,TCGA-AC-A6NO-01,TCGA-AC-A6NO-01A-12D-A33F-05,EE1327D4-4700-49EF-84B1-292DE21BB827,TCGA-AC-A6NO-01,,,,TCGA-AC-A6NO-01,,,5055b564-b80d-4003-b1c1-3fe080c99fc1,,TCGA-AC-A6NO-01A-12D-A33D-01,TCGA-AC-A6NO-01,,5055b564-b80d-4003-b1c1-3fe080c99fc1,TCGA-AC-A6NO-01A-12D-A33D-01,
tcga.ac.a7vb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A7VB-01,250.0,0.0,days,,,,,,,,,,TCGA-AC-A7VB,250.0,0.0,days,250.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AC-A7VB-F66026,TCGA-AC-A7VB,,,Positive,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18806.0,,,0.0,250.0,,,,,,,80-89%,,,2014-10-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,,,NO,15.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,,,No,MX,N1a,T1c,Stage IIA,,A7VB,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2013.0,a0059fcb-6adc-47f4-8601-b7eed9e12576,a0059fcb-6adc-47f4-8601-b7eed9e12576,,,TCGA-AC-A7VB-01,TCGA-AC-A7VB-01A-11D-A357-05,,TCGA-AC-A7VB-01,,,,TCGA-AC-A7VB-01,,,a0059fcb-6adc-47f4-8601-b7eed9e12576,,TCGA-AC-A7VB-01A-11D-A350-01,TCGA-AC-A7VB-01,,a0059fcb-6adc-47f4-8601-b7eed9e12576,TCGA-AC-A7VB-01A-11D-A350-01,
tcga.ac.a7vc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A7VC-01,1.0,0.0,days,,,,,,,,,,TCGA-AC-A7VC,1.0,0.0,days,1.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left,Sentinel node biopsy alone,,,TCGA-AC-A7VC,,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-20479.0,,,0.0,1.0,,,,,,,,,,2014-3-29,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Tumor resection,,,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,MX,N0,T3,Stage IIB,,A7VC,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2013.0,f88a5259-4413-4d0c-9083-600d74caffbc,f88a5259-4413-4d0c-9083-600d74caffbc,,,TCGA-AC-A7VC-01,TCGA-AC-A7VC-01A-11D-A357-05,,TCGA-AC-A7VC-01,,,,TCGA-AC-A7VC-01,,,f88a5259-4413-4d0c-9083-600d74caffbc,,TCGA-AC-A7VC-01A-11D-A350-01,TCGA-AC-A7VC-01,,f88a5259-4413-4d0c-9083-600d74caffbc,TCGA-AC-A7VC-01A-11D-A350-01,
tcga.ac.a8op,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A8OP-01,614.0,0.0,days,,,,,,,,,,TCGA-AC-A8OP,614.0,0.0,days,614.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-AC-A8OP-F66027,TCGA-AC-A8OP,TCGA-AC-A8OP-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-26550.0,921.0,,0.0,614.0,,,,,,,90-99%,,,2014-10-1,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,80.0,NO,Indeterminate,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf,A8OP,TUMOR FREE,,,,,,YES,YES,10-19%,,NO,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,001773a6-9cf3-48a1-8ea1-1f0da4991bc5,001773a6-9cf3-48a1-8ea1-1f0da4991bc5,,,TCGA-AC-A8OP-01,TCGA-AC-A8OP-01A-11D-A36K-05,,TCGA-AC-A8OP-01,,,,TCGA-AC-A8OP-01,,,001773a6-9cf3-48a1-8ea1-1f0da4991bc5,,TCGA-AC-A8OP-01A-11D-A36I-01,TCGA-AC-A8OP-01,,001773a6-9cf3-48a1-8ea1-1f0da4991bc5,TCGA-AC-A8OP-01A-11D-A36I-01,
tcga.ac.a8oq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A8OQ-01,34.0,0.0,days,,,,,,,,,,TCGA-AC-A8OQ,34.0,0.0,days,34.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,,TCGA-AC-A8OQ,TCGA-AC-A8OQ-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-26535.0,742.0,,0.0,34.0,,,,,,,,,,2014-2-26,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Indeterminate,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf,A8OQ,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2011.0,cca6f765-44ff-4540-a961-0a2be4e41f93,cca6f765-44ff-4540-a961-0a2be4e41f93,,,TCGA-AC-A8OQ-01,TCGA-AC-A8OQ-01A-11D-A41Q-05,4B47C521-A9C2-4CF0-91BB-27DD99200EC7,TCGA-AC-A8OQ-01,,,,TCGA-AC-A8OQ-01,,,cca6f765-44ff-4540-a961-0a2be4e41f93,,TCGA-AC-A8OQ-01A-11D-A41E-01,TCGA-AC-A8OQ-01,,cca6f765-44ff-4540-a961-0a2be4e41f93,TCGA-AC-A8OQ-01A-11D-A41E-01,
tcga.ac.a8or,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A8OR-01,40.0,0.0,days,,,,,,,,,,TCGA-AC-A8OR,40.0,0.0,days,40.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Left,Sentinel node biopsy alone,,,TCGA-AC-A8OR,TCGA-AC-A8OR-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-27605.0,98.0,,0.0,40.0,,,,,,,90-99%,,,2014-2-26,FEMALE,,,<10%,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf,A8OR,TUMOR FREE,,,,,,,YES,90-99%,,,Primary Tumor,1,,7th,,YES,NO,AC,Breast,A,LIVING,2013.0,15c73666-b316-4108-97e9-9d0e40540a2c,15c73666-b316-4108-97e9-9d0e40540a2c,,,TCGA-AC-A8OR-01,TCGA-AC-A8OR-01A-21D-A41Q-05,,TCGA-AC-A8OR-01,,,,TCGA-AC-A8OR-01,,,15c73666-b316-4108-97e9-9d0e40540a2c,,TCGA-AC-A8OR-01A-21D-A41E-01,TCGA-AC-A8OR-01,,15c73666-b316-4108-97e9-9d0e40540a2c,TCGA-AC-A8OR-01A-21D-A41E-01,
tcga.ac.a8os,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AC-A8OS-01,70.0,0.0,days,,,,,,,,,,TCGA-AC-A8OS,70.0,0.0,days,70.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,,TCGA-AC-A8OS,,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-26248.0,,,0.0,70.0,,,,,,,90-99%,,,2014-2-26,FEMALE,,,10-19%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Positive,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,MX,N0 (i-),T2,Stage IIA,,A8OS,TUMOR FREE,,,,,,,YES,<10%,,,Primary Tumor,1,,7th,,YES,NO,AC,Breast,,LIVING,2013.0,c119a170-e1ba-4965-a9c6-5c0b41ceefba,c119a170-e1ba-4965-a9c6-5c0b41ceefba,,,TCGA-AC-A8OS-01,TCGA-AC-A8OS-01A-12D-A41Q-05,,TCGA-AC-A8OS-01,,,,TCGA-AC-A8OS-01,,,c119a170-e1ba-4965-a9c6-5c0b41ceefba,,TCGA-AC-A8OS-01A-12D-A41E-01,TCGA-AC-A8OS-01,,c119a170-e1ba-4965-a9c6-5c0b41ceefba,TCGA-AC-A8OS-01A-12D-A41E-01,
tcga.ao.a12b,Stage IIA,63.0,3.0,Stage IIA,2359.0,,Positive,FEMALE,Negative,3.0,3.0,4.0,Negative,M0,Negative,N0,2359.0,0.0,LumA,Luminal B,Positive,LumA/B,-12.0,-3.0,followup,T_Other,T2,LIVING,0.0,TCGA-AO-A12B-01,2989.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-AO-A12B,2989.0,0.0,days,2989.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Sentinel node biopsy alone,,TCGA-AO-A12B-F43473,TCGA-AO-A12B,TCGA-AO-A12B-01A,,Positive,,4+,,,Positive,Simple Mastectomy,,YES,,,-23150.0,2365.0,,0.0,2989.0,,,,,,,90-99%,,Scheduled Follow-up Submission,2013-5-22,FEMALE,,3+ Positive,<10%,,0,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,570.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,3.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf,A12B,TUMOR FREE,,,,,,YES,,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2004.0,44225bb7-92c6-4a6d-b136-bc51666ba84a,44225bb7-92c6-4a6d-b136-bc51666ba84a,TCGA-AO-A12B-01A-21-A13E-20,TCGA-AO-A12B-01A-11D-A10M-09,TCGA-AO-A12B-01,TCGA-AO-A12B-01A-11D-A10N-05,1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c,TCGA-AO-A12B-01,TCGA-AO-A12B-01A-11D-A10M-09,,TCGA-AO-A12B-01,TCGA-AO-A12B-01,TCGA-AO-A12B-01A-11D-A10M-09,,44225bb7-92c6-4a6d-b136-bc51666ba84a,,TCGA-AO-A12B-01A-11D-A10L-01,TCGA-AO-A12B-01,TCGA-AO-A12B-01A-11R-A10J-07,44225bb7-92c6-4a6d-b136-bc51666ba84a,TCGA-AO-A12B-01A-11D-A10L-01,TCGA-AO-A12B-01
tcga.ao.a1ko,Stage IIB,46.0,1.0,Stage IIB,448.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,448.0,0.0,Normal,,Positive,,,,followup,T_Other,T3,LIVING,0.0,TCGA-AO-A1KO-01,622.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 6,mutation c1uster 9,TCGA-AO-A1KO,622.0,0.0,days,622.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AO-A1KO-F20630,TCGA-AO-A1KO,TCGA-AO-A1KO-01A,,Positive,4 Point Scale,4+,4 Point Scale,,Positive,Simple Mastectomy,,YES,,,-16817.0,832.0,,0.0,622.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-20,FEMALE,,,<10%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,4+,YES,,Excisional Biopsy,580.0,NO,Negative,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf,A1KO,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2008.0,62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34,62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34,TCGA-AO-A1KO-01A-41-A17I-20,TCGA-AO-A1KO-01A-31D-A188-09,TCGA-AO-A1KO-01,TCGA-AO-A1KO-01A-31D-A13K-05,a17c27f3-818b-4fbb-aa5d-ab86494f4456,TCGA-AO-A1KO-01,TCGA-AO-A1KO-01A-31D-A188-09,,,TCGA-AO-A1KO-01,TCGA-AO-A1KO-01A-31D-A188-09,,62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34,,TCGA-AO-A1KO-01A-31D-A13J-01,TCGA-AO-A1KO-01,,62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34,TCGA-AO-A1KO-01A-31D-A13J-01,
tcga.ao.a1kp,Stage IIA,77.0,2.0,Stage IIA,2513.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,2513.0,0.0,LumB,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-AO-A1KP-01,2953.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-AO-A1KP,2953.0,0.0,days,2953.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AO-A1KP-F21774,TCGA-AO-A1KP,TCGA-AO-A1KP-01A,,Positive,4 Point Scale,4+,4 Point Scale,,Positive,Simple Mastectomy,,YES,,,-28247.0,2604.0,,0.0,2953.0,,,,,NO,,80-89%,,Scheduled Follow-up Submission,2012-2-20,FEMALE,,,<10%,>=2.0 Positive,1+,,,1.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,360.0,NO,Negative,Negative,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,1.0,True,No,M0,N1,T1,Stage IIA,TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf,A1KP,TUMOR FREE,,,,,,,YES,40-49%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2003.0,773a2357-99b8-40df-b657-f237d9735db9,773a2357-99b8-40df-b657-f237d9735db9,TCGA-AO-A1KP-01A-21-A17I-20,TCGA-AO-A1KP-01A-11D-A13L-09,TCGA-AO-A1KP-01,TCGA-AO-A1KP-01A-11D-A13K-05,a69b3e33-9fa5-47f1-931d-d100136d9d80,TCGA-AO-A1KP-01,TCGA-AO-A1KP-01A-11D-A13L-09,,,TCGA-AO-A1KP-01,TCGA-AO-A1KP-01A-11D-A13L-09,,773a2357-99b8-40df-b657-f237d9735db9,,TCGA-AO-A1KP-01A-11D-A13J-01,TCGA-AO-A1KP-01,,773a2357-99b8-40df-b657-f237d9735db9,TCGA-AO-A1KP-01A-11D-A13J-01,
tcga.ao.a1kq,Stage IIIB,84.0,4.0,Stage IIIB,1519.0,,Positive,MALE,Negative,,,,Negative,M0,Positive,N1,1519.0,0.0,LumB,,Positive,,,,followup,T_Other,T4,LIVING,0.0,TCGA-AO-A1KQ-01,1882.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,,TCGA-AO-A1KQ,1882.0,0.0,days,1882.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,84.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AO-A1KQ-F21775,TCGA-AO-A1KQ,TCGA-AO-A1KQ-01A,,Positive,4 Point Scale,3+,4 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-30859.0,1553.0,,0.0,1882.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-20,MALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,540.0,NO,Negative,,,9.0,Negative,,,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,2.0,0.0,True,No,M0,N1,T4,Stage IIIB,TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf,A1KQ,TUMOR FREE,,,,,,,YES,80-89%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2006.0,204a78d9-67aa-4e49-b285-bbb25c6ed142,204a78d9-67aa-4e49-b285-bbb25c6ed142,TCGA-AO-A1KQ-01A-21-A17I-20,,TCGA-AO-A1KQ-01,TCGA-AO-A1KQ-01A-11D-A13K-05,ccdaef5f-d816-426d-8e4f-b1bc561a11c5,TCGA-AO-A1KQ-01,,,,TCGA-AO-A1KQ-01,,,204a78d9-67aa-4e49-b285-bbb25c6ed142,,TCGA-AO-A1KQ-01A-11D-A13J-01,TCGA-AO-A1KQ-01,,204a78d9-67aa-4e49-b285-bbb25c6ed142,TCGA-AO-A1KQ-01A-11D-A13J-01,
tcga.ao.a1kr,,51.0,1.0,,2140.0,,Negative,FEMALE,,,,,,,,,2140.0,0.0,Basal,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-AO-A1KR-01,2513.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-AO-A1KR,2513.0,0.0,days,2513.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-AO-A1KR-F21768,TCGA-AO-A1KR,TCGA-AO-A1KR-01A,,Negative,4 Point Scale,,3 Point Scale,,Negative,Simple Mastectomy,,YES,,,-18900.0,1932.0,,0.0,2513.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-5-21,FEMALE,,,,,1+,,1,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Negative,Negative,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf,A1KR,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2005.0,6d22f538-114f-48b6-94ba-fb60151ed567,6d22f538-114f-48b6-94ba-fb60151ed567,TCGA-AO-A1KR-01A-21-A17I-20,TCGA-AO-A1KR-01A-12D-A142-09,TCGA-AO-A1KR-01,TCGA-AO-A1KR-01A-12D-A145-05,209b9ca9-04fe-441d-915a-b8f4ef9e4b74,TCGA-AO-A1KR-01,TCGA-AO-A1KR-01A-12D-A142-09,,,TCGA-AO-A1KR-01,TCGA-AO-A1KR-01A-12D-A142-09,,6d22f538-114f-48b6-94ba-fb60151ed567,,TCGA-AO-A1KR-01A-12D-A141-01,TCGA-AO-A1KR-01,,6d22f538-114f-48b6-94ba-fb60151ed567,TCGA-AO-A1KR-01A-12D-A141-01,
tcga.ao.a1ks,Stage IIA,69.0,5.0,Stage IIA,16.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,16.0,0.0,LumB,,Positive,,,,followup,T_Other,T2,LIVING,0.0,TCGA-AO-A1KS-01,350.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-AO-A1KS,350.0,0.0,days,350.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,,TCGA-AO-A1KS-F21777,TCGA-AO-A1KS,TCGA-AO-A1KS-01A,,Positive,4 Point Scale,2+,4 Point Scale,,Positive,Lumpectomy,,YES,,,-25230.0,147.0,,0.0,350.0,,,,,NO,,90-99%,3.2,Scheduled Follow-up Submission,2012-2-20,FEMALE,,,10-19%,Positive >2.2,2+,40.0,3.2,1.0,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,4+,YES,,Core needle biopsy,420.0,NO,Equivocal,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf,A1KS,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,AO,Breast,A,LIVING,2010.0,9eab0553-20cc-41bb-bcdb-9ade0578da82,9eab0553-20cc-41bb-bcdb-9ade0578da82,TCGA-AO-A1KS-01A-21-A17I-20,TCGA-AO-A1KS-01A-11D-A13L-09,TCGA-AO-A1KS-01,TCGA-AO-A1KS-01A-11D-A13K-05,6022e4a0-4bd2-4d51-ac93-56f6b54dfa39,TCGA-AO-A1KS-01,TCGA-AO-A1KS-01A-11D-A13L-09,,,TCGA-AO-A1KS-01,TCGA-AO-A1KS-01A-11D-A13L-09,,9eab0553-20cc-41bb-bcdb-9ade0578da82,,TCGA-AO-A1KS-01A-11D-A13J-01,TCGA-AO-A1KS-01,,9eab0553-20cc-41bb-bcdb-9ade0578da82,TCGA-AO-A1KS-01A-11D-A13J-01,
tcga.ao.a1kt,Stage IIA,78.0,2.0,Stage IIA,541.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,541.0,0.0,LumB,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-AO-A1KT-01,541.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AO-A1KT,,,days,541.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,,TCGA-AO-A1KT-F9905,TCGA-AO-A1KT,TCGA-AO-A1KT-01A,,Positive,4 Point Scale,4+,4 Point Scale,,Positive,Lumpectomy,,YES,,,-28660.0,617.0,,0.0,541.0,,,,,NO,,90-99%,1.7,,2011-4-1,FEMALE,,,10-19%,>2.2 Positive,2+,40.0,2.4,1.4,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,200.0,NO,Equivocal,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,,1.0,1.0,True,[Discrepancy],M0,N1,T1,Stage IIA,TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf,A1KT,TUMOR FREE,,,,,,,YES,40-49%,,YES,Primary Tumor,1,,6th,YES,NO,YES,AO,Breast,A,LIVING,2009.0,82140d3a-0787-4e1e-993d-1b222c073cf8,82140d3a-0787-4e1e-993d-1b222c073cf8,TCGA-AO-A1KT-01A-21-A17I-20,TCGA-AO-A1KT-01A-11D-A13L-09,TCGA-AO-A1KT-01,TCGA-AO-A1KT-01A-11D-A13K-05,c440c6d0-6b35-4764-be41-cd4ca2d3c713,TCGA-AO-A1KT-01,TCGA-AO-A1KT-01A-11D-A13L-09,,,TCGA-AO-A1KT-01,TCGA-AO-A1KT-01A-11D-A13L-09,,82140d3a-0787-4e1e-993d-1b222c073cf8,,TCGA-AO-A1KT-01A-11D-A13J-01,TCGA-AO-A1KT-01,,82140d3a-0787-4e1e-993d-1b222c073cf8,TCGA-AO-A1KT-01A-11D-A13J-01,
tcga.aq.a0y5,Stage IIIA,70.0,3.0,Stage IIIA,,161.0,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N2,161.0,1.0,LumA,,Positive,,,,followup,T_Other,T2,DECEASED,1.0,TCGA-AQ-A0Y5-01,172.0,1.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-AQ-A0Y5,,,days,172.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AQ-A0Y5-F10119,TCGA-AQ-A0Y5,TCGA-AQ-A0Y5-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-25793.0,212.0,172.0,0.0,,,,,,NO,,70-79%,,,2011-4-7,FEMALE,,,,,2+,,,3.8,,Infiltrating Ductal Carcinoma,,Yes,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Positive,Positive,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,,5.0,,False,Yes,MX,N2a,T2,Stage IIIA,TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf,A0Y5,TUMOR FREE,,,,,,,YES,40-49%,,NO,Primary Tumor,1,,7th,YES,YES,NO,AQ,Breast,A,DECEASED,2010.0,9bb258a4-dd26-4c43-bd29-04b68ea3c7ca,9bb258a4-dd26-4c43-bd29-04b68ea3c7ca,,TCGA-AQ-A0Y5-01A-11D-A14K-09,TCGA-AQ-A0Y5-01,TCGA-AQ-A0Y5-01A-11D-A14N-05,,TCGA-AQ-A0Y5-01,TCGA-AQ-A0Y5-01A-11D-A14K-09,,,TCGA-AQ-A0Y5-01,TCGA-AQ-A0Y5-01A-11D-A14K-09,,9bb258a4-dd26-4c43-bd29-04b68ea3c7ca,,TCGA-AQ-A0Y5-01A-11D-A14J-01,TCGA-AQ-A0Y5-01,,9bb258a4-dd26-4c43-bd29-04b68ea3c7ca,TCGA-AQ-A0Y5-01A-11D-A14J-01,
tcga.aq.a1h2,Stage IIIA,84.0,5.0,Stage IIIA,197.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N2,197.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AQ-A1H2-01,475.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation cluster 4,TCGA-AQ-A1H2,475.0,0.0,days,475.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,84.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-AQ-A1H2-F19896,TCGA-AQ-A1H2,TCGA-AQ-A1H2-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-30958.0,156.0,,0.0,475.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-1-3,FEMALE,,,,,2+,,,2.7,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Indeterminate,Positive,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,1.0,,,,,,,,NO,13.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf,A1H2,TUMOR FREE,,,,,,,YES,10-19%,,YES,Primary Tumor,1,,7th,YES,YES,NO,AQ,Breast,A,LIVING,2010.0,8b954cec-cf3e-4b0d-a4e8-cfbc9575a732,8b954cec-cf3e-4b0d-a4e8-cfbc9575a732,TCGA-AQ-A1H2-01A-21-A17I-20,TCGA-AQ-A1H2-01A-11D-A13L-09,TCGA-AQ-A1H2-01,TCGA-AQ-A1H2-01A-11D-A13K-05,8191dc7a-6508-44aa-beb6-397c035c8052,TCGA-AQ-A1H2-01,TCGA-AQ-A1H2-01A-11D-A13L-09,,,TCGA-AQ-A1H2-01,TCGA-AQ-A1H2-01A-11D-A13L-09,,8b954cec-cf3e-4b0d-a4e8-cfbc9575a732,,TCGA-AQ-A1H2-01A-11D-A13J-01,TCGA-AQ-A1H2-01,,8b954cec-cf3e-4b0d-a4e8-cfbc9575a732,TCGA-AQ-A1H2-01A-11D-A13J-01,
tcga.aq.a1h3,Stage IIIC,49.0,2.0,Stage IIIC,138.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,138.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AQ-A1H3-01,989.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,cluster 6,mutation c1uster 9,TCGA-AQ-A1H3,989.0,0.0,days,989.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AQ-A1H3-F50661,TCGA-AQ-A1H3,TCGA-AQ-A1H3-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-18177.0,94.0,,0.0,989.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2013-10-28,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Negative,,NO,23.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,14.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf,A1H3,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,YES,YES,NO,AQ,Breast,A,LIVING,2010.0,554df3b0-e305-4dab-a268-47ad7c1dcffc,554df3b0-e305-4dab-a268-47ad7c1dcffc,TCGA-AQ-A1H3-01A-41-A17I-20,TCGA-AQ-A1H3-01A-31D-A13L-09,TCGA-AQ-A1H3-01,TCGA-AQ-A1H3-01A-31D-A13K-05,ba38e345-7c27-4ab0-a8e9-57b727fec06c,TCGA-AQ-A1H3-01,TCGA-AQ-A1H3-01A-31D-A13L-09,,,TCGA-AQ-A1H3-01,TCGA-AQ-A1H3-01A-31D-A13L-09,,554df3b0-e305-4dab-a268-47ad7c1dcffc,,TCGA-AQ-A1H3-01A-31D-A13J-01,TCGA-AQ-A1H3-01,,554df3b0-e305-4dab-a268-47ad7c1dcffc,TCGA-AQ-A1H3-01A-31D-A13J-01,
tcga.aq.a54n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AQ-A54N-01,78.0,0.0,days,,,,,,,,,,TCGA-AQ-A54N,78.0,0.0,days,78.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-AQ-A54N-F55736,TCGA-AQ-A54N,TCGA-AQ-A54N-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-18741.0,639.0,,0.0,78.0,,,,,,,,,,2014-1-14,FEMALE,,,,,2+,,,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,360.0,NO,Equivocal,Negative,YES,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,M0,N0,T2,Stage IIA,TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf,A54N,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,AQ,Breast,A,LIVING,2011.0,ed3e6c57-a0ec-4441-a1a1-794f3f15e112,ed3e6c57-a0ec-4441-a1a1-794f3f15e112,,,TCGA-AQ-A54N-01,TCGA-AQ-A54N-01A-11D-A268-05,3b93ce2c-bc79-48ef-910d-9d1e7c070008,TCGA-AQ-A54N-01,TCGA-AQ-A54N-01A-11D-A25Q-09,,,TCGA-AQ-A54N-01,,,ed3e6c57-a0ec-4441-a1a1-794f3f15e112,,TCGA-AQ-A54N-01A-11D-A25N-01,TCGA-AQ-A54N-01,,ed3e6c57-a0ec-4441-a1a1-794f3f15e112,TCGA-AQ-A54N-01A-11D-A25N-01,
tcga.aq.a54o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AQ-A54O-01,1001.0,0.0,days,,,,,,,,,,TCGA-AQ-A54O,1001.0,0.0,days,1001.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AQ-A54O-F55731,TCGA-AQ-A54O,TCGA-AQ-A54O-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-18694.0,617.0,,0.0,1001.0,,,,,,,90-99%,,,2014-1-14,MALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,360.0,NO,Negative,,NO,14.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,M0,N0,T2,Stage IIA,TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf,A54O,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,,7th,,YES,NO,AQ,Breast,A,LIVING,2011.0,3c1b6647-26bb-4110-aaea-f542024e8bf3,3c1b6647-26bb-4110-aaea-f542024e8bf3,,,TCGA-AQ-A54O-01,TCGA-AQ-A54O-01A-11D-A268-05,e546ea71-dcab-49bf-b972-d6b6dbe57b8f,TCGA-AQ-A54O-01,TCGA-AQ-A54O-01A-11D-A25Q-09,,,TCGA-AQ-A54O-01,,,3c1b6647-26bb-4110-aaea-f542024e8bf3,,TCGA-AQ-A54O-01A-11D-A25N-01,TCGA-AQ-A54O-01,,3c1b6647-26bb-4110-aaea-f542024e8bf3,TCGA-AQ-A54O-01A-11D-A25N-01,
tcga.aq.a7u7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AQ-A7U7-01,584.0,1.0,days,,,,,,,,,,TCGA-AQ-A7U7,584.0,0.0,days,584.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AQ-A7U7-F68763,TCGA-AQ-A7U7,TCGA-AQ-A7U7-01A,,Positive,,,,,Positive,Other,,YES,,,-20239.0,223.0,584.0,0.0,304.0,,,,,,,80-89%,,,2014-12-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,NO,Negative,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,4.0,0.0,False,Yes,M0,N2a,T2,Stage IIIA,TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf,A7U7,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,L Total Mastectomy,7th,,YES,NO,AQ,Breast,A,DECEASED,2013.0,0f3672e4-ab71-4cb6-9d46-3ae57b58e249,0f3672e4-ab71-4cb6-9d46-3ae57b58e249,,,TCGA-AQ-A7U7-01,TCGA-AQ-A7U7-01A-22D-A357-05,3956ACBB-F98A-4510-95FF-E9A7FFF1AEF7,TCGA-AQ-A7U7-01,,,,TCGA-AQ-A7U7-01,,,0f3672e4-ab71-4cb6-9d46-3ae57b58e249,,TCGA-AQ-A7U7-01A-22D-A350-01,TCGA-AQ-A7U7-01,,0f3672e4-ab71-4cb6-9d46-3ae57b58e249,TCGA-AQ-A7U7-01A-22D-A350-01,
tcga.ar.a1ai,Stage II,47.0,1.0,Stage IIA,1881.0,,Negative,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Negative,N0,1881.0,0.0,Basal,Basal-like,Negative,Basal,-13.0,-12.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AI-01,3296.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-AR-A1AI,3296.0,0.0,days,3296.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AI-F69268,TCGA-AR-A1AI,TCGA-AR-A1AI-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-17229.0,1939.0,,0.0,3296.0,,,588,,,,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,2+,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Fine needle aspiration biopsy,1050.0,NO,Equivocal,Negative,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,"Other, specify",New Primary Tumor,Contralateral Breast,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf,A1AI,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2005.0,52ff562f-6a13-435a-acab-16a064633b1d,52ff562f-6a13-435a-acab-16a064633b1d,TCGA-AR-A1AI-01A-21-A13E-20,TCGA-AR-A1AI-01A-11D-A12Q-09,TCGA-AR-A1AI-01,TCGA-AR-A1AI-01A-11D-A12R-05,d872badb-8c24-48fe-b482-6b3c262a4259,TCGA-AR-A1AI-01,TCGA-AR-A1AI-01A-11D-A12Q-09,,TCGA-AR-A1AI-01,TCGA-AR-A1AI-01,TCGA-AR-A1AI-01A-11D-A12Q-09,,52ff562f-6a13-435a-acab-16a064633b1d,,TCGA-AR-A1AI-01A-11D-A12N-01,TCGA-AR-A1AI-01,TCGA-AR-A1AI-01A-11R-A12P-07,52ff562f-6a13-435a-acab-16a064633b1d,TCGA-AR-A1AI-01A-11D-A12N-01,TCGA-AR-A1AI-01
tcga.ar.a1aj,Stage I,83.0,3.0,Stage I,1604.0,,Positive,FEMALE,Negative,1.0,2.0,2.0,Negative,M0,Negative,N0,1604.0,0.0,Basal,Basal-like,Negative,ReacI,-13.0,-12.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AJ-01,3072.0,0.0,days,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-AR-A1AJ,3072.0,0.0,days,3072.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,83.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AJ-F69269,TCGA-AR-A1AJ,TCGA-AR-A1AJ-01A,,Positive,,,,,Negative,Other,,YES,,,-30489.0,1828.0,,0.0,3072.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf,A1AJ,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,Wide local excision,6th,NO,NO,YES,AR,Breast,A,LIVING,2005.0,98703904-572d-4220-b959-a1293a2e1c33,98703904-572d-4220-b959-a1293a2e1c33,TCGA-AR-A1AJ-01A-31-A13E-20,TCGA-AR-A1AJ-01A-21D-A12Q-09,TCGA-AR-A1AJ-01,TCGA-AR-A1AJ-01A-21D-A12R-05,26cb824a-251d-4b4c-a00c-19de6d7e2562,TCGA-AR-A1AJ-01,TCGA-AR-A1AJ-01A-21D-A12Q-09,,TCGA-AR-A1AJ-01,TCGA-AR-A1AJ-01,TCGA-AR-A1AJ-01A-21D-A12Q-09,,98703904-572d-4220-b959-a1293a2e1c33,,TCGA-AR-A1AJ-01A-21D-A12N-01,TCGA-AR-A1AJ-01,TCGA-AR-A1AJ-01A-21R-A12P-07,98703904-572d-4220-b959-a1293a2e1c33,TCGA-AR-A1AJ-01A-21D-A12N-01,TCGA-AR-A1AJ-01
tcga.ar.a1ak,Stage I,70.0,3.0,Stage I,1558.0,,Positive,FEMALE,Negative,1.0,4.0,3.0,Negative,M0,Negative,N0,1558.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,0.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AK-01,3159.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A1AK,3159.0,0.0,days,3159.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AK-F69271,TCGA-AR-A1AK,,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-25825.0,,,0.0,3159.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,,,No,M0,N0,T1,Stage I,,A1AK,TUMOR FREE,,,,,,YES,YES,10-19%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,,LIVING,2006.0,a3568fd6-4b6d-4507-9c59-1788834d3a75,a3568fd6-4b6d-4507-9c59-1788834d3a75,TCGA-AR-A1AK-01A-31-A13E-20,TCGA-AR-A1AK-01A-21D-A12Q-09,TCGA-AR-A1AK-01,TCGA-AR-A1AK-01A-21D-A12R-05,f0e4daf7-c2e8-40e8-826e-1cb9df14327e,TCGA-AR-A1AK-01,TCGA-AR-A1AK-01A-21D-A12Q-09,,TCGA-AR-A1AK-01,TCGA-AR-A1AK-01,TCGA-AR-A1AK-01A-21D-A12Q-09,,a3568fd6-4b6d-4507-9c59-1788834d3a75,,TCGA-AR-A1AK-01A-21D-A12N-01,TCGA-AR-A1AK-01,TCGA-AR-A1AK-01A-21R-A12P-07,a3568fd6-4b6d-4507-9c59-1788834d3a75,TCGA-AR-A1AK-01A-21D-A12N-01,TCGA-AR-A1AK-01
tcga.ar.a1al,Stage III,60.0,2.0,Stage IIIA,1485.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Positive,N1,1485.0,0.0,LumA,Luminal A,Positive,ReacI,-4.0,0.0,enrollment,T_Other,T3,LIVING,0.0,TCGA-AR-A1AL-01,2971.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation cluster 1,TCGA-AR-A1AL,2971.0,0.0,days,2971.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AL-F69272,TCGA-AR-A1AL,TCGA-AR-A1AL-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-22023.0,1528.0,,0.0,2971.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,630.0,NO,Negative,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,3.0,,True,No,M0,N1,T3,Stage IIIA,TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf,A1AL,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,ad602633-fdd7-4bf1-b3ac-e1c8e0a02934,ad602633-fdd7-4bf1-b3ac-e1c8e0a02934,TCGA-AR-A1AL-01A-31-A13E-20,TCGA-AR-A1AL-01A-21D-A12Q-09,TCGA-AR-A1AL-01,TCGA-AR-A1AL-01A-21D-A12R-05,12c1530b-8aaf-4eb5-bda4-5d3225242d79,TCGA-AR-A1AL-01,TCGA-AR-A1AL-01A-21D-A12Q-09,,TCGA-AR-A1AL-01,TCGA-AR-A1AL-01,TCGA-AR-A1AL-01A-21D-A12Q-09,,ad602633-fdd7-4bf1-b3ac-e1c8e0a02934,,TCGA-AR-A1AL-01A-21D-A12N-01,TCGA-AR-A1AL-01,TCGA-AR-A1AL-01A-21R-A12P-07,ad602633-fdd7-4bf1-b3ac-e1c8e0a02934,TCGA-AR-A1AL-01A-21D-A12N-01,TCGA-AR-A1AL-01
tcga.ar.a1am,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AR-A1AM-01,2991.0,0.0,days,Iq,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AR-A1AM,2991.0,0.0,days,2991.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right Upper Outer Quadrant,,,TCGA-AR-A1AM-F71733,TCGA-AR-A1AM,,,Positive,,,,,Positive,Simple Mastectomy,,,,,-19123.0,,,0.0,2991.0,,,,,,,,,,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,,No,M0,N1,T3,Stage IIIA,,A1AM,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,AR,Breast,,LIVING,2006.0,a58de230-f177-4c58-95ec-55b6edb08452,a58de230-f177-4c58-95ec-55b6edb08452,TCGA-AR-A1AM-01A-31-A24A-20,,TCGA-AR-A1AM-01,TCGA-AR-A1AM-01A-41D-A22B-05,d30acc0b-b6b7-4134-96f5-4b76004ca893,TCGA-AR-A1AM-01,TCGA-AR-A1AM-01A-41D-A228-09,,,TCGA-AR-A1AM-01,,,a58de230-f177-4c58-95ec-55b6edb08452,,TCGA-AR-A1AM-01A-41D-A227-01,TCGA-AR-A1AM-01,,a58de230-f177-4c58-95ec-55b6edb08452,TCGA-AR-A1AM-01A-41D-A227-01,
tcga.ar.a1an,Stage II,46.0,1.0,Stage IIA,1329.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1329.0,0.0,LumA,Luminal A,Positive,,-5.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AN-01,2920.0,0.0,days,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 7,cluster 6,mutation cluster 5,TCGA-AR-A1AN,2920.0,0.0,days,2920.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AN-F69273,TCGA-AR-A1AN,TCGA-AR-A1AN-01A,,Positive,,,,,Positive,Other,,YES,,,-16974.0,1463.0,,0.0,2920.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf,A1AN,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,Wide Local Excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,9046caf3-bbfe-4554-b9d2-11b333ad7704,9046caf3-bbfe-4554-b9d2-11b333ad7704,,TCGA-AR-A1AN-01A-11D-A12Q-09,TCGA-AR-A1AN-01,TCGA-AR-A1AN-01A-11D-A12R-05,,TCGA-AR-A1AN-01,TCGA-AR-A1AN-01A-11D-A12Q-09,,TCGA-AR-A1AN-01,TCGA-AR-A1AN-01,TCGA-AR-A1AN-01A-11D-A12Q-09,,9046caf3-bbfe-4554-b9d2-11b333ad7704,,TCGA-AR-A1AN-01A-11D-A12N-01,TCGA-AR-A1AN-01,TCGA-AR-A1AN-01A-11R-A12P-07,9046caf3-bbfe-4554-b9d2-11b333ad7704,TCGA-AR-A1AN-01A-11D-A12N-01,TCGA-AR-A1AN-01
tcga.ar.a1ao,Stage II,47.0,1.0,Stage IIA,1324.0,,Positive,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Positive,N1,1324.0,0.0,Normal,Normal-like,Negative,Basal,-5.0,-8.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AO-01,2618.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A1AO,2618.0,0.0,days,2618.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AO-F69274,TCGA-AR-A1AO,TCGA-AR-A1AO-01A,,Positive,,,,,Negative,Other,,YES,,,-17332.0,1471.0,,0.0,2618.0,,,,,,,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Negative,,NO,39.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,NO,2.0,,True,No,M0,N1,T1,Stage IIA,TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf,A1AO,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,56183330-0700-46d7-b45f-6d915ae587fa,56183330-0700-46d7-b45f-6d915ae587fa,TCGA-AR-A1AO-01A-21-A13E-20,TCGA-AR-A1AO-01A-11D-A12Q-09,TCGA-AR-A1AO-01,TCGA-AR-A1AO-01A-11D-A12R-05,310b6320-7ad9-4977-9c23-e80e0500e94c,TCGA-AR-A1AO-01,TCGA-AR-A1AO-01A-11D-A12Q-09,,TCGA-AR-A1AO-01,TCGA-AR-A1AO-01,TCGA-AR-A1AO-01A-11D-A12Q-09,,56183330-0700-46d7-b45f-6d915ae587fa,,TCGA-AR-A1AO-01A-11D-A12N-01,TCGA-AR-A1AO-01,TCGA-AR-A1AO-01A-11R-A12P-07,56183330-0700-46d7-b45f-6d915ae587fa,TCGA-AR-A1AO-01A-11D-A12N-01,TCGA-AR-A1AO-01
tcga.ar.a1ap,Stage I,80.0,2.0,Stage I,1215.0,,Positive,FEMALE,Negative,1.0,3.0,3.0,Negative,M0,Negative,N0,1215.0,0.0,LumA,Luminal A,Positive,LumA/B,0.0,0.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AP-01,2856.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-AR-A1AP,2856.0,0.0,days,2856.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AP-F69275,TCGA-AR-A1AP,TCGA-AR-A1AP-01A,Negative,Positive,,,,Mastectomy NOS,Positive,Other,,YES,,,-29406.0,1450.0,,0.0,2856.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,310.0,NO,Equivocal,Negative,NO,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf,A1AP,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,8b0f1897-20d8-492d-9ea9-22f771bbae9d,8b0f1897-20d8-492d-9ea9-22f771bbae9d,TCGA-AR-A1AP-01A-21-A13E-20,TCGA-AR-A1AP-01A-11D-A12Q-09,TCGA-AR-A1AP-01,TCGA-AR-A1AP-01A-11D-A12R-05,07e57b56-5370-4a69-86e4-cdd0955d371b,TCGA-AR-A1AP-01,TCGA-AR-A1AP-01A-11D-A12Q-09,,TCGA-AR-A1AP-01,TCGA-AR-A1AP-01,TCGA-AR-A1AP-01A-11D-A12Q-09,,8b0f1897-20d8-492d-9ea9-22f771bbae9d,,TCGA-AR-A1AP-01A-11D-A12N-01,TCGA-AR-A1AP-01,TCGA-AR-A1AP-01A-11R-A12P-07,8b0f1897-20d8-492d-9ea9-22f771bbae9d,TCGA-AR-A1AP-01A-11D-A12N-01,TCGA-AR-A1AP-01
tcga.ar.a1aq,Stage II,49.0,1.0,Stage IIA,1309.0,,Negative,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Negative,N0,1309.0,0.0,Basal,Basal-like,Negative,Basal,-13.0,-12.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AQ-01,3021.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-AR-A1AQ,3021.0,0.0,days,3021.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AQ-F69276,TCGA-AR-A1AQ,TCGA-AR-A1AQ-01A,,Negative,,,,,Negative,Other,,YES,,,-18109.0,1424.0,,0.0,3021.0,,,,,,,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,180.0,NO,Equivocal,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf,A1AQ,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,747f56be-2fdd-4eb8-99a7-34afd923d8e1,747f56be-2fdd-4eb8-99a7-34afd923d8e1,TCGA-AR-A1AQ-01A-21-A13E-20,TCGA-AR-A1AQ-01A-11D-A12Q-09,TCGA-AR-A1AQ-01,TCGA-AR-A1AQ-01A-11D-A12R-05,23358473-9909-47ff-b683-d046e292d504,TCGA-AR-A1AQ-01,TCGA-AR-A1AQ-01A-11D-A12Q-09,,TCGA-AR-A1AQ-01,TCGA-AR-A1AQ-01,TCGA-AR-A1AQ-01A-11D-A12Q-09,,747f56be-2fdd-4eb8-99a7-34afd923d8e1,,TCGA-AR-A1AQ-01A-11D-A12N-01,TCGA-AR-A1AQ-01,TCGA-AR-A1AQ-01A-11R-A12P-07,747f56be-2fdd-4eb8-99a7-34afd923d8e1,TCGA-AR-A1AQ-01A-11D-A12N-01,TCGA-AR-A1AQ-01
tcga.ar.a1ar,Stage III,50.0,1.0,Stage IIIA,,523.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N2,523.0,1.0,Basal,Basal-like,Negative,,-13.0,0.0,enrollment,T1,T1,DECEASED,1.0,TCGA-AR-A1AR-01,524.0,1.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-AR-A1AR,387.0,1.0,days,524.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-AR-A1AR-F21825,TCGA-AR-A1AR,TCGA-AR-A1AR-01A,,Negative,,,,,Negative,Lumpectomy,,,,,-18482.0,1416.0,524.0,0.0,,,,387,,,,,,Additional New Tumor Event,2012-2-27,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,250.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,"Other, specify",New Primary Tumor,Breast,,YES,5.0,,True,Yes,M0,N2,T1,Stage IIIA,TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf,A1AR,WITH TUMOR,,,,,,,,,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,DECEASED,2007.0,6d066a72-f59f-45a8-ab90-216000b36da4,6d066a72-f59f-45a8-ab90-216000b36da4,,TCGA-AR-A1AR-01A-31D-A135-09,TCGA-AR-A1AR-01,TCGA-AR-A1AR-01A-31D-A138-05,,TCGA-AR-A1AR-01,TCGA-AR-A1AR-01A-31D-A135-09,,TCGA-AR-A1AR-01,TCGA-AR-A1AR-01,TCGA-AR-A1AR-01A-31D-A135-09,,6d066a72-f59f-45a8-ab90-216000b36da4,,TCGA-AR-A1AR-01A-31D-A134-01,TCGA-AR-A1AR-01,TCGA-AR-A1AR-01A-31R-A137-07,6d066a72-f59f-45a8-ab90-216000b36da4,TCGA-AR-A1AR-01A-31D-A134-01,TCGA-AR-A1AR-01
tcga.ar.a1as,Stage II,54.0,3.0,Stage IIB,1242.0,,Positive,FEMALE,Negative,3.0,3.0,3.0,Negative,M0,Positive,N1,1242.0,0.0,LumA,Luminal A,Positive,LumA,-7.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AS-01,1150.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 2,TCGA-AR-A1AS,1150.0,0.0,days,1150.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-AR-A1AS-F49470,TCGA-AR-A1AS,TCGA-AR-A1AS-01A,,Positive,,,,,Positive,Other,,,,,-20028.0,1331.0,,0.0,1150.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Negative,,NO,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf,A1AS,TUMOR FREE,,,,,,NO,YES,70-79%,,YES,Primary Tumor,1,Wide local excision,6th,NO,NO,YES,AR,Breast,A,LIVING,2007.0,e7b64cc3-9b2b-4938-9896-84b640d1586f,e7b64cc3-9b2b-4938-9896-84b640d1586f,TCGA-AR-A1AS-01A-21-A13E-20,TCGA-AR-A1AS-01A-11D-A12Q-09,TCGA-AR-A1AS-01,TCGA-AR-A1AS-01A-11D-A12R-05,0db7dee4-ca2e-4f47-a9bc-5e55ca0df269,TCGA-AR-A1AS-01,TCGA-AR-A1AS-01A-11D-A12Q-09,,TCGA-AR-A1AS-01,TCGA-AR-A1AS-01,TCGA-AR-A1AS-01A-11D-A12Q-09,,e7b64cc3-9b2b-4938-9896-84b640d1586f,,TCGA-AR-A1AS-01A-11D-A12N-01,TCGA-AR-A1AS-01,TCGA-AR-A1AS-01A-11R-A12P-07,e7b64cc3-9b2b-4938-9896-84b640d1586f,TCGA-AR-A1AS-01A-11D-A12N-01,TCGA-AR-A1AS-01
tcga.ar.a1at,Stage II,62.0,,Stage IIA,,1272.0,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,1272.0,1.0,,HER2-enriched,Positive,Her2,-11.0,-5.0,enrollment,T_Other,T2,DECEASED,1.0,TCGA-AR-A1AT-01,1272.0,1.0,days,,,cluster 1,BRCA CIMP c7,BRCA basal-like c6,,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A1AT,1272.0,0.0,days,1272.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AT-F22148,TCGA-AR-A1AT,TCGA-AR-A1AT-01A,,Positive,,,,,Positive,Other,,YES,,,-22942.0,1339.0,1272.0,0.0,,,,,,,,<10%,,Scheduled Follow-up Submission,2012-3-1,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,250.0,NO,Positive,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,1.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf,A1AT,,,,,,,,YES,<10%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,DECEASED,2007.0,e70e1882-b4be-4ed6-9c2d-4e8c84fde633,e70e1882-b4be-4ed6-9c2d-4e8c84fde633,TCGA-AR-A1AT-01A-21-A13E-20,TCGA-AR-A1AT-01A-11D-A12Q-09,TCGA-AR-A1AT-01,TCGA-AR-A1AT-01A-11D-A12R-05,6605222f-3dc9-4a93-987e-a8720dc38b32,,TCGA-AR-A1AT-01A-11D-A12Q-09,,,TCGA-AR-A1AT-01,TCGA-AR-A1AT-01A-11D-A12Q-09,,e70e1882-b4be-4ed6-9c2d-4e8c84fde633,,,TCGA-AR-A1AT-01,TCGA-AR-A1AT-01A-11R-A12P-07,e70e1882-b4be-4ed6-9c2d-4e8c84fde633,,TCGA-AR-A1AT-01
tcga.ar.a1au,Stage III,39.0,4.0,Stage IIIA,1409.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Positive,N2,1409.0,0.0,LumA,Luminal A,Positive,ReacI,-3.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AU-01,2868.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-AR-A1AU,2868.0,0.0,days,2868.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,39.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AU-F71744,TCGA-AR-A1AU,TCGA-AR-A1AU-01A,,Positive,,,,,Positive,Other,,,,,-14564.0,1317.0,,0.0,2868.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,Equivocal,Negative,NO,37.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf,A1AU,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,Total Mastectomy,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,bb07b646-1dcc-4cf5-9aae-1df150e84a84,bb07b646-1dcc-4cf5-9aae-1df150e84a84,TCGA-AR-A1AU-01A-21-A13E-20,TCGA-AR-A1AU-01A-11D-A12Q-09,TCGA-AR-A1AU-01,TCGA-AR-A1AU-01A-11D-A12R-05,48cc7955-160a-4e19-aafc-4fad203a9082,TCGA-AR-A1AU-01,TCGA-AR-A1AU-01A-11D-A12Q-09,,TCGA-AR-A1AU-01,TCGA-AR-A1AU-01,TCGA-AR-A1AU-01A-11D-A12Q-09,,bb07b646-1dcc-4cf5-9aae-1df150e84a84,,TCGA-AR-A1AU-01A-11D-A12N-01,TCGA-AR-A1AU-01,TCGA-AR-A1AU-01A-11R-A12P-07,bb07b646-1dcc-4cf5-9aae-1df150e84a84,TCGA-AR-A1AU-01A-11D-A12N-01,TCGA-AR-A1AU-01
tcga.ar.a1av,Stage II,68.0,3.0,Stage IIB,1295.0,,Positive,MALE,Negative,4.0,5.0,4.0,Negative,M0,Positive,N1,1295.0,0.0,LumA,Luminal B,Positive,LumA/B,-2.0,-5.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AV-01,1864.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-AR-A1AV,1864.0,0.0,days,1864.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left,Axillary lymph node dissection alone,,TCGA-AR-A1AV-F49475,TCGA-AR-A1AV,TCGA-AR-A1AV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-24875.0,1233.0,,0.0,1864.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2013-10-2,MALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,420.0,NO,Negative,,NO,25.0,Negative,,,,,,,,,,,,,,,,,,,,,3.0,7.0,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf,A1AV,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a,dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a,TCGA-AR-A1AV-01A-31-A13E-20,TCGA-AR-A1AV-01A-21D-A12Q-09,TCGA-AR-A1AV-01,TCGA-AR-A1AV-01A-21D-A12R-05,9432773f-696b-4104-9232-c6e6a6a379c2,TCGA-AR-A1AV-01,TCGA-AR-A1AV-01A-21D-A12Q-09,,TCGA-AR-A1AV-01,TCGA-AR-A1AV-01,TCGA-AR-A1AV-01A-21D-A12Q-09,,dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a,,TCGA-AR-A1AV-01A-21D-A12N-01,TCGA-AR-A1AV-01,TCGA-AR-A1AV-01A-21R-A12P-07,dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a,TCGA-AR-A1AV-01A-21D-A12N-01,TCGA-AR-A1AV-01
tcga.ar.a1aw,Stage II,65.0,3.0,Stage IIA,1072.0,,Positive,FEMALE,Negative,2.0,2.0,3.0,Negative,M0,Negative,N0,1072.0,0.0,LumB,Luminal A,Positive,ReacII,-12.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A1AW-01,2632.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 3,TCGA-AR-A1AW,2632.0,0.0,days,2632.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AW-F71714,TCGA-AR-A1AW,TCGA-AR-A1AW-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-23855.0,1157.0,,0.0,2632.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Incisional Biopsy,800.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,3.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf,A1AW,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,cff4a5bc-ba2b-47d6-8d36-6277ae991606,cff4a5bc-ba2b-47d6-8d36-6277ae991606,TCGA-AR-A1AW-01A-11-A13E-20,TCGA-AR-A1AW-01A-21D-A12Q-09,TCGA-AR-A1AW-01,TCGA-AR-A1AW-01A-21D-A12R-05,15e9c25c-1736-4fed-9c7f-5a2f86ee7248,TCGA-AR-A1AW-01,TCGA-AR-A1AW-01A-21D-A12Q-09,,TCGA-AR-A1AW-01,TCGA-AR-A1AW-01,TCGA-AR-A1AW-01A-21D-A12Q-09,,cff4a5bc-ba2b-47d6-8d36-6277ae991606,,TCGA-AR-A1AW-01A-21D-A12N-01,TCGA-AR-A1AW-01,TCGA-AR-A1AW-01A-21R-A12P-07,cff4a5bc-ba2b-47d6-8d36-6277ae991606,TCGA-AR-A1AW-01A-21D-A12N-01,TCGA-AR-A1AW-01
tcga.ar.a1ax,Stage I,64.0,4.0,Stage I,1103.0,,Positive,FEMALE,Positive,3.0,1.0,3.0,Negative,M0,Negative,N0,1103.0,0.0,LumA,Luminal A,Positive,ReacII,0.0,-5.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AX-01,2629.0,0.0,days,Squamous,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-AR-A1AX,2629.0,0.0,days,2629.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AX-F71720,TCGA-AR-A1AX,TCGA-AR-A1AX-01A,,Positive,,,,,Positive,Other,,YES,,,-23507.0,1140.0,,0.0,2629.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,340.0,NO,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf,A1AX,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,66626142-7c5c-4ed0-8ef0-f4133423f275,66626142-7c5c-4ed0-8ef0-f4133423f275,TCGA-AR-A1AX-01A-21-A13E-20,TCGA-AR-A1AX-01A-11D-A12Q-09,TCGA-AR-A1AX-01,TCGA-AR-A1AX-01A-11D-A12R-05,f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8,TCGA-AR-A1AX-01,TCGA-AR-A1AX-01A-11D-A12Q-09,,TCGA-AR-A1AX-01,TCGA-AR-A1AX-01,TCGA-AR-A1AX-01A-11D-A12Q-09,,66626142-7c5c-4ed0-8ef0-f4133423f275,,TCGA-AR-A1AX-01A-11D-A12N-01,TCGA-AR-A1AX-01,TCGA-AR-A1AX-01A-11R-A12P-07,66626142-7c5c-4ed0-8ef0-f4133423f275,TCGA-AR-A1AX-01A-11D-A12N-01,TCGA-AR-A1AX-01
tcga.ar.a1ay,Stage I,65.0,1.0,Stage I,614.0,,Negative,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Negative,N0,614.0,0.0,Basal,Basal-like,Negative,Basal,-13.0,-12.0,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A1AY-01,1026.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-AR-A1AY,1026.0,0.0,days,1026.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A1AY-F49482,TCGA-AR-A1AY,TCGA-AR-A1AY-01A,,Negative,,,,,Negative,Other,,YES,,,-23927.0,1085.0,,0.0,1026.0,,,,,,,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf,A1AY,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide Local Excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2008.0,49c4166c-701a-4f53-8968-99aec3347214,49c4166c-701a-4f53-8968-99aec3347214,TCGA-AR-A1AY-01A-11-A13E-20,TCGA-AR-A1AY-01A-21D-A12Q-09,TCGA-AR-A1AY-01,TCGA-AR-A1AY-01A-21D-A12R-05,1815b916-4da0-4ada-9774-7231a10c6862,TCGA-AR-A1AY-01,TCGA-AR-A1AY-01A-21D-A12Q-09,,TCGA-AR-A1AY-01,TCGA-AR-A1AY-01,TCGA-AR-A1AY-01A-21D-A12Q-09,,49c4166c-701a-4f53-8968-99aec3347214,,TCGA-AR-A1AY-01A-21D-A12N-01,TCGA-AR-A1AY-01,TCGA-AR-A1AY-01A-21R-A12P-07,49c4166c-701a-4f53-8968-99aec3347214,TCGA-AR-A1AY-01A-21D-A12N-01,TCGA-AR-A1AY-01
tcga.ar.a24h,Stage II,65.0,2.0,Stage IIA,3333.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,3333.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24H-01,4894.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 13,,mutation c1uster 9,TCGA-AR-A24H,4894.0,0.0,days,4894.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24H-F65797,TCGA-AR-A24H,,,Positive,,,,,Positive,Other,,,,,-24046.0,,,0.0,4894.0,,,,,,,,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A24H,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Excision,5th,YES,NO,YES,AR,Breast,,LIVING,2001.0,a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c,a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c,,TCGA-AR-A24H-01A-11D-A167-09,TCGA-AR-A24H-01,TCGA-AR-A24H-01A-11D-A16A-05,,TCGA-AR-A24H-01,TCGA-AR-A24H-01A-11D-A167-09,,,TCGA-AR-A24H-01,TCGA-AR-A24H-01A-11D-A167-09,,a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c,,TCGA-AR-A24H-01A-11D-A166-01,TCGA-AR-A24H-01,,a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c,TCGA-AR-A24H-01A-11D-A166-01,
tcga.ar.a24k,Stage II,46.0,3.0,Stage IIA,1548.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1548.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24K-01,1548.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 3,TCGA-AR-A24K,1548.0,0.0,days,1548.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24K-F49485,TCGA-AR-A24K,TCGA-AR-A24K-01A,,Positive,,,,,Positive,Other,,YES,,,-16961.0,2325.0,,0.0,1548.0,,,,,,No value Given,10-19%,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Equivocal,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf,A24K,TUMOR FREE,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2004.0,e3008c10-aa31-40ef-ad50-77fd8ec7a1a9,e3008c10-aa31-40ef-ad50-77fd8ec7a1a9,TCGA-AR-A24K-01A-21-A17I-20,TCGA-AR-A24K-01A-11D-A167-09,TCGA-AR-A24K-01,TCGA-AR-A24K-01A-11D-A16A-05,6308773f-3789-47c1-8254-eaf5f9801868,TCGA-AR-A24K-01,TCGA-AR-A24K-01A-11D-A167-09,,,TCGA-AR-A24K-01,TCGA-AR-A24K-01A-11D-A167-09,,e3008c10-aa31-40ef-ad50-77fd8ec7a1a9,,TCGA-AR-A24K-01A-11D-A166-01,TCGA-AR-A24K-01,,e3008c10-aa31-40ef-ad50-77fd8ec7a1a9,TCGA-AR-A24K-01A-11D-A166-01,
tcga.ar.a24l,Stage II,26.0,5.0,Stage IIB,2221.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,2221.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-AR-A24L-01,2866.0,1.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A24L,1414.0,1.0,days,2866.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,26.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24L-F49488,TCGA-AR-A24L,,,Positive,,,,,Positive,Other,,,,,-9706.0,,2866.0,0.0,2221.0,,,1414,,,,10-19%,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,Locoregional Disease,,,YES,2.0,,,No,M0,N1,T2,Stage IIB,,A24L,WITH TUMOR,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,,DECEASED,2005.0,bfa78a45-16bf-410a-816d-bd369ded91e5,bfa78a45-16bf-410a-816d-bd369ded91e5,TCGA-AR-A24L-01A-21-A17I-20,TCGA-AR-A24L-01A-11D-A167-09,TCGA-AR-A24L-01,TCGA-AR-A24L-01A-11D-A16A-05,e1bd54aa-7e28-47ce-98fb-95593ee07f96,TCGA-AR-A24L-01,TCGA-AR-A24L-01A-11D-A167-09,,,TCGA-AR-A24L-01,TCGA-AR-A24L-01A-11D-A167-09,,bfa78a45-16bf-410a-816d-bd369ded91e5,,TCGA-AR-A24L-01A-11D-A166-01,TCGA-AR-A24L-01,,bfa78a45-16bf-410a-816d-bd369ded91e5,TCGA-AR-A24L-01A-11D-A166-01,
tcga.ar.a24m,Stage III,38.0,3.0,Stage IIIA,1990.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1990.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24M-01,3660.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-AR-A24M,3660.0,0.0,days,3660.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24M-F71732,TCGA-AR-A24M,TCGA-AR-A24M-01A,,Positive,,,,,Positive,Other,,,,,-14119.0,2245.0,,0.0,3660.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,1+,,,,,Mixed Histology (please specify),Mixed invasive ductal and invasive lobular,No,,C50.9,8522/3,C50.9,,YES,,Core needle biopsy,400.0,NO,Negative,,NO,28.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf,A24M,TUMOR FREE,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2005.0,4977200c-765d-475f-8df4-bf8d9a3b0aa9,4977200c-765d-475f-8df4-bf8d9a3b0aa9,TCGA-AR-A24M-01A-21-A17I-20,TCGA-AR-A24M-01A-11D-A167-09,TCGA-AR-A24M-01,TCGA-AR-A24M-01A-11D-A16A-05,8728cab4-4860-4753-aa84-05f91f245005,TCGA-AR-A24M-01,TCGA-AR-A24M-01A-11D-A167-09,,,TCGA-AR-A24M-01,TCGA-AR-A24M-01A-11D-A167-09,,4977200c-765d-475f-8df4-bf8d9a3b0aa9,,TCGA-AR-A24M-01A-11D-A166-01,TCGA-AR-A24M-01,,4977200c-765d-475f-8df4-bf8d9a3b0aa9,TCGA-AR-A24M-01A-11D-A166-01,
tcga.ar.a24n,Stage I,54.0,2.0,Stage I,2074.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2074.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A24N-01,3035.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 3,mutation c1uster 9,TCGA-AR-A24N,3035.0,0.0,days,3035.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24N-F71723,TCGA-AR-A24N,TCGA-AR-A24N-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-19989.0,2219.0,,0.0,3035.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,310.0,NO,Equivocal,Negative,NO,4.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,3.0,3.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf,A24N,TUMOR FREE,,,,,,NO,YES,10-19%,,NO,Primary Tumor,1,,6th,NO,NO,YES,AR,Breast,A,LIVING,2005.0,48bf0fa5-66c2-495d-93ef-943bc7ff31ac,48bf0fa5-66c2-495d-93ef-943bc7ff31ac,TCGA-AR-A24N-01A-21-A17I-20,TCGA-AR-A24N-01A-11D-A167-09,TCGA-AR-A24N-01,TCGA-AR-A24N-01A-11D-A16A-05,90813751-60f8-4e79-bfd3-1f363203a029,TCGA-AR-A24N-01,TCGA-AR-A24N-01A-11D-A167-09,,,TCGA-AR-A24N-01,TCGA-AR-A24N-01A-11D-A167-09,,48bf0fa5-66c2-495d-93ef-943bc7ff31ac,,TCGA-AR-A24N-01A-11D-A166-01,TCGA-AR-A24N-01,,48bf0fa5-66c2-495d-93ef-943bc7ff31ac,TCGA-AR-A24N-01A-11D-A166-01,
tcga.ar.a24o,Stage III,43.0,2.0,Stage IIIA,1997.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1997.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-AR-A24O-01,3607.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-AR-A24O,2561.0,1.0,days,3607.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Left,,,TCGA-AR-A24O-F71713,TCGA-AR-A24O,TCGA-AR-A24O-01A,Negative,Positive,,,,Mastectomy NOS,Positive,Modified Radical Mastectomy,,,,,-15977.0,2213.0,,0.0,3607.0,,,2561,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,,,,,,Mixed Histology (please specify),Lobular carcinoma with ductal features,No,,C50.9,8522/3,C50.9,,YES,,Incisional Biopsy,700.0,NO,Negative,,NO,19.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,YES,7.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf,A24O,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2005.0,2cd8167d-d35f-43e8-927f-cd7decebd9cf,2cd8167d-d35f-43e8-927f-cd7decebd9cf,TCGA-AR-A24O-01A-21-A17I-20,TCGA-AR-A24O-01A-11D-A167-09,TCGA-AR-A24O-01,TCGA-AR-A24O-01A-11D-A16A-05,c364acc4-6658-4deb-97ff-a367022c6958,TCGA-AR-A24O-01,TCGA-AR-A24O-01A-11D-A167-09,,,TCGA-AR-A24O-01,TCGA-AR-A24O-01A-11D-A167-09,,2cd8167d-d35f-43e8-927f-cd7decebd9cf,,TCGA-AR-A24O-01A-11D-A166-01,TCGA-AR-A24O-01,,2cd8167d-d35f-43e8-927f-cd7decebd9cf,TCGA-AR-A24O-01A-11D-A166-01,
tcga.ar.a24p,Stage I,47.0,2.0,Stage I,26.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,26.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A24P-01,84.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 5,TCGA-AR-A24P,84.0,0.0,days,84.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24P-F31403,TCGA-AR-A24P,TCGA-AR-A24P-01A,,Positive,,,,,Positive,Other,,YES,,,-17490.0,2161.0,,0.0,84.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2012-5-2,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,130.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf,A24P,,,,,,,,YES,10-19%,,,Primary Tumor,1,Wide local excision,6th,,NO,YES,AR,Breast,A,LIVING,2005.0,49bdbb64-75a8-4a30-bde6-57f3c2a38f9b,49bdbb64-75a8-4a30-bde6-57f3c2a38f9b,TCGA-AR-A24P-01A-21-A17I-20,TCGA-AR-A24P-01A-11D-A167-09,TCGA-AR-A24P-01,TCGA-AR-A24P-01A-11D-A16A-05,085b7387-61df-4f55-a320-72c165bf8647,TCGA-AR-A24P-01,TCGA-AR-A24P-01A-11D-A167-09,,,TCGA-AR-A24P-01,TCGA-AR-A24P-01A-11D-A167-09,,49bdbb64-75a8-4a30-bde6-57f3c2a38f9b,,TCGA-AR-A24P-01A-11D-A166-01,TCGA-AR-A24P-01,,49bdbb64-75a8-4a30-bde6-57f3c2a38f9b,TCGA-AR-A24P-01A-11D-A166-01,
tcga.ar.a24q,Stage II,49.0,1.0,Stage IIB,2008.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2008.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-AR-A24Q-01,3172.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA c1uster 9,cluster 6,mutation cluster 2,TCGA-AR-A24Q,3172.0,0.0,days,3172.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24Q-F65802,TCGA-AR-A24Q,TCGA-AR-A24Q-01A,,Positive,,,,,Negative,Simple Mastectomy,,,,,-18084.0,1932.0,,0.0,3172.0,,,,,,,<10%,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,590.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf,A24Q,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,72c34d2c-f255-492b-9249-e9e9c506ece2,72c34d2c-f255-492b-9249-e9e9c506ece2,TCGA-AR-A24Q-01A-21-A17I-20,TCGA-AR-A24Q-01A-12D-A167-09,TCGA-AR-A24Q-01,TCGA-AR-A24Q-01A-12D-A16A-05,f39fe8fb-2c5e-403b-aceb-bd9604f1a25e,TCGA-AR-A24Q-01,TCGA-AR-A24Q-01A-12D-A167-09,,,TCGA-AR-A24Q-01,TCGA-AR-A24Q-01A-12D-A167-09,,72c34d2c-f255-492b-9249-e9e9c506ece2,,TCGA-AR-A24Q-01A-12D-A166-01,TCGA-AR-A24Q-01,,72c34d2c-f255-492b-9249-e9e9c506ece2,TCGA-AR-A24Q-01A-12D-A166-01,
tcga.ar.a24r,Stage III,45.0,5.0,Stage IIIA,1745.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1745.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A24R-01,3430.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-AR-A24R,3430.0,0.0,days,3430.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24R-F71731,TCGA-AR-A24R,TCGA-AR-A24R-01A,,Positive,,,,,Positive,Other,,,,,-16642.0,1913.0,,0.0,3430.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Negative,Negative,NO,28.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,6.0,,True,No,M0,N2,T1,Stage IIIA,TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf,A24R,TUMOR FREE,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,401721b2-a1d1-46d3-b73c-ec06df30d61e,401721b2-a1d1-46d3-b73c-ec06df30d61e,TCGA-AR-A24R-01A-21-A17I-20,TCGA-AR-A24R-01A-11D-A167-09,TCGA-AR-A24R-01,TCGA-AR-A24R-01A-11D-A16A-05,1734096f-0942-4abe-acb4-cd6e183080c0,TCGA-AR-A24R-01,TCGA-AR-A24R-01A-11D-A167-09,,,TCGA-AR-A24R-01,TCGA-AR-A24R-01A-11D-A167-09,,401721b2-a1d1-46d3-b73c-ec06df30d61e,,TCGA-AR-A24R-01A-11D-A166-01,TCGA-AR-A24R-01,,401721b2-a1d1-46d3-b73c-ec06df30d61e,TCGA-AR-A24R-01A-11D-A166-01,
tcga.ar.a24s,Stage I,61.0,1.0,Stage I,1888.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1888.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A24S-01,2976.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 2,TCGA-AR-A24S,2976.0,0.0,days,2976.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24S-F31496,TCGA-AR-A24S,TCGA-AR-A24S-01A,,Positive,,,,,Positive,Other,,YES,,,-22587.0,1812.0,,0.0,2976.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2012-5-4,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,520.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf,A24S,,,,,,,,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,3795f6d6-3a1d-4b41-8a4b-e832078e9d48,3795f6d6-3a1d-4b41-8a4b-e832078e9d48,TCGA-AR-A24S-01A-21-A17I-20,TCGA-AR-A24S-01A-11D-A167-09,TCGA-AR-A24S-01,TCGA-AR-A24S-01A-11D-A16A-05,9e00e8b9-5977-4a9c-aef4-c9f3e8007475,TCGA-AR-A24S-01,TCGA-AR-A24S-01A-11D-A167-09,,,TCGA-AR-A24S-01,TCGA-AR-A24S-01A-11D-A167-09,,3795f6d6-3a1d-4b41-8a4b-e832078e9d48,,TCGA-AR-A24S-01A-11D-A166-01,TCGA-AR-A24S-01,,3795f6d6-3a1d-4b41-8a4b-e832078e9d48,TCGA-AR-A24S-01A-11D-A166-01,
tcga.ar.a24t,Stage III,46.0,2.0,Stage IIIC,1620.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,1620.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-AR-A24T-01,3202.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 4,TCGA-AR-A24T,3202.0,0.0,days,3202.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24T-F71728,TCGA-AR-A24T,TCGA-AR-A24T-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-17135.0,1786.0,,0.0,3202.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,490.0,NO,Equivocal,Negative,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,15.0,,True,No,M0,N3,T3,Stage IIIC,TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf,A24T,TUMOR FREE,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,d2e1fdf7-1ac9-49e9-a611-b15c90772bf6,d2e1fdf7-1ac9-49e9-a611-b15c90772bf6,TCGA-AR-A24T-01A-21-A17I-20,TCGA-AR-A24T-01A-11D-A167-09,TCGA-AR-A24T-01,TCGA-AR-A24T-01A-11D-A16A-05,7c08cdc2-f620-4ba3-9a66-37bd23d75d3e,TCGA-AR-A24T-01,TCGA-AR-A24T-01A-11D-A167-09,,,TCGA-AR-A24T-01,TCGA-AR-A24T-01A-11D-A167-09,,d2e1fdf7-1ac9-49e9-a611-b15c90772bf6,,TCGA-AR-A24T-01A-11D-A166-01,TCGA-AR-A24T-01,,d2e1fdf7-1ac9-49e9-a611-b15c90772bf6,TCGA-AR-A24T-01A-11D-A166-01,
tcga.ar.a24u,Stage II,47.0,4.0,Stage IIA,1623.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,1623.0,0.0,Her2,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A24U-01,3128.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 7,mutation c1uster 9,TCGA-AR-A24U,3128.0,0.0,days,3128.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24U-F71738,TCGA-AR-A24U,TCGA-AR-A24U-01A,Negative,Negative,,,,Mastectomy NOS,Negative,Simple Mastectomy,,,,,-17523.0,1763.0,,0.0,3128.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,320.0,NO,Positive,,NO,25.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,NO,2.0,,True,No,M0,N1,T1,Stage IIA,TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf,A24U,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,296c69de-2b77-4b3a-a228-9552a8a9836e,296c69de-2b77-4b3a-a228-9552a8a9836e,TCGA-AR-A24U-01A-21-A17I-20,TCGA-AR-A24U-01A-11D-A167-09,TCGA-AR-A24U-01,TCGA-AR-A24U-01A-11D-A16A-05,c0592373-1465-46d8-984a-2c02e0c53cfc,TCGA-AR-A24U-01,TCGA-AR-A24U-01A-11D-A167-09,,,TCGA-AR-A24U-01,TCGA-AR-A24U-01A-11D-A167-09,,296c69de-2b77-4b3a-a228-9552a8a9836e,,TCGA-AR-A24U-01A-11D-A166-01,TCGA-AR-A24U-01,,296c69de-2b77-4b3a-a228-9552a8a9836e,TCGA-AR-A24U-01A-11D-A166-01,
tcga.ar.a24v,Stage II,52.0,5.0,Stage IIB,1648.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1648.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24V-01,3203.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A24V,3203.0,0.0,days,3203.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24V-F71740,TCGA-AR-A24V,TCGA-AR-A24V-01A,,Positive,,,,,Positive,Other,,YES,,,-19027.0,1720.0,,0.0,3203.0,,,,,,,80-89%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,400.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf,A24V,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,29b04717-c5f2-4d4c-b006-e5c5f0aade7a,29b04717-c5f2-4d4c-b006-e5c5f0aade7a,TCGA-AR-A24V-01A-11-A17I-20,TCGA-AR-A24V-01A-21D-A167-09,TCGA-AR-A24V-01,TCGA-AR-A24V-01A-21D-A16A-05,38c6af12-c50f-4dbe-8130-0b737b29390a,TCGA-AR-A24V-01,TCGA-AR-A24V-01A-21D-A167-09,,,TCGA-AR-A24V-01,TCGA-AR-A24V-01A-21D-A167-09,,29b04717-c5f2-4d4c-b006-e5c5f0aade7a,,TCGA-AR-A24V-01A-21D-A166-01,TCGA-AR-A24V-01,,29b04717-c5f2-4d4c-b006-e5c5f0aade7a,TCGA-AR-A24V-01A-21D-A166-01,
tcga.ar.a24w,,,3.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AR-A24W-01,991.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation c1uster 9,TCGA-AR-A24W,991.0,0.0,days,991.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24W-F49476,TCGA-AR-A24W,,,Positive,,,,,Positive,Other,,,,,-20123.0,,,0.0,991.0,,,,,,,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,3.0,,,No,M0,N1,T2,Stage IIB,,A24W,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,Total Mastectomy,6th,YES,NO,YES,AR,Breast,,LIVING,2006.0,a2f3fd7f-9a5d-44aa-8810-4978abad6e12,a2f3fd7f-9a5d-44aa-8810-4978abad6e12,TCGA-AR-A24W-01A-21-A17I-20,TCGA-AR-A24W-01A-11D-A17G-09,TCGA-AR-A24W-01,TCGA-AR-A24W-01A-11D-A16A-05,bb6402d2-2bc7-461a-8143-4e6939bb6813,TCGA-AR-A24W-01,TCGA-AR-A24W-01A-11D-A17G-09,,,TCGA-AR-A24W-01,TCGA-AR-A24W-01A-11D-A17G-09,,a2f3fd7f-9a5d-44aa-8810-4978abad6e12,,TCGA-AR-A24W-01A-11D-A166-01,TCGA-AR-A24W-01,,a2f3fd7f-9a5d-44aa-8810-4978abad6e12,TCGA-AR-A24W-01A-11D-A166-01,
tcga.ar.a24x,Stage II,52.0,2.0,Stage IIA,1465.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1465.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24X-01,3004.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 4,TCGA-AR-A24X,3004.0,0.0,days,3004.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24X-F71741,TCGA-AR-A24X,TCGA-AR-A24X-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-19030.0,1717.0,,0.0,3004.0,,,,,,,80-89%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Mixed Histology (please specify),Mixed invasive ductal and invasive lobular,No,,C50.9,8522/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Equivocal,Negative,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf,A24X,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,42a7e579-365d-4393-8b98-e4516863299e,42a7e579-365d-4393-8b98-e4516863299e,TCGA-AR-A24X-01A-21-A17I-20,TCGA-AR-A24X-01A-11D-A167-09,TCGA-AR-A24X-01,TCGA-AR-A24X-01A-11D-A16A-05,44e1a92c-dabb-4fdb-936c-bd1dfb2719ac,TCGA-AR-A24X-01,TCGA-AR-A24X-01A-11D-A167-09,,,TCGA-AR-A24X-01,TCGA-AR-A24X-01A-11D-A167-09,,42a7e579-365d-4393-8b98-e4516863299e,,TCGA-AR-A24X-01A-11D-A166-01,TCGA-AR-A24X-01,,42a7e579-365d-4393-8b98-e4516863299e,TCGA-AR-A24X-01A-11D-A166-01,
tcga.ar.a24z,Stage II,57.0,3.0,Stage IIA,1574.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1574.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A24Z-01,3001.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,mutation c1uster 9,TCGA-AR-A24Z,3001.0,0.0,days,3001.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A24Z-F71743,TCGA-AR-A24Z,TCGA-AR-A24Z-01A,,Positive,,,,,Positive,Other,,YES,,,-20900.0,1673.0,,0.0,3001.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf,A24Z,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,Total mastectomy,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,8d0d1eea-9e60-4507-8cfa-1fac66edc8a4,8d0d1eea-9e60-4507-8cfa-1fac66edc8a4,TCGA-AR-A24Z-01A-21-A17I-20,TCGA-AR-A24Z-01A-11D-A167-09,TCGA-AR-A24Z-01,TCGA-AR-A24Z-01A-11D-A16A-05,93fa3c81-01ce-4073-811d-146d1ef739ac,TCGA-AR-A24Z-01,TCGA-AR-A24Z-01A-11D-A167-09,,,TCGA-AR-A24Z-01,TCGA-AR-A24Z-01A-11D-A167-09,,8d0d1eea-9e60-4507-8cfa-1fac66edc8a4,,TCGA-AR-A24Z-01A-11D-A166-01,TCGA-AR-A24Z-01,,8d0d1eea-9e60-4507-8cfa-1fac66edc8a4,TCGA-AR-A24Z-01A-11D-A166-01,
tcga.ar.a250,Stage II,58.0,3.0,Stage IIA,1707.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,1707.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A250-01,2707.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-AR-A250,2707.0,0.0,days,2707.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A250-F65794,TCGA-AR-A250,TCGA-AR-A250-01A,Negative,Positive,,,,Mastectomy NOS,Negative,Other,,,,,-21309.0,1629.0,,0.0,2707.0,,,,,,,70-79%,,,2014-9-30,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Equivocal,Positive,NO,4.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf,A250,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,Wide local excision and simple mastectomy,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,86373f83-264a-4875-8672-749ea434422f,86373f83-264a-4875-8672-749ea434422f,TCGA-AR-A250-01A-41-A17I-20,TCGA-AR-A250-01A-31D-A167-09,TCGA-AR-A250-01,TCGA-AR-A250-01A-31D-A16A-05,1c3c4e67-cd5b-42b6-9cd8-5f18356a8e80,TCGA-AR-A250-01,TCGA-AR-A250-01A-31D-A167-09,,,TCGA-AR-A250-01,TCGA-AR-A250-01A-31D-A167-09,,86373f83-264a-4875-8672-749ea434422f,,TCGA-AR-A250-01A-31D-A166-01,TCGA-AR-A250-01,,86373f83-264a-4875-8672-749ea434422f,TCGA-AR-A250-01A-31D-A166-01,
tcga.ar.a251,Stage III,51.0,1.0,Stage IIIA,1373.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1373.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A251-01,3030.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 7,,mutation c1uster 9,TCGA-AR-A251,3030.0,0.0,days,3030.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A251-F71716,TCGA-AR-A251,TCGA-AR-A251-01A,Negative,Positive,,,,Mastectomy NOS,Negative,Other,,,,,-18771.0,1611.0,,0.0,3030.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,450.0,NO,Equivocal,Negative,NO,7.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf,A251,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2006.0,06760907-c6ec-4b72-bfd4-87811823b8ba,06760907-c6ec-4b72-bfd4-87811823b8ba,TCGA-AR-A251-01A-21-A17I-20,TCGA-AR-A251-01A-12D-A167-09,TCGA-AR-A251-01,TCGA-AR-A251-01A-12D-A16A-05,4378eaf7-993d-40b3-ab7f-1a909c768a47,TCGA-AR-A251-01,TCGA-AR-A251-01A-12D-A167-09,,,TCGA-AR-A251-01,TCGA-AR-A251-01A-12D-A167-09,,06760907-c6ec-4b72-bfd4-87811823b8ba,,TCGA-AR-A251-01A-12D-A166-01,TCGA-AR-A251-01,,06760907-c6ec-4b72-bfd4-87811823b8ba,TCGA-AR-A251-01A-12D-A166-01,
tcga.ar.a252,Stage I,50.0,3.0,Stage I,1236.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1236.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A252-01,2838.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-AR-A252,2838.0,0.0,days,2838.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A252-F71727,TCGA-AR-A252,TCGA-AR-A252-01A,,Positive,,,,,Positive,Other,,YES,,,-18611.0,1405.0,,0.0,2838.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,480.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,1.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf,A252,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,f325c7a8-46b0-4d75-9228-db391c270c71,f325c7a8-46b0-4d75-9228-db391c270c71,TCGA-AR-A252-01A-21-A17I-20,TCGA-AR-A252-01A-11D-A167-09,TCGA-AR-A252-01,TCGA-AR-A252-01A-11D-A16A-05,8fd7447f-07c3-4bd3-a877-7bf96db17d03,TCGA-AR-A252-01,TCGA-AR-A252-01A-11D-A167-09,,,TCGA-AR-A252-01,TCGA-AR-A252-01A-11D-A167-09,,f325c7a8-46b0-4d75-9228-db391c270c71,,TCGA-AR-A252-01A-11D-A166-01,TCGA-AR-A252-01,,f325c7a8-46b0-4d75-9228-db391c270c71,TCGA-AR-A252-01A-11D-A166-01,
tcga.ar.a254,Stage III,50.0,3.0,Stage IIIA,1212.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N2,1212.0,0.0,Her2,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-AR-A254-01,2605.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 5,TCGA-AR-A254,2605.0,0.0,days,2605.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A254-F71726,TCGA-AR-A254,TCGA-AR-A254-01A,,Positive,,,,,Positive,Other,,,,,-18270.0,1381.0,,0.0,2605.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Wide local incision,"Other method, specify:",990.0,NO,Positive,,NO,30.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,9.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf,A254,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,5741e1ce-5d4c-40dc-aa01-e71a45341884,5741e1ce-5d4c-40dc-aa01-e71a45341884,TCGA-AR-A254-01A-11-A17I-20,TCGA-AR-A254-01A-21D-A167-09,TCGA-AR-A254-01,TCGA-AR-A254-01A-21D-A16A-05,a7ba4821-8817-4411-a013-904b5c771b9e,TCGA-AR-A254-01,TCGA-AR-A254-01A-21D-A167-09,,,TCGA-AR-A254-01,TCGA-AR-A254-01A-21D-A167-09,,5741e1ce-5d4c-40dc-aa01-e71a45341884,,TCGA-AR-A254-01A-21D-A166-01,TCGA-AR-A254-01,,5741e1ce-5d4c-40dc-aa01-e71a45341884,TCGA-AR-A254-01A-21D-A166-01,
tcga.ar.a255,Stage I,62.0,5.0,Stage I,1058.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,1058.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-AR-A255-01,2161.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 4,TCGA-AR-A255,2161.0,0.0,days,2161.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A255-F71745,TCGA-AR-A255,TCGA-AR-A255-01A,,Positive,,,,,Positive,Other,,YES,,,-22809.0,1225.0,,0.0,2161.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,250.0,NO,Positive,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf,A255,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,YES,NO,YES,AR,Breast,A,LIVING,2007.0,5f714b76-1ed1-4828-8b66-3627c5d78189,5f714b76-1ed1-4828-8b66-3627c5d78189,TCGA-AR-A255-01A-21-A17I-20,TCGA-AR-A255-01A-11D-A167-09,TCGA-AR-A255-01,TCGA-AR-A255-01A-11D-A16A-05,1f885532-b89a-406c-af84-bcfc9441ae2a,TCGA-AR-A255-01,TCGA-AR-A255-01A-11D-A167-09,,,TCGA-AR-A255-01,TCGA-AR-A255-01A-11D-A167-09,,5f714b76-1ed1-4828-8b66-3627c5d78189,,TCGA-AR-A255-01A-11D-A166-01,TCGA-AR-A255-01,,5f714b76-1ed1-4828-8b66-3627c5d78189,TCGA-AR-A255-01A-11D-A166-01,
tcga.ar.a256,Stage II,45.0,1.0,Stage IIA,2854.0,2854.0,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,2854.0,1.0,Basal,,Negative,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-AR-A256-01,2854.0,1.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,,mutation cluster 5,TCGA-AR-A256,1640.0,1.0,days,2854.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A256-F31923,TCGA-AR-A256,TCGA-AR-A256-01A,,Negative,,,,,Negative,Other,,YES,,,-16642.0,3740.0,2854.0,0.0,,,,1640,,,,,,Scheduled Follow-up Submission,2012-5-11,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,210.0,NO,Negative,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,,,,,,Locoregional Disease,,,YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf,A256,,,,,,,,YES,,,NO,Primary Tumor,1,Mastectomy,5th,YES,NO,YES,AR,Breast,A,DECEASED,2001.0,60534f8f-970a-4308-9844-a3a41dd6c187,60534f8f-970a-4308-9844-a3a41dd6c187,TCGA-AR-A256-01A-21-A17I-20,TCGA-AR-A256-01A-11D-A167-09,TCGA-AR-A256-01,TCGA-AR-A256-01A-11D-A16A-05,c98c88ee-f8ed-444b-a51c-67e6d942a8b5,TCGA-AR-A256-01,TCGA-AR-A256-01A-11D-A167-09,,,TCGA-AR-A256-01,TCGA-AR-A256-01A-11D-A167-09,,60534f8f-970a-4308-9844-a3a41dd6c187,,TCGA-AR-A256-01A-11D-A166-01,TCGA-AR-A256-01,,60534f8f-970a-4308-9844-a3a41dd6c187,TCGA-AR-A256-01A-11D-A166-01,
tcga.ar.a2le,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AR-A2LE-01,5062.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA c1uster 10,,,TCGA-AR-A2LE,5062.0,0.0,days,5062.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Right,Sentinel node biopsy alone,,TCGA-AR-A2LE-F35164,TCGA-AR-A2LE,TCGA-AR-A2LE-01A,,Positive,,,,,Negative,Other,,YES,,,-25499.0,3755.0,,0.0,5062.0,,,4203,,NO,,,,,2015-3-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,320.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",New Primary Tumor,Endometrium,,NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf,A2LE,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Excision,5th,,NO,YES,AR,Breast,A,LIVING,2001.0,5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74,5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74,TCGA-AR-A2LE-01A-21-A24A-20,,TCGA-AR-A2LE-01,TCGA-AR-A2LE-01A-11D-A17Z-05,642d23a8-3c0c-4004-9d50-3787178cb070,TCGA-AR-A2LE-01,TCGA-AR-A2LE-01A-11D-A17W-09,,,TCGA-AR-A2LE-01,,,5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74,,TCGA-AR-A2LE-01A-11D-A17U-01,TCGA-AR-A2LE-01,,5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74,TCGA-AR-A2LE-01A-11D-A17U-01,
tcga.ar.a2lh,,,,,,,,,,,,,,,,,,,Normal,,,,,,,,,,1.0,TCGA-AR-A2LH-01,616.0,1.0,days,Quiet,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-AR-A2LH,434.0,1.0,days,616.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LH-F35165,TCGA-AR-A2LH,TCGA-AR-A2LH-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-20288.0,1661.0,616.0,0.0,,,,434,,YES,,,,,2012-12-6,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,1100.0,NO,Equivocal,Negative,NO,39.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,Bone|Liver,,,,,,,Bone,Distant Metastasis,,,YES,29.0,,True,No,M0,N3,T3,Stage III,TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf,A2LH,,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,AR,Breast,A,DECEASED,2007.0,6aa1a643-013f-43d4-a3e6-a4a946ac3678,6aa1a643-013f-43d4-a3e6-a4a946ac3678,TCGA-AR-A2LH-01A-41-A24A-20,,TCGA-AR-A2LH-01,TCGA-AR-A2LH-01A-31D-A18O-05,eca21066-45f1-49c3-b6ac-d594ed529c0e,TCGA-AR-A2LH-01,TCGA-AR-A2LH-01A-31D-A18P-09,,,TCGA-AR-A2LH-01,,,6aa1a643-013f-43d4-a3e6-a4a946ac3678,,TCGA-AR-A2LH-01A-31D-A18N-01,TCGA-AR-A2LH-01,,6aa1a643-013f-43d4-a3e6-a4a946ac3678,TCGA-AR-A2LH-01A-31D-A18N-01,
tcga.ar.a2lj,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AR-A2LJ-01,2632.0,0.0,days,Iq,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-AR-A2LJ,2632.0,0.0,days,2632.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LJ-F71721,TCGA-AR-A2LJ,TCGA-AR-A2LJ-01A,,Positive,,,,,Positive,Other,,YES,,,-14723.0,1382.0,,0.0,2632.0,,,,,NO,,70-79%,,,2015-3-30,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,540.0,NO,Positive,Positive,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,MX,N1,T3,Stage IIIA,TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf,A2LJ,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,Total Mastectomy,6th,,NO,YES,AR,Breast,A,LIVING,2007.0,52cca577-c5d1-4dff-9e3a-4007beb120db,52cca577-c5d1-4dff-9e3a-4007beb120db,TCGA-AR-A2LJ-01A-21-A24B-20,,TCGA-AR-A2LJ-01,TCGA-AR-A2LJ-01A-12D-A19Z-05,c7155c5f-8110-4eb1-9c42-a959435f5f88,TCGA-AR-A2LJ-01,TCGA-AR-A2LJ-01A-12D-A19Y-09,,,TCGA-AR-A2LJ-01,,,52cca577-c5d1-4dff-9e3a-4007beb120db,,TCGA-AR-A2LJ-01A-12D-A19X-01,TCGA-AR-A2LJ-01,,52cca577-c5d1-4dff-9e3a-4007beb120db,TCGA-AR-A2LJ-01A-12D-A19X-01,
tcga.ar.a2lk,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,1.0,TCGA-AR-A2LK-01,1649.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AR-A2LK,1304.0,1.0,days,1649.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LK-F35203,TCGA-AR-A2LK,TCGA-AR-A2LK-01A,Negative,Positive,,,,Mastectomy NOS,Positive,Other,,,,,-22800.0,1340.0,1649.0,0.0,1304.0,,,1304,,NO,,70-79%,,,2012-12-6,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,650.0,NO,Equivocal,Negative,NO,18.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,,,Positive,,,,,,,,,,,,Positive,,,,,,,,Bone,Distant Metastasis,,,YES,5.0,,True,No,M0,N2,T3,Stage III,TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf,A2LK,,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide local excision,6th,,NO,YES,AR,Breast,A,DECEASED,2007.0,047160f7-3727-4915-b02d-61557350d88b,047160f7-3727-4915-b02d-61557350d88b,TCGA-AR-A2LK-01A-21-A24A-20,,TCGA-AR-A2LK-01,TCGA-AR-A2LK-01A-11D-A17Z-05,bcdf5107-7ac1-4f83-8b7e-30173b7d4760,TCGA-AR-A2LK-01,TCGA-AR-A2LK-01A-11D-A17W-09,,,TCGA-AR-A2LK-01,,,047160f7-3727-4915-b02d-61557350d88b,,TCGA-AR-A2LK-01A-11D-A17U-01,TCGA-AR-A2LK-01,,047160f7-3727-4915-b02d-61557350d88b,TCGA-AR-A2LK-01A-11D-A17U-01,
tcga.ar.a2ll,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,0.0,TCGA-AR-A2LL-01,2012.0,0.0,days,High,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,,TCGA-AR-A2LL,2012.0,0.0,days,2012.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LL-F49493,TCGA-AR-A2LL,TCGA-AR-A2LL-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-25747.0,1315.0,,0.0,2012.0,,,,,NO,,70-79%,,,2013-10-2,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,1300.0,NO,Equivocal,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,Yes,M0,N0,T3,Stage IIB,TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf,A2LL,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,,6th,,NO,YES,AR,Breast,A,LIVING,2007.0,2c08d3bc-c5f6-4077-86b5-633ed85818ec,2c08d3bc-c5f6-4077-86b5-633ed85818ec,TCGA-AR-A2LL-01A-21-A24A-20,,TCGA-AR-A2LL-01,TCGA-AR-A2LL-01A-11D-A17Z-05,6aee5a1d-a53e-4c02-90f5-fdb8e7765573,TCGA-AR-A2LL-01,TCGA-AR-A2LL-01A-11D-A17W-09,,,,,,2c08d3bc-c5f6-4077-86b5-633ed85818ec,,TCGA-AR-A2LL-01A-11D-A17U-01,,,2c08d3bc-c5f6-4077-86b5-633ed85818ec,TCGA-AR-A2LL-01A-11D-A17U-01,
tcga.ar.a2lm,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AR-A2LM-01,1935.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,,,TCGA-AR-A2LM,1935.0,0.0,days,1935.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LM-F71746,TCGA-AR-A2LM,TCGA-AR-A2LM-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-18053.0,1339.0,,0.0,1935.0,,,,,NO,,70-79%,,,2015-3-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,490.0,NO,,Negative,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1,T1,Stage II,TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf,A2LM,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,,6th,,NO,YES,AR,Breast,A,LIVING,2007.0,461cbf67-a11d-4411-95b5-cf83ecf05d02,461cbf67-a11d-4411-95b5-cf83ecf05d02,TCGA-AR-A2LM-01A-21-A24A-20,,TCGA-AR-A2LM-01,TCGA-AR-A2LM-01A-11D-A17Z-05,02ae8e2a-6a69-4de2-b23c-f4e6a3b8ef7d,TCGA-AR-A2LM-01,TCGA-AR-A2LM-01A-11D-A17W-09,,,TCGA-AR-A2LM-01,,,461cbf67-a11d-4411-95b5-cf83ecf05d02,,TCGA-AR-A2LM-01A-11D-A17U-01,TCGA-AR-A2LM-01,,461cbf67-a11d-4411-95b5-cf83ecf05d02,TCGA-AR-A2LM-01A-11D-A17U-01,
tcga.ar.a2ln,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AR-A2LN-01,1161.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-AR-A2LN,1161.0,0.0,days,1161.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LN-F49496,TCGA-AR-A2LN,TCGA-AR-A2LN-01A,,Positive,,,,,Positive,Other,,,,,-23992.0,513.0,,0.0,1161.0,,,,,NO,,70-79%,,,2013-10-2,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,1460.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf,A2LN,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,Mastectomy,7th,,NO,YES,AR,Breast,A,LIVING,2010.0,8a23348d-3371-431e-a6c8-b031cde82279,8a23348d-3371-431e-a6c8-b031cde82279,TCGA-AR-A2LN-01A-31-A24A-20,,TCGA-AR-A2LN-01,TCGA-AR-A2LN-01A-21D-A18O-05,bbf9a555-e910-4604-bffd-d7e76c024c46,TCGA-AR-A2LN-01,TCGA-AR-A2LN-01A-21D-A18P-09,,,TCGA-AR-A2LN-01,,,8a23348d-3371-431e-a6c8-b031cde82279,,TCGA-AR-A2LN-01A-21D-A18N-01,TCGA-AR-A2LN-01,,8a23348d-3371-431e-a6c8-b031cde82279,TCGA-AR-A2LN-01A-21D-A18N-01,
tcga.ar.a2lo,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-AR-A2LO-01,1198.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-AR-A2LO,1198.0,0.0,days,1198.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LO-F49498,TCGA-AR-A2LO,TCGA-AR-A2LO-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-17080.0,486.0,,0.0,1198.0,,,,,NO,,70-79%,,,2013-10-2,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,1650.0,NO,Equivocal,Negative,,16.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf,A2LO,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,LIVING,2010.0,3e71718b-3ab9-4b0d-a92b-52c46e6f1670,3e71718b-3ab9-4b0d-a92b-52c46e6f1670,TCGA-AR-A2LO-01A-41-A24A-20,,TCGA-AR-A2LO-01,TCGA-AR-A2LO-01A-31D-A18O-05,d9a30b5c-ba93-4cee-8ad7-937a95df1679,TCGA-AR-A2LO-01,TCGA-AR-A2LO-01A-31D-A18P-09,,,TCGA-AR-A2LO-01,,,3e71718b-3ab9-4b0d-a92b-52c46e6f1670,,TCGA-AR-A2LO-01A-31D-A19G-01,TCGA-AR-A2LO-01,,3e71718b-3ab9-4b0d-a92b-52c46e6f1670,TCGA-AR-A2LO-01A-31D-A19G-01,
tcga.ar.a2lq,,,,,,,,,,,,,,,,,,,Normal,,,,,,,,,,0.0,TCGA-AR-A2LQ-01,1233.0,0.0,days,Quiet,C3-BRCA/Luminal,,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-AR-A2LQ,1233.0,0.0,days,1233.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LQ-F49500,TCGA-AR-A2LQ,TCGA-AR-A2LQ-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-21865.0,449.0,,0.0,1233.0,,,,,NO,,70-79%,,,2013-10-2,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,1270.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf,A2LQ,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,LIVING,2010.0,7a72bd47-7504-4a59-ae95-096c32f70965,7a72bd47-7504-4a59-ae95-096c32f70965,TCGA-AR-A2LQ-01A-11-A24A-20,,TCGA-AR-A2LQ-01,TCGA-AR-A2LQ-01A-22D-A18O-05,a4b9430f-9ede-4e82-8d92-b7483d029609,TCGA-AR-A2LQ-01,TCGA-AR-A2LQ-01A-22D-A18P-09,,,TCGA-AR-A2LQ-01,,,7a72bd47-7504-4a59-ae95-096c32f70965,,TCGA-AR-A2LQ-01A-22D-A18N-01,TCGA-AR-A2LQ-01,,7a72bd47-7504-4a59-ae95-096c32f70965,TCGA-AR-A2LQ-01A-22D-A18N-01,
tcga.ar.a2lr,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,0.0,TCGA-AR-A2LR-01,1742.0,0.0,days,High,C4-BRCA/Basal,,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 5,,,TCGA-AR-A2LR,1742.0,0.0,days,1742.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A2LR-F71747,TCGA-AR-A2LR,TCGA-AR-A2LR-01A,,Negative,,,,,Negative,Simple Mastectomy,,,,,-18214.0,447.0,,0.0,1742.0,,,,,NO,,,,,2015-3-30,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,800.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,Yes,M0,N0,T1,Stage I,TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf,A2LR,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,LIVING,2010.0,9f693816-6957-413c-a100-54f7bc0eddf9,9f693816-6957-413c-a100-54f7bc0eddf9,TCGA-AR-A2LR-01A-21-A24A-20,,TCGA-AR-A2LR-01,TCGA-AR-A2LR-01A-12D-A18O-05,1504ffd3-5ca4-4858-a554-120455f8d456,TCGA-AR-A2LR-01,TCGA-AR-A2LR-01A-12D-A18P-09,,,,,,9f693816-6957-413c-a100-54f7bc0eddf9,,TCGA-AR-A2LR-01A-12D-A18N-01,,,9f693816-6957-413c-a100-54f7bc0eddf9,TCGA-AR-A2LR-01A-12D-A18N-01,
tcga.ar.a5qm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AR-A5QM-01,2231.0,0.0,days,,,,,,,,,,TCGA-AR-A5QM,2231.0,0.0,days,2231.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A5QM-F43848,TCGA-AR-A5QM,TCGA-AR-A5QM-01A,,Positive,,,,,Positive,Other,,,,,-22780.0,1541.0,,0.0,2231.0,,,968,,,,,,,2014-12-31,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,350.0,NO,Equivocal,,NO,9.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",New Primary Tumor,Malignant melanoma,,NO,0.0,,True,Yes,M0,N0,T2,Stage IIA,TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf,A5QM,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Wide Excision,6th,,NO,YES,AR,Breast,A,LIVING,2008.0,6bbb74ed-93be-4cbe-a854-4ea6aaec0615,6bbb74ed-93be-4cbe-a854-4ea6aaec0615,,,TCGA-AR-A5QM-01,TCGA-AR-A5QM-01A-11D-A27Y-05,049c6f4f-37ba-4507-b37b-0686a3b7bf19,TCGA-AR-A5QM-01,TCGA-AR-A5QM-01A-11D-A27P-09,,,TCGA-AR-A5QM-01,,,6bbb74ed-93be-4cbe-a854-4ea6aaec0615,,TCGA-AR-A5QM-01A-11D-A27O-01,TCGA-AR-A5QM-01,,6bbb74ed-93be-4cbe-a854-4ea6aaec0615,TCGA-AR-A5QM-01A-11D-A27O-01,
tcga.ar.a5qn,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AR-A5QN-01,1013.0,0.0,days,,,,,,,,,,TCGA-AR-A5QN,1013.0,0.0,days,1013.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left,Axillary lymph node dissection alone,,TCGA-AR-A5QN-F69265,TCGA-AR-A5QN,TCGA-AR-A5QN-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-25089.0,328.0,,0.0,1013.0,,,,,,,,,,2014-12-31,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,510.0,NO,Positive,,NO,19.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,10.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf,A5QN,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,LIVING,2012.0,76353751-a05c-432e-a35b-12f2bf62a494,76353751-a05c-432e-a35b-12f2bf62a494,,,TCGA-AR-A5QN-01,TCGA-AR-A5QN-01A-12D-A28C-05,29dda56e-2d14-4864-97a2-03bc1a97e7fd,TCGA-AR-A5QN-01,TCGA-AR-A5QN-01A-12D-A28B-09,,,TCGA-AR-A5QN-01,,,76353751-a05c-432e-a35b-12f2bf62a494,,TCGA-AR-A5QN-01A-12D-A28A-01,TCGA-AR-A5QN-01,,76353751-a05c-432e-a35b-12f2bf62a494,TCGA-AR-A5QN-01A-12D-A28A-01,
tcga.ar.a5qp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-AR-A5QP-01,1185.0,0.0,days,,,,,,,,,,TCGA-AR-A5QP,1185.0,0.0,days,1185.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-AR-A5QP-F69266,TCGA-AR-A5QP,TCGA-AR-A5QP-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-19805.0,498.0,,0.0,1185.0,,,,,,,,,,2014-12-31,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,230.0,NO,Equivocal,,NO,40.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf,A5QP,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,LIVING,2011.0,b2d0c724-40ae-44ca-90eb-ce86a9546c05,b2d0c724-40ae-44ca-90eb-ce86a9546c05,,,TCGA-AR-A5QP-01,TCGA-AR-A5QP-01A-11D-A28C-05,160070ff-2113-459e-b1ab-ffe2167da75d,TCGA-AR-A5QP-01,TCGA-AR-A5QP-01A-11D-A28B-09,,,TCGA-AR-A5QP-01,,,b2d0c724-40ae-44ca-90eb-ce86a9546c05,,TCGA-AR-A5QP-01A-11D-A28A-01,TCGA-AR-A5QP-01,,b2d0c724-40ae-44ca-90eb-ce86a9546c05,TCGA-AR-A5QP-01A-11D-A28A-01,
tcga.ar.a5qq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-AR-A5QQ-01,322.0,1.0,days,,,,,,,,,,TCGA-AR-A5QQ,301.0,1.0,days,322.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Right,Axillary lymph node dissection alone,,TCGA-AR-A5QQ-F42734,TCGA-AR-A5QQ,TCGA-AR-A5QQ-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-24841.0,576.0,322.0,0.0,,,,301,,,,,,,2013-6-10,FEMALE,,,,,1+,,,,,"Other, specify",,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,800.0,NO,Negative,,NO,24.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Lung,Distant Metastasis,"Liver, bone, chest wall, adrenal glands",,YES,1.0,,True,No,M0,N1,T3,Stage IIIA,TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf,A5QQ,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,AR,Breast,A,DECEASED,2011.0,16f90247-c9a5-40d5-a3a1-08bba2d1d266,16f90247-c9a5-40d5-a3a1-08bba2d1d266,,,TCGA-AR-A5QQ-01,TCGA-AR-A5QQ-01A-11D-A28C-05,23195a90-ef03-4655-9b11-4668986a94c3,TCGA-AR-A5QQ-01,TCGA-AR-A5QQ-01A-11D-A28B-09,,,TCGA-AR-A5QQ-01,,,16f90247-c9a5-40d5-a3a1-08bba2d1d266,,TCGA-AR-A5QQ-01A-11D-A28A-01,TCGA-AR-A5QQ-01,,16f90247-c9a5-40d5-a3a1-08bba2d1d266,TCGA-AR-A5QQ-01A-11D-A28A-01,
tcga.b6.a0i1,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,1.0,TCGA-B6-A0I1-01,2361.0,1.0,days,High,,,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 4,,,TCGA-B6-A0I1,1120.0,1.0,days,2361.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,73.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-B6-A0I1-F38909,TCGA-B6-A0I1,TCGA-B6-A0I1-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-26902.0,4248.0,2361.0,0.0,,,1120.0,1120,,,image cytometry,,,,2013-1-3,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Incisional Biopsy,100.0,NO,,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Negative,,,,,,,,,,,,Negative,,,,,,,,Lung,Distant Metastasis,,YES,YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf,A0I1,TUMOR FREE,image cytometry,,,,,NO,YES,,,NO,Primary Tumor,1,,5th,,NO,YES,B6,Breast,A,DECEASED,1998.0,785856fc-d042-4b7f-a137-95b17c59b876,785856fc-d042-4b7f-a137-95b17c59b876,,,TCGA-B6-A0I1-01,TCGA-B6-A0I1-01A-11D-A21R-05,,TCGA-B6-A0I1-01,TCGA-B6-A0I1-01A-11D-A21Q-09,,,TCGA-B6-A0I1-01,,,785856fc-d042-4b7f-a137-95b17c59b876,,TCGA-B6-A0I1-01A-11D-A21P-01,TCGA-B6-A0I1-01,,785856fc-d042-4b7f-a137-95b17c59b876,TCGA-B6-A0I1-01A-11D-A21P-01,
tcga.b6.a1kc,Stage IIA,67.0,4.0,Stage IIB,1326.0,,Positive,FEMALE,,,,,Negative,M0,Positive,N1,1326.0,0.0,LumB,,Negative,,,,followup,T_Other,T2,LIVING,0.0,TCGA-B6-A1KC-01,1326.0,0.0,days,BRCA-LUAD+,,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 5,mutation c1uster 9,TCGA-B6-A1KC,1326.0,0.0,days,1326.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-B6-A1KC-F15740,TCGA-B6-A1KC,,,Positive,,,,,Negative,Lumpectomy,,NO,,,-24791.0,,,0.0,1326.0,,,,,NO,image cytometry,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,1.0,,,No,M0,N1,T2,Stage IIB,,A1KC,TUMOR FREE,image cytometry,,,,49 fmol/mg protein,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,B6,Breast,,LIVING,2003.0,fe5e5b08-d5c0-4165-ae92-bec6a1d98e60,fe5e5b08-d5c0-4165-ae92-bec6a1d98e60,,TCGA-B6-A1KC-01B-11D-A159-09,TCGA-B6-A1KC-01,"TCGA-B6-A1KC-01B-11D-A161-05,TCGA-B6-A1KC-01A-11D-A13K-05",,TCGA-B6-A1KC-01,TCGA-B6-A1KC-01B-11D-A159-09,,,TCGA-B6-A1KC-01,TCGA-B6-A1KC-01B-11D-A159-09,,fe5e5b08-d5c0-4165-ae92-bec6a1d98e60,,TCGA-B6-A1KC-01B-11D-A160-01,TCGA-B6-A1KC-01,,fe5e5b08-d5c0-4165-ae92-bec6a1d98e60,TCGA-B6-A1KC-01B-11D-A160-01,
tcga.b6.a1kf,Stage IIB,68.0,1.0,Stage IIB,3088.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,3088.0,0.0,Basal,,Negative,,,,followup,T_Other,T2,LIVING,0.0,TCGA-B6-A1KF-01,3088.0,0.0,days,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-B6-A1KF,3088.0,0.0,days,3088.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-B6-A1KF-F15739,TCGA-B6-A1KF,,,Negative,,,,,Negative,Other,,NO,,,-24891.0,,,0.0,3088.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,,60-69%,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Equivocal,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,2.0,,,No,M0,N1,T2,Stage IIB,,A1KF,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,Excisional biopsy,5th,YES,NO,YES,B6,Breast,,LIVING,1998.0,e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66,e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66,,TCGA-B6-A1KF-01A-11D-A13L-09,TCGA-B6-A1KF-01,TCGA-B6-A1KF-01A-11D-A13K-05,,TCGA-B6-A1KF-01,TCGA-B6-A1KF-01A-11D-A13L-09,,,TCGA-B6-A1KF-01,TCGA-B6-A1KF-01A-11D-A13L-09,,e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66,,TCGA-B6-A1KF-01A-11D-A13J-01,TCGA-B6-A1KF-01,,e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66,TCGA-B6-A1KF-01A-11D-A13J-01,
tcga.b6.a1ki,Stage I,63.0,2.0,Stage I,2236.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2236.0,0.0,LumA,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-B6-A1KI-01,2236.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 4,TCGA-B6-A1KI,2236.0,0.0,days,2236.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-B6-A1KI-F15737,TCGA-B6-A1KI,TCGA-B6-A1KI-01A,,Positive,,,,,Positive,Other,,NO,,,-23031.0,2634.0,,0.0,2236.0,,,,,NO,image cytometry,,3.1,Scheduled Follow-up Submission,2011-8-29,FEMALE,,,90-99%,,2+,60.0,3.8,1.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,40.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,2.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf,A1KI,TUMOR FREE,image cytometry,,,70 fmol/mg,288 fmol/mg,,YES,,,YES,Primary Tumor,1,Excisional biospy,6th,YES,NO,YES,B6,Breast,A,LIVING,2003.0,7d34b1bc-ac5a-4365-8dae-75b3f2ea5055,7d34b1bc-ac5a-4365-8dae-75b3f2ea5055,,TCGA-B6-A1KI-01A-11D-A14K-09,TCGA-B6-A1KI-01,TCGA-B6-A1KI-01A-11D-A14N-05,,TCGA-B6-A1KI-01,TCGA-B6-A1KI-01A-11D-A14K-09,,,TCGA-B6-A1KI-01,TCGA-B6-A1KI-01A-11D-A14K-09,,7d34b1bc-ac5a-4365-8dae-75b3f2ea5055,,TCGA-B6-A1KI-01A-11D-A14J-01,TCGA-B6-A1KI-01,,7d34b1bc-ac5a-4365-8dae-75b3f2ea5055,TCGA-B6-A1KI-01A-11D-A14J-01,
tcga.b6.a1kn,Stage IIIB,57.0,5.0,Stage IIIC,4233.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,4233.0,0.0,LumB,,Negative,,,,followup,T_Other,T4,LIVING,0.0,TCGA-B6-A1KN-01,4233.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 5,TCGA-B6-A1KN,4233.0,0.0,days,4233.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-B6-A1KN-F15738,TCGA-B6-A1KN,TCGA-B6-A1KN-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-21183.0,4537.0,,0.0,4233.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,80.0,NO,,,,30.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,6.0,,,,,,,,NO,24.0,,True,No,M0,N1,T4b,Stage IIIB,TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf,A1KN,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,5th,YES,NO,YES,B6,Breast,A,LIVING,1998.0,71b773fb-1efb-4d0f-9499-110ba937ade6,71b773fb-1efb-4d0f-9499-110ba937ade6,,TCGA-B6-A1KN-01A-11D-A13L-09,TCGA-B6-A1KN-01,TCGA-B6-A1KN-01A-11D-A13K-05,,TCGA-B6-A1KN-01,TCGA-B6-A1KN-01A-11D-A13L-09,,,TCGA-B6-A1KN-01,TCGA-B6-A1KN-01A-11D-A13L-09,,71b773fb-1efb-4d0f-9499-110ba937ade6,,TCGA-B6-A1KN-01A-11D-A13J-01,TCGA-B6-A1KN-01,,71b773fb-1efb-4d0f-9499-110ba937ade6,TCGA-B6-A1KN-01A-11D-A13J-01,
tcga.b6.a2iu,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-B6-A2IU-01,5176.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-B6-A2IU,4224.0,1.0,days,5176.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,62.0,Right,Axillary lymph node dissection alone,,TCGA-B6-A2IU-F38907,TCGA-B6-A2IU,TCGA-B6-A2IU-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-22905.0,4665.0,,0.0,5176.0,,,4224,,,image cytometry,,,,2013-1-3,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,140.0,NO,,,NO,28.0,Negative,Indeterminate (neither Pre or Postmenopausal),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",New Primary Tumor,Lung,NO,YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf,A2IU,WITH TUMOR,image cytometry,,,,,YES,YES,,,YES,Primary Tumor,1,,5th,,NO,YES,B6,Breast,A,LIVING,1998.0,71a6367e-a876-4f1e-b80c-0e2d7d02e7cd,71a6367e-a876-4f1e-b80c-0e2d7d02e7cd,TCGA-B6-A2IU-01A-21-A24A-20,,TCGA-B6-A2IU-01,TCGA-B6-A2IU-01A-32D-A18O-05,fe9fb778-16b4-47ef-84a1-e5f74c25ae59,TCGA-B6-A2IU-01,TCGA-B6-A2IU-01A-32D-A19T-09,,,TCGA-B6-A2IU-01,,,71a6367e-a876-4f1e-b80c-0e2d7d02e7cd,,TCGA-B6-A2IU-01A-32D-A18N-01,TCGA-B6-A2IU-01,,71a6367e-a876-4f1e-b80c-0e2d7d02e7cd,TCGA-B6-A2IU-01A-32D-A18N-01,
tcga.b6.a3zx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-B6-A3ZX-01,1152.0,1.0,days,,,,,,,,,,TCGA-B6-A3ZX,994.0,1.0,days,1152.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,50.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-B6-A3ZX-F59573,TCGA-B6-A3ZX,,Negative,Negative,4 Point Scale,1+,4 Point Scale,Lumpectomy,Negative,Lumpectomy,,NO,,,-18434.0,,1152.0,0.0,1132.0,,1096.0,994,,,,<10%,,,2014-6-3,FEMALE,,,<10%,,1+,,,,,Mixed Histology (please specify),ductal and lobular,No,,C50.9,8522/3,C50.9,1+,YES,,Core needle biopsy,,,Negative,,NO,7.0,Close,,,,,,,,,,,,,,,,,,,Bone,,,,,,,Bone,Distant Metastasis,,YES,YES,1.0,,,No,M1,N1,T3,Stage IV,,A3ZX,WITH TUMOR,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,B6,Breast,,DECEASED,2007.0,e89806d3-1cd5-4bc0-8e8a-edf823d8f110,e89806d3-1cd5-4bc0-8e8a-edf823d8f110,,,TCGA-B6-A3ZX-01,TCGA-B6-A3ZX-01A-11D-A23D-05,,TCGA-B6-A3ZX-01,TCGA-B6-A3ZX-01A-11D-A23C-09,,,TCGA-B6-A3ZX-01,,,e89806d3-1cd5-4bc0-8e8a-edf823d8f110,,TCGA-B6-A3ZX-01A-11D-A238-01,TCGA-B6-A3ZX-01,,e89806d3-1cd5-4bc0-8e8a-edf823d8f110,TCGA-B6-A3ZX-01A-11D-A238-01,
tcga.b6.a400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A400-01,215.0,0.0,days,,,,,,,,,,TCGA-B6-A400,215.0,0.0,days,215.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-B6-A400-F59655,TCGA-B6-A400,TCGA-B6-A400-01A,,Negative,4 Point Scale,1+,4 Point Scale,,Negative,Lumpectomy,,NO,,,-16022.0,1610.0,,0.0,215.0,,,,,,,<10%,,,2014-6-3,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Tumor resection,20.0,NO,Negative,,YES,5.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf,A400,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,B6,Breast,A,LIVING,2008.0,6b70d210-9cbd-44bc-a770-a075fd0d4672,6b70d210-9cbd-44bc-a770-a075fd0d4672,,,TCGA-B6-A400-01,TCGA-B6-A400-01A-11D-A23D-05,,TCGA-B6-A400-01,TCGA-B6-A400-01A-11D-A23C-09,,,TCGA-B6-A400-01,,,6b70d210-9cbd-44bc-a770-a075fd0d4672,,TCGA-B6-A400-01A-11D-A238-01,TCGA-B6-A400-01,,6b70d210-9cbd-44bc-a770-a075fd0d4672,TCGA-B6-A400-01A-11D-A238-01,
tcga.b6.a401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A401-01,2596.0,0.0,days,,,,,,,,,,TCGA-B6-A401,2596.0,0.0,days,2596.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-B6-A401-F59658,TCGA-B6-A401,TCGA-B6-A401-01A,,Positive,4 Point Scale,3+,4 Point Scale,,Positive,Lumpectomy,,NO,,,-17438.0,1935.0,,0.0,2596.0,,,,,,,80-89%,,,2014-6-3,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,2+,YES,,Core needle biopsy,30.0,NO,Negative,,NO,4.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf,A401,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,6th,,NO,YES,B6,Breast,A,LIVING,2007.0,2a591fdd-c9e5-4c6e-90f8-8f993450a8d7,2a591fdd-c9e5-4c6e-90f8-8f993450a8d7,,,TCGA-B6-A401-01,TCGA-B6-A401-01A-11D-A23D-05,,TCGA-B6-A401-01,TCGA-B6-A401-01A-11D-A23C-09,,,TCGA-B6-A401-01,,,2a591fdd-c9e5-4c6e-90f8-8f993450a8d7,,TCGA-B6-A401-01A-11D-A238-01,TCGA-B6-A401-01,,2a591fdd-c9e5-4c6e-90f8-8f993450a8d7,TCGA-B6-A401-01A-11D-A238-01,
tcga.b6.a402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A402-01,2134.0,0.0,days,,,,,,,,,,TCGA-B6-A402,2330.0,1.0,days,2134.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,47.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-B6-A402-F60751,TCGA-B6-A402,TCGA-B6-A402-01A,,Negative,4 Point Scale,1+,4 Point Scale,,Negative,Lumpectomy,,YES,,,-17314.0,1563.0,,0.0,2134.0,,,2330,,,,<10%,,,2014-7-8,FEMALE,,,<10%,,1+,,,,4.4,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Core needle biopsy,10.0,NO,Negative,,NO,3.0,Negative,,,Positive,2+,,Positive,<10%,,<10%,4.1,3 Point Scale,2+,2+,Negative,,70-79%,,Negative,,,,,3.1,,3 Point Scale,"Other, specify",Locoregional Recurrence,Lymph Node,NO,YES,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf,A402,WITH TUMOR,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,B6,Breast,A,LIVING,2008.0,976a1b88-ed7a-493a-8ac9-3d504edfbc76,976a1b88-ed7a-493a-8ac9-3d504edfbc76,,,TCGA-B6-A402-01,TCGA-B6-A402-01A-11D-A23D-05,,TCGA-B6-A402-01,TCGA-B6-A402-01A-11D-A23C-09,,,TCGA-B6-A402-01,,,976a1b88-ed7a-493a-8ac9-3d504edfbc76,,TCGA-B6-A402-01A-11D-A238-01,TCGA-B6-A402-01,,976a1b88-ed7a-493a-8ac9-3d504edfbc76,TCGA-B6-A402-01A-11D-A238-01,
tcga.b6.a408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A408-01,2072.0,0.0,days,,,,,,,,,,TCGA-B6-A408,2072.0,0.0,days,2072.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left,Axillary lymph node dissection alone,,TCGA-B6-A408-F59666,TCGA-B6-A408,,,Positive,4 Point Scale,3+,4 Point Scale,,Positive,Simple Mastectomy,,NO,,,-20102.0,,,0.0,2072.0,,,,,,,90-99%,2.6,,2014-6-3,FEMALE,,,20-29%,,2+,60.0,2.9,1.2,,Mixed Histology (please specify),ductal and lobular,No,,C50.9,8522/3,C50.9,3+,YES,,Tumor resection,,,Equivocal,Negative,NO,23.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,10.0,,,No,M0,N3a,T2,Stage IIIC,,A408,TUMOR FREE,,,,,,YES,YES,60-69%,,YES,Primary Tumor,1,,6th,,NO,YES,B6,Breast,,LIVING,2008.0,bbb7f769-ac55-4e7f-b0bf-acc36294bb05,bbb7f769-ac55-4e7f-b0bf-acc36294bb05,,,TCGA-B6-A408-01,TCGA-B6-A408-01A-12D-A244-05,,TCGA-B6-A408-01,TCGA-B6-A408-01A-12D-A243-09,,,TCGA-B6-A408-01,,,bbb7f769-ac55-4e7f-b0bf-acc36294bb05,,TCGA-B6-A408-01A-12D-A242-01,TCGA-B6-A408-01,,bbb7f769-ac55-4e7f-b0bf-acc36294bb05,TCGA-B6-A408-01A-12D-A242-01,
tcga.b6.a409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-B6-A409-01,573.0,1.0,days,,,,,,,,,,TCGA-B6-A409,,,days,573.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-B6-A409,TCGA-B6-A409-01A,,Negative,4 Point Scale,1+,4 Point Scale,,Negative,Simple Mastectomy,,NO,,,-16178.0,1480.0,573.0,0.0,,,,,,,,<10%,1.8,,2012-9-20,FEMALE,,,10-19%,,1+,60.0,2,1.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,2+,YES,,Fine needle aspiration biopsy,20.0,NO,Equivocal,Negative,,22.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,YES,6.0,,True,No,M0,N2a,T1c,Stage IIIA,TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf,A409,WITH TUMOR,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,6th,,NO,YES,B6,Breast,A,DECEASED,2008.0,4d9bb08c-d954-4e14-aff2-3bec55cdf1c1,4d9bb08c-d954-4e14-aff2-3bec55cdf1c1,,,TCGA-B6-A409-01,TCGA-B6-A409-01A-11D-A244-05,,TCGA-B6-A409-01,TCGA-B6-A409-01A-11D-A243-09,,,TCGA-B6-A409-01,,,4d9bb08c-d954-4e14-aff2-3bec55cdf1c1,,TCGA-B6-A409-01A-11D-A242-01,TCGA-B6-A409-01,,4d9bb08c-d954-4e14-aff2-3bec55cdf1c1,TCGA-B6-A409-01A-11D-A242-01,
tcga.b6.a40b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A40B-01,3152.0,0.0,days,,,,,,,,,,TCGA-B6-A40B,3152.0,0.0,days,3152.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,76.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-B6-A40B-F59661,TCGA-B6-A40B,TCGA-B6-A40B-01A,,Positive,4 Point Scale,3+,4 Point Scale,,Positive,Lumpectomy,,YES,,,-27811.0,2467.0,,0.0,3152.0,,,,,,,90-99%,,,2014-6-3,FEMALE,,,<10%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,10.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T1b,Stage I,TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf,A40B,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,6th,,NO,YES,B6,Breast,A,LIVING,2005.0,40c7e862-e1f6-4425-af9d-c9d07161a2ed,40c7e862-e1f6-4425-af9d-c9d07161a2ed,,,TCGA-B6-A40B-01,TCGA-B6-A40B-01A-11D-A23D-05,,TCGA-B6-A40B-01,TCGA-B6-A40B-01A-11D-A23C-09,,,TCGA-B6-A40B-01,,,40c7e862-e1f6-4425-af9d-c9d07161a2ed,,TCGA-B6-A40B-01A-11D-A238-01,TCGA-B6-A40B-01,,40c7e862-e1f6-4425-af9d-c9d07161a2ed,TCGA-B6-A40B-01A-11D-A238-01,
tcga.b6.a40c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-B6-A40C-01,2164.0,0.0,days,,,,,,,,,,TCGA-B6-A40C,2164.0,0.0,days,2164.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-B6-A40C-F59660,TCGA-B6-A40C,,,Positive,4 Point Scale,3+,4 Point Scale,,Positive,Simple Mastectomy,,YES,,,-18852.0,,,0.0,2164.0,,,,,,,50-59%,,,2014-6-3,FEMALE,,,<10%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,NO,3.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0 (i-),T3,Stage IIB,,A40C,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,B6,Breast,,LIVING,2005.0,e04bddbb-224b-4c6c-a8c8-88fd42a52ac5,e04bddbb-224b-4c6c-a8c8-88fd42a52ac5,,,TCGA-B6-A40C-01,TCGA-B6-A40C-01A-11D-A23D-05,,TCGA-B6-A40C-01,TCGA-B6-A40C-01A-11D-A23C-09,,,TCGA-B6-A40C-01,,,e04bddbb-224b-4c6c-a8c8-88fd42a52ac5,,TCGA-B6-A40C-01A-11D-A238-01,TCGA-B6-A40C-01,,e04bddbb-224b-4c6c-a8c8-88fd42a52ac5,TCGA-B6-A40C-01A-11D-A238-01,
tcga.bh.a0au,Stage IIA,45.0,1.0,Stage IIA,746.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Negative,N0,746.0,0.0,LumB,Luminal B,Positive,ReacI,-3.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0AU-01,1914.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-BH-A0AU,1914.0,0.0,days,1914.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Inner Quadrant,,,TCGA-BH-A0AU-F60769,TCGA-BH-A0AU,TCGA-BH-A0AU-01A,,Positive,,,,,Positive,Other,,,,,-16688.0,583.0,,0.0,1914.0,,,,,NO,,,,,2014-6-16,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Positive,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf,A0AU,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,left segmental mastectomy with sentinel node dissection,6th,,NO,YES,BH,Breast,A,LIVING,2008.0,d448433c-3c4b-4371-b749-f96af8da2237,d448433c-3c4b-4371-b749-f96af8da2237,TCGA-BH-A0AU-01A-21-A13C-20,TCGA-BH-A0AU-01A-11D-A12Q-09,TCGA-BH-A0AU-01,TCGA-BH-A0AU-01A-11D-A12R-05,6b8a5434-3207-46f0-836b-542e427d22d5,TCGA-BH-A0AU-01,TCGA-BH-A0AU-01A-11D-A12Q-09,,TCGA-BH-A0AU-01,TCGA-BH-A0AU-01,TCGA-BH-A0AU-01A-11D-A12Q-09,,d448433c-3c4b-4371-b749-f96af8da2237,,TCGA-BH-A0AU-01A-11D-A12N-01,TCGA-BH-A0AU-01,TCGA-BH-A0AU-01A-11R-A12P-07,d448433c-3c4b-4371-b749-f96af8da2237,TCGA-BH-A0AU-01A-11D-A12N-01,TCGA-BH-A0AU-01
tcga.bh.a0az,Stage IIIA,47.0,2.0,Stage IIIA,867.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Positive,N1,867.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,-7.0,enrollment,T_Other,T3,LIVING,0.0,TCGA-BH-A0AZ-01,1919.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-BH-A0AZ,1919.0,0.0,days,1919.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right,,,TCGA-BH-A0AZ-F58602,TCGA-BH-A0AZ,,,Positive,,,,,Positive,Other,,,,,-17465.0,,,0.0,1919.0,,,,,NO,,,,,2014-4-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,1.0,,,No,cM0 (i+),N1a,T3,Stage IIIA,,A0AZ,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,total mastectomy with sentinel lymph node biopsy with tissue reconstruction,6th,,NO,YES,BH,Breast,,LIVING,2008.0,cb9d4717-15a8-4499-ae3b-e047e5c2926a,cb9d4717-15a8-4499-ae3b-e047e5c2926a,TCGA-BH-A0AZ-01A-11-A13A-20,TCGA-BH-A0AZ-01A-21D-A12Q-09,TCGA-BH-A0AZ-01,TCGA-BH-A0AZ-01A-21D-A12R-05,e7b4dae9-ba72-4281-a84c-9207120cfd65,TCGA-BH-A0AZ-01,TCGA-BH-A0AZ-01A-21D-A12Q-09,,TCGA-BH-A0AZ-01,TCGA-BH-A0AZ-01,TCGA-BH-A0AZ-01A-21D-A12Q-09,,cb9d4717-15a8-4499-ae3b-e047e5c2926a,,TCGA-BH-A0AZ-01A-21D-A12N-01,TCGA-BH-A0AZ-01,TCGA-BH-A0AZ-01A-21R-A12P-07,cb9d4717-15a8-4499-ae3b-e047e5c2926a,TCGA-BH-A0AZ-01A-21D-A12N-01,TCGA-BH-A0AZ-01
tcga.bh.a0b5,Stage IIIA,40.0,2.0,Stage IIIA,1471.0,,Positive,FEMALE,Negative,1.0,3.0,4.0,Negative,M0,Positive,N2,1471.0,0.0,LumA,Luminal B,Positive,ReacII,-7.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0B5-01,2136.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 1,TCGA-BH-A0B5,2136.0,0.0,days,2136.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Left,,,TCGA-BH-A0B5-F59182,TCGA-BH-A0B5,TCGA-BH-A0B5-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-14920.0,1008.0,,0.0,2136.0,,,,,NO,,,,,2014-5-2,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,700.0,NO,Negative,,NO,24.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,5.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf,A0B5,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2007.0,4b964043-f6dd-4f19-ab4c-439ee68ce2b0,4b964043-f6dd-4f19-ab4c-439ee68ce2b0,TCGA-BH-A0B5-01A-21-A13C-20,TCGA-BH-A0B5-01A-11D-A12Q-09,TCGA-BH-A0B5-01,TCGA-BH-A0B5-01A-11D-A12R-05,e6f7c6af-6c88-4305-a8f4-d8ea46f8b302,TCGA-BH-A0B5-01,TCGA-BH-A0B5-01A-11D-A12Q-09,,TCGA-BH-A0B5-01,TCGA-BH-A0B5-01,TCGA-BH-A0B5-01A-11D-A12Q-09,,4b964043-f6dd-4f19-ab4c-439ee68ce2b0,,TCGA-BH-A0B5-01A-11D-A12N-01,TCGA-BH-A0B5-01,TCGA-BH-A0B5-01A-11R-A12P-07,4b964043-f6dd-4f19-ab4c-439ee68ce2b0,TCGA-BH-A0B5-01A-11D-A12N-01,TCGA-BH-A0B5-01
tcga.bh.a0b6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A0B6-01,2483.0,0.0,days,Squamous,,,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 3,,,TCGA-BH-A0B6,2483.0,0.0,days,2483.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,,,TCGA-BH-A0B6-F61943,TCGA-BH-A0B6,,,Positive,,,,,Positive,Other,,,,,-17346.0,,,0.0,2483.0,,,,,NO,,,,,2014-7-10,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,Yes,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Positive,,NO,4.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,Yes,M0,N0,T1c,Stage I,,A0B6,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,segmental mastectomy with sentinel lymph node biopsy,6th,,NO,YES,BH,Breast,,LIVING,2006.0,b455387f-a8b4-43b8-b898-89628723d7da,b455387f-a8b4-43b8-b898-89628723d7da,TCGA-BH-A0B6-01A-21-A24A-20,,TCGA-BH-A0B6-01,TCGA-BH-A0B6-01A-11D-A19Z-05,e7cb5207-9749-4bfb-9982-58a8efca7a8f,TCGA-BH-A0B6-01,TCGA-BH-A0B6-01A-11D-A19Y-09,,,,,,b455387f-a8b4-43b8-b898-89628723d7da,,TCGA-BH-A0B6-01A-11D-A19X-01,,,b455387f-a8b4-43b8-b898-89628723d7da,TCGA-BH-A0B6-01A-11D-A19X-01,
tcga.bh.a0bf,Stage IIB,56.0,2.0,Stage IIB,781.0,,Positive,FEMALE,Negative,3.0,1.0,4.0,Negative,M0,Positive,N1,781.0,0.0,LumB,Luminal B,Positive,Basal,-2.0,-5.0,enrollment,T_Other,T2,LIVING,1.0,TCGA-BH-A0BF-01,1324.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 3,TCGA-BH-A0BF,1324.0,0.0,days,1324.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Outer Quadrant,,,TCGA-BH-A0BF-F59142,TCGA-BH-A0BF,TCGA-BH-A0BF-01A,,Positive,,,,,Positive,Other,,,,,-20691.0,413.0,1324.0,0.0,782.0,,,,,NO,,,,,2014-5-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,1.0,,True,No,M0,N1mi,T2,Stage IIB,TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf,A0BF,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,Total mastectomy with sentinel lymph node biopsy,6th,,NO,YES,BH,Breast,A,DECEASED,2009.0,3491d44a-675b-4510-8699-2ee83f960d02,3491d44a-675b-4510-8699-2ee83f960d02,TCGA-BH-A0BF-01A-11-A13C-20,TCGA-BH-A0BF-01A-21D-A12Q-09,TCGA-BH-A0BF-01,TCGA-BH-A0BF-01A-21D-A12R-05,3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81,TCGA-BH-A0BF-01,TCGA-BH-A0BF-01A-21D-A12Q-09,,TCGA-BH-A0BF-01,TCGA-BH-A0BF-01,TCGA-BH-A0BF-01A-21D-A12Q-09,,3491d44a-675b-4510-8699-2ee83f960d02,,TCGA-BH-A0BF-01A-21D-A12N-01,TCGA-BH-A0BF-01,TCGA-BH-A0BF-01A-21R-A12P-07,3491d44a-675b-4510-8699-2ee83f960d02,TCGA-BH-A0BF-01A-21D-A12N-01,TCGA-BH-A0BF-01
tcga.bh.a0bs,Stage IIIA,55.0,2.0,Stage IIIA,1640.0,,Positive,FEMALE,Negative,3.0,3.0,3.0,Negative,M0,Positive,N1,1640.0,0.0,LumA,Luminal A,Positive,LumA/B,0.0,-2.0,enrollment,T_Other,T3,LIVING,0.0,TCGA-BH-A0BS-01,2612.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-BH-A0BS,2612.0,0.0,days,2612.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left,,,TCGA-BH-A0BS-F61955,TCGA-BH-A0BS,TCGA-BH-A0BS-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-20374.0,1164.0,,0.0,2612.0,,,,,NO,,,,,2014-8-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,180.0,NO,,Negative,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,,,,,NO,0.0,,True,No,M0,N1c,T3,Stage IIIA,TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf,A0BS,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2007.0,354c08e2-61d3-4cfa-9d26-76d74dcfe44f,354c08e2-61d3-4cfa-9d26-76d74dcfe44f,TCGA-BH-A0BS-01A-21-A13A-20,TCGA-BH-A0BS-01A-11D-A12Q-09,TCGA-BH-A0BS-01,TCGA-BH-A0BS-01A-11D-A12R-05,bc9af2fb-d022-40cc-9fca-685bd206e71b,TCGA-BH-A0BS-01,TCGA-BH-A0BS-01A-11D-A12Q-09,,TCGA-BH-A0BS-01,TCGA-BH-A0BS-01,TCGA-BH-A0BS-01A-11D-A12Q-09,,354c08e2-61d3-4cfa-9d26-76d74dcfe44f,,TCGA-BH-A0BS-01A-11D-A12N-01,TCGA-BH-A0BS-01,TCGA-BH-A0BS-01A-11R-A12P-07,354c08e2-61d3-4cfa-9d26-76d74dcfe44f,TCGA-BH-A0BS-01A-11D-A12N-01,TCGA-BH-A0BS-01
tcga.bh.a0bt,Stage IIA,56.0,4.0,Stage IIA,1386.0,,Positive,FEMALE,Negative,3.0,3.0,3.0,Negative,M0,Positive,N1,1386.0,0.0,LumA,Luminal A,Positive,ReacII,-12.0,-3.0,enrollment,T1,T1,LIVING,0.0,TCGA-BH-A0BT-01,2365.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 6,mutation cluster 3,TCGA-BH-A0BT,2365.0,0.0,days,2365.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Inner Quadrant,,,TCGA-BH-A0BT-F59143,TCGA-BH-A0BT,TCGA-BH-A0BT-01A,,Positive,,,,,Positive,Other,,,,,-20625.0,1167.0,,0.0,2365.0,,,,,NO,,,,,2014-5-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Negative,,NO,,Negative,,,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,,,True,No,M0,N1mi,T1c,Stage IIA,TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf,A0BT,TUMOR FREE,,,,,,YES,,,,YES,Primary Tumor,1,segmental mastectomy with sentinel lymph node excision and biopsy,6th,,NO,YES,BH,Breast,A,LIVING,2007.0,fe8764cf-04ee-480d-96ce-09d0d388f4f6,fe8764cf-04ee-480d-96ce-09d0d388f4f6,TCGA-BH-A0BT-01A-21-A13C-20,TCGA-BH-A0BT-01A-11D-A12Q-09,TCGA-BH-A0BT-01,TCGA-BH-A0BT-01A-11D-A12R-05,99e5ad3c-e46a-4d06-9feb-33f1b3819e6f,TCGA-BH-A0BT-01,TCGA-BH-A0BT-01A-11D-A12Q-09,,TCGA-BH-A0BT-01,TCGA-BH-A0BT-01,TCGA-BH-A0BT-01A-11D-A12Q-09,,fe8764cf-04ee-480d-96ce-09d0d388f4f6,,TCGA-BH-A0BT-01A-11D-A12N-01,TCGA-BH-A0BT-01,TCGA-BH-A0BT-01A-11R-A12P-07,fe8764cf-04ee-480d-96ce-09d0d388f4f6,TCGA-BH-A0BT-01A-11D-A12N-01,TCGA-BH-A0BT-01
tcga.bh.a0bz,Stage IIIA,59.0,4.0,Stage IIIA,1492.0,,Positive,FEMALE,Negative,1.0,1.0,4.0,Negative,M0,Positive,N1,1492.0,0.0,LumB,Luminal B,Positive,X,-2.0,-5.0,enrollment,T_Other,T3,LIVING,0.0,TCGA-BH-A0BZ-01,2255.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 10,TCGA-BH-A0BZ,2255.0,0.0,days,2255.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left,,,TCGA-BH-A0BZ-F58683,TCGA-BH-A0BZ,TCGA-BH-A0BZ-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-21856.0,1084.0,,0.0,2255.0,,,,,NO,,,,,2014-4-21,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,830.0,NO,Negative,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,1.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf,A0BZ,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2007.0,317ffb84-f4a8-435b-907b-b05587d6515e,317ffb84-f4a8-435b-907b-b05587d6515e,TCGA-BH-A0BZ-01A-21-A13B-20,TCGA-BH-A0BZ-01A-31D-A12Q-09,TCGA-BH-A0BZ-01,TCGA-BH-A0BZ-01A-31D-A12R-05,d2de5993-e58f-4d41-812b-2a355dd855ea,TCGA-BH-A0BZ-01,TCGA-BH-A0BZ-01A-31D-A12Q-09,,TCGA-BH-A0BZ-01,TCGA-BH-A0BZ-01,TCGA-BH-A0BZ-01A-31D-A12Q-09,,317ffb84-f4a8-435b-907b-b05587d6515e,,TCGA-BH-A0BZ-01A-31D-A12N-01,TCGA-BH-A0BZ-01,TCGA-BH-A0BZ-01A-31R-A12P-07,317ffb84-f4a8-435b-907b-b05587d6515e,TCGA-BH-A0BZ-01A-31D-A12N-01,TCGA-BH-A0BZ-01
tcga.bh.a0c3,Stage I,47.0,3.0,Stage I,1464.0,,Positive,FEMALE,Negative,3.0,3.0,4.0,Negative,M0,Negative,N0,1464.0,0.0,LumB,Luminal B,Negative,Her2,-4.0,0.0,enrollment,T1,T1,LIVING,0.0,TCGA-BH-A0C3-01,2709.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 5,TCGA-BH-A0C3,2674.0,1.0,days,2709.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left,,,TCGA-BH-A0C3-F63533,TCGA-BH-A0C3,TCGA-BH-A0C3-01A,,Positive,,,,,Negative,Other,,,,,-17221.0,1335.0,,0.0,2709.0,,,2674,,NO,,,,,2014-8-12,FEMALE,,,,,,,,,,Mixed Histology (please specify),with ductal and lobular phenotypes,No,,C50.9,8522/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,Bone,Distant Metastasis,,,YES,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf,A0C3,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,Segmental mastectomy with sentinel node biopsy,6th,,NO,YES,BH,Breast,A,LIVING,2006.0,52a863fe-b210-456b-9c2d-545277362b65,52a863fe-b210-456b-9c2d-545277362b65,TCGA-BH-A0C3-01A-11-A13C-20,TCGA-BH-A0C3-01A-21D-A12Q-09,TCGA-BH-A0C3-01,TCGA-BH-A0C3-01A-21D-A12R-05,42fa3207-2c4f-4499-99b8-fe5275232eed,TCGA-BH-A0C3-01,TCGA-BH-A0C3-01A-21D-A12Q-09,,TCGA-BH-A0C3-01,TCGA-BH-A0C3-01,TCGA-BH-A0C3-01A-21D-A12Q-09,,52a863fe-b210-456b-9c2d-545277362b65,,TCGA-BH-A0C3-01A-21D-A12N-01,TCGA-BH-A0C3-01,TCGA-BH-A0C3-01A-21R-A12P-07,52a863fe-b210-456b-9c2d-545277362b65,TCGA-BH-A0C3-01A-21D-A12N-01,TCGA-BH-A0C3-01
tcga.bh.a0dd,Stage IIB,58.0,3.0,Stage IIB,1393.0,,Positive,MALE,Positive,1.0,3.0,4.0,Negative,M0,Positive,N1,1393.0,0.0,LumB,Luminal B,Positive,LumA/B,-6.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0DD-01,2486.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-BH-A0DD,2486.0,0.0,days,2486.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right,,,TCGA-BH-A0DD-F60386,TCGA-BH-A0DD,TCGA-BH-A0DD-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-21386.0,1248.0,,0.0,2486.0,,,,,NO,,,,,2014-6-9,MALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,430.0,NO,Positive,Positive,NO,22.0,Negative,,,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf,A0DD,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2006.0,e15ff180-38d3-4614-88ee-3645afaab54b,e15ff180-38d3-4614-88ee-3645afaab54b,TCGA-BH-A0DD-01A-21-A13B-20,TCGA-BH-A0DD-01A-31D-A12Q-09,TCGA-BH-A0DD-01,TCGA-BH-A0DD-01A-31D-A12R-05,7ac181c9-6dba-4e27-a5fc-09cf02f735cf,TCGA-BH-A0DD-01,TCGA-BH-A0DD-01A-31D-A12Q-09,,TCGA-BH-A0DD-01,TCGA-BH-A0DD-01,TCGA-BH-A0DD-01A-31D-A12Q-09,,e15ff180-38d3-4614-88ee-3645afaab54b,,TCGA-BH-A0DD-01A-31D-A12N-01,TCGA-BH-A0DD-01,TCGA-BH-A0DD-01A-31R-A12P-07,e15ff180-38d3-4614-88ee-3645afaab54b,TCGA-BH-A0DD-01A-31D-A12N-01,TCGA-BH-A0DD-01
tcga.bh.a0dg,Stage IIA,30.0,3.0,Stage IIA,713.0,,Positive,FEMALE,Negative,1.0,4.0,3.0,Negative,M0,Negative,N0,713.0,0.0,LumA,Luminal A,Negative,ReacI,-4.0,-4.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0DG-01,2041.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-BH-A0DG,2041.0,0.0,days,2041.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,30.0,Right Upper Outer Quadrant,,,TCGA-BH-A0DG-F63658,TCGA-BH-A0DG,,,Positive,,,,,Negative,Other,,,,,-11204.0,,,0.0,2041.0,,,,,NO,,,,,2014-8-14,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0DG,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Total mastectomy,6th,,NO,YES,BH,Breast,,LIVING,2007.0,a6b72c40-c921-4159-abad-b64e20619241,a6b72c40-c921-4159-abad-b64e20619241,TCGA-BH-A0DG-01A-11-A13B-20,TCGA-BH-A0DG-01A-21D-A12Q-09,TCGA-BH-A0DG-01,TCGA-BH-A0DG-01A-21D-A12R-05,c74c7143-1584-4072-872f-405fd8e3bf0c,TCGA-BH-A0DG-01,TCGA-BH-A0DG-01A-21D-A12Q-09,,TCGA-BH-A0DG-01,TCGA-BH-A0DG-01,TCGA-BH-A0DG-01A-21D-A12Q-09,,a6b72c40-c921-4159-abad-b64e20619241,,TCGA-BH-A0DG-01A-21D-A12N-01,TCGA-BH-A0DG-01,TCGA-BH-A0DG-01A-21R-A12P-07,a6b72c40-c921-4159-abad-b64e20619241,TCGA-BH-A0DG-01A-21D-A12N-01,TCGA-BH-A0DG-01
tcga.bh.a0di,Stage IIB,63.0,5.0,Stage IIB,673.0,,Positive,FEMALE,Negative,1.0,4.0,3.0,Negative,M0,Positive,N1,673.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0DI-01,912.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 3,TCGA-BH-A0DI,912.0,0.0,days,912.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,,,TCGA-BH-A0DI-F58698,TCGA-BH-A0DI,TCGA-BH-A0DI-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-23327.0,267.0,,0.0,912.0,,,,,NO,,,,,2014-4-22,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Negative,,NO,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf,A0DI,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2009.0,91285ac6-c627-4101-b551-28f37b947276,91285ac6-c627-4101-b551-28f37b947276,TCGA-BH-A0DI-01A-11-A13B-20,TCGA-BH-A0DI-01A-21D-A12Q-09,TCGA-BH-A0DI-01,TCGA-BH-A0DI-01A-21D-A12R-05,12b20a6c-5b0f-4014-85f5-b411c0ad5651,TCGA-BH-A0DI-01,TCGA-BH-A0DI-01A-21D-A12Q-09,,TCGA-BH-A0DI-01,TCGA-BH-A0DI-01,TCGA-BH-A0DI-01A-21D-A12Q-09,,91285ac6-c627-4101-b551-28f37b947276,,TCGA-BH-A0DI-01A-21D-A12N-01,TCGA-BH-A0DI-01,TCGA-BH-A0DI-01A-21R-A12P-07,91285ac6-c627-4101-b551-28f37b947276,TCGA-BH-A0DI-01A-21D-A12N-01,TCGA-BH-A0DI-01
tcga.bh.a0dv,Stage IIIA,54.0,3.0,Stage IIIA,1374.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1374.0,0.0,LumA,,Positive,ReacII,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-BH-A0DV-01,2064.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,cluster 6,mutation cluster 4,TCGA-BH-A0DV,2064.0,0.0,days,2064.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,,,TCGA-BH-A0DV-F63672,TCGA-BH-A0DV,TCGA-BH-A0DV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-19781.0,975.0,,0.0,2064.0,,,,,NO,,,,,2014-8-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,370.0,NO,Negative,,NO,9.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,9.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf,A0DV,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,BH,Breast,A,LIVING,2007.0,0d029d04-13cd-4870-a9e3-9d2e65c9b0b7,0d029d04-13cd-4870-a9e3-9d2e65c9b0b7,TCGA-BH-A0DV-01A-11-A13B-20,TCGA-BH-A0DV-01A-21D-A12Q-09,TCGA-BH-A0DV-01,TCGA-BH-A0DV-01A-21D-A12R-05,2ddc51b1-8ac4-4b9e-85d3-23c698917d5f,TCGA-BH-A0DV-01,TCGA-BH-A0DV-01A-21D-A12Q-09,,,TCGA-BH-A0DV-01,TCGA-BH-A0DV-01A-21D-A12Q-09,,0d029d04-13cd-4870-a9e3-9d2e65c9b0b7,,TCGA-BH-A0DV-01A-21D-A12N-01,TCGA-BH-A0DV-01,,0d029d04-13cd-4870-a9e3-9d2e65c9b0b7,TCGA-BH-A0DV-01A-21D-A12N-01,
tcga.bh.a0e2,Stage IIIA,49.0,2.0,No_Conversion,435.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,435.0,0.0,LumA,Luminal A,Positive,LumA/B,-8.0,-3.0,followup,T_Other,T2,LIVING,0.0,TCGA-BH-A0E2-01,435.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,,,mutation c1uster 9,TCGA-BH-A0E2,,,days,435.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,,TCGA-BH-A0E2-F4639,TCGA-BH-A0E2,TCGA-BH-A0E2-01A,,Positive,,1+,,,Positive,Modified Radical Mastectomy,,NO,,,-18152.0,210.0,,0.0,435.0,,,,,,H-SCORE 300,90-99%,,,2010-11-16,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,160.0,NO,Negative,,,26.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf,A0E2,TUMOR FREE,H-SCORE 1,,,H-SCORE,H-SCORE,,,<10%,,NO,Primary Tumor,1,,,YES,NO,YES,BH,Breast,A,LIVING,2009.0,b605d803-523b-46e6-b656-7d9888d306cc,b605d803-523b-46e6-b656-7d9888d306cc,TCGA-BH-A0E2-01A-21-A13A-20,TCGA-BH-A0E2-01A-11W-A071-09,TCGA-BH-A0E2-01,TCGA-BH-A0E2-01A-11D-A10P-05,98a8d468-efe1-41ff-a02a-615e09da0330,TCGA-BH-A0E2-01,TCGA-BH-A0E2-01A-11W-A071-09,,TCGA-BH-A0E2-01,TCGA-BH-A0E2-01,TCGA-BH-A0E2-01A-11W-A071-09,,b605d803-523b-46e6-b656-7d9888d306cc,,TCGA-BH-A0E2-01A-11D-A059-01,TCGA-BH-A0E2-01,TCGA-BH-A0E2-01A-11R-A056-07,b605d803-523b-46e6-b656-7d9888d306cc,TCGA-BH-A0E2-01A-11D-A059-01,TCGA-BH-A0E2-01
tcga.bh.a0h3,Stage I,46.0,2.0,Stage I,1149.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1149.0,0.0,LumA,Luminal A,Positive,,-2.0,-4.0,enrollment,T1,T1,LIVING,0.0,TCGA-BH-A0H3-01,1928.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 3,cluster 6,mutation cluster 4,TCGA-BH-A0H3,1928.0,0.0,days,1928.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Upper Outer Quadrant,,,TCGA-BH-A0H3-F58599,TCGA-BH-A0H3,TCGA-BH-A0H3-01A,,Positive,,,,,Positive,Other,,,,,-17152.0,773.0,,0.0,1928.0,,,,,NO,,,,,2014-4-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,80.0,NO,,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf,A0H3,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,Left segmental mastectomy with axillary lymph node dissection,6th,,NO,YES,BH,Breast,A,LIVING,2008.0,4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d,4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d,,TCGA-BH-A0H3-01A-11D-A12Q-09,TCGA-BH-A0H3-01,TCGA-BH-A0H3-01A-11D-A12R-05,,TCGA-BH-A0H3-01,TCGA-BH-A0H3-01A-11D-A12Q-09,,TCGA-BH-A0H3-01,TCGA-BH-A0H3-01,TCGA-BH-A0H3-01A-11D-A12Q-09,,4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d,,TCGA-BH-A0H3-01A-11D-A12N-01,TCGA-BH-A0H3-01,TCGA-BH-A0H3-01A-11R-A12P-07,4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d,TCGA-BH-A0H3-01A-11D-A12N-01,TCGA-BH-A0H3-01
tcga.bh.a0ha,Stage I,31.0,1.0,Stage I,856.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Negative,N0,856.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,-7.0,enrollment,T1,T1,LIVING,0.0,TCGA-BH-A0HA-01,1611.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation cluster 4,TCGA-BH-A0HA,1611.0,0.0,days,1611.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,31.0,Right,,,TCGA-BH-A0HA-F43320,TCGA-BH-A0HA,,,Positive,,,,,Positive,Other,,,,,-11379.0,,,0.0,1611.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-5-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,0.0,,,No,M0,N0 (i-),T1c,Stage I,,A0HA,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,bilateral total mastectomies with right sentinel node biopsy,6th,NO,NO,YES,BH,Breast,,LIVING,2008.0,cffc0fe5-533f-46f8-a54a-2e09c392767d,cffc0fe5-533f-46f8-a54a-2e09c392767d,TCGA-BH-A0HA-01A-21-A13C-20,TCGA-BH-A0HA-01A-11D-A12Q-09,TCGA-BH-A0HA-01,TCGA-BH-A0HA-01A-11D-A12R-05,f1a9fcd6-b351-4300-ab8c-e488c8d76cee,TCGA-BH-A0HA-01,TCGA-BH-A0HA-01A-11D-A12Q-09,,TCGA-BH-A0HA-01,TCGA-BH-A0HA-01,TCGA-BH-A0HA-01A-11D-A12Q-09,,cffc0fe5-533f-46f8-a54a-2e09c392767d,,TCGA-BH-A0HA-01A-11D-A12N-01,TCGA-BH-A0HA-01,TCGA-BH-A0HA-01A-11R-A12P-07,cffc0fe5-533f-46f8-a54a-2e09c392767d,TCGA-BH-A0HA-01A-11D-A12N-01,TCGA-BH-A0HA-01
tcga.bh.a0hn,Stage IA,67.0,,Stage I,516.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,516.0,0.0,,Basal-like,Positive,ReacI,-13.0,0.0,followup,T1,T1,LIVING,0.0,TCGA-BH-A0HN-01,516.0,0.0,days,,,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 11,cluster 6,mutation cluster 14,TCGA-BH-A0HN,,,days,516.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,,TCGA-BH-A0HN-F4811,TCGA-BH-A0HN,TCGA-BH-A0HN-01A,Negative,Positive,,3+,,Mastectomy NOS,Positive,Other,,NO,,,-24731.0,359.0,,0.0,516.0,,,,,,H-SCORE 300,90-99%,1.78,,2010-11-16,FEMALE,,,,,2+,40.0,2.0,1.13,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,130.0,NO,Equivocal,Negative,,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf,A0HN,TUMOR FREE,H-SCORE 290,,,H-SCORE,H-SCORE,,,90-99%,,NO,Primary Tumor,1,Segmental mastectomy,,YES,NO,YES,BH,Breast,A,LIVING,2009.0,6f0cf450-76f1-489d-9890-5093816c0680,6f0cf450-76f1-489d-9890-5093816c0680,TCGA-BH-A0HN-01A-21-A13C-20,TCGA-BH-A0HN-01A-11D-A099-09,TCGA-BH-A0HN-01,TCGA-BH-A0HN-01A-11D-A10P-05,b81e2777-d661-4576-b8dc-e95b03351e27,,TCGA-BH-A0HN-01A-11D-A099-09,,,TCGA-BH-A0HN-01,TCGA-BH-A0HN-01A-11D-A099-09,,6f0cf450-76f1-489d-9890-5093816c0680,,,TCGA-BH-A0HN-01,,6f0cf450-76f1-489d-9890-5093816c0680,,
tcga.bh.a1en,Stage IIA,78.0,3.0,Stage IIA,,2052.0,Negative,FEMALE,Positive,,,,Negative,M0,Negative,N0,2052.0,1.0,Her2,,Negative,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1EN-01,2127.0,1.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-BH-A1EN,,,days,2127.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Right,,,,TCGA-BH-A1EN,TCGA-BH-A1EN-01A,,Negative,,,,,Negative,Other,,,,,-28724.0,4343.0,2127.0,0.0,,,,,,NO,,,,,2011-9-3,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,140.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,3.0,,,,,,,,,,,True,No,M0,NX,T2,Stage IIA,TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf,A1EN,TUMOR FREE,,,,,,,,,,,Primary Tumor,1,right segmental mastectomy,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,a6db80e4-b161-412d-932a-fe2898a1722f,a6db80e4-b161-412d-932a-fe2898a1722f,TCGA-BH-A1EN-01A-21-A17I-20,TCGA-BH-A1EN-01A-11D-A17G-09,TCGA-BH-A1EN-01,TCGA-BH-A1EN-01A-11D-A13K-05,8de8ac77-d6ea-437d-9ca8-ef6f5480eb1b,TCGA-BH-A1EN-01,TCGA-BH-A1EN-01A-11D-A17G-09,,,TCGA-BH-A1EN-01,TCGA-BH-A1EN-01A-11D-A17G-09,,a6db80e4-b161-412d-932a-fe2898a1722f,,TCGA-BH-A1EN-01A-11D-A13J-01,TCGA-BH-A1EN-01,,a6db80e4-b161-412d-932a-fe2898a1722f,TCGA-BH-A1EN-01A-11D-A13J-01,
tcga.bh.a1eo,Stage IIA,68.0,3.0,Stage IIA,,2798.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,2798.0,1.0,LumA,Luminal A,Positive,,-5.0,-3.0,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1EO-01,2798.0,1.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation c1uster 9,TCGA-BH-A1EO,,,days,2798.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Right,,,,TCGA-BH-A1EO,TCGA-BH-A1EO-01A,,Positive,,,,,Positive,Other,,,,,-25136.0,4330.0,2798.0,0.0,,,,,,NO,,,,,2011-9-6,FEMALE,,,,,,,,,,Mixed Histology (please specify),ductal and lobular features,No,,C50.9,8522/3,C50.9,,YES,,Excisional Biopsy,100.0,NO,Negative,,,15.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,,1.0,,True,No,M0,N1,T1c,Stage IIA,TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf,A1EO,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,right segmental mastectomy witrh axillary node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,e6f1450a-6731-4593-82c3-28f839ebf148,e6f1450a-6731-4593-82c3-28f839ebf148,TCGA-BH-A1EO-01A-21-A17I-20,TCGA-BH-A1EO-01A-11D-A135-09,TCGA-BH-A1EO-01,TCGA-BH-A1EO-01A-11D-A138-05,819bff28-56b5-455b-b86d-c803b081d75e,TCGA-BH-A1EO-01,TCGA-BH-A1EO-01A-11D-A135-09,,TCGA-BH-A1EO-01,TCGA-BH-A1EO-01,TCGA-BH-A1EO-01A-11D-A135-09,,e6f1450a-6731-4593-82c3-28f839ebf148,,TCGA-BH-A1EO-01A-11D-A134-01,TCGA-BH-A1EO-01,TCGA-BH-A1EO-01A-11R-A137-07,e6f1450a-6731-4593-82c3-28f839ebf148,TCGA-BH-A1EO-01A-11D-A134-01,TCGA-BH-A1EO-01
tcga.bh.a1es,Stage IIB,35.0,5.0,Stage IIB,,3462.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,3462.0,1.0,LumA,Luminal A,Positive,,-9.0,-3.0,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1ES-01,3462.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-BH-A1ES,,,days,3462.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,35.0,Right Upper Inner Quadrant,,,,TCGA-BH-A1ES,,,Positive,,,,,Positive,Other,,,,,-13138.0,,3462.0,0.0,,,,,,NO,,,,,2011-9-6,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Negative,,,4.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,,1.0,,,No,M0,N1a,T2,Stage IIB,,A1ES,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,total mastectomy with rigth axillary lymph node and sentinel lymph node dissection,5th,,NO,YES,BH,Breast,,DECEASED,1999.0,cbb45082-6d4e-4457-b023-52f9372ae053,cbb45082-6d4e-4457-b023-52f9372ae053,,TCGA-BH-A1ES-01A-11D-A135-09,TCGA-BH-A1ES-01,TCGA-BH-A1ES-01A-11D-A138-05,e6c70136-ae35-4294-a16d-5673f0edbea5,TCGA-BH-A1ES-01,TCGA-BH-A1ES-01A-11D-A135-09,,TCGA-BH-A1ES-01,TCGA-BH-A1ES-01,TCGA-BH-A1ES-01A-11D-A135-09,,cbb45082-6d4e-4457-b023-52f9372ae053,,TCGA-BH-A1ES-01A-11D-A134-01,TCGA-BH-A1ES-01,TCGA-BH-A1ES-01A-11R-A137-07,cbb45082-6d4e-4457-b023-52f9372ae053,TCGA-BH-A1ES-01A-11D-A134-01,TCGA-BH-A1ES-01
tcga.bh.a1et,Stage IIA,55.0,2.0,Stage I,,2520.0,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2520.0,1.0,LumA,Luminal A,Positive,,-12.0,-7.0,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1ET-01,2520.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-BH-A1ET,,,days,2520.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left,,,,TCGA-BH-A1ET,,,Positive,,,,,Positive,Other,,,,,-20425.0,,2520.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,19.0,,,,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,,1.0,,,No,M0,N0,T1,Stage I,,A1ET,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,Left segmental mastectomy with left axillary lymph node dissection,5th,,NO,YES,BH,Breast,,DECEASED,1999.0,b0388c2e-0793-4084-bcc3-454c2ec88931,b0388c2e-0793-4084-bcc3-454c2ec88931,TCGA-BH-A1ET-01A-21-A17I-20,TCGA-BH-A1ET-01A-11D-A135-09,TCGA-BH-A1ET-01,TCGA-BH-A1ET-01A-11D-A138-05,a8e7241b-076a-4fa3-83da-755694823091,TCGA-BH-A1ET-01,TCGA-BH-A1ET-01A-11D-A135-09,,TCGA-BH-A1ET-01,TCGA-BH-A1ET-01,TCGA-BH-A1ET-01A-11D-A135-09,,b0388c2e-0793-4084-bcc3-454c2ec88931,,TCGA-BH-A1ET-01A-11D-A134-01,TCGA-BH-A1ET-01,TCGA-BH-A1ET-01A-11R-A137-07,b0388c2e-0793-4084-bcc3-454c2ec88931,TCGA-BH-A1ET-01A-11D-A134-01,TCGA-BH-A1ET-01
tcga.bh.a1eu,Stage I,83.0,1.0,Stage I,,1286.0,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1286.0,1.0,LumA,Luminal A,Positive,,-5.0,-7.0,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1EU-01,1286.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation cluster 4,TCGA-BH-A1EU,,,days,1286.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,83.0,Right,,,,TCGA-BH-A1EU,TCGA-BH-A1EU-01A,,Positive,,,,,Positive,,,,,,-30339.0,4106.0,1286.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,410.0,NO,Negative,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,,,,True,No,M0,N0,T1,Stage I,TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf,A1EU,TUMOR FREE,,,,,,,NO,,,,Primary Tumor,1,Right segmental mastectomy,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,bfeed1cc-e0f8-493f-a950-829ecb3acccc,bfeed1cc-e0f8-493f-a950-829ecb3acccc,TCGA-BH-A1EU-01A-21-A17I-20,TCGA-BH-A1EU-01A-11D-A135-09,TCGA-BH-A1EU-01,TCGA-BH-A1EU-01A-11D-A138-05,73eb0467-0d24-4ef1-b0e6-ca457ad24f09,TCGA-BH-A1EU-01,TCGA-BH-A1EU-01A-11D-A135-09,,TCGA-BH-A1EU-01,TCGA-BH-A1EU-01,TCGA-BH-A1EU-01A-11D-A135-09,,bfeed1cc-e0f8-493f-a950-829ecb3acccc,,TCGA-BH-A1EU-01A-11D-A134-01,TCGA-BH-A1EU-01,TCGA-BH-A1EU-01A-11R-A137-07,bfeed1cc-e0f8-493f-a950-829ecb3acccc,TCGA-BH-A1EU-01A-11D-A134-01,TCGA-BH-A1EU-01
tcga.bh.a1ev,,45.0,2.0,,,365.0,Positive,FEMALE,,,,,,,,,365.0,1.0,Her2,HER2-enriched,Positive,,-1.0,-5.0,enrollment,,,DECEASED,1.0,TCGA-BH-A1EV-01,365.0,1.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 7,mutation cluster 5,TCGA-BH-A1EV,365.0,0.0,days,365.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left,,,TCGA-BH-A1EV-F59154,TCGA-BH-A1EV,TCGA-BH-A1EV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16504.0,4103.0,365.0,0.0,,,,,,,,,,,2014-5-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,600.0,NO,Positive,,NO,10.0,,,,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,,,,,NO,3.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf,A1EV,WITH TUMOR,,,,,,NO,YES,,,YES,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,4dac7a33-db46-4815-8c6c-fb326959c741,4dac7a33-db46-4815-8c6c-fb326959c741,TCGA-BH-A1EV-01A-21-A17I-20,TCGA-BH-A1EV-01A-11D-A135-09,TCGA-BH-A1EV-01,TCGA-BH-A1EV-01A-11D-A138-05,59c3ce2b-d84e-4d4a-b6dc-ffdb9e3a34f5,TCGA-BH-A1EV-01,TCGA-BH-A1EV-01A-11D-A135-09,,TCGA-BH-A1EV-01,TCGA-BH-A1EV-01,TCGA-BH-A1EV-01A-11D-A135-09,,4dac7a33-db46-4815-8c6c-fb326959c741,,TCGA-BH-A1EV-01A-11D-A134-01,TCGA-BH-A1EV-01,TCGA-BH-A1EV-01A-11R-A137-07,4dac7a33-db46-4815-8c6c-fb326959c741,TCGA-BH-A1EV-01A-11D-A134-01,TCGA-BH-A1EV-01
tcga.bh.a1ew,Stage IIA,38.0,3.0,No_Conversion,,1694.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,1694.0,1.0,LumA,Luminal B,Negative,,-3.0,-3.0,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1EW-01,1694.0,1.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-BH-A1EW,,,days,1694.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Left Upper Outer Quadrant,,,,TCGA-BH-A1EW,TCGA-BH-A1EW-01A,,Negative,,,,,Negative,Other,,,,,-14090.0,4230.0,1694.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,550.0,NO,Negative,,,16.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,,1.0,,True,No,M0,N1b,T2,Stage IIA,TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf,A1EW,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,Left segmental mastectomy with level 1 and level 2 axillary dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,59783c67-6446-44c1-b9b3-505470f54c82,59783c67-6446-44c1-b9b3-505470f54c82,TCGA-BH-A1EW-01A-21-A17I-20,TCGA-BH-A1EW-01A-11D-A135-09,TCGA-BH-A1EW-01,TCGA-BH-A1EW-01A-11D-A138-05,fd676c7e-c137-4699-a8ea-57b72b10ff5b,TCGA-BH-A1EW-01,TCGA-BH-A1EW-01A-11D-A135-09,,TCGA-BH-A1EW-01,TCGA-BH-A1EW-01,TCGA-BH-A1EW-01A-11D-A135-09,,59783c67-6446-44c1-b9b3-505470f54c82,,TCGA-BH-A1EW-01A-11D-A134-01,TCGA-BH-A1EW-01,TCGA-BH-A1EW-01A-11R-A137-07,59783c67-6446-44c1-b9b3-505470f54c82,TCGA-BH-A1EW-01A-11D-A134-01,TCGA-BH-A1EW-01
tcga.bh.a1ex,Stage IIB,67.0,3.0,Stage IIB,,1508.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1508.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1EX-01,1508.0,1.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-BH-A1EX,,,days,1508.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right Lower Inner Quadrant,,,,TCGA-BH-A1EX,,,Positive,,,,,Positive,Other,,,,,-24544.0,,1508.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Positive,Negative,,24.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,,2.0,,,No,M0,N1b,T2,Stage IIB,,A1EX,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy,5th,,NO,YES,BH,Breast,,DECEASED,2000.0,b5c8962b-15d5-45ba-9a5a-a75dfacbaad9,b5c8962b-15d5-45ba-9a5a-a75dfacbaad9,TCGA-BH-A1EX-01A-21-A17I-20,TCGA-BH-A1EX-01A-11D-A13L-09,TCGA-BH-A1EX-01,TCGA-BH-A1EX-01A-11D-A13K-05,e4809caf-a1a9-4d9f-807f-530ae7c2e434,TCGA-BH-A1EX-01,TCGA-BH-A1EX-01A-11D-A13L-09,,,TCGA-BH-A1EX-01,TCGA-BH-A1EX-01A-11D-A13L-09,,b5c8962b-15d5-45ba-9a5a-a75dfacbaad9,,TCGA-BH-A1EX-01A-11D-A13J-01,TCGA-BH-A1EX-01,,b5c8962b-15d5-45ba-9a5a-a75dfacbaad9,TCGA-BH-A1EX-01A-11D-A13J-01,
tcga.bh.a1ey,Stage IIA,79.0,2.0,Stage IIA,,538.0,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,538.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1EY-01,538.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation cluster 3,TCGA-BH-A1EY,396.0,1.0,days,538.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Left Upper Outer Quadrant,,,TCGA-BH-A1EY-F59173,TCGA-BH-A1EY,TCGA-BH-A1EY-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-28940.0,3840.0,538.0,0.0,,,,396,,,,,,,2014-5-2,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,290.0,NO,Negative,,NO,12.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,1.0,,,,Lung,Distant Metastasis,Liver,,YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf,A1EY,WITH TUMOR,,,,,,NO,YES,,,NO,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,2000.0,4a6f7935-86f8-4c08-9d0e-9fe77878f2ce,4a6f7935-86f8-4c08-9d0e-9fe77878f2ce,TCGA-BH-A1EY-01A-21-A17I-20,TCGA-BH-A1EY-01A-11D-A13L-09,TCGA-BH-A1EY-01,TCGA-BH-A1EY-01A-11D-A13K-05,7de680e0-63d0-41b4-ace3-82a8e80aaae3,TCGA-BH-A1EY-01,TCGA-BH-A1EY-01A-11D-A13L-09,,,TCGA-BH-A1EY-01,TCGA-BH-A1EY-01A-11D-A13L-09,,4a6f7935-86f8-4c08-9d0e-9fe77878f2ce,,TCGA-BH-A1EY-01A-11D-A13J-01,TCGA-BH-A1EY-01,,4a6f7935-86f8-4c08-9d0e-9fe77878f2ce,TCGA-BH-A1EY-01A-11D-A13J-01,
tcga.bh.a1f0,Stage IIA,80.0,1.0,Stage IIA,,785.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,785.0,1.0,Basal,Basal-like,Indeterminate,,-13.0,-12.0,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1F0-01,785.0,1.0,days,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,miRNA c1uster 9,cluster 6,mutation cluster 5,TCGA-BH-A1F0,,,days,785.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left,,,,TCGA-BH-A1F0,,,Negative,,,,,Indeterminate,Modified Radical Mastectomy,,,,,-29335.0,,785.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,9.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,,1.0,,,No,M0,N1c,T1a,Stage IIA,,A1F0,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,,DECEASED,2000.0,d31b476c-c047-4e5f-a0cb-eff1065f0121,d31b476c-c047-4e5f-a0cb-eff1065f0121,TCGA-BH-A1F0-01A-21-A17I-20,TCGA-BH-A1F0-01A-11D-A135-09,TCGA-BH-A1F0-01,TCGA-BH-A1F0-01A-11D-A138-05,a4bd17eb-0741-4d81-b457-158367d20ae9,TCGA-BH-A1F0-01,TCGA-BH-A1F0-01A-11D-A135-09,,TCGA-BH-A1F0-01,TCGA-BH-A1F0-01,TCGA-BH-A1F0-01A-11D-A135-09,,d31b476c-c047-4e5f-a0cb-eff1065f0121,,TCGA-BH-A1F0-01A-11D-A134-01,TCGA-BH-A1F0-01,TCGA-BH-A1F0-01A-11R-A137-07,d31b476c-c047-4e5f-a0cb-eff1065f0121,TCGA-BH-A1F0-01A-11D-A134-01,TCGA-BH-A1F0-01
tcga.bh.a1f2,Stage IIIB,53.0,5.0,Stage,,959.0,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,959.0,1.0,LumB,,Positive,,,,enrollment,T_Other,T4,DECEASED,1.0,TCGA-BH-A1F2-01,959.0,1.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 6,mutation cluster 14,TCGA-BH-A1F2,,,days,959.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left,,,,TCGA-BH-A1F2,TCGA-BH-A1F2-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-19701.0,4147.0,959.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8541/3,C50.9,,YES,,Core needle biopsy,230.0,NO,Positive,,,19.0,,,,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,,6.0,,True,No,M0,N1b,T4b,Stage IIIB,TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf,A1F2,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1999.0,dbba4276-4b85-4309-8f98-951313c3a3dc,dbba4276-4b85-4309-8f98-951313c3a3dc,TCGA-BH-A1F2-01A-21-A17I-20,TCGA-BH-A1F2-01A-31D-A13L-09,TCGA-BH-A1F2-01,TCGA-BH-A1F2-01A-31D-A13K-05,9c29c7e9-78b0-434d-a795-343fa6d8d937,TCGA-BH-A1F2-01,TCGA-BH-A1F2-01A-31D-A13L-09,,,TCGA-BH-A1F2-01,TCGA-BH-A1F2-01A-31D-A13L-09,,dbba4276-4b85-4309-8f98-951313c3a3dc,,TCGA-BH-A1F2-01A-31D-A13J-01,TCGA-BH-A1F2-01,,dbba4276-4b85-4309-8f98-951313c3a3dc,TCGA-BH-A1F2-01A-31D-A13J-01,
tcga.bh.a1f5,,62.0,,,,2712.0,Positive,FEMALE,,,,,,,,,2712.0,1.0,LumA,,Positive,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A1F5-01,2712.0,1.0,days,Kirc+,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation c1uster 9,TCGA-BH-A1F5,,,days,2712.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right,,,,TCGA-BH-A1F5,TCGA-BH-A1F5-01A,,Positive,,,,,Positive,,,,,,-22842.0,3091.0,2712.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,,4.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,True,Yes,M0,N1a,T1c,Stage IIA,TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf,A1F5,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,2002.0,07c52f68-8ece-4702-8573-9b21f32df787,07c52f68-8ece-4702-8573-9b21f32df787,TCGA-BH-A1F5-01A-21-A17I-20,TCGA-BH-A1F5-01A-12D-A13L-09,TCGA-BH-A1F5-01,TCGA-BH-A1F5-01A-12D-A13K-05,07dd3a1f-05f8-488d-9b80-4fe5b94923c4,TCGA-BH-A1F5-01,TCGA-BH-A1F5-01A-12D-A13L-09,,,TCGA-BH-A1F5-01,TCGA-BH-A1F5-01A-12D-A13L-09,,07c52f68-8ece-4702-8573-9b21f32df787,,TCGA-BH-A1F5-01A-12D-A13J-01,TCGA-BH-A1F5-01,,07c52f68-8ece-4702-8573-9b21f32df787,TCGA-BH-A1F5-01A-12D-A13J-01,
tcga.bh.a1f6,,51.0,,,,2965.0,Negative,FEMALE,,,,,,,,,2965.0,1.0,Basal,,Negative,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A1F6-01,2965.0,1.0,days,High,C4-BRCA/Basal,,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,,mutation cluster 5,TCGA-BH-A1F6,,,days,2965.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left,,,,TCGA-BH-A1F6,TCGA-BH-A1F6-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-18691.0,5230.0,2965.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,360.0,NO,Negative,,,6.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.0,,True,No,MX,N2a,T4d,,TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf,A1F6,,,,,,,,YES,,,,Primary Tumor,1,,,,NO,YES,BH,Breast,A,DECEASED,1996.0,5f5a884c-ffbd-401a-8689-baded1bdbe50,5f5a884c-ffbd-401a-8689-baded1bdbe50,TCGA-BH-A1F6-01A-21-A17I-20,TCGA-BH-A1F6-01A-11D-A13L-09,TCGA-BH-A1F6-01,TCGA-BH-A1F6-01A-11D-A13K-05,9e1df13d-422b-46a6-8dd0-0f3d943c301b,TCGA-BH-A1F6-01,TCGA-BH-A1F6-01A-11D-A13L-09,,,TCGA-BH-A1F6-01,TCGA-BH-A1F6-01A-11D-A13L-09,,5f5a884c-ffbd-401a-8689-baded1bdbe50,,TCGA-BH-A1F6-01A-11D-A13J-01,TCGA-BH-A1F6-01,,5f5a884c-ffbd-401a-8689-baded1bdbe50,TCGA-BH-A1F6-01A-11D-A13J-01,
tcga.bh.a1f8,Stage IIIB,90.0,1.0,Stage IIIC,,749.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,749.0,1.0,LumB,,Positive,,,,enrollment,T_Other,T4,DECEASED,1.0,TCGA-BH-A1F8-01,763.0,1.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 4,mutation cluster 4,TCGA-BH-A1F8,,,days,763.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Left,,,,TCGA-BH-A1F8,,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-32871.0,,763.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Positive,,,13.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,,12.0,,,No,M0,N2,T4b,Stage IIIB,,A1F8,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,,DECEASED,1999.0,ca39657a-073d-4b89-a3da-900f7c9f1012,ca39657a-073d-4b89-a3da-900f7c9f1012,TCGA-BH-A1F8-01A-21-A17I-20,TCGA-BH-A1F8-01A-11D-A13L-09,TCGA-BH-A1F8-01,TCGA-BH-A1F8-01A-11D-A13K-05,bcc978dd-e7cd-4cff-be13-d6f0926dfc9d,TCGA-BH-A1F8-01,TCGA-BH-A1F8-01A-11D-A13L-09,,,TCGA-BH-A1F8-01,TCGA-BH-A1F8-01A-11D-A13L-09,,ca39657a-073d-4b89-a3da-900f7c9f1012,,TCGA-BH-A1F8-01A-11D-A13J-01,TCGA-BH-A1F8-01,,ca39657a-073d-4b89-a3da-900f7c9f1012,TCGA-BH-A1F8-01A-11D-A13J-01,
tcga.bh.a1fb,Stage IIB,60.0,4.0,Stage IIB,,3669.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,3669.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FB-01,3669.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,,TCGA-BH-A1FB,,,days,3669.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Right,,,,TCGA-BH-A1FB,TCGA-BH-A1FB-01A,,Positive,,,,,Positive,,,,,,-21933.0,3871.0,3669.0,0.0,,,,,,,,,,,2011-9-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Negative,,,15.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,,0.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf,A1FB,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,segmental mastectomy with sentinel lymph node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,2000.0,5b262ec0-72f2-4c54-820e-a39afad67212,5b262ec0-72f2-4c54-820e-a39afad67212,TCGA-BH-A1FB-01A-21-A17I-20,,TCGA-BH-A1FB-01,TCGA-BH-A1FB-01A-11D-A13K-05,ee88f81e-c7f3-41b4-a115-751d02d07fd0,TCGA-BH-A1FB-01,,,,TCGA-BH-A1FB-01,,,5b262ec0-72f2-4c54-820e-a39afad67212,,TCGA-BH-A1FB-01A-11D-A13J-01,TCGA-BH-A1FB-01,,5b262ec0-72f2-4c54-820e-a39afad67212,TCGA-BH-A1FB-01A-11D-A13J-01,
tcga.bh.a1fc,Stage IIA,78.0,4.0,Stage IIA,,3471.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,3471.0,1.0,Basal,,Negative,,,,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1FC-01,3472.0,1.0,days,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-BH-A1FC,,,days,3472.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Right Upper Outer Quadrant,,,,TCGA-BH-A1FC,TCGA-BH-A1FC-01A,,Negative,,,,,Negative,Other,,,,,-28706.0,4456.0,3472.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Fine needle aspiration biopsy,90.0,NO,Negative,,,23.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,,1.0,,True,No,M0,N1b,T1c,Stage IIA,TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf,A1FC,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,localized segmental mastectomy with axillary node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,42e2160c-07b5-4be6-a989-1e3474926d2a,42e2160c-07b5-4be6-a989-1e3474926d2a,TCGA-BH-A1FC-01A-21-A17I-20,TCGA-BH-A1FC-01A-11D-A13L-09,TCGA-BH-A1FC-01,TCGA-BH-A1FC-01A-11D-A13K-05,9ce04c0d-97f2-4acd-a985-c9b162221210,TCGA-BH-A1FC-01,TCGA-BH-A1FC-01A-11D-A13L-09,,,TCGA-BH-A1FC-01,TCGA-BH-A1FC-01A-11D-A13L-09,,42e2160c-07b5-4be6-a989-1e3474926d2a,,TCGA-BH-A1FC-01A-11D-A13J-01,TCGA-BH-A1FC-01,,42e2160c-07b5-4be6-a989-1e3474926d2a,TCGA-BH-A1FC-01A-11D-A13J-01,
tcga.bh.a1fe,Stage IIB,31.0,2.0,Stage IIB,,2273.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,2273.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FE-01,2273.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 3,TCGA-BH-A1FE,,,days,2273.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,31.0,Left,,,,TCGA-BH-A1FE,TCGA-BH-A1FE-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-11650.0,4456.0,2273.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,130.0,NO,,,,12.0,,,,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf,A1FE,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,2cb3a793-6e37-42fd-a544-65aa2d939d50,2cb3a793-6e37-42fd-a544-65aa2d939d50,,TCGA-BH-A1FE-01A-11D-A13L-09,TCGA-BH-A1FE-01,TCGA-BH-A1FE-01A-11D-A13K-05,8e3a6a91-27f1-497a-84dc-76ab2ee74185,TCGA-BH-A1FE-01,TCGA-BH-A1FE-01A-11D-A13L-09,,,TCGA-BH-A1FE-01,TCGA-BH-A1FE-01A-11D-A13L-09,,2cb3a793-6e37-42fd-a544-65aa2d939d50,,TCGA-BH-A1FE-01A-11D-A13J-01,TCGA-BH-A1FE-01,,2cb3a793-6e37-42fd-a544-65aa2d939d50,TCGA-BH-A1FE-01A-11D-A13J-01,
tcga.bh.a1fg,Stage I,88.0,4.0,Stage I,,3738.0,Positive,FEMALE,,,,,Negative,M0,Negative,N0,3738.0,1.0,LumA,,Positive,,,,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1FG-01,3736.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-BH-A1FG,,,days,3736.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,88.0,Left,,,,TCGA-BH-A1FG,TCGA-BH-A1FG-01A,,Positive,,,,,Positive,Other,,,,,-32295.0,4460.0,3736.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,120.0,NO,Negative,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,,,,True,No,M0,NX,T1c,Stage I,TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf,A1FG,,,,,,,,,,,,Primary Tumor,1,segmental mastectomy,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,39fe5d50-f454-4f7b-b07b-1a59b5c828f9,39fe5d50-f454-4f7b-b07b-1a59b5c828f9,TCGA-BH-A1FG-01A-21-A17I-20,TCGA-BH-A1FG-01A-11D-A13L-09,TCGA-BH-A1FG-01,TCGA-BH-A1FG-01A-11D-A13K-05,590744af-fc53-40ec-957f-ca5ca31d76c5,TCGA-BH-A1FG-01,TCGA-BH-A1FG-01A-11D-A13L-09,,,TCGA-BH-A1FG-01,TCGA-BH-A1FG-01A-11D-A13L-09,,39fe5d50-f454-4f7b-b07b-1a59b5c828f9,,TCGA-BH-A1FG-01A-11D-A13J-01,TCGA-BH-A1FG-01,,39fe5d50-f454-4f7b-b07b-1a59b5c828f9,TCGA-BH-A1FG-01A-11D-A13J-01,
tcga.bh.a1fh,Stage IV,47.0,4.0,No_Conversion,,1123.0,Positive,FEMALE,Negative,,,,Positive,M1,Positive,N1,1123.0,1.0,LumA,,Negative,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FH-01,1034.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation c1uster 9,TCGA-BH-A1FH,,,days,1034.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,,,,TCGA-BH-A1FH,TCGA-BH-A1FH-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-17172.0,4670.0,1034.0,0.0,,,,,,YES,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,430.0,NO,,,,13.0,,,,,,,,,,,,,,,,,,,,Bone,,1.0,6.0,,,,,,,,,8.0,,True,No,M1,N1b,T2,Stage IV,TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf,A1FH,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,693a3c69-75bd-435d-874e-f3b90b7ed180,693a3c69-75bd-435d-874e-f3b90b7ed180,TCGA-BH-A1FH-01A-21-A17I-20,TCGA-BH-A1FH-01A-12D-A13L-09,TCGA-BH-A1FH-01,TCGA-BH-A1FH-01A-12D-A13K-05,c2f9d1f7-4fea-4868-a3ec-58f863b4e449,TCGA-BH-A1FH-01,TCGA-BH-A1FH-01A-12D-A13L-09,,,TCGA-BH-A1FH-01,TCGA-BH-A1FH-01A-12D-A13L-09,,693a3c69-75bd-435d-874e-f3b90b7ed180,,TCGA-BH-A1FH-01A-12D-A13J-01,TCGA-BH-A1FH-01,,693a3c69-75bd-435d-874e-f3b90b7ed180,TCGA-BH-A1FH-01A-12D-A13J-01,
tcga.bh.a1fj,Stage IIIA,66.0,3.0,Stage IIIA,,1927.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,1927.0,1.0,LumB,,Positive,,,,enrollment,T_Other,T3,DECEASED,1.0,TCGA-BH-A1FJ-01,1927.0,1.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 2,mutation c1uster 9,TCGA-BH-A1FJ,,,days,1927.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right Upper Outer Quadrant,,,,TCGA-BH-A1FJ,TCGA-BH-A1FJ-01A,,Negative,,,,,Positive,Modified Radical Mastectomy,,,,,-24262.0,4574.0,1927.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,190.0,NO,,,,35.0,,,,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,,6.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf,A1FJ,,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,28bc840d-296e-436e-93b8-9c28c0eaf47a,28bc840d-296e-436e-93b8-9c28c0eaf47a,TCGA-BH-A1FJ-01A-21-A17I-20,TCGA-BH-A1FJ-01A-11D-A13L-09,TCGA-BH-A1FJ-01,TCGA-BH-A1FJ-01A-11D-A13K-05,1efab28c-3820-4638-b688-f34d0daa58d3,TCGA-BH-A1FJ-01,TCGA-BH-A1FJ-01A-11D-A13L-09,,,TCGA-BH-A1FJ-01,TCGA-BH-A1FJ-01A-11D-A13L-09,,28bc840d-296e-436e-93b8-9c28c0eaf47a,,TCGA-BH-A1FJ-01A-11D-A13J-01,TCGA-BH-A1FJ-01,,28bc840d-296e-436e-93b8-9c28c0eaf47a,TCGA-BH-A1FJ-01A-11D-A13J-01,
tcga.bh.a1fl,Stage IIB,69.0,2.0,Stage IIIA,,1673.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1673.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FL-01,1673.0,1.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 6,mutation c1uster 9,TCGA-BH-A1FL,,,days,1673.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Left Upper Outer Quadrant,,,,TCGA-BH-A1FL,TCGA-BH-A1FL-01A,,Positive,,,,,Positive,Other,,,,,-25558.0,4572.0,1673.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,100.0,NO,,,,22.0,,,,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,,4.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf,A1FL,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,0858a026-142c-4428-b05d-fdc22080afd3,0858a026-142c-4428-b05d-fdc22080afd3,TCGA-BH-A1FL-01A-21-A17I-20,TCGA-BH-A1FL-01A-11D-A13L-09,TCGA-BH-A1FL-01,TCGA-BH-A1FL-01A-11D-A13K-05,dcfae1dd-7e5f-49d7-b3b8-171c97913d1a,TCGA-BH-A1FL-01,TCGA-BH-A1FL-01A-11D-A13L-09,,,TCGA-BH-A1FL-01,TCGA-BH-A1FL-01A-11D-A13L-09,,0858a026-142c-4428-b05d-fdc22080afd3,,TCGA-BH-A1FL-01A-11D-A13J-01,TCGA-BH-A1FL-01,,0858a026-142c-4428-b05d-fdc22080afd3,TCGA-BH-A1FL-01A-11D-A13J-01,
tcga.bh.a1fm,Stage IIIA,44.0,1.0,Stage IIIA,,1388.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,1388.0,1.0,LumB,,Negative,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FM-01,1388.0,1.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-BH-A1FM,,,days,1388.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Right Upper Outer Quadrant,,,,TCGA-BH-A1FM,TCGA-BH-A1FM-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-16289.0,4753.0,1388.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,,,,10.0,,,,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,,8.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf,A1FM,,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1998.0,99157b66-ae2a-4ba2-8b28-5653803063a9,99157b66-ae2a-4ba2-8b28-5653803063a9,TCGA-BH-A1FM-01A-21-A17I-20,TCGA-BH-A1FM-01A-11D-A13L-09,TCGA-BH-A1FM-01,TCGA-BH-A1FM-01A-11D-A13K-05,25b0f619-ad2b-437a-bf44-e03cce5ff63f,TCGA-BH-A1FM-01,TCGA-BH-A1FM-01A-11D-A13L-09,,,TCGA-BH-A1FM-01,TCGA-BH-A1FM-01A-11D-A13L-09,,99157b66-ae2a-4ba2-8b28-5653803063a9,,TCGA-BH-A1FM-01A-11D-A13J-01,TCGA-BH-A1FM-01,,99157b66-ae2a-4ba2-8b28-5653803063a9,TCGA-BH-A1FM-01A-11D-A13J-01,
tcga.bh.a1fn,Stage IIA,34.0,1.0,Stage IIA,,2192.0,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,2192.0,1.0,LumB,,Positive,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-BH-A1FN-01,2192.0,1.0,days,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-BH-A1FN,,,days,2192.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,34.0,Right Upper Outer Quadrant,,,,TCGA-BH-A1FN,TCGA-BH-A1FN-01A,,Positive,,,,,Positive,Other,,,,,-12525.0,4838.0,2192.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,80.0,NO,,,,29.0,,,,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf,A1FN,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,segmental mastectomy with axillary lymph node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1997.0,c870e04b-c3b7-495c-8465-7ef2a00fadc7,c870e04b-c3b7-495c-8465-7ef2a00fadc7,TCGA-BH-A1FN-01A-21-A17I-20,TCGA-BH-A1FN-01A-11D-A13L-09,TCGA-BH-A1FN-01,TCGA-BH-A1FN-01A-11D-A13K-05,3d0671e6-de93-4023-b91c-66a2e311fed6,TCGA-BH-A1FN-01,TCGA-BH-A1FN-01A-11D-A13L-09,,,TCGA-BH-A1FN-01,TCGA-BH-A1FN-01A-11D-A13L-09,,c870e04b-c3b7-495c-8465-7ef2a00fadc7,,TCGA-BH-A1FN-01A-11D-A13J-01,TCGA-BH-A1FN-01,,c870e04b-c3b7-495c-8465-7ef2a00fadc7,TCGA-BH-A1FN-01A-11D-A13J-01,
tcga.bh.a1fr,Stage IIIB,73.0,1.0,No_Conversion,,4398.0,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,4398.0,1.0,LumA,,Positive,,,,enrollment,T_Other,T4,DECEASED,1.0,TCGA-BH-A1FR-01,1642.0,1.0,days,Quiet,C3-BRCA/Luminal,cluster 2,KIRC-like c17,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-BH-A1FR,,,days,1642.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,73.0,Right Upper Inner Quadrant,,,,TCGA-BH-A1FR,TCGA-BH-A1FR-01A,,Positive,,,,,Positive,Other,,,,,-26684.0,4876.0,1642.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8523/3,C50.9,,YES,,Core needle biopsy,110.0,NO,,,,10.0,,,,,,,,,,,,,,,,,,,,,,2.0,1.0,,,,,,,,,4.0,,True,No,M0,N1a,T4b,Stage IIIB,TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf,A1FR,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,segmental mastectomy with excision of mass on chest wall and axillary node dissection,5th,,NO,YES,BH,Breast,A,DECEASED,1997.0,56d5aac4-62b4-43e4-b0e4-f40b19a5893f,56d5aac4-62b4-43e4-b0e4-f40b19a5893f,TCGA-BH-A1FR-01A-21-A17I-20,TCGA-BH-A1FR-01A-11D-A13L-09,TCGA-BH-A1FR-01,TCGA-BH-A1FR-01A-11D-A13K-05,a20031de-1d1e-4019-8d09-d8810bea4462,TCGA-BH-A1FR-01,TCGA-BH-A1FR-01A-11D-A13L-09,,,TCGA-BH-A1FR-01,TCGA-BH-A1FR-01A-11D-A13L-09,,56d5aac4-62b4-43e4-b0e4-f40b19a5893f,,TCGA-BH-A1FR-01A-11D-A13J-01,TCGA-BH-A1FR-01,,56d5aac4-62b4-43e4-b0e4-f40b19a5893f,TCGA-BH-A1FR-01A-11D-A13J-01,
tcga.bh.a1fu,Stage IA,44.0,4.0,Stage I,,2192.0,Negative,FEMALE,Positive,,,,Negative,M0,Negative,N0,2192.0,1.0,Normal,,Negative,,,,enrollment,T1,T1,DECEASED,1.0,TCGA-BH-A1FU-01,1688.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,Cluster 5,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 5,TCGA-BH-A1FU,,,days,1688.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Right Upper Outer Quadrant,,,,TCGA-BH-A1FU,TCGA-BH-A1FU-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-16174.0,5041.0,1688.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,110.0,NO,,,,5.0,,,,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf,A1FU,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1997.0,05a4f4ff-cdfd-4332-8146-066657a4c3cc,05a4f4ff-cdfd-4332-8146-066657a4c3cc,,TCGA-BH-A1FU-01A-11D-A14G-09,TCGA-BH-A1FU-01,TCGA-BH-A1FU-01A-11D-A14H-05,,TCGA-BH-A1FU-01,TCGA-BH-A1FU-01A-11D-A14G-09,,,TCGA-BH-A1FU-01,TCGA-BH-A1FU-01A-11D-A14G-09,,05a4f4ff-cdfd-4332-8146-066657a4c3cc,,TCGA-BH-A1FU-01A-11D-A14F-01,TCGA-BH-A1FU-01,,05a4f4ff-cdfd-4332-8146-066657a4c3cc,TCGA-BH-A1FU-01A-11D-A14F-01,
tcga.bh.a201,,64.0,5.0,,209.0,,Positive,FEMALE,,,,,,,,,209.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-BH-A201-01,856.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 6,mutation c1uster 9,TCGA-BH-A201,856.0,0.0,days,856.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Left,,,TCGA-BH-A201-F64222,TCGA-BH-A201,TCGA-BH-A201-01A,,Positive,,,,,Positive,Other,,,,,-23423.0,86.0,,0.0,856.0,,,,,,,,,,2014-8-27,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,2.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1,Stage IA,TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf,A201,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,segmental mastectomy with sentinel lymph node biopsy and wire localization,7th,,NO,YES,BH,Breast,A,LIVING,2011.0,a7050752-eefd-4576-a304-c79dc6fa30e7,a7050752-eefd-4576-a304-c79dc6fa30e7,TCGA-BH-A201-01A-21-A17I-20,TCGA-BH-A201-01A-11D-A14K-09,TCGA-BH-A201-01,TCGA-BH-A201-01A-11D-A14N-05,27773791-0c8a-421a-9469-3e9b93ce80d2,TCGA-BH-A201-01,TCGA-BH-A201-01A-11D-A14K-09,,,TCGA-BH-A201-01,TCGA-BH-A201-01A-11D-A14K-09,,a7050752-eefd-4576-a304-c79dc6fa30e7,,TCGA-BH-A201-01A-11D-A14J-01,TCGA-BH-A201-01,,a7050752-eefd-4576-a304-c79dc6fa30e7,TCGA-BH-A201-01A-11D-A14J-01,
tcga.bh.a202,,60.0,2.0,,22.0,,Positive,FEMALE,,,,,,,,,22.0,0.0,LumB,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-BH-A202-01,795.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 3,TCGA-BH-A202,795.0,0.0,days,795.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Left,,,TCGA-BH-A202-F64226,TCGA-BH-A202,,,Positive,,,,,Positive,Other,,,,,-22052.0,,,0.0,795.0,,,,,,,,,,2014-8-27,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Positive,,NO,4.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage II,,A202,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,segmental mastectomy with sentinel lymph node biopsy,6th,,NO,YES,BH,Breast,,LIVING,2011.0,d3169d74-dd69-4c6b-8232-6e15ac2920b9,d3169d74-dd69-4c6b-8232-6e15ac2920b9,TCGA-BH-A202-01A-21-A17K-20,TCGA-BH-A202-01A-11D-A14K-09,TCGA-BH-A202-01,TCGA-BH-A202-01A-11D-A14N-05,c393111f-c4f6-473b-a396-05dd90d531e1,TCGA-BH-A202-01,TCGA-BH-A202-01A-11D-A14K-09,,,TCGA-BH-A202-01,TCGA-BH-A202-01A-11D-A14K-09,,d3169d74-dd69-4c6b-8232-6e15ac2920b9,,TCGA-BH-A202-01A-11D-A14J-01,TCGA-BH-A202-01,,d3169d74-dd69-4c6b-8232-6e15ac2920b9,TCGA-BH-A202-01A-11D-A14J-01,
tcga.bh.a203,,78.0,3.0,,,1174.0,,FEMALE,,,,,,,,,1174.0,1.0,Her2,,,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A203-01,1174.0,1.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 4,TCGA-BH-A203,,,days,1174.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Right,,,,TCGA-BH-A203,TCGA-BH-A203-01A,,,,,,,,Lumpectomy,,,,,-28609.0,5418.0,1174.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,,340.0,NO,,,,39.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,,35.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf,A203,WITH TUMOR,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1996.0,ff6fb75e-aefc-44e3-accd-c4f690a51cca,ff6fb75e-aefc-44e3-accd-c4f690a51cca,TCGA-BH-A203-01A-21-A17K-20,TCGA-BH-A203-01A-12D-A167-09,TCGA-BH-A203-01,TCGA-BH-A203-01A-12D-A16A-05,570d0406-4cbb-471f-bf26-b07dd4f927cf,TCGA-BH-A203-01,TCGA-BH-A203-01A-12D-A167-09,,,TCGA-BH-A203-01,TCGA-BH-A203-01A-12D-A167-09,,ff6fb75e-aefc-44e3-accd-c4f690a51cca,,TCGA-BH-A203-01A-12D-A166-01,TCGA-BH-A203-01,,ff6fb75e-aefc-44e3-accd-c4f690a51cca,TCGA-BH-A203-01A-12D-A166-01,
tcga.bh.a204,,80.0,4.0,,,2534.0,,FEMALE,,,,,,,,,2534.0,1.0,LumB,,,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A204-01,2534.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,mutation cluster 14,TCGA-BH-A204,,,days,2534.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left,,,,TCGA-BH-A204,TCGA-BH-A204-01A,,,,,,,,Modified Radical Mastectomy,,,,,-29529.0,5538.0,2534.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,420.0,NO,,,,16.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,,2.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf,A204,,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1996.0,19c3c4c7-d34c-47d5-b09f-c5671f49b858,19c3c4c7-d34c-47d5-b09f-c5671f49b858,TCGA-BH-A204-01A-21-A17K-20,TCGA-BH-A204-01A-11D-A159-09,TCGA-BH-A204-01,TCGA-BH-A204-01A-11D-A161-05,6bf2c85b-1783-4017-9305-e1f18c0e7645,TCGA-BH-A204-01,TCGA-BH-A204-01A-11D-A159-09,,,TCGA-BH-A204-01,TCGA-BH-A204-01A-11D-A159-09,,19c3c4c7-d34c-47d5-b09f-c5671f49b858,,TCGA-BH-A204-01A-11D-A160-01,TCGA-BH-A204-01,,19c3c4c7-d34c-47d5-b09f-c5671f49b858,TCGA-BH-A204-01A-11D-A160-01,
tcga.bh.a208,,48.0,3.0,,,1759.0,,FEMALE,,,,,,,,,1759.0,1.0,Normal,,,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A208-01,1759.0,1.0,days,High,C3-BRCA/Luminal,cluster 5,OV-like c1,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 11,,mutation cluster 8,TCGA-BH-A208,,,days,1759.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left,,,,TCGA-BH-A208,TCGA-BH-A208-01A,,,,,,,,Lumpectomy,,,,,-17715.0,5893.0,1759.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,620.0,NO,,,,15.0,,,,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,,3.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf,A208,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1995.0,7a276d04-8f45-4c07-9c24-8b1f50a1202d,7a276d04-8f45-4c07-9c24-8b1f50a1202d,TCGA-BH-A208-01A-21-A17K-20,TCGA-BH-A208-01A-11D-A159-09,TCGA-BH-A208-01,TCGA-BH-A208-01A-11D-A161-05,20175b85-f502-4712-aa9d-f3a96c5921f8,TCGA-BH-A208-01,TCGA-BH-A208-01A-11D-A159-09,,,TCGA-BH-A208-01,TCGA-BH-A208-01A-11D-A159-09,,7a276d04-8f45-4c07-9c24-8b1f50a1202d,,TCGA-BH-A208-01A-11D-A160-01,TCGA-BH-A208-01,,7a276d04-8f45-4c07-9c24-8b1f50a1202d,TCGA-BH-A208-01A-11D-A160-01,
tcga.bh.a209,,77.0,4.0,,,3959.0,Positive,FEMALE,,,,,,,,,3959.0,1.0,LumB,,Positive,,,,enrollment,,,DECEASED,1.0,TCGA-BH-A209-01,3959.0,1.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,,mutation cluster 14,TCGA-BH-A209,,,days,3959.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Left Upper Outer Quadrant,,,,TCGA-BH-A209,TCGA-BH-A209-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-28403.0,5392.0,3959.0,0.0,,,,,,,,,,,2011-9-8,FEMALE,,,,,,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Fine needle aspiration biopsy,390.0,NO,,,,12.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf,A209,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,,5th,,NO,YES,BH,Breast,A,DECEASED,1996.0,9073fc5c-a281-4ed2-a66e-5235a5a55098,9073fc5c-a281-4ed2-a66e-5235a5a55098,TCGA-BH-A209-01A-21-A17K-20,TCGA-BH-A209-01A-11D-A17G-09,TCGA-BH-A209-01,TCGA-BH-A209-01A-11D-A161-05,f89486f5-6292-40bd-a4af-ff27eae691aa,TCGA-BH-A209-01,TCGA-BH-A209-01A-11D-A17G-09,,,TCGA-BH-A209-01,TCGA-BH-A209-01A-11D-A17G-09,,9073fc5c-a281-4ed2-a66e-5235a5a55098,,TCGA-BH-A209-01A-11D-A160-01,TCGA-BH-A209-01,,9073fc5c-a281-4ed2-a66e-5235a5a55098,TCGA-BH-A209-01A-11D-A160-01,
tcga.bh.a28o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A28O-01,1120.0,0.0,days,Quiet,,,Low purity c2,,,miRNA cluster 4,,,TCGA-BH-A28O,1120.0,0.0,days,1120.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-BH-A28O-F64237,TCGA-BH-A28O,TCGA-BH-A28O-01A,,Positive,,,,,Positive,Other,,NO,,,-18501.0,163.0,,0.0,1120.0,,,,,NO,,,,,2014-8-27,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,80.0,NO,Negative,,NO,14.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,14.0,,True,No,M0,N3,T3a,Stage IIIC,TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf,A28O,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Segmental mastectomy,7th,,YES,NO,BH,Breast,A,LIVING,2010.0,7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b,7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b,,,TCGA-BH-A28O-01,TCGA-BH-A28O-01A-11D-A22B-05,,TCGA-BH-A28O-01,TCGA-BH-A28O-01A-11D-A228-09,,,TCGA-BH-A28O-01,,,7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b,,TCGA-BH-A28O-01A-11D-A227-01,TCGA-BH-A28O-01,,7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b,TCGA-BH-A28O-01A-11D-A227-01,
tcga.bh.a28q,,46.0,2.0,,196.0,,Positive,FEMALE,,,,,,,,,196.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-BH-A28Q-01,1119.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,,mutation c1uster 9,TCGA-BH-A28Q,1119.0,0.0,days,1119.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right,,,TCGA-BH-A28Q-F64272,TCGA-BH-A28Q,TCGA-BH-A28Q-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16882.0,223.0,,0.0,1119.0,,,,,,,,,,2014-8-28,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,400.0,NO,Negative,Indeterminate,NO,18.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf,A28Q,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,BH,Breast,A,LIVING,2010.0,5427eb83-38f3-4258-b241-25efae8fa70a,5427eb83-38f3-4258-b241-25efae8fa70a,TCGA-BH-A28Q-01A-21-A17K-20,TCGA-BH-A28Q-01A-11D-A16D-09,TCGA-BH-A28Q-01,TCGA-BH-A28Q-01A-11D-A16G-05,45d40b9a-e057-4d32-b7f5-46d9d4e89d89,TCGA-BH-A28Q-01,TCGA-BH-A28Q-01A-11D-A16D-09,,,TCGA-BH-A28Q-01,TCGA-BH-A28Q-01A-11D-A16D-09,,5427eb83-38f3-4258-b241-25efae8fa70a,,TCGA-BH-A28Q-01A-11D-A16C-01,TCGA-BH-A28Q-01,,5427eb83-38f3-4258-b241-25efae8fa70a,TCGA-BH-A28Q-01A-11D-A16C-01,
tcga.bh.a2l8,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-BH-A2L8-01,612.0,0.0,days,Kirc+,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-BH-A2L8,612.0,0.0,days,612.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-BH-A2L8-F39616,TCGA-BH-A2L8,TCGA-BH-A2L8-01A,,Positive,,,,,Positive,Other,,NO,,,-16658.0,86.0,,0.0,612.0,,,,,NO,,70-79%,,,2013-1-28,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Negative,Negative,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf,A2L8,TUMOR FREE,,,,Oncotype Dx test,Oncotype Dx test,YES,YES,80-89%,,NO,Primary Tumor,1,TOTAL MASTECTOMY,7th,,YES,NO,BH,Breast,A,LIVING,2011.0,c55bb0b8-3417-4142-97f8-c43f1ec56496,c55bb0b8-3417-4142-97f8-c43f1ec56496,TCGA-BH-A2L8-01A-21-A24A-20,,TCGA-BH-A2L8-01,TCGA-BH-A2L8-01A-11D-A18O-05,0c505acf-0d07-4d38-a4cb-ad0311c255b3,TCGA-BH-A2L8-01,TCGA-BH-A2L8-01A-11D-A18P-09,,,TCGA-BH-A2L8-01,,,c55bb0b8-3417-4142-97f8-c43f1ec56496,,TCGA-BH-A2L8-01A-11D-A18N-01,TCGA-BH-A2L8-01,,c55bb0b8-3417-4142-97f8-c43f1ec56496,TCGA-BH-A2L8-01A-11D-A18N-01,
tcga.bh.a42t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-BH-A42T-01,320.0,1.0,days,,,,,,,,,,TCGA-BH-A42T,320.0,0.0,days,320.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Left,Sentinel node biopsy alone,,TCGA-BH-A42T-F61922,TCGA-BH-A42T,TCGA-BH-A42T-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-27731.0,80.0,320.0,0.0,30.0,,,,,,,,,,2014-7-10,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,130.0,NO,Positive,Equivocal,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf,A42T,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,DECEASED,2012.0,59b2f0cb-4789-4642-9aa6-605a1ebb0e32,59b2f0cb-4789-4642-9aa6-605a1ebb0e32,,,TCGA-BH-A42T-01,TCGA-BH-A42T-01A-11D-A244-05,be2031ff-59ba-4ee0-aa0e-9831692a949f,TCGA-BH-A42T-01,TCGA-BH-A42T-01A-11D-A243-09,,,TCGA-BH-A42T-01,,,59b2f0cb-4789-4642-9aa6-605a1ebb0e32,,TCGA-BH-A42T-01A-11D-A242-01,TCGA-BH-A42T-01,,59b2f0cb-4789-4642-9aa6-605a1ebb0e32,TCGA-BH-A42T-01A-11D-A242-01,
tcga.bh.a42u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A42U-01,3364.0,0.0,days,,,,,,,,,,TCGA-BH-A42U,3364.0,0.0,days,3364.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Right,,,TCGA-BH-A42U-F61923,TCGA-BH-A42U,TCGA-BH-A42U-01A,,Negative,,,,,Negative,Simple Mastectomy,,,,,-29330.0,3080.0,,0.0,3364.0,,,,,,,,,,2014-7-10,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,290.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf,A42U,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,6th,,YES,NO,BH,Breast,A,LIVING,2004.0,b3ce7ee4-fc5e-445c-b1ca-5f324b33678a,b3ce7ee4-fc5e-445c-b1ca-5f324b33678a,,,TCGA-BH-A42U-01,TCGA-BH-A42U-01A-12D-A244-05,6bab8423-84c9-41ec-88f7-5efcfcc1ab30,TCGA-BH-A42U-01,TCGA-BH-A42U-01A-12D-A243-09,,,TCGA-BH-A42U-01,,,b3ce7ee4-fc5e-445c-b1ca-5f324b33678a,,TCGA-BH-A42U-01A-12D-A242-01,TCGA-BH-A42U-01,,b3ce7ee4-fc5e-445c-b1ca-5f324b33678a,TCGA-BH-A42U-01A-12D-A242-01,
tcga.bh.a42v,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A42V-01,635.0,0.0,days,,,,,,,,,,TCGA-BH-A42V,635.0,0.0,days,635.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-BH-A42V-F61941,TCGA-BH-A42V,TCGA-BH-A42V-01A,Negative,Positive,,,,Other,Positive,Modified Radical Mastectomy,Reexcision of segmental mastectomy,,,,-15158.0,197.0,,0.0,635.0,,,,,,,,,,2014-7-10,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,60.0,NO,Negative,,NO,3.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1mi,T1c,Stage IB,TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf,A42V,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,2fa59be9-ecde-49b2-b109-7000d5180847,2fa59be9-ecde-49b2-b109-7000d5180847,,,TCGA-BH-A42V-01,TCGA-BH-A42V-01A-11D-A244-05,719aaf42-d96b-466f-b6ac-40439aec2138,TCGA-BH-A42V-01,TCGA-BH-A42V-01A-11D-A243-09,,,TCGA-BH-A42V-01,,,2fa59be9-ecde-49b2-b109-7000d5180847,,TCGA-BH-A42V-01A-11D-A242-01,TCGA-BH-A42V-01,,2fa59be9-ecde-49b2-b109-7000d5180847,TCGA-BH-A42V-01A-11D-A242-01,
tcga.bh.a5iz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A5IZ-01,567.0,0.0,days,,,,,,,,,,TCGA-BH-A5IZ,567.0,0.0,days,567.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left,,,TCGA-BH-A5IZ-F63663,TCGA-BH-A5IZ,TCGA-BH-A5IZ-01A,,Positive,,,,,Negative,Lumpectomy,,,,,-18927.0,140.0,,0.0,567.0,,,,,,,,,,2014-8-14,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Negative,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,cM0 (i+),N1a,T2,Stage IIB,TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf,A5IZ,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,39033a17-79c9-4723-9fa7-fa82f67f5344,39033a17-79c9-4723-9fa7-fa82f67f5344,,,TCGA-BH-A5IZ-01,TCGA-BH-A5IZ-01A-11D-A27Y-05,,TCGA-BH-A5IZ-01,TCGA-BH-A5IZ-01A-11D-A27P-09,,,TCGA-BH-A5IZ-01,,,39033a17-79c9-4723-9fa7-fa82f67f5344,,TCGA-BH-A5IZ-01A-11D-A27O-01,TCGA-BH-A5IZ-01,,39033a17-79c9-4723-9fa7-fa82f67f5344,TCGA-BH-A5IZ-01A-11D-A27O-01,
tcga.bh.a5j0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A5J0-01,715.0,0.0,days,,,,,,,,,,TCGA-BH-A5J0,715.0,0.0,days,715.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left,,,TCGA-BH-A5J0-F63664,TCGA-BH-A5J0,,,Positive,,,,,Positive,Simple Mastectomy,,,,,-23072.0,,,0.0,715.0,,,,,,,,,,2014-8-14,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage IA,,A5J0,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,,LIVING,2012.0,a5f14d53-fe35-494e-b6b1-bc5c8484e4a9,a5f14d53-fe35-494e-b6b1-bc5c8484e4a9,,,TCGA-BH-A5J0-01,TCGA-BH-A5J0-01A-11D-A27Y-05,,TCGA-BH-A5J0-01,TCGA-BH-A5J0-01A-11D-A27P-09,,,TCGA-BH-A5J0-01,,,a5f14d53-fe35-494e-b6b1-bc5c8484e4a9,,TCGA-BH-A5J0-01A-11D-A27O-01,TCGA-BH-A5J0-01,,a5f14d53-fe35-494e-b6b1-bc5c8484e4a9,TCGA-BH-A5J0-01A-11D-A27O-01,
tcga.bh.a6r8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A6R8-01,293.0,0.0,days,,,,,,,,,,TCGA-BH-A6R8,293.0,0.0,days,293.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left,,,TCGA-BH-A6R8-F63677,TCGA-BH-A6R8,TCGA-BH-A6R8-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-16829.0,260.0,,0.0,293.0,,,,,,,,,,2014-8-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,,Negative,NO,4.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf,A6R8,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,2bea5d05-bcad-4a2e-8954-462b589a8aa4,2bea5d05-bcad-4a2e-8954-462b589a8aa4,,,TCGA-BH-A6R8-01,TCGA-BH-A6R8-01A-21D-A33F-05,C23EA212-403F-44F3-B3BC-8F07229D7006,TCGA-BH-A6R8-01,,,,TCGA-BH-A6R8-01,,,2bea5d05-bcad-4a2e-8954-462b589a8aa4,,TCGA-BH-A6R8-01A-21D-A33D-01,TCGA-BH-A6R8-01,,2bea5d05-bcad-4a2e-8954-462b589a8aa4,TCGA-BH-A6R8-01A-21D-A33D-01,
tcga.bh.a6r9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A6R9-01,160.0,0.0,days,,,,,,,,,,TCGA-BH-A6R9,160.0,0.0,days,160.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left,,,TCGA-BH-A6R9-F63678,TCGA-BH-A6R9,TCGA-BH-A6R9-01A,,Negative,,,,,Positive,Modified Radical Mastectomy,,,,,-22325.0,237.0,,0.0,160.0,,,,,,,,,,2014-8-15,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,220.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf,A6R9,TUMOR FREE,,,,,,NO,,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,7c73dae6-4478-4cbc-aee1-0b18e730f7a2,7c73dae6-4478-4cbc-aee1-0b18e730f7a2,,,TCGA-BH-A6R9-01,TCGA-BH-A6R9-01A-21D-A32T-05,8C499FE0-D3D8-41FD-9E45-679C3403942C,TCGA-BH-A6R9-01,,,,TCGA-BH-A6R9-01,,,7c73dae6-4478-4cbc-aee1-0b18e730f7a2,,TCGA-BH-A6R9-01A-21D-A32H-01,TCGA-BH-A6R9-01,,7c73dae6-4478-4cbc-aee1-0b18e730f7a2,TCGA-BH-A6R9-01A-21D-A32H-01,
tcga.bh.a8fy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-BH-A8FY-01,295.0,1.0,days,,,,,,,,,,TCGA-BH-A8FY,295.0,0.0,days,295.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,87.0,Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant,,,,TCGA-BH-A8FY,TCGA-BH-A8FY-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-31932.0,477.0,295.0,0.0,,,,,,,,,,,2014-3-25,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,200.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,Yes,M0,N0 (i+),T1c,Stage IA,TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf,A8FY,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,DECEASED,2012.0,f037b9d3-819b-429d-8e2d-fa8b27008e70,f037b9d3-819b-429d-8e2d-fa8b27008e70,,,TCGA-BH-A8FY-01,TCGA-BH-A8FY-01A-11D-A36K-05,12726541-C142-46CD-8AE1-763DAC0943B7,TCGA-BH-A8FY-01,,,,TCGA-BH-A8FY-01,,,f037b9d3-819b-429d-8e2d-fa8b27008e70,,TCGA-BH-A8FY-01A-11D-A36I-01,TCGA-BH-A8FY-01,,f037b9d3-819b-429d-8e2d-fa8b27008e70,TCGA-BH-A8FY-01A-11D-A36I-01,
tcga.bh.a8fz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A8FZ-01,574.0,0.0,days,,,,,,,,,,TCGA-BH-A8FZ,574.0,0.0,days,574.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left,,,TCGA-BH-A8FZ-F63679,TCGA-BH-A8FZ,TCGA-BH-A8FZ-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-21343.0,468.0,,0.0,574.0,,,,,,,,,,2014-8-27,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Equivocal,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T1b,Stage IA,TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf,A8FZ,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,2281c64c-9394-44f6-a4e7-87c7cce08c13,2281c64c-9394-44f6-a4e7-87c7cce08c13,,,TCGA-BH-A8FZ-01,TCGA-BH-A8FZ-01A-11D-A357-05,2B0ED842-B3E6-42E2-9A1E-7D4F96EF2E9D,TCGA-BH-A8FZ-01,,,,TCGA-BH-A8FZ-01,,,2281c64c-9394-44f6-a4e7-87c7cce08c13,,TCGA-BH-A8FZ-01A-11D-A350-01,TCGA-BH-A8FZ-01,,2281c64c-9394-44f6-a4e7-87c7cce08c13,TCGA-BH-A8FZ-01A-11D-A350-01,
tcga.bh.a8g0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-A8G0-01,662.0,0.0,days,,,,,,,,,,TCGA-BH-A8G0,662.0,0.0,days,662.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left,,,TCGA-BH-A8G0-F64200,TCGA-BH-A8G0,TCGA-BH-A8G0-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-19975.0,436.0,,0.0,662.0,,,,,,,,,,2014-8-27,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,,NO,3.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf,A8G0,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2012.0,8e9f7a7a-3115-4687-9fce-a97e4c3c9cde,8e9f7a7a-3115-4687-9fce-a97e4c3c9cde,,,TCGA-BH-A8G0-01,TCGA-BH-A8G0-01A-11D-A357-05,A05330AE-C933-4E90-941C-2063295F9A7A,TCGA-BH-A8G0-01,,,,TCGA-BH-A8G0-01,,,8e9f7a7a-3115-4687-9fce-a97e4c3c9cde,,TCGA-BH-A8G0-01A-11D-A350-01,TCGA-BH-A8G0-01,,8e9f7a7a-3115-4687-9fce-a97e4c3c9cde,TCGA-BH-A8G0-01A-11D-A350-01,
tcga.bh.ab28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-BH-AB28-01,287.0,0.0,days,,,,,,,,,,TCGA-BH-AB28,287.0,0.0,days,287.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left,,,TCGA-BH-AB28-F64209,TCGA-BH-AB28,TCGA-BH-AB28-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-19570.0,105.0,,0.0,287.0,,,,,,,,,,2015-2-25,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,440.0,NO,Negative,Indeterminate,NO,20.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf,AB28,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,BH,Breast,A,LIVING,2013.0,3cf4fddd-7fb5-4bb6-bca8-412019df4e2d,3cf4fddd-7fb5-4bb6-bca8-412019df4e2d,,,TCGA-BH-AB28-01,TCGA-BH-AB28-01A-31D-A41Q-05,,TCGA-BH-AB28-01,,,,TCGA-BH-AB28-01,,,3cf4fddd-7fb5-4bb6-bca8-412019df4e2d,,TCGA-BH-AB28-01A-31D-A41E-01,TCGA-BH-AB28-01,,3cf4fddd-7fb5-4bb6-bca8-412019df4e2d,TCGA-BH-AB28-01A-31D-A41E-01,
tcga.c8.a1he,Stage IIA,59.0,2.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HE-01,375.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 4,TCGA-C8-A1HE,375.0,0.0,days,375.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right,Axillary lymph node dissection alone,,TCGA-C8-A1HE-F20269,TCGA-C8-A1HE,,,Positive,,,,,Positive,Other,,NO,,,,,,0.0,375.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",,,Equivocal,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,,,,No,M0,N0,T2,Stage IIA,,A1HE,TUMOR FREE,,,,Allred Score 4,Allred Score 7,,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,,LIVING,2010.0,b5f56bfb-6fc1-448f-8c2b-4753084aaa00,b5f56bfb-6fc1-448f-8c2b-4753084aaa00,TCGA-C8-A1HE-01A-21-A17J-20,TCGA-C8-A1HE-01A-11D-A188-09,TCGA-C8-A1HE-01,TCGA-C8-A1HE-01A-11D-A13K-05,f1bdea64-1ae0-442f-83cd-00ae1531f9fb,TCGA-C8-A1HE-01,TCGA-C8-A1HE-01A-11D-A188-09,,,TCGA-C8-A1HE-01,TCGA-C8-A1HE-01A-11D-A188-09,,b5f56bfb-6fc1-448f-8c2b-4753084aaa00,,TCGA-C8-A1HE-01A-11D-A13J-01,TCGA-C8-A1HE-01,,b5f56bfb-6fc1-448f-8c2b-4753084aaa00,TCGA-C8-A1HE-01A-11D-A13J-01,
tcga.c8.a1hf,Stage IIA,48.0,2.0,Stage IIA,0.0,,Negative,FEMALE,Positive,,,,Negative,M0,Negative,N0,0.0,0.0,Her2,HER2-enriched,Positive,,-11.0,-5.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HF-01,332.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 3,TCGA-C8-A1HF,332.0,0.0,days,332.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left,Axillary lymph node dissection alone,,TCGA-C8-A1HF-F19092,TCGA-C8-A1HF,TCGA-C8-A1HF-01A,,Negative,,,,,Positive,Other,,NO,,,,109.0,,0.0,332.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-2,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",460.0,NO,Positive,,,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf,A1HF,TUMOR FREE,,,,Allred Score 3,,,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,62b06301-531d-4fc1-bb00-ede8e507e8f4,62b06301-531d-4fc1-bb00-ede8e507e8f4,TCGA-C8-A1HF-01A-21-A17J-20,TCGA-C8-A1HF-01A-11D-A135-09,TCGA-C8-A1HF-01,TCGA-C8-A1HF-01A-11D-A138-05,c95c9a7c-4192-4100-9452-5def84184e9c,TCGA-C8-A1HF-01,TCGA-C8-A1HF-01A-11D-A135-09,,TCGA-C8-A1HF-01,TCGA-C8-A1HF-01,TCGA-C8-A1HF-01A-11D-A135-09,,62b06301-531d-4fc1-bb00-ede8e507e8f4,,TCGA-C8-A1HF-01A-11D-A134-01,TCGA-C8-A1HF-01,TCGA-C8-A1HF-01A-11R-A137-07,62b06301-531d-4fc1-bb00-ede8e507e8f4,TCGA-C8-A1HF-01A-11D-A134-01,TCGA-C8-A1HF-01
tcga.c8.a1hg,Stage IIA,50.0,4.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,Luminal B,Positive,,-2.0,-5.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HG-01,345.0,0.0,days,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 8,TCGA-C8-A1HG,345.0,0.0,days,345.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right,Axillary lymph node dissection alone,,TCGA-C8-A1HG-F19096,TCGA-C8-A1HG,TCGA-C8-A1HG-01A,,Positive,,,,,Positive,Other,,NO,,,,122.0,,0.0,345.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",300.0,NO,Negative,,,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf,A1HG,TUMOR FREE,,,,Allred Score 7,Allred Score 8,,NO,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,094076d0-97e4-460d-b48c-7ee2371db99d,094076d0-97e4-460d-b48c-7ee2371db99d,TCGA-C8-A1HG-01A-21-A17J-20,TCGA-C8-A1HG-01A-11D-A135-09,TCGA-C8-A1HG-01,TCGA-C8-A1HG-01A-11D-A138-05,3ba46266-c84a-482f-abc7-8756831856e6,TCGA-C8-A1HG-01,TCGA-C8-A1HG-01A-11D-A135-09,,TCGA-C8-A1HG-01,TCGA-C8-A1HG-01,TCGA-C8-A1HG-01A-11D-A135-09,,094076d0-97e4-460d-b48c-7ee2371db99d,,TCGA-C8-A1HG-01A-11D-A134-01,TCGA-C8-A1HG-01,TCGA-C8-A1HG-01A-11R-A137-07,094076d0-97e4-460d-b48c-7ee2371db99d,TCGA-C8-A1HG-01A-11D-A134-01,TCGA-C8-A1HG-01
tcga.c8.a1hi,Stage IIIA,40.0,2.0,Stage IIIA,2.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,2.0,0.0,LumA,Luminal A,Positive,,-5.0,0.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HI-01,343.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-C8-A1HI,343.0,0.0,days,343.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right,Axillary lymph node dissection alone,,TCGA-C8-A1HI-F19099,TCGA-C8-A1HI,TCGA-C8-A1HI-01A,,Positive,,,,,Positive,Other,,,,,,120.0,,0.0,343.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,Yes,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",490.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf,A1HI,TUMOR FREE,,,,Allred Score 6,Allred Score 8,,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,994c96ec-ea0a-4741-8fef-53cdbfe28cfa,994c96ec-ea0a-4741-8fef-53cdbfe28cfa,TCGA-C8-A1HI-01A-21-A17J-20,TCGA-C8-A1HI-01A-11D-A135-09,TCGA-C8-A1HI-01,TCGA-C8-A1HI-01A-11D-A138-05,8e8a6562-23a5-48a7-a06e-efc30fab8f15,TCGA-C8-A1HI-01,TCGA-C8-A1HI-01A-11D-A135-09,,TCGA-C8-A1HI-01,TCGA-C8-A1HI-01,TCGA-C8-A1HI-01A-11D-A135-09,,994c96ec-ea0a-4741-8fef-53cdbfe28cfa,,TCGA-C8-A1HI-01A-11D-A134-01,TCGA-C8-A1HI-01,TCGA-C8-A1HI-01A-11R-A137-07,994c96ec-ea0a-4741-8fef-53cdbfe28cfa,TCGA-C8-A1HI-01A-11D-A134-01,TCGA-C8-A1HI-01
tcga.c8.a1hj,Stage II,53.0,1.0,Stage IIA,5.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,5.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HJ-01,5.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 13,TCGA-C8-A1HJ,,,days,5.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right,Axillary lymph node dissection alone,,,TCGA-C8-A1HJ,TCGA-C8-A1HJ-01A,,Negative,,,,,Negative,Other,,,,,-19629.0,121.0,,0.0,5.0,,,,,NO,,,,,2011-6-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,1070.0,NO,Negative,,,10.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf,A1HJ,TUMOR FREE,,,,,,,YES,,,,Primary Tumor,1,Pateys Surgery,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,c0dd6c33-008d-44e8-b20c-8089bc3e29a3,c0dd6c33-008d-44e8-b20c-8089bc3e29a3,TCGA-C8-A1HJ-01A-21-A17J-20,TCGA-C8-A1HJ-01A-11D-A13L-09,TCGA-C8-A1HJ-01,TCGA-C8-A1HJ-01A-11D-A13K-05,6528f6b1-d0f5-413c-a304-0fa218a132ac,TCGA-C8-A1HJ-01,TCGA-C8-A1HJ-01A-11D-A13L-09,,,TCGA-C8-A1HJ-01,TCGA-C8-A1HJ-01A-11D-A13L-09,,c0dd6c33-008d-44e8-b20c-8089bc3e29a3,,TCGA-C8-A1HJ-01A-11D-A13J-01,TCGA-C8-A1HJ-01,,c0dd6c33-008d-44e8-b20c-8089bc3e29a3,TCGA-C8-A1HJ-01A-11D-A13J-01,
tcga.c8.a1hk,Stage IIB,53.0,5.0,Stage IIB,7.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,7.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HK-01,366.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation cluster 5,TCGA-C8-A1HK,366.0,0.0,days,366.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right,Axillary lymph node dissection alone,,TCGA-C8-A1HK-F19100,TCGA-C8-A1HK,TCGA-C8-A1HK-01A,,Negative,,,,,Negative,Other,,,,,,116.0,,0.0,366.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-2,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",460.0,NO,Positive,,,8.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,4.0,1.0,,,,,,,,NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf,A1HK,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,NO,YES,NO,C8,Breast,A,LIVING,2010.0,83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c,83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c,TCGA-C8-A1HK-01A-11-A17J-20,TCGA-C8-A1HK-01A-21D-A13L-09,TCGA-C8-A1HK-01,TCGA-C8-A1HK-01A-21D-A13K-05,5f7c521f-28b4-46ba-9d1e-a6bf55885d28,TCGA-C8-A1HK-01,TCGA-C8-A1HK-01A-21D-A13L-09,,,TCGA-C8-A1HK-01,TCGA-C8-A1HK-01A-21D-A13L-09,,83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c,,TCGA-C8-A1HK-01A-21D-A13J-01,TCGA-C8-A1HK-01,,83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c,TCGA-C8-A1HK-01A-21D-A13J-01,
tcga.c8.a1hl,Stage IIIA,38.0,5.0,Stage IIIA,2.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,2.0,0.0,LumB,Luminal B,Negative,,-2.0,-3.0,enrollment,T_Other,T3,LIVING,0.0,TCGA-C8-A1HL-01,317.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 4,mutation c1uster 9,TCGA-C8-A1HL,317.0,0.0,days,317.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Left,Axillary lymph node dissection alone,,TCGA-C8-A1HL-F20266,TCGA-C8-A1HL,TCGA-C8-A1HL-01A,,Positive,,,,,Negative,Other,,,,,,94.0,,0.0,317.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,2+,,,,,"Other, specify",,No,,C50.9,8480/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",980.0,NO,Equivocal,,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,,,True,Yes,M0,N1,T3,Stage IIIA,TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf,A1HL,TUMOR FREE,,,,,Allred Score 8,,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,NO,YES,NO,C8,Breast,A,LIVING,2010.0,9d80ba46-b65f-4338-99bc-370f8eaefe4e,9d80ba46-b65f-4338-99bc-370f8eaefe4e,TCGA-C8-A1HL-01A-21-A17J-20,TCGA-C8-A1HL-01A-11D-A135-09,TCGA-C8-A1HL-01,TCGA-C8-A1HL-01A-11D-A138-05,d026ab37-87a8-4486-a09d-0aabeba2dd89,TCGA-C8-A1HL-01,TCGA-C8-A1HL-01A-11D-A135-09,,TCGA-C8-A1HL-01,TCGA-C8-A1HL-01,TCGA-C8-A1HL-01A-11D-A135-09,,9d80ba46-b65f-4338-99bc-370f8eaefe4e,,TCGA-C8-A1HL-01A-11D-A134-01,TCGA-C8-A1HL-01,TCGA-C8-A1HL-01A-11R-A137-07,9d80ba46-b65f-4338-99bc-370f8eaefe4e,TCGA-C8-A1HL-01A-11D-A134-01,TCGA-C8-A1HL-01
tcga.c8.a1hm,Stage II,74.0,3.0,Stage IIA,6.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,6.0,0.0,LumB,Luminal B,Positive,,-2.0,-5.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HM-01,375.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 13,TCGA-C8-A1HM,375.0,0.0,days,375.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left,Axillary lymph node dissection alone,,TCGA-C8-A1HM-F70806,TCGA-C8-A1HM,,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-27063.0,,,0.0,375.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,,,,No,M0,N0,T2,Stage IIA,,A1HM,TUMOR FREE,,,,Allred Score 5,Allred Score 8,YES,NO,,,NO,Primary Tumor,1,,6th,YES,YES,NO,C8,Breast,,LIVING,2010.0,eb908a6f-d6f2-40ef-90da-97438cd2281e,eb908a6f-d6f2-40ef-90da-97438cd2281e,TCGA-C8-A1HM-01A-21-A17J-20,TCGA-C8-A1HM-01A-12D-A135-09,TCGA-C8-A1HM-01,TCGA-C8-A1HM-01A-12D-A138-05,e15bb106-69e3-4af4-bd2f-9c9098aa34e3,TCGA-C8-A1HM-01,TCGA-C8-A1HM-01A-12D-A135-09,,TCGA-C8-A1HM-01,TCGA-C8-A1HM-01,TCGA-C8-A1HM-01A-12D-A135-09,,eb908a6f-d6f2-40ef-90da-97438cd2281e,,TCGA-C8-A1HM-01A-12D-A134-01,TCGA-C8-A1HM-01,TCGA-C8-A1HM-01A-12R-A137-07,eb908a6f-d6f2-40ef-90da-97438cd2281e,TCGA-C8-A1HM-01A-12D-A134-01,TCGA-C8-A1HM-01
tcga.c8.a1hn,Stage II,56.0,,Stage IIA,2.0,,Positive,FEMALE,Equivocal,,,,Negative,M0,Negative,N0,2.0,0.0,LumB,Luminal B,Positive,,-10.0,-5.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A1HN-01,394.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation c1uster 9,TCGA-C8-A1HN,394.0,0.0,days,394.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left,Axillary lymph node dissection alone,,TCGA-C8-A1HN-F71885,TCGA-C8-A1HN,TCGA-C8-A1HN-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-20712.0,88.0,,0.0,394.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-31,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Equivocal,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf,A1HN,TUMOR FREE,,,,Allred Score 3,Allred Score 8,YES,NO,,,NO,Primary Tumor,1,,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,4795628e-50d8-41e0-b3c6-00fe4600dc5d,4795628e-50d8-41e0-b3c6-00fe4600dc5d,TCGA-C8-A1HN-01A-21-A17J-20,TCGA-C8-A1HN-01A-11D-A135-09,TCGA-C8-A1HN-01,TCGA-C8-A1HN-01A-11D-A138-05,4090fc73-565b-4fa8-96c9-958fcb8eda09,TCGA-C8-A1HN-01,TCGA-C8-A1HN-01A-11D-A135-09,,TCGA-C8-A1HN-01,TCGA-C8-A1HN-01,TCGA-C8-A1HN-01A-11D-A135-09,,4795628e-50d8-41e0-b3c6-00fe4600dc5d,,TCGA-C8-A1HN-01A-11D-A134-01,TCGA-C8-A1HN-01,TCGA-C8-A1HN-01A-11R-A137-07,4795628e-50d8-41e0-b3c6-00fe4600dc5d,TCGA-C8-A1HN-01A-11D-A134-01,TCGA-C8-A1HN-01
tcga.c8.a1ho,Stage III,34.0,5.0,Stage IIIC,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-C8-A1HO-01,375.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-C8-A1HO,375.0,0.0,days,375.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,34.0,Left Upper Inner Quadrant,,,TCGA-C8-A1HO-F70802,TCGA-C8-A1HO,TCGA-C8-A1HO-01A,,Positive,,,,,Positive,[Discrepancy],,,,,-12715.0,52.0,,0.0,375.0,,,,,,,,,,2015-3-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,380.0,NO,Negative,,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,,,True,No,M0,N3,T3,Stage IIIC,TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf,A1HO,TUMOR FREE,,,,Allred Score 5,Allred Score 7,YES,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,1d8ecbae-6996-4d9d-bff8-ac761a8309ea,1d8ecbae-6996-4d9d-bff8-ac761a8309ea,TCGA-C8-A1HO-01A-21-A17J-20,TCGA-C8-A1HO-01A-11D-A13L-09,TCGA-C8-A1HO-01,TCGA-C8-A1HO-01A-11D-A13K-05,654028c2-038a-4cfb-95c6-13ad5000346d,TCGA-C8-A1HO-01,TCGA-C8-A1HO-01A-11D-A13L-09,,,TCGA-C8-A1HO-01,TCGA-C8-A1HO-01A-11D-A13L-09,,1d8ecbae-6996-4d9d-bff8-ac761a8309ea,,TCGA-C8-A1HO-01A-11D-A13J-01,TCGA-C8-A1HO-01,,1d8ecbae-6996-4d9d-bff8-ac761a8309ea,TCGA-C8-A1HO-01A-11D-A13J-01,
tcga.c8.a26v,Stage III,47.0,1.0,Stage IIIA,9.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,9.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-C8-A26V-01,616.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,,mutation cluster 8,TCGA-C8-A26V,616.0,0.0,days,616.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right,,,TCGA-C8-A26V-F70799,TCGA-C8-A26V,TCGA-C8-A26V-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-17468.0,143.0,,0.0,616.0,,,,,,,,,,2015-3-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Modified Radical Masectomy,"Other method, specify:",310.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,,,True,No,M0,N2,T3,Stage IIIA,TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf,A26V,TUMOR FREE,,,,Allred Score 8,Allred Score 8,YES,NO,,,YES,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,67a58c72-fa64-4c63-b568-bec834626edf,67a58c72-fa64-4c63-b568-bec834626edf,TCGA-C8-A26V-01A-21-A17K-20,TCGA-C8-A26V-01A-11D-A16D-09,TCGA-C8-A26V-01,TCGA-C8-A26V-01A-11D-A16G-05,a8d7929f-263f-4277-be5e-f01eadc08bc3,TCGA-C8-A26V-01,TCGA-C8-A26V-01A-11D-A16D-09,,,TCGA-C8-A26V-01,TCGA-C8-A26V-01A-11D-A16D-09,,67a58c72-fa64-4c63-b568-bec834626edf,,TCGA-C8-A26V-01A-11D-A16C-01,TCGA-C8-A26V-01,,67a58c72-fa64-4c63-b568-bec834626edf,TCGA-C8-A26V-01A-11D-A16C-01,
tcga.c8.a26w,Stage II,58.0,1.0,Stage IIB,7.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,7.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A26W-01,381.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,,mutation cluster 8,TCGA-C8-A26W,381.0,0.0,days,381.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Upper Outer Quadrant,,,TCGA-C8-A26W-F70796,TCGA-C8-A26W,TCGA-C8-A26W-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-21391.0,142.0,,0.0,381.0,,,,,,,,,,2015-3-9,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,300.0,NO,Equivocal,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf,A26W,TUMOR FREE,,,,Allred Score 8,Allred Score 8,YES,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,bd304a35-2d0c-4b11-bd62-3db480c1e730,bd304a35-2d0c-4b11-bd62-3db480c1e730,TCGA-C8-A26W-01A-21-A17K-20,TCGA-C8-A26W-01A-11D-A16D-09,TCGA-C8-A26W-01,TCGA-C8-A26W-01A-11D-A16G-05,4c5440c5-3eb7-4bfc-a5e7-51e1a55aa219,TCGA-C8-A26W-01,TCGA-C8-A26W-01A-11D-A16D-09,,,TCGA-C8-A26W-01,TCGA-C8-A26W-01A-11D-A16D-09,,bd304a35-2d0c-4b11-bd62-3db480c1e730,,TCGA-C8-A26W-01A-11D-A16C-01,TCGA-C8-A26W-01,,bd304a35-2d0c-4b11-bd62-3db480c1e730,TCGA-C8-A26W-01A-11D-A16C-01,
tcga.c8.a26x,Stage II,58.0,4.0,Stage IIA,11.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,11.0,0.0,Her2,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-C8-A26X-01,376.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,,mutation cluster 3,TCGA-C8-A26X,376.0,0.0,days,376.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,,,TCGA-C8-A26X-F70792,TCGA-C8-A26X,TCGA-C8-A26X-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-21463.0,136.0,,0.0,376.0,,,,,,,,,,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,190.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,,,True,No,M0,N1,T1,Stage IIA,TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf,A26X,TUMOR FREE,,,,,,YES,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,5213da80-35ac-4172-b2e8-de686e73a498,5213da80-35ac-4172-b2e8-de686e73a498,TCGA-C8-A26X-01A-41-A17K-20,TCGA-C8-A26X-01A-31D-A16D-09,TCGA-C8-A26X-01,TCGA-C8-A26X-01A-31D-A16G-05,6a344715-e7bd-49b5-9ca7-0e1060a19710,TCGA-C8-A26X-01,TCGA-C8-A26X-01A-31D-A16D-09,,,TCGA-C8-A26X-01,TCGA-C8-A26X-01A-31D-A16D-09,,5213da80-35ac-4172-b2e8-de686e73a498,,TCGA-C8-A26X-01A-31D-A16C-01,TCGA-C8-A26X-01,,5213da80-35ac-4172-b2e8-de686e73a498,TCGA-C8-A26X-01A-31D-A16C-01,
tcga.c8.a26y,Stage II,90.0,2.0,Stage IIA,13.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,13.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A26Y-01,394.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-C8-A26Y,394.0,0.0,days,394.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Left Upper Outer Quadrant,,,TCGA-C8-A26Y-F70791,TCGA-C8-A26Y,TCGA-C8-A26Y-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-32872.0,134.0,,0.0,394.0,,,,,,,,,,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,140.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf,A26Y,TUMOR FREE,,,,,,NO,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,afad9647-befe-4493-8386-475d0097c716,afad9647-befe-4493-8386-475d0097c716,TCGA-C8-A26Y-01A-21-A17K-20,,TCGA-C8-A26Y-01,TCGA-C8-A26Y-01A-11D-A16G-05,4cf610ef-12f6-4149-ab0b-d0211e9642a6,TCGA-C8-A26Y-01,TCGA-C8-A26Y-01A-11D-A16D-09,,,TCGA-C8-A26Y-01,,,afad9647-befe-4493-8386-475d0097c716,,TCGA-C8-A26Y-01A-11D-A16C-01,TCGA-C8-A26Y-01,,afad9647-befe-4493-8386-475d0097c716,TCGA-C8-A26Y-01A-11D-A16C-01,
tcga.c8.a26z,Stage IIA,59.0,3.0,Stage IIA,4.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,4.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A26Z-01,470.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation c1uster 9,TCGA-C8-A26Z,470.0,0.0,days,470.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right Upper Inner Quadrant,,,TCGA-C8-A26Z-F70835,TCGA-C8-A26Z,TCGA-C8-A26Z-01A,,Positive,,,,,Positive,Other,,,,,,125.0,,0.0,470.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",470.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf,A26Z,TUMOR FREE,,,,Allred Score 4,Allred Score 8,YES,NO,,,NO,Primary Tumor,1,Pateys Surgery,6th,NO,YES,NO,C8,Breast,A,LIVING,2010.0,8213eb8c-db23-4f92-b3d3-07b45eeec76a,8213eb8c-db23-4f92-b3d3-07b45eeec76a,TCGA-C8-A26Z-01A-21-A17K-20,TCGA-C8-A26Z-01A-11D-A16D-09,TCGA-C8-A26Z-01,TCGA-C8-A26Z-01A-11D-A16G-05,fb0eeacf-e38d-42f7-85b5-215ceed54e69,TCGA-C8-A26Z-01,TCGA-C8-A26Z-01A-11D-A16D-09,,,TCGA-C8-A26Z-01,TCGA-C8-A26Z-01A-11D-A16D-09,,8213eb8c-db23-4f92-b3d3-07b45eeec76a,,TCGA-C8-A26Z-01A-11D-A16C-01,TCGA-C8-A26Z-01,,8213eb8c-db23-4f92-b3d3-07b45eeec76a,TCGA-C8-A26Z-01A-11D-A16C-01,
tcga.c8.a273,Stage IIB,29.0,3.0,Stage IIB,6.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,6.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A273-01,513.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation c1uster 9,TCGA-C8-A273,513.0,0.0,days,513.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,29.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-C8-A273-F70833,TCGA-C8-A273,TCGA-C8-A273-01A,,Positive,,,,,Positive,Other,,,,,,168.0,,0.0,513.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",590.0,NO,Negative,,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf,A273,TUMOR FREE,,,,Allred Score 5,Allred Score 8,YES,YES,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa,c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa,TCGA-C8-A273-01A-21-A17K-20,TCGA-C8-A273-01A-11D-A16D-09,TCGA-C8-A273-01,TCGA-C8-A273-01A-11D-A16G-05,67662a35-222b-4c66-a105-86e9332fc019,TCGA-C8-A273-01,TCGA-C8-A273-01A-11D-A16D-09,,,TCGA-C8-A273-01,TCGA-C8-A273-01A-11D-A16D-09,,c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa,,TCGA-C8-A273-01A-11D-A16C-01,TCGA-C8-A273-01,,c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa,TCGA-C8-A273-01A-11D-A16C-01,
tcga.c8.a274,Stage IIA,63.0,2.0,Stage IIA,1.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,1.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A274-01,508.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 1,TCGA-C8-A274,508.0,0.0,days,508.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,,,TCGA-C8-A274-F70831,TCGA-C8-A274,TCGA-C8-A274-01A,,Positive,,,,,Positive,Other,,,,,-23337.0,163.0,,0.0,508.0,,,,,,,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",470.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf,A274,TUMOR FREE,,,,Allred Score 7,Allred Score 8,YES,NO,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,f9521be2-aaaf-414c-a906-3ba53a060614,f9521be2-aaaf-414c-a906-3ba53a060614,TCGA-C8-A274-01A-21-A17K-20,TCGA-C8-A274-01A-11D-A16D-09,TCGA-C8-A274-01,TCGA-C8-A274-01A-11D-A16G-05,99762a09-75aa-4d91-8911-2f259e4f4f40,TCGA-C8-A274-01,TCGA-C8-A274-01A-11D-A16D-09,,,TCGA-C8-A274-01,TCGA-C8-A274-01A-11D-A16D-09,,f9521be2-aaaf-414c-a906-3ba53a060614,,TCGA-C8-A274-01A-11D-A16C-01,TCGA-C8-A274-01,,f9521be2-aaaf-414c-a906-3ba53a060614,TCGA-C8-A274-01A-11D-A16C-01,
tcga.c8.a275,Stage IIA,56.0,3.0,Stage IIA,1.0,,,FEMALE,Positive,,,,Negative,M0,Positive,N1,1.0,0.0,Her2,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-C8-A275-01,1.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 5,TCGA-C8-A275,,,days,1.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Upper Outer Quadrant,,,,TCGA-C8-A275,TCGA-C8-A275-01A,,,,,,,,Other,,,,,-20774.0,169.0,,0.0,1.0,,,,,,,,,,2011-7-21,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,300.0,NO,,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,,,,True,No,M0,N1,T1,Stage IIA,TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf,A275,TUMOR FREE,,,,,,,NO,,,,Primary Tumor,1,Pateys Surgery,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,59c6ed76-762c-4caa-98c1-0886b6d9651c,59c6ed76-762c-4caa-98c1-0886b6d9651c,TCGA-C8-A275-01A-11-A17K-20,TCGA-C8-A275-01A-21D-A16D-09,TCGA-C8-A275-01,TCGA-C8-A275-01A-21D-A16G-05,46fbe024-54ed-49b2-9492-98b4f59c8f51,TCGA-C8-A275-01,TCGA-C8-A275-01A-21D-A16D-09,,,TCGA-C8-A275-01,TCGA-C8-A275-01A-21D-A16D-09,,59c6ed76-762c-4caa-98c1-0886b6d9651c,,TCGA-C8-A275-01A-21D-A16C-01,TCGA-C8-A275-01,,59c6ed76-762c-4caa-98c1-0886b6d9651c,TCGA-C8-A275-01A-21D-A16C-01,
tcga.c8.a278,Stage IIIA,61.0,4.0,Stage IIIA,1.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N2,1.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A278-01,297.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,,mutation cluster 3,TCGA-C8-A278,297.0,0.0,days,297.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left,,,TCGA-C8-A278-F20278,TCGA-C8-A278,TCGA-C8-A278-01A,,Negative,,,,,Negative,Other,,,,,-22598.0,163.0,,0.0,297.0,,,,,,,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Pateys Surgery,"Other method, specify:",630.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf,A278,TUMOR FREE,,,,,,,NO,,,NO,Primary Tumor,1,Pateys Surgery,6th,YES,YES,NO,C8,Breast,A,LIVING,2010.0,8cdae811-9f3f-4c8b-9fe5-e542d30d40f2,8cdae811-9f3f-4c8b-9fe5-e542d30d40f2,TCGA-C8-A278-01A-21-A17K-20,TCGA-C8-A278-01A-11D-A167-09,TCGA-C8-A278-01,TCGA-C8-A278-01A-11D-A16A-05,0b7b4dce-2a48-489f-aa4d-68af0d749a17,TCGA-C8-A278-01,TCGA-C8-A278-01A-11D-A167-09,,,TCGA-C8-A278-01,TCGA-C8-A278-01A-11D-A167-09,,8cdae811-9f3f-4c8b-9fe5-e542d30d40f2,,TCGA-C8-A278-01A-11D-A166-01,TCGA-C8-A278-01,,8cdae811-9f3f-4c8b-9fe5-e542d30d40f2,TCGA-C8-A278-01A-11D-A166-01,
tcga.c8.a27a,Stage IIB,48.0,4.0,Stage IIB,371.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,371.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-C8-A27A-01,747.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-C8-A27A,747.0,0.0,days,747.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right Upper Outer Quadrant,,,TCGA-C8-A27A-F70786,TCGA-C8-A27A,TCGA-C8-A27A-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-17779.0,435.0,,0.0,747.0,,,,,,,,,,2015-3-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,230.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf,A27A,TUMOR FREE,,,,,Allred Score 7,YES,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2010.0,520a6569-bf3a-495f-9460-7f65e4f59687,520a6569-bf3a-495f-9460-7f65e4f59687,TCGA-C8-A27A-01A-21-A17K-20,TCGA-C8-A27A-01A-11D-A167-09,TCGA-C8-A27A-01,TCGA-C8-A27A-01A-11D-A16A-05,6e6b5e9d-fbb0-480b-9300-d9ecdbbde2b7,TCGA-C8-A27A-01,TCGA-C8-A27A-01A-11D-A167-09,,,TCGA-C8-A27A-01,TCGA-C8-A27A-01A-11D-A167-09,,520a6569-bf3a-495f-9460-7f65e4f59687,,TCGA-C8-A27A-01A-11D-A166-01,TCGA-C8-A27A-01,,520a6569-bf3a-495f-9460-7f65e4f59687,TCGA-C8-A27A-01A-11D-A166-01,
tcga.c8.a27b,Stage IIB,48.0,1.0,Stage IIB,30.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,30.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-C8-A27B-01,439.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,miRNA cluster 4,cluster 5,mutation cluster 13,TCGA-C8-A27B,439.0,0.0,days,439.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left,,,TCGA-C8-A27B-F70781,TCGA-C8-A27B,TCGA-C8-A27B-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-17763.0,93.0,,0.0,439.0,,,,,,,,,,2015-3-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,240.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,,,True,No,M0,N0,T3,Stage IIB,TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf,A27B,TUMOR FREE,,,,,,YES,NO,,,NO,Primary Tumor,1,,6th,,YES,NO,C8,Breast,A,LIVING,2011.0,fb03a31f-6611-4343-816d-37a332147eac,fb03a31f-6611-4343-816d-37a332147eac,TCGA-C8-A27B-01A-21-A17K-20,TCGA-C8-A27B-01A-11D-A167-09,TCGA-C8-A27B-01,TCGA-C8-A27B-01A-11D-A16A-05,14732205-f21b-44fc-9e31-7d8f9dde67df,TCGA-C8-A27B-01,TCGA-C8-A27B-01A-11D-A167-09,,,TCGA-C8-A27B-01,TCGA-C8-A27B-01A-11D-A167-09,,fb03a31f-6611-4343-816d-37a332147eac,,TCGA-C8-A27B-01A-11D-A166-01,TCGA-C8-A27B-01,,fb03a31f-6611-4343-816d-37a332147eac,TCGA-C8-A27B-01A-11D-A166-01,
tcga.c8.a3m7,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,1.0,TCGA-C8-A3M7-01,1034.0,1.0,days,Iq,C3-BRCA/Luminal,,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-C8-A3M7,1034.0,1.0,days,1034.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,60.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-C8-A3M7-F70838,TCGA-C8-A3M7,,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-22096.0,,1034.0,0.0,1.0,,,1034,,NO,,,,,2015-3-9,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,,,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,Locoregional Recurrence,,NO,YES,0.0,,,No,M0,N0,T4b,Stage IIIB,,A3M7,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,C8,Breast,,DECEASED,2010.0,b55b6630-7cf5-4bca-b76f-e135271018e4,b55b6630-7cf5-4bca-b76f-e135271018e4,TCGA-C8-A3M7-01A-21-A24A-20,,TCGA-C8-A3M7-01,TCGA-C8-A3M7-01A-12D-A21R-05,c07c21cd-c286-4fd3-b98a-886e161a6ead,TCGA-C8-A3M7-01,TCGA-C8-A3M7-01A-12D-A21Q-09,,,TCGA-C8-A3M7-01,,,b55b6630-7cf5-4bca-b76f-e135271018e4,,TCGA-C8-A3M7-01A-12D-A21P-01,TCGA-C8-A3M7-01,,b55b6630-7cf5-4bca-b76f-e135271018e4,TCGA-C8-A3M7-01A-12D-A21P-01,
tcga.c8.a3m8,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,0.0,TCGA-C8-A3M8-01,394.0,0.0,days,High,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-C8-A3M8,394.0,0.0,days,394.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-C8-A3M8-F70779,TCGA-C8-A3M8,TCGA-C8-A3M8-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-24877.0,264.0,,0.0,394.0,,,,,NO,,,,,2015-3-9,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,280.0,NO,Positive,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,M0,N0,T1c,Stage IA,TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf,A3M8,TUMOR FREE,,Dako,,Allred,Allred,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,C8,Breast,A,LIVING,2011.0,a04ad65d-6d83-4e84-8bd8-3cab2a195642,a04ad65d-6d83-4e84-8bd8-3cab2a195642,TCGA-C8-A3M8-01A-21-A24A-20,,TCGA-C8-A3M8-01,TCGA-C8-A3M8-01A-11D-A212-05,45db31fd-5919-4580-8641-31aec5565486,TCGA-C8-A3M8-01,TCGA-C8-A3M8-01A-11D-A20S-09,,,TCGA-C8-A3M8-01,,,a04ad65d-6d83-4e84-8bd8-3cab2a195642,,TCGA-C8-A3M8-01A-11D-A20R-01,TCGA-C8-A3M8-01,,a04ad65d-6d83-4e84-8bd8-3cab2a195642,TCGA-C8-A3M8-01A-11D-A20R-01,
tcga.c8.a8hp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-C8-A8HP-01,396.0,0.0,days,,,,,,,,,,TCGA-C8-A8HP,396.0,0.0,days,396.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-C8-A8HP-F69610,TCGA-C8-A8HP,TCGA-C8-A8HP-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-21613.0,231.0,,0.0,396.0,,,,,,,,,,2015-1-15,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Core needle biopsy,240.0,NO,Positive,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf,A8HP,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,C8,Breast,A,LIVING,2013.0,02cf1db9-55c0-4ece-b230-966b30cd0b94,02cf1db9-55c0-4ece-b230-966b30cd0b94,,,TCGA-C8-A8HP-01,TCGA-C8-A8HP-01A-11D-A36K-05,0D8764CE-08F0-4612-886E-07065119924F,TCGA-C8-A8HP-01,,,,TCGA-C8-A8HP-01,,,02cf1db9-55c0-4ece-b230-966b30cd0b94,,TCGA-C8-A8HP-01A-11D-A36I-01,TCGA-C8-A8HP-01,,02cf1db9-55c0-4ece-b230-966b30cd0b94,TCGA-C8-A8HP-01A-11D-A36I-01,
tcga.c8.a8hq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-C8-A8HQ-01,380.0,0.0,days,,,,,,,,,,TCGA-C8-A8HQ,380.0,0.0,days,380.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left,Axillary lymph node dissection alone,,TCGA-C8-A8HQ-F69879,TCGA-C8-A8HQ,TCGA-C8-A8HQ-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-19432.0,185.0,,0.0,380.0,,,,,,,,,,2015-1-22,FEMALE,,,,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Negative,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,4.0,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf,A8HQ,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,C8,Breast,A,LIVING,2013.0,7f8c9d62-0803-44d6-9375-b4e71612a0b1,7f8c9d62-0803-44d6-9375-b4e71612a0b1,,,TCGA-C8-A8HQ-01,TCGA-C8-A8HQ-01A-11D-A36K-05,39E9AC4D-F0C1-4629-9C69-09C72747A2E8,TCGA-C8-A8HQ-01,,,,TCGA-C8-A8HQ-01,,,7f8c9d62-0803-44d6-9375-b4e71612a0b1,,TCGA-C8-A8HQ-01A-11D-A36I-01,TCGA-C8-A8HQ-01,,7f8c9d62-0803-44d6-9375-b4e71612a0b1,TCGA-C8-A8HQ-01A-11D-A36I-01,
tcga.c8.a8hr,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-C8-A8HR-01,408.0,0.0,days,,,,,,,,,,TCGA-C8-A8HR,408.0,0.0,days,408.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right,Axillary lymph node dissection alone,,TCGA-C8-A8HR-F69796,TCGA-C8-A8HR,TCGA-C8-A8HR-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-17921.0,162.0,,0.0,408.0,,,,,,,,,,2015-1-20,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,420.0,NO,,,NO,8.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf,A8HR,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,C8,Breast,A,LIVING,2013.0,d817dcee-1322-4949-a6e9-138447e6fc56,d817dcee-1322-4949-a6e9-138447e6fc56,,,TCGA-C8-A8HR-01,TCGA-C8-A8HR-01A-11D-A36K-05,D888CD95-8F1F-48DE-8DDC-70C9AD64579F,TCGA-C8-A8HR-01,,,,TCGA-C8-A8HR-01,,,d817dcee-1322-4949-a6e9-138447e6fc56,,TCGA-C8-A8HR-01A-11D-A36I-01,TCGA-C8-A8HR-01,,d817dcee-1322-4949-a6e9-138447e6fc56,TCGA-C8-A8HR-01A-11D-A36I-01,
tcga.d8.a1j8,Stage IIB,77.0,2.0,Stage IIB,256.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,256.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1J8-01,431.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,,TCGA-D8-A1J8,431.0,0.0,days,431.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1J8-F14040,TCGA-D8-A1J8,,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-28444.0,,,0.0,431.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A1J8,TUMOR FREE,,,,,,,,70-79%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef,ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef,TCGA-D8-A1J8-01A-21-A17J-20,,TCGA-D8-A1J8-01,TCGA-D8-A1J8-01A-11D-A13K-05,f1a4f40a-6d0d-49a8-ab70-d275856a8996,TCGA-D8-A1J8-01,TCGA-D8-A1J8-01A-11D-A13L-09,,,TCGA-D8-A1J8-01,,,ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef,,TCGA-D8-A1J8-01A-11D-A13J-01,TCGA-D8-A1J8-01,,ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef,TCGA-D8-A1J8-01A-11D-A13J-01,
tcga.d8.a1j9,Stage IA,48.0,2.0,Stage I,248.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,248.0,0.0,LumB,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1J9-01,532.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation cluster 8,TCGA-D8-A1J9,532.0,0.0,days,532.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1J9-F20944,TCGA-D8-A1J9,TCGA-D8-A1J9-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-17879.0,211.0,,0.0,532.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,Hecep Test TM DAKO,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,230.0,NO,Positive,,,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,1.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf,A1J9,TUMOR FREE,manual counting,,,0%,10-75%,,,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,ff7159e7-e9f2-4cc8-ab89-f4167d19672c,ff7159e7-e9f2-4cc8-ab89-f4167d19672c,TCGA-D8-A1J9-01A-21-A17J-20,TCGA-D8-A1J9-01A-11D-A13L-09,TCGA-D8-A1J9-01,TCGA-D8-A1J9-01A-11D-A13K-05,07d51184-85a3-4ba7-9cc2-badcb3ccfa23,TCGA-D8-A1J9-01,TCGA-D8-A1J9-01A-11D-A13L-09,,,TCGA-D8-A1J9-01,TCGA-D8-A1J9-01A-11D-A13L-09,,ff7159e7-e9f2-4cc8-ab89-f4167d19672c,,TCGA-D8-A1J9-01A-11D-A13J-01,TCGA-D8-A1J9-01,,ff7159e7-e9f2-4cc8-ab89-f4167d19672c,TCGA-D8-A1J9-01A-11D-A13J-01,
tcga.d8.a1ja,Stage X,60.0,1.0,Stage IIIB,18.0,,Negative,FEMALE,Positive,,,,Negative,M0,Negative,N0,18.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T4,LIVING,0.0,TCGA-D8-A1JA-01,502.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,,TCGA-D8-A1JA,431.0,1.0,days,502.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,YES,NO,,60.0,Left Upper Outer Quadrant,No axillary staging,,TCGA-D8-A1JA-F20941,TCGA-D8-A1JA,TCGA-D8-A1JA-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-21918.0,194.0,,0.0,502.0,,,431,,,manual counting,<10%,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,Hecep Test TM DAKO,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",310.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,Locoregional Disease,,,YES,,,False,No,M0,NX,T4b,,TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf,A1JA,WITH TUMOR,manual counting,,,0%,,,NO,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,ae81378c-ada3-43cb-9855-941467fd856c,ae81378c-ada3-43cb-9855-941467fd856c,TCGA-D8-A1JA-01A-21-A17J-20,,TCGA-D8-A1JA-01,TCGA-D8-A1JA-01A-11D-A13K-05,62f05450-0574-4a36-aaae-6a2d2078950e,TCGA-D8-A1JA-01,TCGA-D8-A1JA-01A-11D-A13L-09,,,TCGA-D8-A1JA-01,,,ae81378c-ada3-43cb-9855-941467fd856c,,TCGA-D8-A1JA-01A-11D-A13J-01,TCGA-D8-A1JA-01,,ae81378c-ada3-43cb-9855-941467fd856c,TCGA-D8-A1JA-01A-11D-A13J-01,
tcga.d8.a1jb,Stage IIB,54.0,3.0,Stage IIB,0.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JB-01,1688.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-D8-A1JB,1688.0,0.0,days,1688.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JB-F72209,TCGA-D8-A1JB,TCGA-D8-A1JB-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-19822.0,232.0,,0.0,1688.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,,Hecep Test TM DAKO,,Path Vysion HER2 D Probe Kit,2+,,not amplified,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,350.0,NO,Equivocal,Positive,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf,A1JB,TUMOR FREE,manual counting,,,10-75%,>75%,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,45fe02d2-5d68-43c4-9cea-7da6e16a55a2,45fe02d2-5d68-43c4-9cea-7da6e16a55a2,TCGA-D8-A1JB-01A-21-A17J-20,TCGA-D8-A1JB-01A-11D-A13L-09,TCGA-D8-A1JB-01,TCGA-D8-A1JB-01A-11D-A13K-05,6c49abf3-08bb-47a4-be2c-6957bf1de2eb,TCGA-D8-A1JB-01,TCGA-D8-A1JB-01A-11D-A13L-09,,,TCGA-D8-A1JB-01,TCGA-D8-A1JB-01A-11D-A13L-09,,45fe02d2-5d68-43c4-9cea-7da6e16a55a2,,TCGA-D8-A1JB-01A-11D-A13J-01,TCGA-D8-A1JB-01,,45fe02d2-5d68-43c4-9cea-7da6e16a55a2,TCGA-D8-A1JB-01A-11D-A13J-01,
tcga.d8.a1jc,Stage IIIA,59.0,5.0,Stage IIIA,178.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,178.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JC-01,480.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-D8-A1JC,480.0,0.0,days,480.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JC-F20847,TCGA-D8-A1JC,TCGA-D8-A1JC-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-21898.0,201.0,,0.0,480.0,,,,,,,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",180.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,4.0,,False,No,M0,N2a,T2,Stage IIIA,TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf,A1JC,TUMOR FREE,,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,d69c60ae-d21b-4e6e-89c5-ef0750a31c71,d69c60ae-d21b-4e6e-89c5-ef0750a31c71,TCGA-D8-A1JC-01A-21-A17J-20,TCGA-D8-A1JC-01A-11D-A13L-09,TCGA-D8-A1JC-01,TCGA-D8-A1JC-01A-11D-A13K-05,57323434-3660-45b6-90fd-6183e75a5b54,TCGA-D8-A1JC-01,TCGA-D8-A1JC-01A-11D-A13L-09,,,TCGA-D8-A1JC-01,TCGA-D8-A1JC-01A-11D-A13L-09,,d69c60ae-d21b-4e6e-89c5-ef0750a31c71,,TCGA-D8-A1JC-01A-11D-A13J-01,TCGA-D8-A1JC-01,,d69c60ae-d21b-4e6e-89c5-ef0750a31c71,TCGA-D8-A1JC-01A-11D-A13J-01,
tcga.d8.a1jd,Stage IIB,41.0,5.0,Stage IIB,273.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,273.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JD-01,552.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1JD,552.0,0.0,days,552.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JD-F20844,TCGA-D8-A1JD,TCGA-D8-A1JD-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-15166.0,230.0,,0.0,552.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,Hecep Test TM DAKO,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,400.0,NO,Negative,,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,3.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf,A1JD,TUMOR FREE,manual counting,,,10-75%,>75%,,,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,f2ee7101-b51e-4f75-95fa-555b5b79af74,f2ee7101-b51e-4f75-95fa-555b5b79af74,TCGA-D8-A1JD-01A-21-A17J-20,TCGA-D8-A1JD-01A-11D-A13L-09,TCGA-D8-A1JD-01,TCGA-D8-A1JD-01A-11D-A13K-05,7788922c-5c28-46e3-9ee9-6fb8aab752d4,TCGA-D8-A1JD-01,TCGA-D8-A1JD-01A-11D-A13L-09,,,TCGA-D8-A1JD-01,TCGA-D8-A1JD-01A-11D-A13L-09,,f2ee7101-b51e-4f75-95fa-555b5b79af74,,TCGA-D8-A1JD-01A-11D-A13J-01,TCGA-D8-A1JD-01,,f2ee7101-b51e-4f75-95fa-555b5b79af74,TCGA-D8-A1JD-01A-11D-A13J-01,
tcga.d8.a1je,Stage IIA,62.0,2.0,Stage IIA,57.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,57.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1JE-01,575.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1JE,575.0,0.0,days,575.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JE-F20759,TCGA-D8-A1JE,,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-22683.0,,,0.0,575.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-8,FEMALE,,Hecep Test TM DAKO,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,3.0,,,No,M0,N1a,T1c,Stage IIA,,A1JE,TUMOR FREE,manual counting,,,10-75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,c7139402-146f-4c49-bcd0-f2a6a378911e,c7139402-146f-4c49-bcd0-f2a6a378911e,TCGA-D8-A1JE-01A-21-A17J-20,TCGA-D8-A1JE-01A-11D-A13L-09,TCGA-D8-A1JE-01,TCGA-D8-A1JE-01A-11D-A13K-05,ad15f06b-4988-4132-9b8c-1c04e14fa98e,TCGA-D8-A1JE-01,TCGA-D8-A1JE-01A-11D-A13L-09,,,TCGA-D8-A1JE-01,TCGA-D8-A1JE-01A-11D-A13L-09,,c7139402-146f-4c49-bcd0-f2a6a378911e,,TCGA-D8-A1JE-01A-11D-A13J-01,TCGA-D8-A1JE-01,,c7139402-146f-4c49-bcd0-f2a6a378911e,TCGA-D8-A1JE-01A-11D-A13J-01,
tcga.d8.a1jf,Stage IIIA,79.0,3.0,Stage IIIA,96.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N2,96.0,0.0,Her2,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1JF-01,366.0,0.0,days,COAD-READ,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 8,TCGA-D8-A1JF,366.0,0.0,days,366.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JF-F14058,TCGA-D8-A1JF,,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-29199.0,,,0.0,366.0,,,,,,,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",,,Negative,,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,3.0,,,,,,,,NO,8.0,,,No,M0,N2a,T1c,Stage IIIA,,A1JF,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,a74b20ca-06f9-47ec-8888-cb01e0ba3257,a74b20ca-06f9-47ec-8888-cb01e0ba3257,TCGA-D8-A1JF-01A-21-A17J-20,TCGA-D8-A1JF-01A-11D-A13L-09,TCGA-D8-A1JF-01,TCGA-D8-A1JF-01A-11D-A13K-05,c9bf8bae-3cf7-4b3f-8fb4-51e9bd4e83a8,TCGA-D8-A1JF-01,TCGA-D8-A1JF-01A-11D-A13L-09,,,TCGA-D8-A1JF-01,TCGA-D8-A1JF-01A-11D-A13L-09,,a74b20ca-06f9-47ec-8888-cb01e0ba3257,,TCGA-D8-A1JF-01A-11D-A13J-01,TCGA-D8-A1JF-01,,a74b20ca-06f9-47ec-8888-cb01e0ba3257,TCGA-D8-A1JF-01A-11D-A13J-01,
tcga.d8.a1jg,Stage IIA,62.0,1.0,Stage IIA,187.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,187.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JG-01,1612.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-D8-A1JG,1612.0,0.0,days,1612.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1JG-F72208,TCGA-D8-A1JG,,,Negative,,,,,Negative,Lumpectomy,,NO,,,-22878.0,,,0.0,1612.0,,,,,,,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,,,,,2+,,not amplified,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",,,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1JG,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,ee8b563d-11bb-4d84-ac53-e2acc8d0275d,ee8b563d-11bb-4d84-ac53-e2acc8d0275d,TCGA-D8-A1JG-01B-21-A17J-20,TCGA-D8-A1JG-01B-11D-A13L-09,TCGA-D8-A1JG-01,TCGA-D8-A1JG-01B-11D-A13K-05,dc251841-a624-484b-b4ce-b149651d3b57,TCGA-D8-A1JG-01,TCGA-D8-A1JG-01B-11D-A13L-09,,,TCGA-D8-A1JG-01,TCGA-D8-A1JG-01B-11D-A13L-09,,ee8b563d-11bb-4d84-ac53-e2acc8d0275d,,TCGA-D8-A1JG-01B-11D-A13J-01,TCGA-D8-A1JG-01,,ee8b563d-11bb-4d84-ac53-e2acc8d0275d,TCGA-D8-A1JG-01B-11D-A13J-01,
tcga.d8.a1jh,Stage IA,56.0,1.0,Stage I,426.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,426.0,0.0,LumA,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-D8-A1JH-01,426.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation cluster 4,TCGA-D8-A1JH,426.0,0.0,days,426.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JH-F14055,TCGA-D8-A1JH,TCGA-D8-A1JH-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-20497.0,263.0,,0.0,426.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,Hecep Test TM DAKO,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,140.0,NO,Negative,,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf,A1JH,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8,00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8,TCGA-D8-A1JH-01A-21-A17J-20,TCGA-D8-A1JH-01A-11D-A188-09,TCGA-D8-A1JH-01,TCGA-D8-A1JH-01A-11D-A13K-05,16c99b80-d0de-4a1e-b8f8-d119431fc8db,TCGA-D8-A1JH-01,TCGA-D8-A1JH-01A-11D-A188-09,,,TCGA-D8-A1JH-01,TCGA-D8-A1JH-01A-11D-A188-09,,00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8,,TCGA-D8-A1JH-01A-11D-A13J-01,TCGA-D8-A1JH-01,,00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8,TCGA-D8-A1JH-01A-11D-A13J-01,
tcga.d8.a1ji,Stage IIA,54.0,2.0,Stage IIA,21.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,21.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1JI-01,577.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-D8-A1JI,577.0,0.0,days,577.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JI-F20757,TCGA-D8-A1JI,TCGA-D8-A1JI-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20072.0,226.0,,0.0,577.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,DAKOHercepTest TM,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,190.0,NO,Negative,,,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,1.0,,,,,,,,NO,2.0,,False,No,MX,N1a,T1c,Stage IIA,TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf,A1JI,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,27706c21-96cb-48e9-88ec-1c52769bfe45,27706c21-96cb-48e9-88ec-1c52769bfe45,TCGA-D8-A1JI-01A-21-A17J-20,TCGA-D8-A1JI-01A-11D-A13L-09,TCGA-D8-A1JI-01,TCGA-D8-A1JI-01A-11D-A13K-05,621f10de-1603-49a6-ab27-8cfc9c4fd621,TCGA-D8-A1JI-01,TCGA-D8-A1JI-01A-11D-A13L-09,,,TCGA-D8-A1JI-01,TCGA-D8-A1JI-01A-11D-A13L-09,,27706c21-96cb-48e9-88ec-1c52769bfe45,,TCGA-D8-A1JI-01A-11D-A13J-01,TCGA-D8-A1JI-01,,27706c21-96cb-48e9-88ec-1c52769bfe45,TCGA-D8-A1JI-01A-11D-A13J-01,
tcga.d8.a1jj,Stage IIA,54.0,1.0,Stage IIA,274.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,274.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JJ-01,611.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 4,mutation cluster 3,TCGA-D8-A1JJ,611.0,0.0,days,611.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1JJ-F20754,TCGA-D8-A1JJ,TCGA-D8-A1JJ-01A,,Positive,,,,,Positive,Other,,,,,-19966.0,260.0,,0.0,611.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,DAKOHercepTest TM,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,240.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf,A1JJ,TUMOR FREE,manual counting,10-75%,,10-75%,>75%,,YES,,,YES,Primary Tumor,1,breast conserving therapy,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,091cb252-dd08-4e9c-939c-749f595713f6,091cb252-dd08-4e9c-939c-749f595713f6,TCGA-D8-A1JJ-01A-11-A17J-20,TCGA-D8-A1JJ-01A-31D-A14K-09,TCGA-D8-A1JJ-01,TCGA-D8-A1JJ-01A-31D-A14N-05,f1275b85-f44d-447b-8def-00e4f4c9b2c0,TCGA-D8-A1JJ-01,TCGA-D8-A1JJ-01A-31D-A14K-09,,,TCGA-D8-A1JJ-01,TCGA-D8-A1JJ-01A-31D-A14K-09,,091cb252-dd08-4e9c-939c-749f595713f6,,TCGA-D8-A1JJ-01A-31D-A14J-01,TCGA-D8-A1JJ-01,,091cb252-dd08-4e9c-939c-749f595713f6,TCGA-D8-A1JJ-01A-31D-A14J-01,
tcga.d8.a1jk,Stage IIA,90.0,1.0,Stage IIA,109.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,109.0,0.0,Basal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JK-01,612.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 4,mutation cluster 3,TCGA-D8-A1JK,612.0,0.0,days,612.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JK-F20751,TCGA-D8-A1JK,TCGA-D8-A1JK-01A,,Negative,,,,,Positive,Modified Radical Mastectomy,,,,,-32872.0,261.0,,0.0,612.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,DAKOHercepTest TM,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,270.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf,A1JK,TUMOR FREE,manual counting,,,,0%,,YES,<10%,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,f7dd2e6b-a87e-467b-890a-3c422ae3dea7,f7dd2e6b-a87e-467b-890a-3c422ae3dea7,TCGA-D8-A1JK-01A-21-A17J-20,TCGA-D8-A1JK-01A-11D-A13L-09,TCGA-D8-A1JK-01,TCGA-D8-A1JK-01A-11D-A13K-05,0f3becf1-2a76-4401-950b-6809dfd90276,TCGA-D8-A1JK-01,TCGA-D8-A1JK-01A-11D-A13L-09,,,TCGA-D8-A1JK-01,TCGA-D8-A1JK-01A-11D-A13L-09,,f7dd2e6b-a87e-467b-890a-3c422ae3dea7,,TCGA-D8-A1JK-01A-11D-A13J-01,TCGA-D8-A1JK-01,,f7dd2e6b-a87e-467b-890a-3c422ae3dea7,TCGA-D8-A1JK-01A-11D-A13J-01,
tcga.d8.a1jl,Stage IIA,72.0,3.0,Stage IIA,265.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,265.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1JL-01,611.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 14,cluster 2,mutation cluster 5,TCGA-D8-A1JL,611.0,0.0,days,611.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JL-F20747,TCGA-D8-A1JL,,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-26484.0,,,0.0,611.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,,DAKOHercepTest TM,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,2.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1JL,TUMOR FREE,manual counting,,,0%,0%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,b4673313-fa18-43e8-a01b-5cdb3cf5425e,b4673313-fa18-43e8-a01b-5cdb3cf5425e,TCGA-D8-A1JL-01A-21-A17J-20,TCGA-D8-A1JL-01A-11D-A13L-09,TCGA-D8-A1JL-01,TCGA-D8-A1JL-01A-11D-A13K-05,c5c33030-617d-46a1-89a5-fa6ddd7d06fc,TCGA-D8-A1JL-01,TCGA-D8-A1JL-01A-11D-A13L-09,,,TCGA-D8-A1JL-01,TCGA-D8-A1JL-01A-11D-A13L-09,,b4673313-fa18-43e8-a01b-5cdb3cf5425e,,TCGA-D8-A1JL-01A-11D-A13J-01,TCGA-D8-A1JL-01,,b4673313-fa18-43e8-a01b-5cdb3cf5425e,TCGA-D8-A1JL-01A-11D-A13J-01,
tcga.d8.a1jn,Stage IIIC,80.0,2.0,Stage IIIC,217.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,217.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-D8-A1JN-01,620.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-D8-A1JN,620.0,0.0,days,620.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left,Axillary lymph node dissection alone,,TCGA-D8-A1JN-F20745,TCGA-D8-A1JN,TCGA-D8-A1JN-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-29331.0,273.0,,0.0,620.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,HER2 amplification - negative,DAKOHercepTest TM,,PathVision HER2 D Probe Kit,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Incisional Biopsy,180.0,NO,Indeterminate,Negative,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,3.0,,,,,,,,NO,11.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf,A1JN,TUMOR FREE,manual counting,,,,>75%,,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,874de789-c1c4-4fd3-b45c-e885f62aaeab,874de789-c1c4-4fd3-b45c-e885f62aaeab,TCGA-D8-A1JN-01A-21-A17J-20,TCGA-D8-A1JN-01A-11D-A13L-09,TCGA-D8-A1JN-01,TCGA-D8-A1JN-01A-11D-A13K-05,42e89a13-3aee-4749-861a-947fc66091bc,TCGA-D8-A1JN-01,TCGA-D8-A1JN-01A-11D-A13L-09,,,TCGA-D8-A1JN-01,TCGA-D8-A1JN-01A-11D-A13L-09,,874de789-c1c4-4fd3-b45c-e885f62aaeab,,TCGA-D8-A1JN-01A-11D-A13J-01,TCGA-D8-A1JN-01,,874de789-c1c4-4fd3-b45c-e885f62aaeab,TCGA-D8-A1JN-01A-11D-A13J-01,
tcga.d8.a1jp,Stage IA,73.0,1.0,Stage I,167.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,167.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1JP-01,639.0,0.0,days,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-D8-A1JP,639.0,0.0,days,639.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,73.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1JP-F20740,TCGA-D8-A1JP,,Negative,Positive,,,,Mastectomy NOS,Positive,Lumpectomy,,,,,-26862.0,,,0.0,639.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,,DAKOHercepTest TM,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,,,,No,M0,N0,T1c,Stage IA,,A1JP,TUMOR FREE,manual counting,,,,>75%,,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,f7461164-08b5-4a5c-ae74-cb4332f5ff7a,f7461164-08b5-4a5c-ae74-cb4332f5ff7a,TCGA-D8-A1JP-01A-21-A17J-20,TCGA-D8-A1JP-01A-11D-A13L-09,TCGA-D8-A1JP-01,TCGA-D8-A1JP-01A-11D-A13K-05,f51d8572-21b5-4b6f-99dd-00ca06c53b6f,TCGA-D8-A1JP-01,TCGA-D8-A1JP-01A-11D-A13L-09,,,TCGA-D8-A1JP-01,TCGA-D8-A1JP-01A-11D-A13L-09,,f7461164-08b5-4a5c-ae74-cb4332f5ff7a,,TCGA-D8-A1JP-01A-11D-A13J-01,TCGA-D8-A1JP-01,,f7461164-08b5-4a5c-ae74-cb4332f5ff7a,TCGA-D8-A1JP-01A-11D-A13J-01,
tcga.d8.a1js,Stage IA,77.0,2.0,Stage I,371.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,371.0,0.0,LumA,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-D8-A1JS-01,371.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-D8-A1JS,371.0,0.0,days,371.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JS-F14051,TCGA-D8-A1JS,TCGA-D8-A1JS-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-28178.0,212.0,,0.0,371.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,Hecep Test TM DAKO,,,1+,,,,,"Other, specify",,No,,C50.9,8503/3,C50.9,,YES,intraoperative examination,"Other method, specify:",190.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf,A1JS,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,b347056d-3ae3-43c7-9e3b-f48cee1bfbb2,b347056d-3ae3-43c7-9e3b-f48cee1bfbb2,TCGA-D8-A1JS-01A-21-A17J-20,TCGA-D8-A1JS-01A-11D-A13L-09,TCGA-D8-A1JS-01,TCGA-D8-A1JS-01A-11D-A13K-05,7ec4164a-68b4-4bbd-a560-b754876e5d33,TCGA-D8-A1JS-01,TCGA-D8-A1JS-01A-11D-A13L-09,,,TCGA-D8-A1JS-01,TCGA-D8-A1JS-01A-11D-A13L-09,,b347056d-3ae3-43c7-9e3b-f48cee1bfbb2,,TCGA-D8-A1JS-01A-11D-A13J-01,TCGA-D8-A1JS-01,,b347056d-3ae3-43c7-9e3b-f48cee1bfbb2,TCGA-D8-A1JS-01A-11D-A13J-01,
tcga.d8.a1jt,Stage IIA,70.0,4.0,Stage IIA,405.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,405.0,0.0,LumB,,Positive,,,,followup,T_Other,T2,LIVING,0.0,TCGA-D8-A1JT-01,405.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-D8-A1JT,405.0,0.0,days,405.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1JT-F14048,TCGA-D8-A1JT,TCGA-D8-A1JT-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-25677.0,250.0,,0.0,405.0,,,,,,,70-79%,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,,,,2+,,not amplified,,,"Other, specify",,No,,C50.9,8523/3,C50.9,,YES,,Fine needle aspiration biopsy,250.0,NO,Equivocal,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf,A1JT,TUMOR FREE,,,,,,,YES,70-79%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,33600bf2-ec43-49d2-93dd-4985feb500aa,33600bf2-ec43-49d2-93dd-4985feb500aa,TCGA-D8-A1JT-01A-41-A17J-20,TCGA-D8-A1JT-01A-31D-A13L-09,TCGA-D8-A1JT-01,TCGA-D8-A1JT-01A-31D-A13K-05,fd766efd-b1bc-4000-97bf-a8f88aea66a7,TCGA-D8-A1JT-01,TCGA-D8-A1JT-01A-31D-A13L-09,,,TCGA-D8-A1JT-01,TCGA-D8-A1JT-01A-31D-A13L-09,,33600bf2-ec43-49d2-93dd-4985feb500aa,,TCGA-D8-A1JT-01A-31D-A13J-01,TCGA-D8-A1JT-01,,33600bf2-ec43-49d2-93dd-4985feb500aa,TCGA-D8-A1JT-01A-31D-A13J-01,
tcga.d8.a1ju,Stage IA,51.0,2.0,Stage I,447.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,447.0,0.0,LumA,,Positive,,,,followup,T1,T1,LIVING,0.0,TCGA-D8-A1JU-01,447.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-D8-A1JU,447.0,0.0,days,447.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1JU-F14045,TCGA-D8-A1JU,TCGA-D8-A1JU-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-18733.0,295.0,,0.0,447.0,,,,,,manual counting,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,450.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf,A1JU,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,8e10b30e-5789-4ad4-a70b-c7a86927ac6b,8e10b30e-5789-4ad4-a70b-c7a86927ac6b,TCGA-D8-A1JU-01A-21-A17J-20,TCGA-D8-A1JU-01A-11D-A13L-09,TCGA-D8-A1JU-01,TCGA-D8-A1JU-01A-11D-A13K-05,226a87df-e0cb-4c94-80ab-9d1bed969e0f,TCGA-D8-A1JU-01,TCGA-D8-A1JU-01A-11D-A13L-09,,,TCGA-D8-A1JU-01,TCGA-D8-A1JU-01A-11D-A13L-09,,8e10b30e-5789-4ad4-a70b-c7a86927ac6b,,TCGA-D8-A1JU-01A-11D-A13J-01,TCGA-D8-A1JU-01,,8e10b30e-5789-4ad4-a70b-c7a86927ac6b,TCGA-D8-A1JU-01A-11D-A13J-01,
tcga.d8.a1x5,Stage IIIC,81.0,5.0,Stage IIIC,171.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N3,171.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1X5-01,565.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,squamous c3,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-D8-A1X5,565.0,0.0,days,565.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,81.0,Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1X5-F29934,TCGA-D8-A1X5,TCGA-D8-A1X5-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-29734.0,197.0,,0.0,565.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-30,FEMALE,,Hercep Test  TM Dako,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,240.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,14.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf,A1X5,TUMOR FREE,manual counting,,,10-75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,95a12af8-5704-4745-b0a0-960f67af8cec,95a12af8-5704-4745-b0a0-960f67af8cec,TCGA-D8-A1X5-01A-21-A17K-20,TCGA-D8-A1X5-01A-11D-A14G-09,TCGA-D8-A1X5-01,TCGA-D8-A1X5-01A-11D-A14H-05,8e7e66c1-ecb2-47e7-a590-56fd4b0cb3b5,TCGA-D8-A1X5-01,TCGA-D8-A1X5-01A-11D-A14G-09,,,TCGA-D8-A1X5-01,TCGA-D8-A1X5-01A-11D-A14G-09,,95a12af8-5704-4745-b0a0-960f67af8cec,,TCGA-D8-A1X5-01A-11D-A14F-01,TCGA-D8-A1X5-01,,95a12af8-5704-4745-b0a0-960f67af8cec,TCGA-D8-A1X5-01A-11D-A14F-01,
tcga.d8.a1x6,Stage IIIA,80.0,4.0,Stage IIIA,236.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,236.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-D8-A1X6-01,541.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,mutation c1uster 9,TCGA-D8-A1X6,541.0,0.0,days,541.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1X6-F29980,TCGA-D8-A1X6,TCGA-D8-A1X6-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-29256.0,173.0,,0.0,541.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-31,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,550.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf,A1X6,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,ac361cbe-2302-4115-8c0f-40845c0ccec9,ac361cbe-2302-4115-8c0f-40845c0ccec9,TCGA-D8-A1X6-01A-21-A17K-20,TCGA-D8-A1X6-01A-11D-A14K-09,TCGA-D8-A1X6-01,TCGA-D8-A1X6-01A-11D-A14N-05,45aa8d7f-2fd6-4413-8191-52872f8d31d7,TCGA-D8-A1X6-01,TCGA-D8-A1X6-01A-11D-A14K-09,,,TCGA-D8-A1X6-01,TCGA-D8-A1X6-01A-11D-A14K-09,,ac361cbe-2302-4115-8c0f-40845c0ccec9,,TCGA-D8-A1X6-01A-11D-A14J-01,TCGA-D8-A1X6-01,,ac361cbe-2302-4115-8c0f-40845c0ccec9,TCGA-D8-A1X6-01A-11D-A14J-01,
tcga.d8.a1x7,Stage IIA,40.0,3.0,Stage IIA,85.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,85.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1X7-01,509.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 9,TCGA-D8-A1X7,509.0,0.0,days,509.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1X7-F29985,TCGA-D8-A1X7,TCGA-D8-A1X7-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-14858.0,141.0,,0.0,509.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-31,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8503/3,C50.9,,YES,,Fine needle aspiration biopsy,170.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf,A1X7,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,6b2497ef-abe8-4f6f-9225-1d700f55ad1c,6b2497ef-abe8-4f6f-9225-1d700f55ad1c,TCGA-D8-A1X7-01A-21-A17K-20,TCGA-D8-A1X7-01A-11D-A14K-09,TCGA-D8-A1X7-01,TCGA-D8-A1X7-01A-11D-A14N-05,436728e0-24a5-4033-86d5-2d24f669ea72,TCGA-D8-A1X7-01,TCGA-D8-A1X7-01A-11D-A14K-09,,,TCGA-D8-A1X7-01,TCGA-D8-A1X7-01A-11D-A14K-09,,6b2497ef-abe8-4f6f-9225-1d700f55ad1c,,TCGA-D8-A1X7-01A-11D-A14J-01,TCGA-D8-A1X7-01,,6b2497ef-abe8-4f6f-9225-1d700f55ad1c,TCGA-D8-A1X7-01A-11D-A14J-01,
tcga.d8.a1x8,Stage IIA,62.0,2.0,Stage IIIA,272.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,272.0,0.0,LumA,,Indeterminate,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1X8-01,783.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation cluster 4,TCGA-D8-A1X8,783.0,0.0,days,783.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1X8-F29428,TCGA-D8-A1X8,TCGA-D8-A1X8-01A,,Positive,,2+,4 Point Scale,,Indeterminate,Modified Radical Mastectomy,,NO,,,-22995.0,225.0,,0.0,783.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-10-19,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,360.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,1.0,,,,,,,,NO,9.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf,A1X8,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,cbc8608e-ffe1-41d5-93c5-66dd665c9bf0,cbc8608e-ffe1-41d5-93c5-66dd665c9bf0,TCGA-D8-A1X8-01A-21-A17K-20,TCGA-D8-A1X8-01A-11D-A14K-09,TCGA-D8-A1X8-01,TCGA-D8-A1X8-01A-11D-A14N-05,9bd7faf1-8b85-4e46-b968-35a1a5cc2cb5,TCGA-D8-A1X8-01,TCGA-D8-A1X8-01A-11D-A14K-09,,,TCGA-D8-A1X8-01,TCGA-D8-A1X8-01A-11D-A14K-09,,cbc8608e-ffe1-41d5-93c5-66dd665c9bf0,,TCGA-D8-A1X8-01A-11D-A14J-01,TCGA-D8-A1X8-01,,cbc8608e-ffe1-41d5-93c5-66dd665c9bf0,TCGA-D8-A1X8-01A-11D-A14J-01,
tcga.d8.a1x9,Stage IIA,66.0,5.0,Stage IIB,380.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,380.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1X9-01,727.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 14,TCGA-D8-A1X9,727.0,0.0,days,727.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1X9-F29431,TCGA-D8-A1X9,TCGA-D8-A1X9-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-24417.0,399.0,,0.0,727.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,,,not amplified,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Indeterminate,Negative,,23.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,3.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf,A1X9,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,2b3d596a-68ca-4c60-bb16-8c0cbd8fb190,2b3d596a-68ca-4c60-bb16-8c0cbd8fb190,TCGA-D8-A1X9-01A-21-A17K-20,TCGA-D8-A1X9-01A-12D-A159-09,TCGA-D8-A1X9-01,TCGA-D8-A1X9-01A-12D-A161-05,4672d6c4-b826-4143-887c-464ab4020a6d,TCGA-D8-A1X9-01,TCGA-D8-A1X9-01A-12D-A159-09,,,TCGA-D8-A1X9-01,TCGA-D8-A1X9-01A-12D-A159-09,,2b3d596a-68ca-4c60-bb16-8c0cbd8fb190,,TCGA-D8-A1X9-01A-12D-A160-01,TCGA-D8-A1X9-01,,2b3d596a-68ca-4c60-bb16-8c0cbd8fb190,TCGA-D8-A1X9-01A-12D-A160-01,
tcga.d8.a1xa,Stage IA,64.0,1.0,Stage I,274.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,274.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XA-01,839.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 5,TCGA-D8-A1XA,839.0,0.0,days,839.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1XA-F29434,TCGA-D8-A1XA,TCGA-D8-A1XA-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-23387.0,218.0,,0.0,839.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-12-3,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",140.0,NO,Equivocal,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf,A1XA,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,79d0e02e-b518-4dce-8c20-00073d04e399,79d0e02e-b518-4dce-8c20-00073d04e399,TCGA-D8-A1XA-01A-21-A17K-20,TCGA-D8-A1XA-01A-11D-A14G-09,TCGA-D8-A1XA-01,TCGA-D8-A1XA-01A-11D-A14H-05,b480ba7d-ad4f-41f6-87a4-ad062ced62ae,TCGA-D8-A1XA-01,TCGA-D8-A1XA-01A-11D-A14G-09,,,TCGA-D8-A1XA-01,TCGA-D8-A1XA-01A-11D-A14G-09,,79d0e02e-b518-4dce-8c20-00073d04e399,,TCGA-D8-A1XA-01A-11D-A14F-01,TCGA-D8-A1XA-01,,79d0e02e-b518-4dce-8c20-00073d04e399,TCGA-D8-A1XA-01A-11D-A14F-01,
tcga.d8.a1xb,Stage IIB,62.0,4.0,Stage IIB,201.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,201.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XB-01,552.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1XB,552.0,0.0,days,552.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XB-F29436,TCGA-D8-A1XB,TCGA-D8-A1XB-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-22976.0,251.0,,0.0,552.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf,A1XB,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,8a2adff0-2527-43fa-ad17-a3081e22f846,8a2adff0-2527-43fa-ad17-a3081e22f846,TCGA-D8-A1XB-01A-21-A17K-20,TCGA-D8-A1XB-01A-11D-A14G-09,TCGA-D8-A1XB-01,TCGA-D8-A1XB-01A-11D-A14H-05,7badd356-a8c5-4c61-a520-27a25695f71e,TCGA-D8-A1XB-01,TCGA-D8-A1XB-01A-11D-A14G-09,,,TCGA-D8-A1XB-01,TCGA-D8-A1XB-01A-11D-A14G-09,,8a2adff0-2527-43fa-ad17-a3081e22f846,,TCGA-D8-A1XB-01A-11D-A14F-01,TCGA-D8-A1XB-01,,8a2adff0-2527-43fa-ad17-a3081e22f846,TCGA-D8-A1XB-01A-11D-A14F-01,
tcga.d8.a1xc,Stage IIIB,85.0,3.0,Stage IIIB,81.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,81.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T4,LIVING,1.0,TCGA-D8-A1XC-01,377.0,1.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation c1uster 9,TCGA-D8-A1XC,,,days,377.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,NO,,85.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XC-F29439,TCGA-D8-A1XC,TCGA-D8-A1XC-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-31220.0,215.0,377.0,0.0,81.0,,,[Discrepancy],,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,1+,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,intraoperative examination,"Other method, specify:",260.0,NO,Negative,,,20.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,Bone,Distant Metastasis,,,YES,1.0,0.0,False,No,M0,N1a,T4b,Stage IIIB,TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf,A1XC,WITH TUMOR,%IHC,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,DECEASED,2010.0,4328ae51-6063-4296-b266-a70bc5dda94f,4328ae51-6063-4296-b266-a70bc5dda94f,TCGA-D8-A1XC-01A-21-A17K-20,TCGA-D8-A1XC-01A-11D-A14G-09,TCGA-D8-A1XC-01,TCGA-D8-A1XC-01A-11D-A14H-05,d91c5cb0-55c9-4cf9-814c-d26df5d0a971,TCGA-D8-A1XC-01,TCGA-D8-A1XC-01A-11D-A14G-09,,,TCGA-D8-A1XC-01,TCGA-D8-A1XC-01A-11D-A14G-09,,4328ae51-6063-4296-b266-a70bc5dda94f,,TCGA-D8-A1XC-01A-11D-A14F-01,TCGA-D8-A1XC-01,,4328ae51-6063-4296-b266-a70bc5dda94f,TCGA-D8-A1XC-01A-11D-A14F-01,
tcga.d8.a1xd,Stage IIIA,36.0,4.0,Stage IIIA,155.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,155.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XD-01,522.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,,TCGA-D8-A1XD,522.0,0.0,days,522.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,36.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XD-F29440,TCGA-D8-A1XD,TCGA-D8-A1XD-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-13510.0,188.0,,0.0,522.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,[Discrepancy],210.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,6.0,,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf,A1XD,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,af520d74-dc8a-4d36-bd2c-80bc23e6d029,af520d74-dc8a-4d36-bd2c-80bc23e6d029,TCGA-D8-A1XD-01A-21-A17K-20,,TCGA-D8-A1XD-01,TCGA-D8-A1XD-01A-11D-A14H-05,71a3ddcc-c443-445f-b3c6-e0d36183ac53,TCGA-D8-A1XD-01,,,,TCGA-D8-A1XD-01,,,af520d74-dc8a-4d36-bd2c-80bc23e6d029,,TCGA-D8-A1XD-01A-11D-A14F-01,TCGA-D8-A1XD-01,,af520d74-dc8a-4d36-bd2c-80bc23e6d029,TCGA-D8-A1XD-01A-11D-A14F-01,
tcga.d8.a1xf,Stage IIA,45.0,3.0,Stage IIA,197.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,197.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XF-01,463.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation c1uster 9,TCGA-D8-A1XF,463.0,0.0,days,463.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XF-F29442,TCGA-D8-A1XF,TCGA-D8-A1XF-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-16787.0,170.0,,0.0,463.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",180.0,NO,Negative,,,8.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,5.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf,A1XF,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,80562b20-3e3e-4f77-8ca2-958f8636d720,80562b20-3e3e-4f77-8ca2-958f8636d720,TCGA-D8-A1XF-01A-21-A17K-20,TCGA-D8-A1XF-01A-11D-A14G-09,TCGA-D8-A1XF-01,TCGA-D8-A1XF-01A-11D-A14H-05,83d58431-912e-4861-90cb-1dffc7d4a8b0,TCGA-D8-A1XF-01,TCGA-D8-A1XF-01A-11D-A14G-09,,,TCGA-D8-A1XF-01,TCGA-D8-A1XF-01A-11D-A14G-09,,80562b20-3e3e-4f77-8ca2-958f8636d720,,TCGA-D8-A1XF-01A-11D-A14F-01,TCGA-D8-A1XF-01,,80562b20-3e3e-4f77-8ca2-958f8636d720,TCGA-D8-A1XF-01A-11D-A14F-01,
tcga.d8.a1xg,Stage IIIB,86.0,3.0,Stage IIIB,196.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,196.0,0.0,LumA,,Negative,,,,enrollment,T_Other,T4,LIVING,0.0,TCGA-D8-A1XG-01,448.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-D8-A1XG,448.0,0.0,days,448.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,86.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XG-F29444,TCGA-D8-A1XG,TCGA-D8-A1XG-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,YES,,,-31748.0,169.0,,0.0,448.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",590.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,1.0,,,,,,,,NO,2.0,0.0,False,No,M0,N1a,T4b,Stage IIIB,TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf,A1XG,TUMOR FREE,,,,,10-75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,56bc2076-bafe-47aa-8255-9f03d438cb00,56bc2076-bafe-47aa-8255-9f03d438cb00,TCGA-D8-A1XG-01A-21-A17K-20,TCGA-D8-A1XG-01A-11D-A14G-09,TCGA-D8-A1XG-01,TCGA-D8-A1XG-01A-11D-A14H-05,c51c59e6-0a2c-4597-88df-59166bf2c096,TCGA-D8-A1XG-01,TCGA-D8-A1XG-01A-11D-A14G-09,,,TCGA-D8-A1XG-01,TCGA-D8-A1XG-01A-11D-A14G-09,,56bc2076-bafe-47aa-8255-9f03d438cb00,,TCGA-D8-A1XG-01A-11D-A14F-01,TCGA-D8-A1XG-01,,56bc2076-bafe-47aa-8255-9f03d438cb00,TCGA-D8-A1XG-01A-11D-A14F-01,
tcga.d8.a1xj,Stage IIIA,76.0,1.0,Stage IIIA,352.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,352.0,0.0,Her2,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-D8-A1XJ-01,663.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 6,cluster 7,mutation cluster 5,TCGA-D8-A1XJ,663.0,0.0,days,663.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,76.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XJ-F30111,TCGA-D8-A1XJ,TCGA-D8-A1XJ-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-27967.0,295.0,,0.0,663.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Hercep Test  TM Dako,,,3+,,,,,"Other, specify",,No,,C50.9,8523/3,C50.9,,YES,,Fine needle aspiration biopsy,440.0,NO,Positive,,,43.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,7.0,,,,,,,,NO,2.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf,A1XJ,TUMOR FREE,manual counting,,,10-75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,ef91ee42-e50f-44f7-967a-48698e920d12,ef91ee42-e50f-44f7-967a-48698e920d12,TCGA-D8-A1XJ-01A-21-A17K-20,TCGA-D8-A1XJ-01A-11D-A14K-09,TCGA-D8-A1XJ-01,TCGA-D8-A1XJ-01A-11D-A14N-05,9dcb0e51-ac2f-4954-ac24-a1c9e20e7c8a,TCGA-D8-A1XJ-01,TCGA-D8-A1XJ-01A-11D-A14K-09,,,TCGA-D8-A1XJ-01,TCGA-D8-A1XJ-01A-11D-A14K-09,,ef91ee42-e50f-44f7-967a-48698e920d12,,TCGA-D8-A1XJ-01A-11D-A14J-01,TCGA-D8-A1XJ-01,,ef91ee42-e50f-44f7-967a-48698e920d12,TCGA-D8-A1XJ-01A-11D-A14J-01,
tcga.d8.a1xk,Stage IB,55.0,1.0,Stage IIB,326.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,326.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XK-01,441.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,miRNA cluster 14,cluster 5,,TCGA-D8-A1XK,441.0,0.0,days,441.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XK-F30074,TCGA-D8-A1XK,TCGA-D8-A1XK-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,,,,-20092.0,275.0,,0.0,441.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-2-4,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,260.0,NO,Negative,,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,3.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf,A1XK,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,e4edbc10-8939-4bbf-befa-ee44229e4394,e4edbc10-8939-4bbf-befa-ee44229e4394,TCGA-D8-A1XK-01A-11-A17K-20,,TCGA-D8-A1XK-01,TCGA-D8-A1XK-01A-21D-A14N-05,567f0c52-eb40-43cc-a34c-a7e1714b420a,TCGA-D8-A1XK-01,TCGA-D8-A1XK-01A-21D-A14K-09,,,TCGA-D8-A1XK-01,,,e4edbc10-8939-4bbf-befa-ee44229e4394,,TCGA-D8-A1XK-01A-21D-A14J-01,TCGA-D8-A1XK-01,,e4edbc10-8939-4bbf-befa-ee44229e4394,TCGA-D8-A1XK-01A-21D-A14J-01,
tcga.d8.a1xl,Stage IIB,34.0,1.0,Stage IIB,319.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,319.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XL-01,606.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 3,TCGA-D8-A1XL,606.0,0.0,days,606.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,34.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XL-F29990,TCGA-D8-A1XL,TCGA-D8-A1XL-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-12668.0,282.0,,0.0,606.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-31,FEMALE,,HercepTest TM Dako,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,260.0,NO,Equivocal,Negative,,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,NO,2.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf,A1XL,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,26f5aec2-a2d8-4151-b975-33d7518e36d0,26f5aec2-a2d8-4151-b975-33d7518e36d0,TCGA-D8-A1XL-01A-21-A17K-20,TCGA-D8-A1XL-01A-11D-A14K-09,TCGA-D8-A1XL-01,TCGA-D8-A1XL-01A-11D-A14N-05,2505f3cc-34a7-448a-9935-97126fec7c57,TCGA-D8-A1XL-01,TCGA-D8-A1XL-01A-11D-A14K-09,,,TCGA-D8-A1XL-01,TCGA-D8-A1XL-01A-11D-A14K-09,,26f5aec2-a2d8-4151-b975-33d7518e36d0,,TCGA-D8-A1XL-01A-11D-A14J-01,TCGA-D8-A1XL-01,,26f5aec2-a2d8-4151-b975-33d7518e36d0,TCGA-D8-A1XL-01A-11D-A14J-01,
tcga.d8.a1xm,Stage IA,57.0,3.0,Stage I,218.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,218.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XM-01,538.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1XM,538.0,0.0,days,538.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1XM-F29445,TCGA-D8-A1XM,TCGA-D8-A1XM-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-21056.0,189.0,,0.0,538.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,200.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf,A1XM,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,3049e9ab-8e65-4264-865a-b7a14e27aae1,3049e9ab-8e65-4264-865a-b7a14e27aae1,TCGA-D8-A1XM-01A-11-A17K-20,TCGA-D8-A1XM-01A-21D-A14K-09,TCGA-D8-A1XM-01,TCGA-D8-A1XM-01A-21D-A14N-05,6885966b-8453-46b3-8f90-6dfc1117e87b,TCGA-D8-A1XM-01,TCGA-D8-A1XM-01A-21D-A14K-09,,,TCGA-D8-A1XM-01,TCGA-D8-A1XM-01A-21D-A14K-09,,3049e9ab-8e65-4264-865a-b7a14e27aae1,,TCGA-D8-A1XM-01A-21D-A14J-01,TCGA-D8-A1XM-01,,3049e9ab-8e65-4264-865a-b7a14e27aae1,TCGA-D8-A1XM-01A-21D-A14J-01,
tcga.d8.a1xo,Stage IIB,56.0,2.0,Stage IIB,242.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,242.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XO-01,1682.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 7,mutation cluster 4,TCGA-D8-A1XO,1682.0,0.0,days,1682.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XO-F72206,TCGA-D8-A1XO,,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20606.0,,,0.0,1682.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,NO,1.0,0.0,,No,M0,N1a,T2,Stage IIB,,A1XO,TUMOR FREE,%IHC,,,>75%,>75%,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2010.0,eddd285e-a946-4e4e-a21d-6e84ed397594,eddd285e-a946-4e4e-a21d-6e84ed397594,TCGA-D8-A1XO-01A-21-A17K-20,TCGA-D8-A1XO-01A-11D-A14K-09,TCGA-D8-A1XO-01,TCGA-D8-A1XO-01A-11D-A14N-05,f75c4694-aa3e-4855-8b51-bfb5de5373fc,TCGA-D8-A1XO-01,TCGA-D8-A1XO-01A-11D-A14K-09,,,TCGA-D8-A1XO-01,TCGA-D8-A1XO-01A-11D-A14K-09,,eddd285e-a946-4e4e-a21d-6e84ed397594,,TCGA-D8-A1XO-01A-11D-A14J-01,TCGA-D8-A1XO-01,,eddd285e-a946-4e4e-a21d-6e84ed397594,TCGA-D8-A1XO-01A-11D-A14J-01,
tcga.d8.a1xq,Stage IIA,69.0,1.0,Stage IIA,177.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,177.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XQ-01,499.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,,TCGA-D8-A1XQ,499.0,0.0,days,499.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XQ-F29449,TCGA-D8-A1XQ,TCGA-D8-A1XQ-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-25345.0,158.0,,0.0,499.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf,A1XQ,TUMOR FREE,,,,,0%,,YES,<10%,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,0c7fc003-950b-4138-8390-036c072b640e,0c7fc003-950b-4138-8390-036c072b640e,TCGA-D8-A1XQ-01A-21-A17K-20,,TCGA-D8-A1XQ-01,TCGA-D8-A1XQ-01A-11D-A14N-05,43fa736b-5235-4357-8ae7-2b0029efecfc,TCGA-D8-A1XQ-01,TCGA-D8-A1XQ-01A-11D-A14K-09,,,TCGA-D8-A1XQ-01,,,0c7fc003-950b-4138-8390-036c072b640e,,TCGA-D8-A1XQ-01A-11D-A14J-01,TCGA-D8-A1XQ-01,,0c7fc003-950b-4138-8390-036c072b640e,TCGA-D8-A1XQ-01A-11D-A14J-01,
tcga.d8.a1xr,Stage IIB,56.0,2.0,Stage IIB,168.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,168.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XR-01,482.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-D8-A1XR,482.0,0.0,days,482.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XR-F29451,TCGA-D8-A1XR,TCGA-D8-A1XR-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20488.0,162.0,,0.0,482.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-6,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,3.0,,,,,,,,NO,2.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf,A1XR,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,9c55164e-fb87-46b5-87ce-cc277ba378f5,9c55164e-fb87-46b5-87ce-cc277ba378f5,TCGA-D8-A1XR-01A-21-A17K-20,TCGA-D8-A1XR-01A-11D-A14K-09,TCGA-D8-A1XR-01,TCGA-D8-A1XR-01A-11D-A14N-05,f97f91f5-8d8b-494d-847c-848251489758,TCGA-D8-A1XR-01,TCGA-D8-A1XR-01A-11D-A14K-09,,,TCGA-D8-A1XR-01,TCGA-D8-A1XR-01A-11D-A14K-09,,9c55164e-fb87-46b5-87ce-cc277ba378f5,,TCGA-D8-A1XR-01A-11D-A14J-01,TCGA-D8-A1XR-01,,9c55164e-fb87-46b5-87ce-cc277ba378f5,TCGA-D8-A1XR-01A-11D-A14J-01,
tcga.d8.a1xs,Stage IIIC,48.0,3.0,Stage IIIC,18.0,,Positive,MALE,Positive,,,,Negative,M0,Positive,N3,18.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XS-01,496.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1XS,496.0,0.0,days,496.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XS-F12133,TCGA-D8-A1XS,TCGA-D8-A1XS-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-17708.0,164.0,,0.0,496.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,MALE,,,,,3+,,,,,"Other, specify",,No,,C50.9,8507/3,C50.9,,YES,,Core needle biopsy,340.0,NO,Positive,,,28.0,Negative,,,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,25.0,0.0,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf,A1XS,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,11b43261-66e4-4c28-8d24-6e38b4295f34,11b43261-66e4-4c28-8d24-6e38b4295f34,TCGA-D8-A1XS-01A-21-A17K-20,TCGA-D8-A1XS-01A-11D-A14K-09,TCGA-D8-A1XS-01,TCGA-D8-A1XS-01A-11D-A14N-05,22edabb4-30a0-4d5d-95f2-3ee9c3883fd1,TCGA-D8-A1XS-01,TCGA-D8-A1XS-01A-11D-A14K-09,,,TCGA-D8-A1XS-01,TCGA-D8-A1XS-01A-11D-A14K-09,,11b43261-66e4-4c28-8d24-6e38b4295f34,,TCGA-D8-A1XS-01A-11D-A14J-01,TCGA-D8-A1XS-01,,11b43261-66e4-4c28-8d24-6e38b4295f34,TCGA-D8-A1XS-01A-11D-A14J-01,
tcga.d8.a1xt,Stage IIA,61.0,1.0,Stage IIA,193.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,193.0,0.0,Her2,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XT-01,506.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-D8-A1XT,506.0,0.0,days,506.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XT-F29454,TCGA-D8-A1XT,TCGA-D8-A1XT-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-22448.0,144.0,,0.0,506.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,230.0,NO,Positive,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,3.0,0.0,False,No,M0,N1a,T1c,Stage IIA,TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf,A1XT,TUMOR FREE,%IHC,,,0%,0%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,47901dff-8acf-4afa-9e42-851d98777085,47901dff-8acf-4afa-9e42-851d98777085,TCGA-D8-A1XT-01A-21-A17K-20,TCGA-D8-A1XT-01A-11D-A14K-09,TCGA-D8-A1XT-01,TCGA-D8-A1XT-01A-11D-A14N-05,0321074c-bcf8-42f7-9212-b2673201860d,TCGA-D8-A1XT-01,TCGA-D8-A1XT-01A-11D-A14K-09,,,TCGA-D8-A1XT-01,TCGA-D8-A1XT-01A-11D-A14K-09,,47901dff-8acf-4afa-9e42-851d98777085,,TCGA-D8-A1XT-01A-11D-A14J-01,TCGA-D8-A1XT-01,,47901dff-8acf-4afa-9e42-851d98777085,TCGA-D8-A1XT-01A-11D-A14J-01,
tcga.d8.a1xu,Stage IA,56.0,,Stage I,149.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,149.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XU-01,395.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-D8-A1XU,395.0,0.0,days,395.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1XU-F29456,TCGA-D8-A1XU,TCGA-D8-A1XU-01A,Negative,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20715.0,102.0,,0.0,395.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,6.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf,A1XU,TUMOR FREE,%IHC,,,10-75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,0718af55-25eb-45b7-9e76-5d663a00dca5,0718af55-25eb-45b7-9e76-5d663a00dca5,TCGA-D8-A1XU-01A-21-A17K-20,TCGA-D8-A1XU-01A-11D-A14K-09,TCGA-D8-A1XU-01,TCGA-D8-A1XU-01A-11D-A14N-05,d4978f30-9304-47e3-a4a7-1c5b32f6ddde,TCGA-D8-A1XU-01,TCGA-D8-A1XU-01A-11D-A14K-09,,,TCGA-D8-A1XU-01,TCGA-D8-A1XU-01A-11D-A14K-09,,0718af55-25eb-45b7-9e76-5d663a00dca5,,TCGA-D8-A1XU-01A-11D-A14J-01,TCGA-D8-A1XU-01,,0718af55-25eb-45b7-9e76-5d663a00dca5,TCGA-D8-A1XU-01A-11D-A14J-01,
tcga.d8.a1xv,Stage IIA,84.0,3.0,Stage IIA,146.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,146.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XV-01,461.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 7,mutation c1uster 9,TCGA-D8-A1XV,461.0,0.0,days,461.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,84.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A1XV-F29457,TCGA-D8-A1XV,TCGA-D8-A1XV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-30830.0,103.0,,0.0,461.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2012-3-19,FEMALE,,,,,2+,,not amplified,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Fine needle aspiration biopsy,420.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,7.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf,A1XV,TUMOR FREE,%IHC,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6,5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6,TCGA-D8-A1XV-01A-21-A17K-20,TCGA-D8-A1XV-01A-11D-A14K-09,TCGA-D8-A1XV-01,TCGA-D8-A1XV-01A-11D-A14N-05,fc4169c4-863c-42b2-9b67-2682355d343d,TCGA-D8-A1XV-01,TCGA-D8-A1XV-01A-11D-A14K-09,,,TCGA-D8-A1XV-01,TCGA-D8-A1XV-01A-11D-A14K-09,,5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6,,TCGA-D8-A1XV-01A-11D-A14J-01,TCGA-D8-A1XV-01,,5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6,TCGA-D8-A1XV-01A-11D-A14J-01,
tcga.d8.a1xw,Stage IIA,53.0,3.0,Stage IIA,117.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,117.0,0.0,Normal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XW-01,1309.0,0.0,days,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-D8-A1XW,1309.0,0.0,days,1309.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-D8-A1XW-F72205,TCGA-D8-A1XW,TCGA-D8-A1XW-01A,,Negative,,,,,Positive,Modified Radical Mastectomy,,NO,,,-19478.0,76.0,,0.0,1309.0,,,,,NO,% IHC,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,310.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf,A1XW,TUMOR FREE,,,,,0%,YES,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,8e24b2f8-459c-4861-9d31-d171e8d1a08b,8e24b2f8-459c-4861-9d31-d171e8d1a08b,TCGA-D8-A1XW-01A-21-A17K-20,TCGA-D8-A1XW-01A-11D-A14K-09,TCGA-D8-A1XW-01,TCGA-D8-A1XW-01A-11D-A14N-05,645dc9bf-f601-46eb-84e0-cb5df8d9981b,TCGA-D8-A1XW-01,TCGA-D8-A1XW-01A-11D-A14K-09,,,TCGA-D8-A1XW-01,TCGA-D8-A1XW-01A-11D-A14K-09,,8e24b2f8-459c-4861-9d31-d171e8d1a08b,,TCGA-D8-A1XW-01A-11D-A14J-01,TCGA-D8-A1XW-01,,8e24b2f8-459c-4861-9d31-d171e8d1a08b,TCGA-D8-A1XW-01A-11D-A14J-01,
tcga.d8.a1xy,Stage IIA,74.0,,Stage IIA,81.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,81.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1XY-01,503.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-D8-A1XY,503.0,0.0,days,503.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XY-F29994,TCGA-D8-A1XY,TCGA-D8-A1XY-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-27106.0,135.0,,0.0,503.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-31,FEMALE,,HerceptTest TM Dako,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,190.0,NO,Positive,,,3.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf,A1XY,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,5b233291-8984-4925-8be4-3911f541a15f,5b233291-8984-4925-8be4-3911f541a15f,TCGA-D8-A1XY-01A-21-A17K-20,TCGA-D8-A1XY-01A-11D-A14K-09,TCGA-D8-A1XY-01,TCGA-D8-A1XY-01A-11D-A14N-05,68b05ccb-ae51-4690-9b4d-e18bc9b4e9ea,TCGA-D8-A1XY-01,TCGA-D8-A1XY-01A-11D-A14K-09,,,TCGA-D8-A1XY-01,TCGA-D8-A1XY-01A-11D-A14K-09,,5b233291-8984-4925-8be4-3911f541a15f,,TCGA-D8-A1XY-01A-11D-A14J-01,TCGA-D8-A1XY-01,,5b233291-8984-4925-8be4-3911f541a15f,TCGA-D8-A1XY-01A-11D-A14J-01,
tcga.d8.a1xz,Stage IIIA,81.0,1.0,Stage IIIA,120.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,120.0,0.0,LumB,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1XZ-01,466.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 5,mutation cluster 13,TCGA-D8-A1XZ,466.0,0.0,days,466.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,81.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1XZ-F30077,TCGA-D8-A1XZ,TCGA-D8-A1XZ-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-29916.0,98.0,,0.0,466.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,130.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,6.0,,False,No,MX,N2a,T1c,Stage IIIA,TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf,A1XZ,TUMOR FREE,,,,,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,8b592b3b-47b5-45fa-98eb-01bf75096605,8b592b3b-47b5-45fa-98eb-01bf75096605,TCGA-D8-A1XZ-01A-21-A17K-20,TCGA-D8-A1XZ-01A-11D-A14K-09,TCGA-D8-A1XZ-01,TCGA-D8-A1XZ-01A-11D-A14N-05,6de7dbf5-0fdb-4871-a5ba-5909cd85f6e1,TCGA-D8-A1XZ-01,TCGA-D8-A1XZ-01A-11D-A14K-09,,,TCGA-D8-A1XZ-01,TCGA-D8-A1XZ-01A-11D-A14K-09,,8b592b3b-47b5-45fa-98eb-01bf75096605,,TCGA-D8-A1XZ-01A-11D-A14J-01,TCGA-D8-A1XZ-01,,8b592b3b-47b5-45fa-98eb-01bf75096605,TCGA-D8-A1XZ-01A-11D-A14J-01,
tcga.d8.a1y0,Stage IIIA,65.0,5.0,Stage IIIA,166.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,166.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A1Y0-01,472.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation c1uster 9,TCGA-D8-A1Y0,472.0,0.0,days,472.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left,Axillary lymph node dissection alone,,TCGA-D8-A1Y0-F30080,TCGA-D8-A1Y0,TCGA-D8-A1Y0-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-24083.0,104.0,,0.0,472.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Incisional Biopsy,190.0,NO,Negative,,,15.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,9.0,,False,No,MX,N2a,T1c,Stage IIIA,TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf,A1Y0,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,8dd30d68-86d0-456f-814c-ae59a5c0a071,8dd30d68-86d0-456f-814c-ae59a5c0a071,TCGA-D8-A1Y0-01A-21-A17K-20,TCGA-D8-A1Y0-01A-11D-A14K-09,TCGA-D8-A1Y0-01,TCGA-D8-A1Y0-01A-11D-A14N-05,afa6d295-e75a-41fa-a678-2b0d4d82cbc2,TCGA-D8-A1Y0-01,TCGA-D8-A1Y0-01A-11D-A14K-09,,,TCGA-D8-A1Y0-01,TCGA-D8-A1Y0-01A-11D-A14K-09,,8dd30d68-86d0-456f-814c-ae59a5c0a071,,TCGA-D8-A1Y0-01A-11D-A14J-01,TCGA-D8-A1Y0-01,,8dd30d68-86d0-456f-814c-ae59a5c0a071,TCGA-D8-A1Y0-01A-11D-A14J-01,
tcga.d8.a1y1,Stage IIIA,80.0,2.0,Stage IIIA,115.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,115.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T3,LIVING,1.0,TCGA-D8-A1Y1-01,302.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 1,TCGA-D8-A1Y1,302.0,0.0,days,302.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1Y1-F30084,TCGA-D8-A1Y1,TCGA-D8-A1Y1-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-29474.0,93.0,302.0,0.0,116.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,200.0,NO,Negative,,,22.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,1.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf,A1Y1,WITH TUMOR,manual counting,,,>75%,10-75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,DECEASED,2010.0,2d49cea0-0d08-4203-afa0-a1252cbf739a,2d49cea0-0d08-4203-afa0-a1252cbf739a,TCGA-D8-A1Y1-01A-11-A17K-20,TCGA-D8-A1Y1-01A-21D-A14K-09,TCGA-D8-A1Y1-01,TCGA-D8-A1Y1-01A-21D-A14N-05,2a4e381f-db2d-4b2e-828c-9264d218439c,TCGA-D8-A1Y1-01,TCGA-D8-A1Y1-01A-21D-A14K-09,,,TCGA-D8-A1Y1-01,TCGA-D8-A1Y1-01A-21D-A14K-09,,2d49cea0-0d08-4203-afa0-a1252cbf739a,,TCGA-D8-A1Y1-01A-21D-A14J-01,TCGA-D8-A1Y1-01,,2d49cea0-0d08-4203-afa0-a1252cbf739a,TCGA-D8-A1Y1-01A-21D-A14J-01,
tcga.d8.a1y2,Stage IIA,71.0,4.0,Stage IIA,72.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,72.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1Y2-01,433.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,,mutation cluster 4,TCGA-D8-A1Y2,433.0,0.0,days,433.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1Y2-F30086,TCGA-D8-A1Y2,TCGA-D8-A1Y2-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-26021.0,65.0,,0.0,433.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Venten,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,470.0,NO,Indeterminate,Negative,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf,A1Y2,TUMOR FREE,manual counting,,,,>75%,,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,4d184421-3a3d-499a-bdb5-230f45e6d16f,4d184421-3a3d-499a-bdb5-230f45e6d16f,TCGA-D8-A1Y2-01A-21-A17K-20,TCGA-D8-A1Y2-01A-11D-A159-09,TCGA-D8-A1Y2-01,TCGA-D8-A1Y2-01A-11D-A161-05,4a0da6ed-16e6-4f14-8f18-0df68e63d002,TCGA-D8-A1Y2-01,TCGA-D8-A1Y2-01A-11D-A159-09,,,TCGA-D8-A1Y2-01,TCGA-D8-A1Y2-01A-11D-A159-09,,4d184421-3a3d-499a-bdb5-230f45e6d16f,,TCGA-D8-A1Y2-01A-11D-A160-01,TCGA-D8-A1Y2-01,,4d184421-3a3d-499a-bdb5-230f45e6d16f,TCGA-D8-A1Y2-01A-11D-A160-01,
tcga.d8.a1y3,Stage IIIA,61.0,4.0,Stage IIIA,124.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,124.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A1Y3-01,430.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,,mutation cluster 5,TCGA-D8-A1Y3,430.0,0.0,days,430.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A1Y3-F30088,TCGA-D8-A1Y3,TCGA-D8-A1Y3-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-22317.0,62.0,,0.0,430.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Venten,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,300.0,NO,Indeterminate,Negative,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,5.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf,A1Y3,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9,e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9,TCGA-D8-A1Y3-01A-21-A17K-20,TCGA-D8-A1Y3-01A-11D-A159-09,TCGA-D8-A1Y3-01,TCGA-D8-A1Y3-01A-11D-A161-05,98a25723-ede5-43a7-988d-5a753c500649,TCGA-D8-A1Y3-01,TCGA-D8-A1Y3-01A-11D-A159-09,,,TCGA-D8-A1Y3-01,TCGA-D8-A1Y3-01A-11D-A159-09,,e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9,,TCGA-D8-A1Y3-01A-11D-A160-01,TCGA-D8-A1Y3-01,,e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9,TCGA-D8-A1Y3-01A-11D-A160-01,
tcga.d8.a27e,Stage IA,66.0,,Stage I,182.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,182.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A27E-01,530.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation c1uster 9,TCGA-D8-A27E,530.0,0.0,days,530.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A27E-F30112,TCGA-D8-A27E,TCGA-D8-A27E-01A,,Positive,,,,,Positive,[Discrepancy],,NO,,,-24315.0,204.0,,0.0,530.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Hercep Test  TM Dako,,,1+,,,,,"Other, specify",,No,,C50.9,8523/3,C50.9,,YES,,Fine needle aspiration biopsy,110.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf,A27E,TUMOR FREE,,,,,>75%,,YES,<10%,,YES,Primary Tumor,1,quadrantectomy,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,5e32f7e7-6022-4ce2-aa79-4c6671493406,5e32f7e7-6022-4ce2-aa79-4c6671493406,TCGA-D8-A27E-01A-21-A17K-20,TCGA-D8-A27E-01A-11D-A16D-09,TCGA-D8-A27E-01,TCGA-D8-A27E-01A-11D-A16G-05,bac504b5-18a0-4fdb-aea0-4b6e76e8eeb9,TCGA-D8-A27E-01,TCGA-D8-A27E-01A-11D-A16D-09,,,TCGA-D8-A27E-01,TCGA-D8-A27E-01A-11D-A16D-09,,5e32f7e7-6022-4ce2-aa79-4c6671493406,,TCGA-D8-A27E-01A-11D-A16C-01,TCGA-D8-A27E-01,,5e32f7e7-6022-4ce2-aa79-4c6671493406,TCGA-D8-A27E-01A-11D-A16C-01,
tcga.d8.a27f,Stage IIA,40.0,1.0,Stage IIA,227.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,227.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27F-01,488.0,0.0,days,BRCA-LUAD+,C1-LUAD-enriched,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,miRNA cluster 12,,mutation cluster 12,TCGA-D8-A27F,488.0,0.0,days,488.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27F-F29515,TCGA-D8-A27F,TCGA-D8-A27F-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-14731.0,166.0,,0.0,488.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-3-21,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",320.0,NO,Negative,,,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf,A27F,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,0a69935d-9552-4792-9b2e-1a630114691e,0a69935d-9552-4792-9b2e-1a630114691e,TCGA-D8-A27F-01A-21-A17K-20,TCGA-D8-A27F-01A-11D-A16D-09,TCGA-D8-A27F-01,TCGA-D8-A27F-01A-11D-A16G-05,7ce10802-b13b-47af-abe3-b8deaf2c64f4,TCGA-D8-A27F-01,TCGA-D8-A27F-01A-11D-A16D-09,,,TCGA-D8-A27F-01,TCGA-D8-A27F-01A-11D-A16D-09,,0a69935d-9552-4792-9b2e-1a630114691e,,TCGA-D8-A27F-01A-11D-A16C-01,TCGA-D8-A27F-01,,0a69935d-9552-4792-9b2e-1a630114691e,TCGA-D8-A27F-01A-11D-A16C-01,
tcga.d8.a27g,Stage IIA,75.0,2.0,Stage IIA,209.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,209.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27G-01,409.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-D8-A27G,409.0,0.0,days,409.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27G-F29519,TCGA-D8-A27G,TCGA-D8-A27G-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-27521.0,156.0,,0.0,409.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-21,FEMALE,,,,,2+,,not amplified,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Equivocal,Negative,,31.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf,A27G,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2010.0,2ba9072c-39b9-438d-9a2c-0726dc3dc659,2ba9072c-39b9-438d-9a2c-0726dc3dc659,TCGA-D8-A27G-01A-21-A17K-20,,TCGA-D8-A27G-01,TCGA-D8-A27G-01A-11D-A16G-05,10a00b30-4059-4d67-90a5-6fc691cb676e,TCGA-D8-A27G-01,TCGA-D8-A27G-01A-11D-A16D-09,,,TCGA-D8-A27G-01,,,2ba9072c-39b9-438d-9a2c-0726dc3dc659,,TCGA-D8-A27G-01A-11D-A16C-01,TCGA-D8-A27G-01,,2ba9072c-39b9-438d-9a2c-0726dc3dc659,TCGA-D8-A27G-01A-11D-A16C-01,
tcga.d8.a27h,Stage IIA,72.0,1.0,Stage IIA,140.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,140.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27H-01,397.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 3,,mutation cluster 2,TCGA-D8-A27H,397.0,0.0,days,397.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Right Upper Outer Quadrant,No axillary staging,,TCGA-D8-A27H-F29536,TCGA-D8-A27H,TCGA-D8-A27H-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-26588.0,84.0,,0.0,397.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-3-22,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",170.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf,A27H,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,123725b8-4f66-4b97-9726-e0c70300d38e,123725b8-4f66-4b97-9726-e0c70300d38e,TCGA-D8-A27H-01A-21-A17K-20,TCGA-D8-A27H-01A-11D-A16D-09,TCGA-D8-A27H-01,TCGA-D8-A27H-01A-11D-A16G-05,54304e23-2f82-43d6-9ace-f054d7a0f410,TCGA-D8-A27H-01,TCGA-D8-A27H-01A-11D-A16D-09,,,TCGA-D8-A27H-01,TCGA-D8-A27H-01A-11D-A16D-09,,123725b8-4f66-4b97-9726-e0c70300d38e,,TCGA-D8-A27H-01A-11D-A16C-01,TCGA-D8-A27H-01,,123725b8-4f66-4b97-9726-e0c70300d38e,TCGA-D8-A27H-01A-11D-A16C-01,
tcga.d8.a27i,Stage IIIA,58.0,3.0,Stage IIIA,185.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,185.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A27I-01,439.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,mutation c1uster 9,TCGA-D8-A27I,439.0,0.0,days,439.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27I-F29521,TCGA-D8-A27I,TCGA-D8-A27I-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-21327.0,132.0,,0.0,439.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-21,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,900.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,4.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf,A27I,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2010.0,6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1,6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1,TCGA-D8-A27I-01A-21-A17L-20,TCGA-D8-A27I-01A-11D-A16D-09,TCGA-D8-A27I-01,TCGA-D8-A27I-01A-11D-A16G-05,19440cd1-daa0-4103-9be8-b878a9c59988,TCGA-D8-A27I-01,TCGA-D8-A27I-01A-11D-A16D-09,,,TCGA-D8-A27I-01,TCGA-D8-A27I-01A-11D-A16D-09,,6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1,,TCGA-D8-A27I-01A-11D-A16C-01,TCGA-D8-A27I-01,,6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1,TCGA-D8-A27I-01A-11D-A16C-01,
tcga.d8.a27k,Stage IIB,47.0,2.0,Stage IIB,118.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,118.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27K-01,1461.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,,mutation cluster 4,TCGA-D8-A27K,1461.0,0.0,days,1461.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27K-F72201,TCGA-D8-A27K,,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-17426.0,,,0.0,1461.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,NO,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,2.0,,,No,M0,N1a,T2,Stage IIB,,A27K,TUMOR FREE,manual counting,,,>75%,>75%,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2011.0,c0ecd31a-9cce-45d2-9d04-89c465f9b55d,c0ecd31a-9cce-45d2-9d04-89c465f9b55d,TCGA-D8-A27K-01A-21-A17L-20,TCGA-D8-A27K-01A-11D-A16D-09,TCGA-D8-A27K-01,TCGA-D8-A27K-01A-11D-A16G-05,d8b985f8-cbad-42bb-995c-42d7f8221ea4,TCGA-D8-A27K-01,TCGA-D8-A27K-01A-11D-A16D-09,,,TCGA-D8-A27K-01,TCGA-D8-A27K-01A-11D-A16D-09,,c0ecd31a-9cce-45d2-9d04-89c465f9b55d,,TCGA-D8-A27K-01A-11D-A16C-01,TCGA-D8-A27K-01,,c0ecd31a-9cce-45d2-9d04-89c465f9b55d,TCGA-D8-A27K-01A-11D-A16C-01,
tcga.d8.a27l,Stage IIB,49.0,4.0,Stage IIIA,125.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,125.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A27L-01,499.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,mutation cluster 14,TCGA-D8-A27L,499.0,0.0,days,499.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-D8-A27L-F29590,TCGA-D8-A27L,TCGA-D8-A27L-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-18025.0,84.0,,0.0,499.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-6-26,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,220.0,NO,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,2.0,,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf,A27L,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,de27ab29-90b0-4d13-8102-1c2bebc4c29a,de27ab29-90b0-4d13-8102-1c2bebc4c29a,TCGA-D8-A27L-01A-21-A17L-20,TCGA-D8-A27L-01A-11D-A16D-09,TCGA-D8-A27L-01,TCGA-D8-A27L-01A-11D-A16G-05,5f8e2312-38bd-45f9-b2e3-4b51674613c6,TCGA-D8-A27L-01,TCGA-D8-A27L-01A-11D-A16D-09,,,TCGA-D8-A27L-01,TCGA-D8-A27L-01A-11D-A16D-09,,de27ab29-90b0-4d13-8102-1c2bebc4c29a,,TCGA-D8-A27L-01A-11D-A16C-01,TCGA-D8-A27L-01,,de27ab29-90b0-4d13-8102-1c2bebc4c29a,TCGA-D8-A27L-01A-11D-A16C-01,
tcga.d8.a27m,Stage IIA,59.0,1.0,Stage I,144.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,144.0,0.0,Basal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A27M-01,410.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 5,,mutation cluster 5,TCGA-D8-A27M,410.0,0.0,days,410.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A27M-F29592,TCGA-D8-A27M,TCGA-D8-A27M-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-21910.0,83.0,,0.0,410.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,140.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf,A27M,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,20486352-7d5f-4065-ab10-7a3f792ec1e1,20486352-7d5f-4065-ab10-7a3f792ec1e1,TCGA-D8-A27M-01A-21-A17L-20,TCGA-D8-A27M-01A-11D-A16D-09,TCGA-D8-A27M-01,TCGA-D8-A27M-01A-11D-A16G-05,1d3de8e5-df7a-4e6c-a929-e03f23ddf78b,TCGA-D8-A27M-01,TCGA-D8-A27M-01A-11D-A16D-09,,,TCGA-D8-A27M-01,TCGA-D8-A27M-01A-11D-A16D-09,,20486352-7d5f-4065-ab10-7a3f792ec1e1,,TCGA-D8-A27M-01A-11D-A16C-01,TCGA-D8-A27M-01,,20486352-7d5f-4065-ab10-7a3f792ec1e1,TCGA-D8-A27M-01A-11D-A16C-01,
tcga.d8.a27n,Stage IIIA,36.0,5.0,Stage IIIA,145.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N2,145.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27N-01,519.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 5,TCGA-D8-A27N,519.0,0.0,days,519.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,36.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27N-F29594,TCGA-D8-A27N,TCGA-D8-A27N-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-13243.0,75.0,,0.0,519.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Positive,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,4.0,0.0,False,No,M0,N2a,T2,Stage IIIA,TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf,A27N,TUMOR FREE,manual counting,,,10-75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,50808f98-d10b-4190-aff7-428f56abb0f9,50808f98-d10b-4190-aff7-428f56abb0f9,TCGA-D8-A27N-01A-21-A17L-20,TCGA-D8-A27N-01A-11D-A16D-09,TCGA-D8-A27N-01,TCGA-D8-A27N-01A-11D-A16G-05,40a0ee09-0c09-4320-8895-74c68841c341,TCGA-D8-A27N-01,TCGA-D8-A27N-01A-11D-A16D-09,,,TCGA-D8-A27N-01,TCGA-D8-A27N-01A-11D-A16D-09,,50808f98-d10b-4190-aff7-428f56abb0f9,,TCGA-D8-A27N-01A-11D-A16C-01,TCGA-D8-A27N-01,,50808f98-d10b-4190-aff7-428f56abb0f9,TCGA-D8-A27N-01A-11D-A16C-01,
tcga.d8.a27p,Stage IIA,64.0,2.0,Stage I,22.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,22.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-D8-A27P-01,49.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,,mutation cluster 4,TCGA-D8-A27P,49.0,0.0,days,49.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-D8-A27P-F29596,TCGA-D8-A27P,TCGA-D8-A27P-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-23576.0,37.0,,0.0,49.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-10-26,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,intraoperative examination,"Other method, specify:",100.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf,A27P,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,D8,Breast,A,LIVING,2011.0,189c7b41-4d4e-422e-85a2-1f575b5c8b5c,189c7b41-4d4e-422e-85a2-1f575b5c8b5c,TCGA-D8-A27P-01A-21-A17L-20,TCGA-D8-A27P-01A-11D-A16D-09,TCGA-D8-A27P-01,TCGA-D8-A27P-01A-11D-A16G-05,ead322fe-b46f-4cc6-a367-5e7681a6f494,TCGA-D8-A27P-01,TCGA-D8-A27P-01A-11D-A16D-09,,,TCGA-D8-A27P-01,TCGA-D8-A27P-01A-11D-A16D-09,,189c7b41-4d4e-422e-85a2-1f575b5c8b5c,,TCGA-D8-A27P-01A-11D-A16C-01,TCGA-D8-A27P-01,,189c7b41-4d4e-422e-85a2-1f575b5c8b5c,TCGA-D8-A27P-01A-11D-A16C-01,
tcga.d8.a27r,Stage IIIC,41.0,5.0,Stage IIIC,90.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,90.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27R-01,29.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,mutation c1uster 9,TCGA-D8-A27R,,,days,29.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A27R-F29701,TCGA-D8-A27R,TCGA-D8-A27R-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-15122.0,50.0,,0.0,29.0,,,,,NO,manual counting,,polisomy,Scheduled Follow-up Submission,2012-4-28,FEMALE,,,,,2+,,not amplified,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,440.0,NO,Equivocal,Negative,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,,11.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf,A27R,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,LIVING,2011.0,70546486-80a3-452c-8722-1bd7b14d5ac4,70546486-80a3-452c-8722-1bd7b14d5ac4,TCGA-D8-A27R-01A-21-A17L-20,TCGA-D8-A27R-01A-11D-A16D-09,TCGA-D8-A27R-01,TCGA-D8-A27R-01A-11D-A16G-05,a5eef620-ca1e-4125-9143-286bada198cf,TCGA-D8-A27R-01,TCGA-D8-A27R-01A-11D-A16D-09,,,TCGA-D8-A27R-01,TCGA-D8-A27R-01A-11D-A16D-09,,70546486-80a3-452c-8722-1bd7b14d5ac4,,TCGA-D8-A27R-01A-11D-A16C-01,TCGA-D8-A27R-01,,70546486-80a3-452c-8722-1bd7b14d5ac4,TCGA-D8-A27R-01A-11D-A16C-01,
tcga.d8.a27t,Stage IIIC,53.0,2.0,Stage IIIC,135.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,135.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27T-01,398.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,,mutation cluster 4,TCGA-D8-A27T,398.0,0.0,days,398.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-D8-A27T-F30096,TCGA-D8-A27T,TCGA-D8-A27T-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-19591.0,68.0,,0.0,398.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Venten,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Negative,,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,12.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf,A27T,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,090d6483-72df-4a55-84ef-5e196d1982cf,090d6483-72df-4a55-84ef-5e196d1982cf,TCGA-D8-A27T-01A-21-A17L-20,TCGA-D8-A27T-01A-11D-A16D-09,TCGA-D8-A27T-01,TCGA-D8-A27T-01A-11D-A16G-05,bc97c384-d3a4-400b-b9f7-cbca9e5356d8,TCGA-D8-A27T-01,TCGA-D8-A27T-01A-11D-A16D-09,,,TCGA-D8-A27T-01,TCGA-D8-A27T-01A-11D-A16D-09,,090d6483-72df-4a55-84ef-5e196d1982cf,,TCGA-D8-A27T-01A-11D-A16C-01,TCGA-D8-A27T-01,,090d6483-72df-4a55-84ef-5e196d1982cf,TCGA-D8-A27T-01A-11D-A16C-01,
tcga.d8.a27v,Stage IIA,62.0,2.0,Stage IIA,73.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,73.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-D8-A27V-01,381.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,,,TCGA-D8-A27V,381.0,0.0,days,381.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A27V-F30105,TCGA-D8-A27V,,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-22958.0,,,0.0,381.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-3-29,FEMALE,,Venten,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A27V,TUMOR FREE,,,,,>75%,,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,,LIVING,2011.0,a4c963fd-c8a6-4dcb-8b6e-159591e61d49,a4c963fd-c8a6-4dcb-8b6e-159591e61d49,TCGA-D8-A27V-01A-21-A24A-20,,TCGA-D8-A27V-01,TCGA-D8-A27V-01A-12D-A17F-05,afa1063a-d82c-4277-a7af-552dd7df54b5,TCGA-D8-A27V-01,TCGA-D8-A27V-01A-12D-A17D-09,,,TCGA-D8-A27V-01,,,a4c963fd-c8a6-4dcb-8b6e-159591e61d49,,TCGA-D8-A27V-01A-12D-A17C-01,TCGA-D8-A27V-01,,a4c963fd-c8a6-4dcb-8b6e-159591e61d49,TCGA-D8-A27V-01A-12D-A17C-01,
tcga.d8.a27w,Stage IIIB,55.0,3.0,Stage IIIB,15.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,15.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T4,LIVING,0.0,TCGA-D8-A27W-01,373.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,mutation c1uster 9,TCGA-D8-A27W,373.0,0.0,days,373.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Right,Axillary lymph node dissection alone,,TCGA-D8-A27W-F30107,TCGA-D8-A27W,TCGA-D8-A27W-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20173.0,43.0,,0.0,373.0,,,,,NO,manual counting,,,Scheduled Follow-up Submission,2012-4-2,FEMALE,,Venten,,Path Vysion HER2 D Probe Kit,2+,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Fine needle aspiration biopsy,390.0,NO,Equivocal,Positive,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,,False,No,M0,N0,T4b,Stage IIIB,TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf,A27W,TUMOR FREE,manual counting,,,>75%,>75%,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,D8,Breast,A,LIVING,2011.0,65843fe1-4da2-4165-8926-a0d6f878a7f8,65843fe1-4da2-4165-8926-a0d6f878a7f8,TCGA-D8-A27W-01A-21-A17L-20,TCGA-D8-A27W-01A-11D-A16D-09,TCGA-D8-A27W-01,TCGA-D8-A27W-01A-11D-A16G-05,14737f59-b01c-4ed7-a08b-3a05926f8d87,TCGA-D8-A27W-01,TCGA-D8-A27W-01A-11D-A16D-09,,,TCGA-D8-A27W-01,TCGA-D8-A27W-01A-11D-A16D-09,,65843fe1-4da2-4165-8926-a0d6f878a7f8,,TCGA-D8-A27W-01A-11D-A16C-01,TCGA-D8-A27W-01,,65843fe1-4da2-4165-8926-a0d6f878a7f8,TCGA-D8-A27W-01A-11D-A16C-01,
tcga.d8.a3z5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-D8-A3Z5-01,1015.0,0.0,days,,,,,,,,,,TCGA-D8-A3Z5,1015.0,0.0,days,1015.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right,Other (specify),mastectomy with TLND,TCGA-D8-A3Z5-F57869,TCGA-D8-A3Z5,TCGA-D8-A3Z5-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-19846.0,418.0,,0.0,1015.0,,,,,NO,,,,,2014-3-28,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,320.0,NO,Negative,,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,19.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf,A3Z5,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,LIVING,2011.0,f47007db-f16a-4721-aac4-c7fb6e9ca868,f47007db-f16a-4721-aac4-c7fb6e9ca868,,,TCGA-D8-A3Z5-01,TCGA-D8-A3Z5-01A-41D-A244-05,4d39d2a1-a65b-4845-8938-cf37bb0ac0ea,TCGA-D8-A3Z5-01,TCGA-D8-A3Z5-01A-41D-A243-09,,,TCGA-D8-A3Z5-01,,,f47007db-f16a-4721-aac4-c7fb6e9ca868,,TCGA-D8-A3Z5-01A-41D-A242-01,TCGA-D8-A3Z5-01,,f47007db-f16a-4721-aac4-c7fb6e9ca868,TCGA-D8-A3Z5-01A-41D-A242-01,
tcga.d8.a3z6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-D8-A3Z6-01,563.0,0.0,days,,,,,,,,,,TCGA-D8-A3Z6,563.0,0.0,days,563.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left,Other (specify),mastectomy with TLND,TCGA-D8-A3Z6-F51367,TCGA-D8-A3Z6,TCGA-D8-A3Z6-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-20629.0,160.0,,0.0,563.0,,,,,NO,,,,,2013-11-18,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,60.0,NO,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,19.0,,False,No,M0,N3a,T3,Stage IIIC,TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf,A3Z6,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,LIVING,2011.0,0593faf5-8fcc-4aba-a926-c06c70cef7a8,0593faf5-8fcc-4aba-a926-c06c70cef7a8,,,TCGA-D8-A3Z6-01,TCGA-D8-A3Z6-01A-11D-A23D-05,,TCGA-D8-A3Z6-01,TCGA-D8-A3Z6-01A-11D-A23C-09,,,TCGA-D8-A3Z6-01,,,0593faf5-8fcc-4aba-a926-c06c70cef7a8,,TCGA-D8-A3Z6-01A-11D-A238-01,TCGA-D8-A3Z6-01,,0593faf5-8fcc-4aba-a926-c06c70cef7a8,TCGA-D8-A3Z6-01A-11D-A238-01,
tcga.d8.a4z1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-D8-A4Z1-01,659.0,0.0,days,,,,,,,,,,TCGA-D8-A4Z1,659.0,0.0,days,659.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Right|Right Upper Inner Quadrant,No axillary staging,,TCGA-D8-A4Z1-F58485,TCGA-D8-A4Z1,,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-25097.0,,,0.0,659.0,,,,,,,70-79%,,,2014-4-11,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage IA,,A4Z1,TUMOR FREE,,,,,,YES,YES,10-19%,,NO,Primary Tumor,1,,7th,,YES,NO,D8,Breast,,LIVING,2012.0,e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72,e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72,,,TCGA-D8-A4Z1-01,TCGA-D8-A4Z1-01A-21D-A268-05,,TCGA-D8-A4Z1-01,TCGA-D8-A4Z1-01A-21D-A25Q-09,,,TCGA-D8-A4Z1-01,,,e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72,,TCGA-D8-A4Z1-01A-21D-A25N-01,TCGA-D8-A4Z1-01,,e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72,TCGA-D8-A4Z1-01A-21D-A25N-01,
tcga.d8.a73u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-D8-A73U-01,492.0,0.0,days,,,,,,,,,,TCGA-D8-A73U,492.0,0.0,days,492.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,88.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-D8-A73U-F57871,TCGA-D8-A73U,TCGA-D8-A73U-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-32208.0,285.0,,0.0,492.0,,,,,,,70-79%,,,2014-3-28,FEMALE,,,<10%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,90.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf,A73U,WITH TUMOR,,,,,,YES,NO,70-79%,,NO,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,LIVING,2012.0,57728a07-cb68-45d9-ac86-eba57e674e1d,57728a07-cb68-45d9-ac86-eba57e674e1d,,,TCGA-D8-A73U-01,TCGA-D8-A73U-01A-11D-A33F-05,B493DB95-AFD7-42BC-A00E-B703F9FB9D1F,TCGA-D8-A73U-01,,,,TCGA-D8-A73U-01,,,57728a07-cb68-45d9-ac86-eba57e674e1d,,TCGA-D8-A73U-01A-11D-A33D-01,TCGA-D8-A73U-01,,57728a07-cb68-45d9-ac86-eba57e674e1d,TCGA-D8-A73U-01A-11D-A33D-01,
tcga.d8.a73w,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-D8-A73W-01,385.0,1.0,days,,,,,,,,,,TCGA-D8-A73W,21.0,1.0,days,385.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,YES,,,79.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-D8-A73W-F72197,TCGA-D8-A73W,TCGA-D8-A73W-01A,,Positive,,,,,Negative,Simple Mastectomy,,NO,,,-29125.0,191.0,385.0,0.0,244.0,,,21,,,,70-79%,,,2015-4-29,FEMALE,,,,,1+,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Tumor resection,230.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,Lung|Bone,,,,,,,Lung,Distant Metastasis,,NO,YES,1.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf,A73W,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,DECEASED,2013.0,ae442e30-9756-46a8-825b-3e5b7ad394d5,ae442e30-9756-46a8-825b-3e5b7ad394d5,,,TCGA-D8-A73W-01,TCGA-D8-A73W-01A-22D-A357-05,411140F2-9383-4269-B52B-D48CC374DBDE,TCGA-D8-A73W-01,,,,TCGA-D8-A73W-01,,,ae442e30-9756-46a8-825b-3e5b7ad394d5,,TCGA-D8-A73W-01A-22D-A350-01,TCGA-D8-A73W-01,,ae442e30-9756-46a8-825b-3e5b7ad394d5,TCGA-D8-A73W-01A-22D-A350-01,
tcga.d8.a73x,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-D8-A73X-01,767.0,0.0,days,,,,,,,,,,TCGA-D8-A73X,767.0,0.0,days,767.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-D8-A73X-F72193,TCGA-D8-A73X,TCGA-D8-A73X-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-19607.0,140.0,,0.0,767.0,,,,,,,70-79%,,,2015-4-29,FEMALE,,,,,1+,,,,,"Other, specify",,No,,C50.9,8211/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf,A73X,TUMOR FREE,,,,,,YES,NO,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,D8,Breast,A,LIVING,2013.0,a982e795-5256-439a-ae7b-9c250eefea53,a982e795-5256-439a-ae7b-9c250eefea53,,,TCGA-D8-A73X-01,TCGA-D8-A73X-01A-11D-A32T-05,062D46A5-FB34-4EF7-86A8-C56A88FC5119,TCGA-D8-A73X-01,,,,TCGA-D8-A73X-01,,,a982e795-5256-439a-ae7b-9c250eefea53,,TCGA-D8-A73X-01A-11D-A32H-01,TCGA-D8-A73X-01,,a982e795-5256-439a-ae7b-9c250eefea53,TCGA-D8-A73X-01A-11D-A32H-01,
tcga.e2.a14n,Stage IIB,37.0,4.0,Stage IIB,1350.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,1350.0,0.0,Basal,Basal-like,Negative,,-13.0,-12.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A14N-01,1434.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 5,cluster 6,mutation cluster 5,TCGA-E2-A14N,1434.0,0.0,days,1434.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,37.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A14N-F19154,TCGA-E2-A14N,TCGA-E2-A14N-01A,,Negative,,,,,Negative,Simple Mastectomy,,NO,,,-13743.0,1240.0,,0.0,1434.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2011-11-17,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,440.0,NO,Negative,,,38.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,1.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf,A14N,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2007.0,6e45dd01-225d-4871-9a3a-f591808ad234,6e45dd01-225d-4871-9a3a-f591808ad234,TCGA-E2-A14N-01A-21-A17I-20,TCGA-E2-A14N-01A-31D-A135-09,TCGA-E2-A14N-01,TCGA-E2-A14N-01A-31D-A138-05,df24b18e-26f0-494d-a7bc-4672b1a0314b,TCGA-E2-A14N-01,TCGA-E2-A14N-01A-31D-A135-09,,TCGA-E2-A14N-01,TCGA-E2-A14N-01,TCGA-E2-A14N-01A-31D-A135-09,,6e45dd01-225d-4871-9a3a-f591808ad234,,TCGA-E2-A14N-01A-31D-A134-01,TCGA-E2-A14N-01,TCGA-E2-A14N-01A-31R-A137-07,6e45dd01-225d-4871-9a3a-f591808ad234,TCGA-E2-A14N-01A-31D-A134-01,TCGA-E2-A14N-01
tcga.e2.a14u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A14U-01,1318.0,0.0,days,Quiet,,,BRCA non-CIMP c9,,,miRNA cluster 5,,,TCGA-E2-A14U,1318.0,0.0,days,1318.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Right Upper Outer Quadrant,Other (specify),Sentinel lymph node dissection,TCGA-E2-A14U-F33622,TCGA-E2-A14U,TCGA-E2-A14U-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-27389.0,796.0,,0.0,1318.0,,,,,NO,Allred score 5+3 = 8,,,Scheduled Follow-up Submission,2012-7-11,FEMALE,,,40-49%,,2+,,,1.04,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,70.0,NO,Equivocal,Negative,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf,A14U,TUMOR FREE,Allred score 5+3 = 8,,,Allred score = 8,Allred score = 8,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,20d25e27-b509-45eb-a734-9b8d6a40c632,20d25e27-b509-45eb-a734-9b8d6a40c632,,,TCGA-E2-A14U-01,TCGA-E2-A14U-01A-11D-A22B-05,,TCGA-E2-A14U-01,TCGA-E2-A14U-01A-11D-A228-09,,,TCGA-E2-A14U-01,,,20d25e27-b509-45eb-a734-9b8d6a40c632,,TCGA-E2-A14U-01A-11D-A227-01,TCGA-E2-A14U-01,,20d25e27-b509-45eb-a734-9b8d6a40c632,TCGA-E2-A14U-01A-11D-A227-01,
tcga.e2.a15i,Stage IIA,44.0,2.0,Stage IIA,411.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,411.0,0.0,LumA,Luminal A,Positive,,-5.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A15I-01,1692.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-E2-A15I,1692.0,0.0,days,1692.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A15I-F70023,TCGA-E2-A15I,TCGA-E2-A15I-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-16163.0,344.0,,0.0,1692.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,,,2+,,,1.04,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,100.0,NO,Equivocal,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,,,,,NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf,A15I,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c,4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c,TCGA-E2-A15I-01A-11-A17I-20,TCGA-E2-A15I-01A-21D-A135-09,TCGA-E2-A15I-01,TCGA-E2-A15I-01A-21D-A138-05,6be5e02d-4e5b-4b24-b603-4512dff0f17c,TCGA-E2-A15I-01,TCGA-E2-A15I-01A-21D-A135-09,,TCGA-E2-A15I-01,TCGA-E2-A15I-01,TCGA-E2-A15I-01A-21D-A135-09,,4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c,,TCGA-E2-A15I-01A-21D-A134-01,TCGA-E2-A15I-01,TCGA-E2-A15I-01A-21R-A137-07,4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c,TCGA-E2-A15I-01A-21D-A134-01,TCGA-E2-A15I-01
tcga.e2.a15j,Stage I,51.0,2.0,Stage I,463.0,,Positive,FEMALE,Negative,1.0,3.0,3.0,Negative,M0,Negative,N0,463.0,0.0,LumA,Luminal A,Positive,LumA/B,-12.0,-3.0,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A15J-01,1640.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-E2-A15J,1640.0,0.0,days,1640.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A15J-F70020,TCGA-E2-A15J,TCGA-E2-A15J-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-18771.0,344.0,,0.0,1640.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,,,2+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,210.0,NO,Equivocal,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf,A15J,TUMOR FREE,,,,Allred score = 8,Allred score = 7,YES,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,376c13fa-ba3e-4f2e-a8bc-87fb70541239,376c13fa-ba3e-4f2e-a8bc-87fb70541239,TCGA-E2-A15J-01A-21-A13E-20,TCGA-E2-A15J-01A-11D-A12Q-09,TCGA-E2-A15J-01,TCGA-E2-A15J-01A-11D-A12R-05,ffe06b3a-f290-463c-bb0e-994c0679f8be,TCGA-E2-A15J-01,TCGA-E2-A15J-01A-11D-A12Q-09,,TCGA-E2-A15J-01,TCGA-E2-A15J-01,TCGA-E2-A15J-01A-11D-A12Q-09,,376c13fa-ba3e-4f2e-a8bc-87fb70541239,,TCGA-E2-A15J-01A-11D-A12N-01,TCGA-E2-A15J-01,TCGA-E2-A15J-01A-11R-A12P-07,376c13fa-ba3e-4f2e-a8bc-87fb70541239,TCGA-E2-A15J-01A-11D-A12N-01,TCGA-E2-A15J-01
tcga.e2.a15k,Stage IIA,58.0,2.0,Stage IIB,34.0,,Positive,FEMALE,Negative,3.0,3.0,4.0,Negative,M0,Positive,N1,34.0,0.0,LumB,Luminal B,Positive,LumA,-12.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A15K-01,275.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E2-A15K,275.0,0.0,days,275.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A15K-F18869,TCGA-E2-A15K,TCGA-E2-A15K-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-21514.0,309.0,,0.0,275.0,,,,,NO,Allred score 5+3 = 8,,,Scheduled Follow-up Submission,2011-11-15,FEMALE,,,10-19%,,2+,,,0.9,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,170.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,2.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf,A15K,TUMOR FREE,Allred score 2+2 = 4,,,Allred score = 4,Allred score = 8,,YES,,,YES,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,141e15ac-1537-4182-9db5-ba2115cd93d6,141e15ac-1537-4182-9db5-ba2115cd93d6,,TCGA-E2-A15K-01A-11D-A12Q-09,TCGA-E2-A15K-01,TCGA-E2-A15K-01A-11D-A12R-05,1afef343-eb28-46d1-ba40-2475188b33c5,TCGA-E2-A15K-01,TCGA-E2-A15K-01A-11D-A12Q-09,,TCGA-E2-A15K-01,TCGA-E2-A15K-01,TCGA-E2-A15K-01A-11D-A12Q-09,,141e15ac-1537-4182-9db5-ba2115cd93d6,,TCGA-E2-A15K-01A-11D-A12N-01,TCGA-E2-A15K-01,TCGA-E2-A15K-01A-11R-A12P-07,141e15ac-1537-4182-9db5-ba2115cd93d6,TCGA-E2-A15K-01A-11D-A12N-01,TCGA-E2-A15K-01
tcga.e2.a1az,Stage IIB,63.0,4.0,Stage IIB,1964.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,1964.0,0.0,Basal,Basal-like,Negative,Basal,-13.0,-12.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1AZ-01,2329.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,,,mutation c1uster 9,TCGA-E2-A1AZ,2329.0,0.0,days,2329.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1AZ-F19462,TCGA-E2-A1AZ,TCGA-E2-A1AZ-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,NO,,,-23230.0,2527.0,,0.0,2329.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-6,FEMALE,,,,,,,,0.42,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,250.0,NO,Indeterminate,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf,A1AZ,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2004.0,fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c,fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c,TCGA-E2-A1AZ-01A-21-A13E-20,TCGA-E2-A1AZ-01A-11D-A12Q-09,TCGA-E2-A1AZ-01,TCGA-E2-A1AZ-01A-11D-A12R-05,187a4af6-1941-419e-a58d-d3fb18510b65,TCGA-E2-A1AZ-01,TCGA-E2-A1AZ-01A-11D-A12Q-09,,TCGA-E2-A1AZ-01,TCGA-E2-A1AZ-01,TCGA-E2-A1AZ-01A-11D-A12Q-09,,fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c,,TCGA-E2-A1AZ-01A-11D-A12N-01,TCGA-E2-A1AZ-01,TCGA-E2-A1AZ-01A-11R-A12P-07,fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c,TCGA-E2-A1AZ-01A-11D-A12N-01,TCGA-E2-A1AZ-01
tcga.e2.a1b0,Stage IIIA,50.0,3.0,Stage IIIA,1271.0,,Negative,FEMALE,Positive,1.0,2.0,2.0,Negative,M0,Positive,N2,1271.0,0.0,Her2,HER2-enriched,Negative,ReacI,-13.0,-10.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1B0-01,1631.0,0.0,days,High,C3-BRCA/Luminal,cluster 5,Cluster 5,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-E2-A1B0,1631.0,0.0,days,1631.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A1B0-F19460,TCGA-E2-A1B0,TCGA-E2-A1B0-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18346.0,1315.0,,0.0,1631.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2011-12-7,FEMALE,,,90-99%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,110.0,NO,Positive,,,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf,A1B0,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2007.0,8bb3543b-5c83-41c6-b81c-b20935c38d72,8bb3543b-5c83-41c6-b81c-b20935c38d72,TCGA-E2-A1B0-01A-21-A13E-20,TCGA-E2-A1B0-01A-11D-A12Q-09,TCGA-E2-A1B0-01,TCGA-E2-A1B0-01A-11D-A12R-05,2eae7190-37af-4257-9a9e-29a8c937a513,TCGA-E2-A1B0-01,TCGA-E2-A1B0-01A-11D-A12Q-09,,TCGA-E2-A1B0-01,TCGA-E2-A1B0-01,TCGA-E2-A1B0-01A-11D-A12Q-09,,8bb3543b-5c83-41c6-b81c-b20935c38d72,,TCGA-E2-A1B0-01A-11D-A12N-01,TCGA-E2-A1B0-01,TCGA-E2-A1B0-01A-11R-A12P-07,8bb3543b-5c83-41c6-b81c-b20935c38d72,TCGA-E2-A1B0-01A-11D-A12N-01,TCGA-E2-A1B0-01
tcga.e2.a1b1,Stage IIB,45.0,3.0,Stage IIB,1361.0,,Positive,FEMALE,Positive,1.0,2.0,3.0,Negative,M0,Positive,N1,1361.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1B1-01,2653.0,0.0,days,Kirc+,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-E2-A1B1,2653.0,0.0,days,2653.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1B1-F70009,TCGA-E2-A1B1,TCGA-E2-A1B1-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-16603.0,1268.0,,0.0,2653.0,,,,,NO,Allred score 3+2 = 5,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,70-79%,,2+,,,15.12,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,300.0,NO,Equivocal,Positive,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,4.0,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf,A1B1,TUMOR FREE,Allred score 2+2 = 4,,,Allred score = 4,Allred score = 5,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2007.0,2aa34033-a6f5-45a8-833b-b433352e58ba,2aa34033-a6f5-45a8-833b-b433352e58ba,TCGA-E2-A1B1-01A-11-A13E-20,TCGA-E2-A1B1-01A-21D-A12Q-09,TCGA-E2-A1B1-01,TCGA-E2-A1B1-01A-21D-A12R-05,c476545a-0d56-4d49-9180-bb707d02a1c9,TCGA-E2-A1B1-01,TCGA-E2-A1B1-01A-21D-A12Q-09,,TCGA-E2-A1B1-01,TCGA-E2-A1B1-01,TCGA-E2-A1B1-01A-21D-A12Q-09,,2aa34033-a6f5-45a8-833b-b433352e58ba,,TCGA-E2-A1B1-01A-21D-A12N-01,TCGA-E2-A1B1-01,TCGA-E2-A1B1-01A-21R-A12P-07,2aa34033-a6f5-45a8-833b-b433352e58ba,TCGA-E2-A1B1-01A-21D-A12N-01,TCGA-E2-A1B1-01
tcga.e2.a1b4,Stage IIIA,74.0,2.0,Stage IIIA,911.0,,Positive,FEMALE,Negative,3.0,3.0,3.0,Negative,M0,Positive,N2,911.0,0.0,LumA,Luminal A,Positive,LumA/B,-12.0,-3.0,enrollment,T1,T1,LIVING,1.0,TCGA-E2-A1B4-01,1004.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,cluster 6,mutation cluster 4,TCGA-E2-A1B4,1004.0,0.0,days,1004.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1B4-F19443,TCGA-E2-A1B4,TCGA-E2-A1B4-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-27241.0,798.0,1004.0,0.0,911.0,,,,,NO,Allred score 5+3 = 8,,,Scheduled Follow-up Submission,2011-12-8,FEMALE,,,10-19%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,110.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,3.0,,True,No,M0,N2a,T1c,Stage IIIA,TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf,A1B4,TUMOR FREE,Allred score 5+3 = 8,,,Allred score = 8,Allred score = 8,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,DECEASED,2008.0,2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6,2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6,TCGA-E2-A1B4-01A-21-A13E-20,TCGA-E2-A1B4-01A-11D-A12Q-09,TCGA-E2-A1B4-01,TCGA-E2-A1B4-01A-11D-A12R-05,4b198843-12fe-41e0-af18-0638dd948c6a,TCGA-E2-A1B4-01,TCGA-E2-A1B4-01A-11D-A12Q-09,,TCGA-E2-A1B4-01,TCGA-E2-A1B4-01,TCGA-E2-A1B4-01A-11D-A12Q-09,,2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6,,TCGA-E2-A1B4-01A-11D-A12N-01,TCGA-E2-A1B4-01,TCGA-E2-A1B4-01A-11R-A12P-07,2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6,TCGA-E2-A1B4-01A-11D-A12N-01,TCGA-E2-A1B4-01
tcga.e2.a1b5,Stage IIA,46.0,3.0,Stage IIA,774.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Negative,N0,774.0,0.0,LumA,Basal-like,Positive,ReacI,-13.0,-12.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1B5-01,984.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-E2-A1B5,984.0,0.0,days,984.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left,Sentinel node biopsy alone,,TCGA-E2-A1B5-F19393,TCGA-E2-A1B5,TCGA-E2-A1B5-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-17039.0,783.0,,0.0,984.0,,,,,NO,Allred score 5+3 = 8,,,Scheduled Follow-up Submission,2011-12-8,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,260.0,NO,Negative,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf,A1B5,TUMOR FREE,Allred score 2+3 = 5,,,Allred score = 5,Allred score = 8,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,a2c80f8e-f08d-4574-90a0-f0651c0a9b1b,a2c80f8e-f08d-4574-90a0-f0651c0a9b1b,TCGA-E2-A1B5-01A-31-A13E-20,TCGA-E2-A1B5-01A-21D-A12Q-09,TCGA-E2-A1B5-01,TCGA-E2-A1B5-01A-21D-A12R-05,96c90192-0896-42a2-bc87-ae6bf8bb5c9f,TCGA-E2-A1B5-01,TCGA-E2-A1B5-01A-21D-A12Q-09,,TCGA-E2-A1B5-01,TCGA-E2-A1B5-01,TCGA-E2-A1B5-01A-21D-A12Q-09,,a2c80f8e-f08d-4574-90a0-f0651c0a9b1b,,TCGA-E2-A1B5-01A-21D-A12N-01,TCGA-E2-A1B5-01,TCGA-E2-A1B5-01A-21R-A12P-07,a2c80f8e-f08d-4574-90a0-f0651c0a9b1b,TCGA-E2-A1B5-01A-21D-A12N-01,TCGA-E2-A1B5-01
tcga.e2.a1b6,Stage IIA,44.0,1.0,Stage IIA,338.0,,Negative,FEMALE,Negative,2.0,2.0,2.0,Negative,M0,Negative,N0,338.0,0.0,,Luminal A,Negative,Basal,-5.0,-7.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1B6-01,867.0,0.0,days,Quiet,C13-AML,cluster 5,Low purity c2,BRCA basal-like c6,,miRNA cluster 15,cluster 6,mutation cluster 5,TCGA-E2-A1B6,867.0,0.0,days,867.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left,Sentinel node biopsy alone,,TCGA-E2-A1B6-F19389,TCGA-E2-A1B6,,,Negative,,,,,Negative,Simple Mastectomy,,NO,,,-16370.0,,,0.0,867.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2011-12-8,FEMALE,,,10-19%,,2+,,,1.03,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Equivocal,Negative,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1B6,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,,LIVING,2008.0,eb398b00-8669-4c22-8285-03cdf76436f3,eb398b00-8669-4c22-8285-03cdf76436f3,TCGA-E2-A1B6-01A-21-A13E-20,TCGA-E2-A1B6-01A-31D-A12Q-09,TCGA-E2-A1B6-01,TCGA-E2-A1B6-01A-31D-A12R-05,dc503863-7967-469b-b966-69dcea2dfb86,TCGA-E2-A1B6-01,TCGA-E2-A1B6-01A-31D-A12Q-09,,TCGA-E2-A1B6-01,TCGA-E2-A1B6-01,TCGA-E2-A1B6-01A-31D-A12Q-09,,eb398b00-8669-4c22-8285-03cdf76436f3,,TCGA-E2-A1B6-01A-31D-A12N-01,TCGA-E2-A1B6-01,TCGA-E2-A1B6-01A-31R-A12P-07,eb398b00-8669-4c22-8285-03cdf76436f3,TCGA-E2-A1B6-01A-31D-A12N-01,TCGA-E2-A1B6-01
tcga.e2.a1bc,Stage IA,63.0,2.0,Stage I,297.0,,Positive,FEMALE,Negative,3.0,4.0,3.0,Negative,M0,Negative,N0,297.0,0.0,LumA,Luminal A,Positive,ReacI,-5.0,-7.0,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1BC-01,501.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 4,TCGA-E2-A1BC,501.0,0.0,days,501.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1BC-F19427,TCGA-E2-A1BC,TCGA-E2-A1BC-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-23168.0,275.0,,0.0,501.0,,,,,NO,,,,Scheduled Follow-up Submission,2011-12-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8524/3,C50.9,,YES,,Tumor resection,100.0,NO,Negative,,,4.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,0.0,,True,Yes,M0,N0,T1c,Stage IA,TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf,A1BC,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,a2cf164c-5b26-43eb-9de9-d1d457a5de06,a2cf164c-5b26-43eb-9de9-d1d457a5de06,TCGA-E2-A1BC-01A-21-A13E-20,TCGA-E2-A1BC-01A-11D-A14G-09,TCGA-E2-A1BC-01,TCGA-E2-A1BC-01A-11D-A12R-05,8d3961ff-444a-4808-a697-c21898446648,TCGA-E2-A1BC-01,TCGA-E2-A1BC-01A-11D-A14G-09,,TCGA-E2-A1BC-01,TCGA-E2-A1BC-01,TCGA-E2-A1BC-01A-11D-A14G-09,,a2cf164c-5b26-43eb-9de9-d1d457a5de06,,TCGA-E2-A1BC-01A-11D-A12N-01,TCGA-E2-A1BC-01,TCGA-E2-A1BC-01A-11R-A12P-07,a2cf164c-5b26-43eb-9de9-d1d457a5de06,TCGA-E2-A1BC-01A-11D-A12N-01,TCGA-E2-A1BC-01
tcga.e2.a1bd,Stage IIA,53.0,2.0,Stage IIA,317.0,,Positive,FEMALE,Negative,3.0,3.0,3.0,Negative,M0,Negative,N0,317.0,0.0,LumA,Luminal A,Positive,LumA,-7.0,-3.0,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1BD-01,1133.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 4,TCGA-E2-A1BD,1133.0,0.0,days,1133.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1BD-F70021,TCGA-E2-A1BD,TCGA-E2-A1BD-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-19627.0,260.0,,0.0,1133.0,,,,,NO,Allred score 5+3 = 8,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,10-19%,,2+,,,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,100.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf,A1BD,TUMOR FREE,Allred score 5+3 = 8,,,Allred score = 8,Allred score = 8,YES,YES,,,YES,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,fa1917b0-c3e1-412d-b063-e74b5cafb8dc,fa1917b0-c3e1-412d-b063-e74b5cafb8dc,TCGA-E2-A1BD-01A-21-A13E-20,TCGA-E2-A1BD-01A-11D-A12Q-09,TCGA-E2-A1BD-01,TCGA-E2-A1BD-01A-11D-A12R-05,139a9795-35ff-4c82-9530-fb103ea5ca8c,TCGA-E2-A1BD-01,TCGA-E2-A1BD-01A-11D-A12Q-09,,TCGA-E2-A1BD-01,TCGA-E2-A1BD-01,TCGA-E2-A1BD-01A-11D-A12Q-09,,fa1917b0-c3e1-412d-b063-e74b5cafb8dc,,TCGA-E2-A1BD-01A-11D-A12N-01,TCGA-E2-A1BD-01,TCGA-E2-A1BD-01A-11R-A12P-07,fa1917b0-c3e1-412d-b063-e74b5cafb8dc,TCGA-E2-A1BD-01A-11D-A12N-01,TCGA-E2-A1BD-01
tcga.e2.a1ie,Stage IIB,61.0,5.0,Stage IIB,983.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,983.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1IE-01,2362.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 12,cluster 6,mutation c1uster 9,TCGA-E2-A1IE,1810.0,1.0,days,2362.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,61.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1IE-F70297,TCGA-E2-A1IE,,,Positive,,,,,Positive,Lumpectomy,,NO,,,-22510.0,,,0.0,2362.0,,,1810,,NO,allred score 5 + 3 = 8,,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,,20-29%,,2+,,,1.05,2.1,Infiltrating Ductal Carcinoma,,No,200.0,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Equivocal,Negative,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Positive,,,,1.0,3 Point Scale,3+,3+,Negative,,,,Positive,,,3.0,6.0,2.2,,3 Point Scale,Liver,Distant Metastasis,,NO,YES,1.0,,,No,M0,N1,T2,Stage IIB,,A1IE,WITH TUMOR,allred score 3 + 3 = 6,,,allred score = 6,allred score = 8,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,,LIVING,2008.0,ec6f69db-ff0b-491c-8b70-d53d0e7ad65f,ec6f69db-ff0b-491c-8b70-d53d0e7ad65f,,TCGA-E2-A1IE-01A-11D-A188-09,TCGA-E2-A1IE-01,TCGA-E2-A1IE-01A-11D-A13K-05,,TCGA-E2-A1IE-01,TCGA-E2-A1IE-01A-11D-A188-09,,,TCGA-E2-A1IE-01,TCGA-E2-A1IE-01A-11D-A188-09,,ec6f69db-ff0b-491c-8b70-d53d0e7ad65f,,TCGA-E2-A1IE-01A-11D-A13J-01,TCGA-E2-A1IE-01,,ec6f69db-ff0b-491c-8b70-d53d0e7ad65f,TCGA-E2-A1IE-01A-11D-A13J-01,
tcga.e2.a1if,Stage I,74.0,2.0,Stage I,956.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,956.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IF-01,1138.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 6,mutation cluster 1,TCGA-E2-A1IF,1138.0,0.0,days,1138.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IF-F19962,TCGA-E2-A1IF,TCGA-E2-A1IF-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-27341.0,932.0,,0.0,1138.0,,,,,NO,allred score 5+3=8,,,Scheduled Follow-up Submission,2011-12-21,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,70.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,6.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf,A1IF,TUMOR FREE,allred score 4+2=6,,,allred score = 6,allred scrore = 8,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,34a8b02b-01a2-4f2d-8e8e-c3358d43665a,34a8b02b-01a2-4f2d-8e8e-c3358d43665a,,TCGA-E2-A1IF-01A-11D-A142-09,TCGA-E2-A1IF-01,TCGA-E2-A1IF-01A-11D-A145-05,,TCGA-E2-A1IF-01,TCGA-E2-A1IF-01A-11D-A142-09,,,TCGA-E2-A1IF-01,TCGA-E2-A1IF-01A-11D-A142-09,,34a8b02b-01a2-4f2d-8e8e-c3358d43665a,,TCGA-E2-A1IF-01A-11D-A141-01,TCGA-E2-A1IF-01,,34a8b02b-01a2-4f2d-8e8e-c3358d43665a,TCGA-E2-A1IF-01A-11D-A141-01,
tcga.e2.a1ig,Stage IIB,45.0,5.0,Stage IIB,755.0,,Positive,FEMALE,,,,,Negative,M0,Positive,N1,755.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1IG-01,2140.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 4,mutation c1uster 9,TCGA-E2-A1IG,2140.0,0.0,days,2140.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IG-F70394,TCGA-E2-A1IG,,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-16757.0,,,0.0,2140.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,1.0,,,No,M0,N1mi,T2,Stage IIB,,A1IG,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,,LIVING,2009.0,d0705a73-e6d0-4282-82b1-76d44bda242f,d0705a73-e6d0-4282-82b1-76d44bda242f,TCGA-E2-A1IG-01A-21-A17J-20,TCGA-E2-A1IG-01A-11D-A142-09,TCGA-E2-A1IG-01,TCGA-E2-A1IG-01A-11D-A145-05,e1a96343-ccc9-4e16-a96d-749528da4dfb,TCGA-E2-A1IG-01,TCGA-E2-A1IG-01A-11D-A142-09,,,TCGA-E2-A1IG-01,TCGA-E2-A1IG-01A-11D-A142-09,,d0705a73-e6d0-4282-82b1-76d44bda242f,,TCGA-E2-A1IG-01A-11D-A141-01,TCGA-E2-A1IG-01,,d0705a73-e6d0-4282-82b1-76d44bda242f,TCGA-E2-A1IG-01A-11D-A141-01,
tcga.e2.a1ih,Stage I,80.0,2.0,Stage I,658.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,658.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IH-01,1026.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation c1uster 10,TCGA-E2-A1IH,1026.0,0.0,days,1026.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IH-F19960,TCGA-E2-A1IH,TCGA-E2-A1IH-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-29444.0,883.0,,0.0,1026.0,,,,,NO,allred score 5+3=8,,,Scheduled Follow-up Submission,2011-12-21,FEMALE,,,20-29%,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,80.0,NO,Equivocal,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf,A1IH,TUMOR FREE,allred score 5+3+8,,,allred score = 8,allred score = 8,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,2d06908f-3332-4b77-b88c-145dc5c4828f,2d06908f-3332-4b77-b88c-145dc5c4828f,,TCGA-E2-A1IH-01A-11D-A188-09,TCGA-E2-A1IH-01,TCGA-E2-A1IH-01A-11D-A13K-05,,TCGA-E2-A1IH-01,TCGA-E2-A1IH-01A-11D-A188-09,,,TCGA-E2-A1IH-01,TCGA-E2-A1IH-01A-11D-A188-09,,2d06908f-3332-4b77-b88c-145dc5c4828f,,TCGA-E2-A1IH-01A-11D-A13J-01,TCGA-E2-A1IH-01,,2d06908f-3332-4b77-b88c-145dc5c4828f,TCGA-E2-A1IH-01A-11D-A13J-01,
tcga.e2.a1ii,Stage I,51.0,2.0,Stage I,850.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,850.0,0.0,Basal,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1II-01,1025.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-E2-A1II,1025.0,0.0,days,1025.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left,Sentinel node biopsy alone,,TCGA-E2-A1II-F19954,TCGA-E2-A1II,,,Negative,,,,,Positive,Lumpectomy,,NO,,,-18788.0,,,0.0,1025.0,,,,,NO,allred score 0 + 0 = 0,,,Scheduled Follow-up Submission,2011-12-21,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Negative,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage I,,A1II,TUMOR FREE,allred score 2+2 = 4,,,allred score = 4,allred score = 0,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,,LIVING,2008.0,f7a5cfcb-623c-4858-ba32-e6ca63c75d2a,f7a5cfcb-623c-4858-ba32-e6ca63c75d2a,,TCGA-E2-A1II-01A-11D-A142-09,TCGA-E2-A1II-01,TCGA-E2-A1II-01A-11D-A145-05,,TCGA-E2-A1II-01,TCGA-E2-A1II-01A-11D-A142-09,,,TCGA-E2-A1II-01,TCGA-E2-A1II-01A-11D-A142-09,,f7a5cfcb-623c-4858-ba32-e6ca63c75d2a,,TCGA-E2-A1II-01A-11D-A141-01,TCGA-E2-A1II-01,,f7a5cfcb-623c-4858-ba32-e6ca63c75d2a,TCGA-E2-A1II-01A-11D-A141-01,
tcga.e2.a1ij,Stage I,57.0,3.0,Stage I,725.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,725.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IJ-01,865.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-E2-A1IJ,865.0,0.0,days,865.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IJ-F19950,TCGA-E2-A1IJ,TCGA-E2-A1IJ-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,NO,,,-20956.0,707.0,,0.0,865.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2011-12-21,FEMALE,,,,,2+,,,1.2,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,70.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf,A1IJ,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2,14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2,,TCGA-E2-A1IJ-01A-11D-A142-09,TCGA-E2-A1IJ-01,TCGA-E2-A1IJ-01A-11D-A145-05,,TCGA-E2-A1IJ-01,TCGA-E2-A1IJ-01A-11D-A142-09,,,TCGA-E2-A1IJ-01,TCGA-E2-A1IJ-01A-11D-A142-09,,14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2,,TCGA-E2-A1IJ-01A-11D-A141-01,TCGA-E2-A1IJ-01,,14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2,TCGA-E2-A1IJ-01A-11D-A141-01,
tcga.e2.a1ik,Stage IIA,71.0,1.0,Stage IIA,518.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,518.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IK-01,1800.0,0.0,days,Quiet,C5-KIRC,cluster 1,Low purity c2,,BRCA nonbasal-like c7,miRNA cluster 6,cluster 7,mutation c1uster 9,TCGA-E2-A1IK,1800.0,0.0,days,1800.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Left,Sentinel node biopsy alone,,TCGA-E2-A1IK-F70395,TCGA-E2-A1IK,TCGA-E2-A1IK-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-26052.0,423.0,,0.0,1800.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,70.0,NO,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf,A1IK,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,96a11934-f6cd-4892-a808-672433f84429,96a11934-f6cd-4892-a808-672433f84429,,TCGA-E2-A1IK-01A-11D-A17G-09,TCGA-E2-A1IK-01,TCGA-E2-A1IK-01A-11D-A145-05,,TCGA-E2-A1IK-01,TCGA-E2-A1IK-01A-11D-A17G-09,,,TCGA-E2-A1IK-01,TCGA-E2-A1IK-01A-11D-A17G-09,,96a11934-f6cd-4892-a808-672433f84429,,TCGA-E2-A1IK-01A-11D-A141-01,TCGA-E2-A1IK-01,,96a11934-f6cd-4892-a808-672433f84429,TCGA-E2-A1IK-01A-11D-A141-01,
tcga.e2.a1il,Stage IIA,78.0,2.0,Stage IIA,14.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,14.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IL-01,118.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-E2-A1IL,118.0,0.0,days,118.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IL-F20276,TCGA-E2-A1IL,TCGA-E2-A1IL-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-28495.0,417.0,,0.0,118.0,,,,,NO,allred score 5+3=8,,,Scheduled Follow-up Submission,2012-1-3,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,120.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf,A1IL,TUMOR FREE,allred score 4 + 3 = 7,,,allred score = 7,allred score = 8,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d,5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d,TCGA-E2-A1IL-01A-21-A17J-20,TCGA-E2-A1IL-01A-11D-A14G-09,TCGA-E2-A1IL-01,TCGA-E2-A1IL-01A-11D-A14H-05,dbdb0a12-88ea-4a7b-a215-e7e83adc666f,TCGA-E2-A1IL-01,TCGA-E2-A1IL-01A-11D-A14G-09,,,TCGA-E2-A1IL-01,TCGA-E2-A1IL-01A-11D-A14G-09,,5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d,,TCGA-E2-A1IL-01A-11D-A14F-01,TCGA-E2-A1IL-01,,5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d,TCGA-E2-A1IL-01A-11D-A14F-01,
tcga.e2.a1in,Stage I,60.0,4.0,Stage I,392.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,392.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IN-01,675.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 3,TCGA-E2-A1IN,675.0,0.0,days,675.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1IN-F20323,TCGA-E2-A1IN,,,Positive,,,,,Positive,Lumpectomy,,NO,,,-22199.0,,,0.0,675.0,,,,,NO,allred score 5+3=8,,,Scheduled Follow-up Submission,2012-1-4,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage I,,A1IN,TUMOR FREE,allred score 5+3+8,,,allred score = 8,allred score = 8,,YES,,,YES,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,,LIVING,2010.0,dde1d3ab-ad71-4526-bc98-058b6049edcf,dde1d3ab-ad71-4526-bc98-058b6049edcf,,TCGA-E2-A1IN-01A-11D-A13L-09,TCGA-E2-A1IN-01,TCGA-E2-A1IN-01A-11D-A13K-05,,TCGA-E2-A1IN-01,TCGA-E2-A1IN-01A-11D-A13L-09,,,TCGA-E2-A1IN-01,TCGA-E2-A1IN-01A-11D-A13L-09,,dde1d3ab-ad71-4526-bc98-058b6049edcf,,TCGA-E2-A1IN-01A-11D-A13J-01,TCGA-E2-A1IN-01,,dde1d3ab-ad71-4526-bc98-058b6049edcf,TCGA-E2-A1IN-01A-11D-A13J-01,
tcga.e2.a1io,Stage I,37.0,1.0,Stage I,448.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,448.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IO-01,1855.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 3,TCGA-E2-A1IO,1855.0,0.0,days,1855.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,37.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1IO-F70391,TCGA-E2-A1IO,TCGA-E2-A1IO-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,NO,,,-13671.0,416.0,,0.0,1855.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,,30-39%,,2+,,,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Equivocal,Negative,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf,A1IO,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,72611671-51cc-4662-b992-6701eb1df987,72611671-51cc-4662-b992-6701eb1df987,,TCGA-E2-A1IO-01A-11D-A142-09,TCGA-E2-A1IO-01,TCGA-E2-A1IO-01A-11D-A145-05,,TCGA-E2-A1IO-01,TCGA-E2-A1IO-01A-11D-A142-09,,,TCGA-E2-A1IO-01,TCGA-E2-A1IO-01A-11D-A142-09,,72611671-51cc-4662-b992-6701eb1df987,,TCGA-E2-A1IO-01A-11D-A141-01,TCGA-E2-A1IO-01,,72611671-51cc-4662-b992-6701eb1df987,TCGA-E2-A1IO-01A-11D-A141-01,
tcga.e2.a1iu,Stage IA,60.0,2.0,Stage I,127.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,127.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1IU-01,337.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 2,mutation cluster 4,TCGA-E2-A1IU,337.0,0.0,days,337.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1IU-F19974,TCGA-E2-A1IU,TCGA-E2-A1IU-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-22279.0,136.0,,0.0,337.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-4,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,270.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,2.0,,,,,,,,NO,0.0,,False,No,M0,N0 (mol+),T1c,Stage IA,TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf,A1IU,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,53c8bbbd-16cd-4790-a99b-f45b0f958157,53c8bbbd-16cd-4790-a99b-f45b0f958157,TCGA-E2-A1IU-01A-21-A17J-20,TCGA-E2-A1IU-01A-11D-A14G-09,TCGA-E2-A1IU-01,TCGA-E2-A1IU-01A-11D-A14H-05,19429156-19ad-44f5-a671-1fef7a6e693c,TCGA-E2-A1IU-01,TCGA-E2-A1IU-01A-11D-A14G-09,,,TCGA-E2-A1IU-01,TCGA-E2-A1IU-01A-11D-A14G-09,,53c8bbbd-16cd-4790-a99b-f45b0f958157,,TCGA-E2-A1IU-01A-11D-A14F-01,TCGA-E2-A1IU-01,,53c8bbbd-16cd-4790-a99b-f45b0f958157,TCGA-E2-A1IU-01A-11D-A14F-01,
tcga.e2.a1l6,Stage IIA,44.0,2.0,Stage IIA,1312.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1312.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1L6-01,1648.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 7,mutation cluster 4,TCGA-E2-A1L6,1648.0,0.0,days,1648.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A1L6-F20570,TCGA-E2-A1L6,TCGA-E2-A1L6-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-16403.0,1325.0,,0.0,1648.0,,,,,NO,allred score 5 + 3 = 8,,,Scheduled Follow-up Submission,2012-1-10,FEMALE,,,40-49%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,110.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf,A1L6,TUMOR FREE,allred score 5 + 3 = 8,,,allred score =  8,allred score = 8,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2007.0,4142c779-86ab-44f5-9371-539bbaa363d2,4142c779-86ab-44f5-9371-539bbaa363d2,TCGA-E2-A1L6-01A-21-A17J-20,TCGA-E2-A1L6-01A-11D-A13L-09,TCGA-E2-A1L6-01,TCGA-E2-A1L6-01A-11D-A13K-05,bca87047-7257-4983-9e8c-e6811b33a10e,TCGA-E2-A1L6-01,TCGA-E2-A1L6-01A-11D-A13L-09,,,TCGA-E2-A1L6-01,TCGA-E2-A1L6-01A-11D-A13L-09,,4142c779-86ab-44f5-9371-539bbaa363d2,,TCGA-E2-A1L6-01A-11D-A13J-01,TCGA-E2-A1L6-01,,4142c779-86ab-44f5-9371-539bbaa363d2,TCGA-E2-A1L6-01A-11D-A13J-01,
tcga.e2.a1l7,Stage IIIA,40.0,1.0,Stage IIIA,633.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N2,633.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1L7-01,1836.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 2,cluster 5,mutation cluster 5,TCGA-E2-A1L7,1619.0,1.0,days,1836.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,YES,,,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A1L7-F70298,TCGA-E2-A1L7,TCGA-E2-A1L7-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-14854.0,548.0,,0.0,1836.0,,1662.0,1619,,NO,Allred score 1+1 = 2,,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,150.0,NO,Negative,,NO,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,Negative,,,,,,,,,,,,Negative,,,2.0,5.0,,,,"Other, specify",New Primary Tumor,left breast,YES,YES,7.0,,False,No,M0,N2,T2,Stage IIIA,TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf,A1L7,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 2,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,ec38c31b-def8-41cc-8656-57ce98f3faa7,ec38c31b-def8-41cc-8656-57ce98f3faa7,TCGA-E2-A1L7-01A-21-A17J-20,TCGA-E2-A1L7-01A-11D-A142-09,TCGA-E2-A1L7-01,TCGA-E2-A1L7-01A-11D-A145-05,9a9baaf4-427c-48cd-ae41-25fd84ae612f,TCGA-E2-A1L7-01,TCGA-E2-A1L7-01A-11D-A142-09,,,TCGA-E2-A1L7-01,TCGA-E2-A1L7-01A-11D-A142-09,,ec38c31b-def8-41cc-8656-57ce98f3faa7,,TCGA-E2-A1L7-01A-11D-A141-01,TCGA-E2-A1L7-01,,ec38c31b-def8-41cc-8656-57ce98f3faa7,TCGA-E2-A1L7-01A-11D-A141-01,
tcga.e2.a1l8,Stage IIA,52.0,2.0,Stage IIB,1015.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1015.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1L8-01,2240.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 6,mutation cluster 4,TCGA-E2-A1L8,2240.0,0.0,days,2240.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A1L8-F70018,TCGA-E2-A1L8,TCGA-E2-A1L8-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-19187.0,912.0,,0.0,2240.0,,,,,NO,allred score 5 + 3 = 8,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,40-49%,,2+,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,180.0,NO,Equivocal,Negative,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,2.0,,False,Yes,M0,N1a,T2,Stage IIB,TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf,A1L8,TUMOR FREE,allred score 4 + 3 = 7,,,allred score = 7,allred score = 8,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,68c8e567-1ac0-40f1-a3a7-a79d77a4ae12,68c8e567-1ac0-40f1-a3a7-a79d77a4ae12,TCGA-E2-A1L8-01A-21-A17J-20,TCGA-E2-A1L8-01A-11D-A13L-09,TCGA-E2-A1L8-01,TCGA-E2-A1L8-01A-11D-A13K-05,da720181-484f-4eff-8f96-b7e4298c751b,TCGA-E2-A1L8-01,TCGA-E2-A1L8-01A-11D-A13L-09,,,TCGA-E2-A1L8-01,TCGA-E2-A1L8-01A-11D-A13L-09,,68c8e567-1ac0-40f1-a3a7-a79d77a4ae12,,TCGA-E2-A1L8-01A-11D-A13J-01,TCGA-E2-A1L8-01,,68c8e567-1ac0-40f1-a3a7-a79d77a4ae12,TCGA-E2-A1L8-01A-11D-A13J-01,
tcga.e2.a1l9,Stage IIB,40.0,3.0,Stage IIA,388.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,388.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1L9-01,598.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 6,mutation cluster 4,TCGA-E2-A1L9,598.0,0.0,days,598.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1L9-F20597,TCGA-E2-A1L9,TCGA-E2-A1L9-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,NO,,,-14868.0,465.0,,0.0,598.0,,,,,NO,,80-89%,,Scheduled Follow-up Submission,2012-1-11,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,40.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf,A1L9,TUMOR FREE,,,,allred score = 7,allred score = 7,,YES,80-89%,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,05329e4e-6623-4044-9abf-46f3ed4ccfd8,05329e4e-6623-4044-9abf-46f3ed4ccfd8,,TCGA-E2-A1L9-01A-11D-A13L-09,TCGA-E2-A1L9-01,TCGA-E2-A1L9-01A-11D-A13K-05,,TCGA-E2-A1L9-01,TCGA-E2-A1L9-01A-11D-A13L-09,,,TCGA-E2-A1L9-01,TCGA-E2-A1L9-01A-11D-A13L-09,,05329e4e-6623-4044-9abf-46f3ed4ccfd8,,TCGA-E2-A1L9-01A-11D-A13J-01,TCGA-E2-A1L9-01,,05329e4e-6623-4044-9abf-46f3ed4ccfd8,TCGA-E2-A1L9-01A-11D-A13J-01,
tcga.e2.a1la,Stage IIA,59.0,5.0,Stage IIA,463.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,463.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1LA-01,748.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 12,TCGA-E2-A1LA,748.0,0.0,days,748.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A1LA-F20586,TCGA-E2-A1LA,TCGA-E2-A1LA-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-21773.0,581.0,,0.0,748.0,,,,,NO,allred score 5 + 3 = 8,,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,,,2+,,,1.15,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,40.0,NO,Equivocal,Negative,,35.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf,A1LA,TUMOR FREE,allred score 5 +3 = 8,,,allred score = 8,allred score = 8,,YES,,,NO,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2009.0,9a56eb8b-99fa-4671-99dc-29776dca4cd6,9a56eb8b-99fa-4671-99dc-29776dca4cd6,,TCGA-E2-A1LA-01A-11D-A142-09,TCGA-E2-A1LA-01,TCGA-E2-A1LA-01A-11D-A145-05,,TCGA-E2-A1LA-01,TCGA-E2-A1LA-01A-11D-A142-09,,,TCGA-E2-A1LA-01,TCGA-E2-A1LA-01A-11D-A142-09,,9a56eb8b-99fa-4671-99dc-29776dca4cd6,,TCGA-E2-A1LA-01A-11D-A141-01,TCGA-E2-A1LA-01,,9a56eb8b-99fa-4671-99dc-29776dca4cd6,TCGA-E2-A1LA-01A-11D-A141-01,
tcga.e2.a1lb,Stage IIB,41.0,1.0,Stage IIB,972.0,,Negative,FEMALE,Positive,,,,Negative,M0,Positive,N1,972.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1LB-01,2306.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-E2-A1LB,2306.0,0.0,days,2306.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A1LB-F70015,TCGA-E2-A1LB,TCGA-E2-A1LB-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-15283.0,909.0,,0.0,2306.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,90-99%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,190.0,NO,Positive,,NO,25.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,NO,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf,A1LB,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,YES,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,acf1ec71-46a5-4e7b-84b1-55203bca29d8,acf1ec71-46a5-4e7b-84b1-55203bca29d8,TCGA-E2-A1LB-01A-21-A17J-20,TCGA-E2-A1LB-01A-11D-A142-09,TCGA-E2-A1LB-01,TCGA-E2-A1LB-01A-11D-A145-05,82c21aa1-4547-4da6-aaf4-ca207c327ea1,TCGA-E2-A1LB-01,TCGA-E2-A1LB-01A-11D-A142-09,,,TCGA-E2-A1LB-01,TCGA-E2-A1LB-01A-11D-A142-09,,acf1ec71-46a5-4e7b-84b1-55203bca29d8,,TCGA-E2-A1LB-01A-11D-A141-01,TCGA-E2-A1LB-01,,acf1ec71-46a5-4e7b-84b1-55203bca29d8,TCGA-E2-A1LB-01A-11D-A141-01,
tcga.e2.a1le,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-E2-A1LE-01,879.0,1.0,days,Squamous,,,BRCA CIMP c7,BRCA basal-like c6,,miRNA cluster 7,,,TCGA-E2-A1LE,361.0,1.0,days,879.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,NO,,71.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A1LE-F20657,TCGA-E2-A1LE,TCGA-E2-A1LE-01A,,Negative,,,,,Negative,Simple Mastectomy,,NO,,,-26239.0,986.0,879.0,0.0,,,,361,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2012-1-18,FEMALE,,,90-99%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,600.0,NO,Positive,,,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Lung,Distant Metastasis,,,YES,27.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf,A1LE,WITH TUMOR,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,DECEASED,2008.0,776c18b3-4e53-41d6-8838-70a6029c07dd,776c18b3-4e53-41d6-8838-70a6029c07dd,TCGA-E2-A1LE-01A-21-A24A-20,,TCGA-E2-A1LE-01,TCGA-E2-A1LE-01A-12D-A19Z-05,fc80abcf-e8e0-4354-8646-d9ea84d87f7d,TCGA-E2-A1LE-01,TCGA-E2-A1LE-01A-12D-A19Y-09,,,TCGA-E2-A1LE-01,,,776c18b3-4e53-41d6-8838-70a6029c07dd,,TCGA-E2-A1LE-01A-12D-A19X-01,TCGA-E2-A1LE-01,,776c18b3-4e53-41d6-8838-70a6029c07dd,TCGA-E2-A1LE-01A-12D-A19X-01,
tcga.e2.a1lg,Stage IIA,50.0,2.0,Stage IIA,350.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,350.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1LG-01,1523.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 5,Low purity c2,KIRC-like c1,BRCA basal-like c8,miRNA cluster 11,cluster 5,mutation cluster 5,TCGA-E2-A1LG,1523.0,0.0,days,1523.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A1LG-F70390,TCGA-E2-A1LG,TCGA-E2-A1LG-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-18492.0,252.0,,0.0,1523.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,,60-69%,,2+,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,310.0,NO,Equivocal,Negative,NO,19.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,,False,Yes,M0,N0,T2,Stage IIA,TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf,A1LG,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,YES,YES,,,NO,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,94d92cd8-21cf-495d-b4fe-8f8c6067fe9e,94d92cd8-21cf-495d-b4fe-8f8c6067fe9e,TCGA-E2-A1LG-01A-41-A17J-20,TCGA-E2-A1LG-01A-21D-A14K-09,TCGA-E2-A1LG-01,TCGA-E2-A1LG-01A-21D-A14N-05,ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075,TCGA-E2-A1LG-01,TCGA-E2-A1LG-01A-21D-A14K-09,,,TCGA-E2-A1LG-01,TCGA-E2-A1LG-01A-21D-A14K-09,,94d92cd8-21cf-495d-b4fe-8f8c6067fe9e,,TCGA-E2-A1LG-01A-21D-A14J-01,TCGA-E2-A1LG-01,,94d92cd8-21cf-495d-b4fe-8f8c6067fe9e,TCGA-E2-A1LG-01A-21D-A14J-01,
tcga.e2.a1lh,Stage I,59.0,3.0,Stage I,2875.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,2875.0,0.0,Basal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1LH-01,3247.0,0.0,days,High,C4-BRCA/Basal,cluster 5,Low purity c2,,BRCA basal-like c8,,,mutation cluster 2,TCGA-E2-A1LH,3247.0,0.0,days,3247.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right,Sentinel node biopsy alone,,TCGA-E2-A1LH-F20649,TCGA-E2-A1LH,TCGA-E2-A1LH-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,NO,,,-21628.0,2998.0,,0.0,3247.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,130.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf,A1LH,TUMOR FREE,,ACIS,,,,,YES,,,YES,Primary Tumor,1,,5th,YES,NO,YES,E2,Breast,A,LIVING,2002.0,66f3892f-f4ec-412c-9c56-a9e9b56a15ee,66f3892f-f4ec-412c-9c56-a9e9b56a15ee,,TCGA-E2-A1LH-01A-11D-A14G-09,TCGA-E2-A1LH-01,TCGA-E2-A1LH-01A-11D-A14H-05,,TCGA-E2-A1LH-01,TCGA-E2-A1LH-01A-11D-A14G-09,,,TCGA-E2-A1LH-01,TCGA-E2-A1LH-01A-11D-A14G-09,,66f3892f-f4ec-412c-9c56-a9e9b56a15ee,,TCGA-E2-A1LH-01A-11D-A14F-01,TCGA-E2-A1LH-01,,66f3892f-f4ec-412c-9c56-a9e9b56a15ee,TCGA-E2-A1LH-01A-11D-A14F-01,
tcga.e2.a1li,Stage IIB,57.0,3.0,Stage IIB,2750.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,2750.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E2-A1LI-01,3121.0,0.0,days,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 7,,mutation c1uster 9,TCGA-E2-A1LI,3121.0,0.0,days,3121.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1LI-F20623,TCGA-E2-A1LI,,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,NO,,,-21064.0,,,0.0,3121.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,,,,,,1.21,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Equivocal,Negative,,2.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,,,No,M0,N1,T2,Stage IIB,,A1LI,TUMOR FREE,,ACIS,,,,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,,LIVING,2003.0,fa643dcc-4f4c-44d0-9f4d-199de04f8d2b,fa643dcc-4f4c-44d0-9f4d-199de04f8d2b,,TCGA-E2-A1LI-01A-12D-A159-09,TCGA-E2-A1LI-01,TCGA-E2-A1LI-01A-12D-A161-05,,TCGA-E2-A1LI-01,TCGA-E2-A1LI-01A-12D-A159-09,,,TCGA-E2-A1LI-01,TCGA-E2-A1LI-01A-12D-A159-09,,fa643dcc-4f4c-44d0-9f4d-199de04f8d2b,,TCGA-E2-A1LI-01A-12D-A160-01,TCGA-E2-A1LI-01,,fa643dcc-4f4c-44d0-9f4d-199de04f8d2b,TCGA-E2-A1LI-01A-12D-A160-01,
tcga.e2.a1lk,Stage IIIC,84.0,4.0,Stage IIIA,,266.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,266.0,1.0,Basal,,Negative,,,,enrollment,T_Other,T3,DECEASED,1.0,TCGA-E2-A1LK-01,266.0,1.0,days,Squamous,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 11,cluster 5,mutation cluster 5,TCGA-E2-A1LK,155.0,1.0,days,266.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,YES,,84.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A1LK-F20620,TCGA-E2-A1LK,,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,200.0,-30757.0,,266.0,0.0,,,,155,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,,80-89%,,2+,,,1.41,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,Equivocal,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Allred Score = 0,Equivocal,2+,Allred score 0+0 = 0,Negative,,,30-39%,0.95,,,,Negative,,,Allred score 0+0 = 0,Negative,,,3.0,5.0,,,,"Other, specify",Locoregional Disease,Left axilla,,YES,11.0,,,No,M0,N3a,T4b,Stage IIIC,,A1LK,WITH TUMOR,Allred score 0+0 = 0,,Allred score = 0,Allred score = 0,Allred score = 0,,YES,,,NO,Primary Tumor,1,,6th,NO,NO,YES,E2,Breast,,DECEASED,2008.0,d6301614-9ba7-4632-bdca-ac1b11e8e811,d6301614-9ba7-4632-bdca-ac1b11e8e811,TCGA-E2-A1LK-01A-11-A17K-20,TCGA-E2-A1LK-01A-21D-A14G-09,TCGA-E2-A1LK-01,TCGA-E2-A1LK-01A-21D-A14H-05,f5fd203d-214a-42f1-aaf9-c9ee9b12c4fc,TCGA-E2-A1LK-01,TCGA-E2-A1LK-01A-21D-A14G-09,,,TCGA-E2-A1LK-01,TCGA-E2-A1LK-01A-21D-A14G-09,,d6301614-9ba7-4632-bdca-ac1b11e8e811,,TCGA-E2-A1LK-01A-21D-A14F-01,TCGA-E2-A1LK-01,,d6301614-9ba7-4632-bdca-ac1b11e8e811,TCGA-E2-A1LK-01A-21D-A14F-01,
tcga.e2.a1ll,Stage IIIA,73.0,1.0,Stage IIIA,1014.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N2,1014.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-E2-A1LL-01,1309.0,0.0,days,Squamous,C2-Squamous-like,cluster 1,BRCA CIMP c7,KIRC-like c1,squamous-like c4,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E2-A1LL,1303.0,1.0,days,1309.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,NO,,73.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A1LL-F20616,TCGA-E2-A1LL,TCGA-E2-A1LL-01A,,Negative,,,,,Negative,Simple Mastectomy,,NO,,,-27028.0,988.0,,0.0,1309.0,,,1303,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2012-1-17,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,290.0,NO,Negative,,,44.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,Liver,Distant Metastasis,,,YES,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf,A1LL,WITH TUMOR,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,E2,Breast,A,LIVING,2008.0,526c9170-0f25-4374-9287-1fc40acb6555,526c9170-0f25-4374-9287-1fc40acb6555,TCGA-E2-A1LL-01A-21-A17J-20,TCGA-E2-A1LL-01A-11D-A142-09,TCGA-E2-A1LL-01,TCGA-E2-A1LL-01A-11D-A145-05,fdf3231f-d485-4a5e-b10b-43d9ab536a66,TCGA-E2-A1LL-01,TCGA-E2-A1LL-01A-11D-A142-09,,,TCGA-E2-A1LL-01,TCGA-E2-A1LL-01A-11D-A142-09,,526c9170-0f25-4374-9287-1fc40acb6555,,TCGA-E2-A1LL-01A-11D-A141-01,TCGA-E2-A1LL-01,,526c9170-0f25-4374-9287-1fc40acb6555,TCGA-E2-A1LL-01A-11D-A141-01,
tcga.e2.a1ls,Stage IA,46.0,,Stage I,239.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,239.0,0.0,Basal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E2-A1LS-01,1604.0,0.0,days,,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 14,,mutation cluster 5,TCGA-E2-A1LS,1604.0,0.0,days,1604.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A1LS-F70016,TCGA-E2-A1LS,TCGA-E2-A1LS-01A,,Negative,,,,,Negative,Simple Mastectomy,,NO,,,-16887.0,176.0,,0.0,1604.0,,,,,NO,Allred score 0+0 = 0,,,Scheduled Follow-up Submission,2015-2-9,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,100.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf,A1LS,TUMOR FREE,Allred score 0+0 = 0,,,Allred score = 0,Allred score = 0,YES,YES,,,NO,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,LIVING,2010.0,81239059-614b-46b7-a21e-224ec62e2939,81239059-614b-46b7-a21e-224ec62e2939,TCGA-E2-A1LS-01A-21-A17J-20,TCGA-E2-A1LS-01A-12D-A159-09,TCGA-E2-A1LS-01,TCGA-E2-A1LS-01A-12D-A161-05,9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65,,TCGA-E2-A1LS-01A-12D-A159-09,,,TCGA-E2-A1LS-01,TCGA-E2-A1LS-01A-12D-A159-09,,81239059-614b-46b7-a21e-224ec62e2939,,,TCGA-E2-A1LS-01,,81239059-614b-46b7-a21e-224ec62e2939,,
tcga.e2.a2p5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-E2-A2P5-01,821.0,1.0,days,High,,,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 5,,,TCGA-E2-A2P5,597.0,1.0,days,821.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,78.0,Left,Axillary lymph node dissection alone,,TCGA-E2-A2P5-F68575,TCGA-E2-A2P5,TCGA-E2-A2P5-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-28621.0,219.0,821.0,0.0,515.0,,,597,,NO,Allred score = 8,,,Scheduled Follow-up Submission,2014-11-26,FEMALE,,,,,,,,1.0,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,260.0,NO,,Negative,NO,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Distant Metastasis,,NO,YES,21.0,,True,Yes,M0,N3,T2,Stage IIIC,TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf,A2P5,WITH TUMOR,Allred score = 8,,,Allred score = 8,Allred score = 8,YES,YES,,,YES,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,A,DECEASED,2011.0,90d04601-4a15-44fc-bf1b-e0859310e644,90d04601-4a15-44fc-bf1b-e0859310e644,TCGA-E2-A2P5-01A-21-A24A-20,,TCGA-E2-A2P5-01,TCGA-E2-A2P5-01A-11D-A19Z-05,b4da5ffb-397d-4760-8e01-a67791dd37fc,TCGA-E2-A2P5-01,TCGA-E2-A2P5-01A-11D-A19Y-09,,,TCGA-E2-A2P5-01,,,90d04601-4a15-44fc-bf1b-e0859310e644,,TCGA-E2-A2P5-01A-11D-A19X-01,TCGA-E2-A2P5-01,,90d04601-4a15-44fc-bf1b-e0859310e644,TCGA-E2-A2P5-01A-11D-A19X-01,
tcga.e2.a2p6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A2P6-01,1051.0,0.0,days,Iq,,,BRCA CIMP c7,,,miRNA cluster 14,,,TCGA-E2-A2P6,1051.0,0.0,days,1051.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A2P6-F68574,TCGA-E2-A2P6,,Negative,Positive,,,,Modified radical mastectomy,Positive,Lumpectomy,,NO,,,-28411.0,,,0.0,1051.0,,,,,NO,Allread score 5+3 = 8,,,Scheduled Follow-up Submission,2014-11-26,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,,Negative,NO,5.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,,No,M0,N1,T2,Stage IIB,,A2P6,TUMOR FREE,Allred score 2+2 = 4,,,Allred score = 4,Allred score = 8,YES,YES,,,NO,Primary Tumor,1,,7th,YES,NO,YES,E2,Breast,,LIVING,2011.0,bc94874b-f73a-44c8-bc6f-9ec50972c9b2,bc94874b-f73a-44c8-bc6f-9ec50972c9b2,,,TCGA-E2-A2P6-01,TCGA-E2-A2P6-01A-11D-A19Z-05,,TCGA-E2-A2P6-01,TCGA-E2-A2P6-01A-11D-A19Y-09,,,TCGA-E2-A2P6-01,,,bc94874b-f73a-44c8-bc6f-9ec50972c9b2,,TCGA-E2-A2P6-01A-11D-A19X-01,TCGA-E2-A2P6-01,,bc94874b-f73a-44c8-bc6f-9ec50972c9b2,TCGA-E2-A2P6-01A-11D-A19X-01,
tcga.e2.a3dx,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-E2-A3DX-01,1325.0,0.0,days,Quiet,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-E2-A3DX,1325.0,0.0,days,1325.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Right,Axillary lymph node dissection alone,,TCGA-E2-A3DX-F70017,TCGA-E2-A3DX,TCGA-E2-A3DX-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-15969.0,142.0,,0.0,1325.0,,,,,NO,,,,,2015-2-9,FEMALE,,,,,,,,7.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,180.0,NO,,Positive,NO,36.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,25.0,,False,No,M0,N3,T2,Stage IIIC,TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf,A3DX,TUMOR FREE,,,,Allred score = 8,Allred score = 7,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2011.0,2424c058-78c6-41dd-86e9-efcd61b72add,2424c058-78c6-41dd-86e9-efcd61b72add,TCGA-E2-A3DX-01A-11-A24A-20,,TCGA-E2-A3DX-01,TCGA-E2-A3DX-01A-21D-A212-05,8439f41b-dd33-46a5-bf4a-f10a23d65b36,TCGA-E2-A3DX-01,TCGA-E2-A3DX-01A-21D-A20S-09,,,TCGA-E2-A3DX-01,,,2424c058-78c6-41dd-86e9-efcd61b72add,,TCGA-E2-A3DX-01A-21D-A20R-01,TCGA-E2-A3DX-01,,2424c058-78c6-41dd-86e9-efcd61b72add,TCGA-E2-A3DX-01A-21D-A20R-01,
tcga.e2.a56z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A56Z-01,252.0,0.0,days,,,,,,,,,,TCGA-E2-A56Z,252.0,0.0,days,252.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E2-A56Z-F67584,TCGA-E2-A56Z,TCGA-E2-A56Z-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-25282.0,254.0,,0.0,252.0,,,,,,Allred 8 = 5+3,10-19%,2.2,,2014-11-6,FEMALE,,,10-19%,,2+,200.0,3.2,1.5,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,150.0,NO,Equivocal,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf,A56Z,TUMOR FREE,Allred 5 = 2+3,,,Allred Score,Allred Score,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2012.0,96af7552-6f51-4abe-8394-b9e966a70228,96af7552-6f51-4abe-8394-b9e966a70228,,,TCGA-E2-A56Z-01,TCGA-E2-A56Z-01A-12D-A29O-05,dc92e37a-e9dd-4055-acaf-bb63ec1d901b,TCGA-E2-A56Z-01,TCGA-E2-A56Z-01A-12D-A29N-09,,,TCGA-E2-A56Z-01,,,96af7552-6f51-4abe-8394-b9e966a70228,,TCGA-E2-A56Z-01A-12D-A29M-01,TCGA-E2-A56Z-01,,96af7552-6f51-4abe-8394-b9e966a70228,TCGA-E2-A56Z-01A-12D-A29M-01,
tcga.e2.a570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A570-01,931.0,0.0,days,,,,,,,,,,TCGA-E2-A570,931.0,0.0,days,931.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-E2-A570-F61335,TCGA-E2-A570,TCGA-E2-A570-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-17456.0,416.0,,0.0,931.0,,,,,,Allred 7 = 5+2,,2.0,,2014-6-27,FEMALE,,,10-19%,,2+,200.0,2.2,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,80.0,NO,Equivocal,Negative,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1mi,T1c,Stage IB,TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf,A570,TUMOR FREE,Allred 8 = 5+3,,,Allred Score,Allred Score,YES,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2011.0,635a7c2c-7731-48c1-948d-4d7ecf05c472,635a7c2c-7731-48c1-948d-4d7ecf05c472,,,TCGA-E2-A570-01,TCGA-E2-A570-01A-11D-A29O-05,,TCGA-E2-A570-01,TCGA-E2-A570-01A-11D-A29N-09,,,TCGA-E2-A570-01,,,635a7c2c-7731-48c1-948d-4d7ecf05c472,,TCGA-E2-A570-01A-11D-A29M-01,TCGA-E2-A570-01,,635a7c2c-7731-48c1-948d-4d7ecf05c472,TCGA-E2-A570-01A-11D-A29M-01,
tcga.e2.a572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A572-01,1208.0,0.0,days,,,,,,,,,,TCGA-E2-A572,1208.0,0.0,days,1208.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Left,Axillary lymph node dissection alone,,TCGA-E2-A572-F65007,TCGA-E2-A572,TCGA-E2-A572-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-26399.0,560.0,,0.0,1208.0,,,,,,,,,,2014-9-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,8.0,True,Yes,M0,N2,T2,Stage IIIA,TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf,A572,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2011.0,43a88718-f528-4d0b-88e6-f2ade6854c53,43a88718-f528-4d0b-88e6-f2ade6854c53,,,TCGA-E2-A572-01,TCGA-E2-A572-01A-13D-A31V-05,7b3b60fa-cd2e-4340-98f8-085f61b2148d,,,,,TCGA-E2-A572-01,,,43a88718-f528-4d0b-88e6-f2ade6854c53,,,TCGA-E2-A572-01,,43a88718-f528-4d0b-88e6-f2ade6854c53,,
tcga.e2.a573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A573-01,1062.0,0.0,days,,,,,,,,,,TCGA-E2-A573,1062.0,0.0,days,1062.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A573-F61338,TCGA-E2-A573,,,Negative,,,,,Negative,Other,,NO,,,-17689.0,,,0.0,1062.0,,,,,,Allred 0 = 0+0,,1.8,,2014-6-27,FEMALE,,,10-19%,,2+,200.0,2.3,1.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,4.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage IA,,A573,TUMOR FREE,Allred 0 = 0+0,,,Allred Score,Allred Score,YES,YES,,,YES,Primary Tumor,1,Partial Mastectomy,7th,,NO,YES,E2,Breast,,LIVING,2011.0,be17bc7b-550a-461b-9f7b-2a5845cc12b2,be17bc7b-550a-461b-9f7b-2a5845cc12b2,,,TCGA-E2-A573-01,TCGA-E2-A573-01A-11D-A29O-05,,TCGA-E2-A573-01,TCGA-E2-A573-01A-11D-A29N-09,,,TCGA-E2-A573-01,,,be17bc7b-550a-461b-9f7b-2a5845cc12b2,,TCGA-E2-A573-01A-11D-A29M-01,TCGA-E2-A573-01,,be17bc7b-550a-461b-9f7b-2a5845cc12b2,TCGA-E2-A573-01A-11D-A29M-01,
tcga.e2.a574,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A574-01,1179.0,0.0,days,,,,,,,,,,TCGA-E2-A574,1179.0,0.0,days,1179.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left,Sentinel node biopsy alone,,TCGA-E2-A574-F70296,TCGA-E2-A574,TCGA-E2-A574-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-16195.0,429.0,,0.0,1179.0,,,,,,Allred 0 = 0+0,,2.8,,2015-2-9,FEMALE,,,10-19%,,2+,200.0,2.8,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,Equivocal,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf,A574,TUMOR FREE,Allred 0 = 0+0,,,Allred Score,Allred Score,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2011.0,fec9b75b-9a91-4979-9056-ecdd852429d8,fec9b75b-9a91-4979-9056-ecdd852429d8,,,TCGA-E2-A574-01,TCGA-E2-A574-01A-11D-A29O-05,19a7926b-5288-4e60-b0a3-ebdb0ff58b1a,TCGA-E2-A574-01,TCGA-E2-A574-01A-11D-A29N-09,,,TCGA-E2-A574-01,,,fec9b75b-9a91-4979-9056-ecdd852429d8,,TCGA-E2-A574-01A-11D-A29M-01,TCGA-E2-A574-01,,fec9b75b-9a91-4979-9056-ecdd852429d8,TCGA-E2-A574-01A-11D-A29M-01,
tcga.e2.a576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A576-01,1043.0,0.0,days,,,,,,,,,,TCGA-E2-A576,1043.0,0.0,days,1043.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-E2-A576-F67575,TCGA-E2-A576,TCGA-E2-A576-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-25350.0,343.0,,0.0,1043.0,,,,,,,,,,2014-11-6,FEMALE,,,,,2+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Fine needle aspiration biopsy,80.0,NO,Equivocal,Negative,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T1c,Stage IA,TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf,A576,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2011.0,1323e58e-5e3f-459a-99ff-e7a6748d3d77,1323e58e-5e3f-459a-99ff-e7a6748d3d77,,,TCGA-E2-A576-01,TCGA-E2-A576-01A-11D-A31V-05,,TCGA-E2-A576-01,,,,TCGA-E2-A576-01,,,1323e58e-5e3f-459a-99ff-e7a6748d3d77,,TCGA-E2-A576-01A-11D-A31T-01,TCGA-E2-A576-01,,1323e58e-5e3f-459a-99ff-e7a6748d3d77,TCGA-E2-A576-01A-11D-A31T-01,
tcga.e2.a9ru,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E2-A9RU-01,538.0,0.0,days,,,,,,,,,,TCGA-E2-A9RU,538.0,0.0,days,538.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E2-A9RU-F70313,TCGA-E2-A9RU,TCGA-E2-A9RU-01A,,Positive,,,,,Negative,Lumpectomy,,YES,,,-32873.0,188.0,,0.0,538.0,,,,,,,70-79%,,,2015-2-9,FEMALE,,,,,2+,,,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,220.0,NO,Equivocal,Negative,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,12.0,,True,No,MX,N3a,T2,Stage IIIC,TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf,A9RU,TUMOR FREE,,,,,Allred Score 6,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,E2,Breast,A,LIVING,2013.0,12037b1a-ef64-4ea7-99c8-703132eb2d1e,12037b1a-ef64-4ea7-99c8-703132eb2d1e,,,TCGA-E2-A9RU-01,TCGA-E2-A9RU-01A-11D-A41Q-05,5492E47A-045A-4CB8-A83D-D30F7E68CCF0,TCGA-E2-A9RU-01,,,,TCGA-E2-A9RU-01,,,12037b1a-ef64-4ea7-99c8-703132eb2d1e,,TCGA-E2-A9RU-01A-11D-A41E-01,TCGA-E2-A9RU-01,,12037b1a-ef64-4ea7-99c8-703132eb2d1e,TCGA-E2-A9RU-01A-11D-A41E-01,
tcga.e9.a1n3,Stage IIIA,70.0,1.0,Stage IIIA,0.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N2,0.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1N3-01,1059.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,,mutation c1uster 9,TCGA-E9-A1N3,1059.0,0.0,days,1059.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N3-F62627,TCGA-E9-A1N3,TCGA-E9-A1N3-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-25714.0,65.0,,0.0,1059.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-7-22,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,230.0,NO,,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,7.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf,A1N3,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,aaddb80d-7710-4aab-8efc-e84da79f9c68,aaddb80d-7710-4aab-8efc-e84da79f9c68,TCGA-E9-A1N3-01A-21-A17J-20,TCGA-E9-A1N3-01A-12D-A159-09,TCGA-E9-A1N3-01,TCGA-E9-A1N3-01A-12D-A161-05,167bccdb-afaa-49f7-b3af-6d5bd49e7422,TCGA-E9-A1N3-01,TCGA-E9-A1N3-01A-12D-A159-09,,,TCGA-E9-A1N3-01,TCGA-E9-A1N3-01A-12D-A159-09,,aaddb80d-7710-4aab-8efc-e84da79f9c68,,TCGA-E9-A1N3-01A-12D-A160-01,TCGA-E9-A1N3-01,,aaddb80d-7710-4aab-8efc-e84da79f9c68,TCGA-E9-A1N3-01A-12D-A160-01,
tcga.e9.a1n4,Stage IIIA,41.0,2.0,Stage IIIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1N4-01,1000.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation c1uster 9,TCGA-E9-A1N4,1000.0,0.0,days,1000.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N4-F39767,TCGA-E9-A1N4,TCGA-E9-A1N4-01A,,Positive,,,,,Positive,,,NO,,,-15055.0,65.0,,0.0,1000.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,310.0,NO,Positive,,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,7.0,,,,,,,,NO,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf,A1N4,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a,55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a,TCGA-E9-A1N4-01A-21-A17K-20,TCGA-E9-A1N4-01A-11D-A14K-09,TCGA-E9-A1N4-01,TCGA-E9-A1N4-01A-11D-A14N-05,e593a9f8-484a-4693-9d6c-75ddc09dea59,TCGA-E9-A1N4-01,TCGA-E9-A1N4-01A-11D-A14K-09,,,TCGA-E9-A1N4-01,TCGA-E9-A1N4-01A-11D-A14K-09,,55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a,,TCGA-E9-A1N4-01A-11D-A14J-01,TCGA-E9-A1N4-01,,55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a,TCGA-E9-A1N4-01A-11D-A14J-01,
tcga.e9.a1n5,Stage IIB,45.0,5.0,Stage IIB,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1N5-01,1120.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation cluster 3,TCGA-E9-A1N5,1120.0,0.0,days,1120.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N5-F39765,TCGA-E9-A1N5,TCGA-E9-A1N5-01A,,Positive,,,,,Positive,,,NO,,,-16736.0,63.0,,0.0,1120.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,190.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,2.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf,A1N5,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,1adf0e70-b1fb-4862-8a01-6454b09636f4,1adf0e70-b1fb-4862-8a01-6454b09636f4,TCGA-E9-A1N5-01A-21-A17J-20,TCGA-E9-A1N5-01A-11D-A14G-09,TCGA-E9-A1N5-01,TCGA-E9-A1N5-01A-11D-A14H-05,1efeb02c-7e68-449e-9f4f-8b8f985ab01e,TCGA-E9-A1N5-01,TCGA-E9-A1N5-01A-11D-A14G-09,,,TCGA-E9-A1N5-01,TCGA-E9-A1N5-01A-11D-A14G-09,,1adf0e70-b1fb-4862-8a01-6454b09636f4,,TCGA-E9-A1N5-01A-11D-A14F-01,TCGA-E9-A1N5-01,,1adf0e70-b1fb-4862-8a01-6454b09636f4,TCGA-E9-A1N5-01A-11D-A14F-01,
tcga.e9.a1n6,Stage IIB,52.0,5.0,Stage IIB,0.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-E9-A1N6-01,678.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,cluster 4,,TCGA-E9-A1N6,443.0,1.0,days,678.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,52.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N6-F63536,TCGA-E9-A1N6,TCGA-E9-A1N6-01A,,Positive,,,,,Positive,,,NO,,,-19327.0,63.0,678.0,0.0,410.0,,,443,,NO,,,,Scheduled Follow-up Submission,2014-8-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,220.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,Bone,Distant Metastasis,,NO,YES,2.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf,A1N6,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2010.0,05b5084f-5e4f-43a3-9819-456a4f24ad82,05b5084f-5e4f-43a3-9819-456a4f24ad82,TCGA-E9-A1N6-01A-21-A17K-20,,TCGA-E9-A1N6-01,TCGA-E9-A1N6-01A-11D-A145-05,4a7c1f26-54e8-40e4-a966-b01498c98782,TCGA-E9-A1N6-01,,,,TCGA-E9-A1N6-01,,,05b5084f-5e4f-43a3-9819-456a4f24ad82,,TCGA-E9-A1N6-01A-11D-A141-01,TCGA-E9-A1N6-01,,05b5084f-5e4f-43a3-9819-456a4f24ad82,TCGA-E9-A1N6-01A-11D-A141-01,
tcga.e9.a1n8,Stage IIA,48.0,1.0,Stage IIA,0.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,Basal,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1N8-01,1039.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-E9-A1N8,1039.0,0.0,days,1039.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N8-F53518,TCGA-E9-A1N8,TCGA-E9-A1N8-01A,,Negative,,,,,,,,NO,,,-17652.0,66.0,,0.0,1039.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-12-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,680.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf,A1N8,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,7d6b6a17-5f1e-4586-9316-195c0e96925c,7d6b6a17-5f1e-4586-9316-195c0e96925c,TCGA-E9-A1N8-01A-21-A17K-20,TCGA-E9-A1N8-01A-11D-A142-09,TCGA-E9-A1N8-01,TCGA-E9-A1N8-01A-11D-A145-05,8ea109e3-1e03-468c-b117-43cbd5c7571d,TCGA-E9-A1N8-01,TCGA-E9-A1N8-01A-11D-A142-09,,,TCGA-E9-A1N8-01,TCGA-E9-A1N8-01A-11D-A142-09,,7d6b6a17-5f1e-4586-9316-195c0e96925c,,TCGA-E9-A1N8-01A-11D-A141-01,TCGA-E9-A1N8-01,,7d6b6a17-5f1e-4586-9316-195c0e96925c,TCGA-E9-A1N8-01A-11D-A141-01,
tcga.e9.a1n9,Stage IIA,58.0,4.0,Stage IIA,0.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,Basal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1N9-01,1101.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-E9-A1N9,1101.0,0.0,days,1101.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1N9-F58373,TCGA-E9-A1N9,,,Negative,,,,,Positive,,,YES,,,-21228.0,,,0.0,1101.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-4-8,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,,,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,5.0,,,,,,,,NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A1N9,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,,LIVING,2011.0,cdada0b1-f90d-40bc-9257-6377987b7baa,cdada0b1-f90d-40bc-9257-6377987b7baa,TCGA-E9-A1N9-01A-21-A17K-20,TCGA-E9-A1N9-01A-11D-A14G-09,TCGA-E9-A1N9-01,TCGA-E9-A1N9-01A-11D-A14H-05,f211c550-de9f-47f6-a1c2-546f560ac335,TCGA-E9-A1N9-01,TCGA-E9-A1N9-01A-11D-A14G-09,,,TCGA-E9-A1N9-01,TCGA-E9-A1N9-01A-11D-A14G-09,,cdada0b1-f90d-40bc-9257-6377987b7baa,,TCGA-E9-A1N9-01A-11D-A14F-01,TCGA-E9-A1N9-01,,cdada0b1-f90d-40bc-9257-6377987b7baa,TCGA-E9-A1N9-01A-11D-A14F-01,
tcga.e9.a1na,Stage IIA,58.0,5.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1NA-01,1112.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-E9-A1NA,1112.0,0.0,days,1112.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1-F39782,TCGA-E9-A1,TCGA-E9-A1-01A,,Positive,,,,,Positive,,,YES,,,-21397.0,42.0,,0.0,1112.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,110.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf,A1,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,7edc6614-6c8b-43ec-87dd-7720961bd174,7edc6614-6c8b-43ec-87dd-7720961bd174,TCGA-E9-A1NA-01A-21-A17K-20,TCGA-E9-A1NA-01A-11D-A142-09,TCGA-E9-A1NA-01,TCGA-E9-A1NA-01A-11D-A145-05,693f43fc-0cb7-44e8-90c4-7c1bc12d7da6,TCGA-E9-A1NA-01,TCGA-E9-A1NA-01A-11D-A142-09,,,TCGA-E9-A1NA-01,TCGA-E9-A1NA-01A-11D-A142-09,,7edc6614-6c8b-43ec-87dd-7720961bd174,,TCGA-E9-A1NA-01A-11D-A141-01,TCGA-E9-A1NA-01,,7edc6614-6c8b-43ec-87dd-7720961bd174,TCGA-E9-A1NA-01A-11D-A141-01,
tcga.e9.a1nd,Stage IIB,75.0,1.0,Stage IIB,0.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1ND-01,1266.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 11,cluster 5,mutation cluster 2,TCGA-E9-A1ND,1266.0,0.0,days,1266.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1ND-F62586,TCGA-E9-A1ND,TCGA-E9-A1ND-01A,,Negative,,,,,Negative,,,YES,,,-27400.0,37.0,,0.0,1266.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-7-21,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,420.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf,A1ND,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,526da11e-9125-4fcd-98d7-02994c9783d1,526da11e-9125-4fcd-98d7-02994c9783d1,TCGA-E9-A1ND-01A-21-A17J-20,TCGA-E9-A1ND-01A-11D-A142-09,TCGA-E9-A1ND-01,TCGA-E9-A1ND-01A-11D-A145-05,c323e6ab-8ba2-4347-a5d0-931a5d9754a1,TCGA-E9-A1ND-01,TCGA-E9-A1ND-01A-11D-A142-09,,,TCGA-E9-A1ND-01,TCGA-E9-A1ND-01A-11D-A142-09,,526da11e-9125-4fcd-98d7-02994c9783d1,,TCGA-E9-A1ND-01A-11D-A141-01,TCGA-E9-A1ND-01,,526da11e-9125-4fcd-98d7-02994c9783d1,TCGA-E9-A1ND-01A-11D-A141-01,
tcga.e9.a1ne,Stage IIB,28.0,1.0,Stage IIB,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1NE-01,1088.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-E9-A1NE,1088.0,0.0,days,1088.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,28.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1NE-F39781,TCGA-E9-A1NE,TCGA-E9-A1NE-01A,,Positive,,,,,Positive,,,YES,,,-10564.0,31.0,,0.0,1088.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,280.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,6.0,,,,,,,,NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf,A1NE,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,92691eb7-5df9-4da9-8bd0-c4f4de528bdc,92691eb7-5df9-4da9-8bd0-c4f4de528bdc,TCGA-E9-A1NE-01A-11-A17K-20,TCGA-E9-A1NE-01A-21D-A14K-09,TCGA-E9-A1NE-01,TCGA-E9-A1NE-01A-21D-A14N-05,8eb2885b-f9c7-4fcc-a9fe-a7673af9a3ec,TCGA-E9-A1NE-01,TCGA-E9-A1NE-01A-21D-A14K-09,,,TCGA-E9-A1NE-01,TCGA-E9-A1NE-01A-21D-A14K-09,,92691eb7-5df9-4da9-8bd0-c4f4de528bdc,,TCGA-E9-A1NE-01A-21D-A14J-01,TCGA-E9-A1NE-01,,92691eb7-5df9-4da9-8bd0-c4f4de528bdc,TCGA-E9-A1NE-01A-21D-A14J-01,
tcga.e9.a1nf,Stage IIA,60.0,5.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-E9-A1NF-01,1072.0,1.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 13,TCGA-E9-A1NF,1072.0,0.0,days,1072.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,,NO,,60.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1NF-F39778,TCGA-E9-A1NF,TCGA-E9-A1NF-01A,,Positive,,,,,Positive,,,YES,,,-21981.0,31.0,1072.0,0.0,610.0,,,90,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,240.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,Lung,Distant Metastasis,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf,A1NF,WITH TUMOR,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2011.0,69e0026c-c87c-4987-8e46-f94d21f6bfb6,69e0026c-c87c-4987-8e46-f94d21f6bfb6,TCGA-E9-A1NF-01A-21-A17K-20,TCGA-E9-A1NF-01A-11D-A14G-09,TCGA-E9-A1NF-01,TCGA-E9-A1NF-01A-11D-A14H-05,710e4246-7a43-4a0a-b6e2-0dddc3420c59,TCGA-E9-A1NF-01,TCGA-E9-A1NF-01A-11D-A14G-09,,,TCGA-E9-A1NF-01,TCGA-E9-A1NF-01A-11D-A14G-09,,69e0026c-c87c-4987-8e46-f94d21f6bfb6,,TCGA-E9-A1NF-01A-11D-A14F-01,TCGA-E9-A1NF-01,,69e0026c-c87c-4987-8e46-f94d21f6bfb6,TCGA-E9-A1NF-01A-11D-A14F-01,
tcga.e9.a1ng,Stage IIA,62.0,1.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-E9-A1NG-01,786.0,1.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 1,TCGA-E9-A1NG,786.0,0.0,days,786.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1NG-F39774,TCGA-E9-A1NG,TCGA-E9-A1NG-01A,,Positive,,,,,Positive,,,YES,,,-22896.0,30.0,786.0,0.0,656.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,380.0,NO,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf,A1NG,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2011.0,91918c5e-3c5c-4674-9a7f-1e93d9cf9949,91918c5e-3c5c-4674-9a7f-1e93d9cf9949,TCGA-E9-A1NG-01A-11-A17K-20,TCGA-E9-A1NG-01A-21D-A14K-09,TCGA-E9-A1NG-01,TCGA-E9-A1NG-01A-21D-A14N-05,38b632fe-cdcb-4b5d-9687-86977604c842,TCGA-E9-A1NG-01,TCGA-E9-A1NG-01A-21D-A14K-09,,,TCGA-E9-A1NG-01,TCGA-E9-A1NG-01A-21D-A14K-09,,91918c5e-3c5c-4674-9a7f-1e93d9cf9949,,TCGA-E9-A1NG-01A-21D-A14J-01,TCGA-E9-A1NG-01,,91918c5e-3c5c-4674-9a7f-1e93d9cf9949,TCGA-E9-A1NG-01A-21D-A14J-01,
tcga.e9.a1nh,Stage IIB,71.0,2.0,Stage IIB,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1NH-01,576.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 4,mutation cluster 4,TCGA-E9-A1NH,576.0,0.0,days,576.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1NH-F35049,TCGA-E9-A1NH,TCGA-E9-A1NH-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-26221.0,30.0,,0.0,576.0,,,,,NO,,,,,2012-9-14,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,140.0,NO,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,3.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf,A1NH,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2011.0,0eb9c5a5-1e4e-4808-882e-858b4d0ed396,0eb9c5a5-1e4e-4808-882e-858b4d0ed396,TCGA-E9-A1NH-01A-21-A17K-20,TCGA-E9-A1NH-01A-11D-A14G-09,TCGA-E9-A1NH-01,TCGA-E9-A1NH-01A-11D-A14H-05,14a33bcb-ec41-48da-9c49-cfbcc3fab7de,TCGA-E9-A1NH-01,TCGA-E9-A1NH-01A-11D-A14G-09,,,TCGA-E9-A1NH-01,TCGA-E9-A1NH-01A-11D-A14G-09,,0eb9c5a5-1e4e-4808-882e-858b4d0ed396,,TCGA-E9-A1NH-01A-11D-A14F-01,TCGA-E9-A1NH-01,,0eb9c5a5-1e4e-4808-882e-858b4d0ed396,TCGA-E9-A1NH-01A-11D-A14F-01,
tcga.e9.a1ni,Stage IIA,51.0,2.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1NI-01,300.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E9-A1NI,300.0,0.0,days,300.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1NI-F52056,TCGA-E9-A1NI,TCGA-E9-A1NI-01A,,Positive,,,,,Positive,,,YES,,,-18985.0,21.0,,0.0,300.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-11-27,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,280.0,NO,Negative,,YES,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf,A1NI,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,07ac0536-240f-46be-9909-a8af1a22e2b8,07ac0536-240f-46be-9909-a8af1a22e2b8,TCGA-E9-A1NI-01A-21-A17K-20,TCGA-E9-A1NI-01A-11W-A16H-09,TCGA-E9-A1NI-01,TCGA-E9-A1NI-01A-11D-A14H-05,e1eda531-b715-4139-9c80-c91ffc100fc2,TCGA-E9-A1NI-01,TCGA-E9-A1NI-01A-11W-A16H-09,,,TCGA-E9-A1NI-01,TCGA-E9-A1NI-01A-11W-A16H-09,,07ac0536-240f-46be-9909-a8af1a22e2b8,,TCGA-E9-A1NI-01A-11D-A14F-01,TCGA-E9-A1NI-01,,07ac0536-240f-46be-9909-a8af1a22e2b8,TCGA-E9-A1NI-01A-11D-A14F-01,
tcga.e9.a1qz,Stage IIA,61.0,3.0,Stage IIA,0.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumA,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1QZ-01,755.0,0.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation c1uster 9,TCGA-E9-A1QZ,755.0,0.0,days,755.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1QZ-F66270,TCGA-E9-A1QZ,TCGA-E9-A1QZ-01A,,,,,,,,,,,,,-22397.0,58.0,,0.0,755.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-10-7,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,590.0,NO,,,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf,A1QZ,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,NO,YES,NO,E9,Breast,A,LIVING,2011.0,64897f59-3a93-4ac3-82d5-66e9f4dc7ac6,64897f59-3a93-4ac3-82d5-66e9f4dc7ac6,TCGA-E9-A1QZ-01A-41-A17J-20,TCGA-E9-A1QZ-01A-21D-A167-09,TCGA-E9-A1QZ-01,TCGA-E9-A1QZ-01A-21D-A16A-05,0794c219-5e82-4c62-9e40-091a0c71c6b4,TCGA-E9-A1QZ-01,TCGA-E9-A1QZ-01A-21D-A167-09,,,TCGA-E9-A1QZ-01,TCGA-E9-A1QZ-01A-21D-A167-09,,64897f59-3a93-4ac3-82d5-66e9f4dc7ac6,,TCGA-E9-A1QZ-01A-21D-A166-01,TCGA-E9-A1QZ-01,,64897f59-3a93-4ac3-82d5-66e9f4dc7ac6,TCGA-E9-A1QZ-01A-21D-A166-01,
tcga.e9.a1r0,Stage IIA,58.0,2.0,Stage IIA,0.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1R0-01,860.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,,mutation cluster 4,TCGA-E9-A1R0,860.0,0.0,days,860.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R0-F41214,TCGA-E9-A1R0,TCGA-E9-A1R0-01A,,,,,,,,,,,,,-21394.0,44.0,,0.0,860.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-3-13,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,400.0,NO,,,NO,12.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,1.0,,True,No,M0,N1,T1c,Stage IIA,TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf,A1R0,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3,4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3,TCGA-E9-A1R0-01A-11-A17J-20,TCGA-E9-A1R0-01A-22D-A16D-09,TCGA-E9-A1R0-01,TCGA-E9-A1R0-01A-22D-A16G-05,79bdc020-426c-41df-8b45-be0425815405,TCGA-E9-A1R0-01,TCGA-E9-A1R0-01A-22D-A16D-09,,,TCGA-E9-A1R0-01,TCGA-E9-A1R0-01A-22D-A16D-09,,4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3,,TCGA-E9-A1R0-01A-22D-A16C-01,TCGA-E9-A1R0-01,,4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3,TCGA-E9-A1R0-01A-22D-A16C-01,
tcga.e9.a1r2,Stage IIIC,51.0,5.0,Stage IIIC,19.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N3,19.0,0.0,LumA,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1R2-01,1063.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 7,mutation c1uster 9,TCGA-E9-A1R2,1063.0,0.0,days,1063.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R2-F57941,TCGA-E9-A1R2,,,Positive,,,,,Negative,Lumpectomy,,NO,,,-18936.0,,,0.0,1063.0,,,,,NO,,90-99%,74,Scheduled Follow-up Submission,2014-3-31,FEMALE,,,90-99%,,,,114,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,,,Equivocal,Negative,YES,19.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,17.0,,,No,MX,N3,T2,Stage IIIC,,A1R2,TUMOR FREE,,,,Two-tier,Two-tier,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,,LIVING,2011.0,e24bfd9d-87b2-44a7-bddc-7b7f60461252,e24bfd9d-87b2-44a7-bddc-7b7f60461252,TCGA-E9-A1R2-01A-21-A17J-20,TCGA-E9-A1R2-01A-11D-A14G-09,TCGA-E9-A1R2-01,TCGA-E9-A1R2-01A-11D-A14H-05,e2a04b43-75e6-4ede-8536-d3cfe5eb9113,TCGA-E9-A1R2-01,TCGA-E9-A1R2-01A-11D-A14G-09,,,TCGA-E9-A1R2-01,TCGA-E9-A1R2-01A-11D-A14G-09,,e24bfd9d-87b2-44a7-bddc-7b7f60461252,,TCGA-E9-A1R2-01A-11D-A14F-01,TCGA-E9-A1R2-01,,e24bfd9d-87b2-44a7-bddc-7b7f60461252,TCGA-E9-A1R2-01A-11D-A14F-01,
tcga.e9.a1r3,Stage IIIC,70.0,2.0,Stage IIIC,64.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N3,64.0,0.0,LumA,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1R3-01,78.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E9-A1R3,78.0,0.0,days,78.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R3-F48697,TCGA-E9-A1R3,TCGA-E9-A1R3-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-25693.0,80.0,,0.0,78.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,420.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,10.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf,A1R3,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,678ba111-3b01-49b7-83d9-165ef0288a34,678ba111-3b01-49b7-83d9-165ef0288a34,TCGA-E9-A1R3-01A-41-A17J-20,TCGA-E9-A1R3-01A-31D-A14K-09,TCGA-E9-A1R3-01,TCGA-E9-A1R3-01A-31D-A14N-05,fa7047e6-5a4e-4979-a1ee-ecac9434f163,TCGA-E9-A1R3-01,TCGA-E9-A1R3-01A-31D-A14K-09,,,TCGA-E9-A1R3-01,TCGA-E9-A1R3-01A-31D-A14K-09,,678ba111-3b01-49b7-83d9-165ef0288a34,,TCGA-E9-A1R3-01A-31D-A14J-01,TCGA-E9-A1R3-01,,678ba111-3b01-49b7-83d9-165ef0288a34,TCGA-E9-A1R3-01A-31D-A14J-01,
tcga.e9.a1r4,Stage IA,66.0,1.0,Stage I,29.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,29.0,0.0,LumB,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1R4-01,186.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 4,mutation cluster 4,TCGA-E9-A1R4,186.0,0.0,days,186.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R4-F48699,TCGA-E9-A1R4,TCGA-E9-A1R4-01A,,,,,,,,,,NO,,,-24181.0,45.0,,0.0,186.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Lumpectomy,"Other method, specify:",430.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf,A1R4,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,11353ea3-2ff0-4658-b528-6aa922dbb665,11353ea3-2ff0-4658-b528-6aa922dbb665,TCGA-E9-A1R4-01A-11-A17J-20,TCGA-E9-A1R4-01A-21D-A14G-09,TCGA-E9-A1R4-01,TCGA-E9-A1R4-01A-21D-A14H-05,146230f2-2e64-46d7-84da-719567028426,TCGA-E9-A1R4-01,TCGA-E9-A1R4-01A-21D-A14G-09,,,TCGA-E9-A1R4-01,TCGA-E9-A1R4-01A-21D-A14G-09,,11353ea3-2ff0-4658-b528-6aa922dbb665,,TCGA-E9-A1R4-01A-21D-A14F-01,TCGA-E9-A1R4-01,,11353ea3-2ff0-4658-b528-6aa922dbb665,TCGA-E9-A1R4-01A-21D-A14F-01,
tcga.e9.a1r5,Stage IA,63.0,2.0,Stage I,42.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,42.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1R5-01,92.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E9-A1R5,92.0,0.0,days,92.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R5-F48700,TCGA-E9-A1R5,TCGA-E9-A1R5-01A,,,,,,,,Lumpectomy,,NO,,,-23116.0,58.0,,0.0,92.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),370.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf,A1R5,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,7b06a333-ba77-41dd-bfd1-4824fe43d06f,7b06a333-ba77-41dd-bfd1-4824fe43d06f,TCGA-E9-A1R5-01A-21-A17J-20,TCGA-E9-A1R5-01A-11D-A14K-09,TCGA-E9-A1R5-01,TCGA-E9-A1R5-01A-11D-A14N-05,95daa854-64b7-48d2-a82b-bacbfea25944,TCGA-E9-A1R5-01,TCGA-E9-A1R5-01A-11D-A14K-09,,,TCGA-E9-A1R5-01,TCGA-E9-A1R5-01A-11D-A14K-09,,7b06a333-ba77-41dd-bfd1-4824fe43d06f,,TCGA-E9-A1R5-01A-11D-A14J-01,TCGA-E9-A1R5-01,,7b06a333-ba77-41dd-bfd1-4824fe43d06f,TCGA-E9-A1R5-01A-11D-A14J-01,
tcga.e9.a1r6,Stage IIA,63.0,4.0,Stage IIA,84.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,84.0,0.0,LumA,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1R6-01,339.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-E9-A1R6,339.0,0.0,days,339.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R6-F39520,TCGA-E9-A1R6,TCGA-E9-A1R6-01A,,,,,,,,Lumpectomy,,NO,,,-23347.0,100.0,,0.0,339.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),730.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,2.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf,A1R6,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2010.0,2b022043-a976-40a7-929e-664b9549c411,2b022043-a976-40a7-929e-664b9549c411,TCGA-E9-A1R6-01A-21-A17J-20,TCGA-E9-A1R6-01A-11D-A14G-09,TCGA-E9-A1R6-01,TCGA-E9-A1R6-01A-11D-A14H-05,e3b3d877-30e8-48f5-bc12-87618c1dbb34,TCGA-E9-A1R6-01,TCGA-E9-A1R6-01A-11D-A14G-09,,,TCGA-E9-A1R6-01,TCGA-E9-A1R6-01A-11D-A14G-09,,2b022043-a976-40a7-929e-664b9549c411,,TCGA-E9-A1R6-01A-11D-A14F-01,TCGA-E9-A1R6-01,,2b022043-a976-40a7-929e-664b9549c411,TCGA-E9-A1R6-01A-11D-A14F-01,
tcga.e9.a1r7,Stage IIA,64.0,5.0,Stage IIA,34.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,34.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1R7-01,1467.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-E9-A1R7,1467.0,0.0,days,1467.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1R7-F71424,TCGA-E9-A1R7,TCGA-E9-A1R7-01A,,,,,,,,Lumpectomy,,NO,,,-23397.0,51.0,,0.0,1467.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-3-25,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),400.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,1.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf,A1R7,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,5ac273e2-3a3f-48a6-8782-956587bab667,5ac273e2-3a3f-48a6-8782-956587bab667,TCGA-E9-A1R7-01A-21-A17J-20,TCGA-E9-A1R7-01A-11D-A14K-09,TCGA-E9-A1R7-01,TCGA-E9-A1R7-01A-11D-A14N-05,95f3d6af-2e61-4df8-b5bd-ce495b3b8b69,TCGA-E9-A1R7-01,TCGA-E9-A1R7-01A-11D-A14K-09,,,TCGA-E9-A1R7-01,TCGA-E9-A1R7-01A-11D-A14K-09,,5ac273e2-3a3f-48a6-8782-956587bab667,,TCGA-E9-A1R7-01A-11D-A14J-01,TCGA-E9-A1R7-01,,5ac273e2-3a3f-48a6-8782-956587bab667,TCGA-E9-A1R7-01A-11D-A14J-01,
tcga.e9.a1ra,Stage IA,48.0,3.0,Stage I,29.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,29.0,0.0,,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1RA-01,1369.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,,miRNA cluster 4,cluster 6,mutation cluster 4,TCGA-E9-A1RA,1369.0,0.0,days,1369.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RA-F68493,TCGA-E9-A1RA,,,,,,,,,,,NO,,,-17699.0,,,0.0,1369.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-11-20,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Lumpectomy,"Other method, specify:",,,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,0.0,,,No,M0,N0,T1c,Stage IA,,A1RA,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,,LIVING,2011.0,da9bcd8c-7f5b-41f4-bff8-7129a88caf22,da9bcd8c-7f5b-41f4-bff8-7129a88caf22,TCGA-E9-A1RA-01A-21-A17J-20,TCGA-E9-A1RA-01A-11D-A14G-09,TCGA-E9-A1RA-01,TCGA-E9-A1RA-01A-11D-A14H-05,e20d43c8-401d-4975-ac2a-b355dd5bd528,TCGA-E9-A1RA-01,TCGA-E9-A1RA-01A-11D-A14G-09,,,TCGA-E9-A1RA-01,TCGA-E9-A1RA-01A-11D-A14G-09,,da9bcd8c-7f5b-41f4-bff8-7129a88caf22,,TCGA-E9-A1RA-01A-11D-A14F-01,TCGA-E9-A1RA-01,,da9bcd8c-7f5b-41f4-bff8-7129a88caf22,TCGA-E9-A1RA-01A-11D-A14F-01,
tcga.e9.a1rb,Stage IIA,40.0,4.0,Stage IIA,21.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,21.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-E9-A1RB-01,976.0,1.0,days,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 5,TCGA-E9-A1RB,976.0,0.0,days,976.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RB-F39530,TCGA-E9-A1RB,TCGA-E9-A1RB-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-14755.0,39.0,976.0,0.0,633.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),490.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf,A1RB,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2011.0,7e2a8676-10a4-4abf-b153-2255e06bcb40,7e2a8676-10a4-4abf-b153-2255e06bcb40,TCGA-E9-A1RB-01A-21-A17J-20,TCGA-E9-A1RB-01A-11D-A17G-09,TCGA-E9-A1RB-01,TCGA-E9-A1RB-01A-11D-A161-05,d0e45995-93b2-4247-85b7-bc7071578e1f,TCGA-E9-A1RB-01,TCGA-E9-A1RB-01A-11D-A17G-09,,,TCGA-E9-A1RB-01,TCGA-E9-A1RB-01A-11D-A17G-09,,7e2a8676-10a4-4abf-b153-2255e06bcb40,,TCGA-E9-A1RB-01A-11D-A160-01,TCGA-E9-A1RB-01,,7e2a8676-10a4-4abf-b153-2255e06bcb40,TCGA-E9-A1RB-01A-11D-A160-01,
tcga.e9.a1rc,Stage IIIC,56.0,3.0,Stage IIIC,1228.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N3,1228.0,0.0,LumA,,,,,,enrollment,T_Other,T4,LIVING,0.0,TCGA-E9-A1RC-01,1224.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation cluster 4,TCGA-E9-A1RC,1224.0,0.0,days,1224.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RC-F48701,TCGA-E9-A1RC,TCGA-E9-A1RC-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-20795.0,1246.0,,0.0,1224.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),620.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,10.0,0.0,True,No,M0,N3,T4b,Stage IIIC,TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf,A1RC,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2007.0,00168e86-d23a-48ae-8c60-36d970051907,00168e86-d23a-48ae-8c60-36d970051907,TCGA-E9-A1RC-01A-21-A17J-20,TCGA-E9-A1RC-01A-11D-A159-09,TCGA-E9-A1RC-01,TCGA-E9-A1RC-01A-11D-A161-05,9243e0b1-b98d-4d50-817a-b2fed305e841,TCGA-E9-A1RC-01,TCGA-E9-A1RC-01A-11D-A159-09,,,TCGA-E9-A1RC-01,TCGA-E9-A1RC-01A-11D-A159-09,,00168e86-d23a-48ae-8c60-36d970051907,,TCGA-E9-A1RC-01A-11D-A160-01,TCGA-E9-A1RC-01,,00168e86-d23a-48ae-8c60-36d970051907,TCGA-E9-A1RC-01A-11D-A160-01,
tcga.e9.a1rd,Stage IIA,67.0,2.0,Stage IIA,20.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,20.0,0.0,LumA,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1RD-01,34.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,,mutation cluster 4,TCGA-E9-A1RD,34.0,0.0,days,34.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RD-F48702,TCGA-E9-A1RD,,,,,,,,,Modified Radical Mastectomy,,NO,,,-24719.0,,,0.0,34.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),,,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1RD,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,,LIVING,2011.0,eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16,eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16,TCGA-E9-A1RD-01A-21-A17J-20,TCGA-E9-A1RD-01A-11D-A159-09,TCGA-E9-A1RD-01,TCGA-E9-A1RD-01A-11D-A161-05,ef7d073e-90b6-4d14-bcad-a6d9759122dc,TCGA-E9-A1RD-01,TCGA-E9-A1RD-01A-11D-A159-09,,,TCGA-E9-A1RD-01,TCGA-E9-A1RD-01A-11D-A159-09,,eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16,,TCGA-E9-A1RD-01A-11D-A160-01,TCGA-E9-A1RD-01,,eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16,TCGA-E9-A1RD-01A-11D-A160-01,
tcga.e9.a1re,Stage IIIA,74.0,4.0,Stage IIIA,47.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N2,47.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1RE-01,1419.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,,mutation cluster 4,TCGA-E9-A1RE,1419.0,0.0,days,1419.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RE-F68732,TCGA-E9-A1RE,TCGA-E9-A1RE-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-27392.0,65.0,,0.0,1419.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-12-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),730.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,9.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf,A1RE,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,dce9e705-2d4f-4786-ad68-fb47615c7f3f,dce9e705-2d4f-4786-ad68-fb47615c7f3f,TCGA-E9-A1RE-01A-21-A17J-20,TCGA-E9-A1RE-01A-11D-A159-09,TCGA-E9-A1RE-01,TCGA-E9-A1RE-01A-11D-A161-05,347208e2-3e3d-4b02-8fc0-1092a95f9bcf,TCGA-E9-A1RE-01,TCGA-E9-A1RE-01A-11D-A159-09,,,TCGA-E9-A1RE-01,TCGA-E9-A1RE-01A-11D-A159-09,,dce9e705-2d4f-4786-ad68-fb47615c7f3f,,TCGA-E9-A1RE-01A-11D-A160-01,TCGA-E9-A1RE-01,,dce9e705-2d4f-4786-ad68-fb47615c7f3f,TCGA-E9-A1RE-01A-11D-A160-01,
tcga.e9.a1rf,Stage IIIA,68.0,5.0,Stage IIIA,38.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N2,38.0,0.0,LumA,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1RF-01,200.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation c1uster 9,TCGA-E9-A1RF,200.0,0.0,days,200.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RF-F48703,TCGA-E9-A1RF,TCGA-E9-A1RF-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-25119.0,56.0,,0.0,200.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),330.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,5.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf,A1RF,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,502939cc-3381-4bc2-9ae6-332846cf836b,502939cc-3381-4bc2-9ae6-332846cf836b,TCGA-E9-A1RF-01A-21-A17J-20,TCGA-E9-A1RF-01A-11D-A159-09,TCGA-E9-A1RF-01,TCGA-E9-A1RF-01A-11D-A161-05,97534d53-162f-4e78-bf68-a227f1c2ae36,TCGA-E9-A1RF-01,TCGA-E9-A1RF-01A-11D-A159-09,,,TCGA-E9-A1RF-01,TCGA-E9-A1RF-01A-11D-A159-09,,502939cc-3381-4bc2-9ae6-332846cf836b,,TCGA-E9-A1RF-01A-11D-A160-01,TCGA-E9-A1RF-01,,502939cc-3381-4bc2-9ae6-332846cf836b,TCGA-E9-A1RF-01A-11D-A160-01,
tcga.e9.a1rg,Stage IIIA,62.0,2.0,Stage IIIA,35.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N2,35.0,0.0,,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1RG-01,647.0,0.0,days,High,C1-LUAD-enriched,cluster 2,Cluster 5,BRCA nonbasal-like c8,,miRNA cluster 2,cluster 5,mutation c1uster 9,TCGA-E9-A1RG,647.0,0.0,days,647.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RG-F39534,TCGA-E9-A1RG,TCGA-E9-A1RG-01A,,,,,,,,Lumpectomy,,NO,,,-22788.0,53.0,,0.0,647.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),540.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,5.0,,,,,,,,NO,4.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf,A1RG,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,dbf09347-4e3e-490e-977f-97d826143634,dbf09347-4e3e-490e-977f-97d826143634,TCGA-E9-A1RG-01A-21-A17J-20,TCGA-E9-A1RG-01A-11D-A14G-09,TCGA-E9-A1RG-01,TCGA-E9-A1RG-01A-11D-A14H-05,4c16616e-47cf-474c-b8c3-f681f390493f,TCGA-E9-A1RG-01,TCGA-E9-A1RG-01A-11D-A14G-09,,,TCGA-E9-A1RG-01,TCGA-E9-A1RG-01A-11D-A14G-09,,dbf09347-4e3e-490e-977f-97d826143634,,TCGA-E9-A1RG-01A-11D-A14F-01,TCGA-E9-A1RG-01,,dbf09347-4e3e-490e-977f-97d826143634,TCGA-E9-A1RG-01A-11D-A14F-01,
tcga.e9.a1rh,Stage IIA,63.0,4.0,Stage IIA,14.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,14.0,0.0,Her2,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A1RH-01,1417.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E9-A1RH,1417.0,0.0,days,1417.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RH-F70141,TCGA-E9-A1RH,TCGA-E9-A1RH-01A,,,,,,,,Lumpectomy,,NO,,,-23224.0,32.0,,0.0,1417.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),410.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf,A1RH,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,422a4277-12f1-42ae-9f94-88d37517b9b0,422a4277-12f1-42ae-9f94-88d37517b9b0,TCGA-E9-A1RH-01A-11-A17J-20,TCGA-E9-A1RH-01A-21D-A167-09,TCGA-E9-A1RH-01,TCGA-E9-A1RH-01A-21D-A16A-05,7daa20aa-d253-4dc4-a90b-c68c6535d837,TCGA-E9-A1RH-01,TCGA-E9-A1RH-01A-21D-A167-09,,,TCGA-E9-A1RH-01,TCGA-E9-A1RH-01A-21D-A167-09,,422a4277-12f1-42ae-9f94-88d37517b9b0,,TCGA-E9-A1RH-01A-21D-A166-01,TCGA-E9-A1RH-01,,422a4277-12f1-42ae-9f94-88d37517b9b0,TCGA-E9-A1RH-01A-21D-A166-01,
tcga.e9.a1ri,Stage IIIA,43.0,2.0,Stage IIIA,48.0,,,FEMALE,,,,,Negative,M0,Positive,N2,48.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A1RI-01,1449.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-E9-A1RI,1449.0,0.0,days,1449.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A1RI-F70144,TCGA-E9-A1RI,TCGA-E9-A1RI-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-15942.0,64.0,,0.0,1449.0,,,,,NO,,,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),290.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,5.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf,A1RI,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,1c77a00e-8cea-48ae-b9b5-193cdecf3604,1c77a00e-8cea-48ae-b9b5-193cdecf3604,TCGA-E9-A1RI-01A-21-A17J-20,TCGA-E9-A1RI-01A-11D-A167-09,TCGA-E9-A1RI-01,TCGA-E9-A1RI-01A-11D-A16A-05,fde109be-d1bb-48df-af59-0bee2ca9ed1e,TCGA-E9-A1RI-01,TCGA-E9-A1RI-01A-11D-A167-09,,,TCGA-E9-A1RI-01,TCGA-E9-A1RI-01A-11D-A167-09,,1c77a00e-8cea-48ae-b9b5-193cdecf3604,,TCGA-E9-A1RI-01A-11D-A166-01,TCGA-E9-A1RI-01,,1c77a00e-8cea-48ae-b9b5-193cdecf3604,TCGA-E9-A1RI-01A-11D-A166-01,
tcga.e9.a226,Stage IIIA,45.0,2.0,Stage IIIA,16.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N2,16.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,1.0,TCGA-E9-A226-01,1048.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 3,TCGA-E9-A226,1048.0,0.0,days,1048.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,45.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A226-F39536,TCGA-E9-A226,TCGA-E9-A226-01A,,,,,,,,Modified Radical Mastectomy,,NO,,,-16511.0,48.0,1048.0,0.0,628.0,,,790,,NO,,,,Scheduled Follow-up Submission,2015-3-2,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),510.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,,,,,Bone,Distant Metastasis,,NO,NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf,A226,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2011.0,2f11f003-9c39-46ba-990f-10d326953f1b,2f11f003-9c39-46ba-990f-10d326953f1b,TCGA-E9-A226-01A-11-A17K-20,TCGA-E9-A226-01A-21D-A159-09,TCGA-E9-A226-01,TCGA-E9-A226-01A-21D-A161-05,67837600-8189-44bd-af2f-1cb30522bc65,TCGA-E9-A226-01,TCGA-E9-A226-01A-21D-A159-09,,,TCGA-E9-A226-01,TCGA-E9-A226-01A-21D-A159-09,,2f11f003-9c39-46ba-990f-10d326953f1b,,TCGA-E9-A226-01A-21D-A160-01,TCGA-E9-A226-01,,2f11f003-9c39-46ba-990f-10d326953f1b,TCGA-E9-A226-01A-21D-A160-01,
tcga.e9.a227,Stage IIB,42.0,2.0,Stage IIB,24.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,24.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A227-01,975.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation cluster 1,TCGA-E9-A227,975.0,0.0,days,975.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,42.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E9-A227-F58571,TCGA-E9-A227,TCGA-E9-A227-01A,Negative,Positive,,4+,,Other,Positive,Lumpectomy,Re-excision of original lumpectomy site,NO,,,-15602.0,66.0,,0.0,975.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2014-4-29,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,4+,YES,,Core needle biopsy,180.0,NO,Negative,,YES,17.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf,A227,TUMOR FREE,,,,Two-tier,Two-tier,,YES,80-89%,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,2f315234-dee1-4f36-b7dc-72280c219a1c,2f315234-dee1-4f36-b7dc-72280c219a1c,TCGA-E9-A227-01A-21-A17K-20,TCGA-E9-A227-01A-11D-A159-09,TCGA-E9-A227-01,TCGA-E9-A227-01A-11D-A161-05,ad8672fa-20e1-4624-ac65-10e1d4f057ed,TCGA-E9-A227-01,TCGA-E9-A227-01A-11D-A159-09,,,TCGA-E9-A227-01,TCGA-E9-A227-01A-11D-A159-09,,2f315234-dee1-4f36-b7dc-72280c219a1c,,TCGA-E9-A227-01A-11D-A160-01,TCGA-E9-A227-01,,2f315234-dee1-4f36-b7dc-72280c219a1c,TCGA-E9-A227-01A-11D-A160-01,
tcga.e9.a228,Stage IIB,58.0,5.0,Stage IIB,0.0,,,FEMALE,Positive,,,,Negative,M0,Positive,N1,0.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A228-01,1285.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,,mutation c1uster 9,TCGA-E9-A228,1285.0,0.0,days,1285.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A228-F65804,TCGA-E9-A228,TCGA-E9-A228-01A,,,,,,,,,,,,,-21294.0,42.0,,0.0,1285.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,740.0,NO,,,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf,A228,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,5903d969-2fd6-4952-b475-a79e6c241efd,5903d969-2fd6-4952-b475-a79e6c241efd,TCGA-E9-A228-01A-41-A17K-20,TCGA-E9-A228-01A-31D-A159-09,TCGA-E9-A228-01,TCGA-E9-A228-01A-31D-A161-05,edcb326a-16d2-4ac1-a8da-de4ffcaca34a,TCGA-E9-A228-01,TCGA-E9-A228-01A-31D-A159-09,,,TCGA-E9-A228-01,TCGA-E9-A228-01A-31D-A159-09,,5903d969-2fd6-4952-b475-a79e6c241efd,,TCGA-E9-A228-01A-31D-A160-01,TCGA-E9-A228-01,,5903d969-2fd6-4952-b475-a79e6c241efd,TCGA-E9-A228-01A-31D-A160-01,
tcga.e9.a229,Stage IA,37.0,5.0,Stage I,0.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A229-01,1148.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation cluster 4,TCGA-E9-A229,1148.0,0.0,days,1148.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,37.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A229-F65803,TCGA-E9-A229,TCGA-E9-A229-01A,,,,,,,,,,,,,-13817.0,56.0,,0.0,1148.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,160.0,NO,,,NO,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf,A229,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,b956a823-b7d5-4a9e-a9d1-c66f0faf544a,b956a823-b7d5-4a9e-a9d1-c66f0faf544a,TCGA-E9-A229-01A-21-A17K-20,TCGA-E9-A229-01A-31D-A17G-09,TCGA-E9-A229-01,TCGA-E9-A229-01A-31D-A161-05,9ff7a9ee-7e6e-4f4d-95f8-d2f6e1e88cc3,TCGA-E9-A229-01,TCGA-E9-A229-01A-31D-A17G-09,,,TCGA-E9-A229-01,TCGA-E9-A229-01A-31D-A17G-09,,b956a823-b7d5-4a9e-a9d1-c66f0faf544a,,TCGA-E9-A229-01A-31D-A160-01,TCGA-E9-A229-01,,b956a823-b7d5-4a9e-a9d1-c66f0faf544a,TCGA-E9-A229-01A-31D-A160-01,
tcga.e9.a22a,Stage IIA,74.0,1.0,Stage IIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A22A-01,1189.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,,mutation c1uster 9,TCGA-E9-A22A,1189.0,0.0,days,1189.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22A-F39785,TCGA-E9-A22A,TCGA-E9-A22A-01A,,Positive,,,,,Negative,,,YES,,,-27288.0,59.0,,0.0,1189.0,,,,,NO,,10-19%,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,340.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf,A22A,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,2513da31-4ee0-49cd-85de-d2bc8e71e2e5,2513da31-4ee0-49cd-85de-d2bc8e71e2e5,TCGA-E9-A22A-01A-21-A17K-20,TCGA-E9-A22A-01A-11D-A159-09,TCGA-E9-A22A-01,TCGA-E9-A22A-01A-11D-A161-05,31514349-7cce-4d67-8dd4-4fb5f7fea530,TCGA-E9-A22A-01,TCGA-E9-A22A-01A-11D-A159-09,,,TCGA-E9-A22A-01,TCGA-E9-A22A-01A-11D-A159-09,,2513da31-4ee0-49cd-85de-d2bc8e71e2e5,,TCGA-E9-A22A-01A-11D-A160-01,TCGA-E9-A22A-01,,2513da31-4ee0-49cd-85de-d2bc8e71e2e5,TCGA-E9-A22A-01A-11D-A160-01,
tcga.e9.a22b,Stage IA,71.0,5.0,Stage I,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,LumA,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A22B-01,1167.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,,mutation c1uster 9,TCGA-E9-A22B,1167.0,0.0,days,1167.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22B-F64425,TCGA-E9-A22B,,,Positive,,,,,Negative,,,YES,,,-26278.0,,,0.0,1167.0,,,,,NO,,10-19%,,Scheduled Follow-up Submission,2014-9-2,FEMALE,,,,,,,,,,Mixed Histology (please specify),Infiltrating ductal and lobular carcinoma,No,,C50.9,8522/3,C50.9,,YES,,Tumor resection,,,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,0.0,,No,M0,N0,T1c,Stage IA,,A22B,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,,LIVING,2011.0,f563bc24-00d1-4637-a073-87744ed7311a,f563bc24-00d1-4637-a073-87744ed7311a,TCGA-E9-A22B-01A-21-A17K-20,TCGA-E9-A22B-01A-11D-A159-09,TCGA-E9-A22B-01,TCGA-E9-A22B-01A-11D-A161-05,be719b89-4746-465d-9b38-1f32c86a2914,TCGA-E9-A22B-01,TCGA-E9-A22B-01A-11D-A159-09,,,TCGA-E9-A22B-01,TCGA-E9-A22B-01A-11D-A159-09,,f563bc24-00d1-4637-a073-87744ed7311a,,TCGA-E9-A22B-01A-11D-A160-01,TCGA-E9-A22B-01,,f563bc24-00d1-4637-a073-87744ed7311a,TCGA-E9-A22B-01A-11D-A160-01,
tcga.e9.a22d,Stage IIA,38.0,5.0,Stage IIA,0.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A22D-01,1248.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation c1uster 9,TCGA-E9-A22D,1248.0,0.0,days,1248.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22D-F39787,TCGA-E9-A22D,TCGA-E9-A22D-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-14115.0,52.0,,0.0,1248.0,,,,,,,10-19%,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,620.0,NO,Positive,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf,A22D,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,1fdac226-ed6b-41a8-9575-67117b4cf035,1fdac226-ed6b-41a8-9575-67117b4cf035,TCGA-E9-A22D-01A-21-A17K-20,TCGA-E9-A22D-01A-11D-A159-09,TCGA-E9-A22D-01,TCGA-E9-A22D-01A-11D-A161-05,4691c2b1-8da2-48b4-9510-badea3a8353f,TCGA-E9-A22D-01,TCGA-E9-A22D-01A-11D-A159-09,,,TCGA-E9-A22D-01,TCGA-E9-A22D-01A-11D-A159-09,,1fdac226-ed6b-41a8-9575-67117b4cf035,,TCGA-E9-A22D-01A-11D-A160-01,TCGA-E9-A22D-01,,1fdac226-ed6b-41a8-9575-67117b4cf035,TCGA-E9-A22D-01A-11D-A160-01,
tcga.e9.a22e,Stage IIIA,56.0,1.0,Stage IIIA,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A22E-01,1269.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 9,,mutation c1uster 9,TCGA-E9-A22E,1269.0,0.0,days,1269.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22E-F63565,TCGA-E9-A22E,TCGA-E9-A22E-01A,,Positive,,,,,Positive,,,YES,,,-20574.0,52.0,,0.0,1269.0,,,,,NO,,10-19%,,Scheduled Follow-up Submission,2014-8-13,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,620.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf,A22E,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b,e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b,TCGA-E9-A22E-01A-21-A17K-20,TCGA-E9-A22E-01A-11D-A159-09,TCGA-E9-A22E-01,TCGA-E9-A22E-01A-11D-A161-05,30d1b1ed-e4da-4758-b523-271f2bc19e6c,TCGA-E9-A22E-01,TCGA-E9-A22E-01A-11D-A159-09,,,TCGA-E9-A22E-01,TCGA-E9-A22E-01A-11D-A159-09,,e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b,,TCGA-E9-A22E-01A-11D-A160-01,TCGA-E9-A22E-01,,e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b,TCGA-E9-A22E-01A-11D-A160-01,
tcga.e9.a22g,Stage IIIA,47.0,1.0,Stage IIA,0.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,0.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A22G-01,1239.0,0.0,days,Squamous,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 1,,mutation cluster 5,TCGA-E9-A22G,1239.0,0.0,days,1239.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22G-F62594,TCGA-E9-A22G,TCGA-E9-A22G-01A,,Negative,,,,,Negative,,,YES,,,-17300.0,45.0,,0.0,1239.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-7-21,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,650.0,NO,Positive,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf,A22G,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,88d93dca-ffae-4d57-9a60-346aec436543,88d93dca-ffae-4d57-9a60-346aec436543,TCGA-E9-A22G-01A-21-A17K-20,TCGA-E9-A22G-01A-11D-A159-09,TCGA-E9-A22G-01,TCGA-E9-A22G-01A-11D-A161-05,62d5983b-ccc1-4700-9cb9-e97ff4bb1277,TCGA-E9-A22G-01,TCGA-E9-A22G-01A-11D-A159-09,,,TCGA-E9-A22G-01,TCGA-E9-A22G-01A-11D-A159-09,,88d93dca-ffae-4d57-9a60-346aec436543,,TCGA-E9-A22G-01A-11D-A160-01,TCGA-E9-A22G-01,,88d93dca-ffae-4d57-9a60-346aec436543,TCGA-E9-A22G-01A-11D-A160-01,
tcga.e9.a22h,Stage IIB,42.0,2.0,Stage IIB,0.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,0.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A22H-01,1232.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,mutation cluster 4,TCGA-E9-A22H,1232.0,0.0,days,1232.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,42.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A22H-F63224,TCGA-E9-A22H,TCGA-E9-A22H-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-15504.0,38.0,,0.0,1232.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2014-8-4,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,500.0,NO,Positive,,NO,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf,A22H,TUMOR FREE,,,,,,YES,YES,10-19%,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,c388d3be-37d9-4377-8c85-f6124b2ad436,c388d3be-37d9-4377-8c85-f6124b2ad436,TCGA-E9-A22H-01A-21-A17K-20,TCGA-E9-A22H-01A-11D-A159-09,TCGA-E9-A22H-01,TCGA-E9-A22H-01A-11D-A161-05,25eba4f9-cda1-4925-8504-5291fd135b5f,TCGA-E9-A22H-01,TCGA-E9-A22H-01A-11D-A159-09,,,TCGA-E9-A22H-01,TCGA-E9-A22H-01A-11D-A159-09,,c388d3be-37d9-4377-8c85-f6124b2ad436,,TCGA-E9-A22H-01A-11D-A160-01,TCGA-E9-A22H-01,,c388d3be-37d9-4377-8c85-f6124b2ad436,TCGA-E9-A22H-01A-11D-A160-01,
tcga.e9.a243,Stage IIA,52.0,3.0,Stage IIA,43.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,43.0,0.0,Basal,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A243-01,612.0,0.0,days,High,C4-BRCA/Basal,cluster 5,OV-like c1,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation cluster 5,TCGA-E9-A243,305.0,1.0,days,612.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,YES,,52.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A243-F56656,TCGA-E9-A243,TCGA-E9-A243-01A,,,,,,,,Lumpectomy,,NO,,305.0,-19035.0,94.0,,0.0,612.0,,,305,,NO,,,,Scheduled Follow-up Submission,2014-2-18,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),270.0,NO,,,YES,10.0,Negative,Peri (6-12 months since last menstrual period),,Negative,,,Negative,,,,,,,,,,,,Negative,,,5.0,3.0,,,,Bone,Distant Metastasis,,,YES,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf,A243,WITH TUMOR,,,,,,,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,619ffb2b-a591-4f3b-aa48-b0c44f4ee36a,619ffb2b-a591-4f3b-aa48-b0c44f4ee36a,TCGA-E9-A243-01A-11-A17K-20,TCGA-E9-A243-01A-21D-A167-09,TCGA-E9-A243-01,TCGA-E9-A243-01A-21D-A16A-05,a1b3b8fa-af81-479c-a27b-485bc4557e82,TCGA-E9-A243-01,TCGA-E9-A243-01A-21D-A167-09,,,TCGA-E9-A243-01,TCGA-E9-A243-01A-21D-A167-09,,619ffb2b-a591-4f3b-aa48-b0c44f4ee36a,,TCGA-E9-A243-01A-21D-A166-01,TCGA-E9-A243-01,,619ffb2b-a591-4f3b-aa48-b0c44f4ee36a,TCGA-E9-A243-01A-21D-A166-01,
tcga.e9.a244,Stage IIA,54.0,1.0,Stage IIA,20.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,20.0,0.0,Basal,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A244-01,21.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA c1uster 9,,mutation cluster 5,TCGA-E9-A244,21.0,0.0,days,21.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A244-F31164,TCGA-E9-A244,TCGA-E9-A244-01A,,,,,,,,Lumpectomy,,NO,,,-19778.0,58.0,,0.0,21.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-4-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),310.0,NO,,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf,A244,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,147d6ebb-7359-449a-9e6a-6c8443ebaa2e,147d6ebb-7359-449a-9e6a-6c8443ebaa2e,TCGA-E9-A244-01A-21-A17K-20,TCGA-E9-A244-01A-11D-A167-09,TCGA-E9-A244-01,TCGA-E9-A244-01A-11D-A16A-05,a6266eec-b341-4642-aed5-9c6cd44f14df,TCGA-E9-A244-01,TCGA-E9-A244-01A-11D-A167-09,,,TCGA-E9-A244-01,TCGA-E9-A244-01A-11D-A167-09,,147d6ebb-7359-449a-9e6a-6c8443ebaa2e,,TCGA-E9-A244-01A-11D-A166-01,TCGA-E9-A244-01,,147d6ebb-7359-449a-9e6a-6c8443ebaa2e,TCGA-E9-A244-01A-11D-A166-01,
tcga.e9.a247,Stage IB,59.0,4.0,Stage I,12.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,12.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A247-01,1186.0,0.0,days,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,mutation c1uster 9,TCGA-E9-A247,1186.0,0.0,days,1186.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A247-F61874,TCGA-E9-A247,TCGA-E9-A247-01A,,,,,,,,,,,,,-21562.0,49.0,,0.0,1186.0,,,,,NO,,,,Scheduled Follow-up Submission,2014-7-23,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Lumpectomy,"Other method, specify:",370.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf,A247,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,3c38c1fe-9f57-4523-9654-c4bc6b02e84f,3c38c1fe-9f57-4523-9654-c4bc6b02e84f,TCGA-E9-A247-01A-21-A17K-20,TCGA-E9-A247-01A-11D-A167-09,TCGA-E9-A247-01,TCGA-E9-A247-01A-11D-A16A-05,572eb344-87fb-46f5-9d4b-81756d946892,TCGA-E9-A247-01,TCGA-E9-A247-01A-11D-A167-09,,,TCGA-E9-A247-01,TCGA-E9-A247-01A-11D-A167-09,,3c38c1fe-9f57-4523-9654-c4bc6b02e84f,,TCGA-E9-A247-01A-11D-A166-01,TCGA-E9-A247-01,,3c38c1fe-9f57-4523-9654-c4bc6b02e84f,TCGA-E9-A247-01A-11D-A166-01,
tcga.e9.a248,Stage IIA,51.0,4.0,Stage IIA,21.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,21.0,0.0,Her2,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A248-01,59.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 1,OV-like c1,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-E9-A248,59.0,0.0,days,59.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A248-F31211,TCGA-E9-A248,TCGA-E9-A248-01A,,,,,,,,Lumpectomy,,NO,,,-18684.0,52.0,,0.0,59.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-4-25,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),540.0,NO,,,,10.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,1.0,3.0,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf,A248,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,0a9215ea-d5d2-41ad-a00d-bd7722f41229,0a9215ea-d5d2-41ad-a00d-bd7722f41229,TCGA-E9-A248-01A-21-A17K-20,TCGA-E9-A248-01A-11D-A167-09,TCGA-E9-A248-01,TCGA-E9-A248-01A-11D-A16A-05,1b143b9f-74db-42c6-903c-b446834bd9f2,TCGA-E9-A248-01,TCGA-E9-A248-01A-11D-A167-09,,,TCGA-E9-A248-01,TCGA-E9-A248-01A-11D-A167-09,,0a9215ea-d5d2-41ad-a00d-bd7722f41229,,TCGA-E9-A248-01A-11D-A166-01,TCGA-E9-A248-01,,0a9215ea-d5d2-41ad-a00d-bd7722f41229,TCGA-E9-A248-01A-11D-A166-01,
tcga.e9.a249,Stage IIA,45.0,2.0,Stage IIA,28.0,,,FEMALE,Negative,,,,Negative,M0,Negative,N0,28.0,0.0,LumB,,,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-E9-A249-01,217.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-E9-A249,217.0,0.0,days,217.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A249-F49108,TCGA-E9-A249,TCGA-E9-A249-01A,,,,,,,,Lumpectomy,,NO,,,-16689.0,59.0,,0.0,217.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-9-25,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),470.0,NO,,,YES,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf,A249,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,5285c747-0cb2-4f6a-83d8-40e45f8e4f6e,5285c747-0cb2-4f6a-83d8-40e45f8e4f6e,TCGA-E9-A249-01A-21-A17K-20,TCGA-E9-A249-01A-11D-A167-09,TCGA-E9-A249-01,TCGA-E9-A249-01A-11D-A16A-05,8917880a-d278-410b-974b-440741ceb6de,TCGA-E9-A249-01,TCGA-E9-A249-01A-11D-A167-09,,,TCGA-E9-A249-01,TCGA-E9-A249-01A-11D-A167-09,,5285c747-0cb2-4f6a-83d8-40e45f8e4f6e,,TCGA-E9-A249-01A-11D-A166-01,TCGA-E9-A249-01,,5285c747-0cb2-4f6a-83d8-40e45f8e4f6e,TCGA-E9-A249-01A-11D-A166-01,
tcga.e9.a24a,Stage IIA,69.0,2.0,Stage IIA,10.0,,,FEMALE,Negative,,,,Negative,M0,Positive,N1,10.0,0.0,LumA,,,,,,enrollment,T1,T1,LIVING,0.0,TCGA-E9-A24A-01,747.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-E9-A24A,747.0,0.0,days,747.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A24A-F39541,TCGA-E9-A24A,TCGA-E9-A24A-01A,,,,,,,,,,NO,,,-25370.0,41.0,,0.0,747.0,,,,,NO,,,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Lumpectomy,"Other method, specify:",390.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,NO,1.0,,True,No,M0,N1,T1c,Stage IIA,TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf,A24A,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,a2bec98a-d946-40d2-b4d9-6495d815de9a,a2bec98a-d946-40d2-b4d9-6495d815de9a,TCGA-E9-A24A-01A-21-A17K-20,TCGA-E9-A24A-01A-11D-A167-09,TCGA-E9-A24A-01,TCGA-E9-A24A-01A-11D-A16A-05,8d96bc5d-6af2-4f5b-82d2-2b8f20848870,TCGA-E9-A24A-01,TCGA-E9-A24A-01A-11D-A167-09,,,TCGA-E9-A24A-01,TCGA-E9-A24A-01A-11D-A167-09,,a2bec98a-d946-40d2-b4d9-6495d815de9a,,TCGA-E9-A24A-01A-11D-A166-01,TCGA-E9-A24A-01,,a2bec98a-d946-40d2-b4d9-6495d815de9a,TCGA-E9-A24A-01A-11D-A166-01,
tcga.e9.a295,,,3.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-E9-A295-01,375.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,mutation cluster 4,TCGA-E9-A295,375.0,0.0,days,375.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A295-F35355,TCGA-E9-A295,TCGA-E9-A295-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-25957.0,63.0,,0.0,375.0,,,,,,,80-89%,,,2012-9-25,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,670.0,NO,Positive,,YES,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf,A295,TUMOR FREE,,,,7,7,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2011.0,28ad8481-78a8-4103-b501-5cfd23ae3e81,28ad8481-78a8-4103-b501-5cfd23ae3e81,TCGA-E9-A295-01A-21-A17K-20,TCGA-E9-A295-01A-11D-A16D-09,TCGA-E9-A295-01,TCGA-E9-A295-01A-11D-A16G-05,21dc7633-3a7e-407d-ae43-88edfef05091,TCGA-E9-A295-01,TCGA-E9-A295-01A-11D-A16D-09,,,TCGA-E9-A295-01,TCGA-E9-A295-01A-11D-A16D-09,,28ad8481-78a8-4103-b501-5cfd23ae3e81,,TCGA-E9-A295-01A-11D-A16C-01,TCGA-E9-A295-01,,28ad8481-78a8-4103-b501-5cfd23ae3e81,TCGA-E9-A295-01A-11D-A16C-01,
tcga.e9.a2js,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,1.0,TCGA-E9-A2JS-01,904.0,1.0,days,High,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-E9-A2JS,524.0,1.0,days,904.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,NO,,72.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A2JS-F40293,TCGA-E9-A2JS,TCGA-E9-A2JS-01A,,,,,,,,Lumpectomy,,NO,,,-26407.0,79.0,904.0,0.0,540.0,,,524,,,,,,Scheduled Follow-up Submission,2013-2-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),420.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Distant Metastasis,Liver,NO,YES,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf,A2JS,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,DECEASED,2011.0,4fe55069-e1b6-4d85-a51a-03a10c6116e2,4fe55069-e1b6-4d85-a51a-03a10c6116e2,TCGA-E9-A2JS-01A-21-A24B-20,,TCGA-E9-A2JS-01,TCGA-E9-A2JS-01A-11D-A17Z-05,e26e41fb-223b-484b-8463-a20e34844050,TCGA-E9-A2JS-01,TCGA-E9-A2JS-01A-11D-A17W-09,,,TCGA-E9-A2JS-01,,,4fe55069-e1b6-4d85-a51a-03a10c6116e2,,TCGA-E9-A2JS-01A-11D-A17U-01,TCGA-E9-A2JS-01,,4fe55069-e1b6-4d85-a51a-03a10c6116e2,TCGA-E9-A2JS-01A-11D-A17U-01,
tcga.e9.a2jt,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-E9-A2JT-01,288.0,0.0,days,Kirc+,C3-BRCA/Luminal,,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-E9-A2JT,288.0,0.0,days,288.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A2JT-F40292,TCGA-E9-A2JT,TCGA-E9-A2JT-01A,,,,,,,,Lumpectomy,,NO,,,-23318.0,94.0,,0.0,288.0,,,,,,,,,Scheduled Follow-up Submission,2013-2-15,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),260.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf,A2JT,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,YES,YES,NO,E9,Breast,A,LIVING,2011.0,95b5e301-f942-43bb-8211-d992948e8136,95b5e301-f942-43bb-8211-d992948e8136,TCGA-E9-A2JT-01A-11-A24A-20,,TCGA-E9-A2JT-01,TCGA-E9-A2JT-01A-22D-A18O-05,013e6c9f-a4fb-4588-9159-562bd6f2721c,TCGA-E9-A2JT-01,TCGA-E9-A2JT-01A-22D-A18P-09,,,TCGA-E9-A2JT-01,,,95b5e301-f942-43bb-8211-d992948e8136,,TCGA-E9-A2JT-01A-22D-A18N-01,TCGA-E9-A2JT-01,,95b5e301-f942-43bb-8211-d992948e8136,TCGA-E9-A2JT-01A-22D-A18N-01,
tcga.e9.a3q9,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-E9-A3Q9-01,1001.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,,TCGA-E9-A3Q9,1001.0,0.0,days,1001.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,78.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A3Q9-F59741,TCGA-E9-A3Q9,TCGA-E9-A3Q9-01A,,Positive,,,,,Positive,,,YES,,,-28715.0,198.0,,0.0,1001.0,,,,,NO,,40-49%,,,2014-5-20,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,580.0,NO,Indeterminate,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,22.0,0.0,True,No,M0,N3,T3,Stage IIIC,TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf,A3Q9,TUMOR FREE,,,,8,8,YES,YES,40-49%,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2011.0,941748e8-5690-4e98-a5f4-d79b0e033ba1,941748e8-5690-4e98-a5f4-d79b0e033ba1,TCGA-E9-A3Q9-01A-21-A24A-20,,TCGA-E9-A3Q9-01,TCGA-E9-A3Q9-01A-11D-A21R-05,acbb7029-4851-48e2-8517-9c69b0f9aaf4,TCGA-E9-A3Q9-01,TCGA-E9-A3Q9-01A-11D-A21Q-09,,,TCGA-E9-A3Q9-01,,,941748e8-5690-4e98-a5f4-d79b0e033ba1,,TCGA-E9-A3Q9-01A-11D-A21P-01,TCGA-E9-A3Q9-01,,941748e8-5690-4e98-a5f4-d79b0e033ba1,TCGA-E9-A3Q9-01A-11D-A21P-01,
tcga.e9.a3qa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A3QA-01,918.0,0.0,days,High,,,Low purity c2,BRCA basal-like c6,,miRNA cluster 4,,,TCGA-E9-A3QA,918.0,0.0,days,918.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,33.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A3QA-F66100,TCGA-E9-A3QA,TCGA-E9-A3QA-01A,,,,,,,,,,,,,-12142.0,282.0,,0.0,918.0,,,,,NO,,,,,2014-10-2,FEMALE,,,,,,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Tumor resection,750.0,NO,,,NO,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf,A3QA,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2011.0,8a7e272c-39f2-42e6-b1d5-7225cf12fceb,8a7e272c-39f2-42e6-b1d5-7225cf12fceb,TCGA-E9-A3QA-01A-71-A24A-20,,TCGA-E9-A3QA-01,TCGA-E9-A3QA-01A-61D-A22B-05,ed7f6269-7805-4032-870a-0f105960bfbc,TCGA-E9-A3QA-01,TCGA-E9-A3QA-01A-61D-A228-09,,,TCGA-E9-A3QA-01,,,8a7e272c-39f2-42e6-b1d5-7225cf12fceb,,TCGA-E9-A3QA-01A-61D-A227-01,TCGA-E9-A3QA-01,,8a7e272c-39f2-42e6-b1d5-7225cf12fceb,TCGA-E9-A3QA-01A-61D-A227-01,
tcga.e9.a3x8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A3X8-01,926.0,0.0,days,,,,,BRCA nonbasal-like c8,,,,,TCGA-E9-A3X8,926.0,0.0,days,926.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A3X8-F59742,TCGA-E9-A3X8,TCGA-E9-A3X8-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-17588.0,233.0,,0.0,926.0,,,,,NO,,20-29%,,,2014-5-20,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,260.0,NO,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,4.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf,A3X8,TUMOR FREE,,,,8,8,YES,YES,20-29%,,YES,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2011.0,b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9,b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9,TCGA-E9-A3X8-01A-21-A24A-20,,TCGA-E9-A3X8-01,TCGA-E9-A3X8-01A-31D-A230-05,1ba9391b-4d20-4637-8c2a-6765cd37beb4,TCGA-E9-A3X8-01,TCGA-E9-A3X8-01A-31D-A22X-09,,,TCGA-E9-A3X8-01,,,b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9,,TCGA-E9-A3X8-01A-31D-A22W-01,TCGA-E9-A3X8-01,,b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9,TCGA-E9-A3X8-01A-31D-A22W-01,
tcga.e9.a54x,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A54X-01,727.0,0.0,days,,,,,,,,,,TCGA-E9-A54X,727.0,0.0,days,727.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,85.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A54X-F66449,TCGA-E9-A54X,TCGA-E9-A54X-01A,,Positive,,3+,,,Positive,Lumpectomy,,NO,,,-31173.0,78.0,,0.0,727.0,,,,,,,90-99%,,,2014-10-15,FEMALE,,,,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,3+,YES,,Core needle biopsy,220.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0 (i-),T1b,Stage IA,TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf,A54X,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,fc36b662-fabd-4caa-81f7-00fe0a3164a6,fc36b662-fabd-4caa-81f7-00fe0a3164a6,,,TCGA-E9-A54X-01,TCGA-E9-A54X-01A-11D-A268-05,4168faaa-8df8-48b5-a9cb-86932b2a0ffe,TCGA-E9-A54X-01,TCGA-E9-A54X-01A-11D-A25Q-09,,,TCGA-E9-A54X-01,,,fc36b662-fabd-4caa-81f7-00fe0a3164a6,,TCGA-E9-A54X-01A-11D-A25N-01,TCGA-E9-A54X-01,,fc36b662-fabd-4caa-81f7-00fe0a3164a6,TCGA-E9-A54X-01A-11D-A25N-01,
tcga.e9.a54y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A54Y-01,725.0,0.0,days,,,,,,,,,,TCGA-E9-A54Y,725.0,0.0,days,725.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,Axillary lymph node dissection alone,,TCGA-E9-A54Y-F66450,TCGA-E9-A54Y,TCGA-E9-A54Y-01A,,Positive,,3+,,,Positive,Modified Radical Mastectomy,,NO,,,-23057.0,76.0,,0.0,725.0,,,,,,,90-99%,,,2014-10-15,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Fine needle aspiration biopsy,370.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,8.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf,A54Y,TUMOR FREE,,,,,,NO,YES,50-59%,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,c11ffcd0-8e82-4815-b30b-2d08945ce0bc,c11ffcd0-8e82-4815-b30b-2d08945ce0bc,,,TCGA-E9-A54Y-01,TCGA-E9-A54Y-01A-11D-A268-05,190643c9-d8a9-4e20-ac54-de58928ddfaf,TCGA-E9-A54Y-01,TCGA-E9-A54Y-01A-11D-A25Q-09,,,TCGA-E9-A54Y-01,,,c11ffcd0-8e82-4815-b30b-2d08945ce0bc,,TCGA-E9-A54Y-01A-11D-A25N-01,TCGA-E9-A54Y-01,,c11ffcd0-8e82-4815-b30b-2d08945ce0bc,TCGA-E9-A54Y-01A-11D-A25N-01,
tcga.e9.a5fk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A5FK-01,812.0,0.0,days,,,,,,,,,,TCGA-E9-A5FK,812.0,0.0,days,812.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A5FK-F70209,TCGA-E9-A5FK,TCGA-E9-A5FK-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-22199.0,77.0,,0.0,812.0,,,,,,,80-89%,,,2015-1-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Cytology (e.g. Peritoneal or pleural fluid),490.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,10.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf,A5FK,TUMOR FREE,,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,6cdd2900-2b84-44d4-a9b3-bf75b12946b9,6cdd2900-2b84-44d4-a9b3-bf75b12946b9,,,TCGA-E9-A5FK-01,TCGA-E9-A5FK-01A-11D-A27Y-05,4dc0a26f-8214-4458-a74d-309dcd10c6a1,TCGA-E9-A5FK-01,TCGA-E9-A5FK-01A-11D-A27P-09,,,TCGA-E9-A5FK-01,,,6cdd2900-2b84-44d4-a9b3-bf75b12946b9,,TCGA-E9-A5FK-01A-11D-A27O-01,TCGA-E9-A5FK-01,,6cdd2900-2b84-44d4-a9b3-bf75b12946b9,TCGA-E9-A5FK-01A-11D-A27O-01,
tcga.e9.a5fl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A5FL-01,24.0,0.0,days,,,,,,,,,,TCGA-E9-A5FL,24.0,0.0,days,24.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A5FL-F56061,TCGA-E9-A5FL,TCGA-E9-A5FL-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,NO,,,-24053.0,73.0,,0.0,24.0,,,,,,,,,,2014-1-24,FEMALE,,,,,,,,,,Metaplastic Carcinoma,,No,,C50.9,8575/3,C50.9,,YES,,Cytology (e.g. Peritoneal or pleural fluid),590.0,NO,Negative,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf,A5FL,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,7810122d-fa8b-483d-9398-aa26fc7fedc5,7810122d-fa8b-483d-9398-aa26fc7fedc5,,,TCGA-E9-A5FL-01,TCGA-E9-A5FL-01A-11D-A27Y-05,dca0a85a-e2c5-4dcf-bc19-4b0374669de4,TCGA-E9-A5FL-01,TCGA-E9-A5FL-01A-11D-A27P-09,,,TCGA-E9-A5FL-01,,,7810122d-fa8b-483d-9398-aa26fc7fedc5,,TCGA-E9-A5FL-01A-11D-A27O-01,TCGA-E9-A5FL-01,,7810122d-fa8b-483d-9398-aa26fc7fedc5,TCGA-E9-A5FL-01A-11D-A27O-01,
tcga.e9.a5uo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A5UO-01,785.0,0.0,days,,,,,,,,,,TCGA-E9-A5UO,785.0,0.0,days,785.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A5UO-F70210,TCGA-E9-A5UO,TCGA-E9-A5UO-01A,,,,,,,,Other,,NO,,,-15050.0,98.0,,0.0,785.0,,,,,,,,,,2015-1-30,FEMALE,,,,,,,,,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Fine needle aspiration biopsy,400.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf,A5UO,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,Partial mastectomy,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,4d601c2f-824f-461e-9270-42db0ab9138e,4d601c2f-824f-461e-9270-42db0ab9138e,,,TCGA-E9-A5UO-01,TCGA-E9-A5UO-01A-11D-A28C-05,9efb2dc7-5c0d-459f-9819-f1ca46df5bb0,TCGA-E9-A5UO-01,TCGA-E9-A5UO-01A-11D-A28B-09,,,TCGA-E9-A5UO-01,,,4d601c2f-824f-461e-9270-42db0ab9138e,,TCGA-E9-A5UO-01A-11D-A28A-01,TCGA-E9-A5UO-01,,4d601c2f-824f-461e-9270-42db0ab9138e,TCGA-E9-A5UO-01A-11D-A28A-01,
tcga.e9.a5up,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A5UP-01,803.0,0.0,days,,,,,,,,,,TCGA-E9-A5UP,803.0,0.0,days,803.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-E9-A5UP-F71525,TCGA-E9-A5UP,TCGA-E9-A5UP-01A,,,,,,,,,,NO,,,-23371.0,85.0,,0.0,803.0,,,,,,,,,,2015-3-26,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8503/3,C50.9,,YES,,Tumor resection,140.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf,A5UP,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,E9,Breast,A,LIVING,2012.0,0a9af348-b2a7-4fad-b939-7eda53e4f5a0,0a9af348-b2a7-4fad-b939-7eda53e4f5a0,,,TCGA-E9-A5UP-01,TCGA-E9-A5UP-01A-11D-A28C-05,7ba6fce9-3ad3-4659-9756-a6642af820e1,TCGA-E9-A5UP-01,TCGA-E9-A5UP-01A-11D-A28B-09,,,TCGA-E9-A5UP-01,,,0a9af348-b2a7-4fad-b939-7eda53e4f5a0,,TCGA-E9-A5UP-01A-11D-A28A-01,TCGA-E9-A5UP-01,,0a9af348-b2a7-4fad-b939-7eda53e4f5a0,TCGA-E9-A5UP-01A-11D-A28A-01,
tcga.e9.a6he,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-E9-A6HE-01,847.0,0.0,days,,,,,,,,,,TCGA-E9-A6HE,847.0,0.0,days,847.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,45.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-E9-A6HE-F70947,TCGA-E9-A6HE,,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-16697.0,,,0.0,847.0,,,,,,,90-99%,1.7,,2015-3-10,FEMALE,,,<10%,,1+,30.0,1.8,1.08,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Negative,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,12.0,,,No,MX,N3,T3,Stage IIIC,,A6HE,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,E9,Breast,,LIVING,2012.0,ce48b228-7e2a-46e9-beca-ab990b5c2b3e,ce48b228-7e2a-46e9-beca-ab990b5c2b3e,,,TCGA-E9-A6HE-01,TCGA-E9-A6HE-01A-11D-A31V-05,a828df39-aa87-48a0-936a-7fd28c031dcf,TCGA-E9-A6HE-01,,,,TCGA-E9-A6HE-01,,,ce48b228-7e2a-46e9-beca-ab990b5c2b3e,,TCGA-E9-A6HE-01A-11D-A31T-01,TCGA-E9-A6HE-01,,ce48b228-7e2a-46e9-beca-ab990b5c2b3e,TCGA-E9-A6HE-01A-11D-A31T-01,
tcga.ew.a1iw,Stage IIB,80.0,2.0,Stage IIB,252.0,,Positive,FEMALE,Positive,,,,Negative,M0,Positive,N1,252.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1IW-01,371.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-EW-A1IW,371.0,0.0,days,371.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1IW-F21380,TCGA-EW-A1IW,TCGA-EW-A1IW-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-29529.0,213.0,,0.0,371.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,+ or -,90-99%,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,90.0,NO,Positive,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,3.0,4.0,,,,,,,,NO,2.0,0.0,True,No,MX,N1a,T2,Stage IIB,TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf,A1IW,TUMOR FREE,,CISH,,,,,YES,90-99%,,NO,Primary Tumor,1,total mastectomy,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,7ddad1e7-783e-4095-87e0-48dbf5c5aa39,7ddad1e7-783e-4095-87e0-48dbf5c5aa39,,TCGA-EW-A1IW-01A-11D-A13L-09,TCGA-EW-A1IW-01,TCGA-EW-A1IW-01A-11D-A13K-05,,TCGA-EW-A1IW-01,TCGA-EW-A1IW-01A-11D-A13L-09,,,TCGA-EW-A1IW-01,TCGA-EW-A1IW-01A-11D-A13L-09,,7ddad1e7-783e-4095-87e0-48dbf5c5aa39,,TCGA-EW-A1IW-01A-11D-A13J-01,TCGA-EW-A1IW-01,,7ddad1e7-783e-4095-87e0-48dbf5c5aa39,TCGA-EW-A1IW-01A-11D-A13J-01,
tcga.ew.a1ix,Stage IIA,48.0,4.0,Stage IIA,1082.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1082.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1IX-01,1208.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 4,TCGA-EW-A1IX,1208.0,0.0,days,1208.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1IX-F21542,TCGA-EW-A1IX,TCGA-EW-A1IX-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-17597.0,1030.0,,0.0,1208.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,<10%,,,,,,,"Other, specify",,No,,C50.9,8524/3,C50.9,3+,YES,,Core needle biopsy,130.0,NO,Negative,,,27.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,1.0,1.0,True,No,MX,N1a,T1b,Stage IIA,TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf,A1IX,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,total mastectomy,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,b908cd1b-b274-4b23-9cd5-b59d93a7a6c2,b908cd1b-b274-4b23-9cd5-b59d93a7a6c2,TCGA-EW-A1IX-01A-21-A17J-20,TCGA-EW-A1IX-01A-12D-A142-09,TCGA-EW-A1IX-01,TCGA-EW-A1IX-01A-12D-A145-05,9b8d5601-180a-45df-a639-787f257c2e95,TCGA-EW-A1IX-01,TCGA-EW-A1IX-01A-12D-A142-09,,,TCGA-EW-A1IX-01,TCGA-EW-A1IX-01A-12D-A142-09,,b908cd1b-b274-4b23-9cd5-b59d93a7a6c2,,TCGA-EW-A1IX-01A-12D-A141-01,TCGA-EW-A1IX-01,,b908cd1b-b274-4b23-9cd5-b59d93a7a6c2,TCGA-EW-A1IX-01A-12D-A141-01,
tcga.ew.a1iy,Stage I,38.0,2.0,Stage I,258.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,258.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1IY-01,258.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 12,cluster 7,mutation cluster 4,TCGA-EW-A1IY,258.0,0.0,days,258.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Right Upper Inner Quadrant,Other (specify),sentinel LN and one non sentinel LN,TCGA-EW-A1IY-F29084,TCGA-EW-A1IY,TCGA-EW-A1IY-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-14122.0,590.0,,0.0,258.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-5,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,50.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,7.0,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T1c,Stage I,TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf,A1IY,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,9b605e4f-fb75-4b02-a827-a6acfeb3c1b2,9b605e4f-fb75-4b02-a827-a6acfeb3c1b2,,TCGA-EW-A1IY-01A-11D-A188-09,TCGA-EW-A1IY-01,TCGA-EW-A1IY-01A-11D-A13K-05,,TCGA-EW-A1IY-01,TCGA-EW-A1IY-01A-11D-A188-09,,,TCGA-EW-A1IY-01,TCGA-EW-A1IY-01A-11D-A188-09,,9b605e4f-fb75-4b02-a827-a6acfeb3c1b2,,TCGA-EW-A1IY-01A-11D-A13J-01,TCGA-EW-A1IY-01,,9b605e4f-fb75-4b02-a827-a6acfeb3c1b2,TCGA-EW-A1IY-01A-11D-A13J-01,
tcga.ew.a1iz,Stage IIIA,53.0,1.0,Stage IIIA,260.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N2,260.0,0.0,,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1IZ-01,554.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-EW-A1IZ,554.0,0.0,days,554.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A1IZ-F21543,TCGA-EW-A1IZ,TCGA-EW-A1IZ-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-19706.0,194.0,,0.0,554.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,stereotactic biopsy,"Other method, specify:",130.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,3.0,,,,,,,,NO,5.0,,True,No,MX,N2a,T2,Stage IIIA,TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf,A1IZ,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,f5c72291-4c3f-456f-97a3-d93878744b54,f5c72291-4c3f-456f-97a3-d93878744b54,TCGA-EW-A1IZ-01A-21-A17J-20,TCGA-EW-A1IZ-01A-11D-A188-09,TCGA-EW-A1IZ-01,TCGA-EW-A1IZ-01A-11D-A13K-05,401f0a1d-c38e-463b-8195-8eba9ea21869,TCGA-EW-A1IZ-01,TCGA-EW-A1IZ-01A-11D-A188-09,,,TCGA-EW-A1IZ-01,TCGA-EW-A1IZ-01A-11D-A188-09,,f5c72291-4c3f-456f-97a3-d93878744b54,,TCGA-EW-A1IZ-01A-11D-A13J-01,TCGA-EW-A1IZ-01,,f5c72291-4c3f-456f-97a3-d93878744b54,TCGA-EW-A1IZ-01A-11D-A13J-01,
tcga.ew.a1j1,Stage IIB,38.0,2.0,Stage IIB,282.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,282.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1J1-01,575.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation cluster 4,TCGA-EW-A1J1,575.0,0.0,days,575.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,38.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1J1-F21181,TCGA-EW-A1J1,TCGA-EW-A1J1-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-14122.0,214.0,,0.0,575.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-3,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,170.0,NO,Negative,,,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,5.0,,,,,,,,NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf,A1J1,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,9d64aa0c-84a6-4e48-b28b-12aaf04813b6,9d64aa0c-84a6-4e48-b28b-12aaf04813b6,TCGA-EW-A1J1-01A-21-A17J-20,TCGA-EW-A1J1-01A-11D-A188-09,TCGA-EW-A1J1-01,TCGA-EW-A1J1-01A-11D-A13K-05,e87551f0-94b3-418c-b313-7cea4e66f70d,TCGA-EW-A1J1-01,TCGA-EW-A1J1-01A-11D-A188-09,,,TCGA-EW-A1J1-01,TCGA-EW-A1J1-01A-11D-A188-09,,9d64aa0c-84a6-4e48-b28b-12aaf04813b6,,TCGA-EW-A1J1-01A-11D-A13J-01,TCGA-EW-A1J1-01,,9d64aa0c-84a6-4e48-b28b-12aaf04813b6,TCGA-EW-A1J1-01A-11D-A13J-01,
tcga.ew.a1j2,Stage IIB,50.0,2.0,Stage IIA,139.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,139.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1J2-01,403.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 13,cluster 6,mutation cluster 4,TCGA-EW-A1J2,403.0,0.0,days,403.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1J2-F21544,TCGA-EW-A1J2,TCGA-EW-A1J2-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-18558.0,51.0,,0.0,403.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,110.0,NO,Negative,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,2.0,6.0,,,,,,,,NO,1.0,1.0,True,No,MX,N1mi,T1c,[Discrepancy],TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf,A1J2,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,total mastectomy,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,5a6b6013-11d0-498d-a014-3ea8e14c61d5,5a6b6013-11d0-498d-a014-3ea8e14c61d5,TCGA-EW-A1J2-01A-11-A17J-20,TCGA-EW-A1J2-01A-21D-A13L-09,TCGA-EW-A1J2-01,TCGA-EW-A1J2-01A-21D-A13K-05,ff844a9f-6c79-4252-bbb3-b5bbf5c3cf6f,TCGA-EW-A1J2-01,TCGA-EW-A1J2-01A-21D-A13L-09,,,TCGA-EW-A1J2-01,TCGA-EW-A1J2-01A-21D-A13L-09,,5a6b6013-11d0-498d-a014-3ea8e14c61d5,,TCGA-EW-A1J2-01A-21D-A13J-01,TCGA-EW-A1J2-01,,5a6b6013-11d0-498d-a014-3ea8e14c61d5,TCGA-EW-A1J2-01A-21D-A13J-01,
tcga.ew.a1j3,Stage IA,61.0,2.0,Stage I,252.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,252.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1J3-01,504.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-EW-A1J3,504.0,0.0,days,504.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1J3-F21351,TCGA-EW-A1J3,TCGA-EW-A1J3-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-22332.0,155.0,,0.0,504.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,90-99%,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,80.0,NO,Positive,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,2.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T1c,Stage IA,TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf,A1J3,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,TOTAL MASTECTOMY,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,6e757a91-de03-4c2d-9088-22235e4b745a,6e757a91-de03-4c2d-9088-22235e4b745a,TCGA-EW-A1J3-01A-21-A17J-20,TCGA-EW-A1J3-01A-11D-A13L-09,TCGA-EW-A1J3-01,TCGA-EW-A1J3-01A-11D-A13K-05,01473e37-dbc5-42f9-b5e1-332a9b47c175,TCGA-EW-A1J3-01,TCGA-EW-A1J3-01A-11D-A13L-09,,,TCGA-EW-A1J3-01,TCGA-EW-A1J3-01A-11D-A13L-09,,6e757a91-de03-4c2d-9088-22235e4b745a,,TCGA-EW-A1J3-01A-11D-A13J-01,TCGA-EW-A1J3-01,,6e757a91-de03-4c2d-9088-22235e4b745a,TCGA-EW-A1J3-01A-11D-A13J-01,
tcga.ew.a1j5,Stage IIB,59.0,5.0,Stage IIB,227.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,227.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-EW-A1J5-01,477.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-EW-A1J5,477.0,0.0,days,477.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left,Sentinel node biopsy alone,,TCGA-EW-A1J5-F21353,TCGA-EW-A1J5,TCGA-EW-A1J5-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-21559.0,123.0,,0.0,477.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,180.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,7.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf,A1J5,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,total mastectomy,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,b1c4af00-f395-47ac-93c7-b32a293ca060,b1c4af00-f395-47ac-93c7-b32a293ca060,TCGA-EW-A1J5-01A-21-A17J-20,TCGA-EW-A1J5-01A-11D-A13L-09,TCGA-EW-A1J5-01,TCGA-EW-A1J5-01A-11D-A13K-05,7470a7db-5af2-4e9e-92f6-d9f8ca74e15d,TCGA-EW-A1J5-01,TCGA-EW-A1J5-01A-11D-A13L-09,,,TCGA-EW-A1J5-01,TCGA-EW-A1J5-01A-11D-A13L-09,,b1c4af00-f395-47ac-93c7-b32a293ca060,,TCGA-EW-A1J5-01A-11D-A13J-01,TCGA-EW-A1J5-01,,b1c4af00-f395-47ac-93c7-b32a293ca060,TCGA-EW-A1J5-01A-11D-A13J-01,
tcga.ew.a1j6,Stage I,70.0,4.0,Stage I,595.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,595.0,0.0,LumB,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1J6-01,875.0,0.0,days,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-EW-A1J6,875.0,0.0,days,875.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1J6-F21347,TCGA-EW-A1J6,TCGA-EW-A1J6-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-25830.0,528.0,,0.0,875.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-2-6,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,80.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,2.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf,A1J6,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,7051836f-e1d4-49dd-8118-4541c0bdde57,7051836f-e1d4-49dd-8118-4541c0bdde57,,TCGA-EW-A1J6-01A-11D-A188-09,TCGA-EW-A1J6-01,TCGA-EW-A1J6-01A-11D-A13K-05,,TCGA-EW-A1J6-01,TCGA-EW-A1J6-01A-11D-A188-09,,,TCGA-EW-A1J6-01,TCGA-EW-A1J6-01A-11D-A188-09,,7051836f-e1d4-49dd-8118-4541c0bdde57,,TCGA-EW-A1J6-01A-11D-A13J-01,TCGA-EW-A1J6-01,,7051836f-e1d4-49dd-8118-4541c0bdde57,TCGA-EW-A1J6-01A-11D-A13J-01,
tcga.ew.a1ov,Stage IIB,56.0,1.0,Stage IIB,522.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,522.0,0.0,Her2,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1OV-01,789.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 12,cluster 5,mutation cluster 4,TCGA-EW-A1OV,789.0,0.0,days,789.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1OV-F29119,TCGA-EW-A1OV,,Negative,Negative,3 Point Scale,,3 Point Scale,Modified radical mastectomy,Negative,Lumpectomy,,YES,,,-20764.0,,,0.0,789.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,1.8,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,Negative,,6.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,5.0,,,,,,,,NO,0.0,1.0,,No,MX,N1mi,T2,Stage IIB,,A1OV,TUMOR FREE,,,,,,,YES,<10%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,,LIVING,2009.0,b21367b5-91a3-4546-ba89-e33c462cb75b,b21367b5-91a3-4546-ba89-e33c462cb75b,TCGA-EW-A1OV-01A-21-A17J-20,TCGA-EW-A1OV-01A-11D-A142-09,TCGA-EW-A1OV-01,TCGA-EW-A1OV-01A-11D-A145-05,c9e8a21c-2cd8-404b-a8dc-7958940df71a,TCGA-EW-A1OV-01,TCGA-EW-A1OV-01A-11D-A142-09,,,TCGA-EW-A1OV-01,TCGA-EW-A1OV-01A-11D-A142-09,,b21367b5-91a3-4546-ba89-e33c462cb75b,,TCGA-EW-A1OV-01A-11D-A141-01,TCGA-EW-A1OV-01,,b21367b5-91a3-4546-ba89-e33c462cb75b,TCGA-EW-A1OV-01A-11D-A141-01,
tcga.ew.a1ow,Stage IIA,58.0,1.0,Stage IIA,463.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,463.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1OW-01,694.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,,,,TCGA-EW-A1OW,694.0,0.0,days,694.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1OW-F29117,TCGA-EW-A1OW,TCGA-EW-A1OW-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,,-21465.0,444.0,,0.0,694.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8090/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf,A1OW,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,21cc5775-0987-4088-b19c-86bf43f09bb2,21cc5775-0987-4088-b19c-86bf43f09bb2,TCGA-EW-A1OW-01A-11-A17J-20,,TCGA-EW-A1OW-01,TCGA-EW-A1OW-01A-21D-A145-05,a4d72446-5d9b-4b8d-af59-9add055da84e,TCGA-EW-A1OW-01,,,,TCGA-EW-A1OW-01,,,21cc5775-0987-4088-b19c-86bf43f09bb2,,TCGA-EW-A1OW-01A-21D-A141-01,TCGA-EW-A1OW-01,,21cc5775-0987-4088-b19c-86bf43f09bb2,TCGA-EW-A1OW-01A-21D-A141-01,
tcga.ew.a1ox,Stage IIA,43.0,3.0,Stage IIA,562.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,562.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1OX-01,911.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 1,mutation c1uster 9,TCGA-EW-A1OX,911.0,0.0,days,911.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Right Upper Inner Quadrant,Other (specify),sentinel + non sentinel,TCGA-EW-A1OX-F29099,TCGA-EW-A1OX,TCGA-EW-A1OX-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-15837.0,550.0,,0.0,911.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Mucinous Carcinoma,,No,,C50.9,8523/3,C50.9,3+,YES,,Core needle biopsy,140.0,NO,Negative,,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,3.0,1.0,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf,A1OX,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,9b5d680e-5662-442c-a8ab-5fd16551b23e,9b5d680e-5662-442c-a8ab-5fd16551b23e,TCGA-EW-A1OX-01A-21-A17J-20,TCGA-EW-A1OX-01A-11D-A142-09,TCGA-EW-A1OX-01,TCGA-EW-A1OX-01A-11D-A145-05,7cf0f94c-e8fc-4237-8cbf-164c073c26b0,TCGA-EW-A1OX-01,TCGA-EW-A1OX-01A-11D-A142-09,,,TCGA-EW-A1OX-01,TCGA-EW-A1OX-01A-11D-A142-09,,9b5d680e-5662-442c-a8ab-5fd16551b23e,,TCGA-EW-A1OX-01A-11D-A141-01,TCGA-EW-A1OX-01,,9b5d680e-5662-442c-a8ab-5fd16551b23e,TCGA-EW-A1OX-01A-11D-A141-01,
tcga.ew.a1oy,Stage IIA,63.0,5.0,Stage IIA,593.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,593.0,0.0,LumB,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1OY-01,908.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 5,TCGA-EW-A1OY,908.0,0.0,days,908.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left,Sentinel node biopsy alone,,TCGA-EW-A1OY-F30950,TCGA-EW-A1OY,TCGA-EW-A1OY-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-23266.0,526.0,,0.0,908.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-23,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,100.0,NO,Negative,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf,A1OY,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,0c3f0857-32d7-4ef6-b303-6e452ee04516,0c3f0857-32d7-4ef6-b303-6e452ee04516,TCGA-EW-A1OY-01A-21-A17J-20,TCGA-EW-A1OY-01A-11D-A142-09,TCGA-EW-A1OY-01,TCGA-EW-A1OY-01A-11D-A145-05,5355fa5f-6aba-4f01-9799-7f1a83eadc2a,TCGA-EW-A1OY-01,TCGA-EW-A1OY-01A-11D-A142-09,,,TCGA-EW-A1OY-01,TCGA-EW-A1OY-01A-11D-A142-09,,0c3f0857-32d7-4ef6-b303-6e452ee04516,,TCGA-EW-A1OY-01A-11D-A141-01,TCGA-EW-A1OY-01,,0c3f0857-32d7-4ef6-b303-6e452ee04516,TCGA-EW-A1OY-01A-11D-A141-01,
tcga.ew.a1oz,Stage IIA,56.0,5.0,Stage IIA,941.0,,Positive,FEMALE,Positive,,,,Negative,M0,Negative,N0,941.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1OZ-01,1229.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation cluster 8,TCGA-EW-A1OZ,1229.0,0.0,days,1229.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1OZ-F29098,TCGA-EW-A1OZ,TCGA-EW-A1OZ-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Other,,YES,,,-20664.0,928.0,,0.0,1229.0,,,,,NO,,90-99%,2,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,20-29%,,2+,40.0,,2.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,210.0,NO,Equivocal,Positive,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,4.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf,A1OZ,TUMOR FREE,,,,,,,YES,<10%,,NO,Primary Tumor,1,total mastectomy,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,73f6a579-eab4-4fbf-bb17-41f1a6614ace,73f6a579-eab4-4fbf-bb17-41f1a6614ace,TCGA-EW-A1OZ-01A-21-A17J-20,TCGA-EW-A1OZ-01A-11D-A142-09,TCGA-EW-A1OZ-01,TCGA-EW-A1OZ-01A-11D-A145-05,ec87ecc1-dbdd-478f-aea6-a982f92222e8,TCGA-EW-A1OZ-01,TCGA-EW-A1OZ-01A-11D-A142-09,,,TCGA-EW-A1OZ-01,TCGA-EW-A1OZ-01A-11D-A142-09,,73f6a579-eab4-4fbf-bb17-41f1a6614ace,,TCGA-EW-A1OZ-01A-11D-A141-01,TCGA-EW-A1OZ-01,,73f6a579-eab4-4fbf-bb17-41f1a6614ace,TCGA-EW-A1OZ-01A-11D-A141-01,
tcga.ew.a1p0,Stage IIB,55.0,4.0,Stage IIB,1121.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,1121.0,0.0,LumB,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P0-01,1251.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA c1uster 10,cluster 7,mutation cluster 4,TCGA-EW-A1P0,1094.0,1.0,days,1251.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,YES,,55.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A1P0-F29105,TCGA-EW-A1P0,TCGA-EW-A1P0-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Modified Radical Mastectomy,,NO,,1105.0,-20107.0,1142.0,,0.0,1251.0,,,1094,,YES,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,"Other, specify",,No,,C50.9,8523/3,C50.9,3+,YES,,Core needle biopsy,190.0,NO,Negative,,,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,1+,,Positive,90-99%,,<10%,,,3+,1+,,,<10%,,Negative,,,5.0,7.0,,,,"Other, specify",Distant Metastasis,mediastinal lymph node,,YES,1.0,,True,No,MX,N1b,T2,Stage IIB,TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf,A1P0,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,16fcbaec-f629-4d04-ab61-3f9b782e710d,16fcbaec-f629-4d04-ab61-3f9b782e710d,TCGA-EW-A1P0-01A-21-A17J-20,TCGA-EW-A1P0-01A-11D-A142-09,TCGA-EW-A1P0-01,TCGA-EW-A1P0-01A-11D-A145-05,d39ecd5c-5a18-46dc-b6e6-356c239d7ec3,TCGA-EW-A1P0-01,TCGA-EW-A1P0-01A-11D-A142-09,,,TCGA-EW-A1P0-01,TCGA-EW-A1P0-01A-11D-A142-09,,16fcbaec-f629-4d04-ab61-3f9b782e710d,,TCGA-EW-A1P0-01A-11D-A141-01,TCGA-EW-A1P0-01,,16fcbaec-f629-4d04-ab61-3f9b782e710d,TCGA-EW-A1P0-01A-11D-A141-01,
tcga.ew.a1p1,Stage IIIC,68.0,1.0,Stage IIIC,919.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N3,919.0,0.0,,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P1-01,1210.0,0.0,days,Kirc+,C5-KIRC,cluster 1,Low purity c2,KIRC-like c1,,miRNA cluster 13,cluster 6,mutation c1uster 9,TCGA-EW-A1P1,1014.0,1.0,days,1210.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,YES,,68.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1P1-F29115,TCGA-EW-A1P1,TCGA-EW-A1P1-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,NO,,1200.0,-24923.0,850.0,,0.0,1210.0,,,1014,,YES,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,2+,,,1.8,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Equivocal,Negative,,32.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Equivocal,1+,,Negative,<10%,,<10%,,,,,,,<10%,,Negative,Lung,,1.0,6.0,,,,Lung,Distant Metastasis,,,YES,11.0,,True,No,MX,N3b,T2,Stage IIIC,TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf,A1P1,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,8a430d45-6511-4900-954e-fd01106d0f22,8a430d45-6511-4900-954e-fd01106d0f22,TCGA-EW-A1P1-01A-21-A17J-20,TCGA-EW-A1P1-01A-31D-A14G-09,TCGA-EW-A1P1-01,TCGA-EW-A1P1-01A-31D-A14H-05,3d649ce7-95df-442d-a4bb-88e71c4f5b10,TCGA-EW-A1P1-01,TCGA-EW-A1P1-01A-31D-A14G-09,,,TCGA-EW-A1P1-01,TCGA-EW-A1P1-01A-31D-A14G-09,,8a430d45-6511-4900-954e-fd01106d0f22,,TCGA-EW-A1P1-01A-31D-A14F-01,TCGA-EW-A1P1-01,,8a430d45-6511-4900-954e-fd01106d0f22,TCGA-EW-A1P1-01A-31D-A14F-01,
tcga.ew.a1p3,Stage IIA,48.0,2.0,Stage IIA,987.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,987.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P3-01,1611.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,mutation c1uster 9,TCGA-EW-A1P3,1611.0,0.0,days,1611.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right Lower Outer Quadrant,Other (specify),SN+1 non sentinel node,TCGA-EW-A1P3-F41142,TCGA-EW-A1P3,TCGA-EW-A1P3-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-17637.0,919.0,,0.0,1611.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2013-3-12,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,150.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,0.0,True,Yes,MX,N0,T2,Stage IIA,TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf,A1P3,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,43c8eaea-f686-4e28-ba9c-360fea61b3ca,43c8eaea-f686-4e28-ba9c-360fea61b3ca,TCGA-EW-A1P3-01A-21-A17J-20,TCGA-EW-A1P3-01A-11D-A142-09,TCGA-EW-A1P3-01,TCGA-EW-A1P3-01A-11D-A145-05,d1b203a1-19d6-4504-a925-2cf22b888095,TCGA-EW-A1P3-01,TCGA-EW-A1P3-01A-11D-A142-09,,,TCGA-EW-A1P3-01,TCGA-EW-A1P3-01A-11D-A142-09,,43c8eaea-f686-4e28-ba9c-360fea61b3ca,,TCGA-EW-A1P3-01A-11D-A141-01,TCGA-EW-A1P3-01,,43c8eaea-f686-4e28-ba9c-360fea61b3ca,TCGA-EW-A1P3-01A-11D-A141-01,
tcga.ew.a1p4,Stage IIA,43.0,1.0,Stage IIA,501.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,501.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P4-01,907.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 4,cluster 5,mutation cluster 5,TCGA-EW-A1P4,907.0,0.0,days,907.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1P4-F29684,TCGA-EW-A1P4,TCGA-EW-A1P4-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Simple Mastectomy,,YES,,,-15989.0,525.0,,0.0,907.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,<10%,,,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Core needle biopsy,290.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf,A1P4,TUMOR FREE,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2009.0,91a5b906-6a04-4f0d-8710-172311e84789,91a5b906-6a04-4f0d-8710-172311e84789,TCGA-EW-A1P4-01A-11-A17J-20,TCGA-EW-A1P4-01A-21D-A142-09,TCGA-EW-A1P4-01,TCGA-EW-A1P4-01A-21D-A145-05,b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a,TCGA-EW-A1P4-01,TCGA-EW-A1P4-01A-21D-A142-09,,,TCGA-EW-A1P4-01,TCGA-EW-A1P4-01A-21D-A142-09,,91a5b906-6a04-4f0d-8710-172311e84789,,TCGA-EW-A1P4-01A-21D-A141-01,TCGA-EW-A1P4-01,,91a5b906-6a04-4f0d-8710-172311e84789,TCGA-EW-A1P4-01A-21D-A141-01,
tcga.ew.a1p5,Stage IIB,77.0,3.0,Stage IIB,365.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,365.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P5-01,703.0,0.0,days,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,cluster 3,mutation cluster 4,TCGA-EW-A1P5,703.0,0.0,days,703.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1P5-F32249,TCGA-EW-A1P5,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-28177.0,,,0.0,703.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-5-15,FEMALE,,,<10%,,,,,1.12,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,Negative,,40.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,3.0,,,,,,,,NO,3.0,0.0,,No,M0,N1a,T2,Stage IIB,,A1P5,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,,LIVING,2010.0,e9d4f9c8-7355-44c4-9b18-923db7bae832,e9d4f9c8-7355-44c4-9b18-923db7bae832,TCGA-EW-A1P5-01A-21-A17J-20,TCGA-EW-A1P5-01A-11D-A142-09,TCGA-EW-A1P5-01,TCGA-EW-A1P5-01A-11D-A145-05,ef44d5ee-0e6f-4ec3-8db0-b0c426708430,TCGA-EW-A1P5-01,TCGA-EW-A1P5-01A-11D-A142-09,,,TCGA-EW-A1P5-01,TCGA-EW-A1P5-01A-11D-A142-09,,e9d4f9c8-7355-44c4-9b18-923db7bae832,,TCGA-EW-A1P5-01A-11D-A141-01,TCGA-EW-A1P5-01,,e9d4f9c8-7355-44c4-9b18-923db7bae832,TCGA-EW-A1P5-01A-11D-A141-01,
tcga.ew.a1p6,Stage IIB,64.0,4.0,Stage IIB,312.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,312.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P6-01,562.0,0.0,days,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 14,cluster 2,mutation c1uster 9,TCGA-EW-A1P6,562.0,0.0,days,562.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1P6-F29114,TCGA-EW-A1P6,TCGA-EW-A1P6-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-23485.0,249.0,,0.0,562.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,50.0,NO,Negative,,,25.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf,A1P6,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,9dddaf60-64ed-4d41-a546-79e86db1101e,9dddaf60-64ed-4d41-a546-79e86db1101e,,TCGA-EW-A1P6-01A-11D-A142-09,TCGA-EW-A1P6-01,TCGA-EW-A1P6-01A-11D-A145-05,,TCGA-EW-A1P6-01,TCGA-EW-A1P6-01A-11D-A142-09,,,TCGA-EW-A1P6-01,TCGA-EW-A1P6-01A-11D-A142-09,,9dddaf60-64ed-4d41-a546-79e86db1101e,,TCGA-EW-A1P6-01A-11D-A141-01,TCGA-EW-A1P6-01,,9dddaf60-64ed-4d41-a546-79e86db1101e,TCGA-EW-A1P6-01A-11D-A141-01,
tcga.ew.a1p7,Stage IIA,59.0,1.0,Stage IIA,635.0,,Negative,FEMALE,Negative,,,,Negative,M0,Negative,N0,635.0,0.0,Normal,,Negative,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1P7-01,915.0,0.0,days,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,,BRCA basal-like c8,miRNA cluster 7,cluster 3,mutation c1uster 9,TCGA-EW-A1P7,729.0,1.0,days,915.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,YES,,59.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A1P7-F29118,TCGA-EW-A1P7,,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,793.0,-21750.0,,,0.0,915.0,,,729,,NO,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,10-19%,,2+,,,1.8,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,3.0,,,,"Other, specify",Distant Metastasis,mediastinal lymph nodes,,YES,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A1P7,WITH TUMOR,,,,,,,YES,<10%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,,LIVING,2009.0,e11a1fd3-d409-4e09-a8ab-5d0afb455263,e11a1fd3-d409-4e09-a8ab-5d0afb455263,,TCGA-EW-A1P7-01A-21D-A142-09,TCGA-EW-A1P7-01,TCGA-EW-A1P7-01A-21D-A145-05,,TCGA-EW-A1P7-01,TCGA-EW-A1P7-01A-21D-A142-09,,,TCGA-EW-A1P7-01,TCGA-EW-A1P7-01A-21D-A142-09,,e11a1fd3-d409-4e09-a8ab-5d0afb455263,,TCGA-EW-A1P7-01A-21D-A141-01,TCGA-EW-A1P7-01,,e11a1fd3-d409-4e09-a8ab-5d0afb455263,TCGA-EW-A1P7-01A-21D-A141-01,
tcga.ew.a1p8,Stage IIIC,58.0,3.0,Stage IIIC,239.0,239.0,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N3,239.0,1.0,Basal,,Negative,,,,enrollment,T_Other,T2,DECEASED,1.0,TCGA-EW-A1P8-01,239.0,1.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 12,TCGA-EW-A1P8,207.0,1.0,days,239.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,NO,,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1P8-F29121,TCGA-EW-A1P8,TCGA-EW-A1P8-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,NO,,,-21501.0,224.0,239.0,0.0,,,,207,,YES,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,160.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Negative,,,Negative,<10%,,<10%,,,,,,,<10%,,Negative,"Lung|Bone|Liver|Other, specify",skin,5.0,5.0,,,,Lung,Distant Metastasis,,,YES,14.0,,True,No,M0,N3b,T2,Stage IIIC,TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf,A1P8,WITH TUMOR,,,,,,,YES,<10%,,NO,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,DECEASED,2010.0,d763ccd4-4a11-4e84-b0a6-1b42da020ce4,d763ccd4-4a11-4e84-b0a6-1b42da020ce4,TCGA-EW-A1P8-01A-21-A17J-20,TCGA-EW-A1P8-01A-11D-A142-09,TCGA-EW-A1P8-01,TCGA-EW-A1P8-01A-11D-A145-05,9729bae9-2494-4ef3-9382-a564fa2a1363,TCGA-EW-A1P8-01,TCGA-EW-A1P8-01A-11D-A142-09,,,TCGA-EW-A1P8-01,TCGA-EW-A1P8-01A-11D-A142-09,,d763ccd4-4a11-4e84-b0a6-1b42da020ce4,,TCGA-EW-A1P8-01A-11D-A141-01,TCGA-EW-A1P8-01,,d763ccd4-4a11-4e84-b0a6-1b42da020ce4,TCGA-EW-A1P8-01A-11D-A141-01,
tcga.ew.a1pa,Stage IIB,59.0,1.0,Stage IIB,267.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,267.0,0.0,LumA,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1PA-01,575.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,,,mutation cluster 5,TCGA-EW-A1PA,575.0,0.0,days,575.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A1PA-F30937,TCGA-EW-A1PA,TCGA-EW-A1PA-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,NO,,,-21837.0,220.0,,0.0,575.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,60.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf,A1PA,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,8c0b7027-f371-4a72-9152-2d00fc54e086,8c0b7027-f371-4a72-9152-2d00fc54e086,TCGA-EW-A1PA-01A-21-A17K-20,TCGA-EW-A1PA-01A-11D-A142-09,TCGA-EW-A1PA-01,TCGA-EW-A1PA-01A-11D-A145-05,281ecf6a-bcfa-485e-bec7-694899bf33ba,TCGA-EW-A1PA-01,TCGA-EW-A1PA-01A-11D-A142-09,,,TCGA-EW-A1PA-01,TCGA-EW-A1PA-01A-11D-A142-09,,8c0b7027-f371-4a72-9152-2d00fc54e086,,TCGA-EW-A1PA-01A-11D-A141-01,TCGA-EW-A1PA-01,,8c0b7027-f371-4a72-9152-2d00fc54e086,TCGA-EW-A1PA-01A-11D-A141-01,
tcga.ew.a1pb,Stage IIIA,70.0,3.0,Stage IIIA,608.0,,Negative,FEMALE,Negative,,,,Negative,M0,Positive,N1,608.0,0.0,Basal,,Negative,,,,enrollment,T_Other,T3,LIVING,0.0,TCGA-EW-A1PB-01,608.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 14,cluster 2,mutation cluster 5,TCGA-EW-A1PB,608.0,0.0,days,608.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A1PB-F29107,TCGA-EW-A1PB,TCGA-EW-A1PB-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Simple Mastectomy,,NO,,,-25770.0,569.0,,0.0,608.0,,,,,,,<10%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,320.0,NO,Negative,,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,2.0,,,,,,,,NO,2.0,,True,No,MX,N1a,T3,Stage IIIA,TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf,A1PB,TUMOR FREE,,,,,,,YES,<10%,,NO,Primary Tumor,1,,6th,NO,NO,YES,EW,Breast,A,LIVING,2009.0,50674dde-30c1-4530-a164-381d5326e29c,50674dde-30c1-4530-a164-381d5326e29c,TCGA-EW-A1PB-01A-21-A17J-20,TCGA-EW-A1PB-01A-11D-A142-09,TCGA-EW-A1PB-01,TCGA-EW-A1PB-01A-11D-A145-05,0bdf178b-3488-411a-bda6-2b7ee3beb0fd,TCGA-EW-A1PB-01,TCGA-EW-A1PB-01A-11D-A142-09,,,TCGA-EW-A1PB-01,TCGA-EW-A1PB-01A-11D-A142-09,,50674dde-30c1-4530-a164-381d5326e29c,,TCGA-EW-A1PB-01A-11D-A141-01,TCGA-EW-A1PB-01,,50674dde-30c1-4530-a164-381d5326e29c,TCGA-EW-A1PB-01A-11D-A141-01,
tcga.ew.a1pc,,,,,,,,,,,,,,,,,,,LumB,,,,,,,,,,0.0,TCGA-EW-A1PC-01,187.0,0.0,days,High,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-EW-A1PC,187.0,0.0,days,187.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Left,Sentinel node biopsy alone,,TCGA-EW-A1PC-F29681,TCGA-EW-A1PC,TCGA-EW-A1PC-01B,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-24434.0,146.0,,0.0,187.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,150.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,MX,N0 (i-),T3,Stage IIB,TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf,A1PC,TUMOR FREE,,,,,,,YES,50-59%,,NO,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,B,LIVING,2011.0,3960601b-c341-45fb-8a8c-ec244ee719ac,3960601b-c341-45fb-8a8c-ec244ee719ac,TCGA-EW-A1PC-01B-21-A24A-20,,TCGA-EW-A1PC-01,TCGA-EW-A1PC-01B-11D-A21R-05,ea4d6b89-3adf-4eb2-a91c-88e799d79af3,TCGA-EW-A1PC-01,TCGA-EW-A1PC-01B-11D-A21Q-09,,,TCGA-EW-A1PC-01,,,3960601b-c341-45fb-8a8c-ec244ee719ac,,TCGA-EW-A1PC-01B-11D-A21P-01,TCGA-EW-A1PC-01,,3960601b-c341-45fb-8a8c-ec244ee719ac,TCGA-EW-A1PC-01B-11D-A21P-01,
tcga.ew.a1pd,Stage IIA,61.0,5.0,Stage IIA,174.0,,Positive,MALE,Positive,,,,Negative,M0,Positive,N1,174.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1PD-01,424.0,0.0,days,High,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 14,cluster 4,mutation c1uster 9,TCGA-EW-A1PD,424.0,0.0,days,424.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1PD-F29106,TCGA-EW-A1PD,TCGA-EW-A1PD-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-22536.0,112.0,,0.0,424.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,MALE,,,20-29%,,2+,,>6.0,2.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,120.0,NO,Equivocal,Positive,,7.0,Negative,,,,,,,,,,,,,,,,,,,,,2.0,4.0,,,,,,,,NO,2.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf,A1PD,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,69971d5c-5be4-4886-bf7c-753de9593a1e,69971d5c-5be4-4886-bf7c-753de9593a1e,TCGA-EW-A1PD-01A-21-A17J-20,TCGA-EW-A1PD-01A-11D-A142-09,TCGA-EW-A1PD-01,TCGA-EW-A1PD-01A-11D-A145-05,1dab2beb-b0c7-4eee-bc45-71997f6077e9,TCGA-EW-A1PD-01,TCGA-EW-A1PD-01A-11D-A142-09,,,TCGA-EW-A1PD-01,TCGA-EW-A1PD-01A-11D-A142-09,,69971d5c-5be4-4886-bf7c-753de9593a1e,,TCGA-EW-A1PD-01A-11D-A141-01,TCGA-EW-A1PD-01,,69971d5c-5be4-4886-bf7c-753de9593a1e,TCGA-EW-A1PD-01A-11D-A141-01,
tcga.ew.a1pe,Stage IIA,56.0,2.0,Stage IIA,139.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,139.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1PE-01,320.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 7,cluster 3,mutation cluster 4,TCGA-EW-A1PE,320.0,0.0,days,320.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A1PE-F29108,TCGA-EW-A1PE,TCGA-EW-A1PE-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,NO,,,-20694.0,44.0,,0.0,320.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8507/3,C50.9,3+,YES,,[Discrepancy],150.0,NO,Negative,,,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,3.0,,,,,,,,NO,1.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf,A1PE,TUMOR FREE,,,,,,,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2011.0,4a21d42c-b231-4ffc-8c15-4bd73bf610b4,4a21d42c-b231-4ffc-8c15-4bd73bf610b4,TCGA-EW-A1PE-01A-21-A17J-20,TCGA-EW-A1PE-01A-11D-A142-09,TCGA-EW-A1PE-01,TCGA-EW-A1PE-01A-11D-A145-05,f5581422-7c21-4ccb-8006-b976b1b49459,TCGA-EW-A1PE-01,TCGA-EW-A1PE-01A-11D-A142-09,,,TCGA-EW-A1PE-01,TCGA-EW-A1PE-01A-11D-A142-09,,4a21d42c-b231-4ffc-8c15-4bd73bf610b4,,TCGA-EW-A1PE-01A-11D-A141-01,TCGA-EW-A1PE-01,,4a21d42c-b231-4ffc-8c15-4bd73bf610b4,TCGA-EW-A1PE-01A-11D-A141-01,
tcga.ew.a1pf,Stage IA,50.0,5.0,Stage I,139.0,,Positive,FEMALE,Negative,,,,Negative,M0,Negative,N0,139.0,0.0,LumA,,Positive,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1PF-01,439.0,0.0,days,Kirc+,,cluster 1,BRCA CIMP c7,,BRCA nonbasal-like c7,miRNA cluster 4,cluster 4,,TCGA-EW-A1PF,439.0,0.0,days,439.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right Upper Outer Quadrant,Other (specify),sentinel + 2 non-sentinel LN,TCGA-EW-A1PF-F29109,TCGA-EW-A1PF,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-18384.0,,,0.0,439.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,4.0,,,,,,,,NO,0.0,0.0,,No,M0,N0,T1c,Stage IA,,A1PF,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,total mastectomy,7th,YES,NO,YES,EW,Breast,,LIVING,2010.0,faa3383f-6f9f-43d8-b61d-4a1522a71444,faa3383f-6f9f-43d8-b61d-4a1522a71444,,,TCGA-EW-A1PF-01,TCGA-EW-A1PF-01A-11D-A145-05,,TCGA-EW-A1PF-01,,,,TCGA-EW-A1PF-01,,,faa3383f-6f9f-43d8-b61d-4a1522a71444,,TCGA-EW-A1PF-01A-11D-A141-01,TCGA-EW-A1PF-01,,faa3383f-6f9f-43d8-b61d-4a1522a71444,TCGA-EW-A1PF-01A-11D-A141-01,
tcga.ew.a1pg,Stage IIB,53.0,1.0,Stage IIB,875.0,,Positive,FEMALE,Negative,,,,Negative,M0,Positive,N1,875.0,0.0,Normal,,Positive,,,,enrollment,T_Other,T2,LIVING,0.0,TCGA-EW-A1PG-01,1051.0,0.0,days,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 14,cluster 6,mutation c1uster 9,TCGA-EW-A1PG,1051.0,0.0,days,1051.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1PG-F29103,TCGA-EW-A1PG,TCGA-EW-A1PG-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-19464.0,829.0,,0.0,1051.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-3-8,FEMALE,,,10-19%,,2+,,<4.0,1.8,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,210.0,NO,Equivocal,Negative,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,1.0,6.0,,,,,,,,NO,1.0,1.0,True,No,MX,N1a,T2,Stage IIB,TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf,A1PG,TUMOR FREE,,,,,,,YES,90-99%,,NO,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,1205dc3c-e766-4a25-b485-c66e301e3b6d,1205dc3c-e766-4a25-b485-c66e301e3b6d,TCGA-EW-A1PG-01A-21-A17J-20,TCGA-EW-A1PG-01A-11D-A142-09,TCGA-EW-A1PG-01,TCGA-EW-A1PG-01A-11D-A145-05,6621baf4-3dc5-4905-99b2-f40d75886fa0,TCGA-EW-A1PG-01,TCGA-EW-A1PG-01A-11D-A142-09,,,TCGA-EW-A1PG-01,TCGA-EW-A1PG-01A-11D-A142-09,,1205dc3c-e766-4a25-b485-c66e301e3b6d,,TCGA-EW-A1PG-01A-11D-A141-01,TCGA-EW-A1PG-01,,1205dc3c-e766-4a25-b485-c66e301e3b6d,TCGA-EW-A1PG-01A-11D-A141-01,
tcga.ew.a1ph,Stage IIA,52.0,1.0,Stage IIA,139.0,,Negative,FEMALE,,,,,Negative,M0,Positive,N1,139.0,0.0,Basal,,Negative,,,,enrollment,T1,T1,LIVING,0.0,TCGA-EW-A1PH-01,607.0,0.0,days,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,,BRCA basal-like c8,miRNA cluster 12,cluster 5,mutation cluster 5,TCGA-EW-A1PH,607.0,0.0,days,607.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A1PH-F41145,TCGA-EW-A1PH,TCGA-EW-A1PH-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,,-19073.0,77.0,,0.0,607.0,,,,,NO,,<10%,,Scheduled Follow-up Submission,2013-3-12,FEMALE,,,<10%,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,70.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,5.0,5.0,,,,,,,,NO,1.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf,A1PH,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2010.0,39413018-090f-46ca-b6df-244124f098c3,39413018-090f-46ca-b6df-244124f098c3,,TCGA-EW-A1PH-01A-11D-A14K-09,TCGA-EW-A1PH-01,TCGA-EW-A1PH-01A-11D-A14N-05,,TCGA-EW-A1PH-01,TCGA-EW-A1PH-01A-11D-A14K-09,,,TCGA-EW-A1PH-01,TCGA-EW-A1PH-01A-11D-A14K-09,,39413018-090f-46ca-b6df-244124f098c3,,TCGA-EW-A1PH-01A-11D-A14J-01,TCGA-EW-A1PH-01,,39413018-090f-46ca-b6df-244124f098c3,TCGA-EW-A1PH-01A-11D-A14J-01,
tcga.ew.a2fr,,,,,,,,,,,,,,,,,,,Her2,,,,,,,,,,0.0,TCGA-EW-A2FR-01,1673.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-EW-A2FR,1673.0,0.0,days,1673.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A2FR-F42056,TCGA-EW-A2FR,TCGA-EW-A2FR-01A,,Negative,3 Point Scale,1+,3 Point Scale,,Negative,Lumpectomy,,NO,,,-21628.0,1015.0,,0.0,1673.0,,,,,NO,,<10%,2,Scheduled Follow-up Submission,2013-4-10,FEMALE,,,10-19%,ratio > 2.2 is positive,2+,40.0,>6,3.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Core needle biopsy,100.0,NO,Equivocal,Positive,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,19.0,,True,No,MX,N3a,T1b,Stage IIIC,TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf,A2FR,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,A,LIVING,2008.0,2bd1673c-b5c0-425b-9e62-c501bf29616b,2bd1673c-b5c0-425b-9e62-c501bf29616b,TCGA-EW-A2FR-01A-21-A24A-20,,TCGA-EW-A2FR-01,TCGA-EW-A2FR-01A-11D-A21R-05,977e315e-d1c6-4ef2-a078-178b88ff0ee5,TCGA-EW-A2FR-01,TCGA-EW-A2FR-01A-11D-A21Q-09,,,TCGA-EW-A2FR-01,,,2bd1673c-b5c0-425b-9e62-c501bf29616b,,TCGA-EW-A2FR-01A-11D-A21P-01,TCGA-EW-A2FR-01,,2bd1673c-b5c0-425b-9e62-c501bf29616b,TCGA-EW-A2FR-01A-11D-A21P-01,
tcga.ew.a2fs,,41.0,5.0,,1173.0,,Positive,FEMALE,,,,,,,,,1173.0,0.0,LumA,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-EW-A2FS-01,1604.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-EW-A2FS,1604.0,0.0,days,1604.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A2FS-F42061,TCGA-EW-A2FS,,,Positive,3 Point Scale,1+,3 Point Scale,,Negative,Lumpectomy,,YES,,,-15302.0,,,0.0,1604.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2013-4-10,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,NO,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,1.0,,,No,MX,N1mi,T2,Stage IIB,,A2FS,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,EW,Breast,,LIVING,2008.0,c0f29396-d239-4f0d-a95a-0838770eb24a,c0f29396-d239-4f0d-a95a-0838770eb24a,TCGA-EW-A2FS-01A-21-A24A-20,,TCGA-EW-A2FS-01,TCGA-EW-A2FS-01A-11D-A17F-05,f5d09917-197f-4ba1-b19d-437841854522,TCGA-EW-A2FS-01,TCGA-EW-A2FS-01A-11D-A17D-09,,,TCGA-EW-A2FS-01,,,c0f29396-d239-4f0d-a95a-0838770eb24a,,TCGA-EW-A2FS-01A-11D-A17C-01,TCGA-EW-A2FS-01,,c0f29396-d239-4f0d-a95a-0838770eb24a,TCGA-EW-A2FS-01A-11D-A17C-01,
tcga.ew.a2fv,,39.0,3.0,,238.0,,Positive,FEMALE,,,,,,,,,238.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-EW-A2FV-01,788.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-EW-A2FV,788.0,0.0,days,788.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,39.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-EW-A2FV-F42065,TCGA-EW-A2FV,TCGA-EW-A2FV-01A,Negative,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-14316.0,133.0,,0.0,788.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2013-4-10,FEMALE,,,<10%,,1+,,,,,"Other, specify",,No,,C50.9,8507/3,C50.9,3+,YES,,Excisional Biopsy,80.0,NO,Negative,,NO,32.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,4.0,,,,,,,,,NO,29.0,,True,No,MX,N3a,T3,Stage IIIC,TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf,A2FV,TUMOR FREE,,,,,,YES,,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2011.0,d60bfd82-87f0-4f13-8e90-6766beb84e9a,d60bfd82-87f0-4f13-8e90-6766beb84e9a,TCGA-EW-A2FV-01A-21-A24A-20,,TCGA-EW-A2FV-01,TCGA-EW-A2FV-01A-11D-A17F-05,65bf3e8b-5558-49a2-a59e-6066ce8f38b5,TCGA-EW-A2FV-01,TCGA-EW-A2FV-01A-11D-A17D-09,,,TCGA-EW-A2FV-01,,,d60bfd82-87f0-4f13-8e90-6766beb84e9a,,TCGA-EW-A2FV-01A-11D-A17C-01,TCGA-EW-A2FV-01,,d60bfd82-87f0-4f13-8e90-6766beb84e9a,TCGA-EW-A2FV-01A-11D-A17C-01,
tcga.ew.a2fw,,52.0,3.0,,190.0,,Positive,FEMALE,,,,,,,,,190.0,0.0,LumB,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-EW-A2FW-01,672.0,0.0,days,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,,TCGA-EW-A2FW,672.0,0.0,days,672.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A2FW-F42062,TCGA-EW-A2FW,TCGA-EW-A2FW-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-19085.0,99.0,,0.0,672.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2013-4-10,FEMALE,,,<10%,,1+,,,,,"Other, specify",,No,,C50.9,8503/3,C50.9,3+,YES,,Core needle biopsy,150.0,NO,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,2.0,,,,,,,,,NO,0.0,0.0,True,No,MX,N0 (i-),T2,Stage IIA,TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf,A2FW,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,YES,NO,YES,EW,Breast,A,LIVING,2011.0,743f2962-126c-4b28-92fa-250b1170b825,743f2962-126c-4b28-92fa-250b1170b825,TCGA-EW-A2FW-01A-21-A24A-20,,TCGA-EW-A2FW-01,TCGA-EW-A2FW-01A-11D-A17F-05,a4c623f3-e037-4a14-9be5-665cfc6a0c65,TCGA-EW-A2FW-01,TCGA-EW-A2FW-01A-11D-A17D-09,,,TCGA-EW-A2FW-01,,,743f2962-126c-4b28-92fa-250b1170b825,,TCGA-EW-A2FW-01A-11D-A17C-01,TCGA-EW-A2FW-01,,743f2962-126c-4b28-92fa-250b1170b825,TCGA-EW-A2FW-01A-11D-A17C-01,
tcga.ew.a3e8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A3E8-01,1035.0,0.0,days,,,,,,,,,,TCGA-EW-A3E8,1035.0,0.0,days,1035.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A3E8-F57617,TCGA-EW-A3E8,TCGA-EW-A3E8-01B,,Positive,,,,,Negative,Simple Mastectomy,,,,,-21922.0,505.0,,0.0,1035.0,,,,,,,,,,2014-3-18,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,50.0,NO,Negative,,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,MX,N0,T3,Stage IIB,TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf,A3E8,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,EW,Breast,B,LIVING,2011.0,37cb523b-c33a-4980-9b06-6e91389ce70e,37cb523b-c33a-4980-9b06-6e91389ce70e,,,TCGA-EW-A3E8-01,TCGA-EW-A3E8-01B-11D-A244-05,,TCGA-EW-A3E8-01,TCGA-EW-A3E8-01B-11D-A243-09,,,TCGA-EW-A3E8-01,,,37cb523b-c33a-4980-9b06-6e91389ce70e,,TCGA-EW-A3E8-01B-11D-A242-01,TCGA-EW-A3E8-01,,37cb523b-c33a-4980-9b06-6e91389ce70e,TCGA-EW-A3E8-01B-11D-A242-01,
tcga.ew.a3u0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A3U0-01,532.0,0.0,days,High,,,Low purity c2,BRCA basal-like c6,,miRNA cluster 4,,,TCGA-EW-A3U0,532.0,0.0,days,532.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left,Sentinel lymph node biopsy plus axillary dissection,,TCGA-EW-A3U0-F42032,TCGA-EW-A3U0,TCGA-EW-A3U0-01A,,Negative,,,,,Negative,Other,,NO,,,-22520.0,182.0,,0.0,532.0,,,,,NO,,,,,2013-4-9,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,280.0,NO,Negative,,NO,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf,A3U0,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,partial left mastectomy,7th,,YES,NO,EW,Breast,A,LIVING,2011.0,4763b4dd-1eef-4503-9381-4baa57cc690f,4763b4dd-1eef-4503-9381-4baa57cc690f,TCGA-EW-A3U0-01A-21-A24A-20,,TCGA-EW-A3U0-01,TCGA-EW-A3U0-01A-11D-A22B-05,0c52f4b2-07d9-4591-a6b7-e4700f8d476d,TCGA-EW-A3U0-01,TCGA-EW-A3U0-01A-11D-A228-09,,,TCGA-EW-A3U0-01,,,4763b4dd-1eef-4503-9381-4baa57cc690f,,TCGA-EW-A3U0-01A-11D-A227-01,TCGA-EW-A3U0-01,,4763b4dd-1eef-4503-9381-4baa57cc690f,TCGA-EW-A3U0-01A-11D-A227-01,
tcga.ew.a423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A423-01,533.0,0.0,days,,,,,,,,,,TCGA-EW-A423,533.0,0.0,days,533.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-EW-A423-F42558,TCGA-EW-A423,TCGA-EW-A423-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-27627.0,161.0,,0.0,533.0,,,,,,,50-59%,,,2014-3-18,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,80.0,NO,Negative,,YES,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf,A423,TUMOR FREE,,,,,,[Discrepancy],YES,<10%,,[Discrepancy],Primary Tumor,1,,7th,,YES,NO,EW,Breast,A,LIVING,2012.0,994c8287-b6e2-4743-80bb-fe8d0076ae44,994c8287-b6e2-4743-80bb-fe8d0076ae44,,,TCGA-EW-A423-01,TCGA-EW-A423-01A-11D-A244-05,9632bb77-ebd1-4a10-86ba-86f090839a31,TCGA-EW-A423-01,TCGA-EW-A423-01A-11D-A243-09,,,TCGA-EW-A423-01,,,994c8287-b6e2-4743-80bb-fe8d0076ae44,,TCGA-EW-A423-01A-11D-A242-01,TCGA-EW-A423-01,,994c8287-b6e2-4743-80bb-fe8d0076ae44,TCGA-EW-A423-01A-11D-A242-01,
tcga.ew.a424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A424-01,715.0,0.0,days,,,,,,,,,,TCGA-EW-A424,715.0,0.0,days,715.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right,Sentinel node biopsy alone,,TCGA-EW-A424-F57612,TCGA-EW-A424,TCGA-EW-A424-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-18850.0,141.0,,0.0,715.0,,,,,,,50-59%,,,2014-3-18,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Positive,,NO,1.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,True,No,MX,N1,T3,Stage IIIA,TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf,A424,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,EW,Breast,A,LIVING,2012.0,1a571942-1f4c-4f93-8ad3-ea84dad7edaa,1a571942-1f4c-4f93-8ad3-ea84dad7edaa,,,TCGA-EW-A424-01,TCGA-EW-A424-01A-11D-A244-05,f3c98936-9cae-4e6c-8ff3-0af1a45b4a24,TCGA-EW-A424-01,,,,TCGA-EW-A424-01,,,1a571942-1f4c-4f93-8ad3-ea84dad7edaa,,TCGA-EW-A424-01A-11D-A242-01,TCGA-EW-A424-01,,1a571942-1f4c-4f93-8ad3-ea84dad7edaa,TCGA-EW-A424-01A-11D-A242-01,
tcga.ew.a6s9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A6S9-01,463.0,0.0,days,,,,,,,,,,TCGA-EW-A6S9,463.0,0.0,days,463.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,34.0,Right|Right Upper Outer Quadrant,,,TCGA-EW-A6S9-F71706,TCGA-EW-A6S9,TCGA-EW-A6S9-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-12755.0,139.0,,0.0,463.0,,,,,,,50-59%,,,2015-3-30,FEMALE,,,50-59%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Positive,,NO,3.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,1.0,True,No,M0,N1,T1c,Stage IIA,TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf,A6S9,TUMOR FREE,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,,,EW,Breast,A,LIVING,2013.0,692abecd-9c2a-48ec-8794-7e84a5317c46,692abecd-9c2a-48ec-8794-7e84a5317c46,,,TCGA-EW-A6S9-01,TCGA-EW-A6S9-01A-22D-A33F-05,58744A3B-FEB8-4ADD-8B01-36397505D052,TCGA-EW-A6S9-01,,,,TCGA-EW-A6S9-01,,,692abecd-9c2a-48ec-8794-7e84a5317c46,,TCGA-EW-A6S9-01A-22D-A33D-01,TCGA-EW-A6S9-01,,692abecd-9c2a-48ec-8794-7e84a5317c46,TCGA-EW-A6S9-01A-22D-A33D-01,
tcga.ew.a6sa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A6SA-01,510.0,0.0,days,,,,,,,,,,TCGA-EW-A6SA,510.0,0.0,days,510.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left|Left Lower Inner Quadrant,Sentinel node biopsy alone,,,TCGA-EW-A6SA,TCGA-EW-A6SA-01A,,Positive,,,,,Negative,Simple Mastectomy,,YES,,,-21623.0,152.0,,0.0,510.0,,,,,,,50-59%,,,2015-2-27,MALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,80.0,NO,Negative,,,4.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,1.0,True,No,MX,N0 (i+),T2,Stage II,TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf,A6SA,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,EW,Breast,A,LIVING,2013.0,2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168,2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168,,,TCGA-EW-A6SA-01,TCGA-EW-A6SA-01A-21D-A32T-05,3C4C4A1F-544E-4CB5-A1E8-50534496B737,TCGA-EW-A6SA-01,,,,TCGA-EW-A6SA-01,,,2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168,,TCGA-EW-A6SA-01A-21D-A32H-01,TCGA-EW-A6SA-01,,2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168,TCGA-EW-A6SA-01A-21D-A32H-01,
tcga.ew.a6sb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A6SB-01,760.0,0.0,days,,,,,,,,,,TCGA-EW-A6SB,760.0,0.0,days,760.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left|Left Upper Inner Quadrant,Sentinel node biopsy alone,,,TCGA-EW-A6SB,TCGA-EW-A6SB-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,YES,,,-22844.0,244.0,,0.0,760.0,,,,,,,,,,2015-3-12,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,200.0,NO,Negative,,,8.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage II,TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf,A6SB,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,,,EW,Breast,A,LIVING,2012.0,5cb6b038-fe0b-48db-af0b-2a25beb8d79b,5cb6b038-fe0b-48db-af0b-2a25beb8d79b,,,TCGA-EW-A6SB-01,TCGA-EW-A6SB-01A-12D-A32T-05,85666B68-022F-4583-83BB-7CD199387E0F,TCGA-EW-A6SB-01,,,,TCGA-EW-A6SB-01,,,5cb6b038-fe0b-48db-af0b-2a25beb8d79b,,TCGA-EW-A6SB-01A-12D-A32H-01,TCGA-EW-A6SB-01,,5cb6b038-fe0b-48db-af0b-2a25beb8d79b,TCGA-EW-A6SB-01A-12D-A32H-01,
tcga.ew.a6sc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A6SC-01,952.0,0.0,days,,,,,,,,,,TCGA-EW-A6SC,952.0,0.0,days,952.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,60.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-EW-A6SC-F71017,TCGA-EW-A6SC,TCGA-EW-A6SC-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-21918.0,350.0,,0.0,952.0,,,,,,,50-59%,,,2015-3-12,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,160.0,NO,Negative,,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf,A6SC,TUMOR FREE,,,,,,YES,YES,40-49%,,YES,Primary Tumor,1,,7th,,,,EW,Breast,A,LIVING,2012.0,3b7ae466-954f-42aa-8e01-9908ef1c8123,3b7ae466-954f-42aa-8e01-9908ef1c8123,,,TCGA-EW-A6SC-01,TCGA-EW-A6SC-01A-12D-A32T-05,79418E7F-949D-489B-B953-B4942BC4C027,TCGA-EW-A6SC-01,,,,TCGA-EW-A6SC-01,,,3b7ae466-954f-42aa-8e01-9908ef1c8123,,TCGA-EW-A6SC-01A-12D-A32H-01,TCGA-EW-A6SC-01,,3b7ae466-954f-42aa-8e01-9908ef1c8123,TCGA-EW-A6SC-01A-12D-A32H-01,
tcga.ew.a6sd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-EW-A6SD-01,1010.0,0.0,days,,,,,,,,,,TCGA-EW-A6SD,1010.0,0.0,days,1010.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,32.0,Left|Left Upper Outer Quadrant,,,,TCGA-EW-A6SD,TCGA-EW-A6SD-01A,,Negative,,,,,Negative,Lumpectomy,,,,,-12006.0,441.0,,0.0,1010.0,,,,,,,<10%,,,2015-3-14,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,210.0,NO,,,,31.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf,A6SD,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,EW,Breast,A,LIVING,2012.0,54d166b6-fb32-4003-b944-8d0f23cfa125,54d166b6-fb32-4003-b944-8d0f23cfa125,,,TCGA-EW-A6SD-01,TCGA-EW-A6SD-01A-12D-A33F-05,9085B5BF-0B41-4E31-940F-BE8AF05ED3EC,TCGA-EW-A6SD-01,,,,TCGA-EW-A6SD-01,,,54d166b6-fb32-4003-b944-8d0f23cfa125,,TCGA-EW-A6SD-01A-12D-A33D-01,TCGA-EW-A6SD-01,,54d166b6-fb32-4003-b944-8d0f23cfa125,TCGA-EW-A6SD-01A-12D-A33D-01,
tcga.gi.a2c8,,,3.0,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-GI-A2C8-01,225.0,0.0,days,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,mutation c1uster 9,TCGA-GI-A2C8,225.0,0.0,days,225.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,Sentinel node biopsy alone,,TCGA-GI-A2C8-F21661,TCGA-GI-A2C8,TCGA-GI-A2C8-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-23103.0,2429.0,,0.0,225.0,,,,,NO,,90-99%,,Scheduled Follow-up Submission,2012-5-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,Yes,,C50.9,8500/3,C50.9,3+,YES,,,100.0,NO,Negative,Negative,,10.0,Negative,,,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,NO,0.0,,False,No,MX,N0,T4b,Stage IIIB,TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf,A2C8,,,,,,,,YES,<10%,,YES,Primary Tumor,1,,6th,YES,NO,YES,GI,Breast,A,LIVING,2004.0,21531069-76ec-4e0f-b915-51c00b2c42f1,21531069-76ec-4e0f-b915-51c00b2c42f1,TCGA-GI-A2C8-01A-21-A17K-20,TCGA-GI-A2C8-01A-11D-A16D-09,TCGA-GI-A2C8-01,TCGA-GI-A2C8-01A-11D-A16G-05,b9f3060c-ac00-4181-acde-92e45a2ae5a8,TCGA-GI-A2C8-01,TCGA-GI-A2C8-01A-11D-A16D-09,,,TCGA-GI-A2C8-01,TCGA-GI-A2C8-01A-11D-A16D-09,,21531069-76ec-4e0f-b915-51c00b2c42f1,,TCGA-GI-A2C8-01A-11D-A16C-01,TCGA-GI-A2C8-01,,21531069-76ec-4e0f-b915-51c00b2c42f1,TCGA-GI-A2C8-01A-11D-A16C-01,
tcga.gi.a2c9,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,0.0,TCGA-GI-A2C9-01,3342.0,0.0,days,High,C4-BRCA/Basal,,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,miRNA cluster 4,,,TCGA-GI-A2C9,3342.0,0.0,days,3342.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-GI-A2C9-F21663,TCGA-GI-A2C9,TCGA-GI-A2C9-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-21534.0,2979.0,,0.0,3342.0,,,,,NO,,,,Scheduled Follow-up Submission,2012-5-8,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0,T3,Stage IIB,TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf,A2C9,TUMOR FREE,,,,,,,YES,,,YES,Primary Tumor,1,,6th,YES,NO,YES,GI,Breast,A,LIVING,2003.0,b5b8fdd8-c4df-4f79-aed5-23ac41f75f18,b5b8fdd8-c4df-4f79-aed5-23ac41f75f18,TCGA-GI-A2C9-01A-21-A24A-20,,TCGA-GI-A2C9-01,TCGA-GI-A2C9-01A-11D-A21R-05,179ce5cd-da63-4c2e-bf72-253129faf128,TCGA-GI-A2C9-01,TCGA-GI-A2C9-01A-11D-A21Q-09,,,TCGA-GI-A2C9-01,,,b5b8fdd8-c4df-4f79-aed5-23ac41f75f18,,TCGA-GI-A2C9-01A-11D-A21P-01,TCGA-GI-A2C9-01,,b5b8fdd8-c4df-4f79-aed5-23ac41f75f18,TCGA-GI-A2C9-01A-11D-A21P-01,
tcga.gm.a2d9,,69.0,,,,1812.0,Positive,FEMALE,,,,,,,,,1812.0,1.0,LumA,,Positive,,,,enrollment,,,DECEASED,1.0,TCGA-GM-A2D9-01,1812.0,1.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,,,TCGA-GM-A2D9,536.0,1.0,days,1812.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,69.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2D9-F47033,TCGA-GM-A2D9,TCGA-GM-A2D9-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-25490.0,1910.0,1812.0,0.0,,,536.0,536,,YES,,90-99%,1.93,,2013-8-21,FEMALE,,,,,,60.0,2.23,1.16,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,130.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Positive,90-99%,,,,,,,,,,,,Bone,,,,,,,Bone,Distant Metastasis,,YES,YES,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf,A2D9,WITH TUMOR,,,,,,YES,YES,40-49%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,DECEASED,2006.0,4ffff9ea-3386-47d5-8974-722037f31849,4ffff9ea-3386-47d5-8974-722037f31849,TCGA-GM-A2D9-01A-21-A24A-20,,TCGA-GM-A2D9-01,TCGA-GM-A2D9-01A-11D-A18O-05,3a04c178-dd57-499e-959e-ba106a878397,TCGA-GM-A2D9-01,TCGA-GM-A2D9-01A-11D-A18P-09,,,TCGA-GM-A2D9-01,,,4ffff9ea-3386-47d5-8974-722037f31849,,TCGA-GM-A2D9-01A-11D-A18N-01,TCGA-GM-A2D9-01,,4ffff9ea-3386-47d5-8974-722037f31849,TCGA-GM-A2D9-01A-11D-A18N-01,
tcga.gm.a2da,,46.0,,,5909.0,,Positive,FEMALE,,,,,,,,,5909.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,1.0,TCGA-GM-A2DA-01,6593.0,1.0,days,Iq,,,BRCA non-CIMP c9,,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DA,3014.0,1.0,days,6593.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,46.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-GM-A2DA-F47040,TCGA-GM-A2DA,,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-16854.0,,6593.0,0.0,5909.0,,,3014,,YES,,90-99%,3.70,,2013-8-21,FEMALE,,,90-99%,,2+,60.0,15,4.05,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,,,Equivocal,Positive,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Distant Metastasis,,NO,YES,2.0,0.0,,No,M0,N1b,T2,Stage IIB,,A2DA,WITH TUMOR,,,,,,YES,YES,50-59%,,YES,Primary Tumor,1,,4th,,NO,YES,GM,Breast,,DECEASED,1993.0,df5061ca-929b-4e23-89fb-6d05c1a9ffa4,df5061ca-929b-4e23-89fb-6d05c1a9ffa4,,,TCGA-GM-A2DA-01,TCGA-GM-A2DA-01A-11D-A18O-05,,TCGA-GM-A2DA-01,TCGA-GM-A2DA-01A-11D-A18P-09,,,TCGA-GM-A2DA-01,,,df5061ca-929b-4e23-89fb-6d05c1a9ffa4,,TCGA-GM-A2DA-01A-11D-A18N-01,TCGA-GM-A2DA-01,,df5061ca-929b-4e23-89fb-6d05c1a9ffa4,TCGA-GM-A2DA-01A-11D-A18N-01,
tcga.gm.a2db,,62.0,,,1615.0,,Negative,FEMALE,,,,,,,,,1615.0,0.0,Her2,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DB-01,2406.0,0.0,days,Squamous,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DB,2406.0,0.0,days,2406.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DB-F47156,TCGA-GM-A2DB,TCGA-GM-A2DB-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-22883.0,1644.0,,0.0,2406.0,,,,,NO,,<10%,1.50,,2013-8-22,FEMALE,,,,,1+,60.0,1.67,1.11,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Negative,Negative,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf,A2DB,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2006.0,e5aeb7a3-1454-4605-a924-d4b1ed082e87,e5aeb7a3-1454-4605-a924-d4b1ed082e87,TCGA-GM-A2DB-01A-21-A24A-20,,TCGA-GM-A2DB-01,TCGA-GM-A2DB-01A-31D-A18O-05,06141302-8b54-448e-811d-c6b69434ec4a,TCGA-GM-A2DB-01,TCGA-GM-A2DB-01A-31D-A19Y-09,,,TCGA-GM-A2DB-01,,,e5aeb7a3-1454-4605-a924-d4b1ed082e87,,TCGA-GM-A2DB-01A-31D-A18N-01,TCGA-GM-A2DB-01,,e5aeb7a3-1454-4605-a924-d4b1ed082e87,TCGA-GM-A2DB-01A-31D-A18N-01,
tcga.gm.a2dc,,57.0,,,1628.0,,Positive,FEMALE,,,,,,,,,1628.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DC-01,2535.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DC,2535.0,0.0,days,2535.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-GM-A2DC-F47061,TCGA-GM-A2DC,,,Positive,,,,,Positive,Lumpectomy,,NO,,,-21122.0,,,0.0,2535.0,,,,,NO,,90-99%,4.43,,2013-8-22,FEMALE,,,,,,60.0,4.70,1.06,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,,Negative,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,,No,M0,N1a,T1c,Stage IIA,,A2DC,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,,LIVING,2006.0,beb2f2cc-8893-4db2-a527-50a7a40d6d4f,beb2f2cc-8893-4db2-a527-50a7a40d6d4f,TCGA-GM-A2DC-01A-21-A24A-20,,TCGA-GM-A2DC-01,TCGA-GM-A2DC-01A-11D-A18O-05,efd14d4d-750d-43ac-ae08-7e75a25ec143,TCGA-GM-A2DC-01,TCGA-GM-A2DC-01A-11D-A18P-09,,,TCGA-GM-A2DC-01,,,beb2f2cc-8893-4db2-a527-50a7a40d6d4f,,TCGA-GM-A2DC-01A-11D-A18N-01,TCGA-GM-A2DC-01,,beb2f2cc-8893-4db2-a527-50a7a40d6d4f,TCGA-GM-A2DC-01A-11D-A18N-01,
tcga.gm.a2dd,,53.0,,,1309.0,,Negative,FEMALE,,,,,,,,,1309.0,0.0,Normal,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DD-01,2282.0,0.0,days,High,C3-BRCA/Luminal,,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DD,2282.0,0.0,days,2282.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Right,Sentinel node biopsy alone,,TCGA-GM-A2DD-F47070,TCGA-GM-A2DD,,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-19415.0,,,0.0,2282.0,,,,,NO,,<10%,1.45,,2013-8-22,FEMALE,,,<10%,,2+,60.0,1.62,1.11,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,Yes,M0,N0 (i-),T1c,Stage I,,A2DD,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,6th,,NO,YES,GM,Breast,,LIVING,2007.0,ddc6e148-34b7-4466-b692-3bb227004e2b,ddc6e148-34b7-4466-b692-3bb227004e2b,TCGA-GM-A2DD-01A-21-A24A-20,,TCGA-GM-A2DD-01,TCGA-GM-A2DD-01A-11D-A17Z-05,cf5d72b5-6d47-450b-90e3-8ffe9e291e75,TCGA-GM-A2DD-01,TCGA-GM-A2DD-01A-11D-A17W-09,,,TCGA-GM-A2DD-01,,,ddc6e148-34b7-4466-b692-3bb227004e2b,,TCGA-GM-A2DD-01A-11D-A17U-01,TCGA-GM-A2DD-01,,ddc6e148-34b7-4466-b692-3bb227004e2b,TCGA-GM-A2DD-01A-11D-A17U-01,
tcga.gm.a2df,,53.0,,,1299.0,,Negative,FEMALE,,,,,,,,,1299.0,0.0,Basal,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DF-01,2155.0,0.0,days,High,C4-BRCA/Basal,,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 5,,,TCGA-GM-A2DF,2155.0,0.0,days,2155.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,53.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,,TCGA-GM-A2DF-F47074,TCGA-GM-A2DF,TCGA-GM-A2DF-01A,,Negative,,,,,Negative,Lumpectomy,,NO,,,-19614.0,1372.0,,0.0,2155.0,,,,,NO,,<10%,1.40,,2013-8-22,FEMALE,,,,,1+,60.0,1.57,1.12,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,100.0,NO,Negative,Negative,NO,32.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,False,No,M0,N1a,T1c,Stage IIA,TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf,A2DF,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2007.0,83f8c292-5ae0-4c58-9f08-e58ce391f4f4,83f8c292-5ae0-4c58-9f08-e58ce391f4f4,TCGA-GM-A2DF-01A-21-A24A-20,,TCGA-GM-A2DF-01,TCGA-GM-A2DF-01A-11D-A17Z-05,1af97bf7-a99d-48f9-9ed1-69612327c1f9,TCGA-GM-A2DF-01,TCGA-GM-A2DF-01A-11D-A17W-09,,,TCGA-GM-A2DF-01,,,83f8c292-5ae0-4c58-9f08-e58ce391f4f4,,TCGA-GM-A2DF-01A-11D-A17U-01,TCGA-GM-A2DF-01,,83f8c292-5ae0-4c58-9f08-e58ce391f4f4,TCGA-GM-A2DF-01A-11D-A17U-01,
tcga.gm.a2dh,,58.0,,,1286.0,,Negative,FEMALE,,,,,,,,,1286.0,0.0,Her2,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DH-01,2193.0,0.0,days,High,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,miRNA c1uster 10,,,TCGA-GM-A2DH,2193.0,0.0,days,2193.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DH-F47081,TCGA-GM-A2DH,,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-21344.0,,,0.0,2193.0,,,,,NO,,<10%,2.80,,2013-8-22,FEMALE,,,,,1+,60.0,2.80,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,Negative,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,,No,M0,N0 (i+),T1c,Stage I,,A2DH,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,6th,,NO,YES,GM,Breast,,LIVING,2007.0,ec2ac902-f5ca-45a5-a72a-1b266360410a,ec2ac902-f5ca-45a5-a72a-1b266360410a,TCGA-GM-A2DH-01A-21-A24A-20,,TCGA-GM-A2DH-01,TCGA-GM-A2DH-01A-11D-A17Z-05,d2a00ef2-dd0f-4bd7-91e5-21e80e8b7e9e,TCGA-GM-A2DH-01,TCGA-GM-A2DH-01A-11D-A17W-09,,,TCGA-GM-A2DH-01,,,ec2ac902-f5ca-45a5-a72a-1b266360410a,,TCGA-GM-A2DH-01A-11D-A17U-01,TCGA-GM-A2DH-01,,ec2ac902-f5ca-45a5-a72a-1b266360410a,TCGA-GM-A2DH-01A-11D-A17U-01,
tcga.gm.a2di,,52.0,,,1883.0,,Negative,FEMALE,,,,,,,,,1883.0,0.0,LumA,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DI-01,2590.0,0.0,days,Squamous,C3-BRCA/Luminal,,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 3,,,TCGA-GM-A2DI,2590.0,0.0,days,2590.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DI-F47089,TCGA-GM-A2DI,TCGA-GM-A2DI-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-19030.0,2144.0,,0.0,2590.0,,,,,NO,,<10%,3.33,,2013-8-22,FEMALE,,,,,,60.0,3.53,1.06,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,150.0,NO,,Negative,NO,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,False,No,M0,N0 (i+),T1c,Stage I,TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf,A2DI,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2005.0,c50e1f9f-6059-4609-876d-938efb8a784e,c50e1f9f-6059-4609-876d-938efb8a784e,TCGA-GM-A2DI-01A-21-A24A-20,,TCGA-GM-A2DI-01,TCGA-GM-A2DI-01A-31D-A18O-05,88140136-0e0a-44e3-84ac-ae2e2724a95f,TCGA-GM-A2DI-01,TCGA-GM-A2DI-01A-31D-A18P-09,,,TCGA-GM-A2DI-01,,,c50e1f9f-6059-4609-876d-938efb8a784e,,TCGA-GM-A2DI-01A-31D-A18N-01,TCGA-GM-A2DI-01,,c50e1f9f-6059-4609-876d-938efb8a784e,TCGA-GM-A2DI-01A-31D-A18N-01,
tcga.gm.a2dk,,58.0,,,1896.0,,Positive,FEMALE,,,,,,,,,1896.0,0.0,LumA,,Negative,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DK-01,2645.0,0.0,days,COAD-READ,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DK,2645.0,0.0,days,2645.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DK-F47094,TCGA-GM-A2DK,TCGA-GM-A2DK-01A,,Positive,,,,,Negative,Lumpectomy,,YES,,,-21198.0,2109.0,,0.0,2645.0,,,,,NO,,90-99%,,,2013-8-22,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf,A2DK,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2005.0,52df7d5d-7236-464f-9394-7c20f8726280,52df7d5d-7236-464f-9394-7c20f8726280,TCGA-GM-A2DK-01A-11-A24A-20,,TCGA-GM-A2DK-01,TCGA-GM-A2DK-01A-21D-A17Z-05,7f74c5f0-6c1f-4b93-a192-ee7d9c492c67,TCGA-GM-A2DK-01,TCGA-GM-A2DK-01A-21D-A17W-09,,,TCGA-GM-A2DK-01,,,52df7d5d-7236-464f-9394-7c20f8726280,,TCGA-GM-A2DK-01A-21D-A17U-01,TCGA-GM-A2DK-01,,52df7d5d-7236-464f-9394-7c20f8726280,TCGA-GM-A2DK-01A-21D-A17U-01,
tcga.gm.a2dl,,50.0,,,2762.0,,Positive,FEMALE,,,,,,,,,2762.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DL-01,3519.0,0.0,days,BRCA-LUAD+,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DL,3519.0,0.0,days,3519.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DL-F47098,TCGA-GM-A2DL,TCGA-GM-A2DL-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-18475.0,2723.0,,0.0,3519.0,,,,,NO,,90-99%,,,2013-8-22,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,130.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf,A2DL,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2003.0,8955404a-c756-4116-9613-dea06077a056,8955404a-c756-4116-9613-dea06077a056,TCGA-GM-A2DL-01A-21-A24A-20,,TCGA-GM-A2DL-01,TCGA-GM-A2DL-01A-11D-A18O-05,eba15eee-e233-45cc-b24d-fd3d99aa7e00,TCGA-GM-A2DL-01,TCGA-GM-A2DL-01A-11D-A18P-09,,,TCGA-GM-A2DL-01,,,8955404a-c756-4116-9613-dea06077a056,,TCGA-GM-A2DL-01A-11D-A18N-01,TCGA-GM-A2DL-01,,8955404a-c756-4116-9613-dea06077a056,TCGA-GM-A2DL-01A-11D-A18N-01,
tcga.gm.a2dm,,57.0,,,2331.0,,Positive,FEMALE,,,,,,,,,2331.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DM-01,3226.0,0.0,days,Quiet,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,,TCGA-GM-A2DM,3226.0,0.0,days,3226.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DM-F47104,TCGA-GM-A2DM,TCGA-GM-A2DM-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-21160.0,2464.0,,0.0,3226.0,,,,,NO,,40-49%,,,2013-8-22,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf,A2DM,TUMOR FREE,,,,,,YES,YES,30-39%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2004.0,8d8fed5e-4b27-472a-93fa-2dba57098576,8d8fed5e-4b27-472a-93fa-2dba57098576,TCGA-GM-A2DM-01A-21-A24A-20,,TCGA-GM-A2DM-01,TCGA-GM-A2DM-01A-11D-A17Z-05,0f5e7aba-bcea-43bb-b280-ad49450691dd,TCGA-GM-A2DM-01,TCGA-GM-A2DM-01A-11D-A17W-09,,,TCGA-GM-A2DM-01,,,8d8fed5e-4b27-472a-93fa-2dba57098576,,TCGA-GM-A2DM-01A-11D-A17U-01,TCGA-GM-A2DM-01,,8d8fed5e-4b27-472a-93fa-2dba57098576,TCGA-GM-A2DM-01A-11D-A17U-01,
tcga.gm.a2dn,,58.0,,,2352.0,,Positive,FEMALE,,,,,,,,,2352.0,0.0,LumA,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DN-01,3091.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 5,,,TCGA-GM-A2DN,3091.0,0.0,days,3091.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-GM-A2DN-F47124,TCGA-GM-A2DN,TCGA-GM-A2DN-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-21288.0,2436.0,,0.0,3091.0,,,,,NO,,90-99%,,,2013-8-22,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,210.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf,A2DN,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2004.0,0872770d-ed18-47c4-8190-212b7250f7cf,0872770d-ed18-47c4-8190-212b7250f7cf,TCGA-GM-A2DN-01A-21-A24A-20,,TCGA-GM-A2DN-01,TCGA-GM-A2DN-01A-11D-A17Z-05,cbb6932d-84f3-4a8f-9518-d8135db77eb2,TCGA-GM-A2DN-01,TCGA-GM-A2DN-01A-11D-A17W-09,,,TCGA-GM-A2DN-01,,,0872770d-ed18-47c4-8190-212b7250f7cf,,TCGA-GM-A2DN-01A-11D-A17U-01,TCGA-GM-A2DN-01,,0872770d-ed18-47c4-8190-212b7250f7cf,TCGA-GM-A2DN-01A-11D-A17U-01,
tcga.gm.a2do,,54.0,,,1622.0,,Positive,FEMALE,,,,,,,,,1622.0,0.0,LumB,,Positive,,,,enrollment,,,LIVING,0.0,TCGA-GM-A2DO-01,2596.0,0.0,days,Kirc+,C3-BRCA/Luminal,,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 4,,,TCGA-GM-A2DO,2596.0,0.0,days,2596.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A2DO-F47151,TCGA-GM-A2DO,TCGA-GM-A2DO-01A,,Positive,,,,,Positive,Lumpectomy,,YES,,,-19842.0,1932.0,,0.0,2596.0,,,,,NO,,90-99%,,,2013-8-22,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf,A2DO,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2006.0,9827d98e-4e2e-44cb-b0a5-f51b74ec0675,9827d98e-4e2e-44cb-b0a5-f51b74ec0675,TCGA-GM-A2DO-01A-21-A24A-20,,TCGA-GM-A2DO-01,TCGA-GM-A2DO-01A-11D-A18O-05,0db11312-24bd-4df2-9bb6-f271db3a0d30,TCGA-GM-A2DO-01,TCGA-GM-A2DO-01A-11D-A19Y-09,,,TCGA-GM-A2DO-01,,,9827d98e-4e2e-44cb-b0a5-f51b74ec0675,,TCGA-GM-A2DO-01A-11D-A18N-01,TCGA-GM-A2DO-01,,9827d98e-4e2e-44cb-b0a5-f51b74ec0675,TCGA-GM-A2DO-01A-11D-A18N-01,
tcga.gm.a3nw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A3NW-01,3361.0,0.0,days,BRCA-LUAD+,,,BRCA CIMP c7,,,miRNA cluster 14,,,TCGA-GM-A3NW,3361.0,0.0,days,3361.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-GM-A3NW-F40398,TCGA-GM-A3NW,,,Negative,,,,,Positive,Simple Mastectomy,,YES,,,-23041.0,,,0.0,3361.0,,,,,NO,,,1.57,,2013-2-18,FEMALE,,,30-39%,,1+,60.0,1.80,1.15,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A3NW,TUMOR FREE,,,,,,YES,YES,20-29%,,NO,Primary Tumor,1,,6th,,NO,YES,GM,Breast,,LIVING,2003.0,e996b750-d0d3-43c8-860a-17da2f607b15,e996b750-d0d3-43c8-860a-17da2f607b15,,,TCGA-GM-A3NW-01,TCGA-GM-A3NW-01A-21D-A22B-05,,TCGA-GM-A3NW-01,TCGA-GM-A3NW-01A-21D-A228-09,,,TCGA-GM-A3NW-01,,,e996b750-d0d3-43c8-860a-17da2f607b15,,TCGA-GM-A3NW-01A-21D-A227-01,TCGA-GM-A3NW-01,,e996b750-d0d3-43c8-860a-17da2f607b15,TCGA-GM-A3NW-01A-21D-A227-01,
tcga.gm.a3ny,,,,,,,,,,,,,,,,,,,LumA,,,,,,,,,,0.0,TCGA-GM-A3NY-01,1162.0,0.0,days,Iq,C3-BRCA/Luminal,,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,miRNA cluster 6,,,TCGA-GM-A3NY,1162.0,0.0,days,1162.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-GM-A3NY-F40403,TCGA-GM-A3NY,TCGA-GM-A3NY-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-26642.0,778.0,,0.0,1162.0,,,,,NO,,90-99%,,,2013-2-19,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,140.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf,A3NY,TUMOR FREE,,,,,,YES,YES,20-29%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2009.0,85c4a097-4567-4bdf-879c-96c9a4f48052,85c4a097-4567-4bdf-879c-96c9a4f48052,TCGA-GM-A3NY-01A-21-A24A-20,,TCGA-GM-A3NY-01,TCGA-GM-A3NY-01A-11D-A21R-05,b6420819-1738-4d07-9a22-c3a38f0755d4,TCGA-GM-A3NY-01,TCGA-GM-A3NY-01A-11D-A21Q-09,,,TCGA-GM-A3NY-01,,,85c4a097-4567-4bdf-879c-96c9a4f48052,,TCGA-GM-A3NY-01A-11D-A21P-01,TCGA-GM-A3NY-01,,85c4a097-4567-4bdf-879c-96c9a4f48052,TCGA-GM-A3NY-01A-11D-A21P-01,
tcga.gm.a3xg,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A3XG-01,1330.0,0.0,days,,,,,,,,,,TCGA-GM-A3XG,1330.0,0.0,days,1330.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-GM-A3XG-F46963,TCGA-GM-A3XG,TCGA-GM-A3XG-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-16948.0,899.0,,0.0,1330.0,,,,,,,90-99%,1.67,,2013-8-20,FEMALE,,,,,1+,60.0,1.73,1.04,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,270.0,NO,Negative,Negative,NO,26.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,0.0,False,No,M0,N1a,T3,Stage IIIA,TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf,A3XG,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2009.0,718c3d2a-517e-4e32-a96b-ef17848d56d8,718c3d2a-517e-4e32-a96b-ef17848d56d8,,,TCGA-GM-A3XG-01,TCGA-GM-A3XG-01A-31D-A244-05,fef9a497-d85c-46eb-9ebf-6a9645462a4a,TCGA-GM-A3XG-01,TCGA-GM-A3XG-01A-31D-A243-09,,,TCGA-GM-A3XG-01,,,718c3d2a-517e-4e32-a96b-ef17848d56d8,,TCGA-GM-A3XG-01A-31D-A242-01,TCGA-GM-A3XG-01,,718c3d2a-517e-4e32-a96b-ef17848d56d8,TCGA-GM-A3XG-01A-31D-A242-01,
tcga.gm.a3xl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A3XL-01,2108.0,0.0,days,,,,,BRCA basal-like c6,,miRNA cluster 4,,,TCGA-GM-A3XL,2108.0,0.0,days,2108.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right|Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-GM-A3XL-F41970,TCGA-GM-A3XL,TCGA-GM-A3XL-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-18171.0,1779.0,,0.0,2108.0,,,,,,,<10%,,,2013-4-8,FEMALE,,,,,,,,0.99,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf,A3XL,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2007.0,29c98197-249e-45c9-96dc-34dfb4ac1430,29c98197-249e-45c9-96dc-34dfb4ac1430,TCGA-GM-A3XL-01A-21-A24A-20,,TCGA-GM-A3XL-01,TCGA-GM-A3XL-01A-11D-A230-05,01083b39-09ef-40dd-86c0-5cb8a2a5a646,TCGA-GM-A3XL-01,TCGA-GM-A3XL-01A-11D-A22X-09,,,TCGA-GM-A3XL-01,,,29c98197-249e-45c9-96dc-34dfb4ac1430,,TCGA-GM-A3XL-01A-11D-A22W-01,TCGA-GM-A3XL-01,,29c98197-249e-45c9-96dc-34dfb4ac1430,TCGA-GM-A3XL-01A-11D-A22W-01,
tcga.gm.a3xn,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A3XN-01,2019.0,0.0,days,,,,,BRCA nonbasal-like c8,,miRNA cluster 4,,,TCGA-GM-A3XN,2019.0,0.0,days,2019.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-GM-A3XN-F46967,TCGA-GM-A3XN,TCGA-GM-A3XN-01A,,Positive,,,,,Positive,Lumpectomy,,NO,,,-16109.0,1627.0,,0.0,2019.0,,,,,,,80-89%,1.73,,2013-8-20,FEMALE,,,,,1+,60.0,1.85,1.07,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Incisional Biopsy,100.0,NO,Negative,Negative,NO,34.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf,A3XN,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2007.0,740c53d0-b037-4475-82b3-044b2f879aac,740c53d0-b037-4475-82b3-044b2f879aac,TCGA-GM-A3XN-01A-21-A24A-20,,TCGA-GM-A3XN-01,TCGA-GM-A3XN-01A-12D-A230-05,dc2ec9a1-7c3d-4265-be91-132bb9456eff,TCGA-GM-A3XN-01,TCGA-GM-A3XN-01A-12D-A22X-09,,,TCGA-GM-A3XN-01,,,740c53d0-b037-4475-82b3-044b2f879aac,,TCGA-GM-A3XN-01A-12D-A22W-01,TCGA-GM-A3XN-01,,740c53d0-b037-4475-82b3-044b2f879aac,TCGA-GM-A3XN-01A-12D-A22W-01,
tcga.gm.a4e0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A4E0-01,2191.0,0.0,days,,,,,,,,,,TCGA-GM-A4E0,2191.0,0.0,days,2191.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-GM-A4E0-F47030,TCGA-GM-A4E0,TCGA-GM-A4E0-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,YES,,,-24788.0,1871.0,,0.0,2191.0,,,,,,,90-99%,,,2013-8-21,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,210.0,NO,,Negative,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,10.0,1.0,False,No,M0,N3a,T3,Stage IIIC,TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf,A4E0,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,GM,Breast,A,LIVING,2007.0,da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0,da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0,,,TCGA-GM-A4E0-01,TCGA-GM-A4E0-01A-12D-A268-05,016da2b9-36c0-4cde-bf58-e0a46e381af9,TCGA-GM-A4E0-01,TCGA-GM-A4E0-01A-12D-A25Q-09,,,TCGA-GM-A4E0-01,,,da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0,,TCGA-GM-A4E0-01A-12D-A25N-01,TCGA-GM-A4E0-01,,da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0,TCGA-GM-A4E0-01A-12D-A25N-01,
tcga.gm.a5pv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A5PV-01,412.0,0.0,days,,,,,,,,,,TCGA-GM-A5PV,412.0,0.0,days,412.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-GM-A5PV,TCGA-GM-A5PV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-23215.0,499.0,,0.0,412.0,,,,,,,90-99%,2.70,,2013-4-12,FEMALE,,,,,,40.0,3.65,1.35,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,190.0,NO,,Negative,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf,A5PV,TUMOR FREE,,,,,,YES,YES,30-39%,,NO,Primary Tumor,1,,7th,,NO,YES,GM,Breast,A,LIVING,2011.0,96c1cfef-0507-46f5-a007-d0f7369cced5,96c1cfef-0507-46f5-a007-d0f7369cced5,,,TCGA-GM-A5PV-01,TCGA-GM-A5PV-01A-11D-A28C-05,a099aed3-9597-47e9-afd2-58e19aba2018,TCGA-GM-A5PV-01,TCGA-GM-A5PV-01A-11D-A28B-09,,,TCGA-GM-A5PV-01,,,96c1cfef-0507-46f5-a007-d0f7369cced5,,TCGA-GM-A5PV-01A-11D-A28A-01,TCGA-GM-A5PV-01,,96c1cfef-0507-46f5-a007-d0f7369cced5,TCGA-GM-A5PV-01A-11D-A28A-01,
tcga.gm.a5px,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-GM-A5PX-01,551.0,0.0,days,,,,,,,,,,TCGA-GM-A5PX,551.0,0.0,days,551.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Left,Sentinel lymph node biopsy plus axillary dissection,,,TCGA-GM-A5PX,TCGA-GM-A5PX-01A,,Positive,,,,,Positive,Simple Mastectomy,,YES,,,-23753.0,616.0,,0.0,551.0,,,,,,,90-99%,1.78,,2013-4-12,FEMALE,,,30-39%,,1+,60.0,1.98,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,110.0,NO,Negative,Negative,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,2.0,False,No,M0,N1mi,T2,Stage IIB,TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf,A5PX,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,7th,,NO,YES,GM,Breast,A,LIVING,2011.0,76f171dd-1980-4504-8dc2-d8c8264458c9,76f171dd-1980-4504-8dc2-d8c8264458c9,,,TCGA-GM-A5PX-01,TCGA-GM-A5PX-01A-12D-A28C-05,e0413f7a-1629-4323-84d0-53d7819eea0e,TCGA-GM-A5PX-01,TCGA-GM-A5PX-01A-12D-A28B-09,,,TCGA-GM-A5PX-01,,,76f171dd-1980-4504-8dc2-d8c8264458c9,,TCGA-GM-A5PX-01A-12D-A28A-01,TCGA-GM-A5PX-01,,76f171dd-1980-4504-8dc2-d8c8264458c9,TCGA-GM-A5PX-01A-12D-A28A-01,
tcga.hn.a2nl,,,,,,,,,,,,,,,,,,,Basal,,,,,,,,,,0.0,TCGA-HN-A2NL-01,79.0,0.0,days,Squamous,C4-BRCA/Basal,,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,miRNA cluster 1,,,TCGA-HN-A2NL,79.0,0.0,days,79.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-HN-A2NL-F60149,TCGA-HN-A2NL,TCGA-HN-A2NL-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-20483.0,,,0.0,79.0,,,,,,,,,,2014-5-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Tumor resection,170.0,NO,Negative,,YES,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf,A2NL,TUMOR FREE,,,,,,YES,YES,,,,Primary Tumor,1,,6th,,NO,YES,HN,Breast,A,LIVING,,6593576c-a4a8-4284-8591-321f980f2e58,6593576c-a4a8-4284-8591-321f980f2e58,TCGA-HN-A2NL-01A-21-A24A-20,,TCGA-HN-A2NL-01,TCGA-HN-A2NL-01A-11D-A18O-05,826ef0de-68ba-4771-a305-97f27770407a,TCGA-HN-A2NL-01,TCGA-HN-A2NL-01A-11D-A18P-09,,,TCGA-HN-A2NL-01,,,6593576c-a4a8-4284-8591-321f980f2e58,,TCGA-HN-A2NL-01A-11D-A18N-01,TCGA-HN-A2NL-01,,6593576c-a4a8-4284-8591-321f980f2e58,TCGA-HN-A2NL-01A-11D-A18N-01,
tcga.hn.a2ob,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-HN-A2OB-01,1900.0,1.0,days,,,,,,,,,,TCGA-HN-A2OB,1552.0,1.0,days,1900.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,NO,,,45.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-HN-A2OB-F71891,TCGA-HN-A2OB,TCGA-HN-A2OB-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-16672.0,,1900.0,0.0,1849.0,,,1552,,,,,1.7,,2015-4-1,FEMALE,,,,,,60.0,2.0,1.2,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,320.0,NO,Negative,Negative,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Negative,1+,,Positive,,,,,3 Point Scale,3+,2+,,,,,Positive,,,,,,,3 Point Scale,Bone,Distant Metastasis,,NO,YES,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf,A2OB,WITH TUMOR,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,HN,Breast,A,DECEASED,,f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e,f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e,,,TCGA-HN-A2OB-01,TCGA-HN-A2OB-01A-21D-A27Y-05,27e8a52c-a4b2-4773-afde-1e2dba0e5822,TCGA-HN-A2OB-01,TCGA-HN-A2OB-01A-21D-A27P-09,,,TCGA-HN-A2OB-01,,,f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e,,TCGA-HN-A2OB-01A-21D-A27O-01,TCGA-HN-A2OB-01,,f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e,TCGA-HN-A2OB-01A-21D-A27O-01,
tcga.jl.a3yw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-JL-A3YW-01,360.0,0.0,days,,,,,BRCA basal-like c6,,,,,TCGA-JL-A3YW,360.0,0.0,days,360.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left,Axillary lymph node dissection alone,,,TCGA-JL-A3YW,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,,,,,,,0.0,360.0,,,,,,,30-39%,,,2012-11-8,FEMALE,,,30-39%,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Tumor resection,,,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,0.0,,No,M0,N1,T2,Stage IIB,,A3YW,,,,,,,NO,YES,30-39%,,NO,Primary Tumor,1,,7th,,YES,NO,JL,Breast,,LIVING,2011.0,a550da17-2d06-49ac-96dc-a2204298ddfb,a550da17-2d06-49ac-96dc-a2204298ddfb,TCGA-JL-A3YW-01A-21-A24B-20,,TCGA-JL-A3YW-01,TCGA-JL-A3YW-01A-12D-A23D-05,c2d6cdae-b8a7-4d4b-a4ee-b4ff66bd1b38,TCGA-JL-A3YW-01,TCGA-JL-A3YW-01A-12D-A23C-09,,,TCGA-JL-A3YW-01,,,a550da17-2d06-49ac-96dc-a2204298ddfb,,TCGA-JL-A3YW-01A-12D-A238-01,TCGA-JL-A3YW-01,,a550da17-2d06-49ac-96dc-a2204298ddfb,TCGA-JL-A3YW-01A-12D-A238-01,
tcga.jl.a3yx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-JL-A3YX-01,352.0,0.0,days,,,,,KIRC-like c1,,miRNA cluster 4,,,TCGA-JL-A3YX,352.0,0.0,days,352.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left,Axillary lymph node dissection alone,,,TCGA-JL-A3YX,TCGA-JL-A3YX-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,,,,,306.0,,0.0,352.0,,,,,,,30-39%,,,2012-11-8,FEMALE,,,30-39%,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Tumor resection,900.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf,A3YX,,,,,,,NO,YES,30-39%,,NO,Primary Tumor,1,,7th,,YES,NO,JL,Breast,A,LIVING,2011.0,b2b92b23-3f2a-4305-8c6c-27c91c67c072,b2b92b23-3f2a-4305-8c6c-27c91c67c072,TCGA-JL-A3YX-01A-21-A24B-20,,TCGA-JL-A3YX-01,TCGA-JL-A3YX-01A-11D-A230-05,28195fde-9084-494d-9b76-a65c7fe11ba9,TCGA-JL-A3YX-01,TCGA-JL-A3YX-01A-11D-A22X-09,,,TCGA-JL-A3YX-01,,,b2b92b23-3f2a-4305-8c6c-27c91c67c072,,TCGA-JL-A3YX-01A-11D-A22W-01,TCGA-JL-A3YX-01,,b2b92b23-3f2a-4305-8c6c-27c91c67c072,TCGA-JL-A3YX-01A-11D-A22W-01,
tcga.ld.a66u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LD-A66U-01,646.0,0.0,days,,,,,,,,,,TCGA-LD-A66U,646.0,0.0,days,646.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-LD-A66U-F63067,TCGA-LD-A66U,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-16101.0,,,0.0,646.0,,,,,,,90-99%,,,2014-7-30,FEMALE,,,<10%,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Negative,,NO,15.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,,No,MX,N1mi,T2,Stage IIB,,A66U,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,LD,Breast,,LIVING,2012.0,d37ab528-22b6-4b9e-b838-4d90f6d8bc14,d37ab528-22b6-4b9e-b838-4d90f6d8bc14,,,TCGA-LD-A66U-01,TCGA-LD-A66U-01A-11D-A31V-05,c65aac48-9f36-4802-8509-a1bff8136db3,TCGA-LD-A66U-01,,,,TCGA-LD-A66U-01,,,d37ab528-22b6-4b9e-b838-4d90f6d8bc14,,TCGA-LD-A66U-01A-11D-A31T-01,TCGA-LD-A66U-01,,d37ab528-22b6-4b9e-b838-4d90f6d8bc14,TCGA-LD-A66U-01A-11D-A31T-01,
tcga.ld.a74u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LD-A74U-01,402.0,0.0,days,,,,,,,,,,TCGA-LD-A74U,402.0,0.0,days,402.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,79.0,Right,Axillary lymph node dissection alone,,TCGA-LD-A74U-F69186,TCGA-LD-A74U,TCGA-LD-A74U-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,,,,-28981.0,59.0,,0.0,402.0,,,,,,,<10%,,,2014-12-30,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,8524/3,C50.9,3+,YES,,Core needle biopsy,210.0,NO,Negative,,NO,12.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,11.0,,True,Yes,M0,N3a,T3,Stage IIIC,TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf,A74U,WITH TUMOR,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,LD,Breast,A,LIVING,2013.0,11782f87-4d58-4897-9a61-7a4605c05eca,11782f87-4d58-4897-9a61-7a4605c05eca,,,TCGA-LD-A74U-01,TCGA-LD-A74U-01A-13D-A33F-05,F4F6B174-8640-46C3-9913-5F5043856ADA,TCGA-LD-A74U-01,,,,TCGA-LD-A74U-01,,,11782f87-4d58-4897-9a61-7a4605c05eca,,TCGA-LD-A74U-01A-13D-A33D-01,TCGA-LD-A74U-01,,11782f87-4d58-4897-9a61-7a4605c05eca,TCGA-LD-A74U-01A-13D-A33D-01,
tcga.ld.a7w5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LD-A7W5-01,216.0,0.0,days,,,,,,,,,,TCGA-LD-A7W5,216.0,0.0,days,216.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-LD-A7W5-F69184,TCGA-LD-A7W5,TCGA-LD-A7W5-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,NO,,,-19169.0,83.0,,0.0,216.0,,,,,,,90-99%,,,2014-12-30,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,360.0,NO,Negative,,NO,23.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,23.0,,True,No,M0,N3a,T2,Stage IIIC,TCGA-LD-A7W5.ADBA741B-AABF-4A33-A61F-C10EE555D175.pdf,A7W5,WITH TUMOR,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,LD,Breast,A,LIVING,2013.0,c83d9436-3f08-4197-9392-ff33fe4c632e,c83d9436-3f08-4197-9392-ff33fe4c632e,,,TCGA-LD-A7W5-01,TCGA-LD-A7W5-01A-22D-A357-05,7DEB3148-9179-4E71-98E3-81DE903CE3E5,TCGA-LD-A7W5-01,,,,TCGA-LD-A7W5-01,,,c83d9436-3f08-4197-9392-ff33fe4c632e,,TCGA-LD-A7W5-01A-22D-A350-01,TCGA-LD-A7W5-01,,c83d9436-3f08-4197-9392-ff33fe4c632e,TCGA-LD-A7W5-01A-22D-A350-01,
tcga.ld.a7w6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LD-A7W6-01,404.0,0.0,days,,,,,,,,,,TCGA-LD-A7W6,404.0,0.0,days,404.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right|Right Upper Inner Quadrant,Axillary lymph node dissection alone,,TCGA-LD-A7W6-F69193,TCGA-LD-A7W6,TCGA-LD-A7W6-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-20077.0,91.0,,0.0,404.0,,,,,,,90-99%,,,2014-12-30,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.2,8524/3,C50.2,3+,YES,,Core needle biopsy,630.0,NO,Negative,,NO,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf,A7W6,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,LD,Breast,A,LIVING,2013.0,da8e08c7-6006-4e66-ae0f-7047177ca02a,da8e08c7-6006-4e66-ae0f-7047177ca02a,,,TCGA-LD-A7W6-01,TCGA-LD-A7W6-01A-81D-A357-05,4F831753-0FF7-4B6E-987C-CCC50799E73D,TCGA-LD-A7W6-01,,,,TCGA-LD-A7W6-01,,,da8e08c7-6006-4e66-ae0f-7047177ca02a,,TCGA-LD-A7W6-01A-81D-A350-01,TCGA-LD-A7W6-01,,da8e08c7-6006-4e66-ae0f-7047177ca02a,TCGA-LD-A7W6-01A-81D-A350-01,
tcga.ld.a9qf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LD-A9QF-01,323.0,0.0,days,,,,,,,,,,TCGA-LD-A9QF,323.0,0.0,days,323.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,73.0,Left,Sentinel node biopsy alone,,TCGA-LD-A9QF-F69216,TCGA-LD-A9QF,TCGA-LD-A9QF-01A,,Negative,,,,,Negative,Simple Mastectomy,,YES,,,-26869.0,85.0,,0.0,323.0,,,,,,,,,,2014-12-30,FEMALE,,,90-99%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Positive,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf,A9QF,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,LD,Breast,A,LIVING,2013.0,c2df60f6-40d5-4fe0-88f8-d168feb0d921,c2df60f6-40d5-4fe0-88f8-d168feb0d921,,,TCGA-LD-A9QF-01,TCGA-LD-A9QF-01A-32D-A41Q-05,1D404A66-9E4B-4AA3-9ADA-A5A789ECF185,TCGA-LD-A9QF-01,,,,TCGA-LD-A9QF-01,,,c2df60f6-40d5-4fe0-88f8-d168feb0d921,,TCGA-LD-A9QF-01A-32D-A41E-01,TCGA-LD-A9QF-01,,c2df60f6-40d5-4fe0-88f8-d168feb0d921,TCGA-LD-A9QF-01A-32D-A41E-01,
tcga.ll.a440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A440-01,759.0,0.0,days,,,,,,,,,,TCGA-LL-A440,759.0,0.0,days,759.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-LL-A440-F46387,TCGA-LL-A440,TCGA-LL-A440-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-22497.0,32.0,,0.0,759.0,,,,,,,90-99%,46,,2013-8-7,FEMALE,,,,,2+,20.0,79,1.7,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,200.0,NO,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,MX,N0 (i-),T1c,Stage IA,TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf,A440,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,f34965fe-e7d5-48bd-b0a0-575cbd895c5a,f34965fe-e7d5-48bd-b0a0-575cbd895c5a,,,TCGA-LL-A440-01,TCGA-LL-A440-01A-11D-A244-05,4bc983f8-0b5f-456c-88be-f1a7e901255b,TCGA-LL-A440-01,TCGA-LL-A440-01A-11D-A243-09,,,TCGA-LL-A440-01,,,f34965fe-e7d5-48bd-b0a0-575cbd895c5a,,TCGA-LL-A440-01A-11D-A242-01,TCGA-LL-A440-01,,f34965fe-e7d5-48bd-b0a0-575cbd895c5a,TCGA-LL-A440-01A-11D-A242-01,
tcga.ll.a441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A441-01,996.0,0.0,days,,,,,,,,,,TCGA-LL-A441,996.0,0.0,days,996.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-LL-A441-F46386,TCGA-LL-A441,TCGA-LL-A441-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,,-22772.0,37.0,,0.0,996.0,,,,,,,,,,2013-8-7,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,300.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0,T1c,Stage IA,TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf,A441,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662,8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662,,,TCGA-LL-A441-01,TCGA-LL-A441-01A-11D-A244-05,76fc75d8-5131-4ccf-9c99-be1dac58876d,TCGA-LL-A441-01,TCGA-LL-A441-01A-11D-A243-09,,,TCGA-LL-A441-01,,,8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662,,TCGA-LL-A441-01A-11D-A242-01,TCGA-LL-A441-01,,8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662,TCGA-LL-A441-01A-11D-A242-01,
tcga.ll.a442,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A442-01,889.0,0.0,days,,,,,,,,,,TCGA-LL-A442,889.0,0.0,days,889.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,56.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-LL-A442-F46384,TCGA-LL-A442,TCGA-LL-A442-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-20495.0,60.0,,0.0,889.0,,,,,,,90-99%,35,,2013-8-7,FEMALE,,,,,2+,20.0,60,1.7,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf,A442,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,7c355987-c70f-43f1-94cc-f4d12afe0132,7c355987-c70f-43f1-94cc-f4d12afe0132,,,TCGA-LL-A442-01,TCGA-LL-A442-01A-11D-A244-05,068153fa-935a-429c-9719-84aebe91f185,TCGA-LL-A442-01,,,,TCGA-LL-A442-01,,,7c355987-c70f-43f1-94cc-f4d12afe0132,,TCGA-LL-A442-01A-11D-A242-01,TCGA-LL-A442-01,,7c355987-c70f-43f1-94cc-f4d12afe0132,TCGA-LL-A442-01A-11D-A242-01,
tcga.ll.a50y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A50Y-01,762.0,0.0,days,,,,,,,,,,TCGA-LL-A50Y,762.0,0.0,days,762.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,84.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-LL-A50Y-F50406,TCGA-LL-A50Y,TCGA-LL-A50Y-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-30934.0,91.0,,0.0,762.0,,,,,,,90-99%,2.5,,2013-10-23,FEMALE,,,,,2+,167.0,2.6,1.0,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,130.0,NO,Equivocal,Negative,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,MX,N0,T2,Stage IIA,TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf,A50Y,TUMOR FREE,,,,,,YES,YES,90-99%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,02a65cb0-158c-478b-b72e-d6bae04429c7,02a65cb0-158c-478b-b72e-d6bae04429c7,,,TCGA-LL-A50Y-01,TCGA-LL-A50Y-01A-11D-A268-05,acabe392-7b49-4967-90b5-81ac53cfec8e,TCGA-LL-A50Y-01,TCGA-LL-A50Y-01A-11D-A25Q-09,,,TCGA-LL-A50Y-01,,,02a65cb0-158c-478b-b72e-d6bae04429c7,,TCGA-LL-A50Y-01A-11D-A25N-01,TCGA-LL-A50Y-01,,02a65cb0-158c-478b-b72e-d6bae04429c7,TCGA-LL-A50Y-01A-11D-A25N-01,
tcga.ll.a5yl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A5YL-01,519.0,0.0,days,,,,,,,,,,TCGA-LL-A5YL,519.0,0.0,days,519.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right|Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-LL-A5YL-F59650,TCGA-LL-A5YL,TCGA-LL-A5YL-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Simple Mastectomy,,,,,-23395.0,84.0,,0.0,519.0,,,,,,,90-99%,2.9,,2014-5-19,FEMALE,,,,,3+,65.0,2.6,0.9,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,570.0,NO,Positive,Negative,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf,A5YL,,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,979d9841-337c-47a3-acaf-77d45e276589,979d9841-337c-47a3-acaf-77d45e276589,,,TCGA-LL-A5YL-01,TCGA-LL-A5YL-01A-12D-A29O-05,daaf11f9-0595-4ad7-9f96-7a3a0a82513e,TCGA-LL-A5YL-01,TCGA-LL-A5YL-01A-12D-A29N-09,,,TCGA-LL-A5YL-01,,,979d9841-337c-47a3-acaf-77d45e276589,,TCGA-LL-A5YL-01A-12D-A29M-01,TCGA-LL-A5YL-01,,979d9841-337c-47a3-acaf-77d45e276589,TCGA-LL-A5YL-01A-12D-A29M-01,
tcga.ll.a5ym,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A5YM-01,466.0,0.0,days,,,,,,,,,,TCGA-LL-A5YM,258.0,1.0,days,466.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,88.0,Left|Left Upper Inner Quadrant,No axillary staging,,TCGA-LL-A5YM-F57541,TCGA-LL-A5YM,TCGA-LL-A5YM-01A,Negative,Positive,3 Point Scale,3+,3 Point Scale,Mastectomy NOS,Positive,Other,,,,,-32478.0,131.0,,0.0,466.0,,258.0,258,,,,90-99%,54,,2014-3-14,FEMALE,,,,,2+,20.0,172,3.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8541/3,C50.9,3+,YES,,Core needle biopsy,280.0,NO,Equivocal,Positive,NO,,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,"Other, specify",Locoregional Recurrence,Skin left chest wall,YES,YES,,,False,No,M0,NX,T4b,Stage IIIB,TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf,A5YM,WITH TUMOR,,,,,,NO,NO,90-99%,,NO,Primary Tumor,1,partial mastectomy,7th,,YES,NO,LL,Breast,A,LIVING,2012.0,02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6,02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6,,,TCGA-LL-A5YM-01,TCGA-LL-A5YM-01A-11D-A28C-05,38350a57-ff95-4cd4-bf2c-44c934606d80,TCGA-LL-A5YM-01,TCGA-LL-A5YM-01A-11D-A28B-09,,,TCGA-LL-A5YM-01,,,02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6,,TCGA-LL-A5YM-01A-11D-A28A-01,TCGA-LL-A5YM-01,,02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6,TCGA-LL-A5YM-01A-11D-A28A-01,
tcga.ll.a5yn,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A5YN-01,447.0,0.0,days,,,,,,,,,,TCGA-LL-A5YN,447.0,0.0,days,447.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-LL-A5YN-F59362,TCGA-LL-A5YN,TCGA-LL-A5YN-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,NO,,,-16884.0,41.0,,0.0,447.0,,,,,,,90-99%,54,,2014-5-9,FEMALE,,,,,2+,20.0,172,3.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,230.0,NO,Equivocal,Positive,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf,A5YN,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,844d9d2c-4467-415f-b66d-a4c35c818310,844d9d2c-4467-415f-b66d-a4c35c818310,,,TCGA-LL-A5YN-01,TCGA-LL-A5YN-01A-11D-A28C-05,297362a8-ec87-42d7-b56a-25a29b04b91d,TCGA-LL-A5YN-01,TCGA-LL-A5YN-01A-11D-A28B-09,,,TCGA-LL-A5YN-01,,,844d9d2c-4467-415f-b66d-a4c35c818310,,TCGA-LL-A5YN-01A-11D-A28A-01,TCGA-LL-A5YN-01,,844d9d2c-4467-415f-b66d-a4c35c818310,TCGA-LL-A5YN-01A-11D-A28A-01,
tcga.ll.a5yo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A5YO-01,440.0,0.0,days,,,,,,,,,,TCGA-LL-A5YO,440.0,0.0,days,440.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-LL-A5YO-F58638,TCGA-LL-A5YO,TCGA-LL-A5YO-01A,,Negative,,,,,Negative,Lumpectomy,,YES,,,-18354.0,47.0,,0.0,440.0,,,,,,,,,,2014-4-17,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,Negative,,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0,T1b,Stage IA,TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf,A5YO,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,4b5b44ea-8589-4aea-a69f-b5d5041b1acd,4b5b44ea-8589-4aea-a69f-b5d5041b1acd,,,TCGA-LL-A5YO-01,TCGA-LL-A5YO-01A-21D-A28C-05,62e25802-1209-470d-8fe1-6c17c1c28b71,TCGA-LL-A5YO-01,TCGA-LL-A5YO-01A-21D-A28B-09,,,TCGA-LL-A5YO-01,,,4b5b44ea-8589-4aea-a69f-b5d5041b1acd,,TCGA-LL-A5YO-01A-21D-A28A-01,TCGA-LL-A5YO-01,,4b5b44ea-8589-4aea-a69f-b5d5041b1acd,TCGA-LL-A5YO-01A-21D-A28A-01,
tcga.ll.a5yp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A5YP-01,450.0,0.0,days,,,,,,,,,,TCGA-LL-A5YP,450.0,0.0,days,450.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right|Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-LL-A5YP-F59323,TCGA-LL-A5YP,TCGA-LL-A5YP-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Modified Radical Mastectomy,,NO,,,-18041.0,29.0,,0.0,450.0,,,,,,,<10%,35,,2014-5-8,FEMALE,,,<10%,,1+,20.0,118,3.4,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,490.0,NO,Negative,Positive,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,False,Yes,M0,N1a,T2,Stage IIB,TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf,A5YP,,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c,5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c,,,TCGA-LL-A5YP-01,TCGA-LL-A5YP-01A-21D-A28C-05,e0457a11-2e43-40f1-a33b-f7cae98e4073,TCGA-LL-A5YP-01,TCGA-LL-A5YP-01A-21D-A28B-09,,,TCGA-LL-A5YP-01,,,5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c,,TCGA-LL-A5YP-01A-21D-A28A-01,TCGA-LL-A5YP-01,,5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c,TCGA-LL-A5YP-01A-21D-A28A-01,
tcga.ll.a6fp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A6FP-01,677.0,0.0,days,,,,,,,,,,TCGA-LL-A6FP,677.0,0.0,days,677.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,90.0,Right Upper Outer Quadrant,No axillary staging,,TCGA-LL-A6FP-F64050,TCGA-LL-A6FP,,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-32873.0,,,0.0,677.0,,,,,,,90-99%,3.1,,2014-8-25,FEMALE,,,,,2+,549.0,2.6,0.9,,Infiltrating Lobular Carcinoma,,Yes,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,,,Equivocal,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,,No,MX,NX,T2,Stage IIA,,A6FP,TUMOR FREE,,,,,,YES,NO,20-29%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,,LIVING,2012.0,b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1,b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1,,,TCGA-LL-A6FP-01,TCGA-LL-A6FP-01A-11D-A31V-05,abc6d9bf-6269-4601-8200-f1e6758789fb,TCGA-LL-A6FP-01,,,,TCGA-LL-A6FP-01,,,b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1,,TCGA-LL-A6FP-01A-11D-A31T-01,TCGA-LL-A6FP-01,,b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1,TCGA-LL-A6FP-01A-11D-A31T-01,
tcga.ll.a6fq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A6FQ-01,80.0,0.0,days,,,,,,,,,,TCGA-LL-A6FQ,,,days,80.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-LL-A6FQ-F58204,TCGA-LL-A6FQ,TCGA-LL-A6FQ-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-28375.0,128.0,,0.0,80.0,,,,,,,90-99%,,,2014-4-2,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,250.0,NO,Negative,,YES,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.0,0.0,False,No,MX,N2a,T2,Stage IIIA,TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf,A6FQ,,,,,,,NO,YES,80-89%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,d490ceb7-e3b2-44ee-8c46-923cbd4374dd,d490ceb7-e3b2-44ee-8c46-923cbd4374dd,,,TCGA-LL-A6FQ-01,TCGA-LL-A6FQ-01A-11D-A31V-05,349f287a-7f9a-4b55-a3ad-0f8527b84b94,TCGA-LL-A6FQ-01,,,,TCGA-LL-A6FQ-01,,,d490ceb7-e3b2-44ee-8c46-923cbd4374dd,,TCGA-LL-A6FQ-01A-11D-A31T-01,TCGA-LL-A6FQ-01,,d490ceb7-e3b2-44ee-8c46-923cbd4374dd,TCGA-LL-A6FQ-01A-11D-A31T-01,
tcga.ll.a6fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A6FR-01,489.0,0.0,days,,,,,,,,,,TCGA-LL-A6FR,489.0,0.0,days,489.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,50.0,Right|Right Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-LL-A6FR-F64045,TCGA-LL-A6FR,TCGA-LL-A6FR-01A,,Negative,,1+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-18520.0,30.0,,0.0,489.0,,,,,,,,,,2014-8-25,FEMALE,,,,,2+,20.0,,2.7,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,250.0,NO,Equivocal,Positive,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf,A6FR,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,1cefed42-1e09-4bff-b323-55faeaee18e1,1cefed42-1e09-4bff-b323-55faeaee18e1,,,TCGA-LL-A6FR-01,TCGA-LL-A6FR-01A-12D-A31V-05,dda737e9-f03b-4125-9b62-3a8fa1e2da16,TCGA-LL-A6FR-01,,,,TCGA-LL-A6FR-01,,,1cefed42-1e09-4bff-b323-55faeaee18e1,,TCGA-LL-A6FR-01A-12D-A31T-01,TCGA-LL-A6FR-01,,1cefed42-1e09-4bff-b323-55faeaee18e1,TCGA-LL-A6FR-01A-12D-A31T-01,
tcga.ll.a73y,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A73Y-01,477.0,0.0,days,,,,,,,,,,TCGA-LL-A73Y,477.0,0.0,days,477.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-LL-A73Y-F67099,TCGA-LL-A73Y,TCGA-LL-A73Y-01A,,Negative,3 Point Scale,3+,3 Point Scale,,Negative,Simple Mastectomy,,NO,,,-24647.0,55.0,,0.0,477.0,,,,,,,,,,2014-10-30,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,60.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0,T1c,Stage IA,TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf,A73Y,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,535ab8cf-47a9-4541-b3ef-223bba76a13e,535ab8cf-47a9-4541-b3ef-223bba76a13e,,,TCGA-LL-A73Y-01,TCGA-LL-A73Y-01A-11D-A33F-05,,TCGA-LL-A73Y-01,,,,TCGA-LL-A73Y-01,,,535ab8cf-47a9-4541-b3ef-223bba76a13e,,TCGA-LL-A73Y-01A-11D-A33D-01,TCGA-LL-A73Y-01,,535ab8cf-47a9-4541-b3ef-223bba76a13e,TCGA-LL-A73Y-01A-11D-A33D-01,
tcga.ll.a73z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-LL-A73Z-01,227.0,1.0,days,,,,,,,,,,TCGA-LL-A73Z,192.0,1.0,days,227.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,NO,NO,,,55.0,Left|Left Lower Inner Quadrant,No axillary staging,,TCGA-LL-A73Z-F64983,TCGA-LL-A73Z,TCGA-LL-A73Z-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Lumpectomy,,NO,,,-20118.0,40.0,227.0,0.0,137.0,,,192,,,,10-19%,2.2,,2014-9-16,FEMALE,,,,,2+,243.0,2.5,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Excisional Biopsy,240.0,NO,Equivocal,Negative,NO,,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,"Other, specify",skin,,,,,,Brain,Distant Metastasis,,NO,YES,,,False,No,M1,NX,T1c,Stage IV,TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf,A73Z,WITH TUMOR,,,,,,YES,NO,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,DECEASED,2013.0,9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126,9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126,,,TCGA-LL-A73Z-01,TCGA-LL-A73Z-01A-11D-A32T-05,31B0CE66-3E66-4210-ABBC-82C85BB9902C,TCGA-LL-A73Z-01,,,,TCGA-LL-A73Z-01,,,9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126,,TCGA-LL-A73Z-01A-11D-A32H-01,TCGA-LL-A73Z-01,,9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126,TCGA-LL-A73Z-01A-11D-A32H-01,
tcga.ll.a740,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A740-01,441.0,0.0,days,,,,,,,,,,TCGA-LL-A740,441.0,0.0,days,441.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-LL-A740-F65059,TCGA-LL-A740,TCGA-LL-A740-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,,-22416.0,37.0,,0.0,441.0,,,,,,,,2.9,,2014-9-18,FEMALE,,,,,2+,113.0,3.3,1.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,410.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf,A740,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,9014d9c4-ab6b-4318-9b07-c00266d9f5a9,9014d9c4-ab6b-4318-9b07-c00266d9f5a9,,,TCGA-LL-A740-01,TCGA-LL-A740-01A-21D-A32T-05,A13762BD-83CD-4DBC-94FE-1879E3A4B5A4,TCGA-LL-A740-01,,,,TCGA-LL-A740-01,,,9014d9c4-ab6b-4318-9b07-c00266d9f5a9,,TCGA-LL-A740-01A-21D-A32H-01,TCGA-LL-A740-01,,9014d9c4-ab6b-4318-9b07-c00266d9f5a9,TCGA-LL-A740-01A-21D-A32H-01,
tcga.ll.a7sz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A7SZ-01,594.0,0.0,days,,,,,,,,,,TCGA-LL-A7SZ,594.0,0.0,days,594.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-LL-A7SZ-F66973,TCGA-LL-A7SZ,TCGA-LL-A7SZ-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Other,,YES,,,-18161.0,63.0,,0.0,594.0,,,,,,,90-99%,,,2014-10-29,FEMALE,,,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,2+,YES,,Core needle biopsy,240.0,NO,Negative,,NO,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf,A7SZ,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,SKIN SPARING RADICAL MASTECTOMY,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,e256282c-da2c-4272-a94b-14cf44da6178,e256282c-da2c-4272-a94b-14cf44da6178,,,TCGA-LL-A7SZ-01,TCGA-LL-A7SZ-01A-32D-A357-05,C972C687-4BA1-4F38-A073-4A2AB182F8B0,TCGA-LL-A7SZ-01,,,,TCGA-LL-A7SZ-01,,,e256282c-da2c-4272-a94b-14cf44da6178,,TCGA-LL-A7SZ-01A-32D-A350-01,TCGA-LL-A7SZ-01,,e256282c-da2c-4272-a94b-14cf44da6178,TCGA-LL-A7SZ-01A-32D-A350-01,
tcga.ll.a7t0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A7T0-01,376.0,0.0,days,,,,,,,,,,TCGA-LL-A7T0,376.0,0.0,days,376.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,TCGA-LL-A7T0-F64970,TCGA-LL-A7T0,TCGA-LL-A7T0-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-25867.0,70.0,,0.0,376.0,,,,,,,90-99%,,,2014-9-16,FEMALE,,,,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Tumor resection,380.0,NO,Positive,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf,A7T0,TUMOR FREE,,,,,,NO,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,67e967d6-be17-4fe1-a1fb-197655fad18d,67e967d6-be17-4fe1-a1fb-197655fad18d,,,TCGA-LL-A7T0-01,TCGA-LL-A7T0-01A-31D-A357-05,,TCGA-LL-A7T0-01,,,,TCGA-LL-A7T0-01,,,67e967d6-be17-4fe1-a1fb-197655fad18d,,TCGA-LL-A7T0-01A-31D-A350-01,TCGA-LL-A7T0-01,,67e967d6-be17-4fe1-a1fb-197655fad18d,TCGA-LL-A7T0-01A-31D-A350-01,
tcga.ll.a8f5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A8F5-01,596.0,0.0,days,,,,,,,,,,TCGA-LL-A8F5,596.0,0.0,days,596.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,,TCGA-LL-A8F5-F66965,TCGA-LL-A8F5,TCGA-LL-A8F5-01A,,Positive,3 Point Scale,,3 Point Scale,,Negative,Lumpectomy,,YES,,,-22544.0,78.0,,0.0,596.0,,,,,,,20-29%,,,2014-10-29,FEMALE,,,<10%,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,1+,YES,,Core needle biopsy,230.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf,A8F5,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,3cc7e12e-2bc8-494c-b74a-de071d711410,3cc7e12e-2bc8-494c-b74a-de071d711410,,,TCGA-LL-A8F5-01,TCGA-LL-A8F5-01A-11D-A36K-05,FBB89BA4-95C2-4EEE-8248-B344B94C696F,TCGA-LL-A8F5-01,,,,TCGA-LL-A8F5-01,,,3cc7e12e-2bc8-494c-b74a-de071d711410,,TCGA-LL-A8F5-01A-11D-A36I-01,TCGA-LL-A8F5-01,,3cc7e12e-2bc8-494c-b74a-de071d711410,TCGA-LL-A8F5-01A-11D-A36I-01,
tcga.ll.a9q3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LL-A9Q3-01,532.0,0.0,days,,,,,,,,,,TCGA-LL-A9Q3,532.0,0.0,days,532.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,69.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-LL-A9Q3-F67103,TCGA-LL-A9Q3,TCGA-LL-A9Q3-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-25477.0,80.0,,0.0,532.0,,,,,,,90-99%,,,2014-10-30,FEMALE,,,,,3+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,610.0,NO,Positive,,NO,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,28.0,0.0,False,No,MX,N3a,T3,Stage IIIC,TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf,A9Q3,TUMOR FREE,,,,,,YES,YES,<10%,,YES,Primary Tumor,1,,7th,,YES,NO,LL,Breast,A,LIVING,2013.0,0aad6d2a-1699-4403-8d45-f0b315ec89c7,0aad6d2a-1699-4403-8d45-f0b315ec89c7,,,TCGA-LL-A9Q3-01,TCGA-LL-A9Q3-01A-11D-A41Q-05,A26726B7-5B72-4AC3-9EDF-F3F13C2E471F,TCGA-LL-A9Q3-01,,,,TCGA-LL-A9Q3-01,,,0aad6d2a-1699-4403-8d45-f0b315ec89c7,,TCGA-LL-A9Q3-01A-11D-A41E-01,TCGA-LL-A9Q3-01,,0aad6d2a-1699-4403-8d45-f0b315ec89c7,TCGA-LL-A9Q3-01A-11D-A41E-01,
tcga.lq.a4e4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-LQ-A4E4-01,849.0,0.0,days,,,,,,,,,,TCGA-LQ-A4E4,681.0,1.0,days,849.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,YES,YES,,,73.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-LQ-A4E4-F52290,TCGA-LQ-A4E4,TCGA-LQ-A4E4-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Modified Radical Mastectomy,,NO,,,-26883.0,414.0,,0.0,849.0,,,681,,,,90-99%,1.1,,2013-12-2,FEMALE,,,,,,60.0,1.1,1.05,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,1+,YES,,Core needle biopsy,200.0,NO,,Negative,NO,26.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Positive,,,,,,,,,,,,Negative,,,,,,,,Bone,Distant Metastasis,,NO,YES,3.0,0.0,True,No,MX,N1a,T3,Stage IIIA,TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf,A4E4,WITH TUMOR,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,NO,YES,LQ,Breast,A,LIVING,2011.0,5965fc49-0ee5-41d8-b673-9ade5c70db71,5965fc49-0ee5-41d8-b673-9ade5c70db71,,,TCGA-LQ-A4E4-01,TCGA-LQ-A4E4-01A-11D-A268-05,610e443b-3ef2-4a65-80f9-6d300736ba70,TCGA-LQ-A4E4-01,TCGA-LQ-A4E4-01A-11D-A25Q-09,,,TCGA-LQ-A4E4-01,,,5965fc49-0ee5-41d8-b673-9ade5c70db71,,TCGA-LQ-A4E4-01A-11D-A25N-01,TCGA-LQ-A4E4-01,,5965fc49-0ee5-41d8-b673-9ade5c70db71,TCGA-LQ-A4E4-01A-11D-A25N-01,
tcga.ms.a51u,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-MS-A51U-01,681.0,0.0,days,,,,,,,,,,TCGA-MS-A51U,681.0,0.0,days,681.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,44.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,,,TCGA-MS-A51U-F59818,TCGA-MS-A51U,TCGA-MS-A51U-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-16213.0,129.0,,0.0,681.0,,,,,NO,,90-99%,,,2014-6-4,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,190.0,NO,Negative,Negative,NO,18.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf,A51U,TUMOR FREE,,,,,,YES,YES,20-29%,,YES,Primary Tumor,1,,7th,,YES,NO,MS,Breast,A,LIVING,2012.0,b41dfa6b-a221-4e03-95d7-428781787067,b41dfa6b-a221-4e03-95d7-428781787067,,,TCGA-MS-A51U-01,TCGA-MS-A51U-01A-31D-A268-05,8eb29e3b-4e9b-481e-9bb2-564d1ee1a5dc,TCGA-MS-A51U-01,TCGA-MS-A51U-01A-31D-A25Q-09,,,TCGA-MS-A51U-01,,,b41dfa6b-a221-4e03-95d7-428781787067,,TCGA-MS-A51U-01A-31D-A25N-01,TCGA-MS-A51U-01,,b41dfa6b-a221-4e03-95d7-428781787067,TCGA-MS-A51U-01A-31D-A25N-01,
tcga.ok.a5q2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OK-A5Q2-01,64.0,0.0,days,,,,,,,,,,TCGA-OK-A5Q2,64.0,0.0,days,64.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Right,Axillary lymph node dissection alone,,,TCGA-OK-A5Q2,,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-21555.0,,,0.0,64.0,,,,,,,90-99%,,,2013-1-22,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,,,,Negative,,,13.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,2.0,,No,MX,N1a,T2,Stage II,,A5Q2,,,,,,,,YES,20-29%,,,Primary Tumor,1,,7th,,YES,NO,OK,Breast,,LIVING,2012.0,b835c127-4f06-4870-a0a4-7f95be0260a4,b835c127-4f06-4870-a0a4-7f95be0260a4,,,TCGA-OK-A5Q2-01,TCGA-OK-A5Q2-01A-11D-A27Y-05,,TCGA-OK-A5Q2-01,TCGA-OK-A5Q2-01A-11D-A27P-09,,,TCGA-OK-A5Q2-01,,,b835c127-4f06-4870-a0a4-7f95be0260a4,,TCGA-OK-A5Q2-01A-11D-A27O-01,TCGA-OK-A5Q2-01,,b835c127-4f06-4870-a0a4-7f95be0260a4,TCGA-OK-A5Q2-01A-11D-A27O-01,
tcga.ol.a5d6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-OL-A5D6-01,1104.0,1.0,days,,,,,,,,,,TCGA-OL-A5D6,1104.0,0.0,days,1104.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A5D6-F55437,TCGA-OL-A5D6,TCGA-OL-A5D6-01A,,Negative,,,,,Negative,Simple Mastectomy,,,,,-26052.0,1378.0,1104.0,0.0,385.0,,,,,,,,,,2014-1-10,FEMALE,,,,,,,,1.13,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,200.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf,A5D6,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,OL,Breast,A,DECEASED,2009.0,5657c6b6-ba04-4dd8-8623-2a3834820f7d,5657c6b6-ba04-4dd8-8623-2a3834820f7d,,,TCGA-OL-A5D6-01,TCGA-OL-A5D6-01A-21D-A27Y-05,,TCGA-OL-A5D6-01,TCGA-OL-A5D6-01A-21D-A27P-09,,,TCGA-OL-A5D6-01,,,5657c6b6-ba04-4dd8-8623-2a3834820f7d,,TCGA-OL-A5D6-01A-21D-A27O-01,TCGA-OL-A5D6-01,,5657c6b6-ba04-4dd8-8623-2a3834820f7d,TCGA-OL-A5D6-01A-21D-A27O-01,
tcga.ol.a5d7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5D7-01,1780.0,0.0,days,,,,,,,,,,TCGA-OL-A5D7,1780.0,0.0,days,1780.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,70.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A5D7-F55439,TCGA-OL-A5D7,TCGA-OL-A5D7-01A,,Negative,,,,,Negative,Lumpectomy,,,,,-25643.0,1415.0,,0.0,1780.0,,,,,,,,,,2014-1-10,FEMALE,,,,,,,,1.36,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,370.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf,A5D7,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,OL,Breast,A,LIVING,2009.0,a9f404db-e7fa-49bf-acca-fccd676f2e7c,a9f404db-e7fa-49bf-acca-fccd676f2e7c,,,TCGA-OL-A5D7-01,TCGA-OL-A5D7-01A-11D-A27Y-05,2cdb08fa-d13c-496e-8f53-9852a8a165ef,TCGA-OL-A5D7-01,TCGA-OL-A5D7-01A-11D-A27P-09,,,TCGA-OL-A5D7-01,,,a9f404db-e7fa-49bf-acca-fccd676f2e7c,,TCGA-OL-A5D7-01A-11D-A27O-01,TCGA-OL-A5D7-01,,a9f404db-e7fa-49bf-acca-fccd676f2e7c,TCGA-OL-A5D7-01A-11D-A27O-01,
tcga.ol.a5d8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5D8-01,973.0,0.0,days,,,,,,,,,,TCGA-OL-A5D8,973.0,0.0,days,973.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Left Lower Outer Quadrant,Other (specify),axillary ultrasound,TCGA-OL-A5D8-F55438,TCGA-OL-A5D8,TCGA-OL-A5D8-01A,,Positive,,,,,Positive,Simple Mastectomy,,NO,,,-14853.0,1357.0,,0.0,973.0,,,,,,,90-99%,2.25,,2014-1-10,FEMALE,,,,,,20.0,2,0.8,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,370.0,NO,,Negative,NO,2.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N0,T3,Stage IIB,TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf,A5D8,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,6th,,NO,YES,OL,Breast,A,LIVING,2009.0,8c435d42-a76a-4078-a593-6a41a2bb6f5e,8c435d42-a76a-4078-a593-6a41a2bb6f5e,,,TCGA-OL-A5D8-01,TCGA-OL-A5D8-01A-11D-A27Y-05,321a0511-ed95-4937-92b2-5a77c86e1f48,TCGA-OL-A5D8-01,TCGA-OL-A5D8-01A-11D-A27P-09,,,TCGA-OL-A5D8-01,,,8c435d42-a76a-4078-a593-6a41a2bb6f5e,,TCGA-OL-A5D8-01A-11D-A27O-01,TCGA-OL-A5D8-01,,8c435d42-a76a-4078-a593-6a41a2bb6f5e,TCGA-OL-A5D8-01A-11D-A27O-01,
tcga.ol.a5da,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5DA-01,1783.0,0.0,days,,,,,,,,,,TCGA-OL-A5DA,1783.0,0.0,days,1783.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A5DA-F55440,TCGA-OL-A5DA,TCGA-OL-A5DA-01A,,Positive,,,,,Positive,Other,,,,,-22411.0,1407.0,,0.0,1783.0,,,,,,,60-69%,,,2014-1-10,FEMALE,1,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,Ultrasound-guided mammotome biopsy,"Other method, specify:",240.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf,A5DA,TUMOR FREE,,,,,,NO,YES,60-69%,,NO,Primary Tumor,1,partial mastectomy,6th,,NO,YES,OL,Breast,A,LIVING,2009.0,b881706f-5ee8-43da-a691-53c036d94494,b881706f-5ee8-43da-a691-53c036d94494,,,TCGA-OL-A5DA-01,TCGA-OL-A5DA-01A-11D-A27Y-05,1e062952-e6da-43a7-ad52-e2eff10461da,TCGA-OL-A5DA-01,TCGA-OL-A5DA-01A-11D-A27P-09,,,TCGA-OL-A5DA-01,,,b881706f-5ee8-43da-a691-53c036d94494,,TCGA-OL-A5DA-01A-11D-A27O-01,TCGA-OL-A5DA-01,,b881706f-5ee8-43da-a691-53c036d94494,TCGA-OL-A5DA-01A-11D-A27O-01,
tcga.ol.a5ru,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RU-01,1219.0,0.0,days,,,,,,,,,,TCGA-OL-A5RU,1219.0,0.0,days,1219.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A5RU-F56569,TCGA-OL-A5RU,TCGA-OL-A5RU-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-23108.0,826.0,,0.0,1219.0,,,,,,,90-99%,,,2014-2-14,FEMALE,,,,,,,,1.02,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,430.0,NO,,Negative,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf,A5RU,TUMOR FREE,,,,,,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2010.0,02873204-1097-45ea-b143-a97f3e047537,02873204-1097-45ea-b143-a97f3e047537,,,TCGA-OL-A5RU-01,TCGA-OL-A5RU-01A-11D-A28C-05,63002326-8f58-4457-b841-9d0773e65587,TCGA-OL-A5RU-01,TCGA-OL-A5RU-01A-11D-A28B-09,,,TCGA-OL-A5RU-01,,,02873204-1097-45ea-b143-a97f3e047537,,TCGA-OL-A5RU-01A-11D-A28A-01,TCGA-OL-A5RU-01,,02873204-1097-45ea-b143-a97f3e047537,TCGA-OL-A5RU-01A-11D-A28A-01,
tcga.ol.a5rv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RV-01,1062.0,0.0,days,,,,,,,,,,TCGA-OL-A5RV,1062.0,0.0,days,1062.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-OL-A5RV-F56564,TCGA-OL-A5RV,TCGA-OL-A5RV-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-15820.0,755.0,,0.0,1062.0,,,,,,,90-99%,,,2014-2-14,FEMALE,,,,,,,,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,370.0,NO,,Negative,NO,29.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,20.0,,True,No,MX,N3,T2,Stage IIIC,TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf,A5RV,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2011.0,2dca31d2-af60-4529-afac-e8838a7ee67c,2dca31d2-af60-4529-afac-e8838a7ee67c,,,TCGA-OL-A5RV-01,TCGA-OL-A5RV-01A-12D-A28C-05,ec9c3ed3-1246-42ab-9120-6a027f56d494,TCGA-OL-A5RV-01,TCGA-OL-A5RV-01A-12D-A28B-09,,,TCGA-OL-A5RV-01,,,2dca31d2-af60-4529-afac-e8838a7ee67c,,TCGA-OL-A5RV-01A-12D-A28A-01,TCGA-OL-A5RV-01,,2dca31d2-af60-4529-afac-e8838a7ee67c,TCGA-OL-A5RV-01A-12D-A28A-01,
tcga.ol.a5rw,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RW-01,1106.0,0.0,days,,,,,,,,,,TCGA-OL-A5RW,1106.0,0.0,days,1106.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,40.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-OL-A5RW-F56568,TCGA-OL-A5RW,,,Negative,,,,,Negative,Lumpectomy,,,,,-14638.0,,,0.0,1106.0,,,,,,,,,,2014-2-14,FEMALE,,,,,,,,1.91,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,,,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,,No,MX,N1,T1c,Stage IIA,,A5RW,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,,LIVING,2010.0,c5a7673a-c45e-4789-a2c8-32889f39c102,c5a7673a-c45e-4789-a2c8-32889f39c102,,,TCGA-OL-A5RW-01,TCGA-OL-A5RW-01A-11D-A28C-05,e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75,TCGA-OL-A5RW-01,TCGA-OL-A5RW-01A-11D-A28B-09,,,TCGA-OL-A5RW-01,,,c5a7673a-c45e-4789-a2c8-32889f39c102,,TCGA-OL-A5RW-01A-11D-A28A-01,TCGA-OL-A5RW-01,,c5a7673a-c45e-4789-a2c8-32889f39c102,TCGA-OL-A5RW-01A-11D-A28A-01,
tcga.ol.a5rx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RX-01,878.0,0.0,days,,,,,,,,,,TCGA-OL-A5RX,878.0,0.0,days,878.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A5RX-F56570,TCGA-OL-A5RX,TCGA-OL-A5RX-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-18942.0,561.0,,0.0,878.0,,,,,,,90-99%,,,2014-2-14,FEMALE,,,,,,,,1.0,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf,A5RX,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2011.0,650c0c98-4432-4e9a-9e83-4ad8a7a0d628,650c0c98-4432-4e9a-9e83-4ad8a7a0d628,,,TCGA-OL-A5RX-01,TCGA-OL-A5RX-01A-11D-A28C-05,7f3a5deb-3015-4ca7-aa12-f46870a5da8e,TCGA-OL-A5RX-01,TCGA-OL-A5RX-01A-11D-A28B-09,,,TCGA-OL-A5RX-01,,,650c0c98-4432-4e9a-9e83-4ad8a7a0d628,,TCGA-OL-A5RX-01A-11D-A28A-01,TCGA-OL-A5RX-01,,650c0c98-4432-4e9a-9e83-4ad8a7a0d628,TCGA-OL-A5RX-01A-11D-A28A-01,
tcga.ol.a5ry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RY-01,752.0,0.0,days,,,,,,,,,,TCGA-OL-A5RY,752.0,0.0,days,752.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,52.0,Right,Sentinel node biopsy alone,,TCGA-OL-A5RY-F56565,TCGA-OL-A5RY,TCGA-OL-A5RY-01A,Negative,Positive,,,,Mastectomy NOS,Negative,Lumpectomy,,,,,-19216.0,421.0,,0.0,752.0,,,,,,,10-19%,,,2014-2-14,FEMALE,,,,,,,,7.6,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,Ultrasound-guided biopsy,"Other method, specify:",300.0,NO,,Positive,NO,25.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf,A5RY,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2011.0,2407816a-86e7-4094-a028-e81c0cda5448,2407816a-86e7-4094-a028-e81c0cda5448,,,TCGA-OL-A5RY-01,TCGA-OL-A5RY-01A-21D-A28C-05,7bd9aba2-054f-48ac-ab14-ee53896d353d,TCGA-OL-A5RY-01,TCGA-OL-A5RY-01A-21D-A28B-09,,,TCGA-OL-A5RY-01,,,2407816a-86e7-4094-a028-e81c0cda5448,,TCGA-OL-A5RY-01A-21D-A28A-01,TCGA-OL-A5RY-01,,2407816a-86e7-4094-a028-e81c0cda5448,TCGA-OL-A5RY-01A-21D-A28A-01,
tcga.ol.a5rz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5RZ-01,679.0,0.0,days,,,,,,,,,,TCGA-OL-A5RZ,679.0,0.0,days,679.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,57.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-OL-A5RZ-F56571,TCGA-OL-A5RZ,,,Positive,,,,,Negative,Simple Mastectomy,,,,,-21038.0,,,0.0,679.0,,,,,,,30-39%,2.0,,2014-2-14,FEMALE,,,,,,,21.0,10.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,,,,Positive,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,,No,MX,N0,T1b,Stage IA,,A5RZ,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,,LIVING,2012.0,fc8c0c74-cd1b-4bc7-ab1d-568d302c5719,fc8c0c74-cd1b-4bc7-ab1d-568d302c5719,,,TCGA-OL-A5RZ-01,TCGA-OL-A5RZ-01A-11D-A28C-05,aae8eb5d-0797-424c-a2a1-6b8d08c7463e,TCGA-OL-A5RZ-01,TCGA-OL-A5RZ-01A-11D-A28B-09,,,TCGA-OL-A5RZ-01,,,fc8c0c74-cd1b-4bc7-ab1d-568d302c5719,,TCGA-OL-A5RZ-01A-11D-A28A-01,TCGA-OL-A5RZ-01,,fc8c0c74-cd1b-4bc7-ab1d-568d302c5719,TCGA-OL-A5RZ-01A-11D-A28A-01,
tcga.ol.a5s0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A5S0-01,620.0,0.0,days,,,,,,,,,,TCGA-OL-A5S0,620.0,0.0,days,620.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Right,Axillary lymph node dissection alone,,TCGA-OL-A5S0-F56567,TCGA-OL-A5S0,TCGA-OL-A5S0-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-24139.0,279.0,,0.0,620.0,,,,,,,30-39%,,,2014-2-14,FEMALE,,,,,,,,3.8,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,530.0,NO,,Positive,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,,True,No,MX,N1a,T2,Stage IIB,TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf,A5S0,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2012.0,f6e02767-7522-4895-bc70-c7de6b1796ab,f6e02767-7522-4895-bc70-c7de6b1796ab,,,TCGA-OL-A5S0-01,TCGA-OL-A5S0-01A-11D-A28C-05,07817555-b5eb-4502-9229-236a38430974,TCGA-OL-A5S0-01,TCGA-OL-A5S0-01A-11D-A28B-09,,,TCGA-OL-A5S0-01,,,f6e02767-7522-4895-bc70-c7de6b1796ab,,TCGA-OL-A5S0-01A-11D-A28A-01,TCGA-OL-A5S0-01,,f6e02767-7522-4895-bc70-c7de6b1796ab,TCGA-OL-A5S0-01A-11D-A28A-01,
tcga.ol.a66h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66H-01,812.0,0.0,days,,,,,,,,,,TCGA-OL-A66H,812.0,0.0,days,812.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,74.0,Right,,,TCGA-OL-A66H-F58492,TCGA-OL-A66H,TCGA-OL-A66H-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-27280.0,441.0,,0.0,812.0,,,,,,,90-99%,1.7,,2014-4-11,FEMALE,,,,,,,1.8,1.03,,Mucinous Carcinoma,,No,,C50.9,8480/3,C50.9,,YES,,Fine needle aspiration biopsy,80.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N1mi,T1c,Stage IB,TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf,A66H,TUMOR FREE,,,,,,NO,YES,80-89%,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2012.0,428ca7a1-6f08-4426-8f2d-28939166df70,428ca7a1-6f08-4426-8f2d-28939166df70,,,TCGA-OL-A66H-01,TCGA-OL-A66H-01A-11D-A29O-05,,TCGA-OL-A66H-01,TCGA-OL-A66H-01A-11D-A29N-09,,,TCGA-OL-A66H-01,,,428ca7a1-6f08-4426-8f2d-28939166df70,,TCGA-OL-A66H-01A-11D-A29M-01,TCGA-OL-A66H-01,,428ca7a1-6f08-4426-8f2d-28939166df70,TCGA-OL-A66H-01A-11D-A29M-01,
tcga.ol.a66i,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66I-01,714.0,0.0,days,,,,,,,,,,TCGA-OL-A66I,714.0,0.0,days,714.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,36.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A66I-F58496,TCGA-OL-A66I,TCGA-OL-A66I-01A,,Negative,,,,,Negative,Lumpectomy,,,,,-13458.0,1715.0,,0.0,714.0,,,,,,,,,,2014-4-11,FEMALE,,,,,,,,1.04,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,240.0,NO,,Negative,YES,13.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,MX,N1mi,T1c,Stage IIA,TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf,A66I,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,OL,Breast,A,LIVING,2008.0,d92ddf45-68b6-42da-9497-8faabcc50be0,d92ddf45-68b6-42da-9497-8faabcc50be0,,,TCGA-OL-A66I-01,TCGA-OL-A66I-01A-21D-A29O-05,3e69923d-a657-4a7f-b605-bd2b9222c94f,TCGA-OL-A66I-01,TCGA-OL-A66I-01A-21D-A29N-09,,,TCGA-OL-A66I-01,,,d92ddf45-68b6-42da-9497-8faabcc50be0,,TCGA-OL-A66I-01A-21D-A29M-01,TCGA-OL-A66I-01,,d92ddf45-68b6-42da-9497-8faabcc50be0,TCGA-OL-A66I-01A-21D-A29M-01,
tcga.ol.a66j,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66J-01,1996.0,0.0,days,,,,,,,,,,TCGA-OL-A66J,1996.0,0.0,days,1996.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,80.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A66J-F58495,TCGA-OL-A66J,,,Positive,,,,,Positive,Lumpectomy,,,,,-29345.0,,,0.0,1996.0,,,,,,,90-99%,,,2014-4-11,FEMALE,,,,,,,,1.5,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,,,,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,,No,MX,N0,T1c,Stage I,,A66J,TUMOR FREE,,,,,,NO,YES,50-59%,,YES,Primary Tumor,1,,6th,,NO,YES,OL,Breast,,LIVING,2008.0,fc8cb6a7-c7ed-4037-8fb9-7530cdebc705,fc8cb6a7-c7ed-4037-8fb9-7530cdebc705,,,TCGA-OL-A66J-01,TCGA-OL-A66J-01A-11D-A29O-05,cffbe18d-d8c9-4bb3-8916-634e6ad7ab8a,TCGA-OL-A66J-01,TCGA-OL-A66J-01A-11D-A29N-09,,,TCGA-OL-A66J-01,,,fc8cb6a7-c7ed-4037-8fb9-7530cdebc705,,TCGA-OL-A66J-01A-11D-A29M-01,TCGA-OL-A66J-01,,fc8cb6a7-c7ed-4037-8fb9-7530cdebc705,TCGA-OL-A66J-01A-11D-A29M-01,
tcga.ol.a66k,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-OL-A66K-01,1275.0,1.0,days,,,,,,,,,,TCGA-OL-A66K,1275.0,0.0,days,1275.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A66K-F58498,TCGA-OL-A66K,TCGA-OL-A66K-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-26299.0,981.0,1275.0,0.0,1021.0,,,,,,,70-79%,,,2014-4-11,FEMALE,,,,,2+,,,1.23,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,230.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf,A66K,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,DECEASED,2010.0,7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf,7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf,,,TCGA-OL-A66K-01,TCGA-OL-A66K-01A-11D-A29O-05,97c6fb8d-f158-4f4c-8139-6a886bf38f99,TCGA-OL-A66K-01,TCGA-OL-A66K-01A-11D-A29N-09,,,TCGA-OL-A66K-01,,,7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf,,TCGA-OL-A66K-01A-11D-A29M-01,TCGA-OL-A66K-01,,7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf,TCGA-OL-A66K-01A-11D-A29M-01,
tcga.ol.a66l,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66L-01,1301.0,0.0,days,,,,,,,,,,TCGA-OL-A66L,1301.0,0.0,days,1301.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Right Lower Inner Quadrant,,,TCGA-OL-A66L-F58493,TCGA-OL-A66L,TCGA-OL-A66L-01A,,Positive,,,,,Positive,Lumpectomy,,,,,-26186.0,952.0,,0.0,1301.0,,,,,,,90-99%,,,2014-4-11,FEMALE,,,,,,,,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,170.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf,A66L,TUMOR FREE,,,,,,NO,YES,90-99%,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2010.0,0df01f96-a14b-4bd9-bddb-1dab47491d2d,0df01f96-a14b-4bd9-bddb-1dab47491d2d,,,TCGA-OL-A66L-01,TCGA-OL-A66L-01A-12D-A31V-05,,TCGA-OL-A66L-01,,,,TCGA-OL-A66L-01,,,0df01f96-a14b-4bd9-bddb-1dab47491d2d,,TCGA-OL-A66L-01A-12D-A31T-01,TCGA-OL-A66L-01,,0df01f96-a14b-4bd9-bddb-1dab47491d2d,TCGA-OL-A66L-01A-12D-A31T-01,
tcga.ol.a66n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66N-01,792.0,0.0,days,,,,,,,,,,TCGA-OL-A66N,792.0,0.0,days,792.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,59.0,Left,Sentinel node biopsy alone,,TCGA-OL-A66N-F58500,TCGA-OL-A66N,TCGA-OL-A66N-01A,,Positive,,,,,Negative,Modified Radical Mastectomy,,,,,-21608.0,505.0,,0.0,792.0,,,,,,,80-89%,,,2014-4-11,FEMALE,,,,,,,,1.1,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,310.0,NO,,Negative,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,13.0,,True,No,MX,N3,T3,Stage IIIC,TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf,A66N,TUMOR FREE,,,,,,NO,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2011.0,43cde130-82ef-43ca-ba81-8ab14588069c,43cde130-82ef-43ca-ba81-8ab14588069c,,,TCGA-OL-A66N-01,TCGA-OL-A66N-01A-12D-A31V-05,3acac7e1-22c1-4a61-847d-bda89e3a10c1,TCGA-OL-A66N-01,,,,TCGA-OL-A66N-01,,,43cde130-82ef-43ca-ba81-8ab14588069c,,TCGA-OL-A66N-01A-12D-A31T-01,TCGA-OL-A66N-01,,43cde130-82ef-43ca-ba81-8ab14588069c,TCGA-OL-A66N-01A-12D-A31T-01,
tcga.ol.a66o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66O-01,528.0,0.0,days,,,,,,,,,,TCGA-OL-A66O,528.0,0.0,days,528.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,39.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A66O-F58497,TCGA-OL-A66O,TCGA-OL-A66O-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,,,,-14272.0,170.0,,0.0,528.0,,,,,,,90-99%,,,2014-4-11,FEMALE,,,,,,,,1.2,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,260.0,NO,,Negative,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,3.0,,True,No,MX,N1a,T2,Stage IIB,TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf,A66O,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2012.0,c7f57147-b774-4209-8b7f-2666f59543d8,c7f57147-b774-4209-8b7f-2666f59543d8,,,TCGA-OL-A66O-01,TCGA-OL-A66O-01A-11D-A31V-05,024e8275-694b-4942-832d-3137b1c5303a,TCGA-OL-A66O-01,,,,TCGA-OL-A66O-01,,,c7f57147-b774-4209-8b7f-2666f59543d8,,TCGA-OL-A66O-01A-11D-A31T-01,TCGA-OL-A66O-01,,c7f57147-b774-4209-8b7f-2666f59543d8,TCGA-OL-A66O-01A-11D-A31T-01,
tcga.ol.a66p,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A66P-01,428.0,0.0,days,,,,,,,,,,TCGA-OL-A66P,428.0,0.0,days,428.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Right,Sentinel node biopsy alone,,TCGA-OL-A66P-F58494,TCGA-OL-A66P,TCGA-OL-A66P-01A,,Negative,,,,,Negative,Simple Mastectomy,,,,,-27489.0,98.0,,0.0,428.0,,,,,,,,,,2014-4-11,FEMALE,,,,,,,,1.13,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,140.0,NO,,Negative,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf,A66P,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2013.0,bbd01868-6fc1-42e7-b375-f0ac1a54a43c,bbd01868-6fc1-42e7-b375-f0ac1a54a43c,,,TCGA-OL-A66P-01,TCGA-OL-A66P-01A-11D-A31V-05,737f4dca-ab51-4053-ad90-6654f312ca6d,TCGA-OL-A66P-01,,,,TCGA-OL-A66P-01,,,bbd01868-6fc1-42e7-b375-f0ac1a54a43c,,TCGA-OL-A66P-01A-11D-A31T-01,TCGA-OL-A66P-01,,bbd01868-6fc1-42e7-b375-f0ac1a54a43c,TCGA-OL-A66P-01A-11D-A31T-01,
tcga.ol.a6vo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A6VO-01,858.0,0.0,days,,,,,,,,,,TCGA-OL-A6VO,858.0,0.0,days,858.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,43.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-OL-A6VO-F59365,TCGA-OL-A6VO,TCGA-OL-A6VO-01A,,Negative,,,,,Negative,Lumpectomy,,,,,-15780.0,507.0,,0.0,858.0,,,,,,,,,,2014-5-10,FEMALE,,,,,,,,1.23,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,120.0,NO,Negative,Negative,NO,7.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf,A6VO,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2012.0,5cb12edf-25a1-40f6-831a-5fb1f56676e1,5cb12edf-25a1-40f6-831a-5fb1f56676e1,,,TCGA-OL-A6VO-01,TCGA-OL-A6VO-01A-12D-A33F-05,79E2C9D4-0FF5-43E0-B7CE-EF665A49853D,TCGA-OL-A6VO-01,,,,TCGA-OL-A6VO-01,,,5cb12edf-25a1-40f6-831a-5fb1f56676e1,,TCGA-OL-A6VO-01A-12D-A33D-01,TCGA-OL-A6VO-01,,5cb12edf-25a1-40f6-831a-5fb1f56676e1,TCGA-OL-A6VO-01A-12D-A33D-01,
tcga.ol.a6vq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A6VQ-01,600.0,0.0,days,,,,,,,,,,TCGA-OL-A6VQ,600.0,0.0,days,600.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,49.0,Right,,,TCGA-OL-A6VQ-F59366,TCGA-OL-A6VQ,TCGA-OL-A6VQ-01A,Negative,Positive,,,,Mastectomy NOS,Positive,Lumpectomy,,,,,-18151.0,278.0,,0.0,600.0,,,,,,,90-99%,,,2014-5-10,FEMALE,,,,,,,,1.05,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,110.0,NO,,Negative,NO,1.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf,A6VQ,TUMOR FREE,,,,,,NO,YES,10-19%,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2012.0,10fbe91f-3570-4cc4-9a86-ea660a86a806,10fbe91f-3570-4cc4-9a86-ea660a86a806,,,TCGA-OL-A6VQ-01,TCGA-OL-A6VQ-01A-12D-A41Q-05,EF77266B-ED91-4FDA-AA99-CCCFAA90E687,TCGA-OL-A6VQ-01,,,,TCGA-OL-A6VQ-01,,,10fbe91f-3570-4cc4-9a86-ea660a86a806,,TCGA-OL-A6VQ-01A-12D-A41E-01,TCGA-OL-A6VQ-01,,10fbe91f-3570-4cc4-9a86-ea660a86a806,TCGA-OL-A6VQ-01A-12D-A41E-01,
tcga.ol.a6vr,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A6VR-01,1220.0,0.0,days,,,,,,,,,,TCGA-OL-A6VR,1220.0,0.0,days,1220.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,48.0,Right,Sentinel lymph node biopsy plus axillary dissection,,TCGA-OL-A6VR-F59367,TCGA-OL-A6VR,TCGA-OL-A6VR-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-17702.0,869.0,,0.0,1220.0,,,,,,,30-39%,,,2014-5-10,FEMALE,,,,,,,,1.23,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,380.0,NO,Negative,Negative,NO,2.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,MX,N0,T1b,Stage IA,TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf,A6VR,TUMOR FREE,,,,,,NO,YES,90-99%,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2011.0,19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4,19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4,,,TCGA-OL-A6VR-01,TCGA-OL-A6VR-01A-32D-A33F-05,,TCGA-OL-A6VR-01,,,,TCGA-OL-A6VR-01,,,19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4,,TCGA-OL-A6VR-01A-32D-A33D-01,TCGA-OL-A6VR-01,,19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4,TCGA-OL-A6VR-01A-32D-A33D-01,
tcga.ol.a97c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-OL-A97C-01,271.0,0.0,days,,,,,,,,,,TCGA-OL-A97C,271.0,0.0,days,271.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Left,,,TCGA-OL-A97C-F66330,TCGA-OL-A97C,TCGA-OL-A97C-01A,,Negative,,,,,Negative,Simple Mastectomy,,,,,-24735.0,216.0,,0.0,271.0,,,,,,,,,,2014-10-31,FEMALE,,,,,,,,,,"Other, specify",,No,,C50.9,9020/3,C50.9,,YES,,Fine needle aspiration biopsy,410.0,NO,,Negative,NO,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf,A97C,TUMOR FREE,,,,,,,YES,,,NO,Primary Tumor,1,,7th,,NO,YES,OL,Breast,A,LIVING,2013.0,590ae2bc-c076-4547-97dc-e2c8a0d396a6,590ae2bc-c076-4547-97dc-e2c8a0d396a6,,,TCGA-OL-A97C-01,TCGA-OL-A97C-01A-32D-A41Q-05,,TCGA-OL-A97C-01,,,,TCGA-OL-A97C-01,,,590ae2bc-c076-4547-97dc-e2c8a0d396a6,,TCGA-OL-A97C-01A-32D-A41E-01,TCGA-OL-A97C-01,,590ae2bc-c076-4547-97dc-e2c8a0d396a6,TCGA-OL-A97C-01A-32D-A41E-01,
tcga.pe.a5dc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-PE-A5DC-01,1430.0,1.0,days,,,,,,,,,,TCGA-PE-A5DC,1430.0,0.0,days,1430.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,72.0,Right Upper Inner Quadrant,,,,TCGA-PE-A5DC,TCGA-PE-A5DC-01A,,Positive,,,,,Positive,,,,,,-26514.0,2858.0,1430.0,0.0,,,,,,,,,,,2013-4-30,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,,350.0,NO,Positive,,,31.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf,A5DC,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,,6th,,NO,YES,PE,Breast,A,DECEASED,2005.0,05a8e240-5384-4a03-abeb-7ef3697c946d,05a8e240-5384-4a03-abeb-7ef3697c946d,,,TCGA-PE-A5DC-01,TCGA-PE-A5DC-01A-12D-A27Y-05,bf2669ec-ff95-4bbd-9d78-451fd90ba389,TCGA-PE-A5DC-01,TCGA-PE-A5DC-01A-12D-A27P-09,,,TCGA-PE-A5DC-01,,,05a8e240-5384-4a03-abeb-7ef3697c946d,,TCGA-PE-A5DC-01A-12D-A27O-01,TCGA-PE-A5DC-01,,05a8e240-5384-4a03-abeb-7ef3697c946d,TCGA-PE-A5DC-01A-12D-A27O-01,
tcga.pe.a5dd,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-PE-A5DD-01,1953.0,0.0,days,,,,,,,,,,TCGA-PE-A5DD,1953.0,0.0,days,1953.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right Lower Inner Quadrant,,,TCGA-PE-A5DD-F66361,TCGA-PE-A5DD,TCGA-PE-A5DD-01A,,Positive,,,,,Negative,Other,,,,,-23686.0,2411.0,,0.0,1953.0,,,,,,,,,,2014-10-13,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Incisional Biopsy,270.0,NO,Positive,Positive,YES,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf,A5DD,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Reexc of biopsy site for gross/micro residual disease,6th,,NO,YES,PE,Breast,A,LIVING,2006.0,38adc5a4-bf82-4a06-a179-e84dd42593da,38adc5a4-bf82-4a06-a179-e84dd42593da,,,TCGA-PE-A5DD-01,TCGA-PE-A5DD-01A-12D-A27Y-05,9e583b42-e1d2-4055-bf6d-eb6122474edf,TCGA-PE-A5DD-01,TCGA-PE-A5DD-01A-12D-A27P-09,,,TCGA-PE-A5DD-01,,,38adc5a4-bf82-4a06-a179-e84dd42593da,,TCGA-PE-A5DD-01A-12D-A27O-01,TCGA-PE-A5DD-01,,38adc5a4-bf82-4a06-a179-e84dd42593da,TCGA-PE-A5DD-01A-12D-A27O-01,
tcga.pe.a5de,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-PE-A5DE-01,2645.0,0.0,days,,,,,,,,,,TCGA-PE-A5DE,2645.0,0.0,days,2645.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,41.0,Left,,,TCGA-PE-A5DE-F66373,TCGA-PE-A5DE,TCGA-PE-A5DE-01A,,Positive,,,,,Positive,Other,,,,,-15216.0,2066.0,,0.0,2645.0,,,,,,,,,,2014-10-13,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,190.0,NO,Negative,,NO,1.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf,A5DE,TUMOR FREE,,,,,,YES,YES,,,YES,Primary Tumor,1,Partial Mastectomy,6th,,NO,YES,PE,Breast,A,LIVING,2007.0,041c71a0-06d5-44a5-8930-7f1dd2a638d1,041c71a0-06d5-44a5-8930-7f1dd2a638d1,,,TCGA-PE-A5DE-01,TCGA-PE-A5DE-01A-11D-A27Y-05,9a364ab7-d541-4771-bf12-11b8628cd9f1,TCGA-PE-A5DE-01,TCGA-PE-A5DE-01A-11D-A27P-09,,,TCGA-PE-A5DE-01,,,041c71a0-06d5-44a5-8930-7f1dd2a638d1,,TCGA-PE-A5DE-01A-11D-A27O-01,TCGA-PE-A5DE-01,,041c71a0-06d5-44a5-8930-7f1dd2a638d1,TCGA-PE-A5DE-01A-11D-A27O-01,
tcga.pl.a8lv,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TCGA-PL-A8LV-01,,,days,,,,,,,,,,TCGA-PL-A8LV,,,days,,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,54.0,Right|Right Upper Outer Quadrant,No axillary staging,,TCGA-PL-A8LV-F64849,TCGA-PL-A8LV,TCGA-PL-A8LV-01A,,,,,,,,,,,,,-19746.0,240.0,,0.0,-7.0,,,,,,,,,,2014-10-17,FEMALE,,,,,,,,,,Medullary Carcinoma,,No,,C50.9,8510/3,C50.9,,YES,,Excisional Biopsy,840.0,NO,,,YES,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,False,No,M0,N0,T4,Stage IIIB,TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf,A8LV,WITH TUMOR,,,,,,,NO,,,NO,Primary Tumor,1,,7th,,YES,NO,PL,Breast,A,LIVING,2013.0,34f3d207-0bfe-4699-b01b-d145942ba488,34f3d207-0bfe-4699-b01b-d145942ba488,,,TCGA-PL-A8LV-01,TCGA-PL-A8LV-01A-21D-A41Q-05,E260A9A0-230C-482C-A3E6-9A4DB6ECD90F,TCGA-PL-A8LV-01,,,,TCGA-PL-A8LV-01,,,34f3d207-0bfe-4699-b01b-d145942ba488,,TCGA-PL-A8LV-01A-21D-A41E-01,TCGA-PL-A8LV-01,,34f3d207-0bfe-4699-b01b-d145942ba488,TCGA-PL-A8LV-01A-21D-A41E-01,
tcga.pl.a8lx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-PL-A8LX-01,5.0,0.0,days,,,,,,,,,,TCGA-PL-A8LX,,,days,5.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,35.0,Left|Left Upper Outer Quadrant,,,TCGA-PL-A8LX-F64852,TCGA-PL-A8LX,TCGA-PL-A8LX-01A,,,,,,,,,,,,,-12840.0,74.0,,0.0,5.0,,,,,,,,,,2014-10-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,540.0,NO,,,YES,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,Bone|Liver,,,,,,,,,,,,,,False,No,M1,N1a,T4,Stage IV,TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf,A8LX,WITH TUMOR,,,,,,NO,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,PL,Breast,A,LIVING,2013.0,19cadb60-b213-4fd3-b5ad-d2b49000b6a3,19cadb60-b213-4fd3-b5ad-d2b49000b6a3,,,TCGA-PL-A8LX-01,TCGA-PL-A8LX-01A-11D-A41Q-05,22B100C7-397E-4940-8A06-94FA7D3F46DC,TCGA-PL-A8LX-01,,,,TCGA-PL-A8LX-01,,,19cadb60-b213-4fd3-b5ad-d2b49000b6a3,,TCGA-PL-A8LX-01A-11D-A41E-01,TCGA-PL-A8LX-01,,19cadb60-b213-4fd3-b5ad-d2b49000b6a3,TCGA-PL-A8LX-01A-11D-A41E-01,
tcga.pl.a8ly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-PL-A8LY-01,8.0,0.0,days,,,,,,,,,,TCGA-PL-A8LY,8.0,0.0,days,8.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,30.0,Right|Right Upper Outer Quadrant,,,TCGA-PL-A8LY-F64851,TCGA-PL-A8LY,TCGA-PL-A8LY-01A,,,,,,,,,,,,,-11199.0,129.0,,0.0,8.0,,,,,,,,,,2014-10-17,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,350.0,NO,,,YES,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,False,No,M0,N0,T3,Stage IIB,TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf,A8LY,WITH TUMOR,,,,,,NO,NO,,,NO,Primary Tumor,1,,7th,,YES,NO,PL,Breast,A,LIVING,2013.0,2ca5942e-dcbf-46f1-8427-1ea7216dc559,2ca5942e-dcbf-46f1-8427-1ea7216dc559,,,TCGA-PL-A8LY-01,TCGA-PL-A8LY-01A-11D-A41Q-05,1133DAAA-33B9-4DA6-B84C-F1C7B576AB64,TCGA-PL-A8LY-01,,,,TCGA-PL-A8LY-01,,,2ca5942e-dcbf-46f1-8427-1ea7216dc559,,TCGA-PL-A8LY-01A-11D-A41E-01,TCGA-PL-A8LY-01,,2ca5942e-dcbf-46f1-8427-1ea7216dc559,TCGA-PL-A8LY-01A-11D-A41E-01,
tcga.pl.a8lz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-PL-A8LZ-01,302.0,0.0,days,,,,,,,,,,TCGA-PL-A8LZ,302.0,0.0,days,302.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,29.0,Left|Left Upper Outer Quadrant,,,TCGA-PL-A8LZ-F64850,TCGA-PL-A8LZ,,,,,,,,,,,,,,-10869.0,,,0.0,302.0,,,,,,,,,,2014-9-15,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Excisional Biopsy,,,,,NO,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,,,,No,M0,N2,T4b,Stage IIIB,,A8LZ,TUMOR FREE,,,,,,YES,,,,NO,Primary Tumor,1,,7th,,YES,NO,PL,Breast,,LIVING,2013.0,de01d9b6-e29d-495e-815a-c7d2a7c15af3,de01d9b6-e29d-495e-815a-c7d2a7c15af3,,,TCGA-PL-A8LZ-01,TCGA-PL-A8LZ-01A-31D-A36K-05,,TCGA-PL-A8LZ-01,,,,TCGA-PL-A8LZ-01,,,de01d9b6-e29d-495e-815a-c7d2a7c15af3,,TCGA-PL-A8LZ-01A-31D-A36I-01,TCGA-PL-A8LZ-01,,de01d9b6-e29d-495e-815a-c7d2a7c15af3,TCGA-PL-A8LZ-01A-31D-A36I-01,
tcga.s3.a6zf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-A6ZF-01,572.0,0.0,days,,,,,,,,,,TCGA-S3-A6ZF,572.0,0.0,days,572.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right|Right Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-S3-A6ZF-F67764,TCGA-S3-A6ZF,TCGA-S3-A6ZF-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-23650.0,107.0,,0.0,572.0,,,,,,CAP scoring guideline 2010,90-99%,39,,2014-11-11,FEMALE,,CAP scoring guideline 2010,50-59%,,2+,20.0,60,1.5,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,1350.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf,A6ZF,TUMOR FREE,CAP scoring guideline 2010,,,moderate,Moderate,YES,YES,40-49%,,NO,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,4d464cde-4885-4b17-9e02-23be26be0540,4d464cde-4885-4b17-9e02-23be26be0540,,,TCGA-S3-A6ZF-01,TCGA-S3-A6ZF-01A-32D-A32T-05,,TCGA-S3-A6ZF-01,,,,TCGA-S3-A6ZF-01,,,4d464cde-4885-4b17-9e02-23be26be0540,,TCGA-S3-A6ZF-01A-32D-A32H-01,TCGA-S3-A6ZF-01,,4d464cde-4885-4b17-9e02-23be26be0540,TCGA-S3-A6ZF-01A-32D-A32H-01,
tcga.s3.a6zg,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-A6ZG-01,562.0,0.0,days,,,,,,,,,,TCGA-S3-A6ZG,562.0,0.0,days,562.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,71.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,,TCGA-S3-A6ZG-F70438,TCGA-S3-A6ZG,TCGA-S3-A6ZG-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Lumpectomy,,YES,,,-26141.0,102.0,,0.0,562.0,,,,,,CAP scoring guideline 2010,90-99%,,,2015-2-26,FEMALE,,CAP scoring guidelines 2010,<10%,,,,,,,Mixed Histology (please specify),Invasive mixed ductal and lobular carcinoma,No,,C50.9,8520/3,C50.9,,YES,,Excisional Biopsy,980.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,0.0,False,No,M0,N1,T2,Stage IIB,TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf,A6ZG,TUMOR FREE,CAP scoring guideline 2010,,,Moderate,Moderate,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,0967df37-66ae-4ab3-a1fd-e196d4bc9995,0967df37-66ae-4ab3-a1fd-e196d4bc9995,,,TCGA-S3-A6ZG-01,TCGA-S3-A6ZG-01A-22D-A32T-05,CA211F7F-3EF6-4AC7-9C51-321C035AA4AF,TCGA-S3-A6ZG-01,,,,TCGA-S3-A6ZG-01,,,0967df37-66ae-4ab3-a1fd-e196d4bc9995,,TCGA-S3-A6ZG-01A-22D-A32H-01,TCGA-S3-A6ZG-01,,0967df37-66ae-4ab3-a1fd-e196d4bc9995,TCGA-S3-A6ZG-01A-22D-A32H-01,
tcga.s3.a6zh,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-A6ZH-01,641.0,0.0,days,,,,,,,,,,TCGA-S3-A6ZH,641.0,0.0,days,641.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,29.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-S3-A6ZH-F68306,TCGA-S3-A6ZH,TCGA-S3-A6ZH-01A,,Positive,3 Point Scale,,3 Point Scale,,Positive,Simple Mastectomy,,NO,,,-10832.0,158.0,,0.0,641.0,,,,,,,90-99%,69,,2014-11-14,FEMALE,,CAP scoring guideline 2010,,CAP scoring guideline 2010,2+,20.0,79,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,580.0,NO,Equivocal,Negative,NO,21.0,Negative,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,14.0,0.0,False,No,MX,N3a,T3,Stage IIIC,TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf,A6ZH,TUMOR FREE,CAP scoring guideline 2010,,,Strong,Strong,YES,YES,80-89%,,YES,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,4cb51871-a26f-467e-8742-bb7c09b26ed2,4cb51871-a26f-467e-8742-bb7c09b26ed2,,,TCGA-S3-A6ZH-01,TCGA-S3-A6ZH-01A-22D-A32T-05,45E0455A-5D80-4D40-ACE5-F70316204288,TCGA-S3-A6ZH-01,,,,TCGA-S3-A6ZH-01,,,4cb51871-a26f-467e-8742-bb7c09b26ed2,,TCGA-S3-A6ZH-01A-22D-A32H-01,TCGA-S3-A6ZH-01,,4cb51871-a26f-467e-8742-bb7c09b26ed2,TCGA-S3-A6ZH-01A-22D-A32H-01,
tcga.s3.aa0z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA0Z-01,629.0,0.0,days,,,,,,,,,,TCGA-S3-AA0Z,629.0,0.0,days,629.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-S3-AA0Z-F70168,TCGA-S3-AA0Z,TCGA-S3-AA0Z-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Modified Radical Mastectomy,,YES,,,-23314.0,204.0,,0.0,629.0,,,,,,CAP scoring guideline 2010,90-99%,33,,2015-2-26,FEMALE,,CAP scoring guideline 2010,10-19%,CAP scoring guideline 2010,1+,20.0,42,1.3,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,330.0,NO,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf,AA0Z,TUMOR FREE,CAP scoring guideline 2010,,,,moderate,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,cfe44709-9e63-4dd4-9778-80176be7fbd9,cfe44709-9e63-4dd4-9778-80176be7fbd9,,,TCGA-S3-AA0Z-01,TCGA-S3-AA0Z-01A-11D-A41Q-05,A46027BA-DFAC-427A-89E3-51088763C0A0,TCGA-S3-AA0Z-01,,,,TCGA-S3-AA0Z-01,,,cfe44709-9e63-4dd4-9778-80176be7fbd9,,TCGA-S3-AA0Z-01A-11D-A41E-01,TCGA-S3-AA0Z-01,,cfe44709-9e63-4dd4-9778-80176be7fbd9,TCGA-S3-AA0Z-01A-11D-A41E-01,
tcga.s3.aa10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA10-01,586.0,0.0,days,,,,,,,,,,TCGA-S3-AA10,586.0,0.0,days,586.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,65.0,Right|Right Upper Outer Quadrant,Axillary lymph node dissection alone,,TCGA-S3-AA10-F70441,TCGA-S3-AA10,TCGA-S3-AA10-01A,,Negative,3 Point Scale,,3 Point Scale,,Negative,Simple Mastectomy,,NO,,,-24075.0,168.0,,0.0,586.0,,,,,,CAP scoring guideline 2010,,,,2015-2-26,FEMALE,,CAP scoring guideline 2010,,,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Fine needle aspiration biopsy,410.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf,AA10,TUMOR FREE,CAP scoring guideline 2010,,,,,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,4c80c4a1-7e99-4f9e-b32c-898ae20206c5,4c80c4a1-7e99-4f9e-b32c-898ae20206c5,,,TCGA-S3-AA10-01,TCGA-S3-AA10-01A-21D-A41Q-05,F3DF6E4D-CA53-4DEA-B48D-652306B60C77,TCGA-S3-AA10-01,,,,TCGA-S3-AA10-01,,,4c80c4a1-7e99-4f9e-b32c-898ae20206c5,,TCGA-S3-AA10-01A-21D-A41E-01,TCGA-S3-AA10-01,,4c80c4a1-7e99-4f9e-b32c-898ae20206c5,TCGA-S3-AA10-01A-21D-A41E-01,
tcga.s3.aa11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA11-01,421.0,0.0,days,,,,,,,,,,TCGA-S3-AA11,421.0,0.0,days,421.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,67.0,Right,Sentinel node biopsy alone,,TCGA-S3-AA11-F67563,TCGA-S3-AA11,TCGA-S3-AA11-01A,,Positive,4 Point Scale,2+,3 Point Scale,,Positive,Lumpectomy,,YES,,,-24813.0,148.0,,0.0,421.0,,,,,,CAP scoring guideline 2010,90-99%,40,,2014-11-7,FEMALE,,CAP scoring guideline 2010,<10%,CAP scoring guideline 2010,2+,20.0,59,1.5,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,280.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf,AA11,TUMOR FREE,CAP scoring guideline 2010,,,,,YES,YES,60-69%,,YES,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,11785b0e-04c6-4cf5-80c6-2c4ffcb206f6,11785b0e-04c6-4cf5-80c6-2c4ffcb206f6,,,TCGA-S3-AA11-01,TCGA-S3-AA11-01A-31D-A41Q-05,424E9C41-A1FA-4342-AFA8-01DA15FD41E7,TCGA-S3-AA11-01,,,,TCGA-S3-AA11-01,,,11785b0e-04c6-4cf5-80c6-2c4ffcb206f6,,TCGA-S3-AA11-01A-31D-A41E-01,TCGA-S3-AA11-01,,11785b0e-04c6-4cf5-80c6-2c4ffcb206f6,TCGA-S3-AA11-01A-31D-A41E-01,
tcga.s3.aa12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA12-01,574.0,0.0,days,,,,,,,,,,TCGA-S3-AA12,574.0,0.0,days,574.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,82.0,Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-S3-AA12-F70442,TCGA-S3-AA12,TCGA-S3-AA12-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Negative,Simple Mastectomy,,NO,,,-30101.0,156.0,,0.0,574.0,,,,,,CAP SCORING GUIDELINE 2010,90-99%,,,2015-2-26,FEMALE,,CAP SCORING GUIDELINE 2010,,CAP SCORING GUIDELINE 2007,1+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,2+,YES,,Core needle biopsy,2190.0,NO,Negative,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,"Lung|Other, specify",left adrenal gland,,,,,,,,,,NO,2.0,0.0,True,Yes,MX,N1a,T3,Stage IIIA,TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf,AA12,TUMOR FREE,CAP SCORING GUIDELINE 2010,,,MODERATE,MODERATE,YES,YES,,,NO,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,a18a4d65-5383-4c29-ac03-959f8b9cb37d,a18a4d65-5383-4c29-ac03-959f8b9cb37d,,,TCGA-S3-AA12-01,TCGA-S3-AA12-01A-11D-A41Q-05,3761BFE6-9A5D-41AB-AA78-DFF11DA7B9B3,TCGA-S3-AA12-01,,,,TCGA-S3-AA12-01,,,a18a4d65-5383-4c29-ac03-959f8b9cb37d,,TCGA-S3-AA12-01A-11D-A41E-01,TCGA-S3-AA12-01,,a18a4d65-5383-4c29-ac03-959f8b9cb37d,TCGA-S3-AA12-01A-11D-A41E-01,
tcga.s3.aa14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA14-01,529.0,0.0,days,,,,,,,,,,TCGA-S3-AA14,529.0,0.0,days,529.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,47.0,Right,Sentinel node biopsy alone,,TCGA-S3-AA14-F70444,TCGA-S3-AA14,TCGA-S3-AA14-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Other,,YES,,,-17352.0,127.0,,0.0,529.0,,,,,,CAP SCORING GUIDELINE 2010,70-79%,,,2015-2-26,FEMALE,,CAP SCORING GUIDELINE 2010,70-79%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,290.0,NO,Positive,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,3.0,True,No,cM0 (i+),N0 (i+),T1,Stage I,TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf,AA14,TUMOR FREE,CAP SCORING GUIDELINE 2010,,,,,YES,YES,70-79%,,YES,Primary Tumor,1,EXCISION WITH NEEDLE WIRE LOCALIZATION,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,eb8b259a-b2b3-4fb1-b9d3-b41480642da7,eb8b259a-b2b3-4fb1-b9d3-b41480642da7,,,TCGA-S3-AA14-01,TCGA-S3-AA14-01A-11D-A41Q-05,0F0662DF-E193-4F71-B2A3-FBE544DA5869,TCGA-S3-AA14-01,,,,TCGA-S3-AA14-01,,,eb8b259a-b2b3-4fb1-b9d3-b41480642da7,,TCGA-S3-AA14-01A-11D-A41E-01,TCGA-S3-AA14-01,,eb8b259a-b2b3-4fb1-b9d3-b41480642da7,TCGA-S3-AA14-01A-11D-A41E-01,
tcga.s3.aa15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA15-01,525.0,0.0,days,,,,,,,,,,TCGA-S3-AA15,525.0,0.0,days,525.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,51.0,Right|Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-S3-AA15-F72098,TCGA-S3-AA15,TCGA-S3-AA15-01A,,Negative,,,3 Point Scale,,Negative,Simple Mastectomy,,YES,,,-18659.0,93.0,,0.0,525.0,,,,,,CAP SCORING GUIDELINE 2010,,,,2015-4-10,FEMALE,,CAP SCORING GUIDELINE 2010,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,990.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,2.0,0.0,True,No,cM0 (i+),N1a,T2,Stage IIB,TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf,AA15,TUMOR FREE,CAP SCORING GUIDELINE 2010,,,,,YES,YES,,,YES,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,181e9c9f-7dbd-4f3a-8298-12797c717e1f,181e9c9f-7dbd-4f3a-8298-12797c717e1f,,,TCGA-S3-AA15-01,TCGA-S3-AA15-01A-11D-A41Q-05,A6D6E30B-1F8A-4B8B-B81C-5E016CBC4561,TCGA-S3-AA15-01,,,,TCGA-S3-AA15-01,,,181e9c9f-7dbd-4f3a-8298-12797c717e1f,,TCGA-S3-AA15-01A-11D-A41E-01,TCGA-S3-AA15-01,,181e9c9f-7dbd-4f3a-8298-12797c717e1f,TCGA-S3-AA15-01A-11D-A41E-01,
tcga.s3.aa17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-S3-AA17-01,424.0,0.0,days,,,,,,,,,,TCGA-S3-AA17,424.0,0.0,days,424.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,64.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,,TCGA-S3-AA17-F67708,TCGA-S3-AA17,TCGA-S3-AA17-01A,,Positive,3 Point Scale,2+,3 Point Scale,,Positive,Simple Mastectomy,,YES,,,-23642.0,92.0,,0.0,424.0,,,,,,CAP SCORING GUIDELINE 2010,90-99%,35,,2014-11-11,FEMALE,,CAP SCORING GUIDELINE 2010,,CAP SCORING GUIDELINE 2010,2+,20.0,61,1.7,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,520.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,1.0,True,Yes,cM0 (i+),N1mi,T2,Stage IIB,TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf,AA17,TUMOR FREE,CAP SCORING GUIDELINE 2010,,,MODERATE,STRONG,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,YES,NO,S3,Breast,A,LIVING,2013.0,5e032694-2d7f-4e11-8800-0451ff71e5fe,5e032694-2d7f-4e11-8800-0451ff71e5fe,,,TCGA-S3-AA17-01,TCGA-S3-AA17-01A-11D-A41Q-05,6D0969F0-27F9-4FF0-B943-F4F4510F917D,TCGA-S3-AA17-01,,,,TCGA-S3-AA17-01,,,5e032694-2d7f-4e11-8800-0451ff71e5fe,,TCGA-S3-AA17-01A-11D-A41E-01,TCGA-S3-AA17-01,,5e032694-2d7f-4e11-8800-0451ff71e5fe,TCGA-S3-AA17-01A-11D-A41E-01,
tcga.ul.aaz6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-UL-AAZ6-01,518.0,0.0,days,,,,,,,,,,TCGA-UL-AAZ6,518.0,0.0,days,518.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,73.0,Right,,,TCGA-UL-AAZ6-F69329,TCGA-UL-AAZ6,TCGA-UL-AAZ6-01A,,Positive,3 Point Scale,,,,Positive,,,,,,-26999.0,187.0,,0.0,518.0,,,,,,,90-99%,,,2015-1-5,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,,170.0,NO,Positive,,NO,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Positive,3+,,Positive,90-99%,,50-59%,,3 Point Scale,3+,1+,,,<10%,,Negative,,,,,,,3 Point Scale,,,,,NO,,,True,No,MX,N0,T2,Stage IIA,TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf,AAZ6,TUMOR FREE,,,,,,YES,,<10%,,NO,Primary Tumor,1,,7th,,YES,NO,UL,Breast,A,LIVING,2013.0,5a6b1292-431d-4057-912f-6c8b8f12aed8,5a6b1292-431d-4057-912f-6c8b8f12aed8,,,TCGA-UL-AAZ6-01,TCGA-UL-AAZ6-01A-11D-A41Q-05,2102D1F5-40E4-41EA-A564-27AABF047BF9,TCGA-UL-AAZ6-01,,,,TCGA-UL-AAZ6-01,,,5a6b1292-431d-4057-912f-6c8b8f12aed8,,TCGA-UL-AAZ6-01A-11D-A41E-01,TCGA-UL-AAZ6-01,,5a6b1292-431d-4057-912f-6c8b8f12aed8,TCGA-UL-AAZ6-01A-11D-A41E-01,
tcga.uu.a93s,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,TCGA-UU-A93S-01,116.0,1.0,days,,,,,,,,,,TCGA-UU-A93S,116.0,0.0,days,116.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,63.0,Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant,No axillary staging,,,TCGA-UU-A93S,TCGA-UU-A93S-01A,,Negative,,,,,Negative,Modified Radical Mastectomy,,YES,,,-23278.0,22.0,116.0,0.0,,,,,,,,,,,2014-11-11,FEMALE,,,90-99%,,3+,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Core needle biopsy,980.0,NO,Positive,,,,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,Bone|Liver,,,,,,,,,,,NO,,,True,No,M1,N3b,T4d,Stage IV,TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf,A93S,WITH TUMOR,,,,,,NO,NO,,,NO,Primary Tumor,1,,7th,,YES,NO,UU,Breast,A,DECEASED,2013.0,24ef9702-a1e5-4276-abb2-87088861d471,24ef9702-a1e5-4276-abb2-87088861d471,,,TCGA-UU-A93S-01,TCGA-UU-A93S-01A-21D-A41Q-05,49836FDA-BD22-48FC-A520-BC9CA5757C04,TCGA-UU-A93S-01,,,,TCGA-UU-A93S-01,,,24ef9702-a1e5-4276-abb2-87088861d471,,TCGA-UU-A93S-01A-21D-A41E-01,TCGA-UU-A93S-01,,24ef9702-a1e5-4276-abb2-87088861d471,TCGA-UU-A93S-01A-21D-A41E-01,
tcga.v7.a7hq,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-V7-A7HQ-01,2033.0,0.0,days,,,,,,,,,,TCGA-V7-A7HQ,2033.0,0.0,days,2033.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,75.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-V7-A7HQ-F71970,TCGA-V7-A7HQ,,Negative,Positive,3 Point Scale,3+,3 Point Scale,Other,Positive,Modified Radical Mastectomy,Additional resection/ margins (taken after first margin positive),NO,,,-27684.0,,,0.0,2033.0,,,,,,,60-69%,1.0,,2015-3-31,FEMALE,,,,,,20.0,1.1,1.1,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,,YES,,Tumor resection,,,,Negative,NO,18.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,,,No,M0,N2a,T1c,Stage IIIA,,A7HQ,TUMOR FREE,,,,,Moderate to strong,YES,YES,80-89%,,YES,Primary Tumor,1,,6th,,NO,YES,V7,Breast,,LIVING,2009.0,d42c079f-31a6-42cd-b02a-ea951b8d15a9,d42c079f-31a6-42cd-b02a-ea951b8d15a9,,,TCGA-V7-A7HQ-01,TCGA-V7-A7HQ-01A-11D-A33F-05,,TCGA-V7-A7HQ-01,,,,TCGA-V7-A7HQ-01,,,d42c079f-31a6-42cd-b02a-ea951b8d15a9,,TCGA-V7-A7HQ-01A-11D-A33D-01,TCGA-V7-A7HQ-01,,d42c079f-31a6-42cd-b02a-ea951b8d15a9,TCGA-V7-A7HQ-01A-11D-A33D-01,
tcga.w8.a86g,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-W8-A86G-01,347.0,0.0,days,,,,,,,,,,TCGA-W8-A86G,347.0,0.0,days,347.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,66.0,Left|Left Lower Inner Quadrant,Sentinel node biopsy alone,,TCGA-W8-A86G-F65574,TCGA-W8-A86G,TCGA-W8-A86G-01A,Negative,Positive,3 Point Scale,1+,3 Point Scale,Other,Positive,Lumpectomy,Mastectomy,YES,,,-24125.0,126.0,,0.0,347.0,,,,,,,90-99%,,,2014-9-25,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,1+,YES,,Core needle biopsy,210.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,False,Yes,MX,N0 (i-),T2a,Stage IIA,TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf,A86G,TUMOR FREE,,,,,,YES,YES,70-79%,,NO,Primary Tumor,1,,7th,,YES,NO,W8,Breast,A,LIVING,2013.0,37106eb9-90ee-4468-aded-0709fa4bba47,37106eb9-90ee-4468-aded-0709fa4bba47,,,TCGA-W8-A86G-01,TCGA-W8-A86G-01A-21D-A36K-05,3927BD5E-5BB3-45A3-886F-639895BA69F8,TCGA-W8-A86G-01,,,,TCGA-W8-A86G-01,,,37106eb9-90ee-4468-aded-0709fa4bba47,,TCGA-W8-A86G-01A-21D-A36I-01,TCGA-W8-A86G-01,,37106eb9-90ee-4468-aded-0709fa4bba47,TCGA-W8-A86G-01A-21D-A36I-01,
tcga.wt.ab41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-WT-AB41-01,1611.0,0.0,days,,,,,,,,,,TCGA-WT-AB41,1611.0,0.0,days,1611.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,55.0,Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,No axillary staging,,TCGA-WT-AB41-F66639,TCGA-WT-AB41,TCGA-WT-AB41-01A,,Positive,3 Point Scale,1+,3 Point Scale,,Positive,Modified Radical Mastectomy,,,,,,1415.0,,0.0,1611.0,,,,,,,90-99%,,,2014-10-21,FEMALE,,,,,,,,,,Infiltrating Ductal Carcinoma,,No,,C50.9,8500/3,C50.9,3+,YES,,Core needle biopsy,110.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,1.0,,False,Yes,MX,N1mi,T2,Stage IIB,TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf,AB41,TUMOR FREE,,,,,,YES,YES,<10%,,NO,Primary Tumor,1,,7th,,NO,YES,WT,Breast,A,LIVING,2010.0,a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa,a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa,,,TCGA-WT-AB41-01,TCGA-WT-AB41-01A-11D-A41Q-05,3A31AEBF-2CC3-4604-8AF6-84DB45550587,TCGA-WT-AB41-01,,,,TCGA-WT-AB41-01,,,a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa,,TCGA-WT-AB41-01A-11D-A41E-01,TCGA-WT-AB41-01,,a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa,TCGA-WT-AB41-01A-11D-A41E-01,
tcga.wt.ab44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-WT-AB44-01,883.0,0.0,days,,,,,,,,,,TCGA-WT-AB44,883.0,0.0,days,883.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,77.0,Left,No axillary staging,,TCGA-WT-AB44-F66640,TCGA-WT-AB44,TCGA-WT-AB44-01A,,Positive,3 Point Scale,3+,3 Point Scale,,Positive,Lumpectomy,,,,,,656.0,,0.0,883.0,,,,,,,90-99%,,,2014-10-21,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,3+,YES,,Core needle biopsy,20.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf,AB44,TUMOR FREE,,,,,,YES,YES,90-99%,,YES,Primary Tumor,1,,7th,,NO,YES,WT,Breast,A,LIVING,2012.0,77ea5b95-f8df-4fae-b271-182680c4a62a,77ea5b95-f8df-4fae-b271-182680c4a62a,,,TCGA-WT-AB44-01,TCGA-WT-AB44-01A-11D-A41Q-05,,TCGA-WT-AB44-01,,,,TCGA-WT-AB44-01,,,77ea5b95-f8df-4fae-b271-182680c4a62a,,TCGA-WT-AB44-01A-11D-A41E-01,TCGA-WT-AB44-01,,77ea5b95-f8df-4fae-b271-182680c4a62a,TCGA-WT-AB44-01A-11D-A41E-01,
tcga.xx.a899,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-XX-A899-01,467.0,0.0,days,,,,,,,,,,TCGA-XX-A899,467.0,0.0,days,467.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-XX-A899-F67626,TCGA-XX-A899,TCGA-XX-A899-01A,,Positive,,,,,Positive,Modified Radical Mastectomy,,NO,,,-17022.0,181.0,,0.0,467.0,,,,,,,90-99%,,,2014-11-11,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,260.0,NO,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,5.0,0.0,False,No,MX,N2a,T1c,Stage IIIA,TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf,A899,TUMOR FREE,,,,strong,strong,YES,YES,70-79%,,YES,Primary Tumor,1,,7th,,NO,YES,XX,Breast,A,LIVING,2013.0,8e339298-3e3c-4b31-96a9-a842e973e583,8e339298-3e3c-4b31-96a9-a842e973e583,,,TCGA-XX-A899-01,TCGA-XX-A899-01A-11D-A36K-05,1D814A7B-DA34-4E53-B6C5-23A22F6B5F10,TCGA-XX-A899-01,,,,TCGA-XX-A899-01,,,8e339298-3e3c-4b31-96a9-a842e973e583,,TCGA-XX-A899-01A-11D-A36I-01,TCGA-XX-A899-01,,8e339298-3e3c-4b31-96a9-a842e973e583,TCGA-XX-A899-01A-11D-A36I-01,
tcga.xx.a89a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-XX-A89A-01,488.0,0.0,days,,,,,,,,,,TCGA-XX-A89A,488.0,0.0,days,488.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,68.0,Left Upper Outer Quadrant,,,TCGA-XX-A89A-F67425,TCGA-XX-A89A,TCGA-XX-A89A-01A,,Positive,,,,,Positive,Simple Mastectomy,,,,,-25000.0,174.0,,0.0,488.0,,,,,,,70-79%,,,2014-11-11,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,,YES,,Core needle biopsy,250.0,NO,Negative,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,,False,No,MX,N0,T3,Stage IIB,TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf,A89A,TUMOR FREE,,,,moderately to strongly,moderately to strongly,NO,YES,70-79%,,YES,Primary Tumor,1,,7th,,NO,YES,XX,Breast,A,LIVING,2013.0,501a70d8-3932-49c0-aa13-774756fb89e3,501a70d8-3932-49c0-aa13-774756fb89e3,,,TCGA-XX-A89A-01,TCGA-XX-A89A-01A-11D-A36K-05,,TCGA-XX-A89A-01,,,,TCGA-XX-A89A-01,,,501a70d8-3932-49c0-aa13-774756fb89e3,,TCGA-XX-A89A-01A-11D-A36I-01,TCGA-XX-A89A-01,,501a70d8-3932-49c0-aa13-774756fb89e3,TCGA-XX-A89A-01A-11D-A36I-01,
tcga.z7.a8r5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-Z7-A8R5-01,3287.0,0.0,days,,,,,,,,,,TCGA-Z7-A8R5,3287.0,1.0,days,3287.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,61.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-Z7-A8R5-F58763,TCGA-Z7-A8R5,TCGA-Z7-A8R5-01A,,Positive,4 Point Scale,1+,4 Point Scale,,Positive,Other,,YES,,,-22280.0,2928.0,,0.0,3287.0,,,3287,,,,,,,2014-7-9,FEMALE,,,,,,,,,,Infiltrating Lobular Carcinoma,,No,,C50.9,8520/3,C50.9,2+,YES,,Core needle biopsy,450.0,NO,Negative,,NO,5.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,,,,,,,,,,,,,,,,,,,Bone,Locoregional Recurrence,,,YES,3.0,3.0,True,Yes,MX,N1a,T3,Stage IIIA,TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf,A8R5,WITH TUMOR,,,,,,YES,YES,,,NO,Primary Tumor,1,Segmental Mastectomy,6th,,NO,YES,Z7,Breast,A,LIVING,2005.0,43c6d23b-2fcd-499e-82ef-10f15d8ede90,43c6d23b-2fcd-499e-82ef-10f15d8ede90,,,TCGA-Z7-A8R5-01,TCGA-Z7-A8R5-01A-42D-A41Q-05,049AE25E-31B6-4E0D-B67F-08B7034BF093,TCGA-Z7-A8R5-01,,,,TCGA-Z7-A8R5-01,,,43c6d23b-2fcd-499e-82ef-10f15d8ede90,,TCGA-Z7-A8R5-01A-42D-A41E-01,TCGA-Z7-A8R5-01,,43c6d23b-2fcd-499e-82ef-10f15d8ede90,TCGA-Z7-A8R5-01A-42D-A41E-01,
tcga.z7.a8r6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,TCGA-Z7-A8R6-01,3256.0,0.0,days,,,,,,,,,,TCGA-Z7-A8R6,3256.0,0.0,days,3256.0,days,TCGA Breast Cancer (BRCA),breast invasive carcinoma,Breast,,,,,46.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,,TCGA-Z7-A8R6-F58752,TCGA-Z7-A8R6,TCGA-Z7-A8R6-01A,,Positive,4 Point Scale,2+,4 Point Scale,,Positive,Lumpectomy,,YES,,,-16955.0,3020.0,,0.0,3256.0,,,,,,,,,,2014-7-9,FEMALE,,,,,1+,,,,,Infiltrating Lobular Carcinoma,,No,,C50.8,8022/3,C50.8,2+,YES,,Tumor resection,520.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,,,,,,,,,,,,,,,,,,,,,,NO,0.0,0.0,True,No,M0,N0,T1c,Stage I,TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf,A8R6,TUMOR FREE,,,,,,YES,YES,,,NO,Primary Tumor,1,,6th,,NO,YES,Z7,Breast,A,LIVING,2005.0,d8a45ca6-8f09-4949-8d55-13259b4826d2,d8a45ca6-8f09-4949-8d55-13259b4826d2,,,TCGA-Z7-A8R6-01,TCGA-Z7-A8R6-01A-11D-A41Q-05,DEEEA4DC-9DF5-4D60-92BF-01AEA22171DD,TCGA-Z7-A8R6-01,,,,TCGA-Z7-A8R6-01,,,d8a45ca6-8f09-4949-8d55-13259b4826d2,,TCGA-Z7-A8R6-01A-11D-A41E-01,TCGA-Z7-A8R6-01,,d8a45ca6-8f09-4949-8d55-13259b4826d2,TCGA-Z7-A8R6-01A-11D-A41E-01,
